code,description,last_updated
A1001007,Dressing for one wound,09-10-2025
A2001007,Dressing for two wounds,09-10-2025
A3001007,Dressing for three wounds,09-10-2025
A4001007,Dressing for four wounds,09-10-2025
A5001007,Dressing for five wounds,09-10-2025
A6001007,Dressing for six wounds,09-10-2025
A7001007,Dressing for seven wounds,09-10-2025
A8001007,Dressing for eight wounds,09-10-2025
A9001007,Dressing for nine or more wounds,09-10-2025
AA001007,Anesthesia services performed personally by anesthesiologist,09-10-2025
AB001007,Audiology service furnished personally by an audiologist without a,09-10-2025
AB002008,Physician/npp order for non-acute hearing assessment unrelated to,09-10-2025
AB003008,"Disequilibrium, or hearing aids, or examinations for the purpose of",09-10-2025
AB004008,"Prescribing, fitting, or changing hearing aids; service may be performed once",09-10-2025
AB005008,"Every 12 months, per beneficiary",09-10-2025
AD001007,Medical supervision by a physician: more than four concurrent anesthesia,09-10-2025
AD002008,Procedures,09-10-2025
AE001007,Registered dietician,09-10-2025
AF001007,Specialty physician,09-10-2025
AG001007,Primary physician,09-10-2025
AH001007,Clinical psychologist,09-10-2025
AI001007,Principal physician of record,09-10-2025
AJ001007,Clinical social worker,09-10-2025
AK001007,Non participating physician,09-10-2025
AM001007,"Physician, team member service",09-10-2025
AO001007,Alternate payment method declined by provider of service,09-10-2025
AP001007,Determination of refractive state was not performed in the course of diagnostic,09-10-2025
AP002008,Ophthalmological examination,09-10-2025
AQ001007,Physician providing a service in an unlisted health professional shortage area,09-10-2025
AQ002008,(hpsa),09-10-2025
AR001007,Physician provider services in a physician scarcity area,09-10-2025
AS001007,"Physician assistant, nurse practitioner, or clinical nurse specialist services",09-10-2025
AS002008,For assistant at surgery,09-10-2025
AT001007,"Acute treatment (this modifier should be used when reporting service 98940,",09-10-2025
AT002008,"98941, 98942)",09-10-2025
AU001007,"Item furnished in conjunction with a urological, ostomy, or tracheostomy supply",09-10-2025
AV001007,"Item furnished in conjunction with a prosthetic device, prosthetic or orthotic",09-10-2025
AW001007,Item furnished in conjunction with a surgical dressing,09-10-2025
AX001007,Item furnished in conjunction with dialysis services,09-10-2025
AY001007,Item or service furnished to an esrd patient that is not for the treatment of,09-10-2025
AY002008,Esrd,09-10-2025
AZ001007,Physician providing a service in a dental health professional shortage area for,09-10-2025
AZ002008,The purpose of an electronic health record incentive payment,09-10-2025
BA001007,Item furnished in conjunction with parenteral enteral nutrition (pen) services,09-10-2025
BL001007,Special acquisition of blood and blood products,09-10-2025
BO001007,"Orally administered nutrition, not by feeding tube",09-10-2025
BP001007,The beneficiary has been informed of the purchase and rental options and has,09-10-2025
BP002008,Elected to purchase the item,09-10-2025
BR001007,The beneficiary has been informed of the purchase and rental options and has,09-10-2025
BR002008,Elected to rent the item,09-10-2025
BU001007,The beneficiary has been informed of the purchase and rental options and after,09-10-2025
BU002008,30 days has not informed the supplier of his/her decision,09-10-2025
CA001007,Procedure payable only in the inpatient setting when performed emergently on an,09-10-2025
CA002008,Outpatient who expires prior to admission,09-10-2025
CB001007,Service ordered by a renal dialysis facility (rdf) physician as part of the,09-10-2025
CB002008,"Esrd beneficiary's dialysis benefit, is not part of the composite rate, and is",09-10-2025
CB003008,Separately reimbursable,09-10-2025
CC001007,Procedure code change (use 'cc' when the procedure code submitted was changed,09-10-2025
CC002008,Either for administrative reasons or because an incorrect code was filed),09-10-2025
CD001007,Amcc test has been ordered by an esrd facility or mcp physician that is part of,09-10-2025
CD002008,The composite rate and is not separately billable,09-10-2025
CE001007,Amcc test has been ordered by an esrd facility or mcp physician that is a,09-10-2025
CE002008,Composite rate test but is beyond the normal frequency covered under the rate,09-10-2025
CE003008,And is separately reimbursable based on medical necessity,09-10-2025
CF001007,Amcc test has been ordered by an esrd facility or mcp physician that is not,09-10-2025
CF002008,Part of the composite rate and is separately billable,09-10-2025
CG001007,Policy criteria applied,09-10-2025
CH001007,"0 percent impaired, limited or restricted",09-10-2025
CI001007,"At least 1 percent but less than 20 percent impaired, limited or restricted",09-10-2025
CJ001007,"At least 20 percent but less than 40 percent impaired, limited or restricted",09-10-2025
CK001007,"At least 40 percent but less than 60 percent impaired, limited or restricted",09-10-2025
CL001007,"At least 60 percent but less than 80 percent impaired, limited or restricted",09-10-2025
CM001007,"At least 80 percent but less than 100 percent impaired, limited or restricted",09-10-2025
CN001007,"100 percent impaired, limited or restricted",09-10-2025
CO001007,Outpatient occupational therapy services furnished in whole or in part by an,09-10-2025
CO002008,Occupational therapy assistant,09-10-2025
CP001007,Adjunctive service related to a procedure assigned to a comprehensive,09-10-2025
CP002008,"Ambulatory payment classification (c-apc) procedure, but reported on a",09-10-2025
CP003008,Different claim,09-10-2025
CQ001007,Outpatient physical therapy services furnished in whole or in part by a,09-10-2025
CQ002008,Physical therapist assistant,09-10-2025
CR001007,Catastrophe/disaster related,09-10-2025
CS001007,Cost-sharing waived for specified covid-19 testing-related services that result,09-10-2025
CS002008,In and order for or administration of a covid-19 test and/or used for,09-10-2025
CS003008,Cost-sharing waived preventive services furnished via telehealth in rural,09-10-2025
CS004008,Health clinics and federally qualified health centers during the covid-19,09-10-2025
CS005008,Public health emergency,09-10-2025
CT001007,Computed tomography services furnished using equipment that does not meet each,09-10-2025
CT002008,Of the attributes of the national electrical manufacturers association (nema),09-10-2025
CT003008,Xr-29-2013 standard,09-10-2025
DA001007,Oral health assessment by a licensed health professional other than a dentist,09-10-2025
E1001007,"Upper left, eyelid",09-10-2025
E2001007,"Lower left, eyelid",09-10-2025
E3001007,"Upper right, eyelid",09-10-2025
E4001007,"Lower right, eyelid",09-10-2025
EA001007,Erythropoietic stimulating agent (esa) administered to treat anemia due to,09-10-2025
EA002008,Anti-cancer chemotherapy,09-10-2025
EB001007,Erythropoietic stimulating agent (esa) administered to treat anemia due to,09-10-2025
EB002008,Anti-cancer radiotherapy,09-10-2025
EC001007,Erythropoietic stimulating agent (esa) administered to treat anemia not due to,09-10-2025
EC002008,Anti-cancer radiotherapy or anti-cancer chemotherapy,09-10-2025
ED001007,Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl),09-10-2025
ED002008,For 3 or more consecutive billing cycles immediately prior to and including the,09-10-2025
ED003008,Current cycle,09-10-2025
EE001007,Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded,09-10-2025
EE002008,13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and,09-10-2025
EE003008,Including the current cycle,09-10-2025
EJ001007,"Subsequent claims for a defined course of therapy, e.g., epo, sodium",09-10-2025
EJ002008,"Hyaluronate, infliximab",09-10-2025
EM001007,Emergency reserve supply (for esrd benefit only),09-10-2025
EP001007,Service provided as part of medicaid early periodic screening diagnosis and,09-10-2025
EP002008,Treatment (epsdt) program,09-10-2025
ER001007,"Items and services furnished by a provider-based, off-campus emergency",09-10-2025
ER002008,Department,09-10-2025
ET001007,Emergency services,09-10-2025
EX001007,Expatriate beneficiary,09-10-2025
EY001007,No physician or other licensed health care provider order for this item or,09-10-2025
EY002008,Service,09-10-2025
F1001007,"Left hand, second digit",09-10-2025
F2001007,"Left hand, third digit",09-10-2025
F3001007,"Left hand, fourth digit",09-10-2025
F4001007,"Left hand, fifth digit",09-10-2025
F5001007,"Right hand, thumb",09-10-2025
F6001007,"Right hand, second digit",09-10-2025
F7001007,"Right hand, third digit",09-10-2025
F8001007,"Right hand, fourth digit",09-10-2025
F9001007,"Right hand, fifth digit",09-10-2025
FA001007,"Left hand, thumb",09-10-2025
FB001007,"Item provided without cost to provider, supplier or practitioner, or full",09-10-2025
FB002008,"Credit received for replaced device (examples, but not limited to, covered",09-10-2025
FB003008,"Under warranty, replaced due to defect, free samples)",09-10-2025
FC001007,Partial credit received for replaced device,09-10-2025
FP001007,Service provided as part of family planning program,09-10-2025
FQ001007,The service was furnished using audio-only communication technology,09-10-2025
FR001007,"The supervising practitioner was present through two-way, audio/video",09-10-2025
FR002008,Communication technology,09-10-2025
FS001007,Split (or shared) evaluation and management visit,09-10-2025
FT001007,Unrelated evaluation and management (e/m) visit on the same day as another e/m,09-10-2025
FT002008,"Visit or during a global procedure (preoperative, postoperative period, or on",09-10-2025
FT003008,"The same day as the procedure, as applicable). (report when an e/m visit is",09-10-2025
FT004008,"Furnished within the global period but is unrelated, or when one or more",09-10-2025
FT005008,Additional e/m visits furnished on the same day are unrelated),09-10-2025
FX001007,X-ray taken using film,09-10-2025
FY001007,X-ray taken using computed radiography technology/cassette-based imaging,09-10-2025
G0001007,"Telehealth services for diagnosis, evaluation, or treatment, of symptoms of an",09-10-2025
G0002008,Acute stroke,09-10-2025
G1001007,Most recent urr reading of less than 60,09-10-2025
G2001007,Most recent urr reading of 60 to 64.9,09-10-2025
G3001007,Most recent urr reading of 65 to 69.9,09-10-2025
G4001007,Most recent urr reading of 70 to 74.9,09-10-2025
G5001007,Most recent urr reading of 75 or greater,09-10-2025
G6001007,Esrd patient for whom less than six dialysis sessions have been provided in a,09-10-2025
G6002008,Month,09-10-2025
G7001007,Pregnancy resulted from rape or incest or pregnancy certified by physician as,09-10-2025
G7002008,Life threatening,09-10-2025
G8001007,"Monitored anesthesia care (mac) for deep complex, complicated, or markedly",09-10-2025
G8002008,Invasive surgical procedure,09-10-2025
G9001007,Monitored anesthesia care for patient who has history of severe,09-10-2025
G9002008,Cardio-pulmonary condition,09-10-2025
GA001007,"Waiver of liability statement issued as required by payer policy, individual",09-10-2025
GA002008,Case,09-10-2025
GB001007,Claim being re-submitted for payment because it is no longer covered under a,09-10-2025
GB002008,Global payment demonstration,09-10-2025
GC001007,This service has been performed in part by a resident under the direction of a,09-10-2025
GC002008,Teaching physician,09-10-2025
GD001007,Units of service exceeds medically unlikely edit value and represents,09-10-2025
GD002008,Reasonable and necessary services,09-10-2025
GE001007,This service has been performed by a resident without the presence of a,09-10-2025
GE002008,Teaching physician under the primary care exception,09-10-2025
GF001007,"Non-physician (e.g. nurse practitioner (np), certified registered nurse",09-10-2025
GF002008,"Anesthetist (crna), certified registered nurse (crn), clinical nurse specialist",09-10-2025
GF003008,"(cns), physician assistant (pa)) services in a critical access hospital",09-10-2025
GG001007,Performance and payment of a screening mammogram and diagnostic mammogram on,09-10-2025
GG002008,"The same patient, same day",09-10-2025
GH001007,Diagnostic mammogram converted from screening mammogram on same day,09-10-2025
GJ001007,"""opt out"" physician or practitioner emergency or urgent service",09-10-2025
GK001007,Reasonable and necessary item/service associated with a ga or gz modifier,09-10-2025
GL001007,"Medically unnecessary upgrade provided instead of non-upgraded item, no charge,",09-10-2025
GL002008,No advance beneficiary notice (abn),09-10-2025
GM001007,Multiple patients on one ambulance trip,09-10-2025
GN001007,Services delivered under an outpatient speech language pathology plan of care,09-10-2025
GO001007,Services delivered under an outpatient occupational therapy plan of care,09-10-2025
GP001007,Services delivered under an outpatient physical therapy plan of care,09-10-2025
GQ001007,Via asynchronous telecommunications system,09-10-2025
GR001007,This service was performed in whole or in part by a resident in a department of,09-10-2025
GR002008,"Veterans affairs medical center or clinic, supervised in accordance with va",09-10-2025
GR003008,Policy,09-10-2025
GS001007,Dosage of erythropoietin stimulating agent has been reduced and maintained in,09-10-2025
GS002008,Response to hematocrit or hemoglobin level,09-10-2025
GT001007,Via interactive audio and video telecommunication systems,09-10-2025
GU001007,"Waiver of liability statement issued as required by payer policy, routine notic",09-10-2025
GV001007,Attending physician not employed or paid under arrangement by the patient's,09-10-2025
GV002008,Hospice provider,09-10-2025
GW001007,Service not related to the hospice patient's terminal condition,09-10-2025
GX001007,"Notice of liability issued, voluntary under payer policy",09-10-2025
GY001007,"Item or service statutorily excluded, does not meet the definition of any",09-10-2025
GY002008,"Medicare benefit or, for non-medicare insurers, is not a contract benefit",09-10-2025
GZ001007,Item or service expected to be denied as not reasonable and necessary,09-10-2025
H9001007,Court-ordered,09-10-2025
HA001007,Child/adolescent program,09-10-2025
HB001007,"Adult program, non geriatric",09-10-2025
HC001007,"Adult program, geriatric",09-10-2025
HD001007,Pregnant/parenting women's program,09-10-2025
HE001007,Mental health program,09-10-2025
HF001007,Substance abuse program,09-10-2025
HG001007,Opioid addiction treatment program,09-10-2025
HH001007,Integrated mental health/substance abuse program,09-10-2025
HI001007,Integrated mental health and intellectual disability/developmental disabilities,09-10-2025
HI002008,Program,09-10-2025
HJ001007,Employee assistance program,09-10-2025
HK001007,Specialized mental health programs for high-risk populations,09-10-2025
HL001007,Intern,09-10-2025
HM001007,Less than bachelor degree level,09-10-2025
HN001007,Bachelors degree level,09-10-2025
HO001007,Masters degree level,09-10-2025
HP001007,Doctoral level,09-10-2025
HQ001007,Group setting,09-10-2025
HR001007,Family/couple with client present,09-10-2025
HS001007,Family/couple without client present,09-10-2025
HT001007,Multi-disciplinary team,09-10-2025
HU001007,Funded by child welfare agency,09-10-2025
HV001007,Funded state addictions agency,09-10-2025
HW001007,Funded by state mental health agency,09-10-2025
HX001007,Funded by county/local agency,09-10-2025
HY001007,Funded by juvenile justice agency,09-10-2025
HZ001007,Funded by criminal justice agency,09-10-2025
J1001007,Competitive acquisition program no-pay submission for a prescription number,09-10-2025
J2001007,"Competitive acquisition program, restocking of emergency drugs after emergency",09-10-2025
J2002008,Administration,09-10-2025
J3001007,"Competitive acquisition program (cap), drug not available through cap as",09-10-2025
J3002008,"Written, reimbursed under average sales price methodology",09-10-2025
J4001007,Dmepos item subject to dmepos competitive bidding program that is furnished by,09-10-2025
J4002008,A hospital upon discharge,09-10-2025
J5001007,Off-the-shelf orthotic subject to dmepos competitive bidding program that is,09-10-2025
J5002008,Furnished as part of a physical therapist or occupational therapist,09-10-2025
J5003008,Professional service,09-10-2025
JA001007,Administered intravenously,09-10-2025
JB001007,Administered subcutaneously,09-10-2025
JC001007,Skin substitute used as a graft,09-10-2025
JD001007,Skin substitute not used as a graft,09-10-2025
JE001007,Administered via dialysate,09-10-2025
JF001007,Compounded drug,09-10-2025
JG001007,"Drug or biological acquired with 340b drug pricing program discount, reported",09-10-2025
JG002008,For informational purposes,09-10-2025
JK001007,One month supply or less of drug or biological,09-10-2025
JL001007,Three month supply of drug or biological,09-10-2025
JW001007,Drug amount discarded/not administered to any patient,09-10-2025
JZ001007,Zero drug amount discarded/not administered to any patient,09-10-2025
K0001007,Lower extremity prosthesis functional level 0 - does not have the ability or,09-10-2025
K0002008,Potential to ambulate or transfer safely with or without assistance and a,09-10-2025
K0003008,Prosthesis does not enhance their quality of life or mobility.,09-10-2025
K1001007,Lower extremity prosthesis functional level 1 - has the ability or potential to,09-10-2025
K1002008,Use a prosthesis for transfers or ambulation on level surfaces at fixed,09-10-2025
K1003008,Cadence. typical of the limited and unlimited household ambulator.,09-10-2025
K2001007,Lower extremity prosthesis functional level 2 - has the ability or potential,09-10-2025
K2002008,For ambulation with the ability to traverse low level environmental barriers,09-10-2025
K2003008,"Such as curbs, stairs or uneven surfaces. typical of the limited community",09-10-2025
K2004008,Ambulator.,09-10-2025
K3001007,Lower extremity prosthesis functional level 3 - has the ability or potential,09-10-2025
K3002008,For ambulation with variable cadence. typical of the community ambulator who,09-10-2025
K3003008,Has the ability to transverse most environmental barriers and may have,09-10-2025
K3004008,"Vocational, therapeutic, or exercise activity that demands prosthetic",09-10-2025
K3005008,Utilization beyond simple locomotion.,09-10-2025
K4001007,Lower extremity prosthesis functional level 4 - has the ability or potential,09-10-2025
K4002008,"For prosthetic ambulation that exceeds the basic ambulation skills, exhibiting",09-10-2025
K4003008,"High impact, stress, or energy levels, typical of the prosthetic demands of the",09-10-2025
K4004008,"Child, active adult, or athlete.",09-10-2025
KA001007,Add on option/accessory for wheelchair,09-10-2025
KB001007,"Beneficiary requested upgrade for abn, more than 4 modifiers identified on clai",09-10-2025
KC001007,Replacement of special power wheelchair interface,09-10-2025
KD001007,Drug or biological infused through dme,09-10-2025
KE001007,Bid under round one of the dmepos competitive bidding program for use with,09-10-2025
KE002008,Non-competitive bid base equipment,09-10-2025
KF001007,Item designated by fda as class iii device,09-10-2025
KG001007,Dmepos item subject to dmepos competitive bidding program number 1,09-10-2025
KH001007,"Dmepos item, initial claim, purchase or first month rental",09-10-2025
KI001007,"Dmepos item, second or third month rental",09-10-2025
KJ001007,"Dmepos item, parenteral enteral nutrition (pen) pump or capped rental, months",09-10-2025
KJ002008,Four to fifteen,09-10-2025
KK001007,Dmepos item subject to dmepos competitive bidding program number 2,09-10-2025
KL001007,Dmepos item delivered via mail,09-10-2025
KM001007,Replacement of facial prosthesis including new impression/moulage,09-10-2025
KN001007,Replacement of facial prosthesis using previous master model,09-10-2025
KO001007,Single drug unit dose formulation,09-10-2025
KP001007,First drug of a multiple drug unit dose formulation,09-10-2025
KQ001007,Second or subsequent drug of a multiple drug unit dose formulation,09-10-2025
KR001007,"Rental item, billing for partial month",09-10-2025
KS001007,Glucose monitor supply for diabetic beneficiary not treated with insulin,09-10-2025
KT001007,Beneficiary resides in a competitive bidding area and travels outside that,09-10-2025
KT002008,Competitive bidding area and receives a competitive bid item,09-10-2025
KU001007,Dmepos item subject to dmepos competitive bidding program number 3,09-10-2025
KV001007,Dmepos item subject to dmepos competitive bidding program that is furnished as,09-10-2025
KV002008,Part of a professional service,09-10-2025
KW001007,Dmepos item subject to dmepos competitive bidding program number 4,09-10-2025
KX001007,Requirements specified in the medical policy have been met,09-10-2025
KY001007,Dmepos item subject to dmepos competitive bidding program number 5,09-10-2025
KZ001007,New coverage not implemented by managed care,09-10-2025
L1001007,Provider attestation that the hospital laboratory test(s) is not packaged under,09-10-2025
L1002008,The hospital opps,09-10-2025
LC001007,Left circumflex coronary artery,09-10-2025
LD001007,Left anterior descending coronary artery,09-10-2025
LL001007,Lease/rental (use the 'll' modifier when dme equipment rental is to be applied,09-10-2025
LL002008,Against the purchase price),09-10-2025
LM001007,Left main coronary artery,09-10-2025
LR001007,Laboratory round trip,09-10-2025
LS001007,Fda-monitored intraocular lens implant,09-10-2025
LT001007,Left side (used to identify procedures performed on the left side of the body),09-10-2025
LU001007,Fractionated payment,09-10-2025
M2001007,Medicare secondary payer (msp),09-10-2025
MA001007,Ordering professional is not required to consult a clinical decision support,09-10-2025
MA002008,Mechanism due to service being rendered to a patient with a suspected or,09-10-2025
MA003008,Confirmed emergency medical condition,09-10-2025
MB001007,Ordering professional is not required to consult a clinical decision support,09-10-2025
MB002008,Mechanism due to the significant hardship exception of insufficient internet,09-10-2025
MB003008,Access,09-10-2025
MC001007,Ordering professional is not required to consult a clinical decision support,09-10-2025
MC002008,Mechanism due to the significant hardship exception of electronic health record,09-10-2025
MC003008,Or clinical decision support mechanism vendor issues,09-10-2025
MD001007,Ordering professional is not required to consult a clinical decision support,09-10-2025
MD002008,Mechanism due to the significant hardship exception of extreme and,09-10-2025
MD003008,Uncontrollable circumstances,09-10-2025
ME001007,The order for this service adheres to appropriate use criteria in the clinical,09-10-2025
ME002008,Decision support mechanism consulted by the ordering professional,09-10-2025
MF001007,The order for this service does not adhere to the appropriate use criteria in,09-10-2025
MF002008,The clinical decision support mechanism consulted by the ordering professional,09-10-2025
MG001007,The order for this service does not have applicable appropriate use criteria in,09-10-2025
MG002008,The qualified clinical decision support mechanism consulted by the ordering,09-10-2025
MG003008,Professional,09-10-2025
MH001007,Unknown if ordering professional consulted a clinical decision support,09-10-2025
MH002008,"Mechanism for this service, related information was not provided to the",09-10-2025
MH003008,Furnishing professional or provider,09-10-2025
MS001007,Six month maintenance and servicing fee for reasonable and necessary parts and,09-10-2025
MS002008,Labor which are not covered under any manufacturer or supplier warranty,09-10-2025
N1001007,Group 1 oxygen coverage criteria met,09-10-2025
N2001007,Group 2 oxygen coverage criteria met,09-10-2025
N3001007,Group 3 oxygen coverage criteria met,09-10-2025
NB001007,"Nebulizer system, any type, fda-cleared for use with specific drug",09-10-2025
NR001007,New when rented (use the 'nr' modifier when dme which was new at the time of,09-10-2025
NR002008,Rental is subsequently purchased),09-10-2025
NU001007,New equipment,09-10-2025
P1001007,A normal healthy patient,09-10-2025
P2001007,A patient with mild systemic disease,09-10-2025
P3001007,A patient with severe systemic disease,09-10-2025
P4001007,A patient with severe systemic disease that is a constant threat to life,09-10-2025
P5001007,A moribund patient who is not expected to survive without the operation,09-10-2025
P6001007,A declared brain-dead patient whose organs are being removed for donor purposes,09-10-2025
PA001007,Surgical or other invasive procedure on wrong body part,09-10-2025
PB001007,Surgical or other invasive procedure on wrong patient,09-10-2025
PC001007,Wrong surgery or other invasive procedure on patient,09-10-2025
PD001007,Diagnostic or related non diagnostic item or service provided in a wholly owned,09-10-2025
PD002008,Or operated entity to a patient who is admitted as an inpatient within 3 days,09-10-2025
PI001007,Positron emission tomography (pet) or pet/computed tomography (ct) to inform,09-10-2025
PI002008,The initial treatment strategy of tumors that are biopsy proven or strongly,09-10-2025
PI003008,Suspected of being cancerous based on other diagnostic testing,09-10-2025
PL001007,Progressive addition lenses,09-10-2025
PM001007,Post mortem,09-10-2025
PN001007,"Non-excepted service provided at an off-campus, outpatient, provider-based",09-10-2025
PN002008,Department of a hospital,09-10-2025
PO001007,"Excepted service provided at an off-campus, outpatient, provider-based",09-10-2025
PO002008,Department of a hospital,09-10-2025
PS001007,Positron emission tomography (pet) or pet/computed tomography (ct) to inform,09-10-2025
PS002008,The subsequent treatment strategy of cancerous tumors when the beneficiary's,09-10-2025
PS003008,Treating physician determines that the pet study is needed to inform subsequent,09-10-2025
PS004008,Anti-tumor strategy,09-10-2025
PT001007,Colorectal cancer screening test; converted to diagnostic test or other,09-10-2025
PT002008,Procedure,09-10-2025
Q0001007,Investigational clinical service provided in a clinical research study that is,09-10-2025
Q0002008,In an approved clinical research study,09-10-2025
Q1001007,Routine clinical service provided in a clinical research study that is in an,09-10-2025
Q1002008,Approved clinical research study,09-10-2025
Q2001007,Demonstration procedure/service,09-10-2025
Q3001007,Live kidney donor surgery and related services,09-10-2025
Q4001007,Service for ordering/referring physician qualifies as a service exemption,09-10-2025
Q5001007,Service furnished under a reciprocal billing arrangement by a substitute,09-10-2025
Q5002008,Physician or by a substitute physical therapist furnishing outpatient physical,09-10-2025
Q5003008,"Therapy services in a health professional shortage area, a medically",09-10-2025
Q5004008,"Underserved area, or a rural area",09-10-2025
Q6001007,Service furnished under a fee-for-time compensation arrangement by a substitute,09-10-2025
Q6002008,Physician or by a substitute physical therapist furnishing outpatient physical,09-10-2025
Q6003008,"Therapy services in a health professional shortage area, a medically",09-10-2025
Q6004008,"Underserved area, or a rural area",09-10-2025
Q7001007,One class a finding,09-10-2025
Q8001007,Two class b findings,09-10-2025
Q9001007,One class b and two class c findings,09-10-2025
QA001007,Prescribed amounts of stationary oxygen for daytime use while at rest and,09-10-2025
QA002008,Nighttime use differ and the average of the two amounts is less than 1 liter,09-10-2025
QA003008,Per minute (lpm),09-10-2025
QB001007,Prescribed amounts of stationary oxygen for daytime use while at rest and,09-10-2025
QB002008,Nighttime use differ and the average of the two amounts exceeds 4 liters per,09-10-2025
QB003008,Minute (lpm) and portable oxygen is prescribed,09-10-2025
QC001007,Single channel monitoring,09-10-2025
QD001007,Recording and storage in solid state memory by a digital recorder,09-10-2025
QE001007,Prescribed amount of stationary oxygen while at rest is less than 1 liter per,09-10-2025
QE002008,Minute (lpm),09-10-2025
QF001007,Prescribed amount of stationary oxygen while at rest exceeds 4 liters per,09-10-2025
QF002008,Minute (lpm) and portable oxygen is prescribed,09-10-2025
QG001007,Prescribed amount of stationary oxygen while at rest is greater than 4 liters,09-10-2025
QG002008,Per minute (lpm),09-10-2025
QH001007,Oxygen conserving device is being used with an oxygen delivery system,09-10-2025
QJ001007,"Services/items provided to a prisoner or patient in state or local custody,",09-10-2025
QJ002008,"However the state or local government, as applicable, meets the requirements in",09-10-2025
QJ003008,42 cfr 411.4 (b),09-10-2025
QK001007,"Medical direction of two, three, or four concurrent anesthesia procedures",09-10-2025
QK002008,Involving qualified individuals,09-10-2025
QL001007,Patient pronounced dead after ambulance called,09-10-2025
QM001007,Ambulance service provided under arrangement by a provider of services,09-10-2025
QN001007,Ambulance service furnished directly by a provider of services,09-10-2025
QP001007,Documentation is on file showing that the laboratory test(s) was ordered,09-10-2025
QP002008,Individually or ordered as a cpt-recognized panel other than automated profile,09-10-2025
QP003008,"Codes 80002-80019, g0058, g0059, and g0060.",09-10-2025
QQ001007,Ordering professional consulted a qualified clinical decision support mechanism,09-10-2025
QQ002008,For this service and the related data was provided to the furnishing,09-10-2025
QQ003008,Professional,09-10-2025
QR001007,Prescribed amounts of stationary oxygen for daytime use while at rest and,09-10-2025
QR002008,Nighttime use differ and the average of the two amounts is greater than 4,09-10-2025
QR003008,Liters per minute (lpm),09-10-2025
QS001007,Monitored anesthesia care service,09-10-2025
QT001007,Recording and storage on tape by an analog tape recorder,09-10-2025
QW001007,Clia waived test,09-10-2025
QX001007,Crna service: with medical direction by a physician,09-10-2025
QY001007,Medical direction of one certified registered nurse anesthetist (crna) by an,09-10-2025
QY002008,Anesthesiologist,09-10-2025
QZ001007,Crna service: without medical direction by a physician,09-10-2025
RA001007,"Replacement of a dme, orthotic or prosthetic item",09-10-2025
RB001007,"Replacement of a part of a dme, orthotic or prosthetic item furnished as part",09-10-2025
RB002008,Of a repair,09-10-2025
RC001007,Right coronary artery,09-10-2025
RD001007,"Drug provided to beneficiary, but not administered ""incident-to""",09-10-2025
RE001007,Furnished in full compliance with fda-mandated risk evaluation and mitigation,09-10-2025
RE002008,Strategy (rems),09-10-2025
RI001007,Ramus intermedius coronary artery,09-10-2025
RR001007,Rental (use the 'rr' modifier when dme is to be rented),09-10-2025
RT001007,Right side (used to identify procedures performed on the right side of the body,09-10-2025
SA001007,Nurse practitioner rendering service in collaboration with a physician,09-10-2025
SB001007,Nurse midwife,09-10-2025
SC001007,Medically necessary service or supply,09-10-2025
SD001007,"Services provided by registered nurse with specialized, highly technical home",09-10-2025
SD002008,Infusion training,09-10-2025
SE001007,State and/or federally-funded programs/services,09-10-2025
SF001007,Second opinion ordered by a professional review organization (pro) per section,09-10-2025
SF002008,"9401, p.l. 99-272 (100% reimbursement - no medicare deductible or coinsurance)",09-10-2025
SG001007,Ambulatory surgical center (asc) facility service,09-10-2025
SH001007,Second concurrently administered infusion therapy,09-10-2025
SJ001007,Third or more concurrently administered infusion therapy,09-10-2025
SK001007,Member of high risk population (use only with codes for immunization),09-10-2025
SL001007,State supplied vaccine,09-10-2025
SM001007,Second surgical opinion,09-10-2025
SN001007,Third surgical opinion,09-10-2025
SQ001007,Item ordered by home health,09-10-2025
SS001007,Home infusion services provided in the infusion suite of the iv therapy provide,09-10-2025
ST001007,Related to trauma or injury,09-10-2025
SU001007,Procedure performed in physician's office (to denote use of facility and,09-10-2025
SU002008,Equipment),09-10-2025
SV001007,Pharmaceuticals delivered to patient's home but not utilized,09-10-2025
SW001007,Services provided by a certified diabetic educator,09-10-2025
SY001007,Persons who are in close contact with member of high-risk population (use only,09-10-2025
SY002008,With codes for immunization),09-10-2025
SZ001007,Habilitative services,09-10-2025
T1001007,"Left foot, second digit",09-10-2025
T2001007,"Left foot, third digit",09-10-2025
T3001007,"Left foot, fourth digit",09-10-2025
T4001007,"Left foot, fifth digit",09-10-2025
T5001007,"Right foot, great toe",09-10-2025
T6001007,"Right foot, second digit",09-10-2025
T7001007,"Right foot, third digit",09-10-2025
T8001007,"Right foot, fourth digit",09-10-2025
T9001007,"Right foot, fifth digit",09-10-2025
TA001007,"Left foot, great toe",09-10-2025
TB001007,"Drug or biological acquired with 340b drug pricing program discount, reported",09-10-2025
TB002008,For informational purposes,09-10-2025
TC001007,"Technical component; under certain circumstances, a charge may be made for the",09-10-2025
TC002008,Technical component alone; under those circumstances the technical component,09-10-2025
TC003008,Charge is identified by adding modifier 'tc' to the usual procedure number;,09-10-2025
TC004008,Technical component charges are institutional charges and not billed separately,09-10-2025
TC005008,"By physicians; however, portable x-ray suppliers only bill for technical",09-10-2025
TC006008,Component and should utilize modifier tc; the charge data from portable x-ray,09-10-2025
TC007008,Suppliers will then be used to build customary and prevailing profiles,09-10-2025
TD001007,Rn,09-10-2025
TE001007,Lpn/lvn,09-10-2025
TF001007,Intermediate level of care,09-10-2025
TG001007,Complex/high tech level of care,09-10-2025
TH001007,"Obstetrical treatment/services, prenatal or postpartum",09-10-2025
TJ001007,"Program group, child and/or adolescent",09-10-2025
TK001007,"Extra patient or passenger, non-ambulance",09-10-2025
TL001007,Early intervention/individualized family service plan (ifsp),09-10-2025
TM001007,Individualized education program (iep),09-10-2025
TN001007,Rural/outside providers' customary service area,09-10-2025
TP001007,"Medical transport, unloaded vehicle",09-10-2025
TQ001007,Basic life support transport by a volunteer ambulance provider,09-10-2025
TR001007,School-based individualized education program (iep) services provided outside,09-10-2025
TR002008,The public school district responsible for the student,09-10-2025
TS001007,Follow-up service,09-10-2025
TT001007,Individualized service provided to more than one patient in same setting,09-10-2025
TU001007,"Special payment rate, overtime",09-10-2025
TV001007,"Special payment rates, holidays/weekends",09-10-2025
TW001007,Back-up equipment,09-10-2025
U1001007,"Medicaid level of care 1, as defined by each state",09-10-2025
U2001007,"Medicaid level of care 2, as defined by each state",09-10-2025
U3001007,"Medicaid level of care 3, as defined by each state",09-10-2025
U4001007,"Medicaid level of care 4, as defined by each state",09-10-2025
U5001007,"Medicaid level of care 5, as defined by each state",09-10-2025
U6001007,"Medicaid level of care 6, as defined by each state",09-10-2025
U7001007,"Medicaid level of care 7, as defined by each state",09-10-2025
U8001007,"Medicaid level of care 8, as defined by each state",09-10-2025
U9001007,"Medicaid level of care 9, as defined by each state",09-10-2025
UA001007,"Medicaid level of care 10, as defined by each state",09-10-2025
UB001007,"Medicaid level of care 11, as defined by each state",09-10-2025
UC001007,"Medicaid level of care 12, as defined by each state",09-10-2025
UD001007,"Medicaid level of care 13, as defined by each state",09-10-2025
UE001007,Used durable medical equipment,09-10-2025
UF001007,Services provided in the morning,09-10-2025
UG001007,Services provided in the afternoon,09-10-2025
UH001007,Services provided in the evening,09-10-2025
UJ001007,Services provided at night,09-10-2025
UK001007,Services provided on behalf of the client to someone other than the client,09-10-2025
UK002008,(collateral relationship),09-10-2025
UN001007,Two patients served,09-10-2025
UP001007,Three patients served,09-10-2025
UQ001007,Four patients served,09-10-2025
UR001007,Five patients served,09-10-2025
US001007,Six or more patients served,09-10-2025
V1001007,Demonstration modifier 1,09-10-2025
V2001007,Demonstration modifier 2,09-10-2025
V3001007,Demonstration modifier 3,09-10-2025
V4001007,Demonstration modifier 4,09-10-2025
V5001007,Vascular catheter (alone or with any other vascular access),09-10-2025
V6001007,Arteriovenous graft (or other vascular access not including a vascular catheter,09-10-2025
V7001007,Arteriovenous fistula only (in use with two needles),09-10-2025
V8001007,Infection present,09-10-2025
V9001007,No infection present,09-10-2025
VM001007,Medicare diabetes prevention program (mdpp) virtual make-up session,09-10-2025
VP001007,Aphakic patient,09-10-2025
X1001007,"Continuous/broad services: for reporting services by clinicians, who provide",09-10-2025
X1002008,"The principal care for a patient, with no planned endpoint of the relationship;",09-10-2025
X1003008,"Services in this category represent comprehensive care, dealing with the entire",09-10-2025
X1004008,"Scope of patient problems, either directly or in a care coordination role;",09-10-2025
X1005008,"Reporting clinician service examples include, but are not limited to: primary",09-10-2025
X1006008,"Care, and clinicians providing comprehensive care to patients in addition to",09-10-2025
X1007008,Specialty care,09-10-2025
X2001007,Continuous/focused services: for reporting services by clinicians whose,09-10-2025
X2002008,Expertise is needed for the ongoing management of a chronic disease or a,09-10-2025
X2003008,Condition that needs to be managed and followed with no planned endpoint to the,09-10-2025
X2004008,Relationship; reporting clinician service examples include but are not limited,09-10-2025
X2005008,To: a rheumatologist taking care of the patient's rheumatoid arthritis,09-10-2025
X2006008,Longitudinally but not providing general primary care services,09-10-2025
X3001007,Episodic/broad services: for reporting services by clinicians who have broad,09-10-2025
X3002008,Responsibility for the comprehensive needs of the patient that is limited to a,09-10-2025
X3003008,Defined period and circumstance such as a hospitalization; reporting clinician,09-10-2025
X3004008,Service examples include but are not limited to the hospitalist's services,09-10-2025
X3005008,Rendered providing comprehensive and general care to a patient while admitted,09-10-2025
X3006008,To the hospital,09-10-2025
X4001007,Episodic/focused services: for reporting services by clinicians who provide,09-10-2025
X4002008,Focused care on particular types of treatment limited to a defined period and,09-10-2025
X4003008,"Circumstance; the patient has a problem, acute or chronic, that will be treated",09-10-2025
X4004008,"With surgery, radiation, or some other type of generally time-limited",09-10-2025
X4005008,Intervention; reporting clinician service examples include but are not limited,09-10-2025
X4006008,"To, the orthopedic surgeon performing a knee replacement and seeing the patient",09-10-2025
X4007008,Through the postoperative period,09-10-2025
X5001007,Diagnostic services requested by another clinician: for reporting services by a,09-10-2025
X5002008,Clinician who furnishes care to the patient only as requested by another,09-10-2025
X5003008,Clinician or subsequent and related services requested by another clinician;,09-10-2025
X5004008,This modifier is reported for patient relationships that may not be adequately,09-10-2025
X5005008,Captured by the above alternative categories; reporting clinician service,09-10-2025
X5006008,"Examples include but are not limited to, the radiologist's interpretation of an",09-10-2025
X5007008,Imaging study requested by another clinician,09-10-2025
XE001007,"Separate encounter, a service that is distinct because it occurred during a",09-10-2025
XE002008,Separate encounter,09-10-2025
XP001007,"Separate practitioner, a service that is distinct because it was performed by a",09-10-2025
XP002008,Different practitioner,09-10-2025
XS001007,"Separate structure, a service that is distinct because it was performed on a",09-10-2025
XS002008,Separate organ/structure,09-10-2025
XU001007,"Unusual non-overlapping service, the use of a service that is distinct because",09-10-2025
XU002008,It does not overlap usual components of the main service,09-10-2025
ZA001007,Novartis/sandoz,09-10-2025
ZB001007,Pfizer/hospira,09-10-2025
ZC001007,Merck/samsung bioepis,09-10-2025
A0021001003,"Ambulance service, outside state per mile, transport (medicaid only)",09-10-2025
A0080001003,"Non-emergency transportation, per mile - vehicle provided by volunteer",09-10-2025
A0080002004,"(individual or organization), with no vested interest",09-10-2025
A0090001003,"Non-emergency transportation, per mile - vehicle provided by individual (family",09-10-2025
A0090002004,"Member, self, neighbor) with vested interest",09-10-2025
A0100001003,Non-emergency transportation; taxi,09-10-2025
A0110001003,"Non-emergency transportation and bus, intra or inter state carrier",09-10-2025
A0120001003,"Non-emergency transportation: mini-bus, mountain area transports, or other",09-10-2025
A0120002004,Transportation systems,09-10-2025
A0130001003,Non-emergency transportation: wheelchair van,09-10-2025
A0140001003,Non-emergency transportation and air travel (private or commercial) intra or,09-10-2025
A0140002004,Inter state,09-10-2025
A0160001003,Non-emergency transportation: per mile - case worker or social worker,09-10-2025
A0170001003,"Transportation ancillary: parking fees, tolls, other",09-10-2025
A0180001003,Non-emergency transportation: ancillary: lodging-recipient,09-10-2025
A0190001003,Non-emergency transportation: ancillary: meals-recipient,09-10-2025
A0200001003,Non-emergency transportation: ancillary: lodging escort,09-10-2025
A0210001003,Non-emergency transportation: ancillary: meals-escort,09-10-2025
A0225001003,"Ambulance service, neonatal transport, base rate, emergency transport, one way",09-10-2025
A0380001003,Bls mileage (per mile),09-10-2025
A0382001003,Bls routine disposable supplies,09-10-2025
A0384001003,Bls specialized service disposable supplies; defibrillation (used by als,09-10-2025
A0384002004,Ambulances and bls ambulances in jurisdictions where defibrillation is,09-10-2025
A0384003004,Permitted in bls ambulances),09-10-2025
A0390001003,Als mileage (per mile),09-10-2025
A0392001003,Als specialized service disposable supplies; defibrillation (to be used only in,09-10-2025
A0392002004,Jurisdictions where defibrillation cannot be performed in bls ambulances),09-10-2025
A0394001003,Als specialized service disposable supplies; iv drug therapy,09-10-2025
A0396001003,Als specialized service disposable supplies; esophageal intubation,09-10-2025
A0398001003,Als routine disposable supplies,09-10-2025
A0420001003,"Ambulance waiting time (als or bls), one half (1/2) hour increments",09-10-2025
A0422001003,"Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation",09-10-2025
A0424001003,"Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged);",09-10-2025
A0424002004,(requires medical review),09-10-2025
A0425001003,"Ground mileage, per statute mile",09-10-2025
A0426001003,"Ambulance service, advanced life support, non-emergency transport, level 1 (als",09-10-2025
A0426002004,1),09-10-2025
A0427001003,"Ambulance service, advanced life support, emergency transport, level 1 (als 1 -",09-10-2025
A0427002004,Emergency),09-10-2025
A0428001003,"Ambulance service, basic life support, non-emergency transport, (bls)",09-10-2025
A0429001003,"Ambulance service, basic life support, emergency transport (bls-emergency)",09-10-2025
A0430001003,"Ambulance service, conventional air services, transport, one way (fixed wing)",09-10-2025
A0431001003,"Ambulance service, conventional air services, transport, one way (rotary wing)",09-10-2025
A0432001003,"Paramedic intercept (pi), rural area, transport furnished by a volunteer",09-10-2025
A0432002004,Ambulance company which is prohibited by state law from billing third party,09-10-2025
A0432003004,Payers,09-10-2025
A0433001003,"Advanced life support, level 2 (als 2)",09-10-2025
A0434001003,Specialty care transport (sct),09-10-2025
A0435001003,"Fixed wing air mileage, per statute mile",09-10-2025
A0436001003,"Rotary wing air mileage, per statute mile",09-10-2025
A0888001003,"Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest",09-10-2025
A0888002004,Appropriate facility),09-10-2025
A0998001003,"Ambulance response and treatment, no transport",09-10-2025
A0999001003,Unlisted ambulance service,09-10-2025
A2001001003,"Innovamatrix ac, per square centimeter",09-10-2025
A2002001003,"Mirragen advanced wound matrix, per square centimeter",09-10-2025
A2004001003,"Xcellistem, 1 mg",09-10-2025
A2005001003,"Microlyte matrix, per square centimeter",09-10-2025
A2006001003,"Novosorb synpath dermal matrix, per square centimeter",09-10-2025
A2007001003,"Restrata, per square centimeter",09-10-2025
A2008001003,"Theragenesis, per square centimeter",09-10-2025
A2009001003,"Symphony, per square centimeter",09-10-2025
A2010001003,"Apis, per square centimeter",09-10-2025
A2011001003,"Supra sdrm, per square centimeter",09-10-2025
A2012001003,"Suprathel, per square centimeter",09-10-2025
A2013001003,"Innovamatrix fs, per square centimeter",09-10-2025
A2014001003,"Omeza collagen matrix, per 100 mg",09-10-2025
A2015001003,"Phoenix wound matrix, per square centimeter",09-10-2025
A2016001003,"Permeaderm b, per square centimeter",09-10-2025
A2017001003,"Permeaderm glove, each",09-10-2025
A2018001003,"Permeaderm c, per square centimeter",09-10-2025
A2019001003,"Kerecis omega3 marigen shield, per square centimeter",09-10-2025
A2020001003,Ac5 advanced wound system (ac5),09-10-2025
A2021001003,"Neomatrix, per square centimeter",09-10-2025
A2022001003,"Innovaburn or innovamatrix xl, per square centimeter",09-10-2025
A2023001003,"Innovamatrix pd, 1 mg",09-10-2025
A2024001003,"Resolve matrix or xenopatch, per square centimeter",09-10-2025
A2025001003,"Miro3d, per cubic centimeter",09-10-2025
A2026001003,"Restrata minimatrix, 5 mg",09-10-2025
A2027001003,"Matriderm, per square centimeter",09-10-2025
A2028001003,"Micromatrix flex, per mg",09-10-2025
A2029001003,"Mirotract wound matrix sheet, per cubic centimeter",09-10-2025
A2030001003,"Miro3d fibers, per milligram",09-10-2025
A2031001003,"Mirodry wound matrix, per square centimeter",09-10-2025
A2032001003,"Myriad matrix, per square centimeter",09-10-2025
A2033001003,"Myriad morcells, 4 milligrams",09-10-2025
A2034001003,"Foundation drs solo, per square centimeter",09-10-2025
A2035001003,"Corplex p or theracor p or allacor p, per milligram",09-10-2025
A2036001003,"Cohealyx collagen dermal matrix, per square centimeter",09-10-2025
A2037001003,"G4derm plus, per milliliter",09-10-2025
A2038001003,"Marigen pacto, per square centimeter",09-10-2025
A2039001003,"Innovamatrix fd, per square centimeter",09-10-2025
A4100001003,"Skin substitute, fda cleared as a device, not otherwise specified",09-10-2025
A4206001003,"Syringe with needle, sterile, 1 cc or less, each",09-10-2025
A4207001003,"Syringe with needle, sterile 2 cc, each",09-10-2025
A4208001003,"Syringe with needle, sterile 3 cc, each",09-10-2025
A4209001003,"Syringe with needle, sterile 5 cc or greater, each",09-10-2025
A4210001003,"Needle-free injection device, each",09-10-2025
A4211001003,Supplies for self-administered injections,09-10-2025
A4212001003,Non-coring needle or stylet with or without catheter,09-10-2025
A4213001003,"Syringe, sterile, 20 cc or greater, each",09-10-2025
A4215001003,"Needle, sterile, any size, each",09-10-2025
A4216001003,"Sterile water, saline and/or dextrose, diluent/flush, 10 ml",09-10-2025
A4217001003,"Sterile water/saline, 500 ml",09-10-2025
A4218001003,"Sterile saline or water, metered dose dispenser, 10 ml",09-10-2025
A4220001003,Refill kit for implantable infusion pump,09-10-2025
A4221001003,"Supplies for maintenance of non-insulin drug infusion catheter, per week (list",09-10-2025
A4221002004,Drugs separately),09-10-2025
A4222001003,"Infusion supplies for external drug infusion pump, per cassette or bag (list",09-10-2025
A4222002004,Drugs separately),09-10-2025
A4223001003,"Infusion supplies not used with external infusion pump, per cassette or bag",09-10-2025
A4223002004,(list drugs separately),09-10-2025
A4224001003,"Supplies for maintenance of insulin infusion catheter, per week",09-10-2025
A4225001003,"Supplies for external insulin infusion pump, syringe type cartridge, sterile,",09-10-2025
A4225002004,Each,09-10-2025
A4226001003,Supplies for maintenance of insulin infusion pump with dosage rate adjustment,09-10-2025
A4226002004,"Using therapeutic continuous glucose sensing, per week",09-10-2025
A4230001003,"Infusion set for external insulin pump, non needle cannula type",09-10-2025
A4231001003,"Infusion set for external insulin pump, needle type",09-10-2025
A4232001003,"Syringe with needle for external insulin pump, sterile, 3 cc",09-10-2025
A4233001003,"Replacement battery, alkaline (other than j cell), for use with medically",09-10-2025
A4233002004,"Necessary home blood glucose monitor owned by patient, each",09-10-2025
A4234001003,"Replacement battery, alkaline, j cell, for use with medically necessary home",09-10-2025
A4234002004,"Blood glucose monitor owned by patient, each",09-10-2025
A4235001003,"Replacement battery, lithium, for use with medically necessary home blood",09-10-2025
A4235002004,"Glucose monitor owned by patient, each",09-10-2025
A4236001003,"Replacement battery, silver oxide, for use with medically necessary home blood",09-10-2025
A4236002004,"Glucose monitor owned by patient, each",09-10-2025
A4238001003,"Supply allowance for adjunctive, non-implanted continuous glucose monitor",09-10-2025
A4238002004,"(cgm), includes all supplies and accessories, 1 month supply = 1 unit of servic",09-10-2025
A4239001003,"Supply allowance for non-adjunctive, non-implanted continuous glucose monitor",09-10-2025
A4239002004,"(cgm), includes all supplies and accessories, 1 month supply = 1 unit of servic",09-10-2025
A4244001003,"Alcohol or peroxide, per pint",09-10-2025
A4245001003,"Alcohol wipes, per box",09-10-2025
A4246001003,"Betadine or phisohex solution, per pint",09-10-2025
A4247001003,"Betadine or iodine swabs/wipes, per box",09-10-2025
A4248001003,"Chlorhexidine containing antiseptic, 1 ml",09-10-2025
A4250001003,Urine test or reagent strips or tablets (100 tablets or strips),09-10-2025
A4252001003,"Blood ketone test or reagent strip, each",09-10-2025
A4253001003,"Blood glucose test or reagent strips for home blood glucose monitor, per 50",09-10-2025
A4253002004,Strips,09-10-2025
A4255001003,"Platforms for home blood glucose monitor, 50 per box",09-10-2025
A4256001003,"Normal, low and high calibrator solution / chips",09-10-2025
A4257001003,"Replacement lens shield cartridge for use with laser skin piercing device, each",09-10-2025
A4258001003,"Spring-powered device for lancet, each",09-10-2025
A4259001003,"Lancets, per box of 100",09-10-2025
A4261001003,Cervical cap for contraceptive use,09-10-2025
A4262001003,"Temporary, absorbable lacrimal duct implant, each",09-10-2025
A4263001003,"Permanent, long term, non-dissolvable lacrimal duct implant, each",09-10-2025
A4264001003,Permanent implantable contraceptive intratubal occlusion device(s) and delivery,09-10-2025
A4264002004,System,09-10-2025
A4265001003,"Paraffin, per pound",09-10-2025
A4266001003,Diaphragm for contraceptive use,09-10-2025
A4267001003,"Contraceptive supply, condom, male, each",09-10-2025
A4268001003,"Contraceptive supply, condom, female, each",09-10-2025
A4269001003,"Contraceptive supply, spermicide (e.g., foam, gel), each",09-10-2025
A4270001003,"Disposable endoscope sheath, each",09-10-2025
A4271001003,Integrated lancing and blood sample testing cartridges for home blood glucose,09-10-2025
A4271002004,"Monitor, per 50 tests",09-10-2025
A4280001003,"Adhesive skin support attachment for use with external breast prosthesis, each",09-10-2025
A4281001003,"Tubing for breast pump, replacement",09-10-2025
A4282001003,"Adapter for breast pump, replacement",09-10-2025
A4283001003,"Cap for breast pump bottle, replacement",09-10-2025
A4284001003,"Breast shield and splash protector for use with breast pump, replacement",09-10-2025
A4285001003,"Polycarbonate bottle for use with breast pump, replacement",09-10-2025
A4286001003,"Locking ring for breast pump, replacement",09-10-2025
A4287001003,"Disposable collection and storage bag for breast milk, any size, any type, each",09-10-2025
A4288001003,"Valve for breast pump, replacement",09-10-2025
A4290001003,"Sacral nerve stimulation test lead, each",09-10-2025
A4300001003,"Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or",09-10-2025
A4300002004,"Peritoneal, etc.) external access",09-10-2025
A4301001003,"Implantable access total catheter, port/reservoir (e.g., venous, arterial,",09-10-2025
A4301002004,"Epidural, subarachnoid, peritoneal, etc.)",09-10-2025
A4305001003,"Disposable drug delivery system, flow rate of 50 ml or greater per hour",09-10-2025
A4306001003,"Disposable drug delivery system, flow rate of less than 50 ml per hour",09-10-2025
A4310001003,Insertion tray without drainage bag and without catheter (accessories only),09-10-2025
A4311001003,"Insertion tray without drainage bag with indwelling catheter, foley type,",09-10-2025
A4311002004,"Two-way latex with coating (teflon, silicone, silicone elastomer or",09-10-2025
A4311003004,"Hydrophilic, etc.)",09-10-2025
A4312001003,"Insertion tray without drainage bag with indwelling catheter, foley type,",09-10-2025
A4312002004,"Two-way, all silicone",09-10-2025
A4313001003,"Insertion tray without drainage bag with indwelling catheter, foley type,",09-10-2025
A4313002004,"Three-way, for continuous irrigation",09-10-2025
A4314001003,"Insertion tray with drainage bag with indwelling catheter, foley type, two-way",09-10-2025
A4314002004,"Latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)",09-10-2025
A4315001003,"Insertion tray with drainage bag with indwelling catheter, foley type, two-way,",09-10-2025
A4315002004,All silicone,09-10-2025
A4316001003,"Insertion tray with drainage bag with indwelling catheter, foley type,",09-10-2025
A4316002004,"Three-way, for continuous irrigation",09-10-2025
A4320001003,"Irrigation tray with bulb or piston syringe, any purpose",09-10-2025
A4321001003,Therapeutic agent for urinary catheter irrigation,09-10-2025
A4322001003,"Irrigation syringe, bulb or piston, each",09-10-2025
A4326001003,"Male external catheter with integral collection chamber, any type, each",09-10-2025
A4327001003,"Female external urinary collection device; meatal cup, each",09-10-2025
A4328001003,"Female external urinary collection device; pouch, each",09-10-2025
A4330001003,"Perianal fecal collection pouch with adhesive, each",09-10-2025
A4331001003,"Extension drainage tubing, any type, any length, with connector/adaptor, for",09-10-2025
A4331002004,"Use with urinary leg bag or urostomy pouch, each",09-10-2025
A4332001003,"Lubricant, individual sterile packet, each",09-10-2025
A4333001003,"Urinary catheter anchoring device, adhesive skin attachment, each",09-10-2025
A4334001003,"Urinary catheter anchoring device, leg strap, each",09-10-2025
A4335001003,Incontinence supply; miscellaneous,09-10-2025
A4336001003,"Incontinence supply, urethral insert, any type, each",09-10-2025
A4337001003,"Incontinence supply, rectal insert, any type, each",09-10-2025
A4338001003,"Indwelling catheter; foley type, two-way latex with coating (teflon, silicone,",09-10-2025
A4338002004,"Silicone elastomer, or hydrophilic, etc.), each",09-10-2025
A4340001003,"Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each",09-10-2025
A4341001003,"Indwelling intraurethral drainage device with valve, patient inserted,",09-10-2025
A4341002004,"Replacement only, each",09-10-2025
A4342001003,Accessories for patient inserted indwelling intraurethral drainage device with,09-10-2025
A4342002004,"Valve, replacement only, each",09-10-2025
A4344001003,"Indwelling catheter, foley type, two-way, all silicone or polyurethane, each",09-10-2025
A4346001003,"Indwelling catheter; foley type, three way for continuous irrigation, each",09-10-2025
A4349001003,"Male external catheter, with or without adhesive, disposable, each",09-10-2025
A4351001003,"Intermittent urinary catheter; straight tip, with or without coating (teflon,",09-10-2025
A4351002004,"Silicone, silicone elastomer, or hydrophilic, etc.), each",09-10-2025
A4352001003,"Intermittent urinary catheter; coude (curved) tip, with or without coating",09-10-2025
A4352002004,"(teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each",09-10-2025
A4353001003,"Intermittent urinary catheter, with insertion supplies",09-10-2025
A4354001003,Insertion tray with drainage bag but without catheter,09-10-2025
A4355001003,Irrigation tubing set for continuous bladder irrigation through a three-way,09-10-2025
A4355002004,"Indwelling foley catheter, each",09-10-2025
A4356001003,External urethral clamp or compression device (not to be used for catheter,09-10-2025
A4356002004,"Clamp), each",09-10-2025
A4357001003,"Bedside drainage bag, day or night, with or without anti-reflux device, with or",09-10-2025
A4357002004,"Without tube, each",09-10-2025
A4358001003,"Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps,",09-10-2025
A4358002004,Each,09-10-2025
A4360001003,"Disposable external urethral clamp or compression device, with pad and/or",09-10-2025
A4360002004,"Pouch, each",09-10-2025
A4361001003,"Ostomy faceplate, each",09-10-2025
A4362001003,"Skin barrier; solid, 4 x 4 or equivalent; each",09-10-2025
A4363001003,"Ostomy clamp, any type, replacement only, each",09-10-2025
A4364001003,"Adhesive, liquid or equal, any type, per oz",09-10-2025
A4366001003,"Ostomy vent, any type, each",09-10-2025
A4367001003,"Ostomy belt, each",09-10-2025
A4368001003,"Ostomy filter, any type, each",09-10-2025
A4369001003,"Ostomy skin barrier, liquid (spray, brush, etc.), per oz",09-10-2025
A4371001003,"Ostomy skin barrier, powder, per oz",09-10-2025
A4372001003,"Ostomy skin barrier, solid 4 x 4 or equivalent, standard wear, with built-in",09-10-2025
A4372002004,"Convexity, each",09-10-2025
A4373001003,"Ostomy skin barrier, with flange (solid, flexible or accordion), with built-in",09-10-2025
A4373002004,"Convexity, any size, each",09-10-2025
A4375001003,"Ostomy pouch, drainable, with faceplate attached, plastic, each",09-10-2025
A4376001003,"Ostomy pouch, drainable, with faceplate attached, rubber, each",09-10-2025
A4377001003,"Ostomy pouch, drainable, for use on faceplate, plastic, each",09-10-2025
A4378001003,"Ostomy pouch, drainable, for use on faceplate, rubber, each",09-10-2025
A4379001003,"Ostomy pouch, urinary, with faceplate attached, plastic, each",09-10-2025
A4380001003,"Ostomy pouch, urinary, with faceplate attached, rubber, each",09-10-2025
A4381001003,"Ostomy pouch, urinary, for use on faceplate, plastic, each",09-10-2025
A4382001003,"Ostomy pouch, urinary, for use on faceplate, heavy plastic, each",09-10-2025
A4383001003,"Ostomy pouch, urinary, for use on faceplate, rubber, each",09-10-2025
A4384001003,"Ostomy faceplate equivalent, silicone ring, each",09-10-2025
A4385001003,"Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in",09-10-2025
A4385002004,"Convexity, each",09-10-2025
A4387001003,"Ostomy pouch, closed, with barrier attached, with built-in convexity (1 piece),",09-10-2025
A4387002004,Each,09-10-2025
A4388001003,"Ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each",09-10-2025
A4389001003,"Ostomy pouch, drainable, with barrier attached, with built-in convexity (1",09-10-2025
A4389002004,"Piece), each",09-10-2025
A4390001003,"Ostomy pouch, drainable, with extended wear barrier attached, with built-in",09-10-2025
A4390002004,"Convexity (1 piece), each",09-10-2025
A4391001003,"Ostomy pouch, urinary, with extended wear barrier attached (1 piece), each",09-10-2025
A4392001003,"Ostomy pouch, urinary, with standard wear barrier attached, with built-in",09-10-2025
A4392002004,"Convexity (1 piece), each",09-10-2025
A4393001003,"Ostomy pouch, urinary, with extended wear barrier attached, with built-in",09-10-2025
A4393002004,"Convexity (1 piece), each",09-10-2025
A4394001003,"Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid",09-10-2025
A4394002004,Ounce,09-10-2025
A4395001003,"Ostomy deodorant for use in ostomy pouch, solid, per tablet",09-10-2025
A4396001003,Ostomy belt with peristomal hernia support,09-10-2025
A4397001003,"Irrigation supply; sleeve, each",09-10-2025
A4398001003,"Ostomy irrigation supply; bag, each",09-10-2025
A4399001003,"Ostomy irrigation supply; cone/catheter, with or without brush",09-10-2025
A4400001003,Ostomy irrigation set,09-10-2025
A4402001003,"Lubricant, per ounce",09-10-2025
A4404001003,"Ostomy ring, each",09-10-2025
A4405001003,"Ostomy skin barrier, non-pectin based, paste, per ounce",09-10-2025
A4406001003,"Ostomy skin barrier, pectin-based, paste, per ounce",09-10-2025
A4407001003,"Ostomy skin barrier, with flange (solid, flexible, or accordion), extended",09-10-2025
A4407002004,"Wear, with built-in convexity, 4 x 4 inches or smaller, each",09-10-2025
A4408001003,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear,",09-10-2025
A4408002004,"With built-in convexity, larger than 4 x 4 inches, each",09-10-2025
A4409001003,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear,",09-10-2025
A4409002004,"Without built-in convexity, 4 x 4 inches or smaller, each",09-10-2025
A4410001003,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear,",09-10-2025
A4410002004,"Without built-in convexity, larger than 4 x 4 inches, each",09-10-2025
A4411001003,"Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, with built-in",09-10-2025
A4411002004,"Convexity, each",09-10-2025
A4412001003,"Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece",09-10-2025
A4412002004,"System), without filter, each",09-10-2025
A4413001003,"Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece",09-10-2025
A4413002004,"System), with filter, each",09-10-2025
A4414001003,"Ostomy skin barrier, with flange (solid, flexible or accordion), without",09-10-2025
A4414002004,"Built-in convexity, 4 x 4 inches or smaller, each",09-10-2025
A4415001003,"Ostomy skin barrier, with flange (solid, flexible or accordion), without",09-10-2025
A4415002004,"Built-in convexity, larger than 4 x 4 inches, each",09-10-2025
A4416001003,"Ostomy pouch, closed, with barrier attached, with filter (1 piece), each",09-10-2025
A4417001003,"Ostomy pouch, closed, with barrier attached, with built-in convexity, with",09-10-2025
A4417002004,"Filter (1 piece), each",09-10-2025
A4418001003,"Ostomy pouch, closed; without barrier attached, with filter (1 piece), each",09-10-2025
A4419001003,"Ostomy pouch, closed; for use on barrier with non-locking flange, with filter",09-10-2025
A4419002004,"(2 piece), each",09-10-2025
A4420001003,"Ostomy pouch, closed; for use on barrier with locking flange (2 piece), each",09-10-2025
A4421001003,Ostomy supply; miscellaneous,09-10-2025
A4422001003,Ostomy absorbent material (sheet/pad/crystal packet) for use in ostomy pouch to,09-10-2025
A4422002004,"Thicken liquid stomal output, each",09-10-2025
A4423001003,"Ostomy pouch, closed; for use on barrier with locking flange, with filter (2",09-10-2025
A4423002004,"Piece), each",09-10-2025
A4424001003,"Ostomy pouch, drainable, with barrier attached, with filter (1 piece), each",09-10-2025
A4425001003,"Ostomy pouch, drainable; for use on barrier with non-locking flange, with",09-10-2025
A4425002004,"Filter (2 piece system), each",09-10-2025
A4426001003,"Ostomy pouch, drainable; for use on barrier with locking flange (2 piece",09-10-2025
A4426002004,"System), each",09-10-2025
A4427001003,"Ostomy pouch, drainable; for use on barrier with locking flange, with filter (2",09-10-2025
A4427002004,"Piece system), each",09-10-2025
A4428001003,"Ostomy pouch, urinary, with extended wear barrier attached, with faucet-type",09-10-2025
A4428002004,"Tap with valve (1 piece), each",09-10-2025
A4429001003,"Ostomy pouch, urinary, with barrier attached, with built-in convexity, with",09-10-2025
A4429002004,"Faucet-type tap with valve (1 piece), each",09-10-2025
A4430001003,"Ostomy pouch, urinary, with extended wear barrier attached, with built-in",09-10-2025
A4430002004,"Convexity, with faucet-type tap with valve (1 piece), each",09-10-2025
A4431001003,"Ostomy pouch, urinary; with barrier attached, with faucet-type tap with valve",09-10-2025
A4431002004,"(1 piece), each",09-10-2025
A4432001003,"Ostomy pouch, urinary; for use on barrier with non-locking flange, with",09-10-2025
A4432002004,"Faucet-type tap with valve (2 piece), each",09-10-2025
A4433001003,"Ostomy pouch, urinary; for use on barrier with locking flange (2 piece), each",09-10-2025
A4434001003,"Ostomy pouch, urinary; for use on barrier with locking flange, with faucet-type",09-10-2025
A4434002004,"Tap with valve (2 piece), each",09-10-2025
A4435001003,"Ostomy pouch, drainable, high output, with extended wear barrier (one-piece",09-10-2025
A4435002004,"System), with or without filter, each",09-10-2025
A4436001003,"Irrigation supply; sleeve, reusable, per month",09-10-2025
A4437001003,"Irrigation supply; sleeve, disposable, per month",09-10-2025
A4438001003,Adhesive clip applied to the skin to secure external electrical nerve,09-10-2025
A4438002004,"Stimulator controller, each",09-10-2025
A4450001003,"Tape, non-waterproof, per 18 square inches",09-10-2025
A4452001003,"Tape, waterproof, per 18 square inches",09-10-2025
A4453001003,"Rectal catheter with or without balloon, for use with any type transanal",09-10-2025
A4453002004,"Irrigation system, each",09-10-2025
A4455001003,"Adhesive remover or solvent (for tape, cement or other adhesive), per ounce",09-10-2025
A4456001003,"Adhesive remover, wipes, any type, each",09-10-2025
A4457001003,"Enema tube, with or without adapter, any type, replacement only, each",09-10-2025
A4458001003,"Enema bag with tubing, reusable",09-10-2025
A4459001003,"Manual transanal irrigation system, includes water reservoir, pump, tubing, and",09-10-2025
A4459002004,"Accessories, without catheter, any type",09-10-2025
A4461001003,"Surgical dressing holder, non-reusable, each",09-10-2025
A4463001003,"Surgical dressing holder, reusable, each",09-10-2025
A4465001003,Non-elastic binder for extremity,09-10-2025
A4466001003,"Garment, belt, sleeve or other covering, elastic or similar stretchable",09-10-2025
A4466002004,"Material, any type, each",09-10-2025
A4467001003,"Belt, strap, sleeve, garment, or covering, any type",09-10-2025
A4468001003,"Exsufflation belt, includes all supplies and accessories",09-10-2025
A4470001003,Gravlee jet washer,09-10-2025
A4480001003,Vabra aspirator,09-10-2025
A4481001003,"Tracheostoma filter, any type, any size, each",09-10-2025
A4483001003,"Moisture exchanger, disposable, for use with invasive mechanical ventilation",09-10-2025
A4490001003,"Surgical stockings above knee length, each",09-10-2025
A4495001003,"Surgical stockings thigh length, each",09-10-2025
A4500001003,"Surgical stockings below knee length, each",09-10-2025
A4510001003,"Surgical stockings full length, each",09-10-2025
A4520001003,"Incontinence garment, any type, (e.g., brief, diaper), each",09-10-2025
A4540001003,"Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves",09-10-2025
A4540002004,Of the upper arm,09-10-2025
A4541001003,Monthly supplies for use of device coded at e0733,09-10-2025
A4542001003,Supplies and accessories for external upper limb tremor stimulator of the,09-10-2025
A4542002004,Peripheral nerves of the wrist,09-10-2025
A4543001003,"Supplies for transcutaneous electrical nerve stimulator, for nerves in the",09-10-2025
A4543002004,"Auricular region, per month",09-10-2025
A4544001003,Electrode for external lower extremity nerve stimulator for restless legs,09-10-2025
A4544002004,Syndrome,09-10-2025
A4545001003,"Supplies and accessories for external tibial nerve stimulator (e.g., socks, gel",09-10-2025
A4545002004,"Pads, electrodes, etc.), needed for one month",09-10-2025
A4550001003,Surgical trays,09-10-2025
A4553001003,"Non-disposable underpads, all sizes",09-10-2025
A4554001003,"Disposable underpads, all sizes",09-10-2025
A4555001003,Electrode/transducer for use with electrical stimulation device used for cancer,09-10-2025
A4555002004,"Treatment, replacement only",09-10-2025
A4556001003,"Electrodes, (e.g., apnea monitor), per pair",09-10-2025
A4557001003,"Lead wires, (e.g., apnea monitor), per pair",09-10-2025
A4558001003,"Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per",09-10-2025
A4558002004,Oz,09-10-2025
A4559001003,"Coupling gel or paste, for use with ultrasound device, per oz",09-10-2025
A4560001003,"Neuromuscular electrical stimulator (nmes), disposable, replacement only",09-10-2025
A4561001003,"Pessary, reusable, rubber, any type",09-10-2025
A4562001003,"Pessary, reusable, non rubber, any type",09-10-2025
A4563001003,"Rectal control system for vaginal insertion, for long term use, includes pump",09-10-2025
A4563002004,"And all supplies and accessories, any type each",09-10-2025
A4564001003,"Pessary, disposable, any type",09-10-2025
A4565001003,Slings,09-10-2025
A4566001003,"Shoulder sling or vest design, abduction restrainer, with or without swathe",09-10-2025
A4566002004,"Control, prefabricated, includes fitting and adjustment",09-10-2025
A4570001003,Splint,09-10-2025
A4575001003,"Topical hyperbaric oxygen chamber, disposable",09-10-2025
A4580001003,"Cast supplies (e.g., plaster)",09-10-2025
A4590001003,"Special casting material (e.g., fiberglass)",09-10-2025
A4593001003,"Neuromodulation stimulator system, adjunct to rehabilitation therapy regime,",09-10-2025
A4593002004,Controller,09-10-2025
A4594001003,"Neuromodulation stimulator system, adjunct to rehabilitation therapy regime,",09-10-2025
A4594002004,Mouthpiece each,09-10-2025
A4595001003,"Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)",09-10-2025
A4596001003,"Cranial electrotherapy stimulation (ces) system supplies and accessories, per",09-10-2025
A4596002004,Month,09-10-2025
A4600001003,"Sleeve for intermittent limb compression device, replacement only, each",09-10-2025
A4601001003,"Lithium ion battery, rechargeable, for non-prosthetic use, replacement",09-10-2025
A4602001003,"Replacement battery for external infusion pump owned by patient, lithium, 1.5",09-10-2025
A4602002004,"Volt, each",09-10-2025
A4604001003,Tubing with integrated heating element for use with positive airway pressure,09-10-2025
A4604002004,Device,09-10-2025
A4605001003,"Tracheal suction catheter, closed system, each",09-10-2025
A4606001003,"Oxygen probe for use with oximeter device, replacement",09-10-2025
A4608001003,"Transtracheal oxygen catheter, each",09-10-2025
A4611001003,"Battery, heavy duty; replacement for patient owned ventilator",09-10-2025
A4612001003,Battery cables; replacement for patient-owned ventilator,09-10-2025
A4613001003,Battery charger; replacement for patient-owned ventilator,09-10-2025
A4614001003,"Peak expiratory flow rate meter, hand held",09-10-2025
A4615001003,"Cannula, nasal",09-10-2025
A4616001003,"Tubing (oxygen), per foot",09-10-2025
A4617001003,Mouth piece,09-10-2025
A4618001003,Breathing circuits,09-10-2025
A4619001003,Face tent,09-10-2025
A4620001003,Variable concentration mask,09-10-2025
A4623001003,"Tracheostomy, inner cannula",09-10-2025
A4624001003,"Tracheal suction catheter, any type other than closed system, each",09-10-2025
A4625001003,Tracheostomy care kit for new tracheostomy,09-10-2025
A4626001003,"Tracheostomy cleaning brush, each",09-10-2025
A4627001003,"Spacer, bag or reservoir, with or without mask, for use with metered dose",09-10-2025
A4627002004,Inhaler,09-10-2025
A4628001003,"Oral and/or oropharyngeal suction catheter, each",09-10-2025
A4629001003,Tracheostomy care kit for established tracheostomy,09-10-2025
A4630001003,"Replacement batteries, medically necessary, transcutaneous electrical",09-10-2025
A4630002004,"Stimulator, owned by patient",09-10-2025
A4633001003,"Replacement bulb/lamp for ultraviolet light therapy system, each",09-10-2025
A4634001003,"Replacement bulb for therapeutic light box, tabletop model",09-10-2025
A4635001003,"Underarm pad, crutch, replacement, each",09-10-2025
A4636001003,"Replacement, handgrip, cane, crutch, or walker, each",09-10-2025
A4637001003,"Replacement, tip, cane, crutch, walker, each.",09-10-2025
A4638001003,"Replacement battery for patient-owned ear pulse generator, each",09-10-2025
A4639001003,"Replacement pad for infrared heating pad system, each",09-10-2025
A4640001003,Replacement pad for use with medically necessary alternating pressure pad owned,09-10-2025
A4640002004,By patient,09-10-2025
A4641001003,"Radiopharmaceutical, diagnostic, not otherwise classified",09-10-2025
A4642001003,"Indium in-111 satumomab pendetide, diagnostic, per study dose, up to 6",09-10-2025
A4642002004,Millicuries,09-10-2025
A4648001003,"Tissue marker, implantable, any type, each",09-10-2025
A4649001003,Surgical supply; miscellaneous,09-10-2025
A4650001003,"Implantable radiation dosimeter, each",09-10-2025
A4651001003,"Calibrated microcapillary tube, each",09-10-2025
A4652001003,Microcapillary tube sealant,09-10-2025
A4653001003,"Peritoneal dialysis catheter anchoring device, belt, each",09-10-2025
A4657001003,"Syringe, with or without needle, each",09-10-2025
A4660001003,Sphygmomanometer/blood pressure apparatus with cuff and stethoscope,09-10-2025
A4663001003,Blood pressure cuff only,09-10-2025
A4670001003,Automatic blood pressure monitor,09-10-2025
A4671001003,"Disposable cycler set used with cycler dialysis machine, each",09-10-2025
A4672001003,"Drainage extension line, sterile, for dialysis, each",09-10-2025
A4673001003,"Extension line with easy lock connectors, used with dialysis",09-10-2025
A4674001003,"Chemicals/antiseptics solution used to clean/sterilize dialysis equipment, per",09-10-2025
A4674002004,8 oz,09-10-2025
A4680001003,"Activated carbon filter for hemodialysis, each",09-10-2025
A4690001003,"Dialyzer (artificial kidneys), all types, all sizes, for hemodialysis, each",09-10-2025
A4706001003,"Bicarbonate concentrate, solution, for hemodialysis, per gallon",09-10-2025
A4707001003,"Bicarbonate concentrate, powder, for hemodialysis, per packet",09-10-2025
A4708001003,"Acetate concentrate solution, for hemodialysis, per gallon",09-10-2025
A4709001003,"Acid concentrate, solution, for hemodialysis, per gallon",09-10-2025
A4714001003,"Treated water (deionized, distilled, or reverse osmosis) for peritoneal",09-10-2025
A4714002004,"Dialysis, per gallon",09-10-2025
A4719001003,"""y set"" tubing for peritoneal dialysis",09-10-2025
A4720001003,"Dialysate solution, any concentration of dextrose, fluid volume greater than",09-10-2025
A4720002004,"249 cc, but less than or equal to 999 cc, for peritoneal dialysis",09-10-2025
A4721001003,"Dialysate solution, any concentration of dextrose, fluid volume greater than",09-10-2025
A4721002004,"999 cc but less than or equal to 1999 cc, for peritoneal dialysis",09-10-2025
A4722001003,"Dialysate solution, any concentration of dextrose, fluid volume greater than",09-10-2025
A4722002004,"1999 cc but less than or equal to 2999 cc, for peritoneal dialysis",09-10-2025
A4723001003,"Dialysate solution, any concentration of dextrose, fluid volume greater than",09-10-2025
A4723002004,"2999 cc but less than or equal to 3999 cc, for peritoneal dialysis",09-10-2025
A4724001003,"Dialysate solution, any concentration of dextrose, fluid volume greater than",09-10-2025
A4724002004,"3999 cc but less than or equal to 4999 cc, for peritoneal dialysis",09-10-2025
A4725001003,"Dialysate solution, any concentration of dextrose, fluid volume greater than",09-10-2025
A4725002004,"4999 cc but less than or equal to 5999 cc, for peritoneal dialysis",09-10-2025
A4726001003,"Dialysate solution, any concentration of dextrose, fluid volume greater than",09-10-2025
A4726002004,"5999 cc, for peritoneal dialysis",09-10-2025
A4728001003,"Dialysate solution, non-dextrose containing, 500 ml",09-10-2025
A4730001003,"Fistula cannulation set for hemodialysis, each",09-10-2025
A4736001003,"Topical anesthetic, for dialysis, per gram",09-10-2025
A4737001003,"Injectable anesthetic, for dialysis, per 10 ml",09-10-2025
A4740001003,"Shunt accessory, for hemodialysis, any type, each",09-10-2025
A4750001003,"Blood tubing, arterial or venous, for hemodialysis, each",09-10-2025
A4755001003,"Blood tubing, arterial and venous combined, for hemodialysis, each",09-10-2025
A4760001003,"Dialysate solution test kit, for peritoneal dialysis, any type, each",09-10-2025
A4765001003,"Dialysate concentrate, powder, additive for peritoneal dialysis, per packet",09-10-2025
A4766001003,"Dialysate concentrate, solution, additive for peritoneal dialysis, per 10 ml",09-10-2025
A4770001003,"Blood collection tube, vacuum, for dialysis, per 50",09-10-2025
A4771001003,"Serum clotting time tube, for dialysis, per 50",09-10-2025
A4772001003,"Blood glucose test strips, for dialysis, per 50",09-10-2025
A4773001003,"Occult blood test strips, for dialysis, per 50",09-10-2025
A4774001003,"Ammonia test strips, for dialysis, per 50",09-10-2025
A4802001003,"Protamine sulfate, for hemodialysis, per 50 mg",09-10-2025
A4860001003,"Disposable catheter tips for peritoneal dialysis, per 10",09-10-2025
A4870001003,Plumbing and/or electrical work for home hemodialysis equipment,09-10-2025
A4890001003,"Contracts, repair and maintenance, for hemodialysis equipment",09-10-2025
A4911001003,"Drain bag/bottle, for dialysis, each",09-10-2025
A4913001003,"Miscellaneous dialysis supplies, not otherwise specified",09-10-2025
A4918001003,"Venous pressure clamp, for hemodialysis, each",09-10-2025
A4927001003,"Gloves, non-sterile, per 100",09-10-2025
A4928001003,"Surgical mask, per 20",09-10-2025
A4929001003,"Tourniquet for dialysis, each",09-10-2025
A4930001003,"Gloves, sterile, per pair",09-10-2025
A4931001003,"Oral thermometer, reusable, any type, each",09-10-2025
A4932001003,"Rectal thermometer, reusable, any type, each",09-10-2025
A5051001003,"Ostomy pouch, closed; with barrier attached (1 piece), each",09-10-2025
A5052001003,"Ostomy pouch, closed; without barrier attached (1 piece), each",09-10-2025
A5053001003,"Ostomy pouch, closed; for use on faceplate, each",09-10-2025
A5054001003,"Ostomy pouch, closed; for use on barrier with flange (2 piece), each",09-10-2025
A5055001003,Stoma cap,09-10-2025
A5056001003,"Ostomy pouch, drainable, with extended wear barrier attached, with filter, (1",09-10-2025
A5056002004,"Piece), each",09-10-2025
A5057001003,"Ostomy pouch, drainable, with extended wear barrier attached, with built in",09-10-2025
A5057002004,"Convexity, with filter, (1 piece), each",09-10-2025
A5061001003,"Ostomy pouch, drainable; with barrier attached, (1 piece), each",09-10-2025
A5062001003,"Ostomy pouch, drainable; without barrier attached (1 piece), each",09-10-2025
A5063001003,"Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each",09-10-2025
A5071001003,"Ostomy pouch, urinary; with barrier attached (1 piece), each",09-10-2025
A5072001003,"Ostomy pouch, urinary; without barrier attached (1 piece), each",09-10-2025
A5073001003,"Ostomy pouch, urinary; for use on barrier with flange (2 piece), each",09-10-2025
A5081001003,"Stoma plug or seal, any type",09-10-2025
A5082001003,Continent device; catheter for continent stoma,09-10-2025
A5083001003,"Continent device, stoma absorptive cover for continent stoma",09-10-2025
A5093001003,Ostomy accessory; convex insert,09-10-2025
A5102001003,"Bedside drainage bottle with or without tubing, rigid or expandable, each",09-10-2025
A5105001003,"Urinary suspensory with leg bag, with or without tube, each",09-10-2025
A5112001003,"Urinary drainage bag, leg or abdomen, latex, with or without tube, with straps,",09-10-2025
A5112002004,Each,09-10-2025
A5113001003,"Leg strap; latex, replacement only, per set",09-10-2025
A5114001003,"Leg strap; foam or fabric, replacement only, per set",09-10-2025
A5120001003,"Skin barrier, wipes or swabs, each",09-10-2025
A5121001003,"Skin barrier; solid, 6 x 6 or equivalent, each",09-10-2025
A5122001003,"Skin barrier; solid, 8 x 8 or equivalent, each",09-10-2025
A5126001003,Adhesive or non-adhesive; disk or foam pad,09-10-2025
A5131001003,"Appliance cleaner, incontinence and ostomy appliances, per 16 oz.",09-10-2025
A5200001003,"Percutaneous catheter/tube anchoring device, adhesive skin attachment",09-10-2025
A5500001003,"For diabetics only, fitting (including follow-up), custom preparation and",09-10-2025
A5500002004,Supply of off-the-shelf depth-inlay shoe manufactured to accommodate,09-10-2025
A5500003004,"Multi-density insert(s), per shoe",09-10-2025
A5501001003,"For diabetics only, fitting (including follow-up), custom preparation and",09-10-2025
A5501002004,"Supply of shoe molded from cast(s) of patient's foot (custom molded shoe), per",09-10-2025
A5501003004,Shoe,09-10-2025
A5503001003,"For diabetics only, modification (including fitting) of off-the-shelf",09-10-2025
A5503002004,"Depth-inlay shoe or custom-molded shoe with roller or rigid rocker bottom, per",09-10-2025
A5503003004,Shoe,09-10-2025
A5504001003,"For diabetics only, modification (including fitting) of off-the-shelf",09-10-2025
A5504002004,"Depth-inlay shoe or custom-molded shoe with wedge(s), per shoe",09-10-2025
A5505001003,"For diabetics only, modification (including fitting) of off-the-shelf",09-10-2025
A5505002004,"Depth-inlay shoe or custom-molded shoe with metatarsal bar, per shoe",09-10-2025
A5506001003,"For diabetics only, modification (including fitting) of off-the-shelf",09-10-2025
A5506002004,"Depth-inlay shoe or custom-molded shoe with off-set heel(s), per shoe",09-10-2025
A5507001003,"For diabetics only, not otherwise specified modification (including fitting) of",09-10-2025
A5507002004,"Off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe",09-10-2025
A5508001003,"For diabetics only, deluxe feature of off-the-shelf depth-inlay shoe or",09-10-2025
A5508002004,"Custom-molded shoe, per shoe",09-10-2025
A5510001003,"For diabetics only, direct formed, compression molded to patient's foot without",09-10-2025
A5510002004,"External heat source, multiple-density insert(s) prefabricated, per shoe",09-10-2025
A5512001003,"For diabetics only, multiple density insert, direct formed, molded to foot",09-10-2025
A5512002004,"After external heat source of 230 degrees fahrenheit or higher, total contact",09-10-2025
A5512003004,"With patient's foot, including arch, base layer minimum of 1/4 inch material of",09-10-2025
A5512004004,"Shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher),",09-10-2025
A5512005004,"Prefabricated, each",09-10-2025
A5513001003,"For diabetics only, multiple density insert, custom molded from model of",09-10-2025
A5513002004,"Patient's foot, total contact with patient's foot, including arch, base layer",09-10-2025
A5513003004,"Minimum of 3/16 inch material of shore a 35 durometer (or higher), includes",09-10-2025
A5513004004,"Arch filler and other shaping material, custom fabricated, each",09-10-2025
A5514001003,"For diabetics only, multiple density insert, made by direct carving with cam",09-10-2025
A5514002004,Technology from a rectified cad model created from a digitized scan of the,09-10-2025
A5514003004,"Patient, total contact with patient's foot, including arch, base layer minimum",09-10-2025
A5514004004,"Of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler",09-10-2025
A5514005004,"And other shaping material, custom fabricated, each",09-10-2025
A6000001003,Non-contact wound warming wound cover for use with the non-contact wound,09-10-2025
A6000002004,Warming device and warming card,09-10-2025
A6010001003,"Collagen based wound filler, dry form, sterile, per gram of collagen",09-10-2025
A6011001003,"Collagen based wound filler, gel/paste, per gram of collagen",09-10-2025
A6021001003,"Collagen dressing, sterile, size 16 sq. in. or less, each",09-10-2025
A6022001003,"Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to",09-10-2025
A6022002004,"48 sq. in., each",09-10-2025
A6023001003,"Collagen dressing, sterile, size more than 48 sq. in., each",09-10-2025
A6024001003,"Collagen dressing wound filler, sterile, per 6 inches",09-10-2025
A6025001003,"Gel sheet for dermal or epidermal application, (e.g., silicone, hydrogel,",09-10-2025
A6025002004,"Other), each",09-10-2025
A6154001003,"Wound pouch, each",09-10-2025
A6196001003,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq.",09-10-2025
A6196002004,"In. or less, each dressing",09-10-2025
A6197001003,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size more",09-10-2025
A6197002004,"Than 16 sq. in. but less than or equal to 48 sq. in., each dressing",09-10-2025
A6198001003,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size more",09-10-2025
A6198002004,"Than 48 sq. in., each dressing",09-10-2025
A6199001003,"Alginate or other fiber gelling dressing, wound filler, sterile, per 6 inches",09-10-2025
A6203001003,"Composite dressing, sterile, pad size 16 sq. in. or less, with any size",09-10-2025
A6203002004,"Adhesive border, each dressing",09-10-2025
A6204001003,"Composite dressing, sterile, pad size more than 16 sq. in. but less than or",09-10-2025
A6204002004,"Equal to 48 sq. in., with any size adhesive border, each dressing",09-10-2025
A6205001003,"Composite dressing, sterile, pad size more than 48 sq. in., with any size",09-10-2025
A6205002004,"Adhesive border, each dressing",09-10-2025
A6206001003,"Contact layer, sterile, 16 sq. in. or less, each dressing",09-10-2025
A6207001003,"Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq.",09-10-2025
A6207002004,"In., each dressing",09-10-2025
A6208001003,"Contact layer, sterile, more than 48 sq. in., each dressing",09-10-2025
A6209001003,"Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without",09-10-2025
A6209002004,"Adhesive border, each dressing",09-10-2025
A6210001003,"Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less",09-10-2025
A6210002004,"Than or equal to 48 sq. in., without adhesive border, each dressing",09-10-2025
A6211001003,"Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without",09-10-2025
A6211002004,"Adhesive border, each dressing",09-10-2025
A6212001003,"Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size",09-10-2025
A6212002004,"Adhesive border, each dressing",09-10-2025
A6213001003,"Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less",09-10-2025
A6213002004,"Than or equal to 48 sq. in., with any size adhesive border, each dressing",09-10-2025
A6214001003,"Foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any",09-10-2025
A6214002004,"Size adhesive border, each dressing",09-10-2025
A6215001003,"Foam dressing, wound filler, sterile, per gram",09-10-2025
A6216001003,"Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without",09-10-2025
A6216002004,"Adhesive border, each dressing",09-10-2025
A6217001003,"Gauze, non-impregnated, non-sterile, pad size more than 16 sq. in. but less",09-10-2025
A6217002004,"Than or equal to 48 sq. in., without adhesive border, each dressing",09-10-2025
A6218001003,"Gauze, non-impregnated, non-sterile, pad size more than 48 sq. in., without",09-10-2025
A6218002004,"Adhesive border, each dressing",09-10-2025
A6219001003,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size",09-10-2025
A6219002004,"Adhesive border, each dressing",09-10-2025
A6220001003,"Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or",09-10-2025
A6220002004,"Equal to 48 sq. in., with any size adhesive border, each dressing",09-10-2025
A6221001003,"Gauze, non-impregnated, sterile, pad size more than 48 sq. in., with any size",09-10-2025
A6221002004,"Adhesive border, each dressing",09-10-2025
A6222001003,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile,",09-10-2025
A6222002004,"Pad size 16 sq. in. or less, without adhesive border, each dressing",09-10-2025
A6223001003,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile,",09-10-2025
A6223002004,"Pad size more than 16 sq. in., but less than or equal to 48 sq. in., without",09-10-2025
A6223003004,"Adhesive border, each dressing",09-10-2025
A6224001003,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile,",09-10-2025
A6224002004,"Pad size more than 48 sq. in., without adhesive border, each dressing",09-10-2025
A6228001003,"Gauze, impregnated, water or normal saline, sterile, pad size 16 sq. in. or",09-10-2025
A6228002004,"Less, without adhesive border, each dressing",09-10-2025
A6229001003,"Gauze, impregnated, water or normal saline, sterile, pad size more than 16 sq.",09-10-2025
A6229002004,"In. but less than or equal to 48 sq. in., without adhesive border, each dressin",09-10-2025
A6230001003,"Gauze, impregnated, water or normal saline, sterile, pad size more than 48 sq.",09-10-2025
A6230002004,"In., without adhesive border, each dressing",09-10-2025
A6231001003,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16",09-10-2025
A6231002004,"Sq. in. or less, each dressing",09-10-2025
A6232001003,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size",09-10-2025
A6232002004,"Greater than 16 sq. in., but less than or equal to 48 sq. in., each dressing",09-10-2025
A6233001003,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size more",09-10-2025
A6233002004,"Than 48 sq. in., each dressing",09-10-2025
A6234001003,"Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less,",09-10-2025
A6234002004,"Without adhesive border, each dressing",09-10-2025
A6235001003,"Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but",09-10-2025
A6235002004,"Less than or equal to 48 sq. in., without adhesive border, each dressing",09-10-2025
A6236001003,"Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in.,",09-10-2025
A6236002004,"Without adhesive border, each dressing",09-10-2025
A6237001003,"Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, with",09-10-2025
A6237002004,"Any size adhesive border, each dressing",09-10-2025
A6238001003,"Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but",09-10-2025
A6238002004,"Less than or equal to 48 sq. in., with any size adhesive border, each dressing",09-10-2025
A6239001003,"Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in.,",09-10-2025
A6239002004,"With any size adhesive border, each dressing",09-10-2025
A6240001003,"Hydrocolloid dressing, wound filler, paste, sterile, per ounce",09-10-2025
A6241001003,"Hydrocolloid dressing, wound filler, dry form, sterile, per gram",09-10-2025
A6242001003,"Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, without",09-10-2025
A6242002004,"Adhesive border, each dressing",09-10-2025
A6243001003,"Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less",09-10-2025
A6243002004,"Than or equal to 48 sq. in., without adhesive border, each dressing",09-10-2025
A6244001003,"Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., without",09-10-2025
A6244002004,"Adhesive border, each dressing",09-10-2025
A6245001003,"Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, with any",09-10-2025
A6245002004,"Size adhesive border, each dressing",09-10-2025
A6246001003,"Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less",09-10-2025
A6246002004,"Than or equal to 48 sq. in., with any size adhesive border, each dressing",09-10-2025
A6247001003,"Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., with",09-10-2025
A6247002004,"Any size adhesive border, each dressing",09-10-2025
A6248001003,"Hydrogel dressing, wound filler, gel, per fluid ounce",09-10-2025
A6250001003,"Skin sealants, protectants, moisturizers, ointments, any type, any size",09-10-2025
A6251001003,"Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or",09-10-2025
A6251002004,"Less, without adhesive border, each dressing",09-10-2025
A6252001003,"Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq.",09-10-2025
A6252002004,"In. but less than or equal to 48 sq. in., without adhesive border, each dressin",09-10-2025
A6253001003,"Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq.",09-10-2025
A6253002004,"In., without adhesive border, each dressing",09-10-2025
A6254001003,"Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or",09-10-2025
A6254002004,"Less, with any size adhesive border, each dressing",09-10-2025
A6255001003,"Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq.",09-10-2025
A6255002004,"In. but less than or equal to 48 sq. in., with any size adhesive border, each",09-10-2025
A6255003004,Dressing,09-10-2025
A6256001003,"Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq.",09-10-2025
A6256002004,"In., with any size adhesive border, each dressing",09-10-2025
A6257001003,"Transparent film, sterile, 16 sq. in. or less, each dressing",09-10-2025
A6258001003,"Transparent film, sterile, more than 16 sq. in. but less than or equal to 48",09-10-2025
A6258002004,"Sq. in., each dressing",09-10-2025
A6259001003,"Transparent film, sterile, more than 48 sq. in., each dressing",09-10-2025
A6260001003,"Wound cleansers, any type, any size",09-10-2025
A6261001003,"Wound filler, gel/paste, per fluid ounce, not otherwise specified",09-10-2025
A6262001003,"Wound filler, dry form, per gram, not otherwise specified",09-10-2025
A6266001003,"Gauze, impregnated, other than water, normal saline, or zinc paste, sterile,",09-10-2025
A6266002004,"Any width, per linear yard",09-10-2025
A6402001003,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive",09-10-2025
A6402002004,"Border, each dressing",09-10-2025
A6403001003,"Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or",09-10-2025
A6403002004,"Equal to 48 sq. in., without adhesive border, each dressing",09-10-2025
A6404001003,"Gauze, non-impregnated, sterile, pad size more than 48 sq. in., without",09-10-2025
A6404002004,"Adhesive border, each dressing",09-10-2025
A6407001003,"Packing strips, non-impregnated, sterile, up to 2 inches in width, per linear",09-10-2025
A6407002004,Yard,09-10-2025
A6410001003,"Eye pad, sterile, each",09-10-2025
A6411001003,"Eye pad, non-sterile, each",09-10-2025
A6412001003,"Eye patch, occlusive, each",09-10-2025
A6413001003,"Adhesive bandage, first-aid type, any size, each",09-10-2025
A6441001003,"Padding bandage, non-elastic, non-woven/non-knitted, width greater than or",09-10-2025
A6441002004,"Equal to three inches and less than five inches, per yard",09-10-2025
A6442001003,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width less than",09-10-2025
A6442002004,"Three inches, per yard",09-10-2025
A6443001003,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than",09-10-2025
A6443002004,"Or equal to three inches and less than five inches, per yard",09-10-2025
A6444001003,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than",09-10-2025
A6444002004,"Or equal to 5 inches, per yard",09-10-2025
A6445001003,"Conforming bandage, non-elastic, knitted/woven, sterile, width less than three",09-10-2025
A6445002004,"Inches, per yard",09-10-2025
A6446001003,"Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or",09-10-2025
A6446002004,"Equal to three inches and less than five inches, per yard",09-10-2025
A6447001003,"Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or",09-10-2025
A6447002004,"Equal to five inches, per yard",09-10-2025
A6448001003,"Light compression bandage, elastic, knitted/woven, width less than three",09-10-2025
A6448002004,"Inches, per yard",09-10-2025
A6449001003,"Light compression bandage, elastic, knitted/woven, width greater than or equal",09-10-2025
A6449002004,"To three inches and less than five inches, per yard",09-10-2025
A6450001003,"Light compression bandage, elastic, knitted/woven, width greater than or equal",09-10-2025
A6450002004,"To five inches, per yard",09-10-2025
A6451001003,"Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25",09-10-2025
A6451002004,"To 1.34 foot pounds at 50% maximum stretch, width greater than or equal to",09-10-2025
A6451003004,"Three inches and less than five inches, per yard",09-10-2025
A6452001003,"High compression bandage, elastic, knitted/woven, load resistance greater than",09-10-2025
A6452002004,"Or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or",09-10-2025
A6452003004,"Equal to three inches and less than five inches, per yard",09-10-2025
A6453001003,"Self-adherent bandage, elastic, non-knitted/non-woven, width less than three",09-10-2025
A6453002004,"Inches, per yard",09-10-2025
A6454001003,"Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or",09-10-2025
A6454002004,"Equal to three inches and less than five inches, per yard",09-10-2025
A6455001003,"Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or",09-10-2025
A6455002004,"Equal to five inches, per yard",09-10-2025
A6456001003,"Zinc paste impregnated bandage, non-elastic, knitted/woven, width greater than",09-10-2025
A6456002004,"Or equal to three inches and less than five inches, per yard",09-10-2025
A6457001003,"Tubular dressing with or without elastic, any width, per linear yard",09-10-2025
A6460001003,"Synthetic resorbable wound dressing, sterile, pad size 16 sq. in. or less,",09-10-2025
A6460002004,"Without adhesive border, each dressing",09-10-2025
A6461001003,"Synthetic resorbable wound dressing, sterile, pad size more than 16 sq. in. but",09-10-2025
A6461002004,"Less than or equal to 48 sq. in., without adhesive border, each dressing",09-10-2025
A6501001003,"Compression burn garment, bodysuit (head to foot), custom fabricated",09-10-2025
A6502001003,"Compression burn garment, chin strap, custom fabricated",09-10-2025
A6503001003,"Compression burn garment, facial hood, custom fabricated",09-10-2025
A6504001003,"Compression burn garment, glove to wrist, custom fabricated",09-10-2025
A6505001003,"Compression burn garment, glove to elbow, custom fabricated",09-10-2025
A6506001003,"Compression burn garment, glove to axilla, custom fabricated",09-10-2025
A6507001003,"Compression burn garment, foot to knee length, custom fabricated",09-10-2025
A6508001003,"Compression burn garment, foot to thigh length, custom fabricated",09-10-2025
A6509001003,"Compression burn garment, upper trunk to waist including arm openings (vest),",09-10-2025
A6509002004,Custom fabricated,09-10-2025
A6510001003,"Compression burn garment, trunk, including arms down to leg openings (leotard),",09-10-2025
A6510002004,Custom fabricated,09-10-2025
A6511001003,"Compression burn garment, lower trunk including leg openings (panty), custom",09-10-2025
A6511002004,Fabricated,09-10-2025
A6512001003,"Compression burn garment, not otherwise classified",09-10-2025
A6513001003,"Compression burn mask, face and/or neck, plastic or equal, custom fabricated",09-10-2025
A6515001003,"Gradient compression wrap with adjustable straps, full leg, each, custom",09-10-2025
A6516001003,"Gradient compression wrap with adjustable straps, foot, each, custom",09-10-2025
A6517001003,"Gradient compression wrap with adjustable straps, below knee, each, custom",09-10-2025
A6518001003,"Gradient compression wrap with adjustable straps, arm, each, custom",09-10-2025
A6519001003,"Gradient compression garment, not otherwise specified, for nighttime use, each",09-10-2025
A6520001003,"Gradient compression garment, glove, padded, for nighttime use, each",09-10-2025
A6521001003,"Gradient compression garment, glove, padded, for nighttime use, custom, each",09-10-2025
A6522001003,"Gradient compression garment, arm, padded, for nighttime use, each",09-10-2025
A6523001003,"Gradient compression garment, arm, padded, for nighttime use, custom, each",09-10-2025
A6524001003,"Gradient compression garment, lower leg and foot, padded, for nighttime use,",09-10-2025
A6524002004,Each,09-10-2025
A6525001003,"Gradient compression garment, lower leg and foot, padded, for nighttime use,",09-10-2025
A6525002004,"Custom, each",09-10-2025
A6526001003,"Gradient compression garment, full leg and foot, padded, for nighttime use, eac",09-10-2025
A6527001003,"Gradient compression garment, full leg and foot, padded, for nighttime use,",09-10-2025
A6527002004,"Custom, each",09-10-2025
A6528001003,"Gradient compression garment, bra, for nighttime use, each",09-10-2025
A6529001003,"Gradient compression garment, bra, for nighttime use, custom, each",09-10-2025
A6530001003,"Gradient compression stocking, below knee, 18-30 mmhg, each",09-10-2025
A6531001003,"Gradient compression stocking, below knee, 30-40 mmhg, used as a surgical",09-10-2025
A6531002004,"Dressing, each",09-10-2025
A6532001003,"Gradient compression stocking, below knee, 40-50 mmhg, used as a surgical",09-10-2025
A6532002004,"Dressing, each",09-10-2025
A6533001003,"Gradient compression stocking, thigh length, 18-30 mmhg, each",09-10-2025
A6534001003,"Gradient compression stocking, thigh length, 30-40 mmhg, each",09-10-2025
A6535001003,"Gradient compression stocking, thigh length, 40 mmhg or greater, each",09-10-2025
A6536001003,"Gradient compression stocking, full length/chap style, 18-30 mmhg, each",09-10-2025
A6537001003,"Gradient compression stocking, full length/chap style, 30-40 mmhg, each",09-10-2025
A6538001003,"Gradient compression stocking, full length/chap style, 40 mmhg or greater, each",09-10-2025
A6539001003,"Gradient compression stocking, waist length, 18-30 mmhg, each",09-10-2025
A6540001003,"Gradient compression stocking, waist length, 30-40 mmhg, each",09-10-2025
A6541001003,"Gradient compression stocking, waist length, 40 mmhg or greater, each",09-10-2025
A6544001003,"Gradient compression stocking, garter belt",09-10-2025
A6545001003,"Gradient compression wrap, non-elastic, below knee, 30-50 mmhg, used as a",09-10-2025
A6545002004,"Surgical dressing, each",09-10-2025
A6549001003,"Gradient compression garment, not otherwise specified, for daytime use, each",09-10-2025
A6550001003,"Wound care set, for negative pressure wound therapy electrical pump, includes",09-10-2025
A6550002004,All supplies and accessories,09-10-2025
A6552001003,"Gradient compression stocking, below knee, 30-40 mmhg, each",09-10-2025
A6553001003,"Gradient compression stocking, below knee, 30-40 mmhg, custom, each",09-10-2025
A6554001003,"Gradient compression stocking, below knee, 40 mmhg or greater, each",09-10-2025
A6555001003,"Gradient compression stocking, below knee, 40 mmhg or greater, custom, each",09-10-2025
A6556001003,"Gradient compression stocking, thigh length, 18-30 mmhg, custom, each",09-10-2025
A6557001003,"Gradient compression stocking, thigh length, 30-40 mmhg, custom, each",09-10-2025
A6558001003,"Gradient compression stocking, thigh length, 40 mmhg or greater, custom, each",09-10-2025
A6559001003,"Gradient compression stocking, full length/chap style, 18-30 mmhg, custom, each",09-10-2025
A6560001003,"Gradient compression stocking, full length/chap style, 30-40 mmhg, custom, each",09-10-2025
A6561001003,"Gradient compression stocking, full length/chap style, 40 mmhg or greater,",09-10-2025
A6561002004,"Custom, each",09-10-2025
A6562001003,"Gradient compression stocking, waist length, 18-30 mmhg, custom, each",09-10-2025
A6563001003,"Gradient compression stocking, waist length, 30-40 mmhg, custom, each",09-10-2025
A6564001003,"Gradient compression stocking, waist length, 40 mmhg or greater, custom, each",09-10-2025
A6565001003,"Gradient compression gauntlet, custom, each",09-10-2025
A6566001003,"Gradient compression garment, neck/head, each",09-10-2025
A6567001003,"Gradient compression garment, neck/head, custom, each",09-10-2025
A6568001003,"Gradient compression garment, torso and shoulder, each",09-10-2025
A6569001003,"Gradient compression garment, torso/shoulder, custom, each",09-10-2025
A6570001003,"Gradient compression garment, genital region, each",09-10-2025
A6571001003,"Gradient compression garment, genital region, custom, each",09-10-2025
A6572001003,"Gradient compression garment, toe caps, each",09-10-2025
A6573001003,"Gradient compression garment, toe caps, custom, each",09-10-2025
A6574001003,"Gradient compression arm sleeve and glove combination, custom, each",09-10-2025
A6575001003,"Gradient compression arm sleeve and glove combination, each",09-10-2025
A6576001003,"Gradient compression arm sleeve, custom, medium weight, each",09-10-2025
A6577001003,"Gradient compression arm sleeve, custom, heavy weight, each",09-10-2025
A6578001003,"Gradient compression arm sleeve, each",09-10-2025
A6579001003,"Gradient compression glove, custom, medium weight, each",09-10-2025
A6580001003,"Gradient compression glove, custom, heavy weight, each",09-10-2025
A6581001003,"Gradient compression glove, each",09-10-2025
A6582001003,"Gradient compression gauntlet, each",09-10-2025
A6583001003,"Gradient compression wrap with adjustable straps, below knee, each",09-10-2025
A6584001003,"Gradient compression wrap with adjustable straps, not otherwise specified",09-10-2025
A6585001003,"Gradient compression wrap with adjustable straps, above knee, each",09-10-2025
A6586001003,"Gradient compression wrap with adjustable straps, full leg, each",09-10-2025
A6587001003,"Gradient compression wrap with adjustable straps, foot, each",09-10-2025
A6588001003,"Gradient compression wrap with adjustable straps, arm, each",09-10-2025
A6589001003,"Gradient pressure wrap with adjustable straps, bra, each",09-10-2025
A6590001003,"External urinary catheters; disposable, with wicking material, for use with",09-10-2025
A6590002004,"Suction pump, per month",09-10-2025
A6591001003,"External urinary catheter; non-disposable, for use with suction pump, per month",09-10-2025
A6593001003,"Accessory for gradient compression garment or wrap with adjustable straps,",09-10-2025
A6593002004,Not-otherwise specified,09-10-2025
A6594001003,"Gradient compression bandaging supply, bandage liner, lower extremity, any size",09-10-2025
A6594002004,"Or length, each",09-10-2025
A6595001003,"Gradient compression bandaging supply, bandage liner, upper extremity, any size",09-10-2025
A6595002004,"Or length, each",09-10-2025
A6596001003,"Gradient compression bandaging supply, conforming gauze, per linear yard, any",09-10-2025
A6596002004,"Width, each",09-10-2025
A6597001003,"Gradient compression bandage roll, elastic long stretch, linear yard, any",09-10-2025
A6597002004,"Width, each",09-10-2025
A6598001003,"Gradient compression bandage roll, elastic medium stretch, per linear yard, any",09-10-2025
A6598002004,"Width, each",09-10-2025
A6599001003,"Gradient compression bandage roll, inelastic short stretch, per linear yard,",09-10-2025
A6599002004,"Any width, each",09-10-2025
A6600001003,"Gradient compression bandaging supply, high density foam sheet, per 250 square",09-10-2025
A6600002004,"Centimeters, each",09-10-2025
A6601001003,"Gradient compression bandaging supply, high density foam pad, any size or",09-10-2025
A6601002004,"Shape, each",09-10-2025
A6602001003,"Gradient compression bandaging supply, high density foam roll for bandage, per",09-10-2025
A6602002004,"Linear yard, any width, each",09-10-2025
A6603001003,"Gradient compression bandaging supply, low density channel foam sheet, per 250",09-10-2025
A6603002004,"Square centimeters, each",09-10-2025
A6604001003,"Gradient compression bandaging supply, low density flat foam sheet, per 250",09-10-2025
A6604002004,"Square centimeters, each",09-10-2025
A6605001003,"Gradient compression bandaging supply, padded foam, per linear yard, any width,",09-10-2025
A6605002004,Each,09-10-2025
A6606001003,"Gradient compression bandaging supply, padded textile, per linear yard, any",09-10-2025
A6606002004,"Width, each",09-10-2025
A6607001003,"Gradient compression bandaging supply, tubular protective absorption layer, per",09-10-2025
A6607002004,"Linear yard, any width, each",09-10-2025
A6608001003,"Gradient compression bandaging supply, tubular protective absorption padded",09-10-2025
A6608002004,"Layer, per linear yard, any width, each",09-10-2025
A6609001003,"Gradient compression bandaging supply, not otherwise specified",09-10-2025
A6610001003,"Gradient compression stocking, below knee, 18-30 mmhg, custom, each",09-10-2025
A6611001003,"Gradient compression wrap with adjustable straps, above knee, each, custom",09-10-2025
A7000001003,"Canister, disposable, used with suction pump, each",09-10-2025
A7001001003,"Canister, non-disposable, used with suction pump, each",09-10-2025
A7002001003,"Tubing, used with suction pump, each",09-10-2025
A7003001003,"Administration set, with small volume nonfiltered pneumatic nebulizer,",09-10-2025
A7003002004,Disposable,09-10-2025
A7004001003,"Small volume nonfiltered pneumatic nebulizer, disposable",09-10-2025
A7005001003,"Administration set, with small volume nonfiltered pneumatic nebulizer,",09-10-2025
A7005002004,Non-disposable,09-10-2025
A7006001003,"Administration set, with small volume filtered pneumatic nebulizer",09-10-2025
A7007001003,"Large volume nebulizer, disposable, unfilled, used with aerosol compressor",09-10-2025
A7008001003,"Large volume nebulizer, disposable, prefilled, used with aerosol compressor",09-10-2025
A7009001003,"Reservoir bottle, non-disposable, used with large volume ultrasonic nebulizer",09-10-2025
A7010001003,"Corrugated tubing, disposable, used with large volume nebulizer, 100 feet",09-10-2025
A7011001003,"Corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet",09-10-2025
A7012001003,"Water collection device, used with large volume nebulizer",09-10-2025
A7013001003,"Filter, disposable, used with aerosol compressor or ultrasonic generator",09-10-2025
A7014001003,"Filter, nondisposable, used with aerosol compressor or ultrasonic generator",09-10-2025
A7015001003,"Aerosol mask, used with dme nebulizer",09-10-2025
A7016001003,"Dome and mouthpiece, used with small volume ultrasonic nebulizer",09-10-2025
A7017001003,"Nebulizer, durable, glass or autoclavable plastic, bottle type, not used with",09-10-2025
A7017002004,Oxygen,09-10-2025
A7018001003,"Water, distilled, used with large volume nebulizer, 1000 ml",09-10-2025
A7020001003,"Interface for cough stimulating device, includes all components, replacement",09-10-2025
A7020002004,Only,09-10-2025
A7021001003,"Supplies and accessories for lung expansion airway clearance, continuous high",09-10-2025
A7021002004,"Frequency oscillation, and nebulization device (e.g., handset, nebulizer kit,",09-10-2025
A7021003004,Biofilter),09-10-2025
A7023001003,"Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical",09-10-2025
A7025001003,"High frequency chest wall oscillation system vest, replacement for use with",09-10-2025
A7025002004,"Patient owned equipment, each",09-10-2025
A7026001003,"High frequency chest wall oscillation system hose, replacement for use with",09-10-2025
A7026002004,"Patient owned equipment, each",09-10-2025
A7027001003,"Combination oral/nasal mask, used with continuous positive airway pressure",09-10-2025
A7027002004,"Device, each",09-10-2025
A7028001003,"Oral cushion for combination oral/nasal mask, replacement only, each",09-10-2025
A7029001003,"Nasal pillows for combination oral/nasal mask, replacement only, pair",09-10-2025
A7030001003,"Full face mask used with positive airway pressure device, each",09-10-2025
A7031001003,"Face mask interface, replacement for full face mask, each",09-10-2025
A7032001003,"Cushion for use on nasal mask interface, replacement only, each",09-10-2025
A7033001003,"Pillow for use on nasal cannula type interface, replacement only, pair",09-10-2025
A7034001003,Nasal interface (mask or cannula type) used with positive airway pressure,09-10-2025
A7034002004,"Device, with or without head strap",09-10-2025
A7035001003,Headgear used with positive airway pressure device,09-10-2025
A7036001003,Chinstrap used with positive airway pressure device,09-10-2025
A7037001003,Tubing used with positive airway pressure device,09-10-2025
A7038001003,"Filter, disposable, used with positive airway pressure device",09-10-2025
A7039001003,"Filter, non disposable, used with positive airway pressure device",09-10-2025
A7040001003,One way chest drain valve,09-10-2025
A7041001003,Water seal drainage container and tubing for use with implanted chest tube,09-10-2025
A7042001003,"Implanted pleural catheter, each",09-10-2025
A7043001003,Vacuum drainage bottle and tubing for use with implanted catheter,09-10-2025
A7044001003,"Oral interface used with positive airway pressure device, each",09-10-2025
A7045001003,Exhalation port with or without swivel used with accessories for positive,09-10-2025
A7045002004,"Airway devices, replacement only",09-10-2025
A7046001003,"Water chamber for humidifier, used with positive airway pressure device,",09-10-2025
A7046002004,"Replacement, each",09-10-2025
A7047001003,"Oral interface used with respiratory suction pump, each",09-10-2025
A7048001003,"Vacuum drainage collection unit and tubing kit, including all supplies needed",09-10-2025
A7048002004,"For collection unit change, for use with implanted catheter, each",09-10-2025
A7049001003,Expiratory positive airway pressure intranasal resistance valve,09-10-2025
A7501001003,"Tracheostoma valve, including diaphragm, each",09-10-2025
A7502001003,"Replacement diaphragm/faceplate for tracheostoma valve, each",09-10-2025
A7503001003,"Filter holder or filter cap, reusable, for use in a tracheostoma heat and",09-10-2025
A7503002004,"Moisture exchange system, each",09-10-2025
A7504001003,"Filter for use in a tracheostoma heat and moisture exchange system, each",09-10-2025
A7505001003,"Housing, reusable without adhesive, for use in a heat and moisture exchange",09-10-2025
A7505002004,"System and/or with a tracheostoma valve, each",09-10-2025
A7506001003,Adhesive disc for use in a heat and moisture exchange system and/or with,09-10-2025
A7506002004,"Tracheostoma valve, any type each",09-10-2025
A7507001003,"Filter holder and integrated filter without adhesive, for use in a tracheostoma",09-10-2025
A7507002004,"Heat and moisture exchange system, each",09-10-2025
A7508001003,"Housing and integrated adhesive, for use in a tracheostoma heat and moisture",09-10-2025
A7508002004,"Exchange system and/or with a tracheostoma valve, each",09-10-2025
A7509001003,"Filter holder and integrated filter housing, and adhesive, for use as a",09-10-2025
A7509002004,"Tracheostoma heat and moisture exchange system, each",09-10-2025
A7520001003,"Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone",09-10-2025
A7520002004,"Or equal, each",09-10-2025
A7521001003,"Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or",09-10-2025
A7521002004,"Equal, each",09-10-2025
A7522001003,"Tracheostomy/laryngectomy tube, stainless steel or equal (sterilizable and",09-10-2025
A7522002004,"Reusable), each",09-10-2025
A7523001003,"Tracheostomy shower protector, each",09-10-2025
A7524001003,"Tracheostoma stent/stud/button, each",09-10-2025
A7525001003,"Tracheostomy mask, each",09-10-2025
A7526001003,"Tracheostomy tube collar/holder, each",09-10-2025
A7527001003,"Tracheostomy/laryngectomy tube plug/stop, each",09-10-2025
A8000001003,"Helmet, protective, soft, prefabricated, includes all components and accessorie",09-10-2025
A8001001003,"Helmet, protective, hard, prefabricated, includes all components and accessorie",09-10-2025
A8002001003,"Helmet, protective, soft, custom fabricated, includes all components and",09-10-2025
A8002002004,Accessories,09-10-2025
A8003001003,"Helmet, protective, hard, custom fabricated, includes all components and",09-10-2025
A8003002004,Accessories,09-10-2025
A8004001003,"Soft interface for helmet, replacement only",09-10-2025
A9150001003,Non-prescription drugs,09-10-2025
A9152001003,"Single vitamin/mineral/trace element, oral, per dose, not otherwise specified",09-10-2025
A9153001003,"Multiple vitamins, with or without minerals and trace elements, oral, per dose,",09-10-2025
A9153002004,Not otherwise specified,09-10-2025
A9154001003,"Artificial saliva, 1 ml",09-10-2025
A9155001003,"Artificial saliva, 30 ml",09-10-2025
A9156001003,"Oral mucoadhesive, any type (liquid, gel, paste, etc.), per 1 ml",09-10-2025
A9180001003,"Pediculosis (lice infestation) treatment, topical, for administration by",09-10-2025
A9180002004,Patient/caretaker,09-10-2025
A9268001003,"Programmer for transient, orally ingested capsule",09-10-2025
A9269001003,"Programable, transient, orally ingested capsule, for use with external",09-10-2025
A9269002004,"Programmer, per month",09-10-2025
A9270001003,Non-covered item or service,09-10-2025
A9272001003,"Wound suction, disposable, includes dressing, all accessories and components,",09-10-2025
A9272002004,"Any type, each",09-10-2025
A9273001003,"Cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type",09-10-2025
A9274001003,"External ambulatory insulin delivery system, disposable, each, includes all",09-10-2025
A9274002004,Supplies and accessories,09-10-2025
A9275001003,"Home glucose disposable monitor, includes test strips",09-10-2025
A9276001003,"Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable",09-10-2025
A9276002004,"Medical equipment interstitial continuous glucose monitoring system, one unit =",09-10-2025
A9276003004,1 day supply,09-10-2025
A9277001003,"Transmitter; external, for use with non-durable medical equipment interstitial",09-10-2025
A9277002004,Continuous glucose monitoring system,09-10-2025
A9278001003,"Receiver (monitor); external, for use with non-durable medical equipment",09-10-2025
A9278002004,Interstitial continuous glucose monitoring system,09-10-2025
A9279001003,"Monitoring feature/device, stand-alone or integrated, any type, includes all",09-10-2025
A9279002004,"Accessories, components and electronics, not otherwise classified",09-10-2025
A9280001003,"Alert or alarm device, not otherwise classified",09-10-2025
A9281001003,"Reaching/grabbing device, any type, any length, each",09-10-2025
A9282001003,"Wig, any type, each",09-10-2025
A9283001003,"Foot pressure off loading/supportive device, any type, each",09-10-2025
A9284001003,"Spirometer, non-electronic, includes all accessories",09-10-2025
A9285001003,Inversion/eversion correction device,09-10-2025
A9286001003,"Hygienic item or device, disposable or non-disposable, any type, each",09-10-2025
A9291001003,"Prescription digital cognitive and/or behavioral therapy, fda cleared, per",09-10-2025
A9291002004,Course of treatment,09-10-2025
A9292001003,"Prescription digital visual therapy, software-only, fda cleared, per course of",09-10-2025
A9292002004,Treatment,09-10-2025
A9293001003,"Fertility cycle (contraception & conception) tracking software application, fda",09-10-2025
A9293002004,"Cleared, per month, includes accessories (e.g., thermometer)",09-10-2025
A9300001003,Exercise equipment,09-10-2025
A9500001003,"Technetium tc-99m sestamibi, diagnostic, per study dose",09-10-2025
A9501001003,"Technetium tc-99m teboroxime, diagnostic, per study dose",09-10-2025
A9502001003,"Technetium tc-99m tetrofosmin, diagnostic, per study dose",09-10-2025
A9503001003,"Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries",09-10-2025
A9504001003,"Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries",09-10-2025
A9505001003,"Thallium tl-201 thallous chloride, diagnostic, per millicurie",09-10-2025
A9506001003,"Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol,",09-10-2025
A9506002004,One crucible,09-10-2025
A9507001003,"Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10",09-10-2025
A9507002004,Millicuries,09-10-2025
A9508001003,"Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie",09-10-2025
A9509001003,"Iodine i-123 sodium iodide, diagnostic, per millicurie",09-10-2025
A9510001003,"Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries",09-10-2025
A9512001003,"Technetium tc-99m pertechnetate, diagnostic, per millicurie",09-10-2025
A9513001003,"Lutetium lu 177, dotatate, therapeutic, 1 millicurie",09-10-2025
A9515001003,"Choline c-11, diagnostic, per study dose up to 20 millicuries",09-10-2025
A9516001003,"Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999",09-10-2025
A9516002004,Microcuries,09-10-2025
A9517001003,"Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie",09-10-2025
A9520001003,"Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries",09-10-2025
A9521001003,"Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries",09-10-2025
A9524001003,"Iodine i-131 iodinated serum albumin, diagnostic, per 5 microcuries",09-10-2025
A9526001003,"Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries",09-10-2025
A9527001003,"Iodine i-125, sodium iodide solution, therapeutic, per millicurie",09-10-2025
A9528001003,"Iodine i-131 sodium iodide capsule(s), diagnostic, per millicurie",09-10-2025
A9529001003,"Iodine i-131 sodium iodide solution, diagnostic, per millicurie",09-10-2025
A9530001003,"Iodine i-131 sodium iodide solution, therapeutic, per millicurie",09-10-2025
A9531001003,"Iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries)",09-10-2025
A9532001003,"Iodine i-125 serum albumin, diagnostic, per 5 microcuries",09-10-2025
A9536001003,"Technetium tc-99m depreotide, diagnostic, per study dose, up to 35 millicuries",09-10-2025
A9537001003,"Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries",09-10-2025
A9538001003,"Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25",09-10-2025
A9538002004,Millicuries,09-10-2025
A9539001003,"Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries",09-10-2025
A9540001003,"Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10",09-10-2025
A9540002004,Millicuries,09-10-2025
A9541001003,"Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20",09-10-2025
A9541002004,Millicuries,09-10-2025
A9542001003,"Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5",09-10-2025
A9542002004,Millicuries,09-10-2025
A9543001003,"Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40",09-10-2025
A9543002004,Millicuries,09-10-2025
A9544001003,"Iodine i-131 tositumomab, diagnostic, per study dose",09-10-2025
A9545001003,"Iodine i-131 tositumomab, therapeutic, per treatment dose",09-10-2025
A9546001003,"Cobalt co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie",09-10-2025
A9547001003,"Indium in-111 oxyquinoline, diagnostic, per 0.5 millicurie",09-10-2025
A9548001003,"Indium in-111 pentetate, diagnostic, per 0.5 millicurie",09-10-2025
A9550001003,"Technetium tc-99m sodium gluceptate, diagnostic, per study dose, up to 25",09-10-2025
A9550002004,Millicurie,09-10-2025
A9551001003,"Technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries",09-10-2025
A9552001003,"Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries",09-10-2025
A9553001003,"Chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250",09-10-2025
A9553002004,Microcuries,09-10-2025
A9554001003,"Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10",09-10-2025
A9554002004,Microcuries,09-10-2025
A9555001003,"Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries",09-10-2025
A9556001003,"Gallium ga-67 citrate, diagnostic, per millicurie",09-10-2025
A9557001003,"Technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries",09-10-2025
A9558001003,"Xenon xe-133 gas, diagnostic, per 10 millicuries",09-10-2025
A9559001003,"Cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1",09-10-2025
A9559002004,Microcurie,09-10-2025
A9560001003,"Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30",09-10-2025
A9560002004,Millicuries,09-10-2025
A9561001003,"Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries",09-10-2025
A9562001003,"Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries",09-10-2025
A9563001003,"Sodium phosphate p-32, therapeutic, per millicurie",09-10-2025
A9564001003,"Chromic phosphate p-32 suspension, therapeutic, per millicurie",09-10-2025
A9566001003,"Technetium tc-99m fanolesomab, diagnostic, per study dose, up to 25 millicuries",09-10-2025
A9567001003,"Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75",09-10-2025
A9567002004,Millicuries,09-10-2025
A9568001003,"Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries",09-10-2025
A9569001003,"Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic,",09-10-2025
A9569002004,Per study dose,09-10-2025
A9570001003,"Indium in-111 labeled autologous white blood cells, diagnostic, per study dose",09-10-2025
A9571001003,"Indium in-111 labeled autologous platelets, diagnostic, per study dose",09-10-2025
A9572001003,"Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries",09-10-2025
A9573001003,"Injection, gadopiclenol, 1 ml",09-10-2025
A9575001003,"Injection, gadoterate meglumine, 0.1 ml",09-10-2025
A9576001003,"Injection, gadoteridol, (prohance multipack), per ml",09-10-2025
A9577001003,"Injection, gadobenate dimeglumine (multihance), per ml",09-10-2025
A9578001003,"Injection, gadobenate dimeglumine (multihance multipack), per ml",09-10-2025
A9579001003,"Injection, gadolinium-based magnetic resonance contrast agent, not otherwise",09-10-2025
A9579002004,"Specified (nos), per ml",09-10-2025
A9580001003,"Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries",09-10-2025
A9581001003,"Injection, gadoxetate disodium, 1 ml",09-10-2025
A9582001003,"Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries",09-10-2025
A9583001003,"Injection, gadofosveset trisodium, 1 ml",09-10-2025
A9584001003,"Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries",09-10-2025
A9585001003,"Injection, gadobutrol, 0.1 ml",09-10-2025
A9586001003,"Florbetapir f18, diagnostic, per study dose, up to 10 millicuries",09-10-2025
A9587001003,"Gallium ga-68, dotatate, diagnostic, 0.1 millicurie",09-10-2025
A9588001003,"Fluciclovine f-18, diagnostic, 1 millicurie",09-10-2025
A9589001003,"Instillation, hexaminolevulinate hydrochloride, 100 mg",09-10-2025
A9590001003,"Iodine i-131, iobenguane, 1 millicurie",09-10-2025
A9591001003,"Fluoroestradiol f 18, diagnostic, 1 millicurie",09-10-2025
A9592001003,"Copper cu-64, dotatate, diagnostic, 1 millicurie",09-10-2025
A9593001003,"Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie",09-10-2025
A9594001003,"Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie",09-10-2025
A9595001003,"Piflufolastat f-18, diagnostic, 1 millicurie",09-10-2025
A9596001003,"Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie",09-10-2025
A9597001003,"Positron emission tomography radiopharmaceutical, diagnostic, for tumor",09-10-2025
A9597002004,"Identification, not otherwise classified",09-10-2025
A9598001003,"Positron emission tomography radiopharmaceutical, diagnostic, for non-tumor",09-10-2025
A9598002004,"Identification, not otherwise classified",09-10-2025
A9599001003,"Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography",09-10-2025
A9599002004,"(pet) imaging, per study dose, not otherwise specified",09-10-2025
A9600001003,"Strontium sr-89 chloride, therapeutic, per millicurie",09-10-2025
A9601001003,"Flortaucipir f 18 injection, diagnostic, 1 millicurie",09-10-2025
A9602001003,"Fluorodopa f-18, diagnostic, per millicurie",09-10-2025
A9603001003,"Injection, pafolacianine, 0.1 mg",09-10-2025
A9604001003,"Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150",09-10-2025
A9604002004,Millicuries,09-10-2025
A9606001003,"Radium ra-223 dichloride, therapeutic, per microcurie",09-10-2025
A9607001003,"Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie",09-10-2025
A9608001003,"Flotufolastat f 18, diagnostic, 1 millicurie",09-10-2025
A9609001003,Fludeoxyglucose f18 up to 15 millicuries,09-10-2025
A9610001003,"Xenon xe-129 hyperpolarized gas, diagnostic, per study dose",09-10-2025
A9611001003,"Flurpiridaz f 18, diagnostic, 1 millicurie",09-10-2025
A9612001003,"Injection, fluorescein, 1 mg",09-10-2025
A9615001003,"Injection, pegulicianine, 1 mg",09-10-2025
A9616001003,"Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurie",09-10-2025
A9697001003,"Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose",09-10-2025
A9698001003,"Non-radioactive contrast imaging material, not otherwise classified, per study",09-10-2025
A9699001003,"Radiopharmaceutical, therapeutic, not otherwise classified",09-10-2025
A9700001003,"Supply of injectable contrast material for use in echocardiography, per study",09-10-2025
A9800001003,"Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie",09-10-2025
A9900001003,"Miscellaneous dme supply, accessory, and/or service component of another hcpcs",09-10-2025
A9900002004,Code,09-10-2025
A9901001003,"Dme delivery, set up, and/or dispensing service component of another hcpcs code",09-10-2025
A9999001003,"Miscellaneous dme supply or accessory, not otherwise specified",09-10-2025
B4034001003,"Enteral feeding supply kit; syringe fed, per day, includes but not limited to",09-10-2025
B4034002004,"Feeding/flushing syringe, administration set tubing, dressings, tape",09-10-2025
B4035001003,"Enteral feeding supply kit; pump fed, per day, includes but not limited to",09-10-2025
B4035002004,"Feeding/flushing syringe, administration set tubing, dressings, tape",09-10-2025
B4036001003,"Enteral feeding supply kit; gravity fed, per day, includes but not limited to",09-10-2025
B4036002004,"Feeding/flushing syringe, administration set tubing, dressings, tape",09-10-2025
B4081001003,Nasogastric tubing with stylet,09-10-2025
B4082001003,Nasogastric tubing without stylet,09-10-2025
B4083001003,Stomach tube - levine type,09-10-2025
B4087001003,"Gastrostomy/jejunostomy tube, standard, any material, any type, each",09-10-2025
B4088001003,"Gastrostomy/jejunostomy tube, low-profile, any material, any type, each",09-10-2025
B4100001003,"Food thickener, administered orally, per ounce",09-10-2025
B4102001003,"Enteral formula, for adults, used to replace fluids and electrolytes (e.g.,",09-10-2025
B4102002004,"Clear liquids), 500 ml = 1 unit",09-10-2025
B4103001003,"Enteral formula, for pediatrics, used to replace fluids and electrolytes (e.g.,",09-10-2025
B4103002004,"Clear liquids), 500 ml = 1 unit",09-10-2025
B4104001003,"Additive for enteral formula (e.g., fiber)",09-10-2025
B4105001003,"In-line cartridge containing digestive enzyme(s) for enteral feeding, each",09-10-2025
B4148001003,"Enteral feeding supply kit; elastomeric control fed, per day, includes but not",09-10-2025
B4148002004,"Limited to feeding/flushing syringe, administration set tubing, dressings, tape",09-10-2025
B4149001003,"Enteral formula, manufactured blenderized natural foods with intact nutrients,",09-10-2025
B4149002004,"Includes proteins, fats, carbohydrates, vitamins and minerals, may include",09-10-2025
B4149003004,"Fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09-10-2025
B4150001003,"Enteral formula, nutritionally complete with intact nutrients, includes",09-10-2025
B4150002004,"Proteins, fats, carbohydrates, vitamins and minerals, may include fiber,",09-10-2025
B4150003004,"Administered through an enteral feeding tube, 100 calories = 1 unit",09-10-2025
B4152001003,"Enteral formula, nutritionally complete, calorically dense (equal to or greater",09-10-2025
B4152002004,"Than 1.5 kcal/ml) with intact nutrients, includes proteins, fats,",09-10-2025
B4152003004,"Carbohydrates, vitamins and minerals, may include fiber, administered through",09-10-2025
B4152004004,"An enteral feeding tube, 100 calories = 1 unit",09-10-2025
B4153001003,"Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and",09-10-2025
B4153002004,"Peptide chain), includes fats, carbohydrates, vitamins and minerals, may",09-10-2025
B4153003004,"Include fiber, administered through an enteral feeding tube, 100 calories = 1",09-10-2025
B4153004004,Unit,09-10-2025
B4154001003,"Enteral formula, nutritionally complete, for special metabolic needs, excludes",09-10-2025
B4154002004,"Inherited disease of metabolism, includes altered composition of proteins,",09-10-2025
B4154003004,"Fats, carbohydrates, vitamins and/or minerals, may include fiber, administered",09-10-2025
B4154004004,"Through an enteral feeding tube, 100 calories = 1 unit",09-10-2025
B4155001003,"Enteral formula, nutritionally incomplete/modular nutrients, includes specific",09-10-2025
B4155002004,"Nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g.,",09-10-2025
B4155003004,"Glutamine, arginine), fat (e.g., medium chain triglycerides) or combination,",09-10-2025
B4155004004,"Administered through an enteral feeding tube, 100 calories = 1 unit",09-10-2025
B4157001003,"Enteral formula, nutritionally complete, for special metabolic needs for",09-10-2025
B4157002004,"Inherited disease of metabolism, includes proteins, fats, carbohydrates,",09-10-2025
B4157003004,"Vitamins and minerals, may include fiber, administered through an enteral",09-10-2025
B4157004004,"Feeding tube, 100 calories = 1 unit",09-10-2025
B4158001003,"Enteral formula, for pediatrics, nutritionally complete with intact nutrients,",09-10-2025
B4158002004,"Includes proteins, fats, carbohydrates, vitamins and minerals, may include",09-10-2025
B4158003004,"Fiber and/or iron, administered through an enteral feeding tube, 100 calories =",09-10-2025
B4158004004,1 unit,09-10-2025
B4159001003,"Enteral formula, for pediatrics, nutritionally complete soy based with intact",09-10-2025
B4159002004,"Nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may",09-10-2025
B4159003004,"Include fiber and/or iron, administered through an enteral feeding tube, 100",09-10-2025
B4159004004,Calories = 1 unit,09-10-2025
B4160001003,"Enteral formula, for pediatrics, nutritionally complete calorically dense",09-10-2025
B4160002004,"(equal to or greater than 0.7 kcal/ml) with intact nutrients, includes",09-10-2025
B4160003004,"Proteins, fats, carbohydrates, vitamins and minerals, may include fiber,",09-10-2025
B4160004004,"Administered through an enteral feeding tube, 100 calories = 1 unit",09-10-2025
B4161001003,"Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain",09-10-2025
B4161002004,"Proteins, includes fats, carbohydrates, vitamins and minerals, may include",09-10-2025
B4161003004,"Fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09-10-2025
B4162001003,"Enteral formula, for pediatrics, special metabolic needs for inherited disease",09-10-2025
B4162002004,"Of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals,",09-10-2025
B4162003004,"May include fiber, administered through an enteral feeding tube, 100 calories =",09-10-2025
B4162004004,1 unit,09-10-2025
B4164001003,"Parenteral nutrition solution: carbohydrates (dextrose), 50% or less (500 ml =",09-10-2025
B4164002004,1 unit) - home mix,09-10-2025
B4168001003,"Parenteral nutrition solution; amino acid, 3.5%, (500 ml = 1 unit) - home mix",09-10-2025
B4172001003,"Parenteral nutrition solution; amino acid, 5.5% through 7%, (500 ml = 1 unit) -",09-10-2025
B4172002004,Home mix,09-10-2025
B4176001003,"Parenteral nutrition solution; amino acid, 7% through 8.5%, (500 ml = 1 unit) -",09-10-2025
B4176002004,Home mix,09-10-2025
B4178001003,"Parenteral nutrition solution: amino acid, greater than 8.5% (500 ml = 1 unit)",09-10-2025
B4178002004,- home mix,09-10-2025
B4180001003,"Parenteral nutrition solution; carbohydrates (dextrose), greater than 50% (500",09-10-2025
B4180002004,Ml = 1 unit) - home mix,09-10-2025
B4185001003,"Parenteral nutrition solution, not otherwise specified, 10 grams lipids",09-10-2025
B4187001003,"Omegaven, 10 grams lipids",09-10-2025
B4189001003,Parenteral nutrition solution; compounded amino acid and carbohydrates with,09-10-2025
B4189002004,"Electrolytes, trace elements, and vitamins, including preparation, any",09-10-2025
B4189003004,"Strength, 10 to 51 grams of protein - premix",09-10-2025
B4193001003,Parenteral nutrition solution; compounded amino acid and carbohydrates with,09-10-2025
B4193002004,"Electrolytes, trace elements, and vitamins, including preparation, any",09-10-2025
B4193003004,"Strength, 52 to 73 grams of protein - premix",09-10-2025
B4197001003,Parenteral nutrition solution; compounded amino acid and carbohydrates with,09-10-2025
B4197002004,"Electrolytes, trace elements and vitamins, including preparation, any strength,",09-10-2025
B4197003004,74 to 100 grams of protein - premix,09-10-2025
B4199001003,Parenteral nutrition solution; compounded amino acid and carbohydrates with,09-10-2025
B4199002004,"Electrolytes, trace elements and vitamins, including preparation, any strength,",09-10-2025
B4199003004,Over 100 grams of protein - premix,09-10-2025
B4216001003,"Parenteral nutrition; additives (vitamins, trace elements, heparin,",09-10-2025
B4216002004,"Electrolytes), home mix, per day",09-10-2025
B4220001003,"Parenteral nutrition supply kit; premix, per day",09-10-2025
B4222001003,"Parenteral nutrition supply kit; home mix, per day",09-10-2025
B4224001003,"Parenteral nutrition administration kit, per day",09-10-2025
B5000001003,Parenteral nutrition solution compounded amino acid and carbohydrates with,09-10-2025
B5000002004,"Electrolytes, trace elements, and vitamins, including preparation, any",09-10-2025
B5000003004,"Strength, renal-aminosyn-rf, nephramine, renamine-premix",09-10-2025
B5100001003,Parenteral nutrition solution compounded amino acid and carbohydrates with,09-10-2025
B5100002004,"Electrolytes, trace elements, and vitamins, including preparation, any",09-10-2025
B5100003004,"Strength, hepatic, hepatamine-premix",09-10-2025
B5200001003,Parenteral nutrition solution compounded amino acid and carbohydrates with,09-10-2025
B5200002004,"Electrolytes, trace elements, and vitamins, including preparation, any",09-10-2025
B5200003004,"Strength, stress-branch chain amino acids-freamine-hbc-premix",09-10-2025
B9000001003,Enteral nutrition infusion pump - without alarm,09-10-2025
B9002001003,"Enteral nutrition infusion pump, any type",09-10-2025
B9004001003,"Parenteral nutrition infusion pump, portable",09-10-2025
B9006001003,"Parenteral nutrition infusion pump, stationary",09-10-2025
B9998001003,Noc for enteral supplies,09-10-2025
B9999001003,Noc for parenteral supplies,09-10-2025
C1052001003,"Hemostatic agent, gastrointestinal, topical",09-10-2025
C1062001003,"Intravertebral body fracture augmentation with implant (e.g., metal, polymer)",09-10-2025
C1300001003,"Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval",09-10-2025
C1600001003,"Catheter, transluminal intravascular lesion preparation device, bladed,",09-10-2025
C1600002004,Sheathed (insertable),09-10-2025
C1601001003,"Endoscope, single-use (i.e. disposable), pulmonary, imaging/illumination device",09-10-2025
C1601002004,(insertable),09-10-2025
C1602001003,"Orthopedic/device/drug matrix/absorbable bone void filler,",09-10-2025
C1602002004,Antimicrobial-eluting (implantable),09-10-2025
C1603001003,"Retrieval device, insertable, laser (used to retrieve intravascular inferior",09-10-2025
C1603002004,Vena cava filter),09-10-2025
C1604001003,"Graft, transmural transvenous arterial bypass (implantable), with all delivery",09-10-2025
C1604002004,System components,09-10-2025
C1605001003,"Pacemaker, leadless, dual chamber (right atrial and right ventricular",09-10-2025
C1605002004,"Implantable components), rate-responsive, including all necessary components",09-10-2025
C1605003004,For implantation,09-10-2025
C1606001003,"Adapter, single-use (i.e. disposable), for attaching ultrasound system to upper",09-10-2025
C1606002004,Gastrointestinal endoscope,09-10-2025
C1713001003,Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable),09-10-2025
C1714001003,"Catheter, transluminal atherectomy, directional",09-10-2025
C1715001003,Brachytherapy needle,09-10-2025
C1716001003,"Brachytherapy source, non-stranded, gold-198, per source",09-10-2025
C1717001003,"Brachytherapy source, non-stranded, high dose rate iridium-192, per source",09-10-2025
C1719001003,"Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source",09-10-2025
C1721001003,"Cardioverter-defibrillator, dual chamber (implantable)",09-10-2025
C1722001003,"Cardioverter-defibrillator, single chamber (implantable)",09-10-2025
C1724001003,"Catheter, transluminal atherectomy, rotational",09-10-2025
C1725001003,"Catheter, transluminal angioplasty, non-laser (may include guidance,",09-10-2025
C1725002004,Infusion/perfusion capability),09-10-2025
C1726001003,"Catheter, balloon dilatation, non-vascular",09-10-2025
C1727001003,"Catheter, balloon tissue dissector, non-vascular (insertable)",09-10-2025
C1728001003,"Catheter, brachytherapy seed administration",09-10-2025
C1729001003,"Catheter, drainage",09-10-2025
C1730001003,"Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer",09-10-2025
C1730002004,Electrodes),09-10-2025
C1731001003,"Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more",09-10-2025
C1731002004,Electrodes),09-10-2025
C1732001003,"Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping",09-10-2025
C1733001003,"Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector",09-10-2025
C1733002004,"Mapping, other than cool-tip",09-10-2025
C1734001003,Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone,09-10-2025
C1734002004,(implantable),09-10-2025
C1735001003,"Catheter(s), intravascular for renal denervation, radiofrequency, including all",09-10-2025
C1735002004,Single use system components,09-10-2025
C1736001003,"Catheter(s), intravascular for renal denervation, ultrasound, including all",09-10-2025
C1736002004,Single use system components,09-10-2025
C1737001003,"Joint fusion and fixation device(s), sacroiliac and pelvis, including all",09-10-2025
C1737002004,System components (implantable),09-10-2025
C1738001003,"Powered, single-use (i.e. disposable) endoscopic ultrasound-guided biopsy devic",09-10-2025
C1739001003,"Tissue marker, uniquely detectable and identifiable with probe/sensor, any",09-10-2025
C1739002004,"Method (implantable), with delivery system",09-10-2025
C1740001003,"Leadless electrode, transmitter, battery (all implantable), for sequential left",09-10-2025
C1740002004,Ventricular pacing,09-10-2025
C1741001003,"Anchor/screw for bone fixation, absorbable (implantable)",09-10-2025
C1742001003,"Pressure monitoring system, compartmental intramuscular (implantable),",09-10-2025
C1742002004,"Continuous, including all components (e.g., introducer, sensor), excludes",09-10-2025
C1742003004,Mobile (wireless) software application,09-10-2025
C1747001003,"Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination",09-10-2025
C1747002004,Device (insertable),09-10-2025
C1748001003,"Endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device",09-10-2025
C1748002004,(insertable),09-10-2025
C1749001003,"Endoscope, retrograde imaging/illumination colonoscope device (implantable)",09-10-2025
C1750001003,"Catheter, hemodialysis/peritoneal, long-term",09-10-2025
C1751001003,"Catheter, infusion, inserted peripherally, centrally or midline (other than",09-10-2025
C1751002004,Hemodialysis),09-10-2025
C1752001003,"Catheter, hemodialysis/peritoneal, short-term",09-10-2025
C1753001003,"Catheter, intravascular ultrasound",09-10-2025
C1754001003,"Catheter, intradiscal",09-10-2025
C1755001003,"Catheter, intraspinal",09-10-2025
C1756001003,"Catheter, pacing, transesophageal",09-10-2025
C1757001003,"Catheter, thrombectomy/embolectomy",09-10-2025
C1758001003,"Catheter, ureteral",09-10-2025
C1759001003,"Catheter, intracardiac echocardiography",09-10-2025
C1760001003,"Closure device, vascular (implantable/insertable)",09-10-2025
C1761001003,"Catheter, transluminal intravascular lithotripsy, coronary",09-10-2025
C1762001003,"Connective tissue, human (includes fascia lata)",09-10-2025
C1763001003,"Connective tissue, non-human (includes synthetic)",09-10-2025
C1764001003,"Event recorder, cardiac (implantable)",09-10-2025
C1765001003,Adhesion barrier,09-10-2025
C1766001003,"Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other",09-10-2025
C1766002004,Than peel-away,09-10-2025
C1767001003,"Generator, neurostimulator (implantable), non-rechargeable",09-10-2025
C1768001003,"Graft, vascular",09-10-2025
C1769001003,Guide wire,09-10-2025
C1770001003,"Imaging coil, magnetic resonance (insertable)",09-10-2025
C1771001003,"Repair device, urinary, incontinence, with sling graft",09-10-2025
C1772001003,"Infusion pump, programmable (implantable)",09-10-2025
C1773001003,"Retrieval device, insertable (used to retrieve fractured medical devices)",09-10-2025
C1776001003,Joint device (implantable),09-10-2025
C1777001003,"Lead, cardioverter-defibrillator, endocardial single coil (implantable)",09-10-2025
C1778001003,"Lead, neurostimulator (implantable)",09-10-2025
C1779001003,"Lead, pacemaker, transvenous vdd single pass",09-10-2025
C1780001003,"Lens, intraocular (new technology)",09-10-2025
C1781001003,Mesh (implantable),09-10-2025
C1782001003,Morcellator,09-10-2025
C1783001003,"Ocular implant, aqueous drainage assist device",09-10-2025
C1784001003,"Ocular device, intraoperative, detached retina",09-10-2025
C1785001003,"Pacemaker, dual chamber, rate-responsive (implantable)",09-10-2025
C1786001003,"Pacemaker, single chamber, rate-responsive (implantable)",09-10-2025
C1787001003,"Patient programmer, neurostimulator",09-10-2025
C1788001003,"Port, indwelling (implantable)",09-10-2025
C1789001003,"Prosthesis, breast (implantable)",09-10-2025
C1813001003,"Prosthesis, penile, inflatable",09-10-2025
C1814001003,"Retinal tamponade device, silicone oil",09-10-2025
C1815001003,"Prosthesis, urinary sphincter (implantable)",09-10-2025
C1816001003,"Receiver and/or transmitter, neurostimulator (implantable)",09-10-2025
C1817001003,"Septal defect implant system, intracardiac",09-10-2025
C1818001003,Integrated keratoprosthesis,09-10-2025
C1819001003,Surgical tissue localization and excision device (implantable),09-10-2025
C1820001003,"Generator, neurostimulator (implantable), with rechargeable battery and",09-10-2025
C1820002004,Charging system,09-10-2025
C1821001003,Interspinous process distraction device (implantable),09-10-2025
C1822001003,"Generator, neurostimulator (implantable), high frequency, with rechargeable",09-10-2025
C1822002004,Battery and charging system,09-10-2025
C1823001003,"Generator, neurostimulator (implantable), non-rechargeable, with transvenous",09-10-2025
C1823002004,Sensing and stimulation leads,09-10-2025
C1824001003,"Generator, cardiac contractility modulation (implantable)",09-10-2025
C1825001003,"Generator, neurostimulator (implantable), non-rechargeable with carotid sinus",09-10-2025
C1825002004,Baroreceptor stimulation lead(s),09-10-2025
C1826001003,"Generator, neurostimulator (implantable), includes closed feedback loop leads",09-10-2025
C1826002004,"And all implantable components, with rechargeable battery and charging system",09-10-2025
C1827001003,"Generator, neurostimulator (implantable), non-rechargeable, with implantable",09-10-2025
C1827002004,Stimulation lead and external paired stimulation controller,09-10-2025
C1830001003,Powered bone marrow biopsy needle,09-10-2025
C1831001003,"Interbody cage, anterior, lateral or posterior, personalized (implantable)",09-10-2025
C1832001003,"Autograft suspension, including cell processing and application, and all system",09-10-2025
C1832002004,Components,09-10-2025
C1833001003,"Monitor, cardiac, including intracardiac lead and all system components",09-10-2025
C1833002004,(implantable),09-10-2025
C1834001003,"Pressure sensor system, includes all components (e.g., introducer, sensor),",09-10-2025
C1834002004,"Intramuscular (implantable), excludes mobile (wireless) software application",09-10-2025
C1839001003,Iris prosthesis,09-10-2025
C1840001003,"Lens, intraocular (telescopic)",09-10-2025
C1841001003,"Retinal prosthesis, includes all internal and external components",09-10-2025
C1842001003,"Retinal prosthesis, includes all internal and external components; add-on to",09-10-2025
C1842002004,C1841,09-10-2025
C1849001003,"Skin substitute, synthetic, resorbable, per square centimeter",09-10-2025
C1874001003,"Stent, coated/covered, with delivery system",09-10-2025
C1875001003,"Stent, coated/covered, without delivery system",09-10-2025
C1876001003,"Stent, non-coated/non-covered, with delivery system",09-10-2025
C1877001003,"Stent, non-coated/non-covered, without delivery system",09-10-2025
C1878001003,"Material for vocal cord medialization, synthetic (implantable)",09-10-2025
C1880001003,Vena cava filter,09-10-2025
C1881001003,Dialysis access system (implantable),09-10-2025
C1882001003,"Cardioverter-defibrillator, other than single or dual chamber (implantable)",09-10-2025
C1883001003,"Adapter/extension, pacing lead or neurostimulator lead (implantable)",09-10-2025
C1884001003,Embolization protective system,09-10-2025
C1885001003,"Catheter, transluminal angioplasty, laser",09-10-2025
C1886001003,"Catheter, extravascular tissue ablation, any modality (insertable)",09-10-2025
C1887001003,"Catheter, guiding (may include infusion/perfusion capability)",09-10-2025
C1888001003,"Catheter, ablation, non-cardiac, endovascular (implantable)",09-10-2025
C1889001003,"Implantable/insertable device, not otherwise classified",09-10-2025
C1890001003,No implantable/insertable device used with device-intensive procedures,09-10-2025
C1891001003,"Infusion pump, non-programmable, permanent (implantable)",09-10-2025
C1892001003,"Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve,",09-10-2025
C1892002004,Peel-away,09-10-2025
C1893001003,"Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve,",09-10-2025
C1893002004,Other than peel-away,09-10-2025
C1894001003,"Introducer/sheath, other than guiding, other than intracardiac",09-10-2025
C1894002004,"Electrophysiological, non-laser",09-10-2025
C1895001003,"Lead, cardioverter-defibrillator, endocardial dual coil (implantable)",09-10-2025
C1896001003,"Lead, cardioverter-defibrillator, other than endocardial single or dual coil",09-10-2025
C1896002004,(implantable),09-10-2025
C1897001003,"Lead, neurostimulator test kit (implantable)",09-10-2025
C1898001003,"Lead, pacemaker, other than transvenous vdd single pass",09-10-2025
C1899001003,"Lead, pacemaker/cardioverter-defibrillator combination (implantable)",09-10-2025
C1900001003,"Lead, left ventricular coronary venous system",09-10-2025
C1982001003,"Catheter, pressure-generating, (e.g., one-way valve, intermittently occlusive)",09-10-2025
C2596001003,"Probe, image-guided, robotic, waterjet ablation",09-10-2025
C2613001003,Lung biopsy plug with delivery system,09-10-2025
C2614001003,"Probe, percutaneous lumbar discectomy",09-10-2025
C2615001003,"Sealant, pulmonary, liquid",09-10-2025
C2616001003,"Brachytherapy source, non-stranded, yttrium-90, per source",09-10-2025
C2617001003,"Stent, non-coronary, temporary, without delivery system",09-10-2025
C2618001003,"Probe/needle, cryoablation",09-10-2025
C2619001003,"Pacemaker, dual chamber, non rate-responsive (implantable)",09-10-2025
C2620001003,"Pacemaker, single chamber, non rate-responsive (implantable)",09-10-2025
C2621001003,"Pacemaker, other than single or dual chamber (implantable)",09-10-2025
C2622001003,"Prosthesis, penile, non-inflatable",09-10-2025
C2623001003,"Catheter, transluminal angioplasty, drug-coated, non-laser",09-10-2025
C2624001003,"Implantable wireless pulmonary artery pressure sensor with delivery catheter,",09-10-2025
C2624002004,Including all system components,09-10-2025
C2625001003,"Stent, non-coronary, temporary, with delivery system",09-10-2025
C2626001003,"Infusion pump, non-programmable, temporary (implantable)",09-10-2025
C2627001003,"Catheter, suprapubic/cystoscopic",09-10-2025
C2628001003,"Catheter, occlusion",09-10-2025
C2629001003,"Introducer/sheath, other than guiding, other than intracardiac",09-10-2025
C2629002004,"Electrophysiological, laser",09-10-2025
C2630001003,"Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector",09-10-2025
C2630002004,"Mapping, cool-tip",09-10-2025
C2631001003,"Repair device, urinary, incontinence, without sling graft",09-10-2025
C2634001003,"Brachytherapy source, non-stranded, high activity, iodine-125, greater than",09-10-2025
C2634002004,"1.01 mci (nist), per source",09-10-2025
C2635001003,"Brachytherapy source, non-stranded, high activity, palladium-103, greater than",09-10-2025
C2635002004,"2.2 mci (nist), per source",09-10-2025
C2636001003,"Brachytherapy linear source, non-stranded, palladium-103, per 1 mm",09-10-2025
C2637001003,"Brachytherapy source, non-stranded, ytterbium-169, per source",09-10-2025
C2638001003,"Brachytherapy source, stranded, iodine-125, per source",09-10-2025
C2639001003,"Brachytherapy source, non-stranded, iodine-125, per source",09-10-2025
C2640001003,"Brachytherapy source, stranded, palladium-103, per source",09-10-2025
C2641001003,"Brachytherapy source, non-stranded, palladium-103, per source",09-10-2025
C2642001003,"Brachytherapy source, stranded, cesium-131, per source",09-10-2025
C2643001003,"Brachytherapy source, non-stranded, cesium-131, per source",09-10-2025
C2644001003,"Brachytherapy source, cesium-131 chloride solution, per millicurie",09-10-2025
C2645001003,"Brachytherapy planar source, palladium-103, per square millimeter",09-10-2025
C2698001003,"Brachytherapy source, stranded, not otherwise specified, per source",09-10-2025
C2699001003,"Brachytherapy source, non-stranded, not otherwise specified, per source",09-10-2025
C5271001003,"Application of low cost skin substitute graft to trunk, arms, legs, total wound",09-10-2025
C5271002004,Surface area up to 100 sq cm; first 25 sq cm or less wound surface area,09-10-2025
C5272001003,"Application of low cost skin substitute graft to trunk, arms, legs, total wound",09-10-2025
C5272002004,"Surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or",09-10-2025
C5272003004,Part thereof (list separately in addition to code for primary procedure),09-10-2025
C5273001003,"Application of low cost skin substitute graft to trunk, arms, legs, total wound",09-10-2025
C5273002004,Surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface,09-10-2025
C5273003004,"Area, or 1% of body area of infants and children",09-10-2025
C5274001003,"Application of low cost skin substitute graft to trunk, arms, legs, total wound",09-10-2025
C5274002004,Surface area greater than or equal to 100 sq cm; each additional 100 sq cm,09-10-2025
C5274003004,"Wound surface area, or part thereof, or each additional 1% of body area of",09-10-2025
C5274004004,"Infants and children, or part thereof (list separately in addition to code for",09-10-2025
C5274005004,Primary procedure),09-10-2025
C5275001003,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth,",09-10-2025
C5275002004,"Neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound",09-10-2025
C5275003004,Surface area up to 100 sq cm; first 25 sq cm or less wound surface area,09-10-2025
C5276001003,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth,",09-10-2025
C5276002004,"Neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound",09-10-2025
C5276003004,"Surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or",09-10-2025
C5276004004,Part thereof (list separately in addition to code for primary procedure),09-10-2025
C5277001003,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth,",09-10-2025
C5277002004,"Neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound",09-10-2025
C5277003004,Surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface,09-10-2025
C5277004004,"Area, or 1% of body area of infants and children",09-10-2025
C5278001003,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth,",09-10-2025
C5278002004,"Neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound",09-10-2025
C5278003004,Surface area greater than or equal to 100 sq cm; each additional 100 sq cm,09-10-2025
C5278004004,"Wound surface area, or part thereof, or each additional 1% of body area of",09-10-2025
C5278005004,"Infants and children, or part thereof (list separately in addition to code for",09-10-2025
C5278006004,Primary procedure),09-10-2025
C7500001003,"Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle",09-10-2025
C7500002004,"And/or fascia, if performed, first 20 sq cm or less with manual preparation and",09-10-2025
C7500003004,"Insertion of deep (e.g., subfacial) drug-delivery device(s)",09-10-2025
C7501001003,"Percutaneous breast biopsies using stereotactic guidance, with placement of",09-10-2025
C7501002004,"Breast localization device(s) (e.g., clip, metallic pellet), when performed,",09-10-2025
C7501003004,"And imaging of the biopsy specimen, when performed, all lesions unilateral and",09-10-2025
C7501004004,"Bilateral (for single lesion biopsy, use appropriate code)",09-10-2025
C7502001003,"Percutaneous breast biopsies using magnetic resonance guidance, with placement",09-10-2025
C7502002004,"Of breast localization device(s) (e.g., clip, metallic pellet), when performed,",09-10-2025
C7502003004,"And imaging of the biopsy specimen, when performed, all lesions unilateral or",09-10-2025
C7502004004,"Bilateral (for single lesion biopsy, use appropriate code)",09-10-2025
C7503001003,Open biopsy or excision of deep cervical node(s) with intraoperative,09-10-2025
C7503002004,"Identification (e.g., mapping) of sentinel lymph node(s) including injection of",09-10-2025
C7503003004,Non-radioactive dye when performed,09-10-2025
C7504001003,"Percutaneous vertebroplasties (bone biopsies included when performed), first",09-10-2025
C7504002004,Cervicothoracic and any additional cervicothoracic or lumbosacral vertebral,09-10-2025
C7504003004,"Bodies, unilateral or bilateral injection, inclusive of all imaging guidance",09-10-2025
C7505001003,"Percutaneous vertebroplasties (bone biopsies included when performed), first",09-10-2025
C7505002004,"Lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies,",09-10-2025
C7505003004,"Unilateral or bilateral injection, inclusive of all imaging guidance",09-10-2025
C7506001003,"Arthrodesis, interphalangeal joints, with or without internal fixation",09-10-2025
C7507001003,"Percutaneous vertebral augmentations, first thoracic and any additional",09-10-2025
C7507002004,"Thoracic or lumbar vertebral bodies, including cavity creations (fracture",09-10-2025
C7507003004,Reductions and bone biopsies included when performed) using mechanical device,09-10-2025
C7507004004,"(e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all",09-10-2025
C7507005004,Imaging guidance,09-10-2025
C7508001003,"Percutaneous vertebral augmentations, first lumbar and any additional thoracic",09-10-2025
C7508002004,"Or lumbar vertebral bodies, including cavity creations (fracture reductions and",09-10-2025
C7508003004,"Bone biopsies included when performed) using mechanical device (e.g.,",09-10-2025
C7508004004,"Kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging",09-10-2025
C7508005004,Guidance,09-10-2025
C7509001003,"Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when",09-10-2025
C7509002004,"Performed, with computer-assisted image-guided navigation, including",09-10-2025
C7509003004,Fluoroscopic guidance when performed,09-10-2025
C7510001003,"Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with",09-10-2025
C7510002004,"Computer-assisted image-guided navigation, including fluoroscopic guidance when",09-10-2025
C7510003004,Performed,09-10-2025
C7511001003,"Bronchoscopy, rigid or flexible, with single or multiple bronchial or",09-10-2025
C7511002004,"Endobronchial biopsy(ies), single or multiple sites, with computer-assisted",09-10-2025
C7511003004,"Image-guided navigation, including fluoroscopic guidance when performed",09-10-2025
C7512001003,"Bronchoscopy, rigid or flexible, with single or multiple bronchial or",09-10-2025
C7512002004,"Endobronchial biopsy(ies), single or multiple sites, with transendoscopic",09-10-2025
C7512003004,Endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic,09-10-2025
C7512004004,"Intervention(s) for peripheral lesion(s), including fluoroscopic guidance when",09-10-2025
C7512005004,Performed,09-10-2025
C7513001003,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic",09-10-2025
C7513002004,"Angiography of the dialysis circuit, including all direct puncture(s) and",09-10-2025
C7513003004,"Catheter placement(s), injection(s) of contrast, all necessary imaging from the",09-10-2025
C7513004004,Arterial anastomosis and adjacent artery through entire venous outflow,09-10-2025
C7513005004,"Including the inferior or superior vena cava, fluoroscopic guidance, with",09-10-2025
C7513006004,"Transluminal balloon angioplasty of central dialysis segment, performed through",09-10-2025
C7513007004,"Dialysis circuit, including all required imaging, radiological supervision and",09-10-2025
C7513008004,"Interpretation, image documentation and report",09-10-2025
C7514001003,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic",09-10-2025
C7514002004,"Angiography of the dialysis circuit, including all direct puncture(s) and",09-10-2025
C7514003004,"Catheter placement(s), injection(s) of contrast, all necessary imaging from the",09-10-2025
C7514004004,Arterial anastomosis and adjacent artery through entire venous outflow,09-10-2025
C7514005004,"Including the inferior or superior vena cava, fluoroscopic guidance, with all",09-10-2025
C7514006004,"Angioplasty in the central dialysis segment, and transcatheter placement of",09-10-2025
C7514007004,"Intravascular stent(s), central dialysis segment, performed through dialysis",09-10-2025
C7514008004,"Circuit, including all required imaging, radiological supervision and",09-10-2025
C7514009004,"Interpretation, image documentation and report",09-10-2025
C7515001003,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic",09-10-2025
C7515002004,"Angiography of the dialysis circuit, including all direct puncture(s) and",09-10-2025
C7515003004,"Catheter placement(s), injection(s) of contrast, all necessary imaging from the",09-10-2025
C7515004004,Arterial anastomosis and adjacent artery through entire venous outflow,09-10-2025
C7515005004,"Including the inferior or superior vena cava, fluoroscopic guidance, with",09-10-2025
C7515006004,Dialysis circuit permanent endovascular embolization or occlusion of main,09-10-2025
C7515007004,"Circuit or any accessory veins, including all required imaging, radiological",09-10-2025
C7515008004,"Supervision and interpretation, image documentation and report",09-10-2025
C7516001003,"Catheter placement in coronary artery(s) for coronary angiography, including",09-10-2025
C7516002004,"Intraprocedural injection(s) for coronary angiography, with endoluminal imaging",09-10-2025
C7516003004,Of initial coronary vessel or graft using intravascular ultrasound (ivus) or,09-10-2025
C7516004004,Optical coherence tomography (oct) during diagnostic evaluation and/or,09-10-2025
C7516005004,"Therapeutic intervention including imaging supervision, interpretation and",09-10-2025
C7516006004,Report,09-10-2025
C7517001003,"Catheter placement in coronary artery(s) for coronary angiography, including",09-10-2025
C7517002004,"Intraprocedural injection(s) for coronary angiography, with iliac and/or",09-10-2025
C7517003004,"Femoral artery angiography, non-selective, bilateral or ipsilateral to catheter",09-10-2025
C7517004004,"Insertion, performed at the same time as cardiac catheterization and/or",09-10-2025
C7517005004,"Coronary angiography, includes positioning or placement of the catheter in the",09-10-2025
C7517006004,"Distal aorta or ipsilateral femoral or iliac artery, injection of dye,",09-10-2025
C7517007004,"Production of permanent images, and radiologic supervision and interpretation",09-10-2025
C7518001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7518002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7518003004,"Interpretation, with catheter placement(s) in bypass graft(s) (internal",09-10-2025
C7518004004,"Mammary, free arterial, venous grafts) including intraprocedural injection(s)",09-10-2025
C7518005004,For bypass graft angiography with endoluminal imaging of initial coronary,09-10-2025
C7518006004,Vessel or graft using intravascular ultrasound (ivus) or optical coherence,09-10-2025
C7518007004,Tomography (oct) during diagnostic evaluation and/or therapeutic intervention,09-10-2025
C7518008004,"Including imaging, supervision, interpretation and report",09-10-2025
C7519001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7519002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7519003004,"Interpretation, with catheter placement(s) in bypass graft(s) (internal",09-10-2025
C7519004004,"Mammary, free arterial, venous grafts) including intraprocedural injection(s)",09-10-2025
C7519005004,For bypass graft angiography with intravascular doppler velocity and/or,09-10-2025
C7519006004,Pressure derived coronary flow reserve measurement (initial coronary vessel or,09-10-2025
C7519007004,Graft) during coronary angiography including pharmacologically induced stress,09-10-2025
C7520001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7520002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7520003004,"Interpretation, with catheter placement(s) in bypass graft(s) (internal",09-10-2025
C7520004004,"Mammary, free arterial, venous grafts) includes intraprocedural injection(s)",09-10-2025
C7520005004,"For bypass graft angiography with iliac and/or femoral artery angiography,",09-10-2025
C7520006004,"Non-selective, bilateral or ipsilateral to catheter insertion, performed at the",09-10-2025
C7520007004,"Same time as cardiac catheterization and/or coronary angiography, includes",09-10-2025
C7520008004,Positioning or placement of the catheter in the distal aorta or ipsilateral,09-10-2025
C7520009004,"Femoral or iliac artery, injection of dye, production of permanent images, and",09-10-2025
C7520010004,Radiologic supervision and interpretation,09-10-2025
C7521001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7521002004,Intraprocedural injection(s) for coronary angiography with right heart,09-10-2025
C7521003004,Catheterization with endoluminal imaging of initial coronary vessel or graft,09-10-2025
C7521004004,Using intravascular ultrasound (ivus) or optical coherence tomography (oct),09-10-2025
C7521005004,During diagnostic evaluation and/or therapeutic intervention including imaging,09-10-2025
C7521006004,"Supervision, interpretation and report",09-10-2025
C7522001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7522002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7522003004,"Interpretation with right heart catheterization, with intravascular doppler",09-10-2025
C7522004004,Velocity and/or pressure derived coronary flow reserve measurement (initial,09-10-2025
C7522005004,Coronary vessel or graft) during coronary angiography including,09-10-2025
C7522006004,Pharmacologically induced stress,09-10-2025
C7523001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7523002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7523003004,"Interpretation, with left heart catheterization including intraprocedural",09-10-2025
C7523004004,"Injection(s) for left ventriculography, when performed, with endoluminal",09-10-2025
C7523005004,Imaging of initial coronary vessel or graft using intravascular ultrasound,09-10-2025
C7523006004,(ivus) or optical coherence tomography (oct) during diagnostic evaluation,09-10-2025
C7523007004,"And/or therapeutic intervention including imaging supervision, interpretation",09-10-2025
C7523008004,And report,09-10-2025
C7524001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7524002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7524003004,"Interpretation, with left heart catheterization including intraprocedural",09-10-2025
C7524004004,"Injection(s) for left ventriculography, when performed, with intravascular",09-10-2025
C7524005004,Doppler velocity and/or pressure derived coronary flow reserve measurement,09-10-2025
C7524006004,(initial coronary vessel or graft) during coronary angiography including,09-10-2025
C7524007004,Pharmacologically induced stress,09-10-2025
C7525001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7525002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7525003004,"Interpretation, with left heart catheterization including intraprocedural",09-10-2025
C7525004004,"Injection(s) for left ventriculography, when performed, catheter placement(s)",09-10-2025
C7525005004,"In bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass",09-10-2025
C7525006004,Graft angiography with endoluminal imaging of initial coronary vessel or graft,09-10-2025
C7525007004,Using intravascular ultrasound (ivus) or optical coherence tomography (oct),09-10-2025
C7525008004,During diagnostic evaluation and/or therapeutic intervention including imaging,09-10-2025
C7525009004,"Supervision, interpretation and report",09-10-2025
C7526001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7526002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7526003004,"Interpretation, with left heart catheterization including intraprocedural",09-10-2025
C7526004004,"Injection(s) for left ventriculography, when performed, catheter placement(s)",09-10-2025
C7526005004,"In bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass",09-10-2025
C7526006004,Graft angiography with intravascular doppler velocity and/or pressure derived,09-10-2025
C7526007004,Coronary flow reserve measurement (initial coronary vessel or graft) during,09-10-2025
C7526008004,Coronary angiography including pharmacologically induced stress,09-10-2025
C7527001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7527002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7527003004,"Interpretation, with right and left heart catheterization including",09-10-2025
C7527004004,"Intraprocedural injection(s) for left ventriculography, when performed, with",09-10-2025
C7527005004,Endoluminal imaging of initial coronary vessel or graft using intravascular,09-10-2025
C7527006004,Ultrasound (ivus) or optical coherence tomography (oct) during diagnostic,09-10-2025
C7527007004,"Evaluation and/or therapeutic intervention including imaging supervision,",09-10-2025
C7527008004,Interpretation and report,09-10-2025
C7528001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7528002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7528003004,"Interpretation, with right and left heart catheterization including",09-10-2025
C7528004004,"Intraprocedural injection(s) for left ventriculography, when performed, with",09-10-2025
C7528005004,Intravascular doppler velocity and/or pressure derived coronary flow reserve,09-10-2025
C7528006004,Measurement (initial coronary vessel or graft) during coronary angiography,09-10-2025
C7528007004,Including pharmacologically induced stress,09-10-2025
C7529001003,"Catheter placement in coronary artery(ies) for coronary angiography, including",09-10-2025
C7529002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7529003004,"Interpretation, with right and left heart catheterization including",09-10-2025
C7529004004,"Intraprocedural injection(s) for left ventriculography, when performed,",09-10-2025
C7529005004,"Catheter placement(s) in bypass graft(s) (internal mammary, free arterial,",09-10-2025
C7529006004,Venous grafts) with bypass graft angiography with intravascular doppler,09-10-2025
C7529007004,Velocity and/or pressure derived coronary flow reserve measurement (initial,09-10-2025
C7529008004,Coronary vessel or graft) during coronary angiography including,09-10-2025
C7529009004,Pharmacologically induced stress,09-10-2025
C7530001003,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic",09-10-2025
C7530002004,"Angiography of the dialysis circuit, including all direct puncture(s) and",09-10-2025
C7530003004,"Catheter placement(s), injection(s) of contrast, all necessary imaging from the",09-10-2025
C7530004004,Arterial anastomosis and adjacent artery through entire venous outflow,09-10-2025
C7530005004,"Including the inferior or superior vena cava, fluoroscopic guidance, with",09-10-2025
C7530006004,"Transluminal balloon angioplasty, peripheral dialysis segment, including all",09-10-2025
C7530007004,Imaging and radiological supervision and interpretation necessary to perform,09-10-2025
C7530008004,"The angioplasty and all angioplasty in the central dialysis segment, with",09-10-2025
C7530009004,"Transcatheter placement of intravascular stent(s), central dialysis segment,",09-10-2025
C7530010004,"Performed through dialysis circuit, including all imaging, radiological",09-10-2025
C7530011004,"Supervision and interpretation, documentation and report",09-10-2025
C7531001003,"Revascularization, endovascular, open or percutaneous, femoral, popliteal",09-10-2025
C7531002004,"Artery(ies), unilateral, with transluminal angioplasty with intravascular",09-10-2025
C7531003004,Ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or,09-10-2025
C7531004004,"Therapeutic intervention, including radiological supervision and interpretation",09-10-2025
C7532001003,Transluminal balloon angioplasty (except lower extremity artery(ies) for,09-10-2025
C7532002004,"Occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit),",09-10-2025
C7532003004,"Initial artery, open or percutaneous, including all imaging and radiological",09-10-2025
C7532004004,Supervision and interpretation necessary to perform the angioplasty within the,09-10-2025
C7532005004,"Same artery, with intravascular ultrasound (initial noncoronary vessel) during",09-10-2025
C7532006004,"Diagnostic evaluation and/or therapeutic intervention, including radiological",09-10-2025
C7532007004,Supervision and interpretation,09-10-2025
C7533001003,"Percutaneous transluminal coronary angioplasty, single major coronary artery or",09-10-2025
C7533002004,Branch with transcatheter placement of radiation delivery device for subsequent,09-10-2025
C7533003004,Coronary intravascular brachytherapy,09-10-2025
C7534001003,"Revascularization, endovascular, open or percutaneous, femoral, popliteal",09-10-2025
C7534002004,"Artery(ies), unilateral, with atherectomy, includes angioplasty within the same",09-10-2025
C7534003004,"Vessel, when performed with intravascular ultrasound (initial noncoronary",09-10-2025
C7534004004,"Vessel) during diagnostic evaluation and/or therapeutic intervention, including",09-10-2025
C7534005004,Radiological supervision and interpretation,09-10-2025
C7535001003,"Revascularization, endovascular, open or percutaneous, femoral, popliteal",09-10-2025
C7535002004,"Artery(ies), unilateral, with transluminal stent placement(s), includes",09-10-2025
C7535003004,"Angioplasty within the same vessel, when performed, with intravascular",09-10-2025
C7535004004,Ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or,09-10-2025
C7535005004,"Therapeutic intervention, including radiological supervision and interpretation",09-10-2025
C7537001003,Insertion of new or replacement of permanent pacemaker with atrial transvenous,09-10-2025
C7537002004,"Electrode(s), with insertion of pacing electrode, cardiac venous system, for",09-10-2025
C7537003004,"Left ventricular pacing, at time of insertion of implantable defibrillator or",09-10-2025
C7537004004,"Pacemaker pulse generator (e.g., for upgrade to dual chamber system)",09-10-2025
C7538001003,Insertion of new or replacement of permanent pacemaker with ventricular,09-10-2025
C7538002004,"Transvenous electrode(s), with insertion of pacing electrode, cardiac venous",09-10-2025
C7538003004,"System, for left ventricular pacing, at time of insertion of implantable",09-10-2025
C7538004004,"Defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber",09-10-2025
C7538005004,System),09-10-2025
C7539001003,Insertion of new or replacement of permanent pacemaker with atrial and,09-10-2025
C7539002004,"Ventricular transvenous electrode(s), with insertion of pacing electrode,",09-10-2025
C7539003004,"Cardiac venous system, for left ventricular pacing, at time of insertion of",09-10-2025
C7539004004,"Implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual",09-10-2025
C7539005004,Chamber system),09-10-2025
C7540001003,Removal of permanent pacemaker pulse generator with replacement of pacemaker,09-10-2025
C7540002004,"Pulse generator, dual lead system, with insertion of pacing electrode, cardiac",09-10-2025
C7540003004,"Venous system, for left ventricular pacing, at time of insertion of implantable",09-10-2025
C7540004004,"Defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber",09-10-2025
C7540005004,System),09-10-2025
C7541001003,"Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including",09-10-2025
C7541002004,"Collection of specimen(s) by brushing or washing, when performed, with",09-10-2025
C7541003004,Endoscopic cannulation of papilla with direct visualization of,09-10-2025
C7541004004,Pancreatic/common bile ducts(s),09-10-2025
C7542001003,"Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or",09-10-2025
C7542002004,"Multiple, with endoscopic cannulation of papilla with direct visualization of",09-10-2025
C7542003004,Pancreatic/common bile ducts(s),09-10-2025
C7543001003,Endoscopic retrograde cholangiopancreatography (ercp) with,09-10-2025
C7543002004,"Sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct",09-10-2025
C7543003004,Visualization of pancreatic/common bile ducts(s),09-10-2025
C7544001003,Endoscopic retrograde cholangiopancreatography (ercp) with removal of,09-10-2025
C7544002004,"Calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of",09-10-2025
C7544003004,Papilla with direct visualization of pancreatic/common bile ducts(s),09-10-2025
C7545001003,"Percutaneous exchange of biliary drainage catheter (eg, external,",09-10-2025
C7545002004,"Internal-external, or conversion of internal-external to external only), with",09-10-2025
C7545003004,"Removal of calculi/debris from biliary duct(s) and/or gallbladder, including",09-10-2025
C7545004004,"Destruction of calculi by any method (eg, mechanical, electrohydraulic,",09-10-2025
C7545005004,"Lithotripsy) when performed, including diagnostic cholangiography(ies) when",09-10-2025
C7545006004,"Performed, imaging guidance (eg, fluoroscopy), and all associated radiological",09-10-2025
C7545007004,Supervision and interpretation,09-10-2025
C7546001003,"Removal and replacement of externally accessible nephroureteral catheter (eg,",09-10-2025
C7546002004,"External/internal stent) requiring fluoroscopic guidance, with ureteral",09-10-2025
C7546003004,"Stricture balloon dilation, including imaging guidance and all associated",09-10-2025
C7546004004,Radiological supervision and interpretation,09-10-2025
C7547001003,"Convert nephrostomy catheter to nephroureteral catheter, percutaneous via",09-10-2025
C7547002004,"Pre-existing nephrostomy tract, with ureteral stricture balloon dilation,",09-10-2025
C7547003004,"Including diagnostic nephrostogram and/or ureterogram when performed, imaging",09-10-2025
C7547004004,"Guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological",09-10-2025
C7547005004,Supervision and interpretation,09-10-2025
C7548001003,"Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon",09-10-2025
C7548002004,"Dilation, including diagnostic nephrostogram and/or ureterogram when performed,",09-10-2025
C7548003004,"Imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated",09-10-2025
C7548004004,Radiological supervision and interpretation,09-10-2025
C7549001003,Change of ureterostomy tube or externally accessible ureteral stent via ileal,09-10-2025
C7549002004,"Conduit with ureteral stricture balloon dilation, including imaging guidance",09-10-2025
C7549003004,"(eg, ultrasound and/or fluoroscopy) and all associated radiological supervision",09-10-2025
C7549004004,And interpretation,09-10-2025
C7550001003,"Cystourethroscopy, with biopsy(ies) with adjunctive blue light cystoscopy with",09-10-2025
C7550002004,Fluorescent imaging agent,09-10-2025
C7551001003,"Excision of major peripheral nerve neuroma, except sciatic, with implantation",09-10-2025
C7551002004,Of nerve end into bone or muscle,09-10-2025
C7552001003,"Catheter placement in coronary artery(s) for coronary angiography, including",09-10-2025
C7552002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7552003004,Interpretation; with catheter placement(s) in bypass graft(s) (internal,09-10-2025
C7552004004,"Mammary, free arterial, venous grafts) including intraprocedural injection(s)",09-10-2025
C7552005004,For bypass graft angiography and right heart catheterization with intravascular,09-10-2025
C7552006004,Doppler velocity and/or pressure derived coronary flow reserve measurement,09-10-2025
C7552007004,(coronary vessel or graft) during coronary angiography including,09-10-2025
C7552008004,"Pharmacologically induced stress, initial vessel",09-10-2025
C7553001003,"Catheter placement in coronary artery(s) for coronary angiography, including",09-10-2025
C7553002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7553003004,Interpretation; with right and left heart catheterization including,09-10-2025
C7553004004,"Intraprocedural injection(s) for left ventriculography, when performed,",09-10-2025
C7553005004,"Catheter placement(s) in bypass graft(s) (internal mammary, free arterial,",09-10-2025
C7553006004,Venous grafts) with bypass graft angiography with pharmacologic agent,09-10-2025
C7553007004,"Administration (eg, inhaled nitric oxide, intravenous infusion of",09-10-2025
C7553008004,"Nitroprusside, dobutamine, milrinone, or other agent) including assessing",09-10-2025
C7553009004,"Hemodynamic measurements before, during, after and repeat pharmacologic agent",09-10-2025
C7553010004,"Administration, when performed",09-10-2025
C7554001003,Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent,09-10-2025
C7554002004,Imaging agent,09-10-2025
C7555001003,"Thyroidectomy, total or complete with parathyroid autotransplantation",09-10-2025
C7556001003,"Bronchoscopy, rigid or flexible, with bronchial alveolar lavage and",09-10-2025
C7556002004,Transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic,09-10-2025
C7556003004,"Or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic",09-10-2025
C7556004004,"Guidance, when performed",09-10-2025
C7557001003,"Catheter placement in coronary artery(s) for coronary angiography, including",09-10-2025
C7557002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7557003004,Interpretation with left heart catheterization including intraprocedural,09-10-2025
C7557004004,"Injection(s) for left ventriculography, when performed and intraprocedural",09-10-2025
C7557005004,Coronary fractional flow reserve (ffr) with 3d functional mapping of,09-10-2025
C7557006004,"Color-coded ffr values for the coronary tree, derived from coronary angiogram",09-10-2025
C7557007004,"Data, for real-time review and interpretation of possible atherosclerotic",09-10-2025
C7557008004,Stenosis(es) intervention,09-10-2025
C7558001003,"Catheter placement in coronary artery(s) for coronary angiography, including",09-10-2025
C7558002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7558003004,Interpretation with right and left heart catheterization including,09-10-2025
C7558004004,"Intraprocedural injection(s) for left ventriculography, when performed,",09-10-2025
C7558005004,"Catheter placement(s) in bypass graft(s) (internal mammary, free arterial,",09-10-2025
C7558006004,Venous grafts) with bypass graft angiography with pharmacologic agent,09-10-2025
C7558007004,"Administration (eg, inhaled nitric oxide, intravenous infusion of",09-10-2025
C7558008004,"Nitroprusside, dobutamine, milrinone, or other agent) including assessing",09-10-2025
C7558009004,"Hemodynamic measurements before, during, after and repeat pharmacologic agent",09-10-2025
C7558010004,"Administration, when performed",09-10-2025
C7560001003,Endoscopic retrograde cholangiopancreatography (ercp) with removal of foreign,09-10-2025
C7560002004,Body(s) or stent(s) from biliary/pancreatic duct(s) and endoscopic cannulation,09-10-2025
C7560003004,Of papilla with direct visualization of pancreatic/common bile duct(s),09-10-2025
C7562001003,"Catheter placement in coronary artery(s) for coronary angiography, including",09-10-2025
C7562002004,"Intraprocedural injection(s) for coronary angiography, imaging supervision and",09-10-2025
C7562003004,Interpretation; with right and left heart catheterization including,09-10-2025
C7562004004,"Intraprocedural injection(s) for left ventriculography, when performed with",09-10-2025
C7562005004,Intraprocedural coronary fractional flow reserve (ffr) with 3d functional,09-10-2025
C7562006004,"Mapping of color-coded ffr values for the coronary tree, derived from coronary",09-10-2025
C7562007004,"Angiogram data, for real-time review and interpretation of possible",09-10-2025
C7562008004,Atherosclerotic stenosis(es) intervention,09-10-2025
C7563001003,Transluminal balloon angioplasty (except lower extremity artery(ies) for,09-10-2025
C7563002004,"Occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit),",09-10-2025
C7563003004,"Open or percutaneous, including all imaging and radiological supervision and",09-10-2025
C7563004004,"Interpretation necessary to perform the angioplasty within the same artery,",09-10-2025
C7563005004,Initial artery and all additional arteries,09-10-2025
C7564001003,"Percutaneous transluminal mechanical thrombectomy, vein(s), including",09-10-2025
C7564002004,Intraprocedural pharmacological thrombolytic injections and fluoroscopic,09-10-2025
C7564003004,Guidance with intravascular ultrasound (noncoronary vessel(s)) during,09-10-2025
C7564004004,"Diagnostic evaluation and/or therapeutic intervention, including radiological",09-10-2025
C7564005004,Supervision and interpretation,09-10-2025
C7565001003,"Repair of anterior abdominal hernia(s) (ie, epigastric, incisional, ventral,",09-10-2025
C7565002004,"Umbilical, spigelian), any approach (i.e., open, laparoscopic, robotic),",09-10-2025
C7565003004,"Recurrent, including implantation of mesh or other prosthesis when performed,",09-10-2025
C7565004004,"Total length of defect(s) less than 3 cm, reducible with removal of total or",09-10-2025
C7565005004,Near total non-infected mesh or other prosthesis at the time of initial or,09-10-2025
C7565006004,Recurrent anterior abdominal hernia repair or parastomal hernia repair,09-10-2025
C7900001003,"Service for diagnosis, evaluation, or treatment of a mental health or",09-10-2025
C7900002004,"Substance use disorder, 15-29 minutes, provided remotely by hospital staff who",09-10-2025
C7900003004,"Are licensed to provide mental health services under applicable state law(s),",09-10-2025
C7900004004,"When the patient is in their home, and there is no associated professional",09-10-2025
C7900005004,Service,09-10-2025
C7901001003,"Service for diagnosis, evaluation, or treatment of a mental health or substance",09-10-2025
C7901002004,"Use disorder, 30-60 minutes, provided remotely by hospital staff who are",09-10-2025
C7901003004,"Licensed to provided mental health services under applicable state law(s), when",09-10-2025
C7901004004,"The patient is in their home, and there is no associated professional service",09-10-2025
C7902001003,"Service for diagnosis, evaluation, or treatment of a mental health or substance",09-10-2025
C7902002004,"Use disorder, each additional 15 minutes, provided remotely by hospital staff",09-10-2025
C7902003004,Who are licensed to provide mental health services under applicable state,09-10-2025
C7902004004,"Law(s), when the patient is in their home, and there is no associated",09-10-2025
C7902005004,Professional service (list separately in addition to code for primary service),09-10-2025
C7903001003,"Group psychotherapy service for diagnosis, evaluation, or treatment of a mental",09-10-2025
C7903002004,Health or substance use disorder provided remotely by hospital staff who are,09-10-2025
C7903003004,"Licensed to provide mental health services under applicable state law(s), when",09-10-2025
C7903004004,"The patient is in their home, and there is no associated professional service",09-10-2025
C8000001003,"Support device, extravascular, for arteriovenous fistula (implantable)",09-10-2025
C8001001003,"3d anatomical segmentation imaging for preoperative planning, data preparation",09-10-2025
C8001002004,"And transmission, obtained from previous diagnostic computed tomographic or",09-10-2025
C8001003004,Magnetic resonance examination of the same anatomy,09-10-2025
C8002001003,"Preparation of skin cell suspension autograft, automated, including all",09-10-2025
C8002002004,Enzymatic processing and device components (do not report with manual,09-10-2025
C8002003004,Suspension preparation),09-10-2025
C8003001003,Implantation of medial knee extraarticular implantable shock absorber spanning,09-10-2025
C8003002004,"The knee joint from distal femur to proximal tibia, open, includes",09-10-2025
C8003003004,"Measurements, positioning and adjustments, with imaging guidance (e.g.,",09-10-2025
C8003004004,Fluoroscopy),09-10-2025
C8004001003,"Simulation angiogram with use of a pressure-generating catheter (e.g., one-way",09-10-2025
C8004002004,"Valve, intermittently occluding), inclusive of all radiological supervision and",09-10-2025
C8004003004,"Interpretation, intraprocedural roadmapping, and imaging guidance necessary to",09-10-2025
C8004004004,"Complete the angiogram, for subsequent therapeutic radioembolization of tumors",09-10-2025
C8005001003,"Bronchoscopy, rigid or flexible, non-thermal transbronchial ablation of",09-10-2025
C8005002004,"Lesion(s) by pulsed electric field (pef) energy, including fluoroscopic and/or",09-10-2025
C8005003004,"Ultrasound guidance, when performed, with computed tomography acquisition(s)",09-10-2025
C8005004004,"And 3d rendering, computer-assisted, image-guided navigation, and endobronchial",09-10-2025
C8005005004,"Ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g.,",09-10-2025
C8005006004,Aspiration[s]/biopsy[ies]) of lung(s) and all mediastinal and/or hilar lymph,09-10-2025
C8005007004,"Node stations or structures, and therapeutic intervention(s)",09-10-2025
C8006001003,"Insertion of pleural-peritoneal shunt with intercostal pump chamber, including",09-10-2025
C8006002004,"Imaging, injection(s) of contrast with radiological supervision and",09-10-2025
C8006003004,"Interpretation, when performed",09-10-2025
C8900001003,"Magnetic resonance angiography with contrast, abdomen",09-10-2025
C8901001003,"Magnetic resonance angiography without contrast, abdomen",09-10-2025
C8902001003,"Magnetic resonance angiography without contrast followed by with contrast,",09-10-2025
C8902002004,Abdomen,09-10-2025
C8903001003,"Magnetic resonance imaging with contrast, breast; unilateral",09-10-2025
C8904001003,"Magnetic resonance imaging without contrast, breast; unilateral",09-10-2025
C8905001003,"Magnetic resonance imaging without contrast followed by with contrast, breast;",09-10-2025
C8905002004,Unilateral,09-10-2025
C8906001003,"Magnetic resonance imaging with contrast, breast; bilateral",09-10-2025
C8907001003,"Magnetic resonance imaging without contrast, breast; bilateral",09-10-2025
C8908001003,"Magnetic resonance imaging without contrast followed by with contrast, breast;",09-10-2025
C8908002004,Bilateral,09-10-2025
C8909001003,"Magnetic resonance angiography with contrast, chest (excluding myocardium)",09-10-2025
C8910001003,"Magnetic resonance angiography without contrast, chest (excluding myocardium)",09-10-2025
C8911001003,"Magnetic resonance angiography without contrast followed by with contrast,",09-10-2025
C8911002004,Chest (excluding myocardium),09-10-2025
C8912001003,"Magnetic resonance angiography with contrast, lower extremity",09-10-2025
C8913001003,"Magnetic resonance angiography without contrast, lower extremity",09-10-2025
C8914001003,"Magnetic resonance angiography without contrast followed by with contrast,",09-10-2025
C8914002004,Lower extremity,09-10-2025
C8918001003,"Magnetic resonance angiography with contrast, pelvis",09-10-2025
C8919001003,"Magnetic resonance angiography without contrast, pelvis",09-10-2025
C8920001003,"Magnetic resonance angiography without contrast followed by with contrast,",09-10-2025
C8920002004,Pelvis,09-10-2025
C8921001003,"Transthoracic echocardiography with contrast, or without contrast followed by",09-10-2025
C8921002004,"With contrast, for congenital cardiac anomalies; complete",09-10-2025
C8922001003,"Transthoracic echocardiography with contrast, or without contrast followed by",09-10-2025
C8922002004,"With contrast, for congenital cardiac anomalies; follow-up or limited study",09-10-2025
C8923001003,"Transthoracic echocardiography with contrast, or without contrast followed by",09-10-2025
C8923002004,"With contrast, real-time with image documentation (2d), includes m-mode",09-10-2025
C8923003004,"Recording, when performed, complete, without spectral or color doppler",09-10-2025
C8923004004,Echocardiography,09-10-2025
C8924001003,"Transthoracic echocardiography with contrast, or without contrast followed by",09-10-2025
C8924002004,"With contrast, real-time with image documentation (2d), includes m-mode",09-10-2025
C8924003004,"Recording, when performed, follow-up or limited study",09-10-2025
C8925001003,"Transesophageal echocardiography (tee) with contrast, or without contrast",09-10-2025
C8925002004,"Followed by with contrast, real time with image documentation (2d) (with or",09-10-2025
C8925003004,"Without m-mode recording); including probe placement, image acquisition,",09-10-2025
C8925004004,Interpretation and report,09-10-2025
C8926001003,"Transesophageal echocardiography (tee) with contrast, or without contrast",09-10-2025
C8926002004,"Followed by with contrast, for congenital cardiac anomalies; including probe",09-10-2025
C8926003004,"Placement, image acquisition, interpretation and report",09-10-2025
C8927001003,"Transesophageal echocardiography (tee) with contrast, or without contrast",09-10-2025
C8927002004,"Followed by with contrast, for monitoring purposes, including probe placement,",09-10-2025
C8927003004,Real time 2-dimensional image acquisition and interpretation leading to ongoing,09-10-2025
C8927004004,(continuous) assessment of (dynamically changing) cardiac pumping function and,09-10-2025
C8927005004,To therapeutic measures on an immediate time basis,09-10-2025
C8928001003,"Transthoracic echocardiography with contrast, or without contrast followed by",09-10-2025
C8928002004,"With contrast, real-time with image documentation (2d), includes m-mode",09-10-2025
C8928003004,"Recording, when performed, during rest and cardiovascular stress test using",09-10-2025
C8928004004,"Treadmill, bicycle exercise and/or pharmacologically induced stress, with",09-10-2025
C8928005004,Interpretation and report,09-10-2025
C8929001003,"Transthoracic echocardiography with contrast, or without contrast followed by",09-10-2025
C8929002004,"With contrast, real-time with image documentation (2d), includes m-mode",09-10-2025
C8929003004,"Recording, when performed, complete, with spectral doppler echocardiography,",09-10-2025
C8929004004,And with color flow doppler echocardiography,09-10-2025
C8930001003,"Transthoracic echocardiography, with contrast, or without contrast followed by",09-10-2025
C8930002004,"With contrast, real-time with image documentation (2d), includes m-mode",09-10-2025
C8930003004,"Recording, when performed, during rest and cardiovascular stress test using",09-10-2025
C8930004004,"Treadmill, bicycle exercise and/or pharmacologically induced stress, with",09-10-2025
C8930005004,Interpretation and report; including performance of continuous,09-10-2025
C8930006004,"Electrocardiographic monitoring, with physician supervision",09-10-2025
C8931001003,"Magnetic resonance angiography with contrast, spinal canal and contents",09-10-2025
C8932001003,"Magnetic resonance angiography without contrast, spinal canal and contents",09-10-2025
C8933001003,"Magnetic resonance angiography without contrast followed by with contrast,",09-10-2025
C8933002004,Spinal canal and contents,09-10-2025
C8934001003,"Magnetic resonance angiography with contrast, upper extremity",09-10-2025
C8935001003,"Magnetic resonance angiography without contrast, upper extremity",09-10-2025
C8936001003,"Magnetic resonance angiography without contrast followed by with contrast,",09-10-2025
C8936002004,Upper extremity,09-10-2025
C8937001003,"Computer-aided detection, including computer algorithm analysis of breast mri",09-10-2025
C8937002004,"Image data for lesion detection/characterization, pharmacokinetic analysis,",09-10-2025
C8937003004,With further physician review for interpretation (list separately in addition,09-10-2025
C8937004004,To code for primary procedure),09-10-2025
C8957001003,Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion,09-10-2025
C8957002004,"(more than 8 hours), requiring use of portable or implantable pump",09-10-2025
C9014001003,"Injection, cerliponase alfa, 1 mg",09-10-2025
C9015001003,"Injection, c-1 esterase inhibitor (human), haegarda, 10 units",09-10-2025
C9016001003,"Injection, triptorelin extended release, 3.75 mg",09-10-2025
C9021001003,"Injection, obinutuzumab, 10 mg",09-10-2025
C9022001003,"Injection, elosulfase alfa, 1mg",09-10-2025
C9023001003,"Injection, testosterone undecanoate, 1 mg",09-10-2025
C9024001003,"Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine",09-10-2025
C9025001003,"Injection, ramucirumab, 5 mg",09-10-2025
C9026001003,"Injection, vedolizumab, 1 mg",09-10-2025
C9027001003,"Injection, pembrolizumab, 1 mg",09-10-2025
C9028001003,"Injection, inotuzumab ozogamicin, 0.1 mg",09-10-2025
C9029001003,"Injection, guselkumab, 1 mg",09-10-2025
C9030001003,"Injection, copanlisib, 1 mg",09-10-2025
C9031001003,"Lutetium lu 177, dotatate, therapeutic, 1 mci",09-10-2025
C9032001003,"Injection, voretigene neparvovec-rzyl, 1 billion vector genome",09-10-2025
C9033001003,"Injection, fosnetupitant 235 mg and palonosetron 0.25 mg",09-10-2025
C9034001003,"Injection, dexamethasone 9%, intraocular, 1 mcg",09-10-2025
C9035001003,"Injection, aripiprazole lauroxil (aristada initio), 1 mg",09-10-2025
C9036001003,"Injection, patisiran, 0.1 mg",09-10-2025
C9037001003,"Injection, risperidone (perseris), 0.5 mg",09-10-2025
C9038001003,"Injection, mogamulizumab-kpkc, 1 mg",09-10-2025
C9039001003,"Injection, plazomicin, 5 mg",09-10-2025
C9040001003,"Injection, fremanezumab-vfrm, 1mg",09-10-2025
C9041001003,"Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg",09-10-2025
C9042001003,"Injection, bendamustine hcl (belrapzo), 1 mg",09-10-2025
C9043001003,"Injection, levoleucovorin, 1 mg",09-10-2025
C9044001003,"Injection, cemiplimab-rwlc, 1 mg",09-10-2025
C9045001003,"Injection, moxetumomab pasudotox-tdfk, 0.01 mg",09-10-2025
C9046001003,"Cocaine hydrochloride nasal solution (goprelto), 1 mg",09-10-2025
C9047001003,"Injection, caplacizumab-yhdp, 1 mg",09-10-2025
C9048001003,"Dexamethasone, lacrimal ophthalmic insert, 0.1 mg",09-10-2025
C9049001003,"Injection, tagraxofusp-erzs, 10 mcg",09-10-2025
C9050001003,"Injection, emapalumab-lzsg, 1 mg",09-10-2025
C9051001003,"Injection, omadacycline, 1 mg",09-10-2025
C9052001003,"Injection, ravulizumab-cwvz, 10 mg",09-10-2025
C9053001003,"Injection, crizanlizumab-tmca, 1 mg",09-10-2025
C9054001003,"Injection, lefamulin (xenleta), 1 mg",09-10-2025
C9055001003,"Injection, brexanolone, 1mg",09-10-2025
C9056001003,"Injection, givosiran, 0.5 mg",09-10-2025
C9057001003,"Injection, cetirizine hydrochloride, 1 mg",09-10-2025
C9058001003,"Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg",09-10-2025
C9059001003,"Injection, meloxicam, 1 mg",09-10-2025
C9060001003,"Fluoroestradiol f18, diagnostic, 1 mci",09-10-2025
C9061001003,"Injection, teprotumumab-trbw, 10 mg",09-10-2025
C9062001003,"Injection, daratumumab 10 mg and hyaluronidase-fihj",09-10-2025
C9063001003,"Injection, eptinezumab-jjmr, 1 mg",09-10-2025
C9064001003,"Mitomycin pyelocalyceal instillation, 1 mg",09-10-2025
C9065001003,"Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg",09-10-2025
C9066001003,"Injection, sacituzumab govitecan-hziy, 2.5 mg",09-10-2025
C9067001003,"Gallium ga-68, dotatoc, diagnostic, 0.01 mci",09-10-2025
C9068001003,"Copper cu-64, dotatate, diagnostic, 1 millicurie",09-10-2025
C9069001003,"Injection, belantamab mafodontin-blmf, 0.5 mg",09-10-2025
C9070001003,"Injection, tafasitamab-cxix, 2 mg",09-10-2025
C9071001003,"Injection, viltolarsen, 10 mg",09-10-2025
C9072001003,"Injection, immune globulin (asceniv), 500 mg",09-10-2025
C9073001003,"Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive",09-10-2025
C9073002004,"Viable t cells, including leukapheresis and dose preparation procedures, per",09-10-2025
C9073003004,Therapeutic dose,09-10-2025
C9074001003,"Injection, lumasiran, 0.5 mg",09-10-2025
C9075001003,"Injection, casimersen, 10 mg",09-10-2025
C9076001003,"Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive",09-10-2025
C9076002004,"Viable t cells, including leukapheresis and dose preparation procedures, per",09-10-2025
C9076003004,Therapeutic dose,09-10-2025
C9077001003,"Injection, cabotegravir and rilpivirine, 2mg/3mg",09-10-2025
C9078001003,"Injection, trilaciclib, 1 mg",09-10-2025
C9079001003,"Injection, evinacumab-dgnb, 5 mg",09-10-2025
C9080001003,"Injection, melphalan flufenamide hydrochloride, 1 mg",09-10-2025
C9081001003,"Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive",09-10-2025
C9081002004,"Viable t cells, including leukapheresis and dose preparation procedures, per",09-10-2025
C9081003004,Therapeutic dose,09-10-2025
C9082001003,"Injection, dostarlimab-gxly, 100 mg",09-10-2025
C9083001003,"Injection, amivantamab-vmjw, 10 mg",09-10-2025
C9084001003,"Injection, loncastuximab tesirine-lpyl, 0.1 mg",09-10-2025
C9085001003,"Injection, avalglucosidase alfa-ngpt, 4 mg",09-10-2025
C9086001003,"Injection, anifrolumab-fnia, 1 mg",09-10-2025
C9087001003,"Injection, cyclophosphamide, (auromedics), 10 mg",09-10-2025
C9088001003,"Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg",09-10-2025
C9089001003,"Bupivacaine, collagen-matrix implant, 1 mg",09-10-2025
C9090001003,"Injection, plasminogen, human-tvmh, 1 mg",09-10-2025
C9091001003,"Injection, sirolimus protein-bound particles, 1 mg",09-10-2025
C9092001003,"Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg",09-10-2025
C9093001003,"Injection, ranibizumab, via sustained release intravitreal implant (susvimo),",09-10-2025
C9093002004,0.1 mg,09-10-2025
C9094001003,"Inj, sutimlimab-jome, 10 mg",09-10-2025
C9095001003,"Inj, tebentafusp-tebn, 1 mcg",09-10-2025
C9096001003,"Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram",09-10-2025
C9097001003,"Inj, faricimab-svoa, 0.1 mg",09-10-2025
C9098001003,"Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation",09-10-2025
C9098002004,"Antigen (bcma) directed car-positive t cells, including leukapheresis and dose",09-10-2025
C9098003004,"Preparation procedures, per therapeutic dose",09-10-2025
C9101001003,"Injection, oliceridine, 0.1 mg",09-10-2025
C9113001003,"Injection, pantoprazole sodium, per vial",09-10-2025
C9121001003,"Injection, argatroban, per 5 mg",09-10-2025
C9122001003,"Mometasone furoate sinus implant, 10 micrograms (sinuva)",09-10-2025
C9132001003,"Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activit",09-10-2025
C9133001003,"Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.",09-10-2025
C9134001003,"Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.",09-10-2025
C9135001003,"Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.",09-10-2025
C9136001003,"Injection, factor viii, fc fusion protein, (recombinant), per i.u.",09-10-2025
C9137001003,"Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.",09-10-2025
C9138001003,"Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.",09-10-2025
C9139001003,"Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.",09-10-2025
C9140001003,"Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.",09-10-2025
C9141001003,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl",09-10-2025
C9141002004,"(jivi), 1 i.u.",09-10-2025
C9142001003,"Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg",09-10-2025
C9143001003,"Cocaine hydrochloride nasal solution (numbrino), 1 mg",09-10-2025
C9144001003,"Injection, bupivacaine (posimir), 1 mg",09-10-2025
C9145001003,"Injection, aprepitant, (aponvie), 1 mg",09-10-2025
C9146001003,"Injection, mirvetuximab soravtansine-gynx, 1 mg",09-10-2025
C9147001003,"Injection, tremelimumab-actl, 1 mg",09-10-2025
C9148001003,"Injection, teclistamab-cqyv, 0.5 mg",09-10-2025
C9149001003,"Injection, teplizumab-mzwv, 5 mcg",09-10-2025
C9150001003,"Xenon xe-129 hyperpolarized gas, diagnostic, per study dose",09-10-2025
C9151001003,"Injection, pegcetacoplan, 1 mg",09-10-2025
C9152001003,"Injection, aripiprazole, (abilify asimtufii), 1 mg",09-10-2025
C9153001003,"Injection, amisulpride, 1 mg",09-10-2025
C9154001003,"Injection, buprenorphine extended-release (brixadi), 1 mg",09-10-2025
C9155001003,"Injection, epcoritamab-bysp, 0.16 mg",09-10-2025
C9156001003,"Flotufolastat f 18, diagnostic, 1 millicurie",09-10-2025
C9157001003,"Injection, tofersen, 1 mg",09-10-2025
C9158001003,"Injection, risperidone, (uzedy), 1 mg",09-10-2025
C9159001003,"Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of",09-10-2025
C9159002004,Factor ix activity,09-10-2025
C9160001003,"Injection, daxibotulinumtoxina-lanm, 1 unit",09-10-2025
C9161001003,"Injection, aflibercept hd, 1 mg",09-10-2025
C9162001003,"Injection, avacincaptad pegol, 0.1 mg",09-10-2025
C9163001003,"Injection, talquetamab-tgvs, 0.25 mg",09-10-2025
C9164001003,"Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2",09-10-2025
C9164002004,Mg),09-10-2025
C9165001003,"Injection, elranatamab-bcmm, 1 mg",09-10-2025
C9166001003,"Injection, secukinumab, intravenous, 1 mg",09-10-2025
C9167001003,"Injection, adamts13, recombinant-krhn, 10 iu",09-10-2025
C9168001003,"Injection, mirikizumab-mrkz, 1 mg",09-10-2025
C9169001003,"Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram",09-10-2025
C9170001003,"Injection, tarlatamab-dlle, 1 mg",09-10-2025
C9171001003,"Injection, pegulicianine, 1 mg",09-10-2025
C9172001003,"Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose",09-10-2025
C9173001003,"Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram",09-10-2025
C9174001003,"Injection, datopotamab deruxtecan-dlnk, 1 mg",09-10-2025
C9175001003,"Injection, treosulfan, 50 mg",09-10-2025
C9248001003,"Injection, clevidipine butyrate, 1 mg",09-10-2025
C9250001003,"Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml",09-10-2025
C9254001003,"Injection, lacosamide, 1 mg",09-10-2025
C9257001003,"Injection, bevacizumab, 0.25 mg",09-10-2025
C9275001003,"Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose",09-10-2025
C9285001003,"Lidocaine 70 mg/tetracaine 70 mg, per patch",09-10-2025
C9290001003,"Injection, bupivacaine liposome, 1 mg",09-10-2025
C9293001003,"Injection, glucarpidase, 10 units",09-10-2025
C9300001003,"Injection, indigotindisulfonate sodium, 1 mg",09-10-2025
C9301001003,"Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells,",09-10-2025
C9301002004,"Including leukapheresis and dose preparation procedures, per therapeutic dose",09-10-2025
C9302001003,"Injection, zanidatamab-hrii, 2 mg",09-10-2025
C9303001003,"Injection, zolbetuximab-clzb, 1 mg",09-10-2025
C9304001003,"Injection, marstacimab-hncq, 0.5 mg",09-10-2025
C9305001003,"Injection, nipocalimab-aahu, 3 mg",09-10-2025
C9306001003,"Injection, telisotuzumab vedotin-tllv, 1 mg",09-10-2025
C9349001003,"Puraply, and puraply antimicrobial, any type, per square centimeter",09-10-2025
C9352001003,"Microporous collagen implantable tube (neuragen nerve guide), per centimeter",09-10-2025
C9352002004,Length,09-10-2025
C9353001003,"Microporous collagen implantable slit tube (neurawrap nerve protector), per",09-10-2025
C9353002004,Centimeter length,09-10-2025
C9354001003,"Acellular pericardial tissue matrix of non-human origin (veritas), per square",09-10-2025
C9354002004,Centimeter,09-10-2025
C9355001003,"Collagen nerve cuff (neuromatrix), per 0.5 centimeter length",09-10-2025
C9356001003,"Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix",09-10-2025
C9356002004,"(tenoglide tendon protector sheet), per square centimeter",09-10-2025
C9358001003,"Dermal substitute, native, non-denatured collagen, fetal bovine origin",09-10-2025
C9358002004,"(surgimend collagen matrix), per 0.5 square centimeters",09-10-2025
C9359001003,Porous purified collagen matrix bone void filler (integra mozaik,09-10-2025
C9359002004,"Osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per",09-10-2025
C9359003004,0.5 cc,09-10-2025
C9360001003,"Dermal substitute, native, non-denatured collagen, neonatal bovine origin",09-10-2025
C9360002004,"(surgimend collagen matrix), per 0.5 square centimeters",09-10-2025
C9361001003,"Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter",09-10-2025
C9361002004,Length,09-10-2025
C9362001003,Porous purified collagen matrix bone void filler (integra mozaik,09-10-2025
C9362002004,"Osteoconductive scaffold strip), per 0.5 cc",09-10-2025
C9363001003,"Skin substitute, integra meshed bilayer wound matrix, per square centimeter",09-10-2025
C9364001003,"Porcine implant, permacol, per square centimeter",09-10-2025
C9399001003,Unclassified drugs or biologicals,09-10-2025
C9407001003,"Iodine i-131 iobenguane, diagnostic, 1 millicurie",09-10-2025
C9408001003,"Iodine i-131 iobenguane, therapeutic, 1 millicurie",09-10-2025
C9441001003,"Injection, ferric carboxymaltose, 1 mg",09-10-2025
C9442001003,"Injection, belinostat, 10 mg",09-10-2025
C9443001003,"Injection, dalbavancin, 10 mg",09-10-2025
C9444001003,"Injection, oritavancin, 10 mg",09-10-2025
C9445001003,"Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units",09-10-2025
C9446001003,"Injection, tedizolid phosphate, 1 mg",09-10-2025
C9447001003,"Injection, phenylephrine and ketorolac, 4 ml vial",09-10-2025
C9448001003,"Netupitant 300 mg and palonosetron 0.5 mg, oral",09-10-2025
C9449001003,"Injection, blinatumomab, 1 mcg",09-10-2025
C9450001003,"Injection, fluocinolone acetonide intravitreal implant, 0.01 mg",09-10-2025
C9451001003,"Injection, peramivir, 1 mg",09-10-2025
C9452001003,"Injection, ceftolozane 50 mg and tazobactam 25 mg",09-10-2025
C9453001003,"Injection, nivolumab, 1 mg",09-10-2025
C9454001003,"Injection, pasireotide long acting, 1 mg",09-10-2025
C9455001003,"Injection, siltuximab, 10 mg",09-10-2025
C9456001003,"Injection, isavuconazonium sulfate, 1 mg",09-10-2025
C9457001003,"Injection, sulfur hexafluoride lipid microsphere, per ml",09-10-2025
C9458001003,"Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries",09-10-2025
C9459001003,"Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries",09-10-2025
C9460001003,"Injection, cangrelor, 1 mg",09-10-2025
C9461001003,"Choline c 11, diagnostic, per study dose",09-10-2025
C9462001003,"Injection, delafloxacin, 1 mg",09-10-2025
C9463001003,"Injection, aprepitant, 1 mg",09-10-2025
C9464001003,"Injection, rolapitant, 0.5 mg",09-10-2025
C9465001003,"Hyaluronan or derivative, durolane, for intra-articular injection, per dose",09-10-2025
C9466001003,"Injection, benralizumab, 1 mg",09-10-2025
C9467001003,"Injection, rituximab and hyaluronidase, 10 mg",09-10-2025
C9468001003,"Injection, factor ix (antihemophilic factor, recombinant), glycopegylated,",09-10-2025
C9468002004,"Rebinyn, 1 i.u.",09-10-2025
C9469001003,"Injection, triamcinolone acetonide, preservative-free, extended-release,",09-10-2025
C9469002004,"Microsphere formulation, 1 mg",09-10-2025
C9470001003,"Injection, aripiprazole lauroxil, 1 mg",09-10-2025
C9471001003,"Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg",09-10-2025
C9472001003,"Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)",09-10-2025
C9473001003,"Injection, mepolizumab, 1 mg",09-10-2025
C9474001003,"Injection, irinotecan liposome, 1 mg",09-10-2025
C9475001003,"Injection, necitumumab, 1 mg",09-10-2025
C9476001003,"Injection, daratumumab, 10 mg",09-10-2025
C9477001003,"Injection, elotuzumab, 1 mg",09-10-2025
C9478001003,"Injection, sebelipase alfa, 1 mg",09-10-2025
C9479001003,"Instillation, ciprofloxacin otic suspension, 6 mg",09-10-2025
C9480001003,"Injection, trabectedin, 0.1 mg",09-10-2025
C9481001003,"Injection, reslizumab, 1 mg",09-10-2025
C9482001003,"Injection, sotalol hydrochloride, 1 mg",09-10-2025
C9483001003,"Injection, atezolizumab, 10 mg",09-10-2025
C9484001003,"Injection, eteplirsen, 10 mg",09-10-2025
C9485001003,"Injection, olaratumab, 10 mg",09-10-2025
C9486001003,"Injection, granisetron extended release, 0.1 mg",09-10-2025
C9487001003,"Ustekinumab, for intravenous injection, 1 mg",09-10-2025
C9488001003,"Injection, conivaptan hydrochloride, 1 mg",09-10-2025
C9489001003,"Injection, nusinersen, 0.1 mg",09-10-2025
C9490001003,"Injection, bezlotoxumab, 10 mg",09-10-2025
C9491001003,"Injection, avelumab, 10 mg",09-10-2025
C9492001003,"Injection, durvalumab, 10 mg",09-10-2025
C9493001003,"Injection, edaravone, 1 mg",09-10-2025
C9494001003,"Injection, ocrelizumab, 1 mg",09-10-2025
C9497001003,"Loxapine, inhalation powder, 10 mg",09-10-2025
C9507001003,"Plasma, high titer covid-19 convalescent, each unit",09-10-2025
C9600001003,"Percutaneous transcatheter placement of drug eluting intracoronary stent(s),",09-10-2025
C9600002004,With coronary angioplasty when performed; single major coronary artery or branc,09-10-2025
C9601001003,"Percutaneous transcatheter placement of drug-eluting intracoronary stent(s),",09-10-2025
C9601002004,With coronary angioplasty when performed; each additional branch of a major,09-10-2025
C9601003004,Coronary artery (list separately in addition to code for primary procedure),09-10-2025
C9602001003,"Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary",09-10-2025
C9602002004,"Stent, with coronary angioplasty when performed; single major coronary artery",09-10-2025
C9602003004,Or branch,09-10-2025
C9603001003,"Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary",09-10-2025
C9603002004,"Stent, with coronary angioplasty when performed; each additional branch of a",09-10-2025
C9603003004,Major coronary artery (list separately in addition to code for primary,09-10-2025
C9603004004,Procedure),09-10-2025
C9604001003,Percutaneous transluminal revascularization of or through coronary artery,09-10-2025
C9604002004,"Bypass graft (internal mammary, free arterial, venous), any combination of",09-10-2025
C9604003004,"Drug-eluting intracoronary stent, atherectomy and angioplasty, including distal",09-10-2025
C9604004004,Protection when performed; single vessel,09-10-2025
C9605001003,Percutaneous transluminal revascularization of or through coronary artery,09-10-2025
C9605002004,"Bypass graft (internal mammary, free arterial, venous), any combination of",09-10-2025
C9605003004,"Drug-eluting intracoronary stent, atherectomy and angioplasty, including distal",09-10-2025
C9605004004,Protection when performed; each additional branch subtended by the bypass graft,09-10-2025
C9605005004,(list separately in addition to code for primary procedure),09-10-2025
C9606001003,Percutaneous transluminal revascularization of acute total/subtotal occlusion,09-10-2025
C9606002004,"During acute myocardial infarction, coronary artery or coronary artery bypass",09-10-2025
C9606003004,"Graft, any combination of drug-eluting intracoronary stent, atherectomy and",09-10-2025
C9606004004,"Angioplasty, including aspiration thrombectomy when performed, single vessel",09-10-2025
C9607001003,"Percutaneous transluminal revascularization of chronic total occlusion,",09-10-2025
C9607002004,"Coronary artery, coronary artery branch, or coronary artery bypass graft, any",09-10-2025
C9607003004,"Combination of drug-eluting intracoronary stent, atherectomy and",09-10-2025
C9607004004,Angioplasty; single vessel,09-10-2025
C9608001003,"Percutaneous transluminal revascularization of chronic total occlusion,",09-10-2025
C9608002004,"Coronary artery, coronary artery branch, or coronary artery bypass graft, any",09-10-2025
C9608003004,"Combination of drug-eluting intracoronary stent, atherectomy and",09-10-2025
C9608004004,"Angioplasty; each additional coronary artery, coronary artery branch, or bypass",09-10-2025
C9608005004,Graft (list separately in addition to code for primary procedure),09-10-2025
C9610001003,"Catheter, transluminal drug delivery with or without angioplasty, coronary,",09-10-2025
C9610002004,Non-laser (insertable),09-10-2025
C9724001003,Endoscopic full-thickness plication of the stomach using endoscopic plication,09-10-2025
C9724002004,System (eps); includes endoscopy,09-10-2025
C9725001003,Placement of endorectal intracavitary applicator for high intensity,09-10-2025
C9725002004,Brachytherapy,09-10-2025
C9726001003,Placement and removal (if performed) of applicator into breast for,09-10-2025
C9726002004,"Intraoperative radiation therapy, add-on to primary breast procedure",09-10-2025
C9727001003,Insertion of implants into the soft palate; minimum of three implants,09-10-2025
C9728001003,Placement of interstitial device(s) for radiation therapy/surgery guidance,09-10-2025
C9728002004,"(e.g., fiducial markers, dosimeter), for other than the following sites (any",09-10-2025
C9728003004,"Approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or",09-10-2025
C9728004004,Multiple,09-10-2025
C9733001003,Non-ophthalmic fluorescent vascular angiography,09-10-2025
C9734001003,"Focused ultrasound ablation/therapeutic intervention, other than uterine",09-10-2025
C9734002004,"Leiomyomata, with magnetic resonance (mr) guidance",09-10-2025
C9735001003,"Anoscopy; with directed submucosal injection(s), any substance",09-10-2025
C9737001003,"Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g.,",09-10-2025
C9737002004,Magnetic band),09-10-2025
C9738001003,Adjunctive blue light cystoscopy with fluorescent imaging agent (list,09-10-2025
C9738002004,Separately in addition to code for primary procedure),09-10-2025
C9739001003,"Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants",09-10-2025
C9740001003,"Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants",09-10-2025
C9741001003,Right heart catheterization with implantation of wireless pressure sensor in,09-10-2025
C9741002004,"The pulmonary artery, including any type of measurement, angiography, imaging",09-10-2025
C9741003004,"Supervision, interpretation, and report",09-10-2025
C9742001003,"Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s),",09-10-2025
C9742002004,"Therapeutic, including diagnostic laryngoscopy, if performed",09-10-2025
C9743001003,Injection/implantation of bulking or spacer material (any type) with or without,09-10-2025
C9743002004,Image guidance (not to be used if a more specific code applies),09-10-2025
C9744001003,"Ultrasound, abdominal, with contrast",09-10-2025
C9745001003,"Nasal endoscopy, surgical; balloon dilation of eustachian tube",09-10-2025
C9746001003,"Transperineal implantation of permanent adjustable balloon continence device,",09-10-2025
C9746002004,"With cystourethroscopy, when performed and/or fluoroscopy, when performed",09-10-2025
C9747001003,"Ablation of prostate, transrectal, high intensity focused ultrasound (hifu),",09-10-2025
C9747002004,Including imaging guidance,09-10-2025
C9748001003,Transurethral destruction of prostate tissue; by radiofrequency water vapor,09-10-2025
C9748002004,(steam) thermal therapy,09-10-2025
C9749001003,Repair of nasal vestibular lateral wall stenosis with implant(s),09-10-2025
C9750001003,Insertion or removal and replacement of intracardiac ischemia monitoring system,09-10-2025
C9750002004,Including imaging supervision and interpretation and peri-operative,09-10-2025
C9750003004,Interrogation and programming; complete system (includes device and electrode),09-10-2025
C9751001003,"Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by",09-10-2025
C9751002004,"Microwave energy, including fluoroscopic guidance, when performed, with",09-10-2025
C9751003004,"Computed tomography acquisition(s) and 3-d rendering, computer-assisted,",09-10-2025
C9751004004,"Image-guided navigation, and endobronchial ultrasound (ebus) guided",09-10-2025
C9751005004,"Transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies])",09-10-2025
C9751006004,And all mediastinal and/or hilar lymph node stations or structures and,09-10-2025
C9751007004,Therapeutic intervention(s),09-10-2025
C9752001003,"Destruction of intraosseous basivertebral nerve, first two vertebral bodies,",09-10-2025
C9752002004,"Including imaging guidance (e.g., fluoroscopy), lumbar/sacrum",09-10-2025
C9753001003,"Destruction of intraosseous basivertebral nerve, each additional vertebral",09-10-2025
C9753002004,"Body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list",09-10-2025
C9753003004,Separately in addition to code for primary procedure),09-10-2025
C9754001003,"Creation of arteriovenous fistula, percutaneous; direct, any site, including",09-10-2025
C9754002004,"All imaging and radiologic supervision and interpretation, when performed and",09-10-2025
C9754003004,"Secondary procedures to redirect blood flow (e.g., transluminal balloon",09-10-2025
C9754004004,"Angioplasty, coil embolization, when performed)",09-10-2025
C9755001003,"Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial",09-10-2025
C9755002004,"And venous catheters and radiofrequency energy, including flow-directing",09-10-2025
C9755003004,"Procedures (e.g., vascular coil embolization with radiologic supervision and",09-10-2025
C9755004004,"Interpretation, when performed) and fistulogram(s), angiography, venography,",09-10-2025
C9755005004,"And/or ultrasound, with radiologic supervision and interpretation, when",09-10-2025
C9755006004,Performed,09-10-2025
C9756001003,Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s),09-10-2025
C9756002004,(sentinel or tumor draining) with administration of indocyanine green (icg),09-10-2025
C9756003004,(list separately in addition to code for primary procedure),09-10-2025
C9757001003,"Laminotomy (hemilaminectomy), with decompression of nerve root(s), including",09-10-2025
C9757002004,"Partial facetectomy, foraminotomy and excision of herniated intervertebral",09-10-2025
C9757003004,"Disc, and repair of annular defect with implantation of bone anchored annular",09-10-2025
C9757004004,"Closure device, including annular defect measurement, alignment and sizing",09-10-2025
C9757005004,"Assessment, and image guidance; 1 interspace, lumbar",09-10-2025
C9758001003,Blinded procedure for nyha class iii/iv heart failure; transcatheter,09-10-2025
C9758002004,"Implantation of interatrial shunt or placebo control, including right heart",09-10-2025
C9758003004,"Catheterization, trans-esophageal echocardiography (tee)/intracardiac",09-10-2025
C9758004004,"Echocardiography (ice), and all imaging with or without guidance (e.g.,",09-10-2025
C9758005004,"Ultrasound, fluoroscopy), performed in an approved investigational device",09-10-2025
C9758006004,Exemption (ide) study,09-10-2025
C9759001003,"Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal,",09-10-2025
C9759002004,"Vascular wall and/or perivascular) therapy, any vessel, including radiological",09-10-2025
C9759003004,"Supervision and interpretation, when performed",09-10-2025
C9760001003,"Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure;",09-10-2025
C9760002004,"Transcatheter implantation of interatrial shunt, including right and left heart",09-10-2025
C9760003004,"Catheterization, transeptal puncture, trans-esophageal echocardiography",09-10-2025
C9760004004,"(tee)/intracardiac echocardiography (ice), and all imaging with or without",09-10-2025
C9760005004,"Guidance (e.g., ultrasound, fluoroscopy), performed in an approved",09-10-2025
C9760006004,Investigational device exemption (ide) study,09-10-2025
C9761001003,"Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and",09-10-2025
C9761002004,"Ureteral catheterization for steerable vacuum aspiration of the kidney,",09-10-2025
C9761003004,"Collecting system, ureter, bladder, and urethra if applicable (must use a",09-10-2025
C9761004004,Steerable ureteral catheter),09-10-2025
C9762001003,"Cardiac magnetic resonance imaging for morphology and function, quantification",09-10-2025
C9762002004,Of segmental dysfunction; with strain imaging,09-10-2025
C9763001003,"Cardiac magnetic resonance imaging for morphology and function, quantification",09-10-2025
C9763002004,Of segmental dysfunction; with stress imaging,09-10-2025
C9764001003,"Revascularization, endovascular, open or percutaneous, lower extremity",09-10-2025
C9764002004,"Artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes",09-10-2025
C9764003004,"Angioplasty within the same vessel(s), when performed",09-10-2025
C9765001003,"Revascularization, endovascular, open or percutaneous, lower extremity",09-10-2025
C9765002004,"Artery(ies), except tibial/peroneal; with intravascular lithotripsy, and",09-10-2025
C9765003004,"Transluminal stent placement(s), includes angioplasty within the same",09-10-2025
C9765004004,"Vessel(s), when performed",09-10-2025
C9766001003,"Revascularization, endovascular, open or percutaneous, lower extremity",09-10-2025
C9766002004,"Artery(ies), except tibial/peroneal; with intravascular lithotripsy and",09-10-2025
C9766003004,"Atherectomy, includes angioplasty within the same vessel(s), when performed",09-10-2025
C9767001003,"Revascularization, endovascular, open or percutaneous, lower extremity",09-10-2025
C9767002004,"Artery(ies), except tibial/peroneal; with intravascular lithotripsy and",09-10-2025
C9767003004,"Transluminal stent placement(s), and atherectomy, includes angioplasty within",09-10-2025
C9767004004,"The same vessel(s), when performed",09-10-2025
C9768001003,Endoscopic ultrasound-guided direct measurement of hepatic portosystemic,09-10-2025
C9768002004,Pressure gradient by any method (list separately in addition to code for,09-10-2025
C9768003004,Primary procedure),09-10-2025
C9769001003,"Cystourethroscopy, with insertion of temporary prostatic implant/stent with",09-10-2025
C9769002004,Fixation/anchor and incisional struts,09-10-2025
C9770001003,"Vitrectomy, mechanical, pars plana approach, with subretinal injection of",09-10-2025
C9770002004,Pharmacologic/biologic agent,09-10-2025
C9771001003,"Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral",09-10-2025
C9771002004,Or bilateral,09-10-2025
C9772001003,"Revascularization, endovascular, open or percutaneous, tibial/peroneal",09-10-2025
C9772002004,"Artery(ies), with intravascular lithotripsy, includes angioplasty within the",09-10-2025
C9772003004,"Same vessel (s), when performed",09-10-2025
C9773001003,"Revascularization, endovascular, open or percutaneous, tibial/peroneal",09-10-2025
C9773002004,"Artery(ies); with intravascular lithotripsy, and transluminal stent",09-10-2025
C9773003004,"Placement(s), includes angioplasty within the same vessel(s), when performed",09-10-2025
C9774001003,"Revascularization, endovascular, open or percutaneous, tibial/peroneal",09-10-2025
C9774002004,"Artery(ies); with intravascular lithotripsy and atherectomy, includes",09-10-2025
C9774003004,"Angioplasty within the same vessel (s), when performed",09-10-2025
C9775001003,"Revascularization, endovascular, open or percutaneous, tibial/peroneal",09-10-2025
C9775002004,Artery(ies); with intravascular lithotripsy and transluminal stent,09-10-2025
C9775003004,"Placement(s), and atherectomy, includes angioplasty within the same vessel (s),",09-10-2025
C9775004004,When performed,09-10-2025
C9776001003,Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile,09-10-2025
C9776002004,"Duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with",09-10-2025
C9776003004,Intravenous administration of indocyanine green (icg) (list separately in,09-10-2025
C9776004004,Addition to code for primary procedure),09-10-2025
C9777001003,"Esophageal mucosal integrity testing by electrical impedance, transoral,",09-10-2025
C9777002004,Includes esophagoscopy or esophagogastroduodenoscopy,09-10-2025
C9778001003,"Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous)",09-10-2025
C9779001003,"Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy,",09-10-2025
C9779002004,"Mucosal closure, when performed",09-10-2025
C9780001003,Insertion of central venous catheter through central venous occlusion via,09-10-2025
C9780002004,"Inferior and superior approaches (e.g., inside-out technique), including",09-10-2025
C9780003004,Imaging guidance,09-10-2025
C9781001003,"Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g.,",09-10-2025
C9781002004,"Balloon), includes debridement (e.g., limited or extensive), subacromial",09-10-2025
C9781003004,"Decompression, acromioplasty, and biceps tenodesis when performed",09-10-2025
C9782001003,Blinded procedure for new york heart association (nyha) class ii or iii heart,09-10-2025
C9782002004,"Failure, or canadian cardiovascular society (ccs) class iii or iv chronic",09-10-2025
C9782003004,Refractory angina; transcatheter intramyocardial transplantation of autologous,09-10-2025
C9782004004,"Bone marrow cells (e.g., mononuclear) or placebo control, autologous bone",09-10-2025
C9782005004,"Marrow harvesting and preparation for transplantation, left heart",09-10-2025
C9782006004,"Catheterization including ventriculography, all laboratory services, and all",09-10-2025
C9782007004,"Imaging with or without guidance (e.g., transthoracic echocardiography,",09-10-2025
C9782008004,"Ultrasound, fluoroscopy), performed in an approved investigational device",09-10-2025
C9782009004,Exemption (ide) study,09-10-2025
C9783001003,Blinded procedure for transcatheter implantation of coronary sinus reduction,09-10-2025
C9783002004,"Device or placebo control, including vascular access and closure, right heart",09-10-2025
C9783003004,"Catheterization, venous and coronary sinus angiography, imaging guidance and",09-10-2025
C9783004004,Supervision and interpretation when performed in an approved investigational,09-10-2025
C9783005004,Device exemption (ide) study,09-10-2025
C9784001003,"Gastric restrictive procedure, endoscopic sleeve gastroplasty, with",09-10-2025
C9784002004,"Esophagogastroduodenoscopy and intraluminal tube insertion, if performed,",09-10-2025
C9784003004,Including all system and tissue anchoring components,09-10-2025
C9785001003,"Endoscopic outlet reduction, gastric pouch application, with endoscopy and",09-10-2025
C9785002004,"Intraluminal tube insertion, if performed, including all system and tissue",09-10-2025
C9785003004,Anchoring components,09-10-2025
C9786001003,Echocardiography image post processing for computer aided detection of heart,09-10-2025
C9786002004,"Failure with preserved ejection fraction, including interpretation and report",09-10-2025
C9787001003,Gastric electrophysiology mapping with simultaneous patient symptom profiling,09-10-2025
C9788001003,"Opto-acoustic imaging, breast (including axilla when performed), unilateral,",09-10-2025
C9788002004,"With image documentation, analysis and report, obtained with ultrasound",09-10-2025
C9788003004,Examination,09-10-2025
C9789001003,"Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis,",09-10-2025
C9789002004,"Any method, including all imaging guidance, including volumetric measurement if",09-10-2025
C9789003004,Performed,09-10-2025
C9790001003,"Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of",09-10-2025
C9790002004,"Malignant renal tissue, including image guidance",09-10-2025
C9791001003,Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast,09-10-2025
C9791002004,"Agent, chest, including preparation and administration of agent",09-10-2025
C9792001003,Blinded or nonblinded procedure for symptomatic new york heart association,09-10-2025
C9792002004,"(nyha) class ii, iii, iva heart failure; transcatheter implantation of left",09-10-2025
C9792003004,"Atrial to coronary sinus shunt using jugular vein access, including all imaging",09-10-2025
C9792004004,Necessary to intra procedurally map the coronary sinus for optimal shunt,09-10-2025
C9792005004,"Placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general",09-10-2025
C9792006004,Anesthesia in an approved investigational device exemption (ide) study),09-10-2025
C9793001003,"3d predictive model generation for pre-planning of a cardiac procedure, using",09-10-2025
C9793002004,Data from cardiac computed tomographic angiography and/or magnetic resonance,09-10-2025
C9793003004,Imaging with report,09-10-2025
C9794001003,"Therapeutic radiology simulation-aided field setting; complex, including",09-10-2025
C9794002004,Acquisition of pet and ct imaging data required for,09-10-2025
C9794003004,"Radiopharmaceutical-directed radiation therapy treatment planning (i.e.,",09-10-2025
C9794004004,Modeling),09-10-2025
C9795001003,"Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or",09-10-2025
C9795002004,"More lesions, including image guidance and real-time positron emissions-based",09-10-2025
C9795003004,"Delivery adjustments to 1 or more lesions, entire course not to exceed 5",09-10-2025
C9795004004,Fractions,09-10-2025
C9796001003,Repair of enterocutaneous fistula small intestine or colon (excluding anorectal,09-10-2025
C9796002004,"Fistula) with plug (e.g., porcine small intestine submucosa [sis])",09-10-2025
C9797001003,Vascular embolization or occlusion procedure with use of a pressure-generating,09-10-2025
C9797002004,"Catheter (e.g., one-way valve, intermittently occluding), inclusive of all",09-10-2025
C9797003004,"Radiological supervision and interpretation, intraprocedural roadmapping, and",09-10-2025
C9797004004,"Imaging guidance necessary to complete the intervention; for tumors, organ",09-10-2025
C9797005004,"Ischemia, or infarction",09-10-2025
C9800001003,Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and,09-10-2025
C9800002004,"Provision of radiesse or sculptra dermal filler, including all items and",09-10-2025
C9800003004,Supplies,09-10-2025
C9803001003,Hospital outpatient clinic visit specimen collection for severe acute,09-10-2025
C9803002004,Respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease,09-10-2025
C9803003004,"[covid-19]), any specimen source",09-10-2025
C9804001003,"Elastomeric infusion pump (e.g., on-q* pump with bolus), including catheter and",09-10-2025
C9804002004,"All disposable system components, non-opioid medical device (must be a",09-10-2025
C9804003004,Qualifying medicare non-opioid medical device for post-surgical pain relief in,09-10-2025
C9804004004,"Accordance with section 4135 of the caa, 2023)",09-10-2025
C9806001003,"Rotary peristaltic infusion pump (e.g., ambit pump), including catheter and all",09-10-2025
C9806002004,"Disposable system components, non-opioid medical device (must be a qualifying",09-10-2025
C9806003004,Medicare non-opioid medical device for post-surgical pain relief in accordance,09-10-2025
C9806004004,"With section 4135 of the caa, 2023)",09-10-2025
C9807001003,"Nerve stimulator, percutaneous, peripheral (e.g., sprint peripheral nerve",09-10-2025
C9807002004,"Stimulation system), including electrode and all disposable system components,",09-10-2025
C9807003004,Non-opioid medical device (must be a qualifying medicare non-opioid medical,09-10-2025
C9807004004,Device for post-surgical pain relief in accordance with section 4135 of the,09-10-2025
C9807005004,"Caa, 2023)",09-10-2025
C9808001003,"Nerve cryoablation probe (e.g., cryoice, cryosphere, cryosphere max, cryoice",09-10-2025
C9808002004,"Cryosphere, cryoice cryo2), including probe and all disposable system",09-10-2025
C9808003004,"Components, non-opioid medical device (must be a qualifying medicare non-opioid",09-10-2025
C9808004004,Medical device for post-surgical pain relief in accordance with section 4135 of,09-10-2025
C9808005004,"The caa, 2023)",09-10-2025
C9809001003,"Cryoablation needle (e.g., iovera system), including needle/tip and all",09-10-2025
C9809002004,"Disposable system components, non-opioid medical device (must be a qualifying",09-10-2025
C9809003004,Medicare non-opioid medical device for post-surgical pain relief in accordance,09-10-2025
C9809004004,"With section 4135 of the caa, 2023)",09-10-2025
C9898001003,Radiolabeled product provided during a hospital inpatient stay,09-10-2025
C9899001003,"Implanted prosthetic device, payable only for inpatients who do not have",09-10-2025
C9899002004,Inpatient coverage,09-10-2025
C9901001003,"Endoscopic defect closure within the entire gastrointestinal tract, including",09-10-2025
C9901002004,"Upper endoscopy (including diagnostic, if performed) or colonoscopy (including",09-10-2025
C9901003004,"Diagnostic, if performed), with all system and tissue anchoring components",09-10-2025
E0100001003,"Cane, includes canes of all materials, adjustable or fixed, with tip",09-10-2025
E0105001003,"Cane, quad or three prong, includes canes of all materials, adjustable or",09-10-2025
E0105002004,"Fixed, with tips",09-10-2025
E0110001003,"Crutches, forearm, includes crutches of various materials, adjustable or fixed,",09-10-2025
E0110002004,"Pair, complete with tips and handgrips",09-10-2025
E0111001003,"Crutch forearm, includes crutches of various materials, adjustable or fixed,",09-10-2025
E0111002004,"Each, with tip and handgrips",09-10-2025
E0112001003,"Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and",09-10-2025
E0112002004,Handgrips,09-10-2025
E0113001003,"Crutch underarm, wood, adjustable or fixed, each, with pad, tip and handgrip",09-10-2025
E0114001003,"Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips",09-10-2025
E0114002004,And handgrips,09-10-2025
E0116001003,"Crutch, underarm, other than wood, adjustable or fixed, with pad, tip,",09-10-2025
E0116002004,"Handgrip, with or without shock absorber, each",09-10-2025
E0117001003,"Crutch, underarm, articulating, spring assisted, each",09-10-2025
E0118001003,"Crutch substitute, lower leg platform, with or without wheels, each",09-10-2025
E0130001003,"Walker, rigid (pickup), adjustable or fixed height",09-10-2025
E0135001003,"Walker, folding (pickup), adjustable or fixed height",09-10-2025
E0140001003,"Walker, with trunk support, adjustable or fixed height, any type",09-10-2025
E0141001003,"Walker, rigid, wheeled, adjustable or fixed height",09-10-2025
E0143001003,"Walker, folding, wheeled, adjustable or fixed height",09-10-2025
E0144001003,"Walker, enclosed, four sided framed, rigid or folding, wheeled with posterior",09-10-2025
E0144002004,Seat,09-10-2025
E0147001003,"Walker, heavy duty, multiple braking system, variable wheel resistance",09-10-2025
E0148001003,"Walker, heavy duty, without wheels, rigid or folding, any type, each",09-10-2025
E0149001003,"Walker, heavy duty, wheeled, rigid or folding, any type",09-10-2025
E0150001003,"Combination wheeled walker with seat and transport chair, folding, adjustable",09-10-2025
E0150002004,Or fixed height,09-10-2025
E0152001003,"Walker, battery powered, wheeled, folding, adjustable or fixed height",09-10-2025
E0153001003,"Platform attachment, forearm crutch, each",09-10-2025
E0154001003,"Platform attachment, walker, each",09-10-2025
E0155001003,"Wheel attachment, rigid pick-up walker, per pair",09-10-2025
E0156001003,"Seat attachment, walker",09-10-2025
E0157001003,"Crutch attachment, walker, each",09-10-2025
E0158001003,"Leg extensions for walker, per set of four (4)",09-10-2025
E0159001003,"Brake attachment for wheeled walker, replacement, each",09-10-2025
E0160001003,"Sitz type bath or equipment, portable, used with or without commode",09-10-2025
E0161001003,"Sitz type bath or equipment, portable, used with or without commode, with",09-10-2025
E0161002004,Faucet attachment/s,09-10-2025
E0162001003,Sitz bath chair,09-10-2025
E0163001003,"Commode chair, mobile or stationary, with fixed arms",09-10-2025
E0165001003,"Commode chair, mobile or stationary, with detachable arms",09-10-2025
E0167001003,"Pail or pan for use with commode chair, replacement only",09-10-2025
E0168001003,"Commode chair, extra wide and/or heavy duty, stationary or mobile, with or",09-10-2025
E0168002004,"Without arms, any type, each",09-10-2025
E0170001003,"Commode chair with integrated seat lift mechanism, electric, any type",09-10-2025
E0171001003,"Commode chair with integrated seat lift mechanism, non-electric, any type",09-10-2025
E0172001003,"Seat lift mechanism placed over or on top of toilet, any type",09-10-2025
E0175001003,"Foot rest, for use with commode chair, each",09-10-2025
E0181001003,"Powered pressure reducing mattress overlay/pad, alternating, with pump,",09-10-2025
E0181002004,Includes heavy duty,09-10-2025
E0182001003,"Pump for alternating pressure pad, for replacement only",09-10-2025
E0183001003,"Powered pressure reducing underlay/pad, alternating, with pump, includes heavy",09-10-2025
E0183002004,Duty,09-10-2025
E0184001003,Dry pressure mattress,09-10-2025
E0185001003,"Gel or gel-like pressure pad for mattress, standard mattress length and width",09-10-2025
E0186001003,Air pressure mattress,09-10-2025
E0187001003,Water pressure mattress,09-10-2025
E0188001003,Synthetic sheepskin pad,09-10-2025
E0189001003,"Lambswool sheepskin pad, any size",09-10-2025
E0190001003,"Positioning cushion/pillow/wedge, any shape or size, includes all components",09-10-2025
E0190002004,And accessories,09-10-2025
E0191001003,"Heel or elbow protector, each",09-10-2025
E0193001003,Powered air flotation bed (low air loss therapy),09-10-2025
E0194001003,Air fluidized bed,09-10-2025
E0196001003,Gel pressure mattress,09-10-2025
E0197001003,"Air pressure pad for mattress, standard mattress length and width",09-10-2025
E0198001003,"Water pressure pad for mattress, standard mattress length and width",09-10-2025
E0199001003,"Dry pressure pad for mattress, standard mattress length and width",09-10-2025
E0200001003,"Heat lamp, without stand (table model), includes bulb, or infrared element",09-10-2025
E0201001003,"Penile contracture device, manual, greater than 3 lbs traction force",09-10-2025
E0202001003,Phototherapy (bilirubin) light with photometer,09-10-2025
E0203001003,"Therapeutic lightbox, minimum 10,000 lux, table top model",09-10-2025
E0205001003,"Heat lamp, with stand, includes bulb, or infrared element",09-10-2025
E0210001003,"Electric heat pad, standard",09-10-2025
E0215001003,"Electric heat pad, moist",09-10-2025
E0217001003,Water circulating heat pad with pump,09-10-2025
E0218001003,"Fluid circulating cold pad with pump, any type",09-10-2025
E0221001003,Infrared heating pad system,09-10-2025
E0225001003,"Hydrocollator unit, includes pads",09-10-2025
E0231001003,"Non-contact wound warming device (temperature control unit, ac adapter and",09-10-2025
E0231002004,Power cord) for use with warming card and wound cover,09-10-2025
E0232001003,Warming card for use with the non contact wound warming device and non contact,09-10-2025
E0232002004,Wound warming wound cover,09-10-2025
E0235001003,"Paraffin bath unit, portable (see medical supply code a4265 for paraffin)",09-10-2025
E0236001003,Pump for water circulating pad,09-10-2025
E0239001003,"Hydrocollator unit, portable",09-10-2025
E0240001003,"Bath/shower chair, with or without wheels, any size",09-10-2025
E0241001003,"Bath tub wall rail, each",09-10-2025
E0242001003,"Bath tub rail, floor base",09-10-2025
E0243001003,"Toilet rail, each",09-10-2025
E0244001003,Raised toilet seat,09-10-2025
E0245001003,Tub stool or bench,09-10-2025
E0246001003,Transfer tub rail attachment,09-10-2025
E0247001003,Transfer bench for tub or toilet with or without commode opening,09-10-2025
E0248001003,"Transfer bench, heavy duty, for tub or toilet with or without commode opening",09-10-2025
E0249001003,"Pad for water circulating heat unit, for replacement only",09-10-2025
E0250001003,"Hospital bed, fixed height, with any type side rails, with mattress",09-10-2025
E0251001003,"Hospital bed, fixed height, with any type side rails, without mattress",09-10-2025
E0255001003,"Hospital bed, variable height, hi-lo, with any type side rails, with mattress",09-10-2025
E0256001003,"Hospital bed, variable height, hi-lo, with any type side rails, without mattres",09-10-2025
E0260001003,"Hospital bed, semi-electric (head and foot adjustment), with any type side",09-10-2025
E0260002004,"Rails, with mattress",09-10-2025
E0261001003,"Hospital bed, semi-electric (head and foot adjustment), with any type side",09-10-2025
E0261002004,"Rails, without mattress",09-10-2025
E0265001003,"Hospital bed, total electric (head, foot and height adjustments), with any type",09-10-2025
E0265002004,"Side rails, with mattress",09-10-2025
E0266001003,"Hospital bed, total electric (head, foot and height adjustments), with any type",09-10-2025
E0266002004,"Side rails, without mattress",09-10-2025
E0270001003,"Hospital bed, institutional type includes: oscillating, circulating and stryker",09-10-2025
E0270002004,"Frame, with mattress",09-10-2025
E0271001003,"Mattress, innerspring",09-10-2025
E0272001003,"Mattress, foam rubber",09-10-2025
E0273001003,Bed board,09-10-2025
E0274001003,Over-bed table,09-10-2025
E0275001003,"Bed pan, standard, metal or plastic",09-10-2025
E0276001003,"Bed pan, fracture, metal or plastic",09-10-2025
E0277001003,Powered pressure-reducing air mattress,09-10-2025
E0280001003,"Bed cradle, any type",09-10-2025
E0290001003,"Hospital bed, fixed height, without side rails, with mattress",09-10-2025
E0291001003,"Hospital bed, fixed height, without side rails, without mattress",09-10-2025
E0292001003,"Hospital bed, variable height, hi-lo, without side rails, with mattress",09-10-2025
E0293001003,"Hospital bed, variable height, hi-lo, without side rails, without mattress",09-10-2025
E0294001003,"Hospital bed, semi-electric (head and foot adjustment), without side rails,",09-10-2025
E0294002004,With mattress,09-10-2025
E0295001003,"Hospital bed, semi-electric (head and foot adjustment), without side rails,",09-10-2025
E0295002004,Without mattress,09-10-2025
E0296001003,"Hospital bed, total electric (head, foot and height adjustments), without side",09-10-2025
E0296002004,"Rails, with mattress",09-10-2025
E0297001003,"Hospital bed, total electric (head, foot and height adjustments), without side",09-10-2025
E0297002004,"Rails, without mattress",09-10-2025
E0300001003,"Pediatric crib, hospital grade, fully enclosed, with or without top enclosure",09-10-2025
E0301001003,"Hospital bed, heavy duty, extra wide, with weight capacity greater than 350",09-10-2025
E0301002004,"Pounds, but less than or equal to 600 pounds, with any type side rails, without",09-10-2025
E0301003004,Mattress,09-10-2025
E0302001003,"Hospital bed, extra heavy duty, extra wide, with weight capacity greater than",09-10-2025
E0302002004,"600 pounds, with any type side rails, without mattress",09-10-2025
E0303001003,"Hospital bed, heavy duty, extra wide, with weight capacity greater than 350",09-10-2025
E0303002004,"Pounds, but less than or equal to 600 pounds, with any type side rails, with",09-10-2025
E0303003004,Mattress,09-10-2025
E0304001003,"Hospital bed, extra heavy duty, extra wide, with weight capacity greater than",09-10-2025
E0304002004,"600 pounds, with any type side rails, with mattress",09-10-2025
E0305001003,"Bed side rails, half length",09-10-2025
E0310001003,"Bed side rails, full length",09-10-2025
E0315001003,"Bed accessory: board, table, or support device, any type",09-10-2025
E0316001003,"Safety enclosure frame/canopy for use with hospital bed, any type",09-10-2025
E0325001003,"Urinal; male, jug-type, any material",09-10-2025
E0326001003,"Urinal; female, jug-type, any material",09-10-2025
E0328001003,"Hospital bed, pediatric, manual, 360 degree side enclosures, top of headboard,",09-10-2025
E0328002004,"Footboard and side rails up to 24 inches above the spring, includes mattress",09-10-2025
E0329001003,"Hospital bed, pediatric, electric or semi-electric, 360 degree side enclosures,",09-10-2025
E0329002004,"Top of headboard, footboard and side rails up to 24 inches above the spring,",09-10-2025
E0329003004,Includes mattress,09-10-2025
E0350001003,Control unit for electronic bowel irrigation/evacuation system,09-10-2025
E0352001003,"Disposable pack (water reservoir bag, speculum, valving mechanism and",09-10-2025
E0352002004,Collection bag/box) for use with the electronic bowel irrigation/evacuation,09-10-2025
E0352003004,System,09-10-2025
E0370001003,Air pressure elevator for heel,09-10-2025
E0371001003,"Nonpowered advanced pressure reducing overlay for mattress, standard mattress",09-10-2025
E0371002004,Length and width,09-10-2025
E0372001003,"Powered air overlay for mattress, standard mattress length and width",09-10-2025
E0373001003,Nonpowered advanced pressure reducing mattress,09-10-2025
E0424001003,"Stationary compressed gaseous oxygen system, rental; includes container,",09-10-2025
E0424002004,"Contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and",09-10-2025
E0424003004,Tubing,09-10-2025
E0425001003,"Stationary compressed gas system, purchase; includes regulator, flowmeter,",09-10-2025
E0425002004,"Humidifier, nebulizer, cannula or mask, and tubing",09-10-2025
E0430001003,"Portable gaseous oxygen system, purchase; includes regulator, flowmeter,",09-10-2025
E0430002004,"Humidifier, cannula or mask, and tubing",09-10-2025
E0431001003,"Portable gaseous oxygen system, rental; includes portable container, regulator,",09-10-2025
E0431002004,"Flowmeter, humidifier, cannula or mask, and tubing",09-10-2025
E0433001003,"Portable liquid oxygen system, rental; home liquefier used to fill portable",09-10-2025
E0433002004,"Liquid oxygen containers, includes portable containers, regulator, flowmeter,",09-10-2025
E0433003004,"Humidifier, cannula or mask and tubing, with or without supply reservoir and",09-10-2025
E0433004004,Contents gauge,09-10-2025
E0434001003,"Portable liquid oxygen system, rental; includes portable container, supply",09-10-2025
E0434002004,"Reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or",09-10-2025
E0434003004,"Mask, and tubing",09-10-2025
E0435001003,"Portable liquid oxygen system, purchase; includes portable container, supply",09-10-2025
E0435002004,"Reservoir, flowmeter, humidifier, contents gauge, cannula or mask, tubing and",09-10-2025
E0435003004,Refill adaptor,09-10-2025
E0439001003,"Stationary liquid oxygen system, rental; includes container, contents,",09-10-2025
E0439002004,"Regulator, flowmeter, humidifier, nebulizer, cannula or mask, & tubing",09-10-2025
E0440001003,"Stationary liquid oxygen system, purchase; includes use of reservoir, contents",09-10-2025
E0440002004,"Indicator, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and",09-10-2025
E0440003004,Tubing,09-10-2025
E0441001003,"Stationary oxygen contents, gaseous, 1 month's supply = 1 unit",09-10-2025
E0442001003,"Stationary oxygen contents, liquid, 1 month's supply = 1 unit",09-10-2025
E0443001003,"Portable oxygen contents, gaseous, 1 month's supply = 1 unit",09-10-2025
E0444001003,"Portable oxygen contents, liquid, 1 month's supply = 1 unit",09-10-2025
E0445001003,Oximeter device for measuring blood oxygen levels non-invasively,09-10-2025
E0446001003,"Topical oxygen delivery system, not otherwise specified, includes all supplies",09-10-2025
E0446002004,And accessories,09-10-2025
E0447001003,"Portable oxygen contents, liquid, 1 month's supply = 1 unit, prescribed amount",09-10-2025
E0447002004,At rest or nighttime exceeds 4 liters per minute (lpm),09-10-2025
E0450001003,"Volume control ventilator, without pressure support mode, may include pressure",09-10-2025
E0450002004,"Control mode, used with invasive interface (e.g., tracheostomy tube)",09-10-2025
E0455001003,"Oxygen tent, excluding croup or pediatric tents",09-10-2025
E0457001003,Chest shell (cuirass),09-10-2025
E0459001003,Chest wrap,09-10-2025
E0460001003,Negative pressure ventilator; portable or stationary,09-10-2025
E0461001003,"Volume control ventilator, without pressure support mode, may include pressure",09-10-2025
E0461002004,"Control mode, used with non-invasive interface (e.g., mask)",09-10-2025
E0462001003,Rocking bed with or without side rails,09-10-2025
E0463001003,"Pressure support ventilator with volume control mode, may include pressure",09-10-2025
E0463002004,"Control mode, used with invasive interface (e.g., tracheostomy tube)",09-10-2025
E0464001003,"Pressure support ventilator with volume control mode, may include pressure",09-10-2025
E0464002004,"Control mode, used with non-invasive interface (e.g., mask)",09-10-2025
E0465001003,"Home ventilator, any type, used with invasive interface, (e.g., tracheostomy",09-10-2025
E0465002004,Tube),09-10-2025
E0466001003,"Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest",09-10-2025
E0466002004,Shell),09-10-2025
E0467001003,"Home ventilator, multi-function respiratory device, also performs any or all of",09-10-2025
E0467002004,"The additional functions of oxygen concentration, drug nebulization,",09-10-2025
E0467003004,"Aspiration, and cough stimulation, includes all accessories, components and",09-10-2025
E0467004004,Supplies for all functions,09-10-2025
E0468001003,"Home ventilator, dual-function respiratory device, also performs additional",09-10-2025
E0468002004,"Function of cough stimulation, includes all accessories, components and",09-10-2025
E0468003004,Supplies for all functions,09-10-2025
E0469001003,"Lung expansion airway clearance, continuous high frequency oscillation, and",09-10-2025
E0469002004,Nebulization device,09-10-2025
E0470001003,"Respiratory assist device, bi-level pressure capability, without backup rate",09-10-2025
E0470002004,"Feature, used with noninvasive interface, e.g., nasal or facial mask",09-10-2025
E0470003004,(intermittent assist device with continuous positive airway pressure device),09-10-2025
E0471001003,"Respiratory assist device, bi-level pressure capability, with back-up rate",09-10-2025
E0471002004,"Feature, used with noninvasive interface, e.g., nasal or facial mask",09-10-2025
E0471003004,(intermittent assist device with continuous positive airway pressure device),09-10-2025
E0472001003,"Respiratory assist device, bi-level pressure capability, with backup rate",09-10-2025
E0472002004,"Feature, used with invasive interface, e.g., tracheostomy tube (intermittent",09-10-2025
E0472003004,Assist device with continuous positive airway pressure device),09-10-2025
E0480001003,"Percussor, electric or pneumatic, home model",09-10-2025
E0481001003,Intrapulmonary percussive ventilation system and related accessories,09-10-2025
E0482001003,"Cough stimulating device, alternating positive and negative airway pressure",09-10-2025
E0483001003,"High frequency chest wall oscillation system, with full anterior and/or",09-10-2025
E0483002004,"Posterior thoracic region receiving simultaneous external oscillation, includes",09-10-2025
E0483003004,"All accessories and supplies, each",09-10-2025
E0484001003,"Oscillatory positive expiratory pressure device, non-electric, any type, each",09-10-2025
E0485001003,"Oral device/appliance used to reduce upper airway collapsibility, adjustable or",09-10-2025
E0485002004,"Non-adjustable, prefabricated, includes fitting and adjustment",09-10-2025
E0486001003,"Oral device/appliance used to reduce upper airway collapsibility, adjustable or",09-10-2025
E0486002004,"Non-adjustable, custom fabricated, includes fitting and adjustment",09-10-2025
E0487001003,"Spirometer, electronic, includes all accessories",09-10-2025
E0490001003,Power source and control electronics unit for oral device/appliance for,09-10-2025
E0490002004,"Neuromuscular electrical stimulation of the tongue muscle, controlled by",09-10-2025
E0490003004,Hardware remote,09-10-2025
E0491001003,Oral device/appliance for neuromuscular electrical stimulation of the tongue,09-10-2025
E0491002004,"Muscle, used in conjunction with the power source and control electronics unit,",09-10-2025
E0491003004,"Controlled by hardware remote, 90-day supply",09-10-2025
E0492001003,Power source and control electronics unit for oral device/appliance for,09-10-2025
E0492002004,"Neuromuscular electrical stimulation of the tongue muscle, controlled by phone",09-10-2025
E0492003004,Application,09-10-2025
E0493001003,Oral device/appliance for neuromuscular electrical stimulation of the tongue,09-10-2025
E0493002004,"Muscle, used in conjunction with the power source and control electronics unit,",09-10-2025
E0493003004,"Controlled by phone application, 90-day supply",09-10-2025
E0500001003,"Ippb machine, all types, with built-in nebulization; manual or automatic",09-10-2025
E0500002004,Valves; internal or external power source,09-10-2025
E0530001003,"Electronic positional obstructive sleep apnea treatment, with sensor, includes",09-10-2025
E0530002004,"All components and accessories, any type",09-10-2025
E0550001003,"Humidifier, durable for extensive supplemental humidification during ippb",09-10-2025
E0550002004,Treatments or oxygen delivery,09-10-2025
E0555001003,"Humidifier, durable, glass or autoclavable plastic bottle type, for use with",09-10-2025
E0555002004,Regulator or flowmeter,09-10-2025
E0560001003,"Humidifier, durable for supplemental humidification during ippb treatment or",09-10-2025
E0560002004,Oxygen delivery,09-10-2025
E0561001003,"Humidifier, non-heated, used with positive airway pressure device",09-10-2025
E0562001003,"Humidifier, heated, used with positive airway pressure device",09-10-2025
E0565001003,"Compressor, air power source for equipment which is not self-contained or",09-10-2025
E0565002004,Cylinder driven,09-10-2025
E0570001003,"Nebulizer, with compressor",09-10-2025
E0572001003,"Aerosol compressor, adjustable pressure, light duty for intermittent use",09-10-2025
E0574001003,Ultrasonic/electronic aerosol generator with small volume nebulizer,09-10-2025
E0575001003,"Nebulizer, ultrasonic, large volume",09-10-2025
E0580001003,"Nebulizer, durable, glass or autoclavable plastic, bottle type, for use with",09-10-2025
E0580002004,Regulator or flowmeter,09-10-2025
E0585001003,"Nebulizer, with compressor and heater",09-10-2025
E0600001003,"Respiratory suction pump, home model, portable or stationary, electric",09-10-2025
E0601001003,Continuous positive airway pressure (cpap) device,09-10-2025
E0602001003,"Breast pump, manual, any type",09-10-2025
E0603001003,"Breast pump, electric (ac and/or dc), any type",09-10-2025
E0604001003,"Breast pump, hospital grade, electric (ac and / or dc), any type",09-10-2025
E0605001003,"Vaporizer, room type",09-10-2025
E0606001003,Postural drainage board,09-10-2025
E0607001003,Home blood glucose monitor,09-10-2025
E0610001003,"Pacemaker monitor, self-contained, (checks battery depletion, includes audible",09-10-2025
E0610002004,And visible check systems),09-10-2025
E0615001003,"Pacemaker monitor, self contained, checks battery depletion and other pacemaker",09-10-2025
E0615002004,"Components, includes digital/visible check systems",09-10-2025
E0616001003,"Implantable cardiac event recorder with memory, activator and programmer",09-10-2025
E0617001003,External defibrillator with integrated electrocardiogram analysis,09-10-2025
E0618001003,"Apnea monitor, without recording feature",09-10-2025
E0619001003,"Apnea monitor, with recording feature",09-10-2025
E0620001003,"Skin piercing device for collection of capillary blood, laser, each",09-10-2025
E0621001003,"Sling or seat, patient lift, canvas or nylon",09-10-2025
E0625001003,"Patient lift, bathroom or toilet, not otherwise classified",09-10-2025
E0627001003,"Seat lift mechanism, electric, any type",09-10-2025
E0628001003,Separate seat lift mechanism for use with patient owned furniture-electric,09-10-2025
E0629001003,"Seat lift mechanism, non-electric, any type",09-10-2025
E0630001003,"Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or",09-10-2025
E0630002004,Pad(s),09-10-2025
E0635001003,"Patient lift, electric with seat or sling",09-10-2025
E0636001003,"Multipositional patient support system, with integrated lift, patient",09-10-2025
E0636002004,Accessible controls,09-10-2025
E0637001003,"Combination sit to stand frame/table system, any size including pediatric, with",09-10-2025
E0637002004,"Seat lift feature, with or without wheels",09-10-2025
E0638001003,"Standing frame/table system, one position (e.g., upright, supine or prone",09-10-2025
E0638002004,"Stander), any size including pediatric, with or without wheels",09-10-2025
E0639001003,"Patient lift, moveable from room to room with disassembly and reassembly,",09-10-2025
E0639002004,Includes all components/accessories,09-10-2025
E0640001003,"Patient lift, fixed system, includes all components/accessories",09-10-2025
E0641001003,"Standing frame/table system, multi-position (e.g., three-way stander), any size",09-10-2025
E0641002004,"Including pediatric, with or without wheels",09-10-2025
E0642001003,"Standing frame/table system, mobile (dynamic stander), any size including",09-10-2025
E0642002004,Pediatric,09-10-2025
E0650001003,"Pneumatic compressor, non-segmental home model",09-10-2025
E0651001003,"Pneumatic compressor, segmental home model without calibrated gradient pressure",09-10-2025
E0652001003,"Pneumatic compressor, segmental home model with calibrated gradient pressure",09-10-2025
E0655001003,"Non-segmental pneumatic appliance for use with pneumatic compressor, half arm",09-10-2025
E0656001003,"Segmental pneumatic appliance for use with pneumatic compressor, trunk",09-10-2025
E0657001003,"Segmental pneumatic appliance for use with pneumatic compressor, chest",09-10-2025
E0658001003,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2",09-10-2025
E0658002004,Full arms and chest,09-10-2025
E0659001003,"Segmental pneumatic appliance for use with pneumatic compressor, integrated,",09-10-2025
E0659002004,"Head, neck and chest",09-10-2025
E0660001003,"Non-segmental pneumatic appliance for use with pneumatic compressor, full leg",09-10-2025
E0665001003,"Non-segmental pneumatic appliance for use with pneumatic compressor, full arm",09-10-2025
E0666001003,"Non-segmental pneumatic appliance for use with pneumatic compressor, half leg",09-10-2025
E0667001003,"Segmental pneumatic appliance for use with pneumatic compressor, full leg",09-10-2025
E0668001003,"Segmental pneumatic appliance for use with pneumatic compressor, full arm",09-10-2025
E0669001003,"Segmental pneumatic appliance for use with pneumatic compressor, half leg",09-10-2025
E0670001003,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2",09-10-2025
E0670002004,Full legs and trunk,09-10-2025
E0671001003,"Segmental gradient pressure pneumatic appliance, full leg",09-10-2025
E0672001003,"Segmental gradient pressure pneumatic appliance, full arm",09-10-2025
E0673001003,"Segmental gradient pressure pneumatic appliance, half leg",09-10-2025
E0675001003,"Pneumatic compression device, high pressure, rapid inflation/deflation cycle,",09-10-2025
E0675002004,For arterial insufficiency (unilateral or bilateral system),09-10-2025
E0676001003,"Intermittent limb compression device (includes all accessories), not otherwise",09-10-2025
E0676002004,Specified,09-10-2025
E0677001003,"Non-pneumatic sequential compression garment, trunk",09-10-2025
E0678001003,"Non-pneumatic sequential compression garment, full leg",09-10-2025
E0679001003,"Non-pneumatic sequential compression garment, half leg",09-10-2025
E0680001003,Non-pneumatic compression controller with sequential calibrated gradient,09-10-2025
E0680002004,Pressure,09-10-2025
E0681001003,Non-pneumatic compression controller without calibrated gradient pressure,09-10-2025
E0682001003,"Non-pneumatic sequential compression garment, full arm",09-10-2025
E0683001003,"Non-pneumatic, non-sequential, peristaltic wave compression pump",09-10-2025
E0691001003,"Ultraviolet light therapy system, includes bulbs/lamps, timer and eye",09-10-2025
E0691002004,Protection; treatment area 2 square feet or less,09-10-2025
E0692001003,"Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye",09-10-2025
E0692002004,"Protection, 4 foot panel",09-10-2025
E0693001003,"Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye",09-10-2025
E0693002004,"Protection, 6 foot panel",09-10-2025
E0694001003,"Ultraviolet multidirectional light therapy system in 6 foot cabinet, includes",09-10-2025
E0694002004,"Bulbs/lamps, timer and eye protection",09-10-2025
E0700001003,"Safety equipment, device or accessory, any type",09-10-2025
E0705001003,"Transfer device, any type, each",09-10-2025
E0710001003,"Restraints, any type (body, chest, wrist or ankle)",09-10-2025
E0711001003,"Upper extremity medical tubing/lines enclosure or covering device, restricts",09-10-2025
E0711002004,Elbow range of motion,09-10-2025
E0715001003,Intravaginal device intended to strengthen pelvic floor muscles during kegel,09-10-2025
E0715002004,Exercises,09-10-2025
E0716001003,Supplies and accessories for intravaginal device intended to strengthen pelvic,09-10-2025
E0716002004,Floor muscles during kegel exercises,09-10-2025
E0720001003,"Transcutaneous electrical nerve stimulation (tens) device, two lead, localized",09-10-2025
E0720002004,Stimulation,09-10-2025
E0721001003,Transcutaneous electrical nerve stimulator for nerves in the auricular region,09-10-2025
E0730001003,"Transcutaneous electrical nerve stimulation (tens) device, four or more leads,",09-10-2025
E0730002004,For multiple nerve stimulation,09-10-2025
E0731001003,Form fitting conductive garment for delivery of tens or nmes (with conductive,09-10-2025
E0731002004,Fibers separated from the patient's skin by layers of fabric),09-10-2025
E0732001003,"Cranial electrotherapy stimulation (ces) system, any type",09-10-2025
E0733001003,Transcutaneous electrical nerve stimulator for electrical stimulation of the,09-10-2025
E0733002004,Trigeminal nerve,09-10-2025
E0734001003,External upper limb tremor stimulator of the peripheral nerves of the wrist,09-10-2025
E0735001003,Non-invasive vagus nerve stimulator,09-10-2025
E0736001003,Transcutaneous tibial nerve stimulator,09-10-2025
E0737001003,"Transcutaneous tibial nerve stimulator, controlled by phone application",09-10-2025
E0738001003,Upper extremity rehabilitation system providing active assistance to facilitate,09-10-2025
E0738002004,"Muscle re-education, include microprocessor, all components and accessories",09-10-2025
E0739001003,Rehabilitation system with interactive interface providing active assistance in,09-10-2025
E0739002004,"Rehabilitation therapy, includes all components and accessories, motors,",09-10-2025
E0739003004,"Microprocessors, sensors",09-10-2025
E0740001003,"Non-implanted pelvic floor electrical stimulator, complete system",09-10-2025
E0743001003,"External lower extremity nerve stimulator for restless legs syndrome, each",09-10-2025
E0744001003,Neuromuscular stimulator for scoliosis,09-10-2025
E0745001003,"Neuromuscular stimulator, electronic shock unit",09-10-2025
E0746001003,"Electromyography (emg), biofeedback device",09-10-2025
E0747001003,"Osteogenesis stimulator, electrical, non-invasive, other than spinal",09-10-2025
E0747002004,Applications,09-10-2025
E0748001003,"Osteogenesis stimulator, electrical, non-invasive, spinal applications",09-10-2025
E0749001003,"Osteogenesis stimulator, electrical, surgically implanted",09-10-2025
E0755001003,Electronic salivary reflex stimulator (intra-oral/non-invasive),09-10-2025
E0760001003,"Osteogenesis stimulator, low intensity ultrasound, non-invasive",09-10-2025
E0761001003,"Non-thermal pulsed high frequency radiowaves, high peak power electromagnetic",09-10-2025
E0761002004,Energy treatment device,09-10-2025
E0762001003,"Transcutaneous electrical joint stimulation device system, includes all",09-10-2025
E0762002004,Accessories,09-10-2025
E0764001003,"Functional neuromuscular stimulation, transcutaneous stimulation of sequential",09-10-2025
E0764002004,"Muscle groups of ambulation with computer control, used for walking by spinal",09-10-2025
E0764003004,"Cord injured, entire system, after completion of training program",09-10-2025
E0765001003,"Fda approved nerve stimulator, for treatment of nausea and vomiting",09-10-2025
E0766001003,"Electrical stimulation device used for cancer treatment, includes all",09-10-2025
E0766002004,"Accessories, any type",09-10-2025
E0767001003,"Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency",09-10-2025
E0767002004,"Electromagnetic field device, for cancer treatment, includes all accessories",09-10-2025
E0769001003,"Electrical stimulation or electromagnetic wound treatment device, not otherwise",09-10-2025
E0769002004,Classified,09-10-2025
E0770001003,"Functional electrical stimulator, transcutaneous stimulation of nerve and/or",09-10-2025
E0770002004,"Muscle groups, any type, complete system, not otherwise specified",09-10-2025
E0776001003,Iv pole,09-10-2025
E0779001003,"Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater",09-10-2025
E0780001003,"Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours",09-10-2025
E0781001003,"Ambulatory infusion pump, single or multiple channels, electric or battery",09-10-2025
E0781002004,"Operated, with administrative equipment, worn by patient",09-10-2025
E0782001003,"Infusion pump, implantable, non-programmable (includes all components, e.g.,",09-10-2025
E0782002004,"Pump, catheter, connectors, etc.)",09-10-2025
E0783001003,"Infusion pump system, implantable, programmable (includes all components, e.g.,",09-10-2025
E0783002004,"Pump, catheter, connectors, etc.)",09-10-2025
E0784001003,"External ambulatory infusion pump, insulin",09-10-2025
E0785001003,Implantable intraspinal (epidural/intrathecal) catheter used with implantable,09-10-2025
E0785002004,"Infusion pump, replacement",09-10-2025
E0786001003,"Implantable programmable infusion pump, replacement (excludes implantable",09-10-2025
E0786002004,Intraspinal catheter),09-10-2025
E0787001003,"External ambulatory infusion pump, insulin, dosage rate adjustment using",09-10-2025
E0787002004,Therapeutic continuous glucose sensing,09-10-2025
E0791001003,"Parenteral infusion pump, stationary, single or multi-channel",09-10-2025
E0830001003,"Ambulatory traction device, all types, each",09-10-2025
E0840001003,"Traction frame, attached to headboard, cervical traction",09-10-2025
E0849001003,"Traction equipment, cervical, free-standing stand/frame, pneumatic, applying",09-10-2025
E0849002004,Traction force to other than mandible,09-10-2025
E0850001003,"Traction stand, free standing, cervical traction",09-10-2025
E0855001003,Cervical traction equipment not requiring additional stand or frame,09-10-2025
E0856001003,"Cervical traction device, with inflatable air bladder(s)",09-10-2025
E0860001003,"Traction equipment, overdoor, cervical",09-10-2025
E0870001003,"Traction frame, attached to footboard, extremity traction, (e.g., buck's)",09-10-2025
E0880001003,"Traction stand, free standing, extremity traction",09-10-2025
E0890001003,"Traction frame, attached to footboard, pelvic traction",09-10-2025
E0900001003,"Traction stand, free standing, pelvic traction, (e.g., buck's)",09-10-2025
E0910001003,"Trapeze bars, a/k/a patient helper, attached to bed, with grab bar",09-10-2025
E0911001003,"Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds,",09-10-2025
E0911002004,"Attached to bed, with grab bar",09-10-2025
E0912001003,"Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds,",09-10-2025
E0912002004,"Free standing, complete with grab bar",09-10-2025
E0920001003,"Fracture frame, attached to bed, includes weights",09-10-2025
E0930001003,"Fracture frame, free standing, includes weights",09-10-2025
E0935001003,Continuous passive motion exercise device for use on knee only,09-10-2025
E0936001003,Continuous passive motion exercise device for use other than knee,09-10-2025
E0940001003,"Trapeze bar, free standing, complete with grab bar",09-10-2025
E0941001003,"Gravity assisted traction device, any type",09-10-2025
E0942001003,Cervical head harness/halter,09-10-2025
E0944001003,Pelvic belt/harness/boot,09-10-2025
E0945001003,Extremity belt/harness,09-10-2025
E0946001003,"Fracture, frame, dual with cross bars, attached to bed, (e.g., balken, 4 poster",09-10-2025
E0947001003,"Fracture frame, attachments for complex pelvic traction",09-10-2025
E0948001003,"Fracture frame, attachments for complex cervical traction",09-10-2025
E0950001003,"Wheelchair accessory, tray, each",09-10-2025
E0951001003,"Heel loop/holder, any type, with or without ankle strap, each",09-10-2025
E0952001003,"Toe loop/holder, any type, each",09-10-2025
E0953001003,"Wheelchair accessory, lateral thigh or knee support, any type including fixed",09-10-2025
E0953002004,"Mounting hardware, each",09-10-2025
E0954001003,"Wheelchair accessory, foot box, any type, includes attachment and mounting",09-10-2025
E0954002004,"Hardware, each foot",09-10-2025
E0955001003,"Wheelchair accessory, headrest, cushioned, any type, including fixed mounting",09-10-2025
E0955002004,"Hardware, each",09-10-2025
E0956001003,"Wheelchair accessory, lateral trunk or hip support, any type, including fixed",09-10-2025
E0956002004,"Mounting hardware, each",09-10-2025
E0957001003,"Wheelchair accessory, medial thigh support, any type, including fixed mounting",09-10-2025
E0957002004,"Hardware, each",09-10-2025
E0958001003,"Manual wheelchair accessory, one-arm drive attachment, each",09-10-2025
E0959001003,"Manual wheelchair accessory, adapter for amputee, each",09-10-2025
E0960001003,"Wheelchair accessory, shoulder harness/straps or chest strap, including any",09-10-2025
E0960002004,Type mounting hardware,09-10-2025
E0961001003,"Manual wheelchair accessory, wheel lock brake extension (handle), each",09-10-2025
E0966001003,"Manual wheelchair accessory, headrest extension, each",09-10-2025
E0967001003,"Manual wheelchair accessory, hand rim with projections, any type, replacement",09-10-2025
E0967002004,"Only, each",09-10-2025
E0968001003,"Commode seat, wheelchair",09-10-2025
E0969001003,"Narrowing device, wheelchair",09-10-2025
E0970001003,"No. 2 footplates, except for elevating leg rest",09-10-2025
E0971001003,"Manual wheelchair accessory, anti-tipping device, each",09-10-2025
E0973001003,"Wheelchair accessory, adjustable height, detachable armrest, complete assembly,",09-10-2025
E0973002004,Each,09-10-2025
E0974001003,"Manual wheelchair accessory, anti-rollback device, each",09-10-2025
E0978001003,"Wheelchair accessory, positioning belt/safety belt/pelvic strap, each",09-10-2025
E0980001003,"Safety vest, wheelchair",09-10-2025
E0981001003,"Wheelchair accessory, seat upholstery, replacement only, each",09-10-2025
E0982001003,"Wheelchair accessory, back upholstery, replacement only, each",09-10-2025
E0983001003,"Manual wheelchair accessory, power add-on to convert manual wheelchair to",09-10-2025
E0983002004,"Motorized wheelchair, joystick control",09-10-2025
E0984001003,"Manual wheelchair accessory, power add-on to convert manual wheelchair to",09-10-2025
E0984002004,"Motorized wheelchair, tiller control",09-10-2025
E0985001003,"Wheelchair accessory, seat lift mechanism",09-10-2025
E0986001003,"Manual wheelchair accessory, power assist system",09-10-2025
E0988001003,"Manual wheelchair accessory, lever-activated, wheel drive, pair",09-10-2025
E0990001003,"Wheelchair accessory, elevating leg rest, complete assembly, each",09-10-2025
E0992001003,"Manual wheelchair accessory, solid seat insert",09-10-2025
E0994001003,"Arm rest, each",09-10-2025
E0995001003,"Wheelchair accessory, calf rest/pad, replacement only, each",09-10-2025
E1002001003,"Wheelchair accessory, power seating system, tilt only",09-10-2025
E1003001003,"Wheelchair accessory, power seating system, recline only, without shear",09-10-2025
E1003002004,Reduction,09-10-2025
E1004001003,"Wheelchair accessory, power seating system, recline only, with mechanical shear",09-10-2025
E1004002004,Reduction,09-10-2025
E1005001003,"Wheelchair accessory, power seating system, recline only, with power shear",09-10-2025
E1005002004,Reduction,09-10-2025
E1006001003,"Wheelchair accessory, power seating system, combination tilt and recline,",09-10-2025
E1006002004,Without shear reduction,09-10-2025
E1007001003,"Wheelchair accessory, power seating system, combination tilt and recline, with",09-10-2025
E1007002004,Mechanical shear reduction,09-10-2025
E1008001003,"Wheelchair accessory, power seating system, combination tilt and recline, with",09-10-2025
E1008002004,Power shear reduction,09-10-2025
E1009001003,"Wheelchair accessory, addition to power seating system, mechanically linked leg",09-10-2025
E1009002004,"Elevation system, including pushrod and leg rest, each",09-10-2025
E1010001003,"Wheelchair accessory, addition to power seating system, power leg elevation",09-10-2025
E1010002004,"System, including leg rest, pair",09-10-2025
E1011001003,"Modification to pediatric size wheelchair, width adjustment package (not to be",09-10-2025
E1011002004,Dispensed with initial chair),09-10-2025
E1012001003,"Wheelchair accessory, addition to power seating system, center mount power",09-10-2025
E1012002004,"Elevating leg rest/platform, complete system, any type, each",09-10-2025
E1014001003,"Reclining back, addition to pediatric size wheelchair",09-10-2025
E1015001003,"Shock absorber for manual wheelchair, each",09-10-2025
E1016001003,"Shock absorber for power wheelchair, each",09-10-2025
E1017001003,"Heavy duty shock absorber for heavy duty or extra heavy duty manual wheelchair,",09-10-2025
E1017002004,Each,09-10-2025
E1018001003,"Heavy duty shock absorber for heavy duty or extra heavy duty power wheelchair,",09-10-2025
E1018002004,Each,09-10-2025
E1020001003,"Residual limb support system for wheelchair, any type",09-10-2025
E1022001003,"Wheelchair transportation securement system, any type includes all components",09-10-2025
E1022002004,And accessories,09-10-2025
E1023001003,"Wheelchair transit securement system, includes all components and accessories",09-10-2025
E1028001003,"Wheelchair accessory, manual swingaway, retractable or removable mounting",09-10-2025
E1028002004,"Hardware, other",09-10-2025
E1029001003,"Wheelchair accessory, ventilator tray, fixed",09-10-2025
E1030001003,"Wheelchair accessory, ventilator tray, gimbaled",09-10-2025
E1031001003,"Rollabout chair, any and all types with casters 5"" or greater",09-10-2025
E1032001003,"Wheelchair accessory, manual swingaway, retractable or removable mounting",09-10-2025
E1032002004,Hardware used with joystick or other drive control interface,09-10-2025
E1033001003,"Wheelchair accessory, manual swingaway, retractable or removable mounting",09-10-2025
E1033002004,"Hardware for headrest, cushioned, any type",09-10-2025
E1034001003,"Wheelchair accessory, manual swingaway, retractable or removable mounting",09-10-2025
E1034002004,"Hardware for lateral trunk or hip support, any type",09-10-2025
E1035001003,"Multi-positional patient transfer system, with integrated seat, operated by",09-10-2025
E1035002004,"Care giver, patient weight capacity up to and including 300 lbs",09-10-2025
E1036001003,"Multi-positional patient transfer system, extra-wide, with integrated seat,",09-10-2025
E1036002004,"Operated by caregiver, patient weight capacity greater than 300 lbs",09-10-2025
E1037001003,"Transport chair, pediatric size",09-10-2025
E1038001003,"Transport chair, adult size, patient weight capacity up to and including 300",09-10-2025
E1038002004,Pounds,09-10-2025
E1039001003,"Transport chair, adult size, heavy duty, patient weight capacity greater than",09-10-2025
E1039002004,300 pounds,09-10-2025
E1050001003,"Fully-reclining wheelchair, fixed full length arms, swing away detachable",09-10-2025
E1050002004,Elevating leg rests,09-10-2025
E1060001003,"Fully-reclining wheelchair, detachable arms, desk or full length, swing away",09-10-2025
E1060002004,Detachable elevating legrests,09-10-2025
E1070001003,"Fully-reclining wheelchair, detachable arms (desk or full length) swing away",09-10-2025
E1070002004,Detachable footrest,09-10-2025
E1083001003,"Hemi-wheelchair, fixed full length arms, swing away detachable elevating leg",09-10-2025
E1083002004,Rest,09-10-2025
E1084001003,"Hemi-wheelchair, detachable arms desk or full length arms, swing away",09-10-2025
E1084002004,Detachable elevating leg rests,09-10-2025
E1085001003,"Hemi-wheelchair, fixed full length arms, swing away detachable foot rests",09-10-2025
E1086001003,"Hemi-wheelchair detachable arms desk or full length, swing away detachable",09-10-2025
E1086002004,Footrests,09-10-2025
E1087001003,"High strength lightweight wheelchair, fixed full length arms, swing away",09-10-2025
E1087002004,Detachable elevating leg rests,09-10-2025
E1088001003,"High strength lightweight wheelchair, detachable arms desk or full length,",09-10-2025
E1088002004,Swing away detachable elevating leg rests,09-10-2025
E1089001003,"High strength lightweight wheelchair, fixed length arms, swing away detachable",09-10-2025
E1089002004,Footrest,09-10-2025
E1090001003,"High strength lightweight wheelchair, detachable arms desk or full length,",09-10-2025
E1090002004,Swing away detachable foot rests,09-10-2025
E1092001003,"Wide heavy duty wheel chair, detachable arms (desk or full length), swing away",09-10-2025
E1092002004,Detachable elevating leg rests,09-10-2025
E1093001003,"Wide heavy duty wheelchair, detachable arms desk or full length arms, swing",09-10-2025
E1093002004,Away detachable footrests,09-10-2025
E1100001003,"Semi-reclining wheelchair, fixed full length arms, swing away detachable",09-10-2025
E1100002004,Elevating leg rests,09-10-2025
E1110001003,"Semi-reclining wheelchair, detachable arms (desk or full length) elevating leg",09-10-2025
E1110002004,Rest,09-10-2025
E1130001003,"Standard wheelchair, fixed full length arms, fixed or swing away detachable",09-10-2025
E1130002004,Footrests,09-10-2025
E1140001003,"Wheelchair, detachable arms, desk or full length, swing away detachable",09-10-2025
E1140002004,Footrests,09-10-2025
E1150001003,"Wheelchair, detachable arms, desk or full length swing away detachable",09-10-2025
E1150002004,Elevating legrests,09-10-2025
E1160001003,"Wheelchair, fixed full length arms, swing away detachable elevating legrests",09-10-2025
E1161001003,"Manual adult size wheelchair, includes tilt in space",09-10-2025
E1170001003,"Amputee wheelchair, fixed full length arms, swing away detachable elevating",09-10-2025
E1170002004,Legrests,09-10-2025
E1171001003,"Amputee wheelchair, fixed full length arms, without footrests or legrest",09-10-2025
E1172001003,"Amputee wheelchair, detachable arms (desk or full length) without footrests or",09-10-2025
E1172002004,Legrest,09-10-2025
E1180001003,"Amputee wheelchair, detachable arms (desk or full length) swing away detachable",09-10-2025
E1180002004,Footrests,09-10-2025
E1190001003,"Amputee wheelchair, detachable arms (desk or full length) swing away detachable",09-10-2025
E1190002004,Elevating legrests,09-10-2025
E1195001003,"Heavy duty wheelchair, fixed full length arms, swing away detachable elevating",09-10-2025
E1195002004,Legrests,09-10-2025
E1200001003,"Amputee wheelchair, fixed full length arms, swing away detachable footrest",09-10-2025
E1220001003,"Wheelchair; specially sized or constructed, (indicate brand name, model number,",09-10-2025
E1220002004,If any) and justification,09-10-2025
E1221001003,"Wheelchair with fixed arm, footrests",09-10-2025
E1222001003,"Wheelchair with fixed arm, elevating legrests",09-10-2025
E1223001003,"Wheelchair with detachable arms, footrests",09-10-2025
E1224001003,"Wheelchair with detachable arms, elevating legrests",09-10-2025
E1225001003,"Wheelchair accessory, manual semi-reclining back, (recline greater than 15",09-10-2025
E1225002004,"Degrees, but less than 80 degrees), each",09-10-2025
E1226001003,"Wheelchair accessory, manual fully reclining back, (recline greater than 80",09-10-2025
E1226002004,"Degrees), each",09-10-2025
E1227001003,Special height arms for wheelchair,09-10-2025
E1228001003,Special back height for wheelchair,09-10-2025
E1229001003,"Wheelchair, pediatric size, not otherwise specified",09-10-2025
E1230001003,Power operated vehicle (three or four wheel nonhighway) specify brand name and,09-10-2025
E1230002004,Model number,09-10-2025
E1231001003,"Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, with seating",09-10-2025
E1231002004,System,09-10-2025
E1232001003,"Wheelchair, pediatric size, tilt-in-space, folding, adjustable, with seating",09-10-2025
E1232002004,System,09-10-2025
E1233001003,"Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, without seating",09-10-2025
E1233002004,System,09-10-2025
E1234001003,"Wheelchair, pediatric size, tilt-in-space, folding, adjustable, without seating",09-10-2025
E1234002004,System,09-10-2025
E1235001003,"Wheelchair, pediatric size, rigid, adjustable, with seating system",09-10-2025
E1236001003,"Wheelchair, pediatric size, folding, adjustable, with seating system",09-10-2025
E1237001003,"Wheelchair, pediatric size, rigid, adjustable, without seating system",09-10-2025
E1238001003,"Wheelchair, pediatric size, folding, adjustable, without seating system",09-10-2025
E1239001003,"Power wheelchair, pediatric size, not otherwise specified",09-10-2025
E1240001003,"Lightweight wheelchair, detachable arms, (desk or full length) swing away",09-10-2025
E1240002004,"Detachable, elevating legrest",09-10-2025
E1250001003,"Lightweight wheelchair, fixed full length arms, swing away detachable footrest",09-10-2025
E1260001003,"Lightweight wheelchair, detachable arms (desk or full length) swing away",09-10-2025
E1260002004,Detachable footrest,09-10-2025
E1270001003,"Lightweight wheelchair, fixed full length arms, swing away detachable elevating",09-10-2025
E1270002004,Legrests,09-10-2025
E1280001003,"Heavy duty wheelchair, detachable arms (desk or full length) elevating legrests",09-10-2025
E1285001003,"Heavy duty wheelchair, fixed full length arms, swing away detachable footrest",09-10-2025
E1290001003,"Heavy duty wheelchair, detachable arms (desk or full length) swing away",09-10-2025
E1290002004,Detachable footrest,09-10-2025
E1295001003,"Heavy duty wheelchair, fixed full length arms, elevating legrest",09-10-2025
E1296001003,Special wheelchair seat height from floor,09-10-2025
E1297001003,"Special wheelchair seat depth, by upholstery",09-10-2025
E1298001003,"Special wheelchair seat depth and/or width, by construction",09-10-2025
E1300001003,"Whirlpool, portable (overtub type)",09-10-2025
E1301001003,"Whirlpool tub, walk-in, portable",09-10-2025
E1310001003,"Whirlpool, non-portable (built-in type)",09-10-2025
E1352001003,"Oxygen accessory, flow regulator capable of positive inspiratory pressure",09-10-2025
E1353001003,Regulator,09-10-2025
E1354001003,"Oxygen accessory, wheeled cart for portable cylinder or portable concentrator,",09-10-2025
E1354002004,"Any type, replacement only, each",09-10-2025
E1355001003,Stand/rack,09-10-2025
E1356001003,"Oxygen accessory, battery pack/cartridge for portable concentrator, any type,",09-10-2025
E1356002004,"Replacement only, each",09-10-2025
E1357001003,"Oxygen accessory, battery charger for portable concentrator, any type,",09-10-2025
E1357002004,"Replacement only, each",09-10-2025
E1358001003,"Oxygen accessory, dc power adapter for portable concentrator, any type,",09-10-2025
E1358002004,"Replacement only, each",09-10-2025
E1372001003,Immersion external heater for nebulizer,09-10-2025
E1390001003,"Oxygen concentrator, single delivery port, capable of delivering 85 percent or",09-10-2025
E1390002004,Greater oxygen concentration at the prescribed flow rate,09-10-2025
E1391001003,"Oxygen concentrator, dual delivery port, capable of delivering 85 percent or",09-10-2025
E1391002004,"Greater oxygen concentration at the prescribed flow rate, each",09-10-2025
E1392001003,"Portable oxygen concentrator, rental",09-10-2025
E1399001003,"Durable medical equipment, miscellaneous",09-10-2025
E1405001003,Oxygen and water vapor enriching system with heated delivery,09-10-2025
E1406001003,Oxygen and water vapor enriching system without heated delivery,09-10-2025
E1500001003,"Centrifuge, for dialysis",09-10-2025
E1510001003,"Kidney, dialysate delivery syst kidney machine, pump recirculating, air removal",09-10-2025
E1510002004,"Syst, flowrate meter, power off, heater and temperature control with alarm,",09-10-2025
E1510003004,"I.v. poles, pressure gauge, concentrate container",09-10-2025
E1520001003,Heparin infusion pump for hemodialysis,09-10-2025
E1530001003,"Air bubble detector for hemodialysis, each, replacement",09-10-2025
E1540001003,"Pressure alarm for hemodialysis, each, replacement",09-10-2025
E1550001003,"Bath conductivity meter for hemodialysis, each",09-10-2025
E1560001003,"Blood leak detector for hemodialysis, each, replacement",09-10-2025
E1570001003,"Adjustable chair, for esrd patients",09-10-2025
E1575001003,"Transducer protectors/fluid barriers, for hemodialysis, any size, per 10",09-10-2025
E1580001003,Unipuncture control system for hemodialysis,09-10-2025
E1590001003,Hemodialysis machine,09-10-2025
E1592001003,Automatic intermittent peritoneal dialysis system,09-10-2025
E1594001003,Cycler dialysis machine for peritoneal dialysis,09-10-2025
E1600001003,Delivery and/or installation charges for hemodialysis equipment,09-10-2025
E1610001003,"Reverse osmosis water purification system, for hemodialysis",09-10-2025
E1615001003,"Deionizer water purification system, for hemodialysis",09-10-2025
E1620001003,"Blood pump for hemodialysis, replacement",09-10-2025
E1625001003,"Water softening system, for hemodialysis",09-10-2025
E1629001003,Tablo hemodialysis system for the billable dialysis service,09-10-2025
E1630001003,Reciprocating peritoneal dialysis system,09-10-2025
E1632001003,"Wearable artificial kidney, each",09-10-2025
E1634001003,"Peritoneal dialysis clamps, each",09-10-2025
E1635001003,Compact (portable) travel hemodialyzer system,09-10-2025
E1636001003,"Sorbent cartridges, for hemodialysis, per 10",09-10-2025
E1637001003,"Hemostats, each",09-10-2025
E1639001003,"Scale, each",09-10-2025
E1699001003,"Dialysis equipment, not otherwise specified",09-10-2025
E1700001003,Jaw motion rehabilitation system,09-10-2025
E1701001003,"Replacement cushions for jaw motion rehabilitation system, pkg. of 6",09-10-2025
E1702001003,"Replacement measuring scales for jaw motion rehabilitation system, pkg. of 200",09-10-2025
E1800001003,"Dynamic adjustable elbow extension and flexion device, includes soft interface",09-10-2025
E1800002004,Material,09-10-2025
E1801001003,"Static progressive stretch/patient actualized serial stretch elbow device,",09-10-2025
E1801002004,"Extension and/or flexion, with or without range of motion adjustment, includes",09-10-2025
E1801003004,All components and accessories,09-10-2025
E1802001003,"Dynamic adjustable forearm pronation/supination device, includes soft interface",09-10-2025
E1802002004,Material,09-10-2025
E1803001003,"Dynamic adjustable elbow extension only device, includes soft interface materia",09-10-2025
E1804001003,"Dynamic adjustable elbow flexion only device, includes soft interface material",09-10-2025
E1805001003,"Dynamic adjustable wrist extension and flexion device, includes soft interface",09-10-2025
E1805002004,Material,09-10-2025
E1806001003,"Static progressive stretch wrist device, flexion and/or extension, with or",09-10-2025
E1806002004,"Without range of motion adjustment, includes all components and accessories",09-10-2025
E1807001003,"Dynamic adjustable wrist extension only device, includes soft interface materia",09-10-2025
E1808001003,"Dynamic adjustable wrist flexion only device, includes soft interface material",09-10-2025
E1810001003,"Dynamic adjustable knee extension and flexion device, includes soft interface",09-10-2025
E1810002004,Material,09-10-2025
E1811001003,"Static progressive stretch/patient actualized serial stretch knee device,",09-10-2025
E1811002004,"Extension and/or flexion, with or without range of motion adjustment, includes",09-10-2025
E1811003004,All components and accessories,09-10-2025
E1812001003,"Dynamic knee, extension/flexion device with active resistance control",09-10-2025
E1813001003,"Dynamic adjustable knee extension only device, includes soft interface material",09-10-2025
E1814001003,"Dynamic adjustable knee flexion only device, includes soft interface material",09-10-2025
E1815001003,"Dynamic adjustable ankle extension and flexion device, includes soft interface",09-10-2025
E1815002004,Material,09-10-2025
E1816001003,"Static progressive stretch/patient actualized serial stretch ankle device,",09-10-2025
E1816002004,"Flexion and/or extension, with or without range of motion adjustment, includes",09-10-2025
E1816003004,All components and accessories,09-10-2025
E1818001003,Static progressive stretch/patient actualized serial stretch forearm pronation,09-10-2025
E1818002004,"/ supination device, with or without range of motion adjustment, includes all",09-10-2025
E1818003004,Components and accessories,09-10-2025
E1820001003,"Replacement soft interface material, dynamic adjustable extension/flexion devic",09-10-2025
E1821001003,Replacement soft interface material/cuffs for bi-directional static progressive,09-10-2025
E1821002004,Stretch device,09-10-2025
E1822001003,"Dynamic adjustable ankle extension only device, includes soft interface materia",09-10-2025
E1823001003,"Dynamic adjustable ankle flexion only device, includes soft interface material",09-10-2025
E1825001003,"Dynamic adjustable finger extension and flexion device, includes soft interface",09-10-2025
E1825002004,Material,09-10-2025
E1826001003,"Dynamic adjustable finger extension only device, includes soft interface",09-10-2025
E1826002004,Material,09-10-2025
E1827001003,"Dynamic adjustable finger flexion only device, includes soft interface material",09-10-2025
E1828001003,"Dynamic adjustable toe extension only device, includes soft interface material",09-10-2025
E1829001003,"Dynamic adjustable toe flexion only device, includes soft interface material",09-10-2025
E1830001003,"Dynamic adjustable toe extension and flexion device, includes soft interface",09-10-2025
E1830002004,Material,09-10-2025
E1831001003,"Static progressive stretch toe device, extension and/or flexion, with or",09-10-2025
E1831002004,"Without range of motion adjustment, includes all components and accessories",09-10-2025
E1832001003,"Static progressive stretch finger device, extension and/or flexion, with or",09-10-2025
E1832002004,"Without range of motion adjustment, includes all components and accessories",09-10-2025
E1840001003,"Dynamic adjustable shoulder flexion / abduction / rotation device, includes",09-10-2025
E1840002004,Soft interface material,09-10-2025
E1841001003,"Static progressive stretch/patient actualized serial stretch shoulder device,",09-10-2025
E1841002004,"With or without range of motion adjustment, includes all components and",09-10-2025
E1841003004,Accessories,09-10-2025
E1902001003,"Communication board, non-electronic augmentative or alternative communication",09-10-2025
E1902002004,Device,09-10-2025
E1905001003,"Virtual reality cognitive behavioral therapy device (cbt), including",09-10-2025
E1905002004,Pre-programmed therapy software,09-10-2025
E2000001003,"Gastric suction pump, home model, portable or stationary, electric",09-10-2025
E2001001003,"Suction pump, home model, portable or stationary, electric, any type, for use",09-10-2025
E2001002004,With external urine and/or fecal management system,09-10-2025
E2100001003,Blood glucose monitor with integrated voice synthesizer,09-10-2025
E2101001003,Blood glucose monitor with integrated lancing/blood sample,09-10-2025
E2102001003,"Adjunctive, non-implanted continuous glucose monitor or receiver",09-10-2025
E2103001003,"Non-adjunctive, non-implanted continuous glucose monitor or receiver",09-10-2025
E2104001003,Home blood glucose monitor for use with integrated lancing/blood sample testing,09-10-2025
E2104002004,Cartridge,09-10-2025
E2120001003,Pulse generator system for tympanic treatment of inner ear endolymphatic fluid,09-10-2025
E2201001003,"Manual wheelchair accessory, nonstandard seat frame, width greater than or",09-10-2025
E2201002004,Equal to 20 inches and less than 24 inches,09-10-2025
E2202001003,"Manual wheelchair accessory, nonstandard seat frame width, 24-27 inches",09-10-2025
E2203001003,"Manual wheelchair accessory, nonstandard seat frame depth, 20 to less than 22",09-10-2025
E2203002004,Inches,09-10-2025
E2204001003,"Manual wheelchair accessory, nonstandard seat frame depth, 22 to 25 inches",09-10-2025
E2205001003,"Manual wheelchair accessory, handrim without projections (includes ergonomic or",09-10-2025
E2205002004,"Contoured), any type, replacement only, each",09-10-2025
E2206001003,"Manual wheelchair accessory, wheel lock assembly, complete, replacement only,",09-10-2025
E2206002004,Each,09-10-2025
E2207001003,"Wheelchair accessory, crutch and cane holder, each",09-10-2025
E2208001003,"Wheelchair accessory, cylinder tank carrier, each",09-10-2025
E2209001003,"Accessory, arm trough, with or without hand support, each",09-10-2025
E2210001003,"Wheelchair accessory, bearings, any type, replacement only, each",09-10-2025
E2211001003,"Manual wheelchair accessory, pneumatic propulsion tire, any size, each",09-10-2025
E2212001003,"Manual wheelchair accessory, tube for pneumatic propulsion tire, any size, each",09-10-2025
E2213001003,"Manual wheelchair accessory, insert for pneumatic propulsion tire (removable),",09-10-2025
E2213002004,"Any type, any size, each",09-10-2025
E2214001003,"Manual wheelchair accessory, pneumatic caster tire, any size, each",09-10-2025
E2215001003,"Manual wheelchair accessory, tube for pneumatic caster tire, any size, each",09-10-2025
E2216001003,"Manual wheelchair accessory, foam filled propulsion tire, any size, each",09-10-2025
E2217001003,"Manual wheelchair accessory, foam filled caster tire, any size, each",09-10-2025
E2218001003,"Manual wheelchair accessory, foam propulsion tire, any size, each",09-10-2025
E2219001003,"Manual wheelchair accessory, foam caster tire, any size, each",09-10-2025
E2220001003,"Manual wheelchair accessory, solid (rubber/plastic) propulsion tire, any size,",09-10-2025
E2220002004,"Replacement only, each",09-10-2025
E2221001003,"Manual wheelchair accessory, solid (rubber/plastic) caster tire (removable),",09-10-2025
E2221002004,"Any size, replacement only, each",09-10-2025
E2222001003,"Manual wheelchair accessory, solid (rubber/plastic) caster tire with integrated",09-10-2025
E2222002004,"Wheel, any size, replacement only, each",09-10-2025
E2224001003,"Manual wheelchair accessory, propulsion wheel excludes tire, any size,",09-10-2025
E2224002004,"Replacement only, each",09-10-2025
E2225001003,"Manual wheelchair accessory, caster wheel excludes tire, any size, replacement",09-10-2025
E2225002004,"Only, each",09-10-2025
E2226001003,"Manual wheelchair accessory, caster fork, any size, replacement only, each",09-10-2025
E2227001003,"Manual wheelchair accessory, gear reduction drive wheel, each",09-10-2025
E2228001003,"Manual wheelchair accessory, wheel braking system and lock, complete, each",09-10-2025
E2230001003,"Manual wheelchair accessory, manual standing system",09-10-2025
E2231001003,"Manual wheelchair accessory, solid seat support base (replaces sling seat),",09-10-2025
E2231002004,Includes any type mounting hardware,09-10-2025
E2291001003,"Back, planar, for pediatric size wheelchair including fixed attaching hardware",09-10-2025
E2292001003,"Seat, planar, for pediatric size wheelchair including fixed attaching hardware",09-10-2025
E2293001003,"Back, contoured, for pediatric size wheelchair including fixed attaching",09-10-2025
E2293002004,Hardware,09-10-2025
E2294001003,"Seat, contoured, for pediatric size wheelchair including fixed attaching",09-10-2025
E2294002004,Hardware,09-10-2025
E2295001003,"Manual wheelchair accessory, for pediatric size wheelchair, dynamic seating",09-10-2025
E2295002004,"Frame, allows coordinated movement of multiple positioning features",09-10-2025
E2298001003,"Complex rehabilitative power wheelchair accessory, power seat elevation system,",09-10-2025
E2298002004,Any type,09-10-2025
E2300001003,"Wheelchair accessory, power seat elevation system, any type",09-10-2025
E2301001003,"Wheelchair accessory, power standing system, any type",09-10-2025
E2310001003,"Power wheelchair accessory, electronic connection between wheelchair controller",09-10-2025
E2310002004,"And one power seating system motor, including all related electronics,",09-10-2025
E2310003004,"Indicator feature, mechanical function selection switch, and fixed mounting",09-10-2025
E2310004004,Hardware,09-10-2025
E2311001003,"Power wheelchair accessory, electronic connection between wheelchair controller",09-10-2025
E2311002004,"And two or more power seating system motors, including all related electronics,",09-10-2025
E2311003004,"Indicator feature, mechanical function selection switch, and fixed mounting",09-10-2025
E2311004004,Hardware,09-10-2025
E2312001003,"Power wheelchair accessory, hand or chin control interface, mini-proportional",09-10-2025
E2312002004,"Remote joystick, proportional, including fixed mounting hardware",09-10-2025
E2313001003,"Power wheelchair accessory, harness for upgrade to expandable controller,",09-10-2025
E2313002004,"Including all fasteners, connectors and mounting hardware, each",09-10-2025
E2321001003,"Power wheelchair accessory, hand control interface, remote joystick,",09-10-2025
E2321002004,"Nonproportional, including all related electronics, mechanical stop switch, and",09-10-2025
E2321003004,Fixed mounting hardware,09-10-2025
E2322001003,"Power wheelchair accessory, hand control interface, multiple mechanical",09-10-2025
E2322002004,"Switches, nonproportional, including all related electronics, mechanical stop",09-10-2025
E2322003004,"Switch, and fixed mounting hardware",09-10-2025
E2323001003,"Power wheelchair accessory, specialty joystick handle for hand control",09-10-2025
E2323002004,"Interface, prefabricated",09-10-2025
E2324001003,"Power wheelchair accessory, chin cup for chin control interface",09-10-2025
E2325001003,"Power wheelchair accessory, sip and puff interface, nonproportional, including",09-10-2025
E2325002004,"All related electronics, mechanical stop switch, and manual swingaway mounting",09-10-2025
E2325003004,Hardware,09-10-2025
E2326001003,"Power wheelchair accessory, breath tube kit for sip and puff interface",09-10-2025
E2327001003,"Power wheelchair accessory, head control interface, mechanical, proportional,",09-10-2025
E2327002004,"Including all related electronics, mechanical direction change switch, and",09-10-2025
E2327003004,Fixed mounting hardware,09-10-2025
E2328001003,"Power wheelchair accessory, head control or extremity control interface,",09-10-2025
E2328002004,"Electronic, proportional, including all related electronics and fixed mounting",09-10-2025
E2328003004,Hardware,09-10-2025
E2329001003,"Power wheelchair accessory, head control interface, contact switch mechanism,",09-10-2025
E2329002004,"Nonproportional, including all related electronics, mechanical stop switch,",09-10-2025
E2329003004,"Mechanical direction change switch, head array, and fixed mounting hardware",09-10-2025
E2330001003,"Power wheelchair accessory, head control interface, proximity switch mechanism,",09-10-2025
E2330002004,"Nonproportional, including all related electronics, mechanical stop switch,",09-10-2025
E2330003004,"Mechanical direction change switch, head array, and fixed mounting hardware",09-10-2025
E2331001003,"Power wheelchair accessory, attendant control, proportional, including all",09-10-2025
E2331002004,Related electronics and fixed mounting hardware,09-10-2025
E2340001003,"Power wheelchair accessory, nonstandard seat frame width, 20-23 inches",09-10-2025
E2341001003,"Power wheelchair accessory, nonstandard seat frame width, 24-27 inches",09-10-2025
E2342001003,"Power wheelchair accessory, nonstandard seat frame depth, 20 or 21 inches",09-10-2025
E2343001003,"Power wheelchair accessory, nonstandard seat frame depth, 22-25 inches",09-10-2025
E2351001003,"Power wheelchair accessory, electronic interface to operate speech generating",09-10-2025
E2351002004,Device using power wheelchair control interface,09-10-2025
E2358001003,"Power wheelchair accessory, group 34 non-sealed lead acid battery, each",09-10-2025
E2359001003,"Power wheelchair accessory, group 34 sealed lead acid battery, each (e.g., gel",09-10-2025
E2359002004,"Cell, absorbed glassmat)",09-10-2025
E2360001003,"Power wheelchair accessory, 22nf non-sealed lead acid battery, each",09-10-2025
E2361001003,"Power wheelchair accessory, 22nf sealed lead acid battery, each, (e.g., gel",09-10-2025
E2361002004,"Cell, absorbed glassmat)",09-10-2025
E2362001003,"Power wheelchair accessory, group 24 non-sealed lead acid battery, each",09-10-2025
E2363001003,"Power wheelchair accessory, group 24 sealed lead acid battery, each (e.g., gel",09-10-2025
E2363002004,"Cell, absorbed glassmat)",09-10-2025
E2364001003,"Power wheelchair accessory, u-1 non-sealed lead acid battery, each",09-10-2025
E2365001003,"Power wheelchair accessory, u-1 sealed lead acid battery, each (e.g., gel cell,",09-10-2025
E2365002004,Absorbed glassmat),09-10-2025
E2366001003,"Power wheelchair accessory, battery charger, single mode, for use with only one",09-10-2025
E2366002004,"Battery type, sealed or non-sealed, each",09-10-2025
E2367001003,"Power wheelchair accessory, battery charger, dual mode, for use with either",09-10-2025
E2367002004,"Battery type, sealed or non-sealed, each",09-10-2025
E2368001003,"Power wheelchair component, drive wheel motor, replacement only",09-10-2025
E2369001003,"Power wheelchair component, drive wheel gear box, replacement only",09-10-2025
E2370001003,"Power wheelchair component, integrated drive wheel motor and gear box",09-10-2025
E2370002004,"Combination, replacement only",09-10-2025
E2371001003,"Power wheelchair accessory, group 27 sealed lead acid battery, (e.g., gel cell,",09-10-2025
E2371002004,"Absorbed glassmat), each",09-10-2025
E2372001003,"Power wheelchair accessory, group 27 non-sealed lead acid battery, each",09-10-2025
E2373001003,"Power wheelchair accessory, hand or chin control interface, compact remote",09-10-2025
E2373002004,"Joystick, proportional, including fixed mounting hardware",09-10-2025
E2374001003,"Power wheelchair accessory, hand or chin control interface, standard remote",09-10-2025
E2374002004,"Joystick (not including controller), proportional, including all related",09-10-2025
E2374003004,"Electronics and fixed mounting hardware, replacement only",09-10-2025
E2375001003,"Power wheelchair accessory, non-expandable controller, including all related",09-10-2025
E2375002004,"Electronics and mounting hardware, replacement only",09-10-2025
E2376001003,"Power wheelchair accessory, expandable controller, including all related",09-10-2025
E2376002004,"Electronics and mounting hardware, replacement only",09-10-2025
E2377001003,"Power wheelchair accessory, expandable controller, including all related",09-10-2025
E2377002004,"Electronics and mounting hardware, upgrade provided at initial issue",09-10-2025
E2378001003,"Power wheelchair component, actuator, replacement only",09-10-2025
E2381001003,"Power wheelchair accessory, pneumatic drive wheel tire, any size, replacement",09-10-2025
E2381002004,"Only, each",09-10-2025
E2382001003,"Power wheelchair accessory, tube for pneumatic drive wheel tire, any size,",09-10-2025
E2382002004,"Replacement only, each",09-10-2025
E2383001003,"Power wheelchair accessory, insert for pneumatic drive wheel tire (removable),",09-10-2025
E2383002004,"Any type, any size, replacement only, each",09-10-2025
E2384001003,"Power wheelchair accessory, pneumatic caster tire, any size, replacement only,",09-10-2025
E2384002004,Each,09-10-2025
E2385001003,"Power wheelchair accessory, tube for pneumatic caster tire, any size,",09-10-2025
E2385002004,"Replacement only, each",09-10-2025
E2386001003,"Power wheelchair accessory, foam filled drive wheel tire, any size, replacement",09-10-2025
E2386002004,"Only, each",09-10-2025
E2387001003,"Power wheelchair accessory, foam filled caster tire, any size, replacement",09-10-2025
E2387002004,"Only, each",09-10-2025
E2388001003,"Power wheelchair accessory, foam drive wheel tire, any size, replacement only,",09-10-2025
E2388002004,Each,09-10-2025
E2389001003,"Power wheelchair accessory, foam caster tire, any size, replacement only, each",09-10-2025
E2390001003,"Power wheelchair accessory, solid (rubber/plastic) drive wheel tire, any size,",09-10-2025
E2390002004,"Replacement only, each",09-10-2025
E2391001003,"Power wheelchair accessory, solid (rubber/plastic) caster tire (removable), any",09-10-2025
E2391002004,"Size, replacement only, each",09-10-2025
E2392001003,"Power wheelchair accessory, solid (rubber/plastic) caster tire with integrated",09-10-2025
E2392002004,"Wheel, any size, replacement only, each",09-10-2025
E2394001003,"Power wheelchair accessory, drive wheel excludes tire, any size, replacement",09-10-2025
E2394002004,"Only, each",09-10-2025
E2395001003,"Power wheelchair accessory, caster wheel excludes tire, any size, replacement",09-10-2025
E2395002004,"Only, each",09-10-2025
E2396001003,"Power wheelchair accessory, caster fork, any size, replacement only, each",09-10-2025
E2397001003,"Power wheelchair accessory, lithium-based battery, each",09-10-2025
E2398001003,"Wheelchair accessory, dynamic positioning hardware for back",09-10-2025
E2402001003,"Negative pressure wound therapy electrical pump, stationary or portable",09-10-2025
E2500001003,"Speech generating device, digitized speech, using pre-recorded messages, less",09-10-2025
E2500002004,Than or equal to 8 minutes recording time,09-10-2025
E2502001003,"Speech generating device, digitized speech, using pre-recorded messages,",09-10-2025
E2502002004,Greater than 8 minutes but less than or equal to 20 minutes recording time,09-10-2025
E2504001003,"Speech generating device, digitized speech, using pre-recorded messages,",09-10-2025
E2504002004,Greater than 20 minutes but less than or equal to 40 minutes recording time,09-10-2025
E2506001003,"Speech generating device, digitized speech, using pre-recorded messages,",09-10-2025
E2506002004,Greater than 40 minutes recording time,09-10-2025
E2508001003,"Speech generating device, synthesized speech, requiring message formulation by",09-10-2025
E2508002004,Spelling and access by physical contact with the device,09-10-2025
E2510001003,"Speech generating device, synthesized speech, permitting multiple methods of",09-10-2025
E2510002004,Message formulation and multiple methods of device access,09-10-2025
E2511001003,"Speech generating software program, for personal computer or personal digital",09-10-2025
E2511002004,Assistant,09-10-2025
E2512001003,"Accessory for speech generating device, mounting system",09-10-2025
E2513001003,"Accessory for speech generating device, electromyographic sensor",09-10-2025
E2599001003,"Accessory for speech generating device, not otherwise classified",09-10-2025
E2601001003,"General use wheelchair seat cushion, width less than 22 inches, any depth",09-10-2025
E2602001003,"General use wheelchair seat cushion, width 22 inches or greater, any depth",09-10-2025
E2603001003,"Skin protection wheelchair seat cushion, width less than 22 inches, any depth",09-10-2025
E2604001003,"Skin protection wheelchair seat cushion, width 22 inches or greater, any depth",09-10-2025
E2605001003,"Positioning wheelchair seat cushion, width less than 22 inches, any depth",09-10-2025
E2606001003,"Positioning wheelchair seat cushion, width 22 inches or greater, any depth",09-10-2025
E2607001003,"Skin protection and positioning wheelchair seat cushion, width less than 22",09-10-2025
E2607002004,"Inches, any depth",09-10-2025
E2608001003,"Skin protection and positioning wheelchair seat cushion, width 22 inches or",09-10-2025
E2608002004,"Greater, any depth",09-10-2025
E2609001003,"Custom fabricated wheelchair seat cushion, any size",09-10-2025
E2610001003,"Wheelchair seat cushion, powered",09-10-2025
E2611001003,"General use wheelchair back cushion, width less than 22 inches, any height,",09-10-2025
E2611002004,Including any type mounting hardware,09-10-2025
E2612001003,"General use wheelchair back cushion, width 22 inches or greater, any height,",09-10-2025
E2612002004,Including any type mounting hardware,09-10-2025
E2613001003,"Positioning wheelchair back cushion, posterior, width less than 22 inches, any",09-10-2025
E2613002004,"Height, including any type mounting hardware",09-10-2025
E2614001003,"Positioning wheelchair back cushion, posterior, width 22 inches or greater, any",09-10-2025
E2614002004,"Height, including any type mounting hardware",09-10-2025
E2615001003,"Positioning wheelchair back cushion, posterior-lateral, width less than 22",09-10-2025
E2615002004,"Inches, any height, including any type mounting hardware",09-10-2025
E2616001003,"Positioning wheelchair back cushion, posterior-lateral, width 22 inches or",09-10-2025
E2616002004,"Greater, any height, including any type mounting hardware",09-10-2025
E2617001003,"Custom fabricated wheelchair back cushion, any size, including any type",09-10-2025
E2617002004,Mounting hardware,09-10-2025
E2619001003,"Replacement cover for wheelchair seat cushion or back cushion, each",09-10-2025
E2620001003,"Positioning wheelchair back cushion, planar back with lateral supports, width",09-10-2025
E2620002004,"Less than 22 inches, any height, including any type mounting hardware",09-10-2025
E2621001003,"Positioning wheelchair back cushion, planar back with lateral supports, width",09-10-2025
E2621002004,"22 inches or greater, any height, including any type mounting hardware",09-10-2025
E2622001003,"Skin protection wheelchair seat cushion, adjustable, width less than 22 inches,",09-10-2025
E2622002004,Any depth,09-10-2025
E2623001003,"Skin protection wheelchair seat cushion, adjustable, width 22 inches or",09-10-2025
E2623002004,"Greater, any depth",09-10-2025
E2624001003,"Skin protection and positioning wheelchair seat cushion, adjustable, width less",09-10-2025
E2624002004,"Than 22 inches, any depth",09-10-2025
E2625001003,"Skin protection and positioning wheelchair seat cushion, adjustable, width 22",09-10-2025
E2625002004,"Inches or greater, any depth",09-10-2025
E2626001003,"Wheelchair accessory, shoulder elbow, mobile arm support attached to",09-10-2025
E2626002004,"Wheelchair, balanced, adjustable",09-10-2025
E2627001003,"Wheelchair accessory, shoulder elbow, mobile arm support attached to",09-10-2025
E2627002004,"Wheelchair, balanced, adjustable rancho type",09-10-2025
E2628001003,"Wheelchair accessory, shoulder elbow, mobile arm support attached to",09-10-2025
E2628002004,"Wheelchair, balanced, reclining",09-10-2025
E2629001003,"Wheelchair accessory, shoulder elbow, mobile arm support attached to",09-10-2025
E2629002004,"Wheelchair, balanced, friction arm support (friction dampening to proximal and",09-10-2025
E2629003004,Distal joints),09-10-2025
E2630001003,"Wheelchair accessory, shoulder elbow, mobile arm support, monosuspension arm",09-10-2025
E2630002004,"And hand support, overhead elbow forearm hand sling support, yoke type",09-10-2025
E2630003004,Suspension support,09-10-2025
E2631001003,"Wheelchair accessory, addition to mobile arm support, elevating proximal arm",09-10-2025
E2632001003,"Wheelchair accessory, addition to mobile arm support, offset or lateral rocker",09-10-2025
E2632002004,Arm with elastic balance control,09-10-2025
E2633001003,"Wheelchair accessory, addition to mobile arm support, supinator",09-10-2025
E3000001003,"Speech volume modulation system, any type, including all components and",09-10-2025
E3000002004,Accessories,09-10-2025
E3200001003,"Gait modulation system, rhythmic auditory stimulation, including restricted",09-10-2025
E3200002004,"Therapy software, all components and accessories, prescription only",09-10-2025
E8000001003,"Gait trainer, pediatric size, posterior support, includes all accessories and",09-10-2025
E8000002004,Components,09-10-2025
E8001001003,"Gait trainer, pediatric size, upright support, includes all accessories and",09-10-2025
E8001002004,Components,09-10-2025
E8002001003,"Gait trainer, pediatric size, anterior support, includes all accessories and",09-10-2025
E8002002004,Components,09-10-2025
G0008001003,Administration of influenza virus vaccine,09-10-2025
G0009001003,Administration of pneumococcal vaccine,09-10-2025
G0010001003,Administration of hepatitis b vaccine,09-10-2025
G0011001003,Individual counseling for pre-exposure prophylaxis (prep) by physician or,09-10-2025
G0011002004,Qualified health care professional (qhp) to prevent human immunodeficiency,09-10-2025
G0011003004,"Virus (hiv), includes hiv risk assessment (initial or continued assessment of",09-10-2025
G0011004004,"Risk), hiv risk reduction and medication adherence, 15-30 minutes",09-10-2025
G0012001003,"Injection of pre-exposure prophylaxis (prep) drug for hiv prevention, under",09-10-2025
G0012002004,Skin or into muscle,09-10-2025
G0013001003,Individual counseling for pre-exposure prophylaxis (prep) by clinical staff to,09-10-2025
G0013002004,"Prevent human immunodeficiency virus (hiv), includes: hiv risk assessment",09-10-2025
G0013003004,"(initial or continued assessment of risk), hiv risk reduction and medication",09-10-2025
G0013004004,Adherence,09-10-2025
G0017001003,Psychotherapy for crisis furnished in an applicable site of service (any place,09-10-2025
G0017002004,Of service at which the non-facility rate for psychotherapy for crisis services,09-10-2025
G0017003004,"Applies, other than the office setting); first 60 minutes",09-10-2025
G0018001003,Psychotherapy for crisis furnished in an applicable site of service (any place,09-10-2025
G0018002004,Of service at which the non-facility rate for psychotherapy for crisis services,09-10-2025
G0018003004,"Applies, other than the office setting); each additional 30 minutes (list",09-10-2025
G0018004004,Separately in addition to code for primary service),09-10-2025
G0019001003,Community health integration services performed by certified or trained,09-10-2025
G0019002004,"Auxiliary personnel, including a community health worker, under the direction",09-10-2025
G0019003004,"Of a physician or other practitioner; 60 minutes per calendar month, in the",09-10-2025
G0019004004,Following activities to address social determinants of health (sdoh) need(s),09-10-2025
G0019005004,That are significantly limiting the ability to diagnose or treat problem(s),09-10-2025
G0019006004,"Addressed in an initiating visit: person-centered assessment, performed to",09-10-2025
G0019007004,Better understand the individualized context of the intersection between the,09-10-2025
G0019008004,Sdoh need(s) and the problem(s) addressed in the initiating visit. ++,09-10-2025
G0019009004,"Conducting a person-centered assessment to understand patient's life story,",09-10-2025
G0019010004,"Strengths, needs, goals, preferences and desired outcomes, including",09-10-2025
G0019011004,Understanding cultural and linguistic factors and including unmet sdoh needs,09-10-2025
G0019012004,(that are not separately billed). ++ facilitating patient-driven goal-setting,09-10-2025
G0019013004,And establishing an action plan. ++ providing tailored support to the patient,09-10-2025
G0019014004,"As needed to accomplish the practitioner's treatment plan. practitioner, home-,",09-10-2025
G0019015004,And community-based care coordination. ++ coordinating receipt of needed,09-10-2025
G0019016004,"Services from healthcare practitioners, providers, and facilities; and from",09-10-2025
G0019017004,"Home- and community-based service providers, social service providers, and",09-10-2025
G0019018004,"Caregiver (if applicable). ++ communication with practitioners, home- and",09-10-2025
G0019019004,"Community-based service providers, hospitals, and skilled nursing facilities",09-10-2025
G0019020004,(or other health care facilities) regarding the patient's psychosocial,09-10-2025
G0019021004,"Strengths and needs, functional deficits, goals, preferences, and desired",09-10-2025
G0019022004,"Outcomes, including cultural and linguistic factors. ++ coordination of care",09-10-2025
G0019023004,"Transitions between and among health care practitioners and settings, including",09-10-2025
G0019024004,Transitions involving referral to other clinicians; follow-up after an,09-10-2025
G0019025004,"Emergency department visit; or follow-up after discharges from hospitals,",09-10-2025
G0019026004,Skilled nursing facilities or other health care facilities. ++ facilitating,09-10-2025
G0019027004,"Access to community-based social services (e.g., housing, utilities,",09-10-2025
G0019028004,"Transportation, food assistance) to address the sdoh need(s). health education-",09-10-2025
G0019029004,Helping the patient contextualize health education provided by the patient's,09-10-2025
G0019030004,"Treatment team with the patient's individual needs, goals, and preferences, in",09-10-2025
G0019031004,"The context of the sdoh need(s), and educating the patient on how to best",09-10-2025
G0019032004,"Participate in medical decision-making. building patient self-advocacy skills,",09-10-2025
G0019033004,So that the patient can interact with members of the health care team and,09-10-2025
G0019034004,"Related community-based services addressing the sdoh need(s), in ways that are",09-10-2025
G0019035004,More likely to promote personalized and effective diagnosis or treatment.,09-10-2025
G0019036004,Health care access / health system navigation. ++ helping the patient access,09-10-2025
G0019037004,"Healthcare, including identifying appropriate practitioners or providers for",09-10-2025
G0019038004,Clinical care and helping secure appointments with them. facilitating,09-10-2025
G0019039004,"Behavioral change as necessary for meeting diagnosis and treatment goals,",09-10-2025
G0019040004,Including promoting patient motivation to participate in care and reach,09-10-2025
G0019041004,Person-centered diagnosis or treatment goals. facilitating and providing social,09-10-2025
G0019042004,And emotional support to help the patient cope with the problem(s) addressed in,09-10-2025
G0019043004,"The initiating visit, the sdoh need(s), and adjust daily routines to better",09-10-2025
G0019044004,Meet diagnosis and treatment goals. leveraging lived experience when applicable,09-10-2025
G0019045004,"To provide support, mentorship, or inspiration to meet treatment goals",09-10-2025
G0022001003,"Community health integration services, each additional 30 minutes per calendar",09-10-2025
G0022002004,Month (list separately in addition to g0019),09-10-2025
G0023001003,Principal illness navigation services by certified or trained auxiliary,09-10-2025
G0023002004,"Personnel under the direction of a physician or other practitioner, including a",09-10-2025
G0023003004,"Patient navigator; 60 minutes per calendar month, in the following activities:",09-10-2025
G0023004004,"Person-centered assessment, performed to better understand the individual",09-10-2025
G0023005004,"Context of the serious, high-risk condition. ++ conducting a person-centered",09-10-2025
G0023006004,"Assessment to understand the patient's life story, strengths, needs, goals,",09-10-2025
G0023007004,"Preferences, and desired outcomes, including understanding cultural and",09-10-2025
G0023008004,Linguistic factors and including unmet sdoh needs (that are not separately,09-10-2025
G0023009004,Billed). ++ facilitating patient-driven goal setting and establishing an action,09-10-2025
G0023010004,Plan. ++ providing tailored support as needed to accomplish the practitioner's,09-10-2025
G0023011004,"Treatment plan. identifying or referring patient (and caregiver or family, if",09-10-2025
G0023012004,"Applicable) to appropriate supportive services. practitioner, home, and",09-10-2025
G0023013004,Community-based care coordination. ++ coordinating receipt of needed services,09-10-2025
G0023014004,"From healthcare practitioners, providers, and facilities; home- and",09-10-2025
G0023015004,Community-based service providers; and caregiver (if applicable). ++,09-10-2025
G0023016004,"Communication with practitioners, home-, and community-based service providers,",09-10-2025
G0023017004,"Hospitals, and skilled nursing facilities (or other health care facilities)",09-10-2025
G0023018004,"Regarding the patient's psychosocial strengths and needs, functional deficits,",09-10-2025
G0023019004,"Goals, preferences, and desired outcomes, including cultural and linguistic",09-10-2025
G0023020004,Factors. ++ coordination of care transitions between and among health care,09-10-2025
G0023021004,"Practitioners and settings, including transitions involving referral to other",09-10-2025
G0023022004,Clinicians; follow-up after an emergency department visit; or follow-up after,09-10-2025
G0023023004,"Discharges from hospitals, skilled nursing facilities or other health care",09-10-2025
G0023024004,"Facilities. ++ facilitating access to community-based social services (e.g.,",09-10-2025
G0023025004,"Housing, utilities, transportation, food assistance) as needed to address sdoh",09-10-2025
G0023026004,Need(s). health education- helping the patient contextualize health education,09-10-2025
G0023027004,"Provided by the patient's treatment team with the patient's individual needs,",09-10-2025
G0023028004,"Goals, preferences, and sdoh need(s), and educating the patient (and caregiver",09-10-2025
G0023029004,If applicable) on how to best participate in medical decision-making. building,09-10-2025
G0023030004,"Patient self-advocacy skills, so that the patient can interact with members of",09-10-2025
G0023031004,"The health care team and related community-based services (as needed), in ways",09-10-2025
G0023032004,That are more likely to promote personalized and effective treatment of their,09-10-2025
G0023033004,Condition. health care access / health system navigation. ++ helping the,09-10-2025
G0023034004,"Patient access healthcare, including identifying appropriate practitioners or",09-10-2025
G0023035004,"Providers for clinical care, and helping secure appointments with them. ++",09-10-2025
G0023036004,Providing the patient with information/resources to consider participation in,09-10-2025
G0023037004,Clinical trials or clinical research as applicable. facilitating behavioral,09-10-2025
G0023038004,"Change as necessary for meeting diagnosis and treatment goals, including",09-10-2025
G0023039004,Promoting patient motivation to participate in care and reach person-centered,09-10-2025
G0023040004,Diagnosis or treatment goals. facilitating and providing social and emotional,09-10-2025
G0023041004,"Support to help the patient cope with the condition, sdoh need(s), and adjust",09-10-2025
G0023042004,Daily routines to better meet diagnosis and treatment goals. leverage,09-10-2025
G0023043004,"Knowledge of the serious, high-risk condition and/or lived experience when",09-10-2025
G0023044004,"Applicable to provide support, mentorship, or inspiration to meet treatment",09-10-2025
G0023045004,Goals,09-10-2025
G0024001003,"Principal illness navigation services, additional 30 minutes per calendar month",09-10-2025
G0024002004,(list separately in addition to g0023),09-10-2025
G0027001003,Semen analysis; presence and/or motility of sperm excluding huhner,09-10-2025
G0028001003,"Documentation of medical reason(s) for not screening for tobacco use (e.g.,",09-10-2025
G0028002004,"Limited life expectancy, other medical reason)",09-10-2025
G0029001003,Tobacco screening not performed or tobacco cessation intervention not provided,09-10-2025
G0029002004,During the measurement period or in the six months prior to the measurement,09-10-2025
G0029003004,Period,09-10-2025
G0030001003,Patient screened for tobacco use and received tobacco cessation intervention,09-10-2025
G0030002004,During the measurement period or in the six months prior to the measurement,09-10-2025
G0030003004,"Period (counseling, pharmacotherapy, or both), if identified as a tobacco user",09-10-2025
G0031001003,Palliative care services given to patient any time during the measurement perio,09-10-2025
G0032001003,Two or more antipsychotic prescriptions ordered for patients who had a,09-10-2025
G0032002004,"Diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or",09-10-2025
G0032003004,Between january 1 of the year prior to the measurement period and the index,09-10-2025
G0032004004,Prescription start date (ipsd) for antipsychotics,09-10-2025
G0033001003,Two or more benzodiazepine prescriptions ordered for patients who had a,09-10-2025
G0033002004,"Diagnosis of seizure disorders, rapid eye movement sleep behavior disorder,",09-10-2025
G0033003004,"Benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety",09-10-2025
G0033004004,Disorder on or between january 1 of the year prior to the measurement period,09-10-2025
G0033005004,And the ipsd for benzodiazepines,09-10-2025
G0034001003,Patients receiving palliative care during the measurement period,09-10-2025
G0035001003,Patient has any emergency department encounter during the performance period,09-10-2025
G0035002004,With place of service indicator 23,09-10-2025
G0036001003,Patient or care partner decline assessment,09-10-2025
G0037001003,"On date of encounter, patient is not able to participate in assessment or",09-10-2025
G0037002004,"Screening, including non-verbal patients, delirious, severely aphasic, severely",09-10-2025
G0037003004,"Developmentally delayed, severe visual or hearing impairment and for those",09-10-2025
G0037004004,"Patients, no knowledgeable informant available",09-10-2025
G0038001003,Clinician determines patient does not require referral,09-10-2025
G0039001003,"Patient not referred, reason not otherwise specified",09-10-2025
G0040001003,Patient already receiving physical/occupational/speech/recreational therapy,09-10-2025
G0040002004,During the measurement period,09-10-2025
G0041001003,Patient and/or care partner decline referral,09-10-2025
G0042001003,"Referral to physical, occupational, speech, or recreational therapy",09-10-2025
G0043001003,Patients with mechanical prosthetic heart valve,09-10-2025
G0044001003,Patients with moderate or severe mitral stenosis,09-10-2025
G0045001003,Clinical follow-up and mrs score assessed at 90 days following endovascular,09-10-2025
G0045002004,Stroke intervention,09-10-2025
G0046001003,Clinical follow-up and mrs score not assessed at 90 days following endovascular,09-10-2025
G0046002004,Stroke intervention,09-10-2025
G0047001003,Pediatric patient with minor blunt head trauma and pecarn prediction criteria,09-10-2025
G0047002004,Are not assessed,09-10-2025
G0048001003,Patients who receive palliative care services any time during the intake period,09-10-2025
G0048002004,Through the end of the measurement year,09-10-2025
G0049001003,With maintenance hemodialysis (in-center and home hd) for the complete,09-10-2025
G0049002004,Reporting month,09-10-2025
G0050001003,Patients with a catheter that have limited life expectancy,09-10-2025
G0051001003,Patients under hospice care in the current reporting month,09-10-2025
G0052001003,Patients on peritoneal dialysis for any portion of the reporting month,09-10-2025
G0053001003,Advancing rheumatology patient care mips value pathways,09-10-2025
G0054001003,Coordinating stroke care to promote prevention and cultivate positive outcomes,09-10-2025
G0054002004,Mips value pathways,09-10-2025
G0055001003,Advancing care for heart disease mips value pathways,09-10-2025
G0056001003,Optimizing chronic disease management mips value pathways,09-10-2025
G0057001003,Proposed adopting best practices and promoting patient safety within emergency,09-10-2025
G0057002004,Medicine mips value pathways,09-10-2025
G0058001003,Improving care for lower extremity joint repair mips value pathways,09-10-2025
G0059001003,Patient safety and support of positive experiences with anesthesia mips value,09-10-2025
G0059002004,Pathways,09-10-2025
G0060001003,Allergy/immunology mips specialty set,09-10-2025
G0061001003,Anesthesiology mips specialty set,09-10-2025
G0062001003,Audiology mips specialty set,09-10-2025
G0063001003,Cardiology mips specialty set,09-10-2025
G0064001003,Certified nurse midwife mips specialty set,09-10-2025
G0065001003,Chiropractic medicine mips specialty set,09-10-2025
G0066001003,Clinical social work mips specialty set,09-10-2025
G0067001003,Dentistry mips specialty set,09-10-2025
G0068001003,"Professional services for the administration of anti-infective, pain",09-10-2025
G0068002004,"Management, chelation, pulmonary hypertension, inotropic, or other intravenous",09-10-2025
G0068003004,Infusion drug or biological (excluding chemotherapy or other highly complex,09-10-2025
G0068004004,Drug or biological) for each infusion drug administration calendar day in the,09-10-2025
G0068005004,"Individual's home, each 15 minutes",09-10-2025
G0069001003,Professional services for the administration of subcutaneous immunotherapy or,09-10-2025
G0069002004,Other subcutaneous infusion drug or biological for each infusion drug,09-10-2025
G0069003004,"Administration calendar day in the individual's home, each 15 minutes",09-10-2025
G0070001003,Professional services for the administration of intravenous chemotherapy or,09-10-2025
G0070002004,Other intravenous highly complex drug or biological infusion for each infusion,09-10-2025
G0070003004,"Drug administration calendar day in the individual's home, each 15 minutes",09-10-2025
G0071001003,Payment for communication technology-based services for 5 minutes or more of a,09-10-2025
G0071002004,Virtual (non-face-to-face) communication between an rural health clinic (rhc),09-10-2025
G0071003004,Or federally qualified health center (fqhc) practitioner and rhc or fqhc,09-10-2025
G0071004004,"Patient, or 5 minutes or more of remote evaluation of recorded video and/or",09-10-2025
G0071005004,"Images by an rhc or fqhc practitioner, occurring in lieu of an office visit;",09-10-2025
G0071006004,Rhc or fqhc only,09-10-2025
G0076001003,Brief (20 minutes) care management home visit for a new patient. for use only,09-10-2025
G0076002004,In a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G0076003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0076004004,Facility),09-10-2025
G0077001003,Limited (30 minutes) care management home visit for a new patient. for use only,09-10-2025
G0077002004,In a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G0077003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0077004004,Facility),09-10-2025
G0078001003,Moderate (45 minutes) care management home visit for a new patient. for use,09-10-2025
G0078002004,Only in a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G0078003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0078004004,Facility),09-10-2025
G0079001003,Comprehensive (60 minutes) care management home visit for a new patient. for,09-10-2025
G0079002004,Use only in a medicare-approved cmmi model. (services must be furnished within,09-10-2025
G0079003004,"A beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0079004004,Facility),09-10-2025
G0080001003,Extensive (75 minutes) care management home visit for a new patient. for use,09-10-2025
G0080002004,Only in a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G0080003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0080004004,Facility),09-10-2025
G0081001003,Brief (20 minutes) care management home visit for an existing patient. for use,09-10-2025
G0081002004,Only in a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G0081003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0081004004,Facility),09-10-2025
G0082001003,Limited (30 minutes) care management home visit for an existing patient. for,09-10-2025
G0082002004,Use only in a medicare-approved cmmi model. (services must be furnished within,09-10-2025
G0082003004,"A beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0082004004,Facility),09-10-2025
G0083001003,Moderate (45 minutes) care management home visit for an existing patient. for,09-10-2025
G0083002004,Use only in a medicare-approved cmmi model. (services must be furnished within,09-10-2025
G0083003004,"A beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0083004004,Facility),09-10-2025
G0084001003,Comprehensive (60 minutes) care management home visit for an existing patient.,09-10-2025
G0084002004,For use only in a medicare-approved cmmi model. (services must be furnished,09-10-2025
G0084003004,"Within a beneficiary's home, domiciliary, rest home, assisted living and/or",09-10-2025
G0084004004,Nursing facility),09-10-2025
G0085001003,Extensive (75 minutes) care management home visit for an existing patient. for,09-10-2025
G0085002004,Use only in a medicare-approved cmmi model. (services must be furnished within,09-10-2025
G0085003004,"A beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0085004004,Facility),09-10-2025
G0086001003,Limited (30 minutes) care management home care plan oversight. for use only in,09-10-2025
G0086002004,A medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G0086003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0086004004,Facility),09-10-2025
G0087001003,Comprehensive (60 minutes) care management home care plan oversight. for use,09-10-2025
G0087002004,Only in a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G0087003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G0087004004,Facility),09-10-2025
G0088001003,"Professional services, initial visit, for the administration of anti-infective,",09-10-2025
G0088002004,"Pain management, chelation, pulmonary hypertension, inotropic, or other",09-10-2025
G0088003004,Intravenous infusion drug or biological (excluding chemotherapy or other highly,09-10-2025
G0088004004,Complex drug or biological) for each infusion drug administration calendar day,09-10-2025
G0088005004,"In the individual's home, each 15 minutes",09-10-2025
G0089001003,"Professional services, initial visit, for the administration of subcutaneous",09-10-2025
G0089002004,Immunotherapy or other subcutaneous infusion drug or biological for each,09-10-2025
G0089003004,"Infusion drug administration calendar day in the individual's home, each 15",09-10-2025
G0089004004,Minutes,09-10-2025
G0090001003,"Professional services, initial visit, for the administration of intravenous",09-10-2025
G0090002004,Chemotherapy or other highly complex infusion drug or biological for each,09-10-2025
G0090003004,"Infusion drug administration calendar day in the individual's home, each 15",09-10-2025
G0090004004,Minutes,09-10-2025
G0101001003,Cervical or vaginal cancer screening; pelvic and clinical breast examination,09-10-2025
G0102001003,Prostate cancer screening; digital rectal examination,09-10-2025
G0103001003,Prostate cancer screening; prostate specific antigen test (psa),09-10-2025
G0104001003,Colorectal cancer screening; flexible sigmoidoscopy,09-10-2025
G0105001003,Colorectal cancer screening; colonoscopy on individual at high risk,09-10-2025
G0106001003,"Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy,",09-10-2025
G0106002004,Barium enema,09-10-2025
G0108001003,"Diabetes outpatient self-management training services, individual, per 30",09-10-2025
G0108002004,Minutes,09-10-2025
G0109001003,"Diabetes outpatient self-management training services, group session (2 or",09-10-2025
G0109002004,"More), per 30 minutes",09-10-2025
G0117001003,Glaucoma screening for high risk patients furnished by an optometrist or,09-10-2025
G0117002004,Ophthalmologist,09-10-2025
G0118001003,Glaucoma screening for high risk patient furnished under the direct supervision,09-10-2025
G0118002004,Of an optometrist or ophthalmologist,09-10-2025
G0120001003,"Colorectal cancer screening; alternative to g0105, screening colonoscopy,",09-10-2025
G0120002004,Barium enema.,09-10-2025
G0121001003,Colorectal cancer screening; colonoscopy on individual not meeting criteria for,09-10-2025
G0121002004,High risk,09-10-2025
G0122001003,Colorectal cancer screening; barium enema,09-10-2025
G0123001003,"Screening cytopathology, cervical or vaginal (any reporting system), collected",09-10-2025
G0123002004,"In preservative fluid, automated thin layer preparation, screening by",09-10-2025
G0123003004,Cytotechnologist under physician supervision,09-10-2025
G0124001003,"Screening cytopathology, cervical or vaginal (any reporting system), collected",09-10-2025
G0124002004,"In preservative fluid, automated thin layer preparation, requiring",09-10-2025
G0124003004,Interpretation by physician,09-10-2025
G0127001003,"Trimming of dystrophic nails, any number",09-10-2025
G0128001003,Direct (face-to-face with patient) skilled nursing services of a registered,09-10-2025
G0128002004,"Nurse provided in a comprehensive outpatient rehabilitation facility, each 10",09-10-2025
G0128003004,Minutes beyond the first 5 minutes,09-10-2025
G0129001003,Occupational therapy services requiring the skills of a qualified occupational,09-10-2025
G0129002004,"Therapist, furnished as a component of a partial hospitalization or intensive",09-10-2025
G0129003004,"Outpatient treatment program, per session (45 minutes or more)",09-10-2025
G0130001003,"Single energy x-ray absorptiometry (sexa) bone density study, one or more",09-10-2025
G0130002004,"Sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)",09-10-2025
G0136001003,"Administration of a standardized, evidence-based social determinants of health",09-10-2025
G0136002004,"Risk assessment tool, 5-15 minutes",09-10-2025
G0137001003,"Intensive outpatient services; weekly bundle, minimum of 9 services over a 7",09-10-2025
G0137002004,"Contiguous day period, which can include individual and group therapy with",09-10-2025
G0137003004,Physicians or psychologists (or other mental health professionals to the extent,09-10-2025
G0137004004,Authorized under state law); occupational therapy requiring the skills of a,09-10-2025
G0137005004,"Qualified occupational therapist; services of social workers, trained",09-10-2025
G0137006004,"Psychiatric nurses, and other staff trained to work with psychiatric patients;",09-10-2025
G0137007004,Individualized activity therapies that are not primarily recreational or,09-10-2025
G0137008004,Diversionary; family counseling (the primary purpose of which is treatment of,09-10-2025
G0137009004,The individual's condition); patient training and education (to the extent that,09-10-2025
G0137010004,Training and educational activities are closely and clearly related to,09-10-2025
G0137011004,Individual's care and treatment); diagnostic services; and such other items and,09-10-2025
G0137012004,Services (excluding meals and transportation) that are reasonable and necessary,09-10-2025
G0137013004,"For the diagnosis or active treatment of the individual's condition, reasonably",09-10-2025
G0137014004,Expected to improve or maintain the individual's condition and functional level,09-10-2025
G0137015004,"And to prevent relapse or hospitalization, and furnished pursuant to such",09-10-2025
G0137016004,Guidelines relating to frequency and duration of services in accordance with a,09-10-2025
G0137017004,Physician certification and plan of treatment (provision of the services by a,09-10-2025
G0137018004,Medicare-enrolled opioid treatment program); list separately in addition to,09-10-2025
G0137019004,Code for primary procedure,09-10-2025
G0138001003,"Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier",09-10-2025
G0138002004,Acquisition and clinical supervision of oral administration of miglustat in,09-10-2025
G0138003004,Preparation of receipt of cipaglucosidase alfa-atga,09-10-2025
G0140001003,Principal illness navigation - peer support by certified or trained auxiliary,09-10-2025
G0140002004,"Personnel under the direction of a physician or other practitioner, including a",09-10-2025
G0140003004,"Certified peer specialist; 60 minutes per calendar month, in the following",09-10-2025
G0140004004,"Activities: person-centered interview, performed to better understand the",09-10-2025
G0140005004,"Individual context of the serious, high-risk condition. ++ conducting a",09-10-2025
G0140006004,"Person-centered interview to understand the patient's life story, strengths,",09-10-2025
G0140007004,"Needs, goals, preferences, and desired outcomes, including understanding",09-10-2025
G0140008004,"Cultural and linguistic factors, and including unmet sdoh needs (that are not",09-10-2025
G0140009004,Billed separately). ++ facilitating patient-driven goal setting and,09-10-2025
G0140010004,Establishing an action plan. ++ providing tailored support as needed to,09-10-2025
G0140011004,Accomplish the person-centered goals in the practitioner's treatment plan.,09-10-2025
G0140012004,"Identifying or referring patient (and caregiver or family, if applicable) to",09-10-2025
G0140013004,"Appropriate supportive services. practitioner, home, and community-based care",09-10-2025
G0140014004,"Communication. ++ assist the patient in communicating with their practitioners,",09-10-2025
G0140015004,"Home-, and community-based service providers, hospitals, and skilled nursing",09-10-2025
G0140016004,Facilities (or other health care facilities) regarding the patient's,09-10-2025
G0140017004,"Psychosocial strengths and needs, goals, preferences, and desired outcomes,",09-10-2025
G0140018004,Including cultural and linguistic factors. ++ facilitating access to,09-10-2025
G0140019004,"Community-based social services (e.g., housing, utilities, transportation, food",09-10-2025
G0140020004,Assistance) as needed to address sdoh need(s). health education. helping the,09-10-2025
G0140021004,Patient contextualize health education provided by the patient's treatment team,09-10-2025
G0140022004,"With the patient's individual needs, goals, preferences, and sdoh need(s), and",09-10-2025
G0140023004,Educating the patient (and caregiver if applicable) on how to best participate,09-10-2025
G0140024004,"In medical decision-making. building patient self-advocacy skills, so that the",09-10-2025
G0140025004,Patient can interact with members of the health care team and related,09-10-2025
G0140026004,"Community-based services (as needed), in ways that are more likely to promote",09-10-2025
G0140027004,Personalized and effective treatment of their condition. developing and,09-10-2025
G0140028004,Proposing strategies to help meet person-centered treatment goals and,09-10-2025
G0140029004,Supporting the patient in using chosen strategies to reach person-centered,09-10-2025
G0140030004,Treatment goals. facilitating and providing social and emotional support to,09-10-2025
G0140031004,"Help the patient cope with the condition, sdoh need(s), and adjust daily",09-10-2025
G0140032004,Routines to better meet person-centered diagnosis and treatment goals. leverage,09-10-2025
G0140033004,"Knowledge of the serious, high-risk condition and/or lived experience when",09-10-2025
G0140034004,"Applicable to provide support, mentorship, or inspiration to meet treatment",09-10-2025
G0140035004,Goals,09-10-2025
G0141001003,"Screening cytopathology smears, cervical or vaginal, performed by automated",09-10-2025
G0141002004,"System, with manual rescreening, requiring interpretation by physician",09-10-2025
G0143001003,"Screening cytopathology, cervical or vaginal (any reporting system), collected",09-10-2025
G0143002004,"In preservative fluid, automated thin layer preparation, with manual screening",09-10-2025
G0143003004,And rescreening by cytotechnologist under physician supervision,09-10-2025
G0144001003,"Screening cytopathology, cervical or vaginal (any reporting system), collected",09-10-2025
G0144002004,"In preservative fluid, automated thin layer preparation, with screening by",09-10-2025
G0144003004,"Automated system, under physician supervision",09-10-2025
G0145001003,"Screening cytopathology, cervical or vaginal (any reporting system), collected",09-10-2025
G0145002004,"In preservative fluid, automated thin layer preparation, with screening by",09-10-2025
G0145003004,Automated system and manual rescreening under physician supervision,09-10-2025
G0146001003,"Principal illness navigation - peer support, additional 30 minutes per calendar",09-10-2025
G0146002004,Month (list separately in addition to g0140),09-10-2025
G0147001003,"Screening cytopathology smears, cervical or vaginal, performed by automated",09-10-2025
G0147002004,System under physician supervision,09-10-2025
G0148001003,"Screening cytopathology smears, cervical or vaginal, performed by automated",09-10-2025
G0148002004,System with manual rescreening,09-10-2025
G0151001003,Services performed by a qualified physical therapist in the home health or,09-10-2025
G0151002004,"Hospice setting, each 15 minutes",09-10-2025
G0152001003,Services performed by a qualified occupational therapist in the home health or,09-10-2025
G0152002004,"Hospice setting, each 15 minutes",09-10-2025
G0153001003,Services performed by a qualified speech-language pathologist in the home,09-10-2025
G0153002004,"Health or hospice setting, each 15 minutes",09-10-2025
G0154001003,Direct skilled nursing services of a licensed nurse (lpn or rn) in the home,09-10-2025
G0154002004,"Health or hospice setting, each 15 minutes",09-10-2025
G0155001003,"Services of clinical social worker in home health or hospice settings, each 15",09-10-2025
G0155002004,Minutes,09-10-2025
G0156001003,"Services of home health/hospice aide in home health or hospice settings, each",09-10-2025
G0156002004,15 minutes,09-10-2025
G0157001003,Services performed by a qualified physical therapist assistant in the home,09-10-2025
G0157002004,"Health or hospice setting, each 15 minutes",09-10-2025
G0158001003,Services performed by a qualified occupational therapist assistant in the home,09-10-2025
G0158002004,"Health or hospice setting, each 15 minutes",09-10-2025
G0159001003,"Services performed by a qualified physical therapist, in the home health",09-10-2025
G0159002004,"Setting, in the establishment or delivery of a safe and effective physical",09-10-2025
G0159003004,"Therapy maintenance program, each 15 minutes",09-10-2025
G0160001003,"Services performed by a qualified occupational therapist, in the home health",09-10-2025
G0160002004,"Setting, in the establishment or delivery of a safe and effective occupational",09-10-2025
G0160003004,"Therapy maintenance program, each 15 minutes",09-10-2025
G0161001003,"Services performed by a qualified speech-language pathologist, in the home",09-10-2025
G0161002004,"Health setting, in the establishment or delivery of a safe and effective",09-10-2025
G0161003004,"Speech-language pathology maintenance program, each 15 minutes",09-10-2025
G0162001003,Skilled services by a registered nurse (rn) for management and evaluation of,09-10-2025
G0162002004,The plan of care; each 15 minutes (the patient's underlying condition or,09-10-2025
G0162003004,Complication requires an rn to ensure that essential non-skilled care achieves,09-10-2025
G0162004004,Its purpose in the home health or hospice setting),09-10-2025
G0163001003,Skilled services of a licensed nurse (lpn or rn) for the observation and,09-10-2025
G0163002004,"Assessment of the patient's condition, each 15 minutes (the change in the",09-10-2025
G0163003004,Patient's condition requires skilled nursing personnel to identify and evaluate,09-10-2025
G0163004004,The patient's need for possible modification of treatment in the home health or,09-10-2025
G0163005004,Hospice setting),09-10-2025
G0164001003,"Skilled services of a licensed nurse (lpn or rn), in the training and/or",09-10-2025
G0164002004,"Education of a patient or family member, in the home health or hospice setting,",09-10-2025
G0164003004,Each 15 minutes,09-10-2025
G0166001003,"External counterpulsation, per treatment session",09-10-2025
G0168001003,Wound closure utilizing tissue adhesive(s) only,09-10-2025
G0173001003,"Linear accelerator based stereotactic radiosurgery, complete course of therapy",09-10-2025
G0173002004,In one session,09-10-2025
G0175001003,Scheduled interdisciplinary team conference (minimum of three exclusive of,09-10-2025
G0175002004,Patient care nursing staff) with patient present,09-10-2025
G0176001003,"Activity therapy, such as music, dance, art or play therapies not for",09-10-2025
G0176002004,"Recreation, related to the care and treatment of patient's disabling mental",09-10-2025
G0176003004,"Health problems, per session (45 minutes or more)",09-10-2025
G0177001003,Training and educational services related to the care and treatment of,09-10-2025
G0177002004,Patient's disabling mental health problems per session (45 minutes or more),09-10-2025
G0179001003,Physician or allowed practitioner re-certification for medicare-covered home,09-10-2025
G0179002004,"Health services under a home health plan of care (patient not present),",09-10-2025
G0179003004,Including contacts with home health agency and review of reports of patient,09-10-2025
G0179004004,Status required by physicians and allowed practitioners to affirm the initial,09-10-2025
G0179005004,Implementation of the plan of care,09-10-2025
G0180001003,Physician or allowed practitioner certification for medicare-covered home,09-10-2025
G0180002004,"Health services under a home health plan of care (patient not present),",09-10-2025
G0180003004,Including contacts with home health agency and review of reports of patient,09-10-2025
G0180004004,Status required by physicians and allowed practitioners to affirm the initial,09-10-2025
G0180005004,Implementation of the plan of care,09-10-2025
G0181001003,Physician or allowed practitioner supervision of a patient receiving,09-10-2025
G0181002004,Medicare-covered services provided by a participating home health agency,09-10-2025
G0181003004,(patient not present) requiring complex and multidisciplinary care modalities,09-10-2025
G0181004004,Involving regular physician or allowed practitioner development and/or revision,09-10-2025
G0181005004,Of care plans,09-10-2025
G0182001003,Physician supervision of a patient under a medicare-approved hospice (patient,09-10-2025
G0182002004,Not present) requiring complex and multidisciplinary care modalities involving,09-10-2025
G0182003004,"Regular physician development and/or revision of care plans, review of",09-10-2025
G0182004004,"Subsequent reports of patient status, review of laboratory and other studies,",09-10-2025
G0182005004,Communication (including telephone calls) with other health care professionals,09-10-2025
G0182006004,"Involved in the patient's care, integration of new information into the medical",09-10-2025
G0182007004,"Treatment plan and/or adjustment of medical therapy, within a calendar month,",09-10-2025
G0182008004,30 minutes or more,09-10-2025
G0183001003,"Quantitative software measurements of cardiac volume, cardiac chambers volumes",09-10-2025
G0183002004,And left ventricular wall mass derived from ct scan(s) data of the chest/heart,09-10-2025
G0183003004,(with or without contrast),09-10-2025
G0186001003,"Destruction of localized lesion of choroid (for example, choroidal",09-10-2025
G0186002004,"Neovascularization); photocoagulation, feeder vessel technique (one or more",09-10-2025
G0186003004,Sessions),09-10-2025
G0202001003,"Screening mammography, bilateral (2-view study of each breast), including",09-10-2025
G0202002004,Computer-aided detection (cad) when performed,09-10-2025
G0204001003,"Diagnostic mammography, including computer-aided detection (cad) when",09-10-2025
G0204002004,Performed; bilateral,09-10-2025
G0206001003,"Diagnostic mammography, including computer-aided detection (cad) when",09-10-2025
G0206002004,Performed; unilateral,09-10-2025
G0219001003,Pet imaging whole body; melanoma for non-covered indications,09-10-2025
G0235001003,"Pet imaging, any site, not otherwise specified",09-10-2025
G0237001003,Therapeutic procedures to increase strength or endurance of respiratory,09-10-2025
G0237002004,"Muscles, face to face, one on one, each 15 minutes (includes monitoring)",09-10-2025
G0238001003,"Therapeutic procedures to improve respiratory function, other than described by",09-10-2025
G0238002004,"G0237, one on one, face to face, per 15 minutes (includes monitoring)",09-10-2025
G0239001003,Therapeutic procedures to improve respiratory function or increase strength or,09-10-2025
G0239002004,"Endurance of respiratory muscles, two or more individuals (includes monitoring)",09-10-2025
G0245001003,Initial physician evaluation and management of a diabetic patient with diabetic,09-10-2025
G0245002004,Sensory neuropathy resulting in a loss of protective sensation (lops) which,09-10-2025
G0245003004,"Must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical",09-10-2025
G0245004004,Examination that consists of at least the following elements: (a) visual,09-10-2025
G0245005004,"Inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a",09-10-2025
G0245006004,"Protective sensation, (c) evaluation of foot structure and biomechanics, (d)",09-10-2025
G0245007004,"Evaluation of vascular status and skin integrity, and (e) evaluation and",09-10-2025
G0245008004,Recommendation of footwear and (4) patient education,09-10-2025
G0246001003,Follow-up physician evaluation and management of a diabetic patient with,09-10-2025
G0246002004,Diabetic sensory neuropathy resulting in a loss of protective sensation (lops),09-10-2025
G0246003004,"To include at least the following: (1) a patient history, (2) a physical",09-10-2025
G0246004004,"Examination that includes: (a) visual inspection of the forefoot, hindfoot and",09-10-2025
G0246005004,"Toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot",09-10-2025
G0246006004,"Structure and biomechanics, (d) evaluation of vascular status and skin",09-10-2025
G0246007004,"Integrity, and (e) evaluation and recommendation of footwear, and (3) patient",09-10-2025
G0246008004,Education,09-10-2025
G0247001003,Routine foot care by a physician of a diabetic patient with diabetic sensory,09-10-2025
G0247002004,"Neuropathy resulting in a loss of protective sensation (lops) to include, the",09-10-2025
G0247003004,Local care of superficial wounds (i.e. superficial to muscle and fascia) and at,09-10-2025
G0247004004,"Least the following if present: (1) local care of superficial wounds, (2)",09-10-2025
G0247005004,"Debridement of corns and calluses, and (3) trimming and debridement of nails",09-10-2025
G0248001003,"Demonstration, prior to initiation of home inr monitoring, for patient with",09-10-2025
G0248002004,"Either mechanical heart valve(s), chronic atrial fibrillation, or venous",09-10-2025
G0248003004,"Thromboembolism who meets medicare coverage criteria, under the direction of a",09-10-2025
G0248004004,Physician; includes: face-to-face demonstration of use and care of the inr,09-10-2025
G0248005004,"Monitor, obtaining at least one blood sample, provision of instructions for",09-10-2025
G0248006004,"Reporting home inr test results, and documentation of patient's ability to",09-10-2025
G0248007004,Perform testing and report results,09-10-2025
G0249001003,Provision of test materials and equipment for home inr monitoring of patient,09-10-2025
G0249002004,"With either mechanical heart valve(s), chronic atrial fibrillation, or venous",09-10-2025
G0249003004,Thromboembolism who meets medicare coverage criteria; includes: provision of,09-10-2025
G0249004004,Materials for use in the home and reporting of test results to physician;,09-10-2025
G0249005004,"Testing not occurring more frequently than once a week; testing materials,",09-10-2025
G0249006004,Billing units of service include 4 tests,09-10-2025
G0250001003,"Physician review, interpretation, and patient management of home inr testing",09-10-2025
G0250002004,"For patient with either mechanical heart valve(s), chronic atrial fibrillation,",09-10-2025
G0250003004,Or venous thromboembolism who meets medicare coverage criteria; testing not,09-10-2025
G0250004004,Occurring more frequently than once a week; billing units of service include 4,09-10-2025
G0250005004,Tests,09-10-2025
G0251001003,"Linear accelerator based stereotactic radiosurgery, delivery including",09-10-2025
G0251002004,"Collimator changes and custom plugging, fractionated treatment, all lesions,",09-10-2025
G0251003004,"Per session, maximum five sessions per course of treatment",09-10-2025
G0252001003,"Pet imaging, full and partial-ring pet scanners only, for initial diagnosis of",09-10-2025
G0252002004,"Breast cancer and/or surgical planning for breast cancer (e.g., initial staging",09-10-2025
G0252003004,Of axillary lymph nodes),09-10-2025
G0255001003,"Current perception threshold/sensory nerve conduction test, (snct) per limb,",09-10-2025
G0255002004,Any nerve,09-10-2025
G0257001003,Unscheduled or emergency dialysis treatment for an esrd patient in a hospital,09-10-2025
G0257002004,Outpatient department that is not certified as an esrd facility,09-10-2025
G0259001003,Injection procedure for sacroiliac joint; arthrography,09-10-2025
G0260001003,"Injection procedure for sacroiliac joint; provision of anesthetic, steroid",09-10-2025
G0260002004,"And/or other therapeutic agent, with or without arthrography",09-10-2025
G0268001003,Removal of impacted cerumen (one or both ears) by physician on same date of,09-10-2025
G0268002004,Service as audiologic function testing,09-10-2025
G0269001003,"Placement of occlusive device into either a venous or arterial access site,",09-10-2025
G0269002004,"Post surgical or interventional procedure (e.g., angioseal plug, vascular plug)",09-10-2025
G0270001003,Medical nutrition therapy; reassessment and subsequent intervention(s),09-10-2025
G0270002004,"Following second referral in same year for change in diagnosis, medical",09-10-2025
G0270003004,Condition or treatment regimen (including additional hours needed for renal,09-10-2025
G0270004004,"Disease), individual, face to face with the patient, each 15 minutes",09-10-2025
G0271001003,"Medical nutrition therapy, reassessment and subsequent intervention(s)",09-10-2025
G0271002004,"Following second referral in same year for change in diagnosis, medical",09-10-2025
G0271003004,"Condition, or treatment regimen (including additional hours needed for renal",09-10-2025
G0271004004,"Disease), group (2 or more individuals), each 30 minutes",09-10-2025
G0276001003,"Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar",09-10-2025
G0276002004,"Decompression (pild) or placebo-control, performed in an approved coverage with",09-10-2025
G0276003004,Evidence development (ced) clinical trial,09-10-2025
G0277001003,"Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval",09-10-2025
G0278001003,"Iliac and/or femoral artery angiography, non-selective, bilateral or",09-10-2025
G0278002004,"Ipsilateral to catheter insertion, performed at the same time as cardiac",09-10-2025
G0278003004,"Catheterization and/or coronary angiography, includes positioning or placement",09-10-2025
G0278004004,"Of the catheter in the distal aorta or ipsilateral femoral or iliac artery,",09-10-2025
G0278005004,"Injection of dye, production of permanent images, and radiologic supervision",09-10-2025
G0278006004,And interpretation (list separately in addition to primary procedure),09-10-2025
G0279001003,"Diagnostic digital breast tomosynthesis, unilateral or bilateral (list",09-10-2025
G0279002004,Separately in addition to 77065 or 77066),09-10-2025
G0281001003,"Electrical stimulation, (unattended), to one or more areas, for chronic stage",09-10-2025
G0281002004,"Iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous",09-10-2025
G0281003004,Stasis ulcers not demonstrating measurable signs of healing after 30 days of,09-10-2025
G0281004004,"Conventional care, as part of a therapy plan of care",09-10-2025
G0282001003,"Electrical stimulation, (unattended), to one or more areas, for wound care",09-10-2025
G0282002004,Other than described in g0281,09-10-2025
G0283001003,"Electrical stimulation (unattended), to one or more areas for indication(s)",09-10-2025
G0283002004,"Other than wound care, as part of a therapy plan of care",09-10-2025
G0288001003,"Reconstruction, computed tomographic angiography of aorta for surgical planning",09-10-2025
G0288002004,For vascular surgery,09-10-2025
G0289001003,"Arthroscopy, knee, surgical, for removal of loose body, foreign body,",09-10-2025
G0289002004,Debridement/shaving of articular cartilage (chondroplasty) at the time of other,09-10-2025
G0289003004,Surgical knee arthroscopy in a different compartment of the same knee,09-10-2025
G0293001003,"Noncovered surgical procedure(s) using conscious sedation, regional, general or",09-10-2025
G0293002004,"Spinal anesthesia in a medicare qualifying clinical trial, per day",09-10-2025
G0294001003,"Noncovered procedure(s) using either no anesthesia or local anesthesia only, in",09-10-2025
G0294002004,"A medicare qualifying clinical trial, per day",09-10-2025
G0295001003,"Electromagnetic therapy, to one or more areas, for wound care other than",09-10-2025
G0295002004,Described in g0329 or for other uses,09-10-2025
G0296001003,Counseling visit to discuss need for lung cancer screening using low dose ct,09-10-2025
G0296002004,Scan (ldct) (service is for eligibility determination and shared decision,09-10-2025
G0296003004,Making),09-10-2025
G0297001003,Low dose ct scan (ldct) for lung cancer screening,09-10-2025
G0299001003,Direct skilled nursing services of a registered nurse (rn) in the home health,09-10-2025
G0299002004,"Or hospice setting, each 15 minutes",09-10-2025
G0300001003,Direct skilled nursing services of a licensed practical nurse (lpn) in the home,09-10-2025
G0300002004,"Health or hospice setting, each 15 minutes",09-10-2025
G0302001003,"Pre-operative pulmonary surgery services for preparation for lvrs, complete",09-10-2025
G0302002004,"Course of services, to include a minimum of 16 days of services",09-10-2025
G0303001003,"Pre-operative pulmonary surgery services for preparation for lvrs, 10 to 15",09-10-2025
G0303002004,Days of services,09-10-2025
G0304001003,"Pre-operative pulmonary surgery services for preparation for lvrs, 1 to 9 days",09-10-2025
G0304002004,Of services,09-10-2025
G0305001003,"Post-discharge pulmonary surgery services after lvrs, minimum of 6 days of",09-10-2025
G0305002004,Services,09-10-2025
G0306001003,"Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and",09-10-2025
G0306002004,Automated wbc differential count,09-10-2025
G0307001003,"Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)",09-10-2025
G0308001003,Creation of subcutaneous pocket with insertion of 180 day implantable,09-10-2025
G0308002004,"Interstitial glucose sensor, including system activation and patient training",09-10-2025
G0309001003,Removal of implantable interstitial glucose sensor with creation of,09-10-2025
G0309002004,Subcutaneous pocket at different anatomic site and insertion of new 180 day,09-10-2025
G0309003004,"Implantable sensor, including system activation",09-10-2025
G0310001003,Immunization counseling by a physician or other qualified health care,09-10-2025
G0310002004,Professional when the vaccine(s) is not administered on the same date of,09-10-2025
G0310003004,"Service, 5 to 15 mins time (this code is used for medicaid billing purposes)",09-10-2025
G0311001003,Immunization counseling by a physician or other qualified health care,09-10-2025
G0311002004,Professional when the vaccine(s) is not administered on the same date of,09-10-2025
G0311003004,"Service, 16-30 mins time (this code is used for medicaid billing purposes)",09-10-2025
G0312001003,Immunization counseling by a physician or other qualified health care,09-10-2025
G0312002004,Professional when the vaccine(s) is not administered on the same date of,09-10-2025
G0312003004,"Service for ages under 21, 5 to 15 mins time (this code is used for medicaid",09-10-2025
G0312004004,Billing purposes),09-10-2025
G0313001003,Immunization counseling by a physician or other qualified health care,09-10-2025
G0313002004,Professional when the vaccine(s) is not administered on the same date of,09-10-2025
G0313003004,"Service for ages under 21, 16-30 mins time (this code is used for medicaid",09-10-2025
G0313004004,Billing purposes),09-10-2025
G0314001003,Immunization counseling by a physician or other qualified health care,09-10-2025
G0314002004,"Professional for covid-19, ages under 21, 16-30 mins time (this code is used",09-10-2025
G0314003004,"For the medicaid early and periodic screening, diagnostic, and treatment",09-10-2025
G0314004004,Benefit (epsdt),09-10-2025
G0315001003,Immunization counseling by a physician or other qualified health care,09-10-2025
G0315002004,"Professional for covid-19, ages under 21, 5-15 mins time (this code is used for",09-10-2025
G0315003004,"The medicaid early and periodic screening, diagnostic, and treatment benefit",09-10-2025
G0315004004,(epsdt),09-10-2025
G0316001003,Prolonged hospital inpatient or observation care evaluation and management,09-10-2025
G0316002004,Service(s) beyond the total time for the primary service (when the primary,09-10-2025
G0316003004,Service has been selected using time on the date of the primary service); each,09-10-2025
G0316004004,"Additional 15 minutes by the physician or qualified healthcare professional,",09-10-2025
G0316005004,With or without direct patient contact (list separately in addition to cpt,09-10-2025
G0316006004,"Codes 99223, 99233, and 99236 for hospital inpatient or observation care",09-10-2025
G0316007004,Evaluation and management services). (do not report g0316 on the same date of,09-10-2025
G0316008004,"Service as other prolonged services for evaluation and management 99358, 99359,",09-10-2025
G0316009004,"99418, 99415, 99416). (do not report g0316 for any time unit less than 15",09-10-2025
G0316010004,Minutes),09-10-2025
G0317001003,Prolonged nursing facility evaluation and management service(s) beyond,09-10-2025
G0317002004,The total time for the primary service (when the primary service has been,09-10-2025
G0317003004,Selected using time on the date of the primary service); each additional 15,09-10-2025
G0317004004,"Minutes by the physician or qualified healthcare professional, with or without",09-10-2025
G0317005004,"Direct patient contact (list separately in addition to cpt codes 99306, 99310",09-10-2025
G0317006004,For nursing facility evaluation and management services). (do not report g0317,09-10-2025
G0317007004,On the same date of service as other prolonged services for evaluation and,09-10-2025
G0317008004,"Management 99358, 99359, 99418). (do not report g0317 for any time unit less",09-10-2025
G0317009004,Than 15 minutes),09-10-2025
G0318001003,Prolonged home or residence evaluation and management service(s) beyond the,09-10-2025
G0318002004,Total time for the primary service (when the primary service has been selected,09-10-2025
G0318003004,Using time on the date of the primary service); each additional 15 minutes by,09-10-2025
G0318004004,"The physician or qualified healthcare professional, with or without direct",09-10-2025
G0318005004,"Patient contact (list separately in addition to cpt codes 99345, 99350 for home",09-10-2025
G0318006004,Or residence evaluation and management services). (do not report g0318 on the,09-10-2025
G0318007004,Same date of service as other prolonged services for evaluation and management,09-10-2025
G0318008004,"99358, 99359, 99417). (do not report g0318 for any time unit less than 15",09-10-2025
G0318009004,Minutes),09-10-2025
G0320001003,Home health services furnished using synchronous telemedicine rendered via a,09-10-2025
G0320002004,Real-time two-way audio and video telecommunications system,09-10-2025
G0321001003,Home health services furnished using synchronous telemedicine rendered via,09-10-2025
G0321002004,Telephone or other real-time interactive audio-only telecommunications system,09-10-2025
G0322001003,The collection of physiologic data digitally stored and/or transmitted by the,09-10-2025
G0322002004,"Patient to the home health agency (i.e., remote patient monitoring)",09-10-2025
G0323001003,"Care management services for behavioral health conditions, at least 20 minutes",09-10-2025
G0323002004,"Of clinical psychologist, clinical social worker, mental health counselor, or",09-10-2025
G0323003004,"Marriage and family therapist time, per calendar month. (these services include",09-10-2025
G0323004004,"The following required elements: initial assessment or follow-up monitoring,",09-10-2025
G0323005004,Including the use of applicable validated rating scales; behavioral health care,09-10-2025
G0323006004,"Planning in relation to behavioral/psychiatric health problems, including",09-10-2025
G0323007004,Revision for patients who are not progressing or whose status changes;,09-10-2025
G0323008004,"Facilitating and coordinating treatment such as psychotherapy, coordination",09-10-2025
G0323009004,With and/or referral to physicians and practitioners who are authorized by,09-10-2025
G0323010004,"Medicare to prescribe medications and furnish e/m services, counseling and/or",09-10-2025
G0323011004,Psychiatric consultation; and continuity of care with a designated member of,09-10-2025
G0323012004,The care team),09-10-2025
G0327001003,Colorectal cancer screening; blood-based biomarker,09-10-2025
G0328001003,"Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3",09-10-2025
G0328002004,Simultaneous,09-10-2025
G0329001003,"Electromagnetic therapy, to one or more areas for chronic stage iii and stage",09-10-2025
G0329002004,"Iv pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers",09-10-2025
G0329003004,Not demonstrating measurable signs of healing after 30 days of conventional,09-10-2025
G0329004004,Care as part of a therapy plan of care,09-10-2025
G0330001003,Facility services for dental rehabilitation procedure(s) performed on a patient,09-10-2025
G0330002004,"Who requires monitored anesthesia (e.g., general, intravenous sedation",09-10-2025
G0330003004,(monitored anesthesia care) and use of an operating room,09-10-2025
G0333001003,Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a,09-10-2025
G0333002004,Beneficiary,09-10-2025
G0337001003,"Hospice evaluation and counseling services, pre-election",09-10-2025
G0339001003,"Image-guided robotic linear accelerator-based stereotactic radiosurgery,",09-10-2025
G0339002004,Complete course of therapy in one session or first session of fractionated,09-10-2025
G0339003004,Treatment,09-10-2025
G0340001003,"Image-guided robotic linear accelerator-based stereotactic radiosurgery,",09-10-2025
G0340002004,"Delivery including collimator changes and custom plugging, fractionated",09-10-2025
G0340003004,"Treatment, all lesions, per session, second through fifth sessions, maximum",09-10-2025
G0340004004,Five sessions per course of treatment,09-10-2025
G0341001003,"Percutaneous islet cell transplant, includes portal vein catheterization and",09-10-2025
G0341002004,Infusion,09-10-2025
G0342001003,"Laparoscopy for islet cell transplant, includes portal vein catheterization and",09-10-2025
G0342002004,Infusion,09-10-2025
G0343001003,"Laparotomy for islet cell transplant, includes portal vein catheterization and",09-10-2025
G0343002004,Infusion,09-10-2025
G0364001003,Bone marrow aspiration performed with bone marrow biopsy through the same,09-10-2025
G0364002004,Incision on the same date of service,09-10-2025
G0365001003,Vessel mapping of vessels for hemodialysis access (services for preoperative,09-10-2025
G0365002004,Vessel mapping prior to creation of hemodialysis access using an autogenous,09-10-2025
G0365003004,"Hemodialysis conduit, including arterial inflow and venous outflow)",09-10-2025
G0372001003,Physician service required to establish and document the need for a power,09-10-2025
G0372002004,Mobility device,09-10-2025
G0378001003,"Hospital observation service, per hour",09-10-2025
G0379001003,Direct admission of patient for hospital observation care,09-10-2025
G0380001003,Level 1 hospital emergency department visit provided in a type b emergency,09-10-2025
G0380002004,Department; (the ed must meet at least one of the following requirements: (1),09-10-2025
G0380003004,It is licensed by the state in which it is located under applicable state law,09-10-2025
G0380004004,As an emergency room or emergency department; (2) it is held out to the public,09-10-2025
G0380005004,"(by name, posted signs, advertising, or other means) as a place that provides",09-10-2025
G0380006004,Care for emergency medical conditions on an urgent basis without requiring a,09-10-2025
G0380007004,Previously scheduled appointment; or (3) during the calendar year immediately,09-10-2025
G0380008004,Preceding the calendar year in which a determination under 42 cfr 489.24 is,09-10-2025
G0380009004,"Being made, based on a representative sample of patient visits that occurred",09-10-2025
G0380010004,"During that calendar year, it provides at least one-third of all of its",09-10-2025
G0380011004,Outpatient visits for the treatment of emergency medical conditions on an,09-10-2025
G0380012004,Urgent basis without requiring a previously scheduled appointment),09-10-2025
G0381001003,Level 2 hospital emergency department visit provided in a type b emergency,09-10-2025
G0381002004,Department; (the ed must meet at least one of the following requirements: (1),09-10-2025
G0381003004,It is licensed by the state in which it is located under applicable state law,09-10-2025
G0381004004,As an emergency room or emergency department; (2) it is held out to the public,09-10-2025
G0381005004,"(by name, posted signs, advertising, or other means) as a place that provides",09-10-2025
G0381006004,Care for emergency medical conditions on an urgent basis without requiring a,09-10-2025
G0381007004,Previously scheduled appointment; or (3) during the calendar year immediately,09-10-2025
G0381008004,Preceding the calendar year in which a determination under 42 cfr 489.24 is,09-10-2025
G0381009004,"Being made, based on a representative sample of patient visits that occurred",09-10-2025
G0381010004,"During that calendar year, it provides at least one-third of all of its",09-10-2025
G0381011004,Outpatient visits for the treatment of emergency medical conditions on an,09-10-2025
G0381012004,Urgent basis without requiring a previously scheduled appointment),09-10-2025
G0382001003,Level 3 hospital emergency department visit provided in a type b emergency,09-10-2025
G0382002004,Department; (the ed must meet at least one of the following requirements: (1),09-10-2025
G0382003004,It is licensed by the state in which it is located under applicable state law,09-10-2025
G0382004004,As an emergency room or emergency department; (2) it is held out to the public,09-10-2025
G0382005004,"(by name, posted signs, advertising, or other means) as a place that provides",09-10-2025
G0382006004,Care for emergency medical conditions on an urgent basis without requiring a,09-10-2025
G0382007004,Previously scheduled appointment; or (3) during the calendar year immediately,09-10-2025
G0382008004,Preceding the calendar year in which a determination under 42 cfr 489.24 is,09-10-2025
G0382009004,"Being made, based on a representative sample of patient visits that occurred",09-10-2025
G0382010004,"During that calendar year, it provides at least one-third of all of its",09-10-2025
G0382011004,Outpatient visits for the treatment of emergency medical conditions on an,09-10-2025
G0382012004,Urgent basis without requiring a previously scheduled appointment),09-10-2025
G0383001003,Level 4 hospital emergency department visit provided in a type b emergency,09-10-2025
G0383002004,Department; (the ed must meet at least one of the following requirements: (1),09-10-2025
G0383003004,It is licensed by the state in which it is located under applicable state law,09-10-2025
G0383004004,As an emergency room or emergency department; (2) it is held out to the public,09-10-2025
G0383005004,"(by name, posted signs, advertising, or other means) as a place that provides",09-10-2025
G0383006004,Care for emergency medical conditions on an urgent basis without requiring a,09-10-2025
G0383007004,Previously scheduled appointment; or (3) during the calendar year immediately,09-10-2025
G0383008004,Preceding the calendar year in which a determination under 42 cfr 489.24 is,09-10-2025
G0383009004,"Being made, based on a representative sample of patient visits that occurred",09-10-2025
G0383010004,"During that calendar year, it provides at least one-third of all of its",09-10-2025
G0383011004,Outpatient visits for the treatment of emergency medical conditions on an,09-10-2025
G0383012004,Urgent basis without requiring a previously scheduled appointment),09-10-2025
G0384001003,Level 5 hospital emergency department visit provided in a type b emergency,09-10-2025
G0384002004,Department; (the ed must meet at least one of the following requirements: (1),09-10-2025
G0384003004,It is licensed by the state in which it is located under applicable state law,09-10-2025
G0384004004,As an emergency room or emergency department; (2) it is held out to the public,09-10-2025
G0384005004,"(by name, posted signs, advertising, or other means) as a place that provides",09-10-2025
G0384006004,Care for emergency medical conditions on an urgent basis without requiring a,09-10-2025
G0384007004,Previously scheduled appointment; or (3) during the calendar year immediately,09-10-2025
G0384008004,Preceding the calendar year in which a determination under 42 cfr 489.24 is,09-10-2025
G0384009004,"Being made, based on a representative sample of patient visits that occurred",09-10-2025
G0384010004,"During that calendar year, it provides at least one-third of all of its",09-10-2025
G0384011004,Outpatient visits for the treatment of emergency medical conditions on an,09-10-2025
G0384012004,Urgent basis without requiring a previously scheduled appointment),09-10-2025
G0389001003,Ultrasound b-scan and/or real time with image documentation; for abdominal,09-10-2025
G0389002004,Aortic aneurysm (aaa) screening,09-10-2025
G0390001003,Trauma response team associated with hospital critical care service,09-10-2025
G0396001003,Alcohol and/or substance (other than tobacco) misuse structured assessment,09-10-2025
G0396002004,"(e.g., audit, dast), and brief intervention 15 to 30 minutes",09-10-2025
G0397001003,Alcohol and/or substance (other than tobacco) misuse structured assessment,09-10-2025
G0397002004,"(e.g., audit, dast), and intervention, greater than 30 minutes",09-10-2025
G0398001003,"Home sleep study test (hst) with type ii portable monitor, unattended; minimum",09-10-2025
G0398002004,"Of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and",09-10-2025
G0398003004,Oxygen saturation,09-10-2025
G0399001003,"Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4",09-10-2025
G0399002004,"Channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen",09-10-2025
G0399003004,Saturation,09-10-2025
G0400001003,"Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3",09-10-2025
G0400002004,Channels,09-10-2025
G0402001003,"Initial preventive physical examination; face-to-face visit, services limited",09-10-2025
G0402002004,To new beneficiary during the first 12 months of medicare enrollment,09-10-2025
G0403001003,"Electrocardiogram, routine ecg with 12 leads; performed as a screening for the",09-10-2025
G0403002004,Initial preventive physical examination with interpretation and report,09-10-2025
G0404001003,"Electrocardiogram, routine ecg with 12 leads; tracing only, without",09-10-2025
G0404002004,"Interpretation and report, performed as a screening for the initial preventive",09-10-2025
G0404003004,Physical examination,09-10-2025
G0405001003,"Electrocardiogram, routine ecg with 12 leads; interpretation and report only,",09-10-2025
G0405002004,Performed as a screening for the initial preventive physical examination,09-10-2025
G0406001003,"Follow-up inpatient consultation, limited, physicians typically spend 15",09-10-2025
G0406002004,Minutes communicating with the patient via telehealth,09-10-2025
G0407001003,"Follow-up inpatient consultation, intermediate, physicians typically spend 25",09-10-2025
G0407002004,Minutes communicating with the patient via telehealth,09-10-2025
G0408001003,"Follow-up inpatient consultation, complex, physicians typically spend 35",09-10-2025
G0408002004,Minutes communicating with the patient via telehealth,09-10-2025
G0409001003,"Social work and psychological services, directly relating to and/or furthering",09-10-2025
G0409002004,"The patient's rehabilitation goals, each 15 minutes, face-to-face; individual",09-10-2025
G0409003004,(services provided by a corf-qualified social worker or psychologist in a corf),09-10-2025
G0410001003,"Group psychotherapy other than of a multiple-family group, in a partial",09-10-2025
G0410002004,"Hospitalization or intensive outpatient setting, approximately 45 to 50 minutes",09-10-2025
G0411001003,"Interactive group psychotherapy, in a partial hospitalization or intensive",09-10-2025
G0411002004,"Outpatient setting, approximately 45 to 50 minutes",09-10-2025
G0412001003,"Open treatment of iliac spine(s), tuberosity avulsion, or iliac wing",09-10-2025
G0412002004,"Fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do",09-10-2025
G0412003004,"Not disrupt the pelvic ring includes internal fixation, when performed",09-10-2025
G0413001003,Percutaneous skeletal fixation of posterior pelvic bone fracture and/or,09-10-2025
G0413002004,"Dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or",09-10-2025
G0413003004,"Bilateral, (includes ilium, sacroiliac joint and/or sacrum)",09-10-2025
G0414001003,Open treatment of anterior pelvic bone fracture and/or dislocation for fracture,09-10-2025
G0414002004,"Patterns which disrupt the pelvic ring, unilateral or bilateral, includes",09-10-2025
G0414003004,Internal fixation when performed (includes pubic symphysis and/or,09-10-2025
G0414004004,Superior/inferior rami),09-10-2025
G0415001003,"Open treatment of posterior pelvic bone fracture and/or dislocation, for",09-10-2025
G0415002004,"Fracture patterns which disrupt the pelvic ring, unilateral or bilateral,",09-10-2025
G0415003004,"Includes internal fixation, when performed (includes ilium, sacroiliac joint",09-10-2025
G0415004004,And/or sacrum),09-10-2025
G0416001003,"Surgical pathology, gross and microscopic examinations, for prostate needle",09-10-2025
G0416002004,"Biopsy, any method",09-10-2025
G0417001003,"Surgical pathology, gross and microscopic examination, for prostate needle",09-10-2025
G0417002004,"Biopsy, any method, 21-40 specimens",09-10-2025
G0418001003,"Surgical pathology, gross and microscopic examination, for prostate needle",09-10-2025
G0418002004,"Biopsy, any method, 41-60 specimens",09-10-2025
G0419001003,"Surgical pathology, gross and microscopic examination, for prostate needle",09-10-2025
G0419002004,"Biopsy, any method, >60 specimens",09-10-2025
G0420001003,Face-to-face educational services related to the care of chronic kidney,09-10-2025
G0420002004,"Disease; individual, per session, per one hour",09-10-2025
G0421001003,Face-to-face educational services related to the care of chronic kidney,09-10-2025
G0421002004,"Disease; group, per session, per one hour",09-10-2025
G0422001003,Intensive cardiac rehabilitation; with or without continuous ecg monitoring,09-10-2025
G0422002004,"With exercise, per session",09-10-2025
G0423001003,Intensive cardiac rehabilitation; with or without continuous ecg monitoring;,09-10-2025
G0423002004,"Without exercise, per session",09-10-2025
G0424001003,"Pulmonary rehabilitation, including exercise (includes monitoring), one hour,",09-10-2025
G0424002004,"Per session, up to two sessions per day",09-10-2025
G0425001003,"Telehealth consultation, emergency department or initial inpatient, typically",09-10-2025
G0425002004,30 minutes communicating with the patient via telehealth,09-10-2025
G0426001003,"Telehealth consultation, emergency department or initial inpatient, typically",09-10-2025
G0426002004,50 minutes communicating with the patient via telehealth,09-10-2025
G0427001003,"Telehealth consultation, emergency department or initial inpatient, typically",09-10-2025
G0427002004,70 minutes or more communicating with the patient via telehealth,09-10-2025
G0428001003,"Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi,",09-10-2025
G0428002004,"Collagen scaffold, menaflex)",09-10-2025
G0429001003,Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome,09-10-2025
G0429002004,"(lds) (e.g., as a result of highly active antiretroviral therapy)",09-10-2025
G0431001003,"Drug screen, qualitative; multiple drug classes by high complexity test method",09-10-2025
G0431002004,"(e.g., immunoassay, enzyme assay), per patient encounter",09-10-2025
G0432001003,"Infectious agent antibody detection by enzyme immunoassay (eia) technique,",09-10-2025
G0432002004,"Hiv-1 and/or hiv-2, screening",09-10-2025
G0433001003,Infectious agent antibody detection by enzyme-linked immunosorbent assay,09-10-2025
G0433002004,"(elisa) technique, hiv-1 and/or hiv-2, screening",09-10-2025
G0434001003,"Drug screen, other than chromatographic; any number of drug classes, by clia",09-10-2025
G0434002004,"Waived test or moderate complexity test, per patient encounter",09-10-2025
G0435001003,"Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2,",09-10-2025
G0435002004,Screening,09-10-2025
G0436001003,Smoking and tobacco cessation counseling visit for the asymptomatic patient;,09-10-2025
G0436002004,"Intermediate, greater than 3 minutes, up to 10 minutes",09-10-2025
G0437001003,Smoking and tobacco cessation counseling visit for the asymptomatic patient;,09-10-2025
G0437002004,"Intensive, greater than 10 minutes",09-10-2025
G0438001003,Annual wellness visit; includes a personalized prevention plan of service,09-10-2025
G0438002004,"(pps), initial visit",09-10-2025
G0439001003,"Annual wellness visit, includes a personalized prevention plan of service",09-10-2025
G0439002004,"(pps), subsequent visit",09-10-2025
G0442001003,"Annual alcohol misuse screening, 5 to 15 minutes",09-10-2025
G0443001003,"Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes",09-10-2025
G0444001003,"Annual depression screening, 5 to 15 minutes",09-10-2025
G0445001003,High intensity behavioral counseling to prevent sexually transmitted infection;,09-10-2025
G0445002004,"Face-to-face, individual, includes: education, skills training and guidance on",09-10-2025
G0445003004,"How to change sexual behavior; performed semi-annually, 30 minutes",09-10-2025
G0446001003,"Annual, face-to-face intensive behavioral therapy for cardiovascular disease,",09-10-2025
G0446002004,"Individual, 15 minutes",09-10-2025
G0447001003,"Face-to-face behavioral counseling for obesity, 15 minutes",09-10-2025
G0448001003,Insertion or replacement of a permanent pacing cardioverter-defibrillator,09-10-2025
G0448002004,"System with transvenous lead(s), single or dual chamber with insertion of",09-10-2025
G0448003004,"Pacing electrode, cardiac venous system, for left ventricular pacing",09-10-2025
G0451001003,"Development testing, with interpretation and report, per standardized",09-10-2025
G0451002004,Instrument form,09-10-2025
G0452001003,Molecular pathology procedure; physician interpretation and report,09-10-2025
G0453001003,"Continuous intraoperative neurophysiology monitoring, from outside the",09-10-2025
G0453002004,"Operating room (remote or nearby), per patient, (attention directed exclusively",09-10-2025
G0453003004,To one patient) each 15 minutes (list in addition to primary procedure),09-10-2025
G0454001003,Physician documentation of face-to-face visit for durable medical equipment,09-10-2025
G0454002004,"Determination performed by nurse practitioner, physician assistant or clinical",09-10-2025
G0454003004,Nurse specialist,09-10-2025
G0455001003,"Preparation with instillation of fecal microbiota by any method, including",09-10-2025
G0455002004,Assessment of donor specimen,09-10-2025
G0456001003,"Negative pressure wound therapy, (e.g. vacuum assisted drainage collection)",09-10-2025
G0456002004,"Using a mechanically-powered device, not durable medical equipment, including",09-10-2025
G0456003004,"Provision of cartridge and dressing(s), topical application(s), wound",09-10-2025
G0456004004,"Assessment, and instructions for ongoing care, per session; total wounds(s)",09-10-2025
G0456005004,Surface area less than or equal to 50 square centimeters,09-10-2025
G0457001003,"Negative pressure wound therapy, (e.g. vacuum assisted drainage collection)",09-10-2025
G0457002004,"Using a mechanically-powered device, not durable medical equipment, including",09-10-2025
G0457003004,"Provision of cartridge and dressing(s), topical application(s), wound",09-10-2025
G0457004004,"Assessment, and instructions for ongoing care, per session; total wounds(s)",09-10-2025
G0457005004,Surface area greater than 50 square centimeters,09-10-2025
G0458001003,"Low dose rate (ldr) prostate brachytherapy services, composite rate",09-10-2025
G0459001003,"Inpatient telehealth pharmacologic management, including prescription, use, and",09-10-2025
G0459002004,Review of medication with no more than minimal medical psychotherapy,09-10-2025
G0460001003,Autologous platelet rich plasma or other blood-derived product for non-diabetic,09-10-2025
G0460002004,"Chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or",09-10-2025
G0460003004,"Mixing, and all other preparatory procedures, administration and dressings, per",09-10-2025
G0460004004,Treatment,09-10-2025
G0461001003,"Immunohistochemistry or immunocytochemistry, per specimen; first single or",09-10-2025
G0461002004,Multiplex antibody stain,09-10-2025
G0462001003,"Immunohistochemistry or immunocytochemistry, per specimen; each additional",09-10-2025
G0462002004,Single or multiplex antibody stain (list separately in addition to code for,09-10-2025
G0462003004,Primary procedure),09-10-2025
G0463001003,Hospital outpatient clinic visit for assessment and management of a patient,09-10-2025
G0464001003,"Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g.,",09-10-2025
G0464002004,"Kras, ndrg4 and bmp3)",09-10-2025
G0465001003,Autologous platelet rich plasma (prp) or other blood-derived product for,09-10-2025
G0465002004,"Diabetic chronic wounds/ulcers, using an fda-cleared device for this",09-10-2025
G0465003004,"Indication, (includes as applicable administration, dressings, phlebotomy,",09-10-2025
G0465004004,"Centrifugation or mixing, and all other preparatory procedures, per treatment)",09-10-2025
G0466001003,"Federally qualified health center (fqhc) visit, new patient; a",09-10-2025
G0466002004,"Medically-necessary, face-to-face encounter (one-on-one) between a new patient",09-10-2025
G0466003004,And a fqhc practitioner during which time one or more fqhc services are,09-10-2025
G0466004004,Rendered and includes a typical bundle of medicare-covered services that would,09-10-2025
G0466005004,Be furnished per diem to a patient receiving a fqhc visit,09-10-2025
G0467001003,"Federally qualified health center (fqhc) visit, established patient; a",09-10-2025
G0467002004,"Medically-necessary, face-to-face encounter (one-on-one) between an established",09-10-2025
G0467003004,Patient and a fqhc practitioner during which time one or more fqhc services are,09-10-2025
G0467004004,Rendered and includes a typical bundle of medicare-covered services that would,09-10-2025
G0467005004,Be furnished per diem to a patient receiving a fqhc visit,09-10-2025
G0468001003,"Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that",09-10-2025
G0468002004,Includes an initial preventive physical examination (ippe) or annual wellness,09-10-2025
G0468003004,Visit (awv) and includes a typical bundle of medicare-covered services that,09-10-2025
G0468004004,Would be furnished per diem to a patient receiving an ippe or awv,09-10-2025
G0469001003,"Federally qualified health center (fqhc) visit, mental health, new patient; a",09-10-2025
G0469002004,"Medically-necessary, face-to-face mental health encounter (one-on-one) between",09-10-2025
G0469003004,A new patient and a fqhc practitioner during which time one or more fqhc,09-10-2025
G0469004004,Services are rendered and includes a typical bundle of medicare-covered,09-10-2025
G0469005004,Services that would be furnished per diem to a patient receiving a mental,09-10-2025
G0469006004,Health visit,09-10-2025
G0470001003,"Federally qualified health center (fqhc) visit, mental health, established",09-10-2025
G0470002004,"Patient; a medically-necessary, face-to-face mental health encounter",09-10-2025
G0470003004,(one-on-one) between an established patient and a fqhc practitioner during,09-10-2025
G0470004004,Which time one or more fqhc services are rendered and includes a typical bundle,09-10-2025
G0470005004,Of medicare-covered services that would be furnished per diem to a patient,09-10-2025
G0470006004,Receiving a mental health visit,09-10-2025
G0471001003,Collection of venous blood by venipuncture or urine sample by catheterization,09-10-2025
G0471002004,From an individual in a skilled nursing facility (snf) or by a laboratory on,09-10-2025
G0471003004,Behalf of a home health agency (hha),09-10-2025
G0472001003,"Hepatitis c antibody screening, for individual at high risk and other covered",09-10-2025
G0472002004,Indication(s),09-10-2025
G0473001003,"Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes",09-10-2025
G0475001003,"Hiv antigen/antibody, combination assay, screening",09-10-2025
G0476001003,Infectious agent detection by nucleic acid (dna or rna); human papillomavirus,09-10-2025
G0476002004,"(hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59,",09-10-2025
G0476003004,"68) for cervical cancer screening, must be performed in addition to pap test",09-10-2025
G0477001003,"Drug test(s), presumptive, any number of drug classes; any number of devices or",09-10-2025
G0477002004,"Procedures, (e.g., immunoassay) capable of being read by direct optical",09-10-2025
G0477003004,"Observation only (e.g., dipsticks, cups, cards, cartridges), includes sample",09-10-2025
G0477004004,"Validation when performed, per date of service",09-10-2025
G0478001003,"Drug test(s), presumptive, any number of drug classes; any number of devices or",09-10-2025
G0478002004,"Procedures, (e.g., immunoassay) read by instrument-assisted direct optical",09-10-2025
G0478003004,"Observation (e.g., dipsticks, cups, cards, cartridges), includes sample",09-10-2025
G0478004004,"Validation when performed, per date of service",09-10-2025
G0479001003,"Drug test(s), presumptive, any number of drug classes; any number of devices or",09-10-2025
G0479002004,"Procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme",09-10-2025
G0479003004,"Assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes",09-10-2025
G0479004004,"Sample validation when performed, per date of service",09-10-2025
G0480001003,"Drug test(s), definitive, utilizing (1) drug identification methods able to",09-10-2025
G0480002004,Identify individual drugs and distinguish between structural isomers (but not,09-10-2025
G0480003004,"Necessarily stereoisomers), including, but not limited to gc/ms (any type,",09-10-2025
G0480004004,"Single or tandem) and lc/ms (any type, single or tandem and excluding",09-10-2025
G0480005004,"Immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g.,",09-10-2025
G0480006004,"Alcohol dehydrogenase)), (2) stable isotope or other universally recognized",09-10-2025
G0480007004,"Internal standards in all samples (e.g., to control for matrix effects,",09-10-2025
G0480008004,"Interferences and variations in signal strength), and (3) method or",09-10-2025
G0480009004,"Drug-specific calibration and matrix-matched quality control material (e.g., to",09-10-2025
G0480010004,Control for instrument variations and mass spectral drift); qualitative or,09-10-2025
G0480011004,"Quantitative, all sources, includes specimen validity testing, per day; 1-7",09-10-2025
G0480012004,"Drug class(es), including metabolite(s) if performed",09-10-2025
G0481001003,"Drug test(s), definitive, utilizing (1) drug identification methods able to",09-10-2025
G0481002004,Identify individual drugs and distinguish between structural isomers (but not,09-10-2025
G0481003004,"Necessarily stereoisomers), including, but not limited to gc/ms (any type,",09-10-2025
G0481004004,"Single or tandem) and lc/ms (any type, single or tandem and excluding",09-10-2025
G0481005004,"Immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g.,",09-10-2025
G0481006004,"Alcohol dehydrogenase)), (2) stable isotope or other universally recognized",09-10-2025
G0481007004,"Internal standards in all samples (e.g., to control for matrix effects,",09-10-2025
G0481008004,"Interferences and variations in signal strength), and (3) method or",09-10-2025
G0481009004,"Drug-specific calibration and matrix-matched quality control material (e.g., to",09-10-2025
G0481010004,Control for instrument variations and mass spectral drift); qualitative or,09-10-2025
G0481011004,"Quantitative, all sources, includes specimen validity testing, per day; 8-14",09-10-2025
G0481012004,"Drug class(es), including metabolite(s) if performed",09-10-2025
G0482001003,"Drug test(s), definitive, utilizing (1) drug identification methods able to",09-10-2025
G0482002004,Identify individual drugs and distinguish between structural isomers (but not,09-10-2025
G0482003004,"Necessarily stereoisomers), including, but not limited to gc/ms (any type,",09-10-2025
G0482004004,"Single or tandem) and lc/ms (any type, single or tandem and excluding",09-10-2025
G0482005004,"Immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g.,",09-10-2025
G0482006004,"Alcohol dehydrogenase)), (2) stable isotope or other universally recognized",09-10-2025
G0482007004,"Internal standards in all samples (e.g., to control for matrix effects,",09-10-2025
G0482008004,"Interferences and variations in signal strength), and (3) method or",09-10-2025
G0482009004,"Drug-specific calibration and matrix-matched quality control material (e.g., to",09-10-2025
G0482010004,Control for instrument variations and mass spectral drift); qualitative or,09-10-2025
G0482011004,"Quantitative, all sources, includes specimen validity testing, per day; 15-21",09-10-2025
G0482012004,"Drug class(es), including metabolite(s) if performed",09-10-2025
G0483001003,"Drug test(s), definitive, utilizing (1) drug identification methods able to",09-10-2025
G0483002004,Identify individual drugs and distinguish between structural isomers (but not,09-10-2025
G0483003004,"Necessarily stereoisomers), including, but not limited to gc/ms (any type,",09-10-2025
G0483004004,"Single or tandem) and lc/ms (any type, single or tandem and excluding",09-10-2025
G0483005004,"Immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g.,",09-10-2025
G0483006004,"Alcohol dehydrogenase)), (2) stable isotope or other universally recognized",09-10-2025
G0483007004,"Internal standards in all samples (e.g., to control for matrix effects,",09-10-2025
G0483008004,"Interferences and variations in signal strength), and (3) method or",09-10-2025
G0483009004,"Drug-specific calibration and matrix-matched quality control material (e.g., to",09-10-2025
G0483010004,Control for instrument variations and mass spectral drift); qualitative or,09-10-2025
G0483011004,"Quantitative, all sources, includes specimen validity testing, per day; 22 or",09-10-2025
G0483012004,"More drug class(es), including metabolite(s) if performed",09-10-2025
G0490001003,Face-to-face home health nursing visit by a rural health clinic (rhc) or,09-10-2025
G0490002004,Federally qualified health center (fqhc) in an area with a shortage of home,09-10-2025
G0490003004,Health agencies; (services limited to rn or lpn only),09-10-2025
G0491001003,Dialysis procedure at a medicare certified esrd facility for acute kidney,09-10-2025
G0491002004,Injury without esrd,09-10-2025
G0492001003,Dialysis procedure with single evaluation by a physician or other qualified,09-10-2025
G0492002004,Health care professional for acute kidney injury without esrd,09-10-2025
G0493001003,Skilled services of a registered nurse (rn) for the observation and assessment,09-10-2025
G0493002004,"Of the patient's condition, each 15 minutes (the change in the patient's",09-10-2025
G0493003004,Condition requires skilled nursing personnel to identify and evaluate the,09-10-2025
G0493004004,Patient's need for possible modification of treatment in the home health or,09-10-2025
G0493005004,Hospice setting),09-10-2025
G0494001003,Skilled services of a licensed practical nurse (lpn) for the observation and,09-10-2025
G0494002004,"Assessment of the patient's condition, each 15 minutes (the change in the",09-10-2025
G0494003004,Patient's condition requires skilled nursing personnel to identify and evaluate,09-10-2025
G0494004004,The patient's need for possible modification of treatment in the home health or,09-10-2025
G0494005004,Hospice setting),09-10-2025
G0495001003,"Skilled services of a registered nurse (rn), in the training and/or education",09-10-2025
G0495002004,"Of a patient or family member, in the home health or hospice setting, each 15",09-10-2025
G0495003004,Minutes,09-10-2025
G0496001003,"Skilled services of a licensed practical nurse (lpn), in the training and/or",09-10-2025
G0496002004,"Education of a patient or family member, in the home health or hospice setting,",09-10-2025
G0496003004,Each 15 minutes,09-10-2025
G0498001003,"Chemotherapy administration, intravenous infusion technique; initiation of",09-10-2025
G0498002004,"Infusion in the office/clinic setting using office/clinic pump/supplies, with",09-10-2025
G0498003004,"Continuation of the infusion in the community setting (e.g., home, domiciliary,",09-10-2025
G0498004004,Rest home or assisted living) using a portable pump provided by the,09-10-2025
G0498005004,"Office/clinic, includes follow up office/clinic visit at the conclusion of the",09-10-2025
G0498006004,Infusion,09-10-2025
G0499001003,"Hepatitis b screening in non-pregnant, high risk individual includes hepatitis",09-10-2025
G0499002004,"B surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to",09-10-2025
G0499003004,"Hepatitis b core antigen (anti-hbc), and is followed by a neutralizing",09-10-2025
G0499004004,"Confirmatory test, when performed, only for an initially reactive hbsag result",09-10-2025
G0500001003,Moderate sedation services provided by the same physician or other qualified,09-10-2025
G0500002004,Health care professional performing a gastrointestinal endoscopic service that,09-10-2025
G0500003004,"Sedation supports, requiring the presence of an independent trained observer to",09-10-2025
G0500004004,Assist in the monitoring of the patient's level of consciousness and,09-10-2025
G0500005004,Physiological status; initial 15 minutes of intra-service time; patient age 5,09-10-2025
G0500006004,"Years or older (additional time may be reported with 99153, as appropriate)",09-10-2025
G0501001003,Resource-intensive services for patients for whom the use of specialized,09-10-2025
G0501002004,"Mobility-assistive technology (such as adjustable height chairs or tables,",09-10-2025
G0501003004,"Patient lift, and adjustable padded leg supports) is medically necessary and",09-10-2025
G0501004004,"Used during the provision of an office/outpatient, evaluation and management",09-10-2025
G0501005004,Visit (list separately in addition to primary service),09-10-2025
G0502001003,"Initial psychiatric collaborative care management, first 70 minutes in the",09-10-2025
G0502002004,"First calendar month of behavioral health care manager activities, in",09-10-2025
G0502003004,"Consultation with a psychiatric consultant, and directed by the treating",09-10-2025
G0502004004,"Physician or other qualified health care professional, with the following",09-10-2025
G0502005004,Required elements: outreach to and engagement in treatment of a patient,09-10-2025
G0502006004,Directed by the treating physician or other qualified health care professional;,09-10-2025
G0502007004,"Initial assessment of the patient, including administration of validated rating",09-10-2025
G0502008004,"Scales, with the development of an individualized treatment plan; review by",09-10-2025
G0502009004,The psychiatric consultant with modifications of the plan if recommended;,09-10-2025
G0502010004,Entering patient in a registry and tracking patient follow-up and progress,09-10-2025
G0502011004,"Using the registry, with appropriate documentation, and participation in weekly",09-10-2025
G0502012004,Caseload consultation with the psychiatric consultant; and provision of brief,09-10-2025
G0502013004,"Interventions using evidence-based techniques such as behavioral activation,",09-10-2025
G0502014004,"Motivational interviewing, and other focused treatment strategies",09-10-2025
G0503001003,"Subsequent psychiatric collaborative care management, first 60 minutes in a",09-10-2025
G0503002004,"Subsequent month of behavioral health care manager activities, in consultation",09-10-2025
G0503003004,"With a psychiatric consultant, and directed by the treating physician or other",09-10-2025
G0503004004,"Qualified health care professional, with the following required elements:",09-10-2025
G0503005004,"Tracking patient follow-up and progress using the registry, with appropriate",09-10-2025
G0503006004,Documentation; participation in weekly caseload consultation with the,09-10-2025
G0503007004,Psychiatric consultant; ongoing collaboration with and coordination of the,09-10-2025
G0503008004,Patient's mental health care with the treating physician or other qualified,09-10-2025
G0503009004,Health care professional and any other treating mental health providers;,09-10-2025
G0503010004,"Additional review of progress and recommendations for changes in treatment, as",09-10-2025
G0503011004,"Indicated, including medications, based on recommendations provided by the",09-10-2025
G0503012004,Psychiatric consultant; provision of brief interventions using evidence-based,09-10-2025
G0503013004,"Techniques such as behavioral activation, motivational interviewing, and other",09-10-2025
G0503014004,Focused treatment strategies; monitoring of patient outcomes using validated,09-10-2025
G0503015004,Rating scales; and relapse prevention planning with patients as they achieve,09-10-2025
G0503016004,Remission of symptoms and/or other treatment goals and are prepared for,09-10-2025
G0503017004,Discharge from active treatment,09-10-2025
G0504001003,"Initial or subsequent psychiatric collaborative care management, each",09-10-2025
G0504002004,Additional 30 minutes in a calendar month of behavioral health care manager,09-10-2025
G0504003004,"Activities, in consultation with a psychiatric consultant, and directed by the",09-10-2025
G0504004004,Treating physician or other qualified health care professional (list separately,09-10-2025
G0504005004,In addition to code for primary procedure); (use g0504 in conjunction with,09-10-2025
G0504006004,"G0502, g0503)",09-10-2025
G0505001003,Cognition and functional assessment using standardized instruments with,09-10-2025
G0505002004,"Development of recorded care plan for the patient with cognitive impairment,",09-10-2025
G0505003004,"History obtained from patient and/or caregiver, in office or other outpatient",09-10-2025
G0505004004,Setting or home or domiciliary or rest home,09-10-2025
G0506001003,Comprehensive assessment of and care planning for patients requiring chronic,09-10-2025
G0506002004,Care management services (list separately in addition to primary monthly care,09-10-2025
G0506003004,Management service),09-10-2025
G0507001003,"Care management services for behavioral health conditions, at least 20 minutes",09-10-2025
G0507002004,"Of clinical staff time, directed by a physician or other qualified health care",09-10-2025
G0507003004,"Professional, per calendar month, with the following required elements: initial",09-10-2025
G0507004004,"Assessment or follow-up monitoring, including the use of applicable validated",09-10-2025
G0507005004,Rating scales; behavioral health care planning in relation to,09-10-2025
G0507006004,"Behavioral/psychiatric health problems, including revision for patients who are",09-10-2025
G0507007004,Not progressing or whose status changes; facilitating and coordinating,09-10-2025
G0507008004,"Treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric",09-10-2025
G0507009004,Consultation; and continuity of care with a designated member of the care team,09-10-2025
G0508001003,"Telehealth consultation, critical care, initial , physicians typically spend 60",09-10-2025
G0508002004,Minutes communicating with the patient and providers via telehealth,09-10-2025
G0509001003,"Telehealth consultation, critical care, subsequent, physicians typically spend",09-10-2025
G0509002004,50 minutes communicating with the patient and providers via telehealth,09-10-2025
G0511001003,"Rural health clinic or federally qualified health center (rhc or fqhc) only,",09-10-2025
G0511002004,"General care management, 20 minutes or more of clinical staff time for chronic",09-10-2025
G0511003004,Care management services or behavioral health integration services directed by,09-10-2025
G0511004004,"An rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month",09-10-2025
G0512001003,"Rural health clinic or federally qualified health center (rhc/fqhc) only,",09-10-2025
G0512002004,"Psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of",09-10-2025
G0512003004,Clinical staff time for psychiatric cocm services directed by an rhc or fqhc,09-10-2025
G0512004004,"Practitioner (physician, np, pa, or cnm) and including services furnished by a",09-10-2025
G0512005004,"Behavioral health care manager and consultation with a psychiatric consultant,",09-10-2025
G0512006004,Per calendar month,09-10-2025
G0513001003,Prolonged preventive service(s) (beyond the typical service time of the primary,09-10-2025
G0513002004,"Procedure), in the office or other outpatient setting requiring direct patient",09-10-2025
G0513003004,Contact beyond the usual service; first 30 minutes (list separately in addition,09-10-2025
G0513004004,To code for preventive service),09-10-2025
G0514001003,Prolonged preventive service(s) (beyond the typical service time of the primary,09-10-2025
G0514002004,"Procedure), in the office or other outpatient setting requiring direct patient",09-10-2025
G0514003004,Contact beyond the usual service; each additional 30 minutes (list separately,09-10-2025
G0514004004,In addition to code g0513 for additional 30 minutes of preventive service),09-10-2025
G0515001003,"Development of cognitive skills to improve attention, memory, problem solving",09-10-2025
G0515002004,"(includes compensatory training), direct (one-on-one) patient contact, each 15",09-10-2025
G0515003004,Minutes,09-10-2025
G0516001003,"Insertion of non-biodegradable drug delivery implants, 4 or more (services for",09-10-2025
G0516002004,Subdermal rod implant),09-10-2025
G0517001003,"Removal of non-biodegradable drug delivery implants, 4 or more (services for",09-10-2025
G0517002004,Subdermal implants),09-10-2025
G0518001003,"Removal with reinsertion, non-biodegradable drug delivery implants, 4 or more",09-10-2025
G0518002004,(services for subdermal implants),09-10-2025
G0519001003,"Management of new patient-caregiver dyad with dementia, low complexity, for use",09-10-2025
G0519002004,In cmmi model,09-10-2025
G0520001003,"Management of new patient-caregiver dyad with dementia, moderate complexity,",09-10-2025
G0520002004,For use in cmmi model,09-10-2025
G0521001003,"Management of new patient-caregiver dyad with dementia, high complexity, for",09-10-2025
G0521002004,Use in cmmi model,09-10-2025
G0522001003,"Management of a new patient with dementia, low complexity, for use in cmmi mode",09-10-2025
G0523001003,"Management of a new patient with dementia, moderate to high complexity, for use",09-10-2025
G0523002004,In cmmi model,09-10-2025
G0524001003,"Management of established patient-caregiver dyad with dementia, low complexity,",09-10-2025
G0524002004,For use in cmmi model,09-10-2025
G0525001003,"Management of established patient-caregiver dyad with dementia, moderate",09-10-2025
G0525002004,"Complexity, for use in cmmi model",09-10-2025
G0526001003,"Management of established patient-caregiver dyad with dementia, high",09-10-2025
G0526002004,"Complexity, for use in cmmi model",09-10-2025
G0527001003,"Management of established patient with dementia, low complexity, for use in",09-10-2025
G0527002004,Cmmi model,09-10-2025
G0528001003,"Management of established patient with dementia, moderate to high complexity,",09-10-2025
G0528002004,For use in cmmi model,09-10-2025
G0529001003,"In-home respite care, 4-hour unit, for use in cmmi model",09-10-2025
G0530001003,"Adult day center, 8-hour unit, for use in cmmi model",09-10-2025
G0531001003,"Facility-based respite, 24-hour unit, for use in cmmi model",09-10-2025
G0532001003,"Take-home supply of nasal nalmefene hydrochloride; one carton of two, 2.7 mg",09-10-2025
G0532002004,Per 0.1 ml nasal sprays (provision of the services by a medicare-enrolled,09-10-2025
G0532003004,Opioid treatment program);( list separately in addition to each primary code),09-10-2025
G0533001003,"Medication assisted treatment, buprenorphine (injectable) administered on a",09-10-2025
G0533002004,"Weekly basis; weekly bundle including dispensing and/or administration,",09-10-2025
G0533003004,"Substance use counseling, individual and group therapy, and toxicology testing",09-10-2025
G0533004004,If performed (provision of the services by a medicare-enrolled opioid treatment,09-10-2025
G0533005004,Program),09-10-2025
G0534001003,"Coordinated care and/or referral services, such as to adequate and accessible",09-10-2025
G0534002004,"Community resources to address unmet health-related social needs, including",09-10-2025
G0534003004,Harm reduction interventions and recovery support services a patient needs and,09-10-2025
G0534004004,"Wishes to pursue, which significantly limit the ability to diagnose or treat an",09-10-2025
G0534005004,Opioid use disorder; each additional 30 minutes of services (provision of the,09-10-2025
G0534006004,Services by a medicare-enrolled opioid treatment program); (list separately in,09-10-2025
G0534007004,Addition to each primary code),09-10-2025
G0535001003,"Patient navigational services, provided directly or by referral; including",09-10-2025
G0535002004,Helping the patient to navigate health systems and identify care providers and,09-10-2025
G0535003004,"Supportive services, to build patient self-advocacy and communication skills",09-10-2025
G0535004004,"With care providers, and to promote patient-driven action plans and goals; each",09-10-2025
G0535005004,Additional 30 minutes of services (provision of the services by a,09-10-2025
G0535006004,Medicare-enrolled opioid treatment program); (list separately in addition to,09-10-2025
G0535007004,Each primary code),09-10-2025
G0536001003,"Peer recovery support services, provided directly or by referral; including",09-10-2025
G0536002004,"Leveraging knowledge of the condition or lived experience to provide support,",09-10-2025
G0536003004,"Mentorship, or inspiration to meet oud treatment and recovery goals; conducting",09-10-2025
G0536004004,"A person-centered interview to understand the patient's life story, strengths,",09-10-2025
G0536005004,"Needs, goals, preferences, and desired outcomes; developing and proposing",09-10-2025
G0536006004,Strategies to help meet person-centered treatment goals; assisting the patient,09-10-2025
G0536007004,In locating or navigating recovery support services; each additional 30 minutes,09-10-2025
G0536008004,Of services (provision of the services by a medicare-enrolled opioid treatment,09-10-2025
G0536009004,Program); (list separately in addition to each primary code),09-10-2025
G0537001003,"Administration of a standardized, evidence-based atherosclerotic cardiovascular",09-10-2025
G0537002004,"Disease (ascvd) risk assessment, 5-15 minutes, not more often than every 12",09-10-2025
G0537003004,Months,09-10-2025
G0538001003,Atherosclerotic cardiovascular disease (ascvd) risk management services;,09-10-2025
G0538002004,Clinical staff time; per calendar month,09-10-2025
G0539001003,Caregiver training in behavior management/modification for caregiver(s) of,09-10-2025
G0539002004,"Patients with a mental or physical health diagnosis, administered by physician",09-10-2025
G0539003004,"Or other qualified health care professional (without the patient present),",09-10-2025
G0539004004,Face-to-face; initial 30 minutes,09-10-2025
G0540001003,Caregiver training in behavior management/modification for,09-10-2025
G0540002004,Parent(s)/guardian(s)/caregiver(s) of patients with a mental or physical health,09-10-2025
G0540003004,"Diagnosis, administered by physician or other qualified health care",09-10-2025
G0540004004,"Professional (without the patient present), face-to-face; each additional 15",09-10-2025
G0540005004,Minutes,09-10-2025
G0541001003,Caregiver training in direct care strategies and techniques to support care for,09-10-2025
G0541002004,Patients with an ongoing condition or illness and to reduce complications,09-10-2025
G0541003004,"(including, but not limited to, techniques to prevent decubitus ulcer",09-10-2025
G0541004004,"Formation, wound care, and infection control) (without the patient present),",09-10-2025
G0541005004,Face-to-face; initial 30 minutes,09-10-2025
G0542001003,Caregiver training in direct care strategies and techniques to support care for,09-10-2025
G0542002004,Patients with an ongoing condition or illness and to reduce complications,09-10-2025
G0542003004,"(including, but not limited to, techniques to prevent decubitus ulcer",09-10-2025
G0542004004,"Formation, wound care, and infection control) (without the patient present),",09-10-2025
G0542005004,Face-to-face; each additional 15 minutes (list separately in addition to code,09-10-2025
G0542006004,For primary service) (use g0542 in conjunction with g0541),09-10-2025
G0543001003,Group caregiver training in direct care strategies and techniques to support,09-10-2025
G0543002004,Care for patients with an ongoing condition or illness and to reduce,09-10-2025
G0543003004,"Complications (including, but not limited to, techniques to prevent decubitus",09-10-2025
G0543004004,"Ulcer formation, wound care, and infection control) (without the patient",09-10-2025
G0543005004,"Present), face-to-face with multiple sets of caregivers",09-10-2025
G0544001003,Post discharge telephonic follow-up contacts performed in conjunction with a,09-10-2025
G0544002004,Discharge from the emergency department for behavioral health or other crisis,09-10-2025
G0544003004,"Encounter, 4 calls per calendar month",09-10-2025
G0545001003,Visit complexity inherent to hospital inpatient or observation care associated,09-10-2025
G0545002004,With a confirmed or suspected infectious disease by an infectious diseases,09-10-2025
G0545003004,"Specialist, including disease transmission risk assessment and mitigation,",09-10-2025
G0545004004,"Public health investigation, analysis, and testing, and complex antimicrobial",09-10-2025
G0545005004,"Therapy counseling and treatment (add-on code, list separately in addition to",09-10-2025
G0545006004,"Hospital inpatient or observation evaluation and management visit, initial,",09-10-2025
G0545007004,"Same day discharge, subsequent or discharge)",09-10-2025
G0546001003,Interprofessional telephone/internet/electronic health record assessment and,09-10-2025
G0546002004,Management service provided by a practitioner in a specialty whose covered,09-10-2025
G0546003004,Services are limited by statute to services for the diagnosis and treatment of,09-10-2025
G0546004004,"Mental illness, including a verbal and written report to the patient's",09-10-2025
G0546005004,Treating/requesting practitioner; 5-10 minutes of medical consultative,09-10-2025
G0546006004,Discussion and review,09-10-2025
G0547001003,Interprofessional telephone/internet/electronic health record assessment and,09-10-2025
G0547002004,Management service provided by a practitioner in a specialty whose covered,09-10-2025
G0547003004,Services are limited by statute to services for the diagnosis and treatment of,09-10-2025
G0547004004,"Mental illness, including a verbal and written report to the patient's",09-10-2025
G0547005004,Treating/requesting practitioner; 11-20 minutes of medical consultative,09-10-2025
G0547006004,Discussion and review,09-10-2025
G0548001003,Interprofessional telephone/internet/electronic health record assessment and,09-10-2025
G0548002004,Management service provided by a practitioner in a specialty whose covered,09-10-2025
G0548003004,Services are limited by statute to services for the diagnosis and treatment of,09-10-2025
G0548004004,"Mental illness, including a verbal and written report to the patient's",09-10-2025
G0548005004,Treating/requesting practitioner; 21-30 minutes of medical consultative,09-10-2025
G0548006004,Discussion and review,09-10-2025
G0549001003,Interprofessional telephone/internet/electronic health record assessment and,09-10-2025
G0549002004,Management service provided by a practitioner in a specialty whose covered,09-10-2025
G0549003004,Services are limited by statute to services for the diagnosis and treatment of,09-10-2025
G0549004004,"Mental illness, including a verbal and written report to the patient's",09-10-2025
G0549005004,Treating/requesting practitioner; 31 or more minutes of medical consultative,09-10-2025
G0549006004,Discussion and review,09-10-2025
G0550001003,Interprofessional telephone/internet/electronic health record assessment and,09-10-2025
G0550002004,Management service provided by a practitioner in a specialty whose covered,09-10-2025
G0550003004,Services are limited by statute to services for the diagnosis and treatment of,09-10-2025
G0550004004,"Mental illness, including a written report to the patient's treating/requesting",09-10-2025
G0550005004,"Practitioner, 5 minutes or more of medical consultative time",09-10-2025
G0551001003,Interprofessional telephone/internet/electronic health record referral,09-10-2025
G0551002004,Service(s) provided by a treating/requesting practitioner in a specialty whose,09-10-2025
G0551003004,Covered services are limited by statute to services for the diagnosis and,09-10-2025
G0551004004,"Treatment of mental illness, 30 minutes",09-10-2025
G0552001003,Supply of digital mental health treatment device and initial education and,09-10-2025
G0552002004,"Onboarding, per course of treatment that augments a behavioral therapy plan",09-10-2025
G0553001003,First 20 minutes of monthly treatment management services directly related to,09-10-2025
G0553002004,The patient's therapeutic use of the digital mental health treatment (dmht),09-10-2025
G0553003004,"Device that augments a behavioral therapy plan, physician/other qualified",09-10-2025
G0553004004,Health care professional time reviewing information related to the use of the,09-10-2025
G0553005004,"Dmht device, including patient observations and patient specific inputs in a",09-10-2025
G0553006004,Calendar month and requiring at least one interactive communication with the,09-10-2025
G0553007004,Patient/caregiver during the calendar month,09-10-2025
G0554001003,Each additional 20 minutes of monthly treatment management services directly,09-10-2025
G0554002004,Related to the patient's therapeutic use of the digital mental health treatment,09-10-2025
G0554003004,"(dmht) device that augments a behavioral therapy plan, physician/other",09-10-2025
G0554004004,Qualified health care professional time reviewing data generated from the dmht,09-10-2025
G0554005004,Device from patient observations and patient specific inputs in a calendar,09-10-2025
G0554006004,Month and requiring at least one interactive communication with the,09-10-2025
G0554007004,Patient/caregiver during the calendar month,09-10-2025
G0555001003,"Provision of replacement patient electronics system (e.g., system pillow,",09-10-2025
G0555002004,Handheld reader) for home pulmonary artery pressure monitoring,09-10-2025
G0556001003,Advanced primary care management services for a patient with one chronic,09-10-2025
G0556002004,"Condition [expected to last at least 12 months, or until the death of the",09-10-2025
G0556003004,"Patient, which place the patient at significant risk of death, acute",09-10-2025
G0556004004,"Exacerbation/decompensation, or functional decline], or fewer, provided by",09-10-2025
G0556005004,Clinical staff and directed by a physician or other qualified health care,09-10-2025
G0556006004,Professional who is responsible for all primary care and serves as the,09-10-2025
G0556007004,"Continuing focal point for all needed health care services, per calendar month,",09-10-2025
G0556008004,"With the following elements, as appropriate: consent; ++ inform the patient of",09-10-2025
G0556009004,The availability of the service; that only one practitioner can furnish and be,09-10-2025
G0556010004,Paid for the service during a calendar month; of the right to stop the services,09-10-2025
G0556011004,At any time (effective at the end of the calendar month); and that cost sharing,09-10-2025
G0556012004,May apply. ++ document in patient's medical record that consent was obtained.,09-10-2025
G0556013004,Initiation during a qualifying visit for new patients or patients not seen,09-10-2025
G0556014004,"Within 3 years; provide 24/7 access for urgent needs to care team/practitioner,",09-10-2025
G0556015004,Including providing patients/caregivers with a way to contact health care,09-10-2025
G0556016004,Professionals in the practice to discuss urgent needs regardless of the time of,09-10-2025
G0556017004,Day or day of week; continuity of care with a designated member of the care,09-10-2025
G0556018004,Team with whom the patient is able to schedule successive routine appointments;,09-10-2025
G0556019004,Deliver care in alternative ways to traditional office visits to best meet the,09-10-2025
G0556020004,"Patient's needs, such as home visits and/or expanded hours; overall",09-10-2025
G0556021004,Comprehensive care management; ++ systematic needs assessment (medical and,09-10-2025
G0556022004,Psychosocial). ++ system-based approaches to ensure receipt of preventive,09-10-2025
G0556023004,"Services. ++ medication reconciliation, management and oversight of",09-10-2025
G0556024004,"Self-management. development, implementation, revision, and maintenance of an",09-10-2025
G0556025004,Electronic patient-centered comprehensive care plan with typical care plan,09-10-2025
G0556026004,Elements when clinically relevant; ++ care plan is available timely within and,09-10-2025
G0556027004,Outside the billing practice as appropriate to individuals involved in the,09-10-2025
G0556028004,"Beneficiary's care, can be routinely accessed and updated by care",09-10-2025
G0556029004,"Team/practitioner, and copy of care plan to patient/caregiver; coordination of",09-10-2025
G0556030004,"Care transitions between and among health care providers and settings,",09-10-2025
G0556031004,Including referrals to other clinicians and follow-up after an emergency,09-10-2025
G0556032004,"Department visit and discharges from hospitals, skilled nursing facilities or",09-10-2025
G0556033004,Other health care facilities as applicable; ++ ensure timely exchange of,09-10-2025
G0556034004,Electronic health information with other practitioners and providers to support,09-10-2025
G0556035004,"Continuity of care. ++ ensure timely follow-up communication (direct contact,",09-10-2025
G0556036004,"Telephone, electronic) with the patient and/or caregiver after an emergency",09-10-2025
G0556037004,"Department visit and discharges from hospitals, skilled nursing facilities, or",09-10-2025
G0556038004,"Other health care facilities, within 7 calendar days of discharge, as",09-10-2025
G0556039004,Clinically indicated. ongoing communication and coordinating receipt of needed,09-10-2025
G0556040004,"Services from practitioners, home- and community-based service providers,",09-10-2025
G0556041004,"Community-based social service providers, hospitals, and skilled nursing",09-10-2025
G0556042004,"Facilities (or other health care facilities), and document communication",09-10-2025
G0556043004,"Regarding the patient's psychosocial strengths and needs, functional deficits,",09-10-2025
G0556044004,"Goals, preferences, and desired outcomes, including cultural and linguistic",09-10-2025
G0556045004,"Factors, in the patient's medical record; enhanced opportunities for the",09-10-2025
G0556046004,Beneficiary and any caregiver to communicate with the care team/practitioner,09-10-2025
G0556047004,Regarding the beneficiary's care through the use of asynchronous,09-10-2025
G0556048004,"Non-face-to-face consultation methods other than telephone, such as secure",09-10-2025
G0556049004,"Messaging, email, internet, or patient portal, and other",09-10-2025
G0556050004,"Communication-technology based services, including remote evaluation of",09-10-2025
G0556051004,Pre-recorded patient information and interprofessional telephone/internet/ehr,09-10-2025
G0556052004,"Referral service(s), to maintain ongoing communication with patients, as",09-10-2025
G0556053004,Appropriate; ++ ensure access to patient-initiated digital communications that,09-10-2025
G0556054004,"Require a clinical decision, such as virtual check-ins and digital online",09-10-2025
G0556055004,Assessment and management and e/m visits (or e-visits). analyze patient,09-10-2025
G0556056004,"Population data to identify gaps in care and offer additional interventions, as",09-10-2025
G0556057004,"Appropriate; risk stratify the practice population based on defined diagnoses,",09-10-2025
G0556058004,"Claims, or other electronic data to identify and target services to patients;",09-10-2025
G0556059004,"Be assessed through performance measurement of primary care quality, total cost",09-10-2025
G0556060004,"Of care, and meaningful use of certified ehr technology",09-10-2025
G0557001003,Advanced primary care management services for a patient with multiple (two or,09-10-2025
G0557002004,"More) chronic conditions expected to last at least 12 months, or until the",09-10-2025
G0557003004,"Death of the patient, which place the patient at significant risk of death,",09-10-2025
G0557004004,"Acute exacerbation/decompensation, or functional decline, provided by clinical",09-10-2025
G0557005004,Staff and directed by a physician or other qualified health care professional,09-10-2025
G0557006004,Who is responsible for all primary care and serves as the continuing focal,09-10-2025
G0557007004,"Point for all needed health care services, per calendar month, with the",09-10-2025
G0557008004,"Following elements, as appropriate: consent; ++ inform the patient of the",09-10-2025
G0557009004,Availability of the service; that only one practitioner can furnish and be paid,09-10-2025
G0557010004,For the service during a calendar month; of the right to stop the services at,09-10-2025
G0557011004,Any time (effective at the end of the calendar month); and that cost sharing,09-10-2025
G0557012004,May apply. ++ document in patient's medical record that consent was obtained.,09-10-2025
G0557013004,Initiation during a qualifying visit for new patients or patients not seen,09-10-2025
G0557014004,"Within 3 years; provide 24/7 access for urgent needs to care team/practitioner,",09-10-2025
G0557015004,Including providing patients/caregivers with a way to contact health care,09-10-2025
G0557016004,Professionals in the practice to discuss urgent needs regardless of the time of,09-10-2025
G0557017004,Day or day of week; continuity of care with a designated member of the care,09-10-2025
G0557018004,Team with whom the patient is able to schedule successive routine appointments;,09-10-2025
G0557019004,Deliver care in alternative ways to traditional office visits to best meet the,09-10-2025
G0557020004,"Patient's needs, such as home visits and/or expanded hours; overall",09-10-2025
G0557021004,Comprehensive care management; ++ systematic needs assessment (medical and,09-10-2025
G0557022004,Psychosocial). ++ system-based approaches to ensure receipt of preventive,09-10-2025
G0557023004,"Services. ++ medication reconciliation, management and oversight of",09-10-2025
G0557024004,"Self-management. development, implementation, revision, and maintenance of an",09-10-2025
G0557025004,Electronic patient-centered comprehensive care plan; ++ care plan is available,09-10-2025
G0557026004,Timely within and outside the billing practice as appropriate to individuals,09-10-2025
G0557027004,"Involved in the beneficiary's care, can be routinely accessed and updated by",09-10-2025
G0557028004,"Care team/practitioner, and copy of care plan to patient/caregiver;",09-10-2025
G0557029004,Coordination of care transitions between and among health care providers and,09-10-2025
G0557030004,"Settings, including referrals to other clinicians and follow-up after an",09-10-2025
G0557031004,"Emergency department visit and discharges from hospitals, skilled nursing",09-10-2025
G0557032004,Facilities or other health care facilities as applicable; ++ ensure timely,09-10-2025
G0557033004,Exchange of electronic health information with other practitioners and,09-10-2025
G0557034004,Providers to support continuity of care. ++ ensure timely follow-up,09-10-2025
G0557035004,"Communication (direct contact, telephone, electronic) with the patient and/or",09-10-2025
G0557036004,"Caregiver after an emergency department visit and discharges from hospitals,",09-10-2025
G0557037004,"Skilled nursing facilities, or other health care facilities, within 7 calendar",09-10-2025
G0557038004,"Days of discharge, as clinically indicated. ongoing communication and",09-10-2025
G0557039004,"Coordinating receipt of needed services from practitioners, home- and",09-10-2025
G0557040004,"Community-based service providers, community-based social service providers,",09-10-2025
G0557041004,"Hospitals, and skilled nursing facilities (or other health care facilities),",09-10-2025
G0557042004,And document communication regarding the patient's psychosocial strengths and,09-10-2025
G0557043004,"Needs, functional deficits, goals, preferences, and desired outcomes, including",09-10-2025
G0557044004,"Cultural and linguistic factors, in the patient's medical record; enhanced",09-10-2025
G0557045004,Opportunities for the beneficiary and any caregiver to communicate with the,09-10-2025
G0557046004,Care team/practitioner regarding the beneficiary's care through the use of,09-10-2025
G0557047004,"Asynchronous non-face-to-face consultation methods other than telephone, such",09-10-2025
G0557048004,"As secure messaging, email, internet, or patient portal, and other",09-10-2025
G0557049004,"Communication-technology based services, including remote evaluation of",09-10-2025
G0557050004,Pre-recorded patient information and interprofessional telephone/internet/ehr,09-10-2025
G0557051004,"Referral service(s), to maintain ongoing communication with patients, as",09-10-2025
G0557052004,Appropriate; ++ ensure access to patient-initiated digital communications that,09-10-2025
G0557053004,"Require a clinical decision, such as virtual check-ins and digital online",09-10-2025
G0557054004,Assessment and management and e/m visits (or e-visits). analyze patient,09-10-2025
G0557055004,"Population data to identify gaps in care and offer additional interventions, as",09-10-2025
G0557056004,"Appropriate; risk stratify the practice population based on defined diagnoses,",09-10-2025
G0557057004,"Claims, or other electronic data to identify and target services to patients;",09-10-2025
G0557058004,"Be assessed through performance measurement of primary care quality, total cost",09-10-2025
G0557059004,"Of care, and meaningful use of certified ehr technology",09-10-2025
G0558001003,Advanced primary care management services for a patient that is a qualified,09-10-2025
G0558002004,Medicare beneficiary with multiple (two or more) chronic conditions expected to,09-10-2025
G0558003004,"Last at least 12 months, or until the death of the patient, which place the",09-10-2025
G0558004004,"Patient at significant risk of death, acute exacerbation/decompensation, or",09-10-2025
G0558005004,"Functional decline, provided by clinical staff and directed by a physician or",09-10-2025
G0558006004,Other qualified health care professional who is responsible for all primary,09-10-2025
G0558007004,Care and serves as the continuing focal point for all needed health care,09-10-2025
G0558008004,"Services, per calendar month, with the following elements, as appropriate:",09-10-2025
G0558009004,Consent; ++ inform the patient of the availability of the service; that only,09-10-2025
G0558010004,One practitioner can furnish and be paid for the service during a calendar,09-10-2025
G0558011004,Month; of the right to stop the services at any time (effective at the end of,09-10-2025
G0558012004,The calendar month); and that cost sharing may apply. ++ document in patient's,09-10-2025
G0558013004,Medical record that consent was obtained. initiation during a qualifying visit,09-10-2025
G0558014004,For new patients or patients not seen within 3 years; provide 24/7 access for,09-10-2025
G0558015004,"Urgent needs to care team/practitioner, including providing patients/caregivers",09-10-2025
G0558016004,With a way to contact health care professionals in the practice to discuss,09-10-2025
G0558017004,Urgent needs regardless of the time of day or day of week; continuity of care,09-10-2025
G0558018004,With a designated member of the care team with whom the patient is able to,09-10-2025
G0558019004,Schedule successive routine appointments; deliver care in alternative ways to,09-10-2025
G0558020004,"Traditional office visits to best meet the patient's needs, such as home visits",09-10-2025
G0558021004,And/or expanded hours; overall comprehensive care management; ++ systematic,09-10-2025
G0558022004,Needs assessment (medical and psychosocial). ++ system-based approaches to,09-10-2025
G0558023004,"Ensure receipt of preventive services. ++ medication reconciliation,",09-10-2025
G0558024004,"Management and oversight of self-management. development, implementation,",09-10-2025
G0558025004,"Revision, and maintenance of an electronic patient-centered comprehensive care",09-10-2025
G0558026004,Plan; ++ care plan is available timely within and outside the billing practice,09-10-2025
G0558027004,"As appropriate to individuals involved in the beneficiary's care, can be",09-10-2025
G0558028004,"Routinely accessed and updated by care team/practitioner, and copy of care plan",09-10-2025
G0558029004,To patient/caregiver; coordination of care transitions between and among health,09-10-2025
G0558030004,"Care providers and settings, including referrals to other clinicians and",09-10-2025
G0558031004,"Follow-up after an emergency department visit and discharges from hospitals,",09-10-2025
G0558032004,Skilled nursing facilities or other health care facilities as applicable; ++,09-10-2025
G0558033004,Ensure timely exchange of electronic health information with other,09-10-2025
G0558034004,Practitioners and providers to support continuity of care. ++ ensure timely,09-10-2025
G0558035004,"Follow-up communication (direct contact, telephone, electronic) with the",09-10-2025
G0558036004,Patient and/or caregiver after an emergency department visit and discharges,09-10-2025
G0558037004,"From hospitals, skilled nursing facilities, or other health care facilities,",09-10-2025
G0558038004,"Within 7 calendar days of discharge, as clinically indicated. ongoing",09-10-2025
G0558039004,"Communication and coordinating receipt of needed services from practitioners,",09-10-2025
G0558040004,"Home- and community-based service providers, community-based social service",09-10-2025
G0558041004,"Providers, hospitals, and skilled nursing facilities (or other health care",09-10-2025
G0558042004,"Facilities), and document communication regarding the patient's psychosocial",09-10-2025
G0558043004,"Strengths and needs, functional deficits, goals, preferences, and desired",09-10-2025
G0558044004,"Outcomes, including cultural and linguistic factors, in the patient's medical",09-10-2025
G0558045004,Record; enhanced opportunities for the beneficiary and any caregiver to,09-10-2025
G0558046004,Communicate with the care team/practitioner regarding the beneficiary's care,09-10-2025
G0558047004,Through the use of asynchronous non-face-to-face consultation methods other,09-10-2025
G0558048004,"Than telephone, such as secure messaging, email, internet, or patient portal,",09-10-2025
G0558049004,"And other communication-technology based services, including remote evaluation",09-10-2025
G0558050004,Of pre-recorded patient information and interprofessional,09-10-2025
G0558051004,"Telephone/internet/ehr referral service(s), to maintain ongoing communication",09-10-2025
G0558052004,"With patients, as appropriate; ++ ensure access to patient-initiated digital",09-10-2025
G0558053004,"Communications that require a clinical decision, such as virtual check-ins and",09-10-2025
G0558054004,Digital online assessment and management and e/m visits (or e-visits). analyze,09-10-2025
G0558055004,Patient population data to identify gaps in care and offer additional,09-10-2025
G0558056004,"Interventions, as appropriate; risk stratify the practice population based on",09-10-2025
G0558057004,"Defined diagnoses, claims, or other electronic data to identify and target",09-10-2025
G0558058004,Services to patients; be assessed through performance measurement of primary,09-10-2025
G0558059004,"Care quality, total cost of care, and meaningful use of certified ehr technolog",09-10-2025
G0559001003,Post-operative follow-up visit complexity inherent to evaluation and management,09-10-2025
G0559002004,"Services addressing surgical procedure(s), provided by a physician or qualified",09-10-2025
G0559003004,Health care professional who is not the practitioner who performed the,09-10-2025
G0559004004,Procedure (or in the same group practice) and is of the same or of a different,09-10-2025
G0559005004,"Specialty than the practitioner who performed the procedure, within the 90-day",09-10-2025
G0559006004,"Global period of the procedure(s), once per 90-day global period, when there",09-10-2025
G0559007004,Has not been a formal transfer of care and requires the following required,09-10-2025
G0559008004,"Elements, when possible and applicable: reading available surgical note to",09-10-2025
G0559009004,"Understand the relative success of the procedure, the anatomy that was",09-10-2025
G0559010004,"Affected, and potential complications that could have arisen due to the unique",09-10-2025
G0559011004,Circumstances of the patient's operation. research the procedure to,09-10-2025
G0559012004,Determine expected post-operative course and potential complications (in the,09-10-2025
G0559013004,Case of doing a post-op for a procedure outside the specialty). evaluate and,09-10-2025
G0559014004,Physically examine the patient to determine whether the post-operative course,09-10-2025
G0559015004,Is progressing appropriately. communicate with the practitioner who,09-10-2025
G0559016004,Performed the procedure if any questions or concerns arise. (list separately in,09-10-2025
G0559017004,"Addition to office/outpatient evaluation and management visit, new or",09-10-2025
G0559018004,Established),09-10-2025
G0560001003,"Safety planning interventions, each 20 minutes personally performed by the",09-10-2025
G0560002004,"Billing practitioner, including assisting the patient in the identification of",09-10-2025
G0560003004,The following personalized elements of a safety plan: recognizing warning signs,09-10-2025
G0560004004,Of an impending suicidal or substance use-related crisis; employing internal,09-10-2025
G0560005004,Coping strategies; utilizing social contacts and social settings as a means of,09-10-2025
G0560006004,Distraction from suicidal thoughts or risky substance use; utilizing family,09-10-2025
G0560007004,"Members, significant others, caregivers, and/or friends to help resolve the",09-10-2025
G0560008004,Crisis; contacting mental health or substance use disorder professionals or,09-10-2025
G0560009004,Agencies; and making the environment safe,09-10-2025
G0561001003,Tympanostomy with local or topical anesthesia and insertion of a ventilating,09-10-2025
G0561002004,"Tube when performed with tympanostomy tube delivery device, unilateral (list",09-10-2025
G0561003004,Separately in addition to 69433) (do not use in conjunction with 0583t),09-10-2025
G0562001003,"Therapeutic radiology simulation-aided field setting; complex, including",09-10-2025
G0562002004,Acquisition of pet and ct imaging data required for,09-10-2025
G0562003004,"Radiopharmaceutical-directed radiation therapy treatment planning (i.e.,",09-10-2025
G0562004004,Modeling),09-10-2025
G0563001003,"Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or",09-10-2025
G0563002004,"More lesions, including image guidance and real-time positron emissions-based",09-10-2025
G0563003004,"Delivery adjustments to 1 or more lesions, entire course not to exceed 5",09-10-2025
G0563004004,Fractions,09-10-2025
G0564001003,Creation of subcutaneous pocket with insertion of 365 day implantable,09-10-2025
G0564002004,"Interstitial glucose sensor, including system activation and patient training",09-10-2025
G0565001003,Removal of implantable interstitial glucose sensor with creation of,09-10-2025
G0565002004,Subcutaneous pocket at different anatomic site and insertion of new 365 day,09-10-2025
G0565003004,"Implantable sensor, including system activation",09-10-2025
G0566001003,"3d radiodensity-value bone imaging, algorithm derived, from previous magnetic",09-10-2025
G0566002004,Resonance examination of the same anatomy,09-10-2025
G0567001003,"Infectious agent detection by nucleic acid (dna or rna); hepatitis c,",09-10-2025
G0567002004,"Screening, amplified probe technique",09-10-2025
G0659001003,"Drug test(s), definitive, utilizing drug identification methods able to",09-10-2025
G0659002004,Identify individual drugs and distinguish between structural isomers (but not,09-10-2025
G0659003004,"Necessarily stereoisomers), including but not limited to gc/ms (any type,",09-10-2025
G0659004004,"Single or tandem) and lc/ms (any type, single or tandem), excluding",09-10-2025
G0659005004,"Immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g.,",09-10-2025
G0659006004,"Alcohol dehydrogenase), performed without method or drug-specific calibration,",09-10-2025
G0659007004,"Without matrix-matched quality control material, or without use of stable",09-10-2025
G0659008004,"Isotope or other universally recognized internal standard(s) for each drug,",09-10-2025
G0659009004,"Drug metabolite or drug class per specimen; qualitative or quantitative, all",09-10-2025
G0659010004,"Sources, includes specimen validity testing, per day, any number of drug classe",09-10-2025
G0908001003,Most recent hemoglobin (hgb) level > 12.0 g/dl,09-10-2025
G0909001003,"Hemoglobin level measurement not documented, reason not given",09-10-2025
G0910001003,Most recent hemoglobin level <= 12.0 g/dl,09-10-2025
G0913001003,Improvement in visual function achieved within 90 days following cataract,09-10-2025
G0913002004,Surgery,09-10-2025
G0914001003,Patient care survey was not completed by patient,09-10-2025
G0915001003,Improvement in visual function not achieved within 90 days following cataract,09-10-2025
G0915002004,Surgery,09-10-2025
G0916001003,Satisfaction with care achieved within 90 days following cataract surgery,09-10-2025
G0917001003,Patient care survey was not completed by patient,09-10-2025
G0918001003,Satisfaction with care not achieved within 90 days following cataract surgery,09-10-2025
G0919001003,Influenza immunization ordered or recommended (to be given at alternate,09-10-2025
G0919002004,Location or alternate provider); vaccine not available at time of visit,09-10-2025
G0920001003,"Type, anatomic location, and activity all documented",09-10-2025
G0921001003,"Documentation of patient reason(s) for not being able to assess (e.g., patient",09-10-2025
G0921002004,Refuses endoscopic and/or radiologic assessment),09-10-2025
G0922001003,"No documentation of disease type, anatomic location, and activity, reason not",09-10-2025
G0922002004,Given,09-10-2025
G1000001003,"Clinical decision support mechanism applied pathways, as defined by the",09-10-2025
G1000002004,Medicare appropriate use criteria program,09-10-2025
G1001001003,"Clinical decision support mechanism evicore, as defined by the medicare",09-10-2025
G1001002004,Appropriate use criteria program,09-10-2025
G1002001003,"Clinical decision support mechanism medcurrent, as defined by the medicare",09-10-2025
G1002002004,Appropriate use criteria program,09-10-2025
G1003001003,"Clinical decision support mechanism medicalis, as defined by the medicare",09-10-2025
G1003002004,Appropriate use criteria program,09-10-2025
G1004001003,"Clinical decision support mechanism national decision support company, as",09-10-2025
G1004002004,Defined by the medicare appropriate use criteria program,09-10-2025
G1005001003,"Clinical decision support mechanism national imaging associates, as defined by",09-10-2025
G1005002004,The medicare appropriate use criteria program,09-10-2025
G1006001003,"Clinical decision support mechanism test appropriate, as defined by the",09-10-2025
G1006002004,Medicare appropriate use criteria program,09-10-2025
G1007001003,"Clinical decision support mechanism aim specialty health, as defined by the",09-10-2025
G1007002004,Medicare appropriate use criteria program,09-10-2025
G1008001003,"Clinical decision support mechanism cranberry peak, as defined by the medicare",09-10-2025
G1008002004,Appropriate use criteria program,09-10-2025
G1009001003,"Clinical decision support mechanism sage health management solutions, as",09-10-2025
G1009002004,Defined by the medicare appropriate use criteria program,09-10-2025
G1010001003,"Clinical decision support mechanism stanson, as defined by the medicare",09-10-2025
G1010002004,Appropriate use criteria program,09-10-2025
G1011001003,"Clinical decision support mechanism, qualified tool not otherwise specified, as",09-10-2025
G1011002004,Defined by the medicare appropriate use criteria program,09-10-2025
G1012001003,"Clinical decision support mechanism agilemd, as defined by the medicare",09-10-2025
G1012002004,Appropriate use criteria program,09-10-2025
G1013001003,"Clinical decision support mechanism evidencecare imagingcare, as defined by the",09-10-2025
G1013002004,Medicare appropriate use criteria program,09-10-2025
G1014001003,"Clinical decision support mechanism inveniqa semantic answers in medicine, as",09-10-2025
G1014002004,Defined by the medicare appropriate use criteria program,09-10-2025
G1015001003,"Clinical decision support mechanism reliant medical group, as defined by the",09-10-2025
G1015002004,Medicare appropriate use criteria program,09-10-2025
G1016001003,"Clinical decision support mechanism speed of care, as defined by the medicare",09-10-2025
G1016002004,Appropriate use criteria program,09-10-2025
G1017001003,"Clinical decision support mechanism healthhelp, as defined by the medicare",09-10-2025
G1017002004,Appropriate use criteria program,09-10-2025
G1018001003,"Clinical decision support mechanism infinx, as defined by the medicare",09-10-2025
G1018002004,Appropriate use criteria program,09-10-2025
G1019001003,"Clinical decision support mechanism logicnets, as defined by the medicare",09-10-2025
G1019002004,Appropriate use criteria program,09-10-2025
G1020001003,"Clinical decision support mechanism curbside clinical augmented workflow, as",09-10-2025
G1020002004,Defined by the medicare appropriate use criteria program,09-10-2025
G1021001003,Clinical decision support mechanism ehealthline clinical decision support,09-10-2025
G1021002004,"Mechanism, as defined by the medicare appropriate use criteria program",09-10-2025
G1022001003,Clinical decision support mechanism intermountain clinical decision support,09-10-2025
G1022002004,"Mechanism, as defined by the medicare appropriate use criteria program",09-10-2025
G1023001003,"Clinical decision support mechanism persivia clinical decision support, as",09-10-2025
G1023002004,Defined by the medicare appropriate use criteria program,09-10-2025
G1024001003,"Clinical decision support mechanism radrite, as defined by the medicare",09-10-2025
G1024002004,Appropriate use criteria program,09-10-2025
G1025001003,Patient-months where there are more than one medicare capitated payment (mcp),09-10-2025
G1025002004,Provider listed for the month,09-10-2025
G1026001003,The number of adult patient-months in the denominator who were on maintenance,09-10-2025
G1026002004,Hemodialysis using a catheter continuously for three months or longer under the,09-10-2025
G1026003004,Care of the same practitioner or group partner as of the last hemodialysis,09-10-2025
G1026004004,Session of the reporting month,09-10-2025
G1027001003,The number of adult patient-months in the denominator who were on maintenance,09-10-2025
G1027002004,Hemodialysis under the care of the same practitioner or group partner as of the,09-10-2025
G1027003004,Last hemodialysis session of the reporting month using a catheter continuously,09-10-2025
G1027004004,For less than three months,09-10-2025
G1028001003,Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray,09-10-2025
G1028002004,(provision of the services by a medicare-enrolled opioid treatment program);,09-10-2025
G1028003004,List separately in addition to code for primary procedure,09-10-2025
G2000001003,"Blinded administration of convulsive therapy procedure, either",09-10-2025
G2000002004,"Electroconvulsive therapy (ect, current covered gold standard) or magnetic",09-10-2025
G2000003004,"Seizure therapy (mst, non-covered experimental therapy), performed in an",09-10-2025
G2000004004,"Approved ide-based clinical trial, per treatment session",09-10-2025
G2001001003,Brief (20 minutes) in-home visit for a new patient post-discharge. for use only,09-10-2025
G2001002004,In a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G2001003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G2001004004,Facility within 90 days following discharge from an inpatient facility and no,09-10-2025
G2001005004,More than 9 times.),09-10-2025
G2002001003,Limited (30 minutes) in-home visit for a new patient post-discharge. for use,09-10-2025
G2002002004,Only in a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G2002003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G2002004004,Facility within 90 days following discharge from an inpatient facility and no,09-10-2025
G2002005004,More than 9 times.),09-10-2025
G2003001003,Moderate (45 minutes) in-home visit for a new patient post-discharge. for use,09-10-2025
G2003002004,Only in a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G2003003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G2003004004,Facility within 90 days following discharge from an inpatient facility and no,09-10-2025
G2003005004,More than 9 times.),09-10-2025
G2004001003,Comprehensive (60 minutes) in-home visit for a new patient post-discharge. for,09-10-2025
G2004002004,Use only in a medicare-approved cmmi model. (services must be furnished within,09-10-2025
G2004003004,"A beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G2004004004,Facility within 90 days following discharge from an inpatient facility and no,09-10-2025
G2004005004,More than 9 times.),09-10-2025
G2005001003,Extensive (75 minutes) in-home visit for a new patient post-discharge. for use,09-10-2025
G2005002004,Only in a medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G2005003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G2005004004,Facility within 90 days following discharge from an inpatient facility and no,09-10-2025
G2005005004,More than 9 times.),09-10-2025
G2006001003,Brief (20 minutes) in-home visit for an existing patient post-discharge. for,09-10-2025
G2006002004,Use only in a medicare-approved cmmi model. (services must be furnished within,09-10-2025
G2006003004,"A beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G2006004004,Facility within 90 days following discharge from an inpatient facility and no,09-10-2025
G2006005004,More than 9 times.),09-10-2025
G2007001003,Limited (30 minutes) in-home visit for an existing patient post-discharge. for,09-10-2025
G2007002004,Use only in a medicare-approved cmmi model. (services must be furnished within,09-10-2025
G2007003004,"A beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G2007004004,Facility within 90 days following discharge from an inpatient facility and no,09-10-2025
G2007005004,More than 9 times.),09-10-2025
G2008001003,Moderate (45 minutes) in-home visit for an existing patient post-discharge. for,09-10-2025
G2008002004,Use only in a medicare-approved cmmi model. (services must be furnished within,09-10-2025
G2008003004,"A beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G2008004004,Facility within 90 days following discharge from an inpatient facility and no,09-10-2025
G2008005004,More than 9 times.),09-10-2025
G2009001003,Comprehensive (60 minutes) in-home visit for an existing patient,09-10-2025
G2009002004,Post-discharge. for use only in a medicare-approved cmmi model. (services must,09-10-2025
G2009003004,"Be furnished within a beneficiary's home, domiciliary, rest home, assisted",09-10-2025
G2009004004,Living and/or nursing facility within 90 days following discharge from an,09-10-2025
G2009005004,Inpatient facility and no more than 9 times.),09-10-2025
G2010001003,Remote evaluation of recorded video and/or images submitted by an established,09-10-2025
G2010002004,"Patient (e.g., store and forward), including interpretation with follow-up with",09-10-2025
G2010003004,"The patient within 24 business hours, not originating from a related e/m",09-10-2025
G2010004004,Service provided within the previous 7 days nor leading to an e/m service or,09-10-2025
G2010005004,Procedure within the next 24 hours or soonest available appointment,09-10-2025
G2011001003,Alcohol and/or substance (other than tobacco) misuse structured assessment,09-10-2025
G2011002004,"(e.g., audit, dast), and brief intervention, 5-14 minutes",09-10-2025
G2012001003,"Brief communication technology-based service, e.g. virtual check-in, by a",09-10-2025
G2012002004,Physician or other qualified health care professional who can report evaluation,09-10-2025
G2012003004,"And management services, provided to an established patient, not originating",09-10-2025
G2012004004,From a related e/m service provided within the previous 7 days nor leading to,09-10-2025
G2012005004,An e/m service or procedure within the next 24 hours or soonest available,09-10-2025
G2012006004,Appointment; 5-10 minutes of medical discussion,09-10-2025
G2013001003,Extensive (75 minutes) in-home visit for an existing patient post-discharge.,09-10-2025
G2013002004,For use only in a medicare-approved cmmi model. (services must be furnished,09-10-2025
G2013003004,"Within a beneficiary's home, domiciliary, rest home, assisted living and/or",09-10-2025
G2013004004,Nursing facility within 90 days following discharge from an inpatient facility,09-10-2025
G2013005004,And no more than 9 times.),09-10-2025
G2014001003,Limited (30 minutes) care plan oversight. for use only in a medicare-approved,09-10-2025
G2014002004,"Cmmi model. (services must be furnished within a beneficiary's home,",09-10-2025
G2014003004,"Domiciliary, rest home, assisted living and/or nursing facility within 90 days",09-10-2025
G2014004004,Following discharge from an inpatient facility and no more than 9 times.),09-10-2025
G2015001003,Comprehensive (60 mins) home care plan oversight. for use only in a,09-10-2025
G2015002004,Medicare-approved cmmi model. (services must be furnished within a,09-10-2025
G2015003004,"Beneficiary's home, domiciliary, rest home, assisted living and/or nursing",09-10-2025
G2015004004,Facility within 90 days following discharge from an inpatient facility.),09-10-2025
G2020001003,Services for high intensity clinical services associated with the initial,09-10-2025
G2020002004,Engagement and outreach of beneficiaries assigned to the sip component of the,09-10-2025
G2020003004,Pcf model (do not bill with chronic care management codes),09-10-2025
G2021001003,Health care practitioners rendering treatment in place (tip),09-10-2025
G2022001003,"A model participant (ambulance supplier/provider), the beneficiary refuses",09-10-2025
G2022002004,Services covered under the model (transport to an alternate,09-10-2025
G2022003004,Destination/treatment in place),09-10-2025
G2023001003,Specimen collection for severe acute respiratory syndrome coronavirus 2,09-10-2025
G2023002004,"(sars-cov-2) (coronavirus disease [covid-19]), any specimen source",09-10-2025
G2024001003,Specimen collection for severe acute respiratory syndrome coronavirus 2,09-10-2025
G2024002004,(sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or,09-10-2025
G2024003004,"By a laboratory on behalf of a hha, any specimen source",09-10-2025
G2025001003,Payment for a telehealth distant site service furnished by a rural health,09-10-2025
G2025002004,Clinic (rhc) or federally qualified health center (fqhc) only,09-10-2025
G2058001003,"Chronic care management services, each additional 20 minutes of clinical staff",09-10-2025
G2058002004,"Time directed by a physician or other qualified health care professional, per",09-10-2025
G2058003004,Calendar month (list separately in addition to code for primary procedure). (do,09-10-2025
G2058004004,Not report g2058 for care management services of less than 20 minutes,09-10-2025
G2058005004,Additional to the first 20 minutes of chronic care management services during a,09-10-2025
G2058006004,"Calendar month). (use g2058 in conjunction with 99490). (do not report 99490,",09-10-2025
G2058007004,"G2058 in the same calendar month as 99487, 99489, 99491)).",09-10-2025
G2061001003,Qualified nonphysician healthcare professional online assessment and management,09-10-2025
G2061002004,"Service, for an established patient, for up to seven days, cumulative time",09-10-2025
G2061003004,During the 7 days; 5-10 minutes,09-10-2025
G2062001003,Qualified nonphysician healthcare professional online assessment and management,09-10-2025
G2062002004,"Service, for an established patient, for up to seven days, cumulative time",09-10-2025
G2062003004,During the 7 days; 11-20 minutes,09-10-2025
G2063001003,Qualified nonphysician healthcare professional online assessment and management,09-10-2025
G2063002004,"Service, for an established patient, for up to seven days, cumulative time",09-10-2025
G2063003004,During the 7 days; 21 or more minutes,09-10-2025
G2064001003,"Comprehensive care management services for a single high-risk disease, e.g.,",09-10-2025
G2064002004,"Principal care management, at least 30 minutes of physician or other qualified",09-10-2025
G2064003004,Health care professional time per calendar month with the following elements:,09-10-2025
G2064004004,"One complex chronic condition lasting at least 3 months, which is the focus",09-10-2025
G2064005004,"Of the care plan, the condition is of sufficient severity to place patient at",09-10-2025
G2064006004,"Risk of hospitalization or have been the cause of a recent hospitalization, the",09-10-2025
G2064007004,"Condition requires development or revision of disease-specific care plan, the",09-10-2025
G2064008004,"Condition requires frequent adjustments in the medication regimen, and/or the",09-10-2025
G2064009004,Management of the condition is unusually complex due to comorbidities,09-10-2025
G2065001003,"Comprehensive care management for a single high-risk disease services, e.g.",09-10-2025
G2065002004,"Principal care management, at least 30 minutes of clinical staff time directed",09-10-2025
G2065003004,"By a physician or other qualified health care professional, per calendar month",09-10-2025
G2065004004,With the following elements: one complex chronic condition lasting at least 3,09-10-2025
G2065005004,"Months, which is the focus of the care plan, the condition is of sufficient",09-10-2025
G2065006004,Severity to place patient at risk of hospitalization or have been cause of a,09-10-2025
G2065007004,"Recent hospitalization, the condition requires development or revision of",09-10-2025
G2065008004,"Disease-specific care plan, the condition requires frequent adjustments in the",09-10-2025
G2065009004,"Medication regimen, and/or the management of the condition is unusually complex",09-10-2025
G2065010004,Due to comorbidities,09-10-2025
G2066001003,"Interrogation device evaluation(s), (remote) up to 30 days; implantable",09-10-2025
G2066002004,"Cardiovascular physiologic monitor system, implantable loop recorder system, or",09-10-2025
G2066003004,"Subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt",09-10-2025
G2066004004,"Of transmissions and technician review, technical support and distribution of",09-10-2025
G2066005004,Results,09-10-2025
G2067001003,"Medication assisted treatment, methadone; weekly bundle including dispensing",09-10-2025
G2067002004,"And/or administration, substance use counseling, individual and group therapy,",09-10-2025
G2067003004,"And toxicology testing, if performed (provision of the services by a",09-10-2025
G2067004004,Medicare-enrolled opioid treatment program),09-10-2025
G2068001003,"Medication assisted treatment, buprenorphine (oral); weekly bundle including",09-10-2025
G2068002004,"Dispensing and/or administration, substance use counseling, individual and",09-10-2025
G2068003004,"Group therapy, and toxicology testing if performed (provision of the services",09-10-2025
G2068004004,By a medicare-enrolled opioid treatment program),09-10-2025
G2069001003,"Medication assisted treatment, buprenorphine (injectable) administered on a",09-10-2025
G2069002004,"Monthly basis; bundle including dispensing and/or administration, substance use",09-10-2025
G2069003004,"Counseling, individual and group therapy, and toxicology testing if performed",09-10-2025
G2069004004,(provision of the services by a medicare-enrolled opioid treatment program),09-10-2025
G2070001003,"Medication assisted treatment, buprenorphine (implant insertion); weekly bundle",09-10-2025
G2070002004,"Including dispensing and/or administration, substance use counseling,",09-10-2025
G2070003004,"Individual and group therapy, and toxicology testing if performed (provision of",09-10-2025
G2070004004,The services by a medicare-enrolled opioid treatment program),09-10-2025
G2071001003,"Medication assisted treatment, buprenorphine (implant removal); weekly bundle",09-10-2025
G2071002004,"Including dispensing and/or administration, substance use counseling,",09-10-2025
G2071003004,"Individual and group therapy, and toxicology testing if performed (provision of",09-10-2025
G2071004004,The services by a medicare-enrolled opioid treatment program),09-10-2025
G2072001003,"Medication assisted treatment, buprenorphine (implant insertion and removal);",09-10-2025
G2072002004,"Weekly bundle including dispensing and/or administration, substance use",09-10-2025
G2072003004,"Counseling, individual and group therapy, and toxicology testing if performed",09-10-2025
G2072004004,(provision of the services by a medicare-enrolled opioid treatment program),09-10-2025
G2073001003,"Medication assisted treatment, naltrexone; weekly bundle including dispensing",09-10-2025
G2073002004,"And/or administration, substance use counseling, individual and group therapy,",09-10-2025
G2073003004,And toxicology testing if performed (provision of the services by a,09-10-2025
G2073004004,Medicare-enrolled opioid treatment program),09-10-2025
G2074001003,"Medication assisted treatment, weekly bundle not including the drug, including",09-10-2025
G2074002004,"Substance use counseling, individual and group therapy, and toxicology testing",09-10-2025
G2074003004,If performed (provision of the services by a medicare-enrolled opioid treatment,09-10-2025
G2074004004,Program),09-10-2025
G2075001003,"Medication assisted treatment, medication not otherwise specified; weekly",09-10-2025
G2075002004,"Bundle including dispensing and/or administration, substance use counseling,",09-10-2025
G2075003004,"Individual and group therapy, and toxicology testing, if performed (provision",09-10-2025
G2075004004,Of the services by a medicare-enrolled opioid treatment program),09-10-2025
G2076001003,"Intake activities, including initial medical examination that is conducted by",09-10-2025
G2076002004,"An appropriately licensed practitioner and preparation of a care plan, which",09-10-2025
G2076003004,"May be informed by administration of a standardized, evidence-based social",09-10-2025
G2076004004,Determinants of health risk assessment to identify unmet health-related social,09-10-2025
G2076005004,"Needs, and that includes the patient's goals and mutually agreed-upon actions",09-10-2025
G2076006004,"For the patient to meet those goals, including harm reduction interventions;",09-10-2025
G2076007004,"The patient's needs and goals in the areas of education, vocational training,",09-10-2025
G2076008004,"And employment; and the medical and psychiatric, psychosocial, economic, legal,",09-10-2025
G2076009004,"Housing, and other recovery support services that a patient needs and wishes to",09-10-2025
G2076010004,"Pursue, conducted by an appropriately licensed/credentialed personnel",09-10-2025
G2076011004,(provision of the services by a medicare-enrolled opioid treatment program);,09-10-2025
G2076012004,List separately in addition to each primary code,09-10-2025
G2077001003,Periodic assessment; assessing periodically by an otp practitioner and includes,09-10-2025
G2077002004,"A review of moud dosing, treatment response, other substance use disorder",09-10-2025
G2077003004,"Treatment needs, responses and patient-identified goals, and other relevant",09-10-2025
G2077004004,Physical and psychiatric treatment needs and goals; assessment may be informed,09-10-2025
G2077005004,"By administration of a standardized, evidence-based social determinants of",09-10-2025
G2077006004,"Health risk assessment to identify unmet health-related social needs, or the",09-10-2025
G2077007004,Need and interest for harm reduction interventions and recovery support,09-10-2025
G2077008004,Services (provision of the services by a medicare-enrolled opioid treatment,09-10-2025
G2077009004,Program); list separately in addition to each primary code,09-10-2025
G2078001003,Take-home supply of methadone; up to 7 additional day supply (provision of the,09-10-2025
G2078002004,Services by a medicare-enrolled opioid treatment program); list separately in,09-10-2025
G2078003004,Addition to code for primary procedure,09-10-2025
G2079001003,Take-home supply of buprenorphine (oral); up to 7 additional day supply,09-10-2025
G2079002004,(provision of the services by a medicare-enrolled opioid treatment program);,09-10-2025
G2079003004,List separately in addition to code for primary procedure,09-10-2025
G2080001003,Each additional 30 minutes of counseling in a week of medication assisted,09-10-2025
G2080002004,"Treatment, (provision of the services by a medicare-enrolled opioid treatment",09-10-2025
G2080003004,Program); list separately in addition to code for primary procedure,09-10-2025
G2081001003,Patients age 66 and older in institutional special needs plans (snp) or,09-10-2025
G2081002004,"Residing in long-term care with a pos code 32, 33, 34, 54 or 56 for more than",09-10-2025
G2081003004,90 consecutive days during the measurement period,09-10-2025
G2082001003,Office or other outpatient visit for the evaluation and management of an,09-10-2025
G2082002004,Established patient that requires the supervision of a physician or other,09-10-2025
G2082003004,Qualified health care professional and provision of up to 56 mg of esketamine,09-10-2025
G2082004004,"Nasal self-administration, includes 2 hours post-administration observation",09-10-2025
G2083001003,Office or other outpatient visit for the evaluation and management of an,09-10-2025
G2083002004,Established patient that requires the supervision of a physician or other,09-10-2025
G2083003004,Qualified health care professional and provision of greater than 56 mg,09-10-2025
G2083004004,"Esketamine nasal self-administration, includes 2 hours post-administration",09-10-2025
G2083005004,Observation,09-10-2025
G2086001003,"Office-based treatment for opioid use disorder, including development of the",09-10-2025
G2086002004,"Treatment plan, care coordination, individual therapy and group therapy and",09-10-2025
G2086003004,Counseling; at least 70 minutes in the first calendar month,09-10-2025
G2087001003,"Office-based treatment for opioid use disorder, including care coordination,",09-10-2025
G2087002004,Individual therapy and group therapy and counseling; at least 60 minutes in a,09-10-2025
G2087003004,Subsequent calendar month,09-10-2025
G2088001003,"Office-based treatment for opioid use disorder, including care coordination,",09-10-2025
G2088002004,Individual therapy and group therapy and counseling; each additional 30 minutes,09-10-2025
G2088003004,Beyond the first 120 minutes (list separately in addition to code for primary,09-10-2025
G2088004004,Procedure),09-10-2025
G2089001003,Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0%,09-10-2025
G2090001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2090002004,Frailty during the measurement period and a dispensed medication for dementia,09-10-2025
G2090003004,During the measurement period or the year prior to the measurement period,09-10-2025
G2091001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2091002004,Frailty during the measurement period and an advanced illness diagnosis during,09-10-2025
G2091003004,The measurement period or the year prior to the measurement period,09-10-2025
G2092001003,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker,09-10-2025
G2092002004,(arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy prescribed or,09-10-2025
G2092003004,Currently being taken,09-10-2025
G2093001003,Documentation of medical reason(s) for not prescribing ace inhibitor or arb or,09-10-2025
G2093002004,"Arni therapy (e.g., hypotensive patients who are at immediate risk of",09-10-2025
G2093003004,"Cardiogenic shock, hospitalized patients who have experienced marked azotemia,",09-10-2025
G2093004004,"Allergy, intolerance, other medical reasons)",09-10-2025
G2094001003,Documentation of patient reason(s) for not prescribing ace inhibitor or arb or,09-10-2025
G2094002004,"Arni therapy (e.g., patient declined, other patient reasons)",09-10-2025
G2095001003,Documentation of system reason(s) for not prescribing ace inhibitor or arb or,09-10-2025
G2095002004,"Arni therapy (e.g., other system reasons)",09-10-2025
G2096001003,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker,09-10-2025
G2096002004,(arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not,09-10-2025
G2096003004,"Prescribed, reason not given",09-10-2025
G2097001003,Episodes where the patient had a competing diagnosis on or within three days,09-10-2025
G2097002004,"After the episode date (e.g., intestinal infection, pertussis, bacterial",09-10-2025
G2097003004,"Infection, lyme disease, otitis media, acute sinusitis, chronic sinusitis,",09-10-2025
G2097004004,"Infection of the adenoids, prostatitis, cellulitis, mastoiditis, or bone",09-10-2025
G2097005004,"Infections, acute lymphadenitis, impetigo, skin staph infections,",09-10-2025
G2097006004,"Pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia,",09-10-2025
G2097007004,"Inflammatory diseases [female reproductive organs]), infections of the kidney,",09-10-2025
G2097008004,Cystitis or uti),09-10-2025
G2098001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2098002004,Frailty during the measurement period and a dispensed medication for dementia,09-10-2025
G2098003004,During the measurement period or the year prior to the measurement period,09-10-2025
G2099001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2099002004,Frailty during the measurement period and an advanced illness diagnosis during,09-10-2025
G2099003004,The measurement period or the year prior to the measurement period,09-10-2025
G2100001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2100002004,Frailty during the measurement period and a dispensed medication for dementia,09-10-2025
G2100003004,During the measurement period or the year prior to the measurement period,09-10-2025
G2101001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2101002004,Frailty during the measurement period and an advanced illness diagnosis during,09-10-2025
G2101003004,The measurement period or the year prior to the measurement period,09-10-2025
G2102001003,Dilated retinal eye exam with interpretation by an ophthalmologist or,09-10-2025
G2102002004,Optometrist documented and reviewed,09-10-2025
G2103001003,Seven standard field stereoscopic photos with interpretation by an,09-10-2025
G2103002004,Ophthalmologist or optometrist documented and reviewed,09-10-2025
G2104001003,Eye imaging validated to match diagnosis from seven standard field stereoscopic,09-10-2025
G2104002004,Photos results documented and reviewed,09-10-2025
G2105001003,Patient age 66 or older in institutional special needs plans (snp) or residing,09-10-2025
G2105002004,"In long-term care with pos code 32, 33, 34, 54 or 56 for more than 90",09-10-2025
G2105003004,Consecutive days during the measurement period,09-10-2025
G2106001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2106002004,Frailty during the measurement period and a dispensed medication for dementia,09-10-2025
G2106003004,During the measurement period or the year prior to the measurement period,09-10-2025
G2107001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2107002004,Frailty during the measurement period and an advanced illness diagnosis during,09-10-2025
G2107003004,The measurement period or the year prior to the measurement period,09-10-2025
G2108001003,Patient age 66 or older in institutional special needs plans (snp) or residing,09-10-2025
G2108002004,"In long-term care with pos code 32, 33, 34, 54 or 56 for more than 90",09-10-2025
G2108003004,Consecutive days during the measurement period,09-10-2025
G2109001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2109002004,Frailty during the measurement period and a dispensed medication for dementia,09-10-2025
G2109003004,During the measurement period or the year prior to the measurement period,09-10-2025
G2110001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
G2110002004,Frailty during the measurement period and either one acute inpatient encounter,09-10-2025
G2110003004,"With a diagnosis of advanced illness or two outpatient, observation, ed or",09-10-2025
G2110004004,Nonacute inpatient encounters on different dates of service with an advanced,09-10-2025
G2110005004,Illness diagnosis during the measurement period or the year prior to the,09-10-2025
G2110006004,Measurement period,09-10-2025
G2112001003,"Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is",09-10-2025
G2112002004,"Worsening, or glucocorticoid use is for less than 6 months",09-10-2025
G2113001003,Patient receiving >5 mg daily prednisone (or equivalent) for longer than 6,09-10-2025
G2113002004,"Months, and improvement or no change in disease activity",09-10-2025
G2114001003,Patients 66-80 years of age with at least one claim/encounter for frailty,09-10-2025
G2114002004,During the measurement period and a dispensed medication for dementia during,09-10-2025
G2114003004,The measurement period or the year prior to the measurement period,09-10-2025
G2115001003,Patients 66 - 80 years of age with at least one claim/encounter for frailty,09-10-2025
G2115002004,During the measurement period and a dispensed medication for dementia during,09-10-2025
G2115003004,The measurement period or the year prior to the measurement period,09-10-2025
G2116001003,Patients 66 - 80 years of age with at least one claim/encounter for frailty,09-10-2025
G2116002004,During the measurement period and an advanced illness diagnosis during the,09-10-2025
G2116003004,Measurement period or the year prior to the measurement period,09-10-2025
G2117001003,Patients 66-80 years of age with at least one claim/encounter for frailty,09-10-2025
G2117002004,During the measurement period and either one acute inpatient encounter with a,09-10-2025
G2117003004,"Diagnosis of advanced illness or two outpatient, observation, ed or nonacute",09-10-2025
G2117004004,Inpatient encounters on different dates of service with an advanced illness,09-10-2025
G2117005004,Diagnosis during the measurement period or the year prior to the measurement,09-10-2025
G2117006004,Period,09-10-2025
G2118001003,Patients 81 years of age and older with at least one claim/encounter for,09-10-2025
G2118002004,Frailty during the measurement period,09-10-2025
G2119001003,"Within the past 2 years, calcium and/or vitamin d optimization has been ordered",09-10-2025
G2119002004,Or performed,09-10-2025
G2120001003,"Within the past 2 years, calcium and/or vitamin d optimization has not been",09-10-2025
G2120002004,Ordered or performed,09-10-2025
G2121001003,"Depression, anxiety, apathy, and psychosis assessed",09-10-2025
G2122001003,"Depression, anxiety, apathy, and psychosis not assessed",09-10-2025
G2123001003,Patients 66-80 years of age and had at least one claim/encounter for frailty,09-10-2025
G2123002004,During the measurement period and either one acute inpatient encounter with a,09-10-2025
G2123003004,"Diagnosis of advanced illness or two outpatient, observation, ed or nonacute",09-10-2025
G2123004004,Inpatient encounters on different dates of service with an advanced illness,09-10-2025
G2123005004,Diagnosis during the measurement period or the year prior to the measurement,09-10-2025
G2123006004,Period,09-10-2025
G2124001003,Patients 66-80 years of age and had at least one claim/encounter for frailty,09-10-2025
G2124002004,During the measurement period and a dispensed dementia medication,09-10-2025
G2125001003,Patients 81 years of age and older with at least one claim/encounter for,09-10-2025
G2125002004,Frailty during the six months prior to the measurement period through december,09-10-2025
G2125003004,31 of the measurement period,09-10-2025
G2126001003,Patients 66-80 years of age with at least one claim/encounter for frailty,09-10-2025
G2126002004,During the measurement period and an advanced illness diagnosis during the,09-10-2025
G2126003004,Measurement period or the year prior to the measurement period,09-10-2025
G2127001003,Patients 66-80 years of age with at least one claim/encounter for frailty,09-10-2025
G2127002004,During the measurement period and a dispensed medication for dementia during,09-10-2025
G2127003004,The measurement period or the year prior to the measurement period,09-10-2025
G2128001003,Documentation of medical reason(s) for not on a daily aspirin or other,09-10-2025
G2128002004,"Antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed,",09-10-2025
G2128003004,"Blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or",09-10-2025
G2128004004,Documentation of active anticoagulant use during the measurement period),09-10-2025
G2129001003,Procedure-related bp's not taken during an outpatient visit. examples include,09-10-2025
G2129002004,"Same day surgery, ambulatory service center, g.i. lab, dialysis, infusion",09-10-2025
G2129003004,"Center, chemotherapy",09-10-2025
G2130001003,Patients age 66 or older in institutional special needs plans (snp) or residing,09-10-2025
G2130002004,"In long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days",09-10-2025
G2130003004,During the measurement period,09-10-2025
G2131001003,Patients 81 years and older with a diagnosis of frailty,09-10-2025
G2132001003,Patients 66-80 years of age with at least one claim/encounter for frailty,09-10-2025
G2132002004,During the measurement period and a dispensed medication for dementia during,09-10-2025
G2132003004,The measurement period or the year prior to the measurement period,09-10-2025
G2133001003,Patients 66-80 years of age with at least one claim/encounter for frailty,09-10-2025
G2133002004,During the measurement period and either one acute inpatient encounter with a,09-10-2025
G2133003004,"Diagnosis of advanced illness or two outpatient, observation, ed or nonacute",09-10-2025
G2133004004,Inpatient encounters on different dates of service with an advanced illness,09-10-2025
G2133005004,Diagnosis during the measurement period or the year prior to the measurement,09-10-2025
G2133006004,Period,09-10-2025
G2134001003,Patients 66 years of age or older with at least one claim/encounter for frailty,09-10-2025
G2134002004,During the measurement period and a dispensed medication for dementia during,09-10-2025
G2134003004,The measurement period or the year prior to the measurement period,09-10-2025
G2135001003,Patients 66 years of age or older with at least one claim/encounter for frailty,09-10-2025
G2135002004,During the measurement period and either one acute inpatient encounter with a,09-10-2025
G2135003004,"Diagnosis of advanced illness or two outpatient, observation, ed or nonacute",09-10-2025
G2135004004,Inpatient encounters on different dates of service with an advanced illness,09-10-2025
G2135005004,Diagnosis during the measurement period or the year prior to the measurement,09-10-2025
G2135006004,Period,09-10-2025
G2136001003,Back pain measured by the visual analog scale (vas) or numeric pain scale at,09-10-2025
G2136002004,Three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or,09-10-2025
G2136003004,Back pain measured by the visual analog scale (vas) or numeric pain scale,09-10-2025
G2136004004,Within three months preoperatively and at three months (6 - 20 weeks),09-10-2025
G2136005004,Postoperatively demonstrated an improvement of 5.0 points or greater,09-10-2025
G2137001003,Back pain measured by the visual analog scale (vas) or numeric pain scale at,09-10-2025
G2137002004,Three months (6 - 20 weeks) postoperatively was greater than 3.0 and back pain,09-10-2025
G2137003004,Measured by the visual analog scale (vas) or numeric pain scale within three,09-10-2025
G2137004004,Months preoperatively and at three months (6 - 20 weeks) postoperatively,09-10-2025
G2137005004,Demonstrated improvement of less than 5.0 points,09-10-2025
G2138001003,Back pain as measured by the visual analog scale (vas) or numeric pain scale at,09-10-2025
G2138002004,One year (9 to 15 months) postoperatively was less than or equal to 3.0 or back,09-10-2025
G2138003004,Pain measured by the visual analog scale (vas) or numeric pain scale within,09-10-2025
G2138004004,Three months preoperatively and at one year (9 to 15 months) postoperatively,09-10-2025
G2138005004,Demonstrated an improvement of 5.0 points or greater,09-10-2025
G2139001003,Back pain measured by the visual analog scale (vas) or numeric pain scale at,09-10-2025
G2139002004,One year (9 to 15 months) postoperatively was greater than 3.0 and back pain,09-10-2025
G2139003004,Measured by the visual analog scale (vas) or numeric pain scale within three,09-10-2025
G2139004004,Months preoperatively and at one year (9 to 15 months) postoperatively,09-10-2025
G2139005004,Demonstrated improvement of less than 5.0 points,09-10-2025
G2140001003,Leg pain measured by the visual analog scale (vas) or numeric pain scale at,09-10-2025
G2140002004,Three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or,09-10-2025
G2140003004,Leg pain measured by the visual analog scale (vas) or numeric pain scale within,09-10-2025
G2140004004,Three months preoperatively and at three months (6 - 20 weeks) postoperatively,09-10-2025
G2140005004,Demonstrated an improvement of 5.0 points or greater,09-10-2025
G2141001003,Leg pain measured by the visual analog scale (vas) or numeric pain scale at,09-10-2025
G2141002004,Three months (6 - 20 weeks) postoperatively was greater than 3.0 and leg pain,09-10-2025
G2141003004,Measured by the visual analog scale (vas) or numeric pain scale within three,09-10-2025
G2141004004,Months preoperatively and at three months (6 - 20 weeks) postoperatively,09-10-2025
G2141005004,Demonstrated improvement of less than 5.0 points,09-10-2025
G2142001003,Functional status measured by the oswestry disability index (odi version 2.1a),09-10-2025
G2142002004,At one year (9 to 15 months) postoperatively was less than or equal to 22 or,09-10-2025
G2142003004,Functional status measured by the odi version 2.1a within three months,09-10-2025
G2142004004,Preoperatively and at one year (9 to 15 months) postoperatively demonstrated an,09-10-2025
G2142005004,Improvement of 30 points or greater,09-10-2025
G2143001003,Functional status measured by the oswestry disability index (odi version 2.1a),09-10-2025
G2143002004,At one year (9 to 15 months) postoperatively was greater than 22 and functional,09-10-2025
G2143003004,Status measured by the odi version 2.1a within three months preoperatively and,09-10-2025
G2143004004,At one year (9 to 15 months) postoperatively demonstrated an improvement of,09-10-2025
G2143005004,Less than 30 points,09-10-2025
G2144001003,Functional status measured by the oswestry disability index (odi version 2.1a),09-10-2025
G2144002004,At three months (6-20 weeks) postoperatively was less than or equal to 22 or,09-10-2025
G2144003004,Functional status measured by the odi version 2.1a within three months,09-10-2025
G2144004004,Preoperatively and at three months (6-20 weeks) postoperatively demonstrated an,09-10-2025
G2144005004,Improvement of 30 points or greater,09-10-2025
G2145001003,Functional status measured by the oswestry disability index (odi version 2.1a),09-10-2025
G2145002004,At three months (6 - 20 weeks) postoperatively was greater than 22 and,09-10-2025
G2145003004,Functional status measured by the odi version 2.1a within three months,09-10-2025
G2145004004,Preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated,09-10-2025
G2145005004,An improvement of less than 30 points,09-10-2025
G2146001003,Leg pain as measured by the visual analog scale (vas) or numeric pain scale at,09-10-2025
G2146002004,One year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg,09-10-2025
G2146003004,Pain measured by the visual analog scale (vas) or numeric pain scale within,09-10-2025
G2146004004,Three months preoperatively and at one year (9 to 15 months) postoperatively,09-10-2025
G2146005004,Demonstrated an improvement of 5.0 points or greater,09-10-2025
G2147001003,Leg pain measured by the visual analog scale (vas) or numeric pain scale at one,09-10-2025
G2147002004,Year (9 to 15 months) postoperatively was greater than 3.0 and leg pain,09-10-2025
G2147003004,Measured by the visual analog scale (vas) or numeric pain scale within three,09-10-2025
G2147004004,Months preoperatively and at one year (9 to 15 months) postoperatively,09-10-2025
G2147005004,Demonstrated improvement of less than 5.0 points,09-10-2025
G2148001003,Multimodal pain management was used,09-10-2025
G2149001003,Documentation of medical reason(s) for not using multimodal pain management,09-10-2025
G2149002004,"(e.g., allergy to multiple classes of analgesics, intubated patient, hepatic",09-10-2025
G2149003004,"Failure, patient reports no pain during pacu stay, other medical reason(s))",09-10-2025
G2150001003,Multimodal pain management was not used,09-10-2025
G2151001003,Documentation stating patient has a diagnosis of a degenerative neurological,09-10-2025
G2151002004,"Condition such as als, ms, or parkinson's diagnosed at any time before or",09-10-2025
G2151003004,During the episode of care,09-10-2025
G2152001003,Residual score for the neck impairment successfully calculated and the score,09-10-2025
G2152002004,Was equal to zero (0) or greater than zero (> 0),09-10-2025
G2153001003,In hospice or using hospice services during the measurement period,09-10-2025
G2154001003,Patient received at least one td vaccine or one tdap vaccine between nine years,09-10-2025
G2154002004,Prior to the start of the measurement period and the end of the measurement,09-10-2025
G2154003004,Period,09-10-2025
G2155001003,Patient had history of at least one of the following contraindications any time,09-10-2025
G2155002004,"During or before the measurement period: anaphylaxis due to tdap vaccine,",09-10-2025
G2155003004,Anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or,09-10-2025
G2155004004,"Td vaccination (post tetanus vaccination encephalitis, post diphtheria",09-10-2025
G2155005004,Vaccination encephalitis or post pertussis vaccination encephalitis.),09-10-2025
G2156001003,Patient did not receive at least one td vaccine or one tdap vaccine between,09-10-2025
G2156002004,Nine years prior to the start of the measurement period and the end of the,09-10-2025
G2156003004,Measurement period; or have history of at least one of the following,09-10-2025
G2156004004,Contraindications any time during or before the measurement period: anaphylaxis,09-10-2025
G2156005004,"Due to tdap vaccine, anaphylaxis due to td vaccine or its components;",09-10-2025
G2156006004,Encephalopathy due to tdap or td vaccination (post tetanus vaccination,09-10-2025
G2156007004,"Encephalitis, post diphtheria vaccination encephalitis or post pertussis",09-10-2025
G2156008004,Vaccination encephalitis.),09-10-2025
G2157001003,Patients received both the 13-valent pneumococcal conjugate vaccine and the,09-10-2025
G2157002004,"23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with",09-10-2025
G2157003004,The first occurrence after the age of 60 before or during the measurement perio,09-10-2025
G2158001003,Patient had prior pneumococcal vaccine adverse reaction any time during or,09-10-2025
G2158002004,Before the measurement period,09-10-2025
G2159001003,Patient did not receive both the 13-valent pneumococcal conjugate vaccine and,09-10-2025
G2159002004,"The 23-valent pneumococcal polysaccharide vaccine at least 12 months apart,",09-10-2025
G2159003004,With the first occurrence after the age of 60 before or during measurement,09-10-2025
G2159004004,Period; or have prior pneumococcal vaccine adverse reaction any time during or,09-10-2025
G2159005004,Before the measurement period,09-10-2025
G2160001003,Patient received at least one dose of the herpes zoster live vaccine or two,09-10-2025
G2160002004,Doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime,09-10-2025
G2160003004,On or after the patient's 50th birthday before or during the measurement period,09-10-2025
G2161001003,Patient had prior adverse reaction caused by zoster vaccine or its components,09-10-2025
G2161002004,Any time during or before the measurement period,09-10-2025
G2162001003,Patient did not receive at least one dose of the herpes zoster live vaccine or,09-10-2025
G2162002004,Two doses of the herpes zoster recombinant vaccine (at least 28 days apart),09-10-2025
G2162003004,Anytime on or after the patient's 50th birthday before or during the,09-10-2025
G2162004004,Measurement period; or have prior adverse reaction caused by zoster vaccine or,09-10-2025
G2162005004,Its components any time during or before the measurement period,09-10-2025
G2163001003,Patient received an influenza vaccine on or between july 1 of the year prior to,09-10-2025
G2163002004,The measurement period and june 30 of the measurement period,09-10-2025
G2164001003,Patient had a prior influenza virus vaccine adverse reaction any time before or,09-10-2025
G2164002004,During the measurement period,09-10-2025
G2165001003,Patient did not receive an influenza vaccine on or between july 1 of the year,09-10-2025
G2165002004,Prior to the measurement period and june 30 of the measurement period; or did,09-10-2025
G2165003004,Not have a prior influenza virus vaccine adverse reaction any time before or,09-10-2025
G2165004004,During the measurement period,09-10-2025
G2166001003,Patient refused to participate at admission and/or discharge; patient unable to,09-10-2025
G2166002004,"Complete the neck fs prom at admission or discharge due to cognitive deficit,",09-10-2025
G2166003004,"Visual deficit, motor deficit, language barrier, or low reading level, and a",09-10-2025
G2166004004,Suitable proxy/recorder is not available; patient self-discharged early;,09-10-2025
G2166005004,Medical reason,09-10-2025
G2167001003,Residual score for the neck impairment successfully calculated and the score,09-10-2025
G2167002004,Was less than zero (< 0),09-10-2025
G2168001003,Services performed by a physical therapist assistant in the home health setting,09-10-2025
G2168002004,"In the delivery of a safe and effective physical therapy maintenance program,",09-10-2025
G2168003004,Each 15 minutes,09-10-2025
G2169001003,Services performed by an occupational therapist assistant in the home health,09-10-2025
G2169002004,Setting in the delivery of a safe and effective occupational therapy,09-10-2025
G2169003004,"Maintenance program, each 15 minutes",09-10-2025
G2170001003,"Percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue",09-10-2025
G2170002004,"Approximation using thermal resistance energy, and secondary procedures to",09-10-2025
G2170003004,"Redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization)",09-10-2025
G2170004004,"When performed, and includes all imaging and radiologic guidance, supervision",09-10-2025
G2170005004,"And interpretation, when performed",09-10-2025
G2171001003,"Percutaneous arteriovenous fistula creation (avf), direct, any site, using",09-10-2025
G2171002004,"Magnetic-guided arterial and venous catheters and radiofrequency energy,",09-10-2025
G2171003004,"Including flow-directing procedures (e.g., vascular coil embolization with",09-10-2025
G2171004004,"Radiologic supervision and interpretation, wen performed) and fistulogram(s),",09-10-2025
G2171005004,"Angiography, enography, and/or ultrasound, with radiologic supervision and",09-10-2025
G2171006004,"Interpretation, when performed",09-10-2025
G2172001003,All inclusive payment for services related to highly coordinated and integrated,09-10-2025
G2172002004,Opioid use disorder (oud) treatment services furnished for the demonstration,09-10-2025
G2172003004,Project,09-10-2025
G2173001003,Uri episodes where the patient had a comorbid condition during the 12 months,09-10-2025
G2173002004,"Prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic",09-10-2025
G2173003004,"Fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid",09-10-2025
G2173004004,Lung disease),09-10-2025
G2174001003,Uri episodes where the patient is taking antibiotics (table 1) in the 30 days,09-10-2025
G2174002004,Prior to the episode date,09-10-2025
G2175001003,Episodes where the patient had a comorbid condition during the 12 months prior,09-10-2025
G2175002004,"To or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis,",09-10-2025
G2175003004,"Chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung",09-10-2025
G2175004004,Disease),09-10-2025
G2176001003,"Outpatient, ed, or observation visits that result in an inpatient admission",09-10-2025
G2177001003,Acute bronchitis/bronchiolitis episodes when the patient had a new or refill,09-10-2025
G2177002004,Prescription of antibiotics (table 1) in the 30 days prior to the episode date,09-10-2025
G2178001003,Clinician documented that patient was not an eligible candidate for lower,09-10-2025
G2178002004,"Extremity neurological exam measure, for example patient bilateral amputee;",09-10-2025
G2178003004,Patient has condition that would not allow them to accurately respond to a,09-10-2025
G2178004004,"Neurological exam (dementia, alzheimer's, etc.); patient has previously",09-10-2025
G2178005004,Documented diabetic peripheral neuropathy with loss of protective sensation,09-10-2025
G2179001003,Clinician documented that patient had medical reason for not performing lower,09-10-2025
G2179002004,Extremity neurological exam,09-10-2025
G2180001003,Clinician documented that patient was not an eligible candidate for evaluation,09-10-2025
G2180002004,Of footwear as patient is bilateral lower extremity amputee,09-10-2025
G2181001003,Bmi not documented due to medical reason or patient refusal of height or weight,09-10-2025
G2181002004,Measurement,09-10-2025
G2182001003,Patient receiving first-time biologic and/or immune response modifier therapy,09-10-2025
G2183001003,Documentation patient unable to communicate and informant not available,09-10-2025
G2184001003,Patient does not have a caregiver,09-10-2025
G2185001003,Documentation caregiver is trained and certified in dementia care,09-10-2025
G2186001003,Patient /caregiver dyad has been referred to appropriate resources and,09-10-2025
G2186002004,Connection to those resources is confirmed,09-10-2025
G2187001003,Patients with clinical indications for imaging of the head: head trauma,09-10-2025
G2188001003,Patients with clinical indications for imaging of the head: new or change in,09-10-2025
G2188002004,Headache above 50 years of age,09-10-2025
G2189001003,Patients with clinical indications for imaging of the head: abnormal neurologic,09-10-2025
G2189002004,Exam,09-10-2025
G2190001003,Patients with clinical indications for imaging of the head: headache radiating,09-10-2025
G2190002004,To the neck,09-10-2025
G2191001003,Patients with clinical indications for imaging of the head: positional headache,09-10-2025
G2192001003,Patients with clinical indications for imaging of the head: temporal headaches,09-10-2025
G2192002004,In patients over 55 years of age,09-10-2025
G2193001003,Patients with clinical indications for imaging of the head: new onset headache,09-10-2025
G2193002004,In pre-school children or younger (<6 years of age),09-10-2025
G2194001003,Patients with clinical indications for imaging of the head: new onset headache,09-10-2025
G2194002004,In pediatric patients with disabilities for which headache is a concern as,09-10-2025
G2194003004,Inferred from behavior,09-10-2025
G2195001003,Patients with clinical indications for imaging of the head: occipital headache,09-10-2025
G2195002004,In children,09-10-2025
G2196001003,Patient identified as an unhealthy alcohol user when screened for unhealthy,09-10-2025
G2196002004,Alcohol use using a systematic screening method,09-10-2025
G2197001003,Patient screened for unhealthy alcohol use using a systematic screening method,09-10-2025
G2197002004,And not identified as an unhealthy alcohol user,09-10-2025
G2198001003,Documentation of medical reason(s) for not screening for unhealthy alcohol use,09-10-2025
G2198002004,"Using a systematic screening method (e.g., limited life expectancy, other",09-10-2025
G2198003004,Medical reasons),09-10-2025
G2199001003,Patient not screened for unhealthy alcohol use using a systematic screening,09-10-2025
G2199002004,Method,09-10-2025
G2200001003,Patient identified as an unhealthy alcohol user received brief counseling,09-10-2025
G2201001003,"Documentation of medical reason(s) for not providing brief counseling (e.g.,",09-10-2025
G2201002004,"Limited life expectancy, other medical reasons)",09-10-2025
G2202001003,Patient did not receive brief counseling if identified as an unhealthy alcohol,09-10-2025
G2202002004,User,09-10-2025
G2203001003,Documentation of medical reason(s) for not providing brief counseling if,09-10-2025
G2203002004,"Identified as an unhealthy alcohol user (e.g., limited life expectancy, other",09-10-2025
G2203003004,Medical reasons),09-10-2025
G2204001003,Patients between 45 and 85 years of age who received a screening colonoscopy,09-10-2025
G2204002004,During the performance period,09-10-2025
G2205001003,Patients with pregnancy during adjuvant treatment course,09-10-2025
G2206001003,Patient received adjuvant treatment course including both chemotherapy and,09-10-2025
G2206002004,Her2-targeted therapy,09-10-2025
G2207001003,Reason for not administering adjuvant treatment course including both,09-10-2025
G2207002004,Chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4;,09-10-2025
G2207003004,"Karnofsky <=50), cardiac contraindications, insufficient renal function,",09-10-2025
G2207004004,"Insufficient hepatic function, other active or secondary cancer diagnoses,",09-10-2025
G2207005004,"Other medical contraindications, patients who died during initial treatment",09-10-2025
G2207006004,Course or transferred during or after initial treatment course),09-10-2025
G2208001003,Patient did not receive adjuvant treatment course including both chemotherapy,09-10-2025
G2208002004,And her2-targeted therapy,09-10-2025
G2209001003,Patient refused to participate,09-10-2025
G2210001003,Residual score for the neck impairment not measured because the patient did not,09-10-2025
G2210002004,"Complete the neck fs prom at initial evaluation and/or near discharge, reason",09-10-2025
G2210003004,Not given,09-10-2025
G2211001003,Visit complexity inherent to evaluation and management associated with medical,09-10-2025
G2211002004,Care services that serve as the continuing focal point for all needed health,09-10-2025
G2211003004,Care services and/or with medical care services that are part of ongoing care,09-10-2025
G2211004004,"Related to a patient's single, serious condition or a complex condition.",09-10-2025
G2211005004,"(add-on code, list separately in addition to office/outpatient evaluation and",09-10-2025
G2211006004,"Management visit, new or established)",09-10-2025
G2212001003,Prolonged office or other outpatient evaluation and management service(s),09-10-2025
G2212002004,Beyond the maximum required time of the primary procedure which has been,09-10-2025
G2212003004,Selected using total time on the date of the primary service; each additional,09-10-2025
G2212004004,"15 minutes by the physician or qualified healthcare professional, with or",09-10-2025
G2212005004,"Without direct patient contact (list separately in addition to cpt codes 99205,",09-10-2025
G2212006004,"99215, 99483 for office or other outpatient evaluation and management services)",09-10-2025
G2212007004,"(do not report g2212 on the same date of service as 99358, 99359, 99415,",09-10-2025
G2212008004,99416). (do not report g2212 for any time unit less than 15 minutes),09-10-2025
G2213001003,Initiation of medication for the treatment of opioid use disorder in the,09-10-2025
G2213002004,"Emergency department setting, including assessment, referral to ongoing care,",09-10-2025
G2213003004,And arranging access to supportive services (list separately in addition to,09-10-2025
G2213004004,Code for primary procedure),09-10-2025
G2214001003,"Initial or subsequent psychiatric collaborative care management, first 30",09-10-2025
G2214002004,"Minutes in a month of behavioral health care manager activities, in",09-10-2025
G2214003004,"Consultation with a psychiatric consultant, and directed by the treating",09-10-2025
G2214004004,Physician or other qualified health care professional,09-10-2025
G2215001003,Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray,09-10-2025
G2215002004,(provision of the services by a medicare-enrolled opioid treatment program);,09-10-2025
G2215003004,List separately in addition to code for primary procedure,09-10-2025
G2216001003,Take-home supply of injectable naloxone (provision of the services by a,09-10-2025
G2216002004,Medicare-enrolled opioid treatment program); list separately in addition to,09-10-2025
G2216003004,Code for primary procedure,09-10-2025
G2250001003,Remote assessment of recorded video and/or images submitted by an established,09-10-2025
G2250002004,"Patient (e.g., store and forward), including interpretation with follow-up with",09-10-2025
G2250003004,"The patient within 24 business hours, not originating from a related service",09-10-2025
G2250004004,Provided within the previous 7 days nor leading to a service or procedure,09-10-2025
G2250005004,Within the next 24 hours or soonest available appointment,09-10-2025
G2251001003,"Brief communication technology-based service, e.g. virtual check-in, by a",09-10-2025
G2251002004,Qualified health care professional who cannot report evaluation and management,09-10-2025
G2251003004,"Services, provided to an established patient, not originating from a related",09-10-2025
G2251004004,Service provided within the previous 7 days nor leading to a service or,09-10-2025
G2251005004,Procedure within the next 24 hours or soonest available appointment; 5-10,09-10-2025
G2251006004,Minutes of clinical discussion,09-10-2025
G2252001003,"Brief communication technology-based service, e.g. virtual check-in, by a",09-10-2025
G2252002004,Physician or other qualified health care professional who can report evaluation,09-10-2025
G2252003004,"And management services, provided to an established patient, not originating",09-10-2025
G2252004004,From a related e/m service provided within the previous 7 days nor leading to,09-10-2025
G2252005004,An e/m service or procedure within the next 24 hours or soonest available,09-10-2025
G2252006004,Appointment; 11-20 minutes of medical discussion,09-10-2025
G3001001003,"Administration and supply of tositumomab, 450 mg",09-10-2025
G3002001003,"Chronic pain management and treatment, monthly bundle including, diagnosis;",09-10-2025
G3002002004,Assessment and monitoring; administration of a validated pain rating scale or,09-10-2025
G3002003004,"Tool; the development, implementation, revision, and/or maintenance of a",09-10-2025
G3002004004,"Person-centered care plan that includes strengths, goals, clinical needs, and",09-10-2025
G3002005004,Desired outcomes; overall treatment management; facilitation and coordination,09-10-2025
G3002006004,Of any necessary behavioral health treatment; medication management; pain and,09-10-2025
G3002007004,Health literacy counseling; any necessary chronic pain related crisis care; and,09-10-2025
G3002008004,Ongoing communication and care coordination between relevant practitioners,09-10-2025
G3002009004,"Furnishing care, e.g. physical therapy and occupational therapy, complementary",09-10-2025
G3002010004,"And integrative approaches, and community-based care, as appropriate. required",09-10-2025
G3002011004,Initial face-to-face visit at least 30 minutes provided by a physician or other,09-10-2025
G3002012004,Qualified health professional; first 30 minutes personally provided by,09-10-2025
G3002013004,"Physician or other qualified health care professional, per calendar month.",09-10-2025
G3002014004,"(when using g3002, 30 minutes must be met or exceeded.)",09-10-2025
G3003001003,Each additional 15 minutes of chronic pain management and treatment by a,09-10-2025
G3003002004,"Physician or other qualified health care professional, per calendar month.",09-10-2025
G3003003004,"(list separately in addition to code for g3002. when using g3003, 15 minutes",09-10-2025
G3003004004,Must be met or exceeded.),09-10-2025
G4000001003,Dermatology mips specialty set,09-10-2025
G4001001003,Diagnostic radiology mips specialty set,09-10-2025
G4002001003,Electrophysiology cardiac specialist mips specialty set,09-10-2025
G4003001003,Emergency medicine mips specialty set,09-10-2025
G4004001003,Endocrinology mips specialty set,09-10-2025
G4005001003,Family medicine mips specialty set,09-10-2025
G4006001003,Gastro-enterology mips specialty set,09-10-2025
G4007001003,General surgery mips specialty set,09-10-2025
G4008001003,Geriatrics mips specialty set,09-10-2025
G4009001003,Hospitalists mips specialty set,09-10-2025
G4010001003,Infectious disease mips specialty set,09-10-2025
G4011001003,Internal medicine mips specialty set,09-10-2025
G4012001003,Interventional radiology mips specialty set,09-10-2025
G4013001003,Mental/behavioral and psychiatry mips specialty set,09-10-2025
G4014001003,Nephrology mips specialty set,09-10-2025
G4015001003,Neurology mips specialty set,09-10-2025
G4016001003,Neurosurgical mips specialty set,09-10-2025
G4017001003,Nutrition/dietician mips specialty set,09-10-2025
G4018001003,Obstetrics/gynecology mips specialty set,09-10-2025
G4019001003,Oncology/hematology mips specialty set,09-10-2025
G4020001003,Ophthalmology/optometry mips specialty set,09-10-2025
G4021001003,Orthopedic surgery mips specialty set,09-10-2025
G4022001003,Otolaryngology mips specialty set,09-10-2025
G4023001003,Pathology mips specialty set,09-10-2025
G4024001003,Pediatrics mips specialty set,09-10-2025
G4025001003,Physical medicine mips specialty set,09-10-2025
G4026001003,Physical therapy/occupational therapy mips specialty set,09-10-2025
G4027001003,Plastic surgery mips specialty set,09-10-2025
G4028001003,Podiatry mips specialty set,09-10-2025
G4029001003,Preventive medicine mips specialty set,09-10-2025
G4030001003,Pulmonology mips specialty set,09-10-2025
G4031001003,Radiation oncology mips specialty set,09-10-2025
G4032001003,Rheumatology mips specialty set,09-10-2025
G4033001003,Skilled nursing facility mips specialty set,09-10-2025
G4034001003,Speech language pathology mips specialty set,09-10-2025
G4035001003,Thoracic surgery mips specialty set,09-10-2025
G4036001003,Urgent care mips specialty set,09-10-2025
G4037001003,Urology mips specialty set,09-10-2025
G4038001003,Vascular surgery mips specialty set,09-10-2025
G6001001003,Ultrasonic guidance for placement of radiation therapy fields,09-10-2025
G6002001003,Stereoscopic x-ray guidance for localization of target volume for the delivery,09-10-2025
G6002002004,Of radiation therapy,09-10-2025
G6003001003,"Radiation treatment delivery, single treatment area, single port or parallel",09-10-2025
G6003002004,"Opposed ports, simple blocks or no blocks: up to 5 mev",09-10-2025
G6004001003,"Radiation treatment delivery, single treatment area, single port or parallel",09-10-2025
G6004002004,"Opposed ports, simple blocks or no blocks: 6-10 mev",09-10-2025
G6005001003,"Radiation treatment delivery, single treatment area, single port or parallel",09-10-2025
G6005002004,"Opposed ports, simple blocks or no blocks: 11-19 mev",09-10-2025
G6006001003,"Radiation treatment delivery, single treatment area, single port or parallel",09-10-2025
G6006002004,"Opposed ports, simple blocks or no blocks: 20 mev or greater",09-10-2025
G6007001003,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a",09-10-2025
G6007002004,"Single treatment area, use of multiple blocks: up to 5 mev",09-10-2025
G6008001003,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a",09-10-2025
G6008002004,"Single treatment area, use of multiple blocks: 6-10 mev",09-10-2025
G6009001003,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a",09-10-2025
G6009002004,"Single treatment area, use of multiple blocks: 11-19 mev",09-10-2025
G6010001003,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a",09-10-2025
G6010002004,"Single treatment area, use of multiple blocks: 20 mev or greater",09-10-2025
G6011001003,"Radiation treatment delivery, 3 or more separate treatment areas, custom",09-10-2025
G6011002004,"Blocking, tangential ports, wedges, rotational beam, compensators, electron",09-10-2025
G6011003004,Beam; up to 5 mev,09-10-2025
G6012001003,"Radiation treatment delivery, 3 or more separate treatment areas, custom",09-10-2025
G6012002004,"Blocking, tangential ports, wedges, rotational beam, compensators, electron",09-10-2025
G6012003004,Beam; 6-10 mev,09-10-2025
G6013001003,"Radiation treatment delivery,3 or more separate treatment areas, custom",09-10-2025
G6013002004,"Blocking, tangential ports, wedges, rotational beam, compensators, electron",09-10-2025
G6013003004,Beam; 11-19 mev,09-10-2025
G6014001003,"Radiation treatment delivery, 3 or more separate treatment areas, custom",09-10-2025
G6014002004,"Blocking, tangential ports, wedges, rotational beam, compensators, electron",09-10-2025
G6014003004,Beam; 20 mev or greater,09-10-2025
G6015001003,"Intensity modulated treatment delivery, single or multiple fields/arcs,via",09-10-2025
G6015002004,"Narrow spatially and temporally modulated beams, binary, dynamic mlc, per",09-10-2025
G6015003004,Treatment session,09-10-2025
G6016001003,Compensator-based beam modulation treatment delivery of inverse planned,09-10-2025
G6016002004,"Treatment using 3 or more high resolution (milled or cast) compensator,",09-10-2025
G6016003004,"Convergent beam modulated fields, per treatment session",09-10-2025
G6017001003,Intra-fraction localization and tracking of target or patient motion during,09-10-2025
G6017002004,"Delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface",09-10-2025
G6017003004,"Tracking), each fraction of treatment",09-10-2025
G6018001003,"Ileoscopy, through stoma; with transendoscopic stent placement (includes",09-10-2025
G6018002004,Predilation),09-10-2025
G6019001003,"Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other",09-10-2025
G6019002004,"Lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or",09-10-2025
G6019003004,Snare technique,09-10-2025
G6020001003,Colonoscopy through stoma; with transendoscopic stent placement (includes,09-10-2025
G6020002004,Predilation),09-10-2025
G6021001003,"Unlisted procedure, intestine",09-10-2025
G6022001003,"Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other",09-10-2025
G6022002004,"Lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or",09-10-2025
G6022003004,Snare technique,09-10-2025
G6023001003,"Sigmoidoscopy, flexible; with transendoscopic stent placement (includes",09-10-2025
G6023002004,Predilation),09-10-2025
G6024001003,"Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s),",09-10-2025
G6024002004,"Polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps,",09-10-2025
G6024003004,Bipolar cautery or snare technique,09-10-2025
G6025001003,"Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent",09-10-2025
G6025002004,Placement (includes predilation),09-10-2025
G6027001003,"Anoscopy, high resolution (hra) (with magnification and chemical agent",09-10-2025
G6027002004,"Enhancement); diagnostic, including collection of specimen(s) by brushing or",09-10-2025
G6027003004,Washing when performed,09-10-2025
G6028001003,"Anoscopy, high resolution (hra) (with magnification and chemical agent",09-10-2025
G6028002004,Enhancement); with biopsy(ies),09-10-2025
G6030001003,Amitriptyline,09-10-2025
G6031001003,Benzodiazepines,09-10-2025
G6032001003,Desipramine,09-10-2025
G6034001003,Doxepin,09-10-2025
G6035001003,Gold,09-10-2025
G6036001003,Assay of imipramine,09-10-2025
G6037001003,Nortriptyline,09-10-2025
G6038001003,Salicylate,09-10-2025
G6039001003,Acetaminophen,09-10-2025
G6040001003,Alcohol (ethanol); any specimen except breath,09-10-2025
G6041001003,"Alkaloids, urine, quantitative",09-10-2025
G6042001003,Amphetamine or methamphetamine,09-10-2025
G6043001003,"Barbiturates, not elsewhere specified",09-10-2025
G6044001003,Cocaine or metabolite,09-10-2025
G6045001003,Dihydrocodeinone,09-10-2025
G6046001003,Dihydromorphinone,09-10-2025
G6047001003,Dihydrotestosterone,09-10-2025
G6048001003,Dimethadione,09-10-2025
G6049001003,Epiandrosterone,09-10-2025
G6050001003,Ethchlorvynol,09-10-2025
G6051001003,Flurazepam,09-10-2025
G6052001003,Meprobamate,09-10-2025
G6053001003,Methadone,09-10-2025
G6054001003,Methsuximide,09-10-2025
G6055001003,Nicotine,09-10-2025
G6056001003,"Opiate(s), drug and metabolites, each procedure",09-10-2025
G6057001003,Phenothiazine,09-10-2025
G6058001003,"Drug confirmation, each procedure",09-10-2025
G8126001003,Patient with a diagnosis of major depression documented as being treated with,09-10-2025
G8126002004,Antidepressant medication during the entire 84 day (12 week) acute treatment,09-10-2025
G8126003004,Phase,09-10-2025
G8127001003,Patient with a diagnosis of major depression not documented as being treated,09-10-2025
G8127002004,With antidepressant medication during the entire 84 day (12 week) acute,09-10-2025
G8127003004,Treatment phase,09-10-2025
G8128001003,Clinician documented that patient was not an eligible candidate for,09-10-2025
G8128002004,Antidepressant medication during the entire 12 week acute treatment phase,09-10-2025
G8128003004,Measure,09-10-2025
G8395001003,Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or,09-10-2025
G8395002004,Mildly depressed left ventricular systolic function,09-10-2025
G8396001003,Left ventricular ejection fraction (lvef) not performed or documented,09-10-2025
G8397001003,"Dilated macular or fundus exam performed, including documentation of the",09-10-2025
G8397002004,Presence or absence of macular edema and level of severity of retinopathy,09-10-2025
G8398001003,Dilated macular or fundus exam not performed,09-10-2025
G8399001003,Patient with documented results of a central dual-energy x-ray absorptiometry,09-10-2025
G8399002004,(dxa) ever being performed,09-10-2025
G8400001003,Patient with central dual-energy x-ray absorptiometry (dxa) results not,09-10-2025
G8400002004,"Documented, reason not given",09-10-2025
G8401001003,Clinician documented that patient was not an eligible candidate for screening,09-10-2025
G8404001003,Lower extremity neurological exam performed and documented,09-10-2025
G8405001003,Lower extremity neurological exam not performed,09-10-2025
G8406001003,Clinician documented that patient was not an eligible candidate for lower,09-10-2025
G8406002004,Extremity neurological exam measure,09-10-2025
G8410001003,Footwear evaluation performed and documented,09-10-2025
G8415001003,Footwear evaluation was not performed,09-10-2025
G8416001003,Clinician documented that patient was not an eligible candidate for footwear,09-10-2025
G8416002004,Evaluation measure,09-10-2025
G8417001003,Bmi is documented above normal parameters and a follow-up plan is documented,09-10-2025
G8418001003,Bmi is documented below normal parameters and a follow-up plan is documented,09-10-2025
G8419001003,"Bmi documented outside normal parameters, no follow-up plan documented, no",09-10-2025
G8419002004,Reason given,09-10-2025
G8420001003,Bmi is documented within normal parameters and no follow-up plan is required,09-10-2025
G8421001003,Bmi not documented and no reason is given,09-10-2025
G8422001003,"Bmi not documented, documentation the patient is not eligible for bmi",09-10-2025
G8422002004,Calculation,09-10-2025
G8427001003,"Eligible clinician attests to documenting in the medical record they obtained,",09-10-2025
G8427002004,"Updated, or reviewed the patient's current medications",09-10-2025
G8428001003,"Current list of medications not documented as obtained, updated, or reviewed by",09-10-2025
G8428002004,"The eligible clinician, reason not given",09-10-2025
G8430001003,"Documentation of a medical reason(s) for not documenting, updating, or",09-10-2025
G8430002004,"Reviewing the patient's current medications list (e.g., patient is in an urgent",09-10-2025
G8430003004,Or emergent medical situation),09-10-2025
G8431001003,Screening for depression is documented as being positive and a follow-up plan,09-10-2025
G8431002004,Is documented,09-10-2025
G8432001003,"Depression screening not documented, reason not given",09-10-2025
G8433001003,"Screening for depression not completed, documented patient or medical reason",09-10-2025
G8442001003,"Pain assessment not documented as being performed, documentation the patient is",09-10-2025
G8442002004,Not eligible for a pain assessment using a standardized tool at the time of the,09-10-2025
G8442003004,Encounter,09-10-2025
G8450001003,Beta-blocker therapy prescribed,09-10-2025
G8451001003,Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by,09-10-2025
G8451002004,"The clinician (e.g., low blood pressure, fluid overload, asthma, patients",09-10-2025
G8451003004,"Recently treated with an intravenous positive inotropic agent, allergy,",09-10-2025
G8451004004,"Intolerance, other medical reasons, patient declined, other patient reasons)",09-10-2025
G8452001003,Beta-blocker therapy not prescribed,09-10-2025
G8458001003,Clinician documented that patient is not an eligible candidate for genotype,09-10-2025
G8458002004,Testing; patient not receiving antiviral treatment for hepatitis c during the,09-10-2025
G8458003004,"Measurement period (e.g. genotype test done prior to the reporting period,",09-10-2025
G8458004004,"Patient declines, patient not a candidate for antiviral treatment)",09-10-2025
G8460001003,Clinician documented that patient is not an eligible candidate for quantitative,09-10-2025
G8460002004,Rna testing at week 12; patient not receiving antiviral treatment for hepatitis,09-10-2025
G8460003004,C,09-10-2025
G8461001003,Patient receiving antiviral treatment for hepatitis c during the measurement,09-10-2025
G8461002004,Period,09-10-2025
G8464001003,Clinician documented that prostate cancer patient is not an eligible candidate,09-10-2025
G8464002004,For adjuvant hormonal therapy; low or intermediate risk of recurrence or risk,09-10-2025
G8464003004,Of recurrence not determined,09-10-2025
G8465001003,High or very high risk of recurrence of prostate cancer,09-10-2025
G8473001003,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker,09-10-2025
G8473002004,(arb) therapy prescribed,09-10-2025
G8474001003,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker,09-10-2025
G8474002004,"(arb) therapy not prescribed for reasons documented by the clinician (e.g.,",09-10-2025
G8474003004,"Allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases",09-10-2025
G8474004004,"Of the aortic or mitral valve, other medical reasons) or (e.g., patient",09-10-2025
G8474005004,"Declined, other patient reasons)",09-10-2025
G8475001003,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker,09-10-2025
G8475002004,"(arb) therapy not prescribed, reason not given",09-10-2025
G8476001003,Most recent blood pressure has a systolic measurement of < 140 mmhg and a,09-10-2025
G8476002004,Diastolic measurement of < 90 mmhg,09-10-2025
G8477001003,Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a,09-10-2025
G8477002004,Diastolic measurement of >= 90 mmhg,09-10-2025
G8478001003,"Blood pressure measurement not performed or documented, reason not given",09-10-2025
G8482001003,Influenza immunization administered or previously received,09-10-2025
G8483001003,Influenza immunization was not administered for reasons documented by clinician,09-10-2025
G8483002004,"(e.g., patient allergy or other medical reasons, patient declined or other",09-10-2025
G8483003004,"Patient reasons, vaccine not available or other system reasons)",09-10-2025
G8484001003,"Influenza immunization was not administered, reason not given",09-10-2025
G8485001003,I intend to report the diabetes mellitus (dm) measures group,09-10-2025
G8486001003,I intend to report the preventive care measures group,09-10-2025
G8487001003,I intend to report the chronic kidney disease (ckd) measures group,09-10-2025
G8489001003,I intend to report the coronary artery disease (cad) measures group,09-10-2025
G8490001003,I intend to report the rheumatoid arthritis (ra) measures group,09-10-2025
G8491001003,I intend to report the hiv/aids measures group,09-10-2025
G8492001003,I intend to report the perioperative care measures group,09-10-2025
G8493001003,I intend to report the back pain measures group,09-10-2025
G8494001003,All quality actions for the applicable measures in the diabetes mellitus (dm),09-10-2025
G8494002004,Measures group have been performed for this patient,09-10-2025
G8495001003,All quality actions for the applicable measures in the chronic kidney disease,09-10-2025
G8495002004,(ckd) measures group have been performed for this patient,09-10-2025
G8496001003,All quality actions for the applicable measures in the preventive care measures,09-10-2025
G8496002004,Group have been performed for this patient,09-10-2025
G8497001003,All quality actions for the applicable measures in the coronary artery bypass,09-10-2025
G8497002004,Graft (cabg) measures group have been performed for this patient,09-10-2025
G8498001003,All quality actions for the applicable measures in the coronary artery disease,09-10-2025
G8498002004,(cad) measures group have been performed for this patient,09-10-2025
G8499001003,All quality actions for the applicable measures in the rheumatoid arthritis,09-10-2025
G8499002004,(ra) measures group have been performed for this patient,09-10-2025
G8500001003,All quality actions for the applicable measures in the hiv/aids measures group,09-10-2025
G8500002004,Have been performed for this patient,09-10-2025
G8501001003,All quality actions for the applicable measures in the perioperative care,09-10-2025
G8501002004,Measures group have been performed for this patient,09-10-2025
G8502001003,All quality actions for the applicable measures in the back pain measures group,09-10-2025
G8502002004,Have been performed for this patient,09-10-2025
G8506001003,Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin,09-10-2025
G8506002004,Receptor blocker (arb) therapy,09-10-2025
G8509001003,"Pain assessment documented as positive using a standardized tool, follow-up",09-10-2025
G8509002004,"Plan not documented, reason not given",09-10-2025
G8510001003,"Screening for depression is documented as negative, a follow-up plan is not",09-10-2025
G8510002004,Required,09-10-2025
G8511001003,"Screening for depression documented as positive, follow-up plan not documented,",09-10-2025
G8511002004,Reason not given,09-10-2025
G8530001003,Autogenous av fistula received,09-10-2025
G8531001003,Clinician documented that patient was not an eligible candidate for autogenous,09-10-2025
G8531002004,Av fistula,09-10-2025
G8532001003,Clinician documented that patient received vascular access other than,09-10-2025
G8532002004,"Autogenous av fistula, reason not given",09-10-2025
G8535001003,Elder maltreatment screen not documented; documentation that patient is not,09-10-2025
G8535002004,Eligible for the elder maltreatment screen at the time of the encounter related,09-10-2025
G8535003004,To one of the following reasons: (1) patient refuses to participate in the,09-10-2025
G8535004004,"Screening and has reasonable decisional capacity for self-protection, or (2)",09-10-2025
G8535005004,Patient is in an urgent or emergent situation where time is of the essence and,09-10-2025
G8535006004,To delay treatment to perform the screening would jeopardize the patient's,09-10-2025
G8535007004,Health status,09-10-2025
G8536001003,"No documentation of an elder maltreatment screen, reason not given",09-10-2025
G8539001003,Functional outcome assessment documented as positive using a standardized tool,09-10-2025
G8539002004,And a care plan based on identified deficiencies is documented within two days,09-10-2025
G8539003004,Of the functional outcome assessment,09-10-2025
G8540001003,"Functional outcome assessment not documented as being performed, documentation",09-10-2025
G8540002004,The patient is not eligible for a functional outcome assessment using a,09-10-2025
G8540003004,Standardized tool at the time of the encounter,09-10-2025
G8541001003,"Functional outcome assessment using a standardized tool not documented, reason",09-10-2025
G8541002004,Not given,09-10-2025
G8542001003,Functional outcome assessment using a standardized tool is documented; no,09-10-2025
G8542002004,"Functional deficiencies identified, care plan not required",09-10-2025
G8543001003,Documentation of a positive functional outcome assessment using a standardized,09-10-2025
G8543002004,"Tool; care plan not documented within two days of assessment, reason not given",09-10-2025
G8544001003,I intend to report the coronary artery bypass graft (cabg) measures group,09-10-2025
G8545001003,I intend to report the hepatitis c measures group,09-10-2025
G8547001003,I intend to report the ischemic vascular disease (ivd) measures group,09-10-2025
G8548001003,I intend to report the heart failure (hf) measures group,09-10-2025
G8549001003,All quality actions for the applicable measures in the hepatitis c measures,09-10-2025
G8549002004,Group have been performed for this patient,09-10-2025
G8551001003,All quality actions for the applicable measures in the heart failure (hf),09-10-2025
G8551002004,Measures group have been performed for this patient,09-10-2025
G8552001003,All quality actions for the applicable measures in the ischemic vascular,09-10-2025
G8552002004,Disease (ivd) measures group have been performed for this patient,09-10-2025
G8559001003,Patient referred to a physician (preferably a physician with training in,09-10-2025
G8559002004,Disorders of the ear) for an otologic evaluation,09-10-2025
G8560001003,Patient has a history of active drainage from the ear within the previous 90,09-10-2025
G8560002004,Days,09-10-2025
G8561001003,Patient is not eligible for the referral for otologic evaluation for patients,09-10-2025
G8561002004,With a history of active drainage measure,09-10-2025
G8562001003,Patient does not have a history of active drainage from the ear within the,09-10-2025
G8562002004,Previous 90 days,09-10-2025
G8563001003,Patient not referred to a physician (preferably a physician with training in,09-10-2025
G8563002004,"Disorders of the ear) for an otologic evaluation, reason not given",09-10-2025
G8564001003,Patient was referred to a physician (preferably a physician with training in,09-10-2025
G8564002004,"Disorders of the ear) for an otologic evaluation, reason not specified)",09-10-2025
G8565001003,Verification and documentation of sudden or rapidly progressive hearing loss,09-10-2025
G8566001003,"Patient is not eligible for the ""referral for otologic evaluation for sudden or",09-10-2025
G8566002004,"Rapidly progressive hearing loss"" measure",09-10-2025
G8567001003,Patient does not have verification and documentation of sudden or rapidly,09-10-2025
G8567002004,Progressive hearing loss,09-10-2025
G8568001003,Patient was not referred to a physician (preferably a physician with training,09-10-2025
G8568002004,"In disorders of the ear) for an otologic evaluation, reason not given",09-10-2025
G8569001003,Prolonged postoperative intubation (> 24 hrs) required,09-10-2025
G8570001003,Prolonged postoperative intubation (> 24 hrs) not required,09-10-2025
G8571001003,Development of deep sternal wound infection/mediastinitis within 30 days,09-10-2025
G8571002004,Postoperatively,09-10-2025
G8572001003,No deep sternal wound infection/mediastinitis,09-10-2025
G8573001003,Stroke following isolated cabg surgery,09-10-2025
G8574001003,No stroke following isolated cabg surgery,09-10-2025
G8575001003,Developed postoperative renal failure or required dialysis,09-10-2025
G8576001003,No postoperative renal failure/dialysis not required,09-10-2025
G8577001003,"Re-exploration required due to mediastinal bleeding with or without tamponade,",09-10-2025
G8577002004,"Unplanned coronary artery intervention (native, vessel, graft, or both), valve",09-10-2025
G8577003004,"Dysfunction, aortic reintervention, or other cardiac reason",09-10-2025
G8578001003,Re-exploration not required due to mediastinal bleeding with or without,09-10-2025
G8578002004,"Tamponade, unplanned coronary artery intervention (native, vessel, graft, or",09-10-2025
G8578003004,"Both), valve dysfunction, aortic reintervention, or other cardiac reason",09-10-2025
G8579001003,Antiplatelet medication at discharge,09-10-2025
G8580001003,Antiplatelet medication contraindicated,09-10-2025
G8581001003,No antiplatelet medication at discharge,09-10-2025
G8582001003,Beta-blocker at discharge,09-10-2025
G8583001003,Beta-blocker contraindicated,09-10-2025
G8584001003,No beta-blocker at discharge,09-10-2025
G8585001003,Anti-lipid treatment at discharge,09-10-2025
G8586001003,Anti-lipid treatment contraindicated,09-10-2025
G8587001003,No anti-lipid treatment at discharge,09-10-2025
G8593001003,"Lipid profile results documented and reviewed (must include total cholesterol,",09-10-2025
G8593002004,"Hdl-c, triglycerides and calculated ldl-c)",09-10-2025
G8594001003,"Lipid profile not performed, reason not given",09-10-2025
G8595001003,Most recent ldl-c < 100 mg/dl,09-10-2025
G8597001003,Most recent ldl-c >= 100 mg/dl,09-10-2025
G8598001003,Aspirin or another antiplatelet therapy used,09-10-2025
G8599001003,"Aspirin or another antiplatelet therapy not used, reason not given",09-10-2025
G8600001003,Iv thrombolytic therapy initiated within 4.5 hours (<= 270 minutes) of time,09-10-2025
G8600002004,Last known well,09-10-2025
G8601001003,Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time,09-10-2025
G8601002004,Last known well for reasons documented by clinician (e.g. patient enrolled in,09-10-2025
G8601003004,"Clinical trial for stroke, patient admitted for elective carotid intervention)",09-10-2025
G8602001003,Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time,09-10-2025
G8602002004,"Last known well, reason not given",09-10-2025
G8627001003,Surgical procedure performed within 30 days following cataract surgery for,09-10-2025
G8627002004,"Major complications (e.g., retained nuclear fragments, endophthalmitis,",09-10-2025
G8627003004,"Dislocated or wrong power iol, retinal detachment, or wound dehiscence)",09-10-2025
G8628001003,Surgical procedure not performed within 30 days following cataract surgery for,09-10-2025
G8628002004,"Major complications (e.g., retained nuclear fragments, endophthalmitis,",09-10-2025
G8628003004,"Dislocated or wrong power iol, retinal detachment, or wound dehiscence)",09-10-2025
G8629001003,Documentation of order for prophylactic parenteral antibiotic to be given,09-10-2025
G8629002004,"Within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical",09-10-2025
G8629003004,Incision (or start of procedure when no incision is required),09-10-2025
G8630001003,Documentation that administration of prophylactic parenteral antibiotics was,09-10-2025
G8630002004,"Initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior",09-10-2025
G8630003004,"To surgical incision (or start of procedure when no incision is required), as",09-10-2025
G8630004004,Ordered,09-10-2025
G8631001003,Clinician documented that patient was not an eligible candidate for ordering,09-10-2025
G8631002004,Prophylactic parenteral antibiotics to be given within one hour (if,09-10-2025
G8631003004,"Fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start",09-10-2025
G8631004004,Of procedure when no incision is required),09-10-2025
G8632001003,Prophylactic parenteral antibiotics were not ordered to be given or given,09-10-2025
G8632002004,"Within one hour (if fluoroquinolone or vancomycin, two hours) prior to the",09-10-2025
G8632003004,"Surgical incision (or start of procedure when no incision is required), reason",09-10-2025
G8632004004,Not given,09-10-2025
G8633001003,Pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribe,09-10-2025
G8634001003,Clinician documented patient not an eligible candidate to receive pharmacologic,09-10-2025
G8634002004,Therapy for osteoporosis,09-10-2025
G8635001003,"Pharmacologic therapy for osteoporosis was not prescribed, reason not given",09-10-2025
G8645001003,I intend to report the asthma measures group,09-10-2025
G8646001003,All quality actions for the applicable measures in the asthma measures group,09-10-2025
G8646002004,Have been performed for this patient,09-10-2025
G8647001003,Residual score for the knee impairment successfully calculated and the score,09-10-2025
G8647002004,Was equal to zero (0) or greater than zero (> 0),09-10-2025
G8648001003,Residual score for the knee impairment successfully calculated and the score,09-10-2025
G8648002004,Was less than zero (< 0),09-10-2025
G8649001003,Risk-adjusted functional status change residual score for the knee impairment,09-10-2025
G8649002004,Not measured because the patient did not complete the fs status survey near,09-10-2025
G8649003004,"Discharge, patient not appropriate",09-10-2025
G8650001003,Residual score for the knee impairment not measured because the patient did not,09-10-2025
G8650002004,"Complete the lepf prom at initial evaluation and/or near discharge, reason not",09-10-2025
G8650003004,Given,09-10-2025
G8651001003,Residual score for the hip impairment successfully calculated and the score was,09-10-2025
G8651002004,Equal to zero (0) or greater than zero (> 0),09-10-2025
G8652001003,Residual score for the hip impairment successfully calculated and the score was,09-10-2025
G8652002004,Less than zero (< 0),09-10-2025
G8653001003,Risk-adjusted functional status change residual scores for the hip impairment,09-10-2025
G8653002004,Not measured because the patient did not complete the fs status survey near,09-10-2025
G8653003004,"Discharge, patient not appropriate",09-10-2025
G8654001003,Residual score for the hip impairment not measured because the patient did not,09-10-2025
G8654002004,"Complete the lepf prom at initial evaluation and/or near discharge, reason not",09-10-2025
G8654003004,Given,09-10-2025
G8655001003,"Residual score for the lower leg, foot or ankle impairment successfully",09-10-2025
G8655002004,Calculated and the score was equal to zero (0) or greater than zero ( > 0),09-10-2025
G8656001003,"Residual score for the lower leg, foot or ankle impairment successfully",09-10-2025
G8656002004,Calculated and the score was less than zero (< 0),09-10-2025
G8657001003,"Risk-adjusted functional status change residual score for the lower leg, foot",09-10-2025
G8657002004,Or ankle impairment not measured because the patient did not complete the fs,09-10-2025
G8657003004,"Status survey near discharge, patient not appropriate",09-10-2025
G8658001003,"Residual score for the lower leg, foot or ankle impairment not measured because",09-10-2025
G8658002004,The patient did not complete the lepf prom at initial evaluation and/or near,09-10-2025
G8658003004,"Discharge, reason not given",09-10-2025
G8659001003,Residual score for the low back impairment successfully calculated and the,09-10-2025
G8659002004,Score was equal to zero (0) or greater than zero (> 0),09-10-2025
G8660001003,Residual score for the low back impairment successfully calculated and the,09-10-2025
G8660002004,Score was less than zero (< 0),09-10-2025
G8661001003,Risk-adjusted functional status change residual score for the low back,09-10-2025
G8661002004,Impairment not measured because the patient did not complete the fs status,09-10-2025
G8661003004,"Survey near discharge, patient not appropriate",09-10-2025
G8662001003,Residual score for the low back impairment not measured because the patient did,09-10-2025
G8662002004,"Not complete the low back fs prom at initial evaluation and/or near discharge,",09-10-2025
G8662003004,Reason not given,09-10-2025
G8663001003,Residual score for the shoulder impairment successfully calculated and the,09-10-2025
G8663002004,Score was equal to zero (0) or greater than zero (> 0),09-10-2025
G8664001003,Residual score for the shoulder impairment successfully calculated and the,09-10-2025
G8664002004,Score was less than zero (< 0),09-10-2025
G8665001003,Risk-adjusted functional status change residual score for the shoulder,09-10-2025
G8665002004,Impairment not measured because the patient did not complete the fs status,09-10-2025
G8665003004,"Survey near discharge, patient not appropriate",09-10-2025
G8666001003,Residual score for the shoulder impairment not measured because the patient did,09-10-2025
G8666002004,"Not complete the shoulder fs prom at initial evaluation and/or near discharge,",09-10-2025
G8666003004,Reason not given,09-10-2025
G8667001003,"Residual score for the elbow, wrist or hand impairment successfully calculated",09-10-2025
G8667002004,And the score was equal to zero (0) or greater than zero (> 0),09-10-2025
G8668001003,"Residual score for the elbow, wrist or hand impairment successfully calculated",09-10-2025
G8668002004,And the score was less than zero (< 0),09-10-2025
G8669001003,"Risk-adjusted functional status change residual score for the elbow, wrist or",09-10-2025
G8669002004,Hand impairment not measured because the patient did not complete the fs status,09-10-2025
G8669003004,"Survey near discharge, patient not appropriate",09-10-2025
G8670001003,"Residual score for the elbow, wrist or hand impairment not measured because the",09-10-2025
G8670002004,Patient did not complete the elbow/wrist/hand fs prom at initial evaluation,09-10-2025
G8670003004,"And/or near discharge, reason not given",09-10-2025
G8671001003,"Risk-adjusted functional status change residual score for the neck, cranium,",09-10-2025
G8671002004,"Mandible, thoracic spine, ribs or other general orthopedic impairment",09-10-2025
G8671003004,Successfully calculated and the score was equal to zero (0) or greater than,09-10-2025
G8671004004,Zero (> 0),09-10-2025
G8672001003,"Risk-adjusted functional status change residual score for the neck, cranium,",09-10-2025
G8672002004,"Mandible, thoracic spine, ribs or other general orthopedic impairment",09-10-2025
G8672003004,Successfully calculated and the score was less than zero (< 0),09-10-2025
G8673001003,"Risk-adjusted functional status change residual score for the neck, cranium,",09-10-2025
G8673002004,"Mandible, thoracic spine, ribs or other general orthopedic impairment not",09-10-2025
G8673003004,Measured because the patient did not complete the fs status survey near,09-10-2025
G8673004004,"Discharge, patient not appropriate",09-10-2025
G8674001003,"Risk-adjusted functional status change residual score for the neck, cranium,",09-10-2025
G8674002004,"Mandible, thoracic spine, ribs or other general orthopedic impairment not",09-10-2025
G8674003004,Measured because the patient did not complete the general orthopedic fs prom at,09-10-2025
G8674004004,"Initial evaluation and/or near discharge, reason not given",09-10-2025
G8682001003,Lvf testing documented as being performed prior to discharge or in the previous,09-10-2025
G8682002004,12 months,09-10-2025
G8683001003,Lvf testing not performed prior to discharge or in the previous 12 months for a,09-10-2025
G8683002004,Medical or patient documented reason,09-10-2025
G8685001003,Lvf testing not documented as being performed prior to discharge or in the,09-10-2025
G8685002004,"Previous 12 months, reason not given",09-10-2025
G8694001003,Current or prior left ventricular ejection fraction (lvef) < = 40% or,09-10-2025
G8694002004,Documentation of moderate or severe lvsd,09-10-2025
G8696001003,Antithrombotic therapy prescribed at discharge,09-10-2025
G8697001003,"Antithrombotic therapy not prescribed for documented reasons (e.g., patient had",09-10-2025
G8697002004,"Stroke during hospital stay, patient expired during inpatient stay, other",09-10-2025
G8697003004,"Medical reason(s)); (e.g., patient left against medical advice, other patient",09-10-2025
G8697004004,Reason(s)),09-10-2025
G8698001003,"Antithrombotic therapy was not prescribed at discharge, reason not given",09-10-2025
G8699001003,"Rehabilitation services (occupational, physical or speech) ordered at or prior",09-10-2025
G8699002004,To discharge,09-10-2025
G8700001003,"Rehabilitation services (occupational, physical or speech) not indicated at or",09-10-2025
G8700002004,Prior to discharge,09-10-2025
G8701001003,"Rehabilitation services were not ordered, reason not otherwise specified",09-10-2025
G8702001003,Documentation that prophylactic antibiotics were given within 4 hours prior to,09-10-2025
G8702002004,Surgical incision or intraoperatively,09-10-2025
G8703001003,Documentation that prophylactic antibiotics were neither given within 4 hours,09-10-2025
G8703002004,Prior to surgical incision nor intraoperatively,09-10-2025
G8704001003,12-lead electrocardiogram (ecg) performed,09-10-2025
G8705001003,Documentation of medical reason(s) for not performing a 12-lead,09-10-2025
G8705002004,Electrocardiogram (ecg),09-10-2025
G8706001003,Documentation of patient reason(s) for not performing a 12-lead,09-10-2025
G8706002004,Electrocardiogram (ecg),09-10-2025
G8707001003,"12-lead electrocardiogram (ecg) not performed, reason not given",09-10-2025
G8708001003,Patient not prescribed antibiotic,09-10-2025
G8709001003,Uri episodes when the patient had competing diagnoses on or three days after,09-10-2025
G8709002004,"The episode date (e.g., intestinal infection, pertussis, bacterial infection,",09-10-2025
G8709003004,"Lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute",09-10-2025
G8709004004,"Tonsillitis, chronic sinusitis, infection of the",09-10-2025
G8709005004,"Pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone",09-10-2025
G8709006004,"Infections, acute lymphadenitis, impetigo, skin staph infections,",09-10-2025
G8709007004,"Pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia,",09-10-2025
G8709008004,"Inflammatory diseases [female reproductive organs]), infections of the kidney,",09-10-2025
G8709009004,"Cystitis or uti, and acne)",09-10-2025
G8710001003,Patient prescribed antibiotic,09-10-2025
G8711001003,Prescribed antibiotic on or within 3 days after the episode date,09-10-2025
G8712001003,Antibiotic not prescribed or dispensed,09-10-2025
G8713001003,Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] /,09-10-2025
G8713002004,Volume [v]),09-10-2025
G8714001003,Hemodialysis treatment performed exactly three times per week for > 90 days,09-10-2025
G8717001003,"Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason",09-10-2025
G8717002004,Not given,09-10-2025
G8718001003,Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt],09-10-2025
G8718002004,/ volume [v]),09-10-2025
G8720001003,Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]),09-10-2025
G8721001003,"Pt category (primary tumor), pn category (regional lymph nodes), and histologic",09-10-2025
G8721002004,Grade were documented in pathology report,09-10-2025
G8722001003,"Documentation of medical reason(s) for not including the pt category, the pn",09-10-2025
G8722002004,"Category or the histologic grade in the pathology report (e.g., re-excision",09-10-2025
G8722003004,Without residual tumor; non-carcinomasanal canal),09-10-2025
G8723001003,Specimen site is other than anatomic location of primary tumor,09-10-2025
G8724001003,"Pt category, pn category and histologic grade were not documented in the",09-10-2025
G8724002004,"Pathology report, reason not given",09-10-2025
G8725001003,"Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total",09-10-2025
G8725002004,Cholesterol),09-10-2025
G8726001003,"Clinician has documented reason for not performing fasting lipid profile (e.g.,",09-10-2025
G8726002004,"Patient declined, other patient reasons)",09-10-2025
G8728001003,"Fasting lipid profile not performed, reason not given",09-10-2025
G8730001003,Pain assessment documented as positive using a standardized tool and a,09-10-2025
G8730002004,Follow-up plan is documented,09-10-2025
G8731001003,"Pain assessment using a standardized tool is documented as negative, no",09-10-2025
G8731002004,Follow-up plan required,09-10-2025
G8732001003,"No documentation of pain assessment, reason not given",09-10-2025
G8733001003,Elder maltreatment screen documented as positive and a follow-up plan is,09-10-2025
G8733002004,Documented,09-10-2025
G8734001003,"Elder maltreatment screen documented as negative, follow-up is not required",09-10-2025
G8735001003,"Elder maltreatment screen documented as positive, follow-up plan not",09-10-2025
G8735002004,"Documented, reason not given",09-10-2025
G8736001003,Most current ldl-c <100mg/dl,09-10-2025
G8737001003,Most current ldl-c >=100mg/dl,09-10-2025
G8738001003,Left ventricular ejection fraction (lvef) < 40% or documentation of severely or,09-10-2025
G8738002004,Moderately depressed left ventricular systolic function,09-10-2025
G8739001003,Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or,09-10-2025
G8739002004,Mildly depressed left ventricular systolic function,09-10-2025
G8740001003,"Left ventricular ejection fraction (lvef) not performed or assessed, reason not",09-10-2025
G8740002004,Given,09-10-2025
G8749001003,"Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs",09-10-2025
G8749002004,"Such as weakness, or any other sign suggesting systemic spread) or absence of",09-10-2025
G8749003004,"Symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom",09-10-2025
G8749004004,Suggesting the possibility of systemic spread of melanoma),09-10-2025
G8751001003,"Smoking status and exposure to second hand smoke in the home not assessed,",09-10-2025
G8751002004,Reason not given,09-10-2025
G8752001003,Most recent systolic blood pressure < 140 mmhg,09-10-2025
G8753001003,Most recent systolic blood pressure >= 140 mmhg,09-10-2025
G8754001003,Most recent diastolic blood pressure < 90 mmhg,09-10-2025
G8755001003,Most recent diastolic blood pressure >= 90 mmhg,09-10-2025
G8756001003,"No documentation of blood pressure measurement, reason not given",09-10-2025
G8757001003,All quality actions for the applicable measures in the chronic obstructive,09-10-2025
G8757002004,Pulmonary disease (copd) measures group have been performed for this patient,09-10-2025
G8758001003,All quality actions for the applicable measures in the inflammatory bowel,09-10-2025
G8758002004,Disease (ibd) measures group have been performed for this patient,09-10-2025
G8759001003,All quality actions for the applicable measures in the sleep apnea measures,09-10-2025
G8759002004,Group have been performed for this patient,09-10-2025
G8761001003,All quality actions for the applicable measures in the dementia measures group,09-10-2025
G8761002004,Have been performed for this patient,09-10-2025
G8762001003,All quality actions for the applicable measures in the parkinson's disease,09-10-2025
G8762002004,Measures group have been performed for this patient,09-10-2025
G8763001003,All quality actions for the applicable measures in the hypertension (htn),09-10-2025
G8763002004,Measures group have been performed for this patient,09-10-2025
G8764001003,All quality actions for the applicable measures in the cardiovascular,09-10-2025
G8764002004,Prevention measures group have bee performed for this patient,09-10-2025
G8765001003,All quality actions for the applicable measures in the cataract measures group,09-10-2025
G8765002004,Have been performed for this patient,09-10-2025
G8767001003,"Lipid panel results documented and reviewed (must include total cholesterol,",09-10-2025
G8767002004,"Hdl-c, triglycerides and calculated ldl-c)",09-10-2025
G8768001003,"Documentation of medical reason(s) for not performing lipid profile (e.g.,",09-10-2025
G8768002004,Patients with palliative goals or for whom treatment of hypertension with,09-10-2025
G8768003004,Standard treatment goals is not clinically appropriate),09-10-2025
G8769001003,"Lipid profile not performed, reason not given",09-10-2025
G8770001003,Urine protein test result documented and reviewed,09-10-2025
G8771001003,Documentation of diagnosis of chronic kidney disease,09-10-2025
G8772001003,"Documentation of medical reason(s) for not performing urine protein test (e.g.,",09-10-2025
G8772002004,Patients with palliative goals or for whom treatment of hypertension with,09-10-2025
G8772003004,Standard treatment goals is not cllinically appropriate),09-10-2025
G8773001003,"Urine protein test was not performed, reason not given",09-10-2025
G8774001003,Serum creatinine test result documented and reviewed,09-10-2025
G8775001003,Documentation of medical reason(s) for not performing serum creatinine test,09-10-2025
G8775002004,"(e.g., patients with palliative goals or for whom treatment of hypertension",09-10-2025
G8775003004,With standard treatment goals is not clinically appropriate),09-10-2025
G8776001003,"Serum creatinine test not performed, reason not given",09-10-2025
G8777001003,Diabetes screening test performed,09-10-2025
G8778001003,Documentation of medical reason(s) for not performing diabetes screening test,09-10-2025
G8778002004,"(e.g., patients with a diagnosis of diabetes, or with palliative goals or for",09-10-2025
G8778003004,Whom treatment of hypertension with standard treatment goals is not clinically,09-10-2025
G8778004004,Appropriate),09-10-2025
G8779001003,"Diabetes screening test not performed, reason not given",09-10-2025
G8780001003,Counseling for diet and physical activity performed,09-10-2025
G8781001003,Documentation of medical reason(s) for patient not receiving counseling for,09-10-2025
G8781002004,"Diet and physical activity (e.g., patients with palliative goals or for whom",09-10-2025
G8781003004,Treatment of hypertension with standard treatment goals is not clinically,09-10-2025
G8781004004,Appropriate),09-10-2025
G8782001003,"Counseling for diet and physical activity not performed, reason not given",09-10-2025
G8783001003,"Normal blood pressure reading documented, follow-up not required",09-10-2025
G8784001003,"Patient not eligible (e.g., documentation the patient is not eligible due to",09-10-2025
G8784002004,"Active diagnosis of hypertension, patient refuses, urgent or emergent situation",09-10-2025
G8785001003,"Blood pressure reading not documented, reason not given",09-10-2025
G8797001003,Specimen site other than anatomic location of esophagus,09-10-2025
G8798001003,Specimen site other than anatomic location of prostate,09-10-2025
G8806001003,Performance of trans-abdominal or trans-vaginal ultrasound and pregnancy,09-10-2025
G8806002004,Location documented,09-10-2025
G8807001003,Trans-abdominal or trans-vaginal ultrasound not performed for reasons,09-10-2025
G8807002004,"Documented by clinician (e.g., patient has a documented intrauterine pregnancy",09-10-2025
G8807003004,[iup]),09-10-2025
G8808001003,"Trans-abdominal or trans-vaginal ultrasound not performed, reason not given",09-10-2025
G8809001003,Rh-immunoglobulin (rhogam) ordered,09-10-2025
G8810001003,Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician,09-10-2025
G8810002004,"(e.g., patient had prior documented receipt of rhogam within 12 weeks, patient",09-10-2025
G8810003004,Refusal),09-10-2025
G8811001003,"Documentation rh-immunoglobulin (rhogam) was not ordered, reason not given",09-10-2025
G8815001003,Documented reason in the medical records for why the statin therapy was not,09-10-2025
G8815002004,"Prescribed (i.e., lower extremity bypass was for a patient with",09-10-2025
G8815003004,Non-artherosclerotic disease),09-10-2025
G8816001003,Statin medication prescribed at discharge,09-10-2025
G8817001003,"Statin therapy not prescribed at discharge, reason not given",09-10-2025
G8818001003,Patient discharge to home no later than post-operative day #7,09-10-2025
G8825001003,Patient not discharged to home by post-operative day #7,09-10-2025
G8826001003,Patient discharged to home no later than post-operative day #2 following evar,09-10-2025
G8833001003,Patient not discharged to home by post-operative day #2 following evar,09-10-2025
G8834001003,Patient discharged to home no later than post-operative day #2 following cea,09-10-2025
G8838001003,Patient not discharged to home by post-operative day #2 following cea,09-10-2025
G8839001003,"Sleep apnea symptoms assessed, including presence or absence of snoring and",09-10-2025
G8839002004,Daytime sleepiness,09-10-2025
G8840001003,Documentation of reason(s) for not documenting an assessment of sleep symptoms,09-10-2025
G8840002004,"(e.g., patient didn't have initial daytime sleepiness, patient visited between",09-10-2025
G8840003004,Initial testing and initiation of therapy),09-10-2025
G8841001003,"Sleep apnea symptoms not assessed, reason not given",09-10-2025
G8842001003,"Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory",09-10-2025
G8842002004,Event index (rei) documented or measured within 2 months after initial,09-10-2025
G8842003004,Evaluation for suspected obstructive sleep apnea,09-10-2025
G8843001003,"Documentation of reason(s) for not measuring an apnea hypopnea index (ahi), a",09-10-2025
G8843002004,"Respiratory disturbance index (rdi), or a respiratory event index (rei) within",09-10-2025
G8843003004,"2 months after initial evaluation for suspected obstructive sleep apnea (e.g.,",09-10-2025
G8843004004,"Medical, neurological, or psychiatric disease that prohibits successful",09-10-2025
G8843005004,"Completion of a sleep study, patients for whom a sleep study would present a",09-10-2025
G8843006004,"Bigger risk than benefit or would pose an undue burden, dementia, patients",09-10-2025
G8843007004,"Previously diagnosed with osa and severity assessed by another provider,",09-10-2025
G8843008004,"Patients who decline ahi/rdi/rei measurement, patients who had a financial",09-10-2025
G8843009004,"Reason for not completing testing, test was ordered but not completed, patients",09-10-2025
G8843010004,Decline because their insurance (payer) does not cover the expense),09-10-2025
G8844001003,"Apnea hypopnea index (ahi), respiratory disturbance index (rdi), or respiratory",09-10-2025
G8844002004,Event index (rei) not documented or measured within 2 months after initial,09-10-2025
G8844003004,"Evaluation for suspected obstructive sleep apnea, reason not given",09-10-2025
G8845001003,Positive airway pressure therapy prescribed,09-10-2025
G8846001003,Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or,09-10-2025
G8846002004,Respiratory disturbance index (rdi) of 15 or greater),09-10-2025
G8848001003,Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory,09-10-2025
G8848002004,Disturbance index (rdi) of less than 15),09-10-2025
G8849001003,Documentation of reason(s) for not prescribing positive airway pressure therapy,09-10-2025
G8849002004,"(e.g., patient unable to tolerate, alternative therapies use, patient declined,",09-10-2025
G8849003004,"Financial, insurance coverage)",09-10-2025
G8850001003,"Positive airway pressure therapy not prescribed, reason not given",09-10-2025
G8851001003,Adherence to therapy was assessed at least annually through an objective,09-10-2025
G8851002004,Informatics system or through self-reporting (if objective reporting is not,09-10-2025
G8851003004,"Available, documented)",09-10-2025
G8852001003,Positive airway pressure therapy was prescribed,09-10-2025
G8853001003,Positive airway pressure therapy not prescribed,09-10-2025
G8854001003,Documentation of reason(s) for not objectively reporting adherence to,09-10-2025
G8854002004,"Evidence-based therapy (e.g., patients who have been diagnosed with a terminal",09-10-2025
G8854003004,"Or advanced disease with an expected life span of less than 6 months, patients",09-10-2025
G8854004004,"Who decline therapy, patients who do not return for follow-up at least",09-10-2025
G8854005004,"Annually, patients unable to access/afford therapy, patient's insurance will",09-10-2025
G8854006004,Not cover therapy),09-10-2025
G8855001003,Adherence to therapy was not assessed at least annually through an objective,09-10-2025
G8855002004,Informatics system or through self-reporting (if objective reporting is not,09-10-2025
G8855003004,"Available), reason not given",09-10-2025
G8856001003,Referral to a physician for an otologic evaluation performed,09-10-2025
G8857001003,"Patient is not eligible for the referral for otologic evaluation measure (e.g.,",09-10-2025
G8857002004,Patients who are already under the care of a physician for acute or chronic,09-10-2025
G8857003004,Dizziness),09-10-2025
G8858001003,"Referral to a physician for an otologic evaluation not performed, reason not",09-10-2025
G8858002004,Given,09-10-2025
G8859001003,Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or,09-10-2025
G8859002004,Greater consecutive days,09-10-2025
G8860001003,Patients who have received dose of corticosteroids greater than or equal to,09-10-2025
G8860002004,10mg/day for 60 or greater consecutive days,09-10-2025
G8861001003,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered",09-10-2025
G8861002004,"And documented, review of systems and medication history or pharmacologic",09-10-2025
G8861003004,Therapy (other than minerals/vitamins) for osteoporosis prescribed,09-10-2025
G8862001003,Patients not receiving corticosteroids greater than or equal to 10mg/day for 60,09-10-2025
G8862002004,Or greater consecutive days,09-10-2025
G8863001003,"Patients not assessed for risk of bone loss, reason not given",09-10-2025
G8864001003,Pneumococcal vaccine administered or previously received,09-10-2025
G8865001003,Documentation of medical reason(s) for not administering or previously,09-10-2025
G8865002004,"Receiving pneumococcal vaccine (e.g., patient allergic reaction, potential",09-10-2025
G8865003004,Adverse drug reaction),09-10-2025
G8866001003,Documentation of patient reason(s) for not administering or previously,09-10-2025
G8866002004,"Receiving pneumococcal vaccine (e.g., patient refusal)",09-10-2025
G8867001003,"Pneumococcal vaccine not administered or previously received, reason not given",09-10-2025
G8868001003,Patients receiving a first course of anti-tnf therapy,09-10-2025
G8869001003,Patient has documented immunity to hepatitis b and initiating anti-tnf therapy,09-10-2025
G8870001003,Hepatitis b vaccine injection administered or previously received and is,09-10-2025
G8870002004,Receiving a first course of anti-tnf therapy,09-10-2025
G8871001003,Patient not receiving a first course of anti-tnf therapy,09-10-2025
G8872001003,Excised tissue evaluated by imaging intraoperatively to confirm successful,09-10-2025
G8872002004,Inclusion of targeted lesion,09-10-2025
G8873001003,Patients with needle localization specimens which are not amenable to,09-10-2025
G8873002004,"Intraoperative imaging such as mri needle wire localization, or targets which",09-10-2025
G8873003004,Are tentatively identified on mammogram or ultrasound which do not contain a,09-10-2025
G8873004004,Biopsy marker but which can be verified on intraoperative inspection or,09-10-2025
G8873005004,"Pathology (e.g., needle biopsy site where the biopsy marker is remote from the",09-10-2025
G8873006004,Actual biopsy site),09-10-2025
G8874001003,Excised tissue not evaluated by imaging intraoperatively to confirm successful,09-10-2025
G8874002004,Inclusion of targeted lesion,09-10-2025
G8875001003,Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy,09-10-2025
G8875002004,Method,09-10-2025
G8876001003,Documentation of reason(s) for not performing minimally invasive biopsy to,09-10-2025
G8876002004,"Diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant,",09-10-2025
G8876003004,"Chest wall, etc., lesion could not be adequately visualized for needle biopsy,",09-10-2025
G8876004004,"Patient condition prevents needle biopsy [weight, breast thickness, etc.], duct",09-10-2025
G8876005004,"Excision without imaging abnormality, prophylactic mastectomy, reduction",09-10-2025
G8876006004,"Mammoplasty, excisional biopsy performed by another physician)",09-10-2025
G8877001003,Clinician did not attempt to achieve the diagnosis of breast cancer,09-10-2025
G8877002004,"Preoperatively by a minimally invasive biopsy method, reason not given",09-10-2025
G8878001003,Sentinel lymph node biopsy procedure performed,09-10-2025
G8879001003,Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer,09-10-2025
G8880001003,"Documentation of reason(s) sentinel lymph node biopsy not performed (e.g.,",09-10-2025
G8880002004,"Reasons could include but not limited to; non-invasive cancer, incidental",09-10-2025
G8880003004,"Discovery of breast cancer on prophylactic mastectomy, incidental discovery of",09-10-2025
G8880004004,"Breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node",09-10-2025
G8880005004,"(ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer,",09-10-2025
G8880006004,"Recurrent invasive breast cancer, clinically node positive after neoadjuvant",09-10-2025
G8880007004,"Systemic therapy, patient refusal after informed consent, patient with",09-10-2025
G8880008004,"Significant age, comorbidities, or limited life expectancy and favorable tumor;",09-10-2025
G8880009004,Adjuvant systemic therapy unlikely to change),09-10-2025
G8881001003,Stage of breast cancer is greater than t1n0m0 or t2n0m0,09-10-2025
G8882001003,"Sentinel lymph node biopsy procedure not performed, reason not given",09-10-2025
G8883001003,"Biopsy results reviewed, communicated, tracked and documented",09-10-2025
G8884001003,Clinician documented reason that patient's biopsy results were not reviewed,09-10-2025
G8885001003,"Biopsy results not reviewed, communicated, tracked or documented",09-10-2025
G8886001003,Most recent blood pressure under control,09-10-2025
G8887001003,Documentation of medical reason(s) for most recent blood pressure not being,09-10-2025
G8887002004,"Under control (e.g., patients with palliative goals or for whom treatment of",09-10-2025
G8887003004,Hypertension with standard treatment goals is not clinically appropriate),09-10-2025
G8888001003,"Most recent blood pressure not under control, results documented and reviewed",09-10-2025
G8889001003,"No documentation of blood pressure measurement, reason not given",09-10-2025
G8890001003,"Most recent ldl-c under control, results documented and reviewed",09-10-2025
G8891001003,Documentation of medical reason(s) for most recent ldl-c not under control,09-10-2025
G8891002004,"(e.g., patients with palliative goals for whom treatment of hypertension with",09-10-2025
G8891003004,Standard treatment goals is not clinically appropriate),09-10-2025
G8892001003,Documentation of medical reason(s) for not performing ldl-c test (e.g. patients,09-10-2025
G8892002004,With palliative goals or for whom treatment of hypertension with standard,09-10-2025
G8892003004,Treatment goals is not clinically appropriate),09-10-2025
G8893001003,"Most recent ldl-c not under control, results documented and reviewed",09-10-2025
G8894001003,"Ldl-c not performed, reason not given",09-10-2025
G8895001003,Oral aspirin or other antithrombotic therapy prescribed,09-10-2025
G8896001003,Documentation of medical reason(s) for not prescribing oral aspirin or other,09-10-2025
G8896002004,"Antithrombotic therapy (e.g., patient documented to be low risk or patient with",09-10-2025
G8896003004,Terminal illness or treatment of hypertension with standard treatment goals is,09-10-2025
G8896004004,"Not clinically appropriate, or for whom risk of aspirin or other antithrombotic",09-10-2025
G8896005004,Therapy exceeds potential benefits such as for individuals whose blood pressure,09-10-2025
G8896006004,Is poorly controlled),09-10-2025
G8897001003,"Oral aspirin or other antithrombotic therapy was not prescribed, reason not",09-10-2025
G8897002004,Given,09-10-2025
G8898001003,I intend to report the chronic obstructive pulmonary disease (copd) measures,09-10-2025
G8898002004,Group,09-10-2025
G8899001003,I intend to report the inflammatory bowel disease (ibd) measures group,09-10-2025
G8900001003,I intend to report the sleep apnea measures group,09-10-2025
G8902001003,I intend to report the dementia measures group,09-10-2025
G8903001003,I intend to report the parkinson's disease measures group,09-10-2025
G8904001003,I intend to report the hypertension (htn) measures group,09-10-2025
G8905001003,I intend to report the cardiovascular prevention measures group,09-10-2025
G8906001003,I intend to report the cataract measures group,09-10-2025
G8907001003,Patient documented not to have experienced any of the following events: a burn,09-10-2025
G8907002004,Prior to discharge; a fall within the facility; wrong,09-10-2025
G8907003004,Site/side/patient/procedure/implant event; or a hospital transfer or hospital,09-10-2025
G8907004004,Admission upon discharge from the facility,09-10-2025
G8908001003,Patient documented to have received a burn prior to discharge,09-10-2025
G8909001003,Patient documented not to have received a burn prior to discharge,09-10-2025
G8910001003,Patient documented to have experienced a fall within asc,09-10-2025
G8911001003,Patient documented not to have experienced a fall within ambulatory surgical,09-10-2025
G8911002004,Center,09-10-2025
G8912001003,"Patient documented to have experienced a wrong site, wrong side, wrong patient,",09-10-2025
G8912002004,Wrong procedure or wrong implant event,09-10-2025
G8913001003,"Patient documented not to have experienced a wrong site, wrong side, wrong",09-10-2025
G8913002004,"Patient, wrong procedure or wrong implant event",09-10-2025
G8914001003,Patient documented to have experienced a hospital transfer or hospital,09-10-2025
G8914002004,Admission upon discharge from asc,09-10-2025
G8915001003,Patient documented not to have experienced a hospital transfer or hospital,09-10-2025
G8915002004,Admission upon discharge from asc,09-10-2025
G8916001003,Patient with preoperative order for iv antibiotic surgical site infection (ssi),09-10-2025
G8916002004,"Prophylaxis, antibiotic initiated on time",09-10-2025
G8917001003,Patient with preoperative order for iv antibiotic surgical site infection (ssi),09-10-2025
G8917002004,"Prophylaxis, antibiotic not initiated on time",09-10-2025
G8918001003,Patient without preoperative order for iv antibiotic surgical site infection,09-10-2025
G8918002004,(ssi) prophylaxis,09-10-2025
G8923001003,Current or prior left ventricular ejection fraction (lvef) <= 40% or,09-10-2025
G8923002004,Documentation of moderately or severely depressed left ventricular systolic,09-10-2025
G8923003004,Function,09-10-2025
G8924001003,Spirometry results documented (fev1/fvc < 70%),09-10-2025
G8925001003,"Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or",09-10-2025
G8925002004,Patient does not have copd symptoms,09-10-2025
G8926001003,"Spirometry test not performed or documented, reason not given",09-10-2025
G8927001003,"Adjuvant chemotherapy referred, prescribed or previously received for ajcc",09-10-2025
G8927002004,"Stage iii, colon cancer",09-10-2025
G8928001003,"Adjuvant chemotherapy not prescribed or previously received, for documented",09-10-2025
G8928002004,"Reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior",09-10-2025
G8928003004,"To the current visit date, patient's diagnosis date is within 120 days of the",09-10-2025
G8928004004,"End of the 12 month reporting period, patient's cancer has metastasized,",09-10-2025
G8928005004,"Medical contraindication/allergy, poor performance status, other medical",09-10-2025
G8928006004,"Reasons, patient refusal, other patient reasons, patient is currently enrolled",09-10-2025
G8928007004,"In a clinical trial that precludes prescription of chemotherapy, other system",09-10-2025
G8928008004,Reasons),09-10-2025
G8929001003,"Adjuvant chemotherapy not prescribed or previously received, reason not given",09-10-2025
G8930001003,Assessment of depression severity at the initial evaluation,09-10-2025
G8931001003,"Assessment of depression severity not documented, reason not given",09-10-2025
G8932001003,Suicide risk assessed at the initial evaluation,09-10-2025
G8933001003,"Suicide risk not assessed at the initial evaluation, reason not given",09-10-2025
G8934001003,Current or prior left ventricular ejection fraction (lvef) <=40% or,09-10-2025
G8934002004,Documentation of moderately or severely depressed left ventricular systolic,09-10-2025
G8934003004,Function,09-10-2025
G8935001003,Clinician prescribed angiotensin converting enzyme (ace) inhibitor or,09-10-2025
G8935002004,Angiotensin receptor blocker (arb) therapy,09-10-2025
G8936001003,Clinician documented that patient was not an eligible candidate for angiotensin,09-10-2025
G8936002004,Converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy,09-10-2025
G8936003004,"(eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor,",09-10-2025
G8936004004,"Diseases of the aortic or mitral valve, other medical reasons) or (eg, patient",09-10-2025
G8936005004,"Declined, other patient reasons)",09-10-2025
G8937001003,Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or,09-10-2025
G8937002004,"Angiotensin receptor blocker (arb) therapy, reason not given",09-10-2025
G8938001003,"Bmi is documented as being outside of normal parameters, follow-up plan is not",09-10-2025
G8938002004,"Documented, documentation the patient is not eligible",09-10-2025
G8939001003,"Pain assessment documented as positive, follow-up plan not documented,",09-10-2025
G8939002004,Documentation the patient is not eligible at the time of the encounter,09-10-2025
G8940001003,"Screening for depression documented as positive, a follow-up plan not",09-10-2025
G8940002004,"Completed, documented reason",09-10-2025
G8941001003,"Elder maltreatment screen documented as positive, follow-up plan not",09-10-2025
G8941002004,"Documented, documentation the patient is not eligible for follow-up plan at the",09-10-2025
G8941003004,Time of the encounter,09-10-2025
G8942001003,Functional outcome assessment using a standardized tool is documented within,09-10-2025
G8942002004,"The previous 30 days and a care plan, based on identified deficiencies is",09-10-2025
G8942003004,Documented within two days of the functional outcome assessment,09-10-2025
G8943001003,Ldl-c result not present or not within 12 months prior,09-10-2025
G8944001003,Ajcc melanoma cancer stage 0 through iic melanoma,09-10-2025
G8946001003,Minimally invasive biopsy method attempted but not diagnostic of breast cancer,09-10-2025
G8946002004,"(e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular",09-10-2025
G8946003004,"Neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical",09-10-2025
G8946004004,"Columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing",09-10-2025
G8946005004,"Lesion, papillary lesion, or any lesion with spindle cells)",09-10-2025
G8947001003,One or more neuropsychiatric symptoms,09-10-2025
G8948001003,No neuropsychiatric symptoms,09-10-2025
G8949001003,Documentation of patient reason(s) for patient not receiving counseling for,09-10-2025
G8949002004,"Diet and physical activity (e.g., patient is not willing to discuss diet or",09-10-2025
G8949003004,"Exercise interventions to help control blood pressure, or the patient said",09-10-2025
G8949004004,He/she refused to make these changes),09-10-2025
G8950001003,"Elevated or hypertensive blood pressure reading documented, and the indicated",09-10-2025
G8950002004,Follow-up is documented,09-10-2025
G8951001003,"Pre-hypertensive or hypertensive blood pressure reading documented, indicated",09-10-2025
G8951002004,"Follow-up not documented, documentation the patient is not eligible",09-10-2025
G8952001003,"Elevated or hypertensive blood pressure reading documented, indicated follow-up",09-10-2025
G8952002004,"Not documented, reason not given",09-10-2025
G8953001003,All quality actions for the applicable measures in the oncology measures group,09-10-2025
G8953002004,Have been performed for this patient,09-10-2025
G8955001003,Most recent assessment of adequacy of volume management documented,09-10-2025
G8956001003,Patient receiving maintenance hemodialysis in an outpatient dialysis facility,09-10-2025
G8957001003,Patient not receiving maintenance hemodialysis in an outpatient dialysis,09-10-2025
G8957002004,Facility,09-10-2025
G8958001003,"Assessment of adequacy of volume management not documented, reason not given",09-10-2025
G8959001003,Clinician treating major depressive disorder communicates to clinician treating,09-10-2025
G8959002004,Comorbid condition,09-10-2025
G8960001003,Clinician treating major depressive disorder did not communicate to clinician,09-10-2025
G8960002004,"Treating comorbid condition, reason not given",09-10-2025
G8961001003,Cardiac stress imaging test primarily performed on low-risk surgery patient for,09-10-2025
G8961002004,Preoperative evaluation within 30 days preceding this surgery,09-10-2025
G8962001003,Cardiac stress imaging test performed on patient for any reason including those,09-10-2025
G8962002004,Who did not have low risk surgery or test that was performed more than 30 days,09-10-2025
G8962003004,Preceding low risk surgery,09-10-2025
G8963001003,Cardiac stress imaging performed primarily for monitoring of asymptomatic,09-10-2025
G8963002004,Patient who had pci within 2 years,09-10-2025
G8964001003,Cardiac stress imaging test performed primarily for any other reason than,09-10-2025
G8964002004,"Monitoring of asymptomatic patient who had pci within 2 years (e.g.,",09-10-2025
G8964003004,"Symptomatic patient, patient greater than 2 years since pci, initial",09-10-2025
G8964004004,"Evaluation, etc)",09-10-2025
G8965001003,Cardiac stress imaging test primarily performed on low chd risk patient for,09-10-2025
G8965002004,Initial detection and risk assessment,09-10-2025
G8966001003,Cardiac stress imaging test performed on symptomatic or higher than low chd,09-10-2025
G8966002004,Risk patient or for any reason other than initial detection and risk assessment,09-10-2025
G8967001003,Fda approved oral anticoagulant is prescribed,09-10-2025
G8968001003,Documentation of medical reason(s) for not prescribing an fda-approved,09-10-2025
G8968002004,"Anticoagulant (e.g., present or planned atrial appendage occlusion or ligation",09-10-2025
G8968003004,Or patient being currently enrolled in a clinical trial related to af/atrial,09-10-2025
G8968004004,Flutter treatment),09-10-2025
G8969001003,Documentation of patient reason(s) for not prescribing an oral anticoagulant,09-10-2025
G8969002004,"That is fda approved for the prevention of thromboembolism (e.g., patient",09-10-2025
G8969003004,Preference for not receiving anticoagulation),09-10-2025
G8970001003,No risk factors or one moderate risk factor for thromboembolism,09-10-2025
G8971001003,"Warfarin or another oral anticoagulant that is fda approved not prescribed,",09-10-2025
G8971002004,Reason not given,09-10-2025
G8972001003,One or more high risk factors for thromboembolism or more than one moderate,09-10-2025
G8972002004,Risk factor for thromboembolism,09-10-2025
G8973001003,Most recent hemoglobin (hgb) level < 10 g/dl,09-10-2025
G8974001003,"Hemoglobin level measurement not documented, reason not given",09-10-2025
G8975001003,Documentation of medical reason(s) for patient having a hemoglobin level < 10,09-10-2025
G8975002004,"G/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell",09-10-2025
G8975003004,"Anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease,",09-10-2025
G8975004004,"Anemia related to chemotherapy for diagnosis of malignancy, postoperative",09-10-2025
G8975005004,"Bleeding, active bloodstream or peritoneal infection], other medical reasons)",09-10-2025
G8976001003,Most recent hemoglobin (hgb) level >= 10 g/dl,09-10-2025
G8977001003,I intend to report the oncology measures group,09-10-2025
G8978001003,"Mobility: walking & moving around functional limitation, current status, at",09-10-2025
G8978002004,Therapy episode outset and at reporting intervals,09-10-2025
G8979001003,"Mobility: walking & moving around functional limitation, projected goal status,",09-10-2025
G8979002004,"At therapy episode outset, at reporting intervals, and at discharge or to end",09-10-2025
G8979003004,Reporting,09-10-2025
G8980001003,"Mobility: walking & moving around functional limitation, discharge status, at",09-10-2025
G8980002004,Discharge from therapy or to end reporting,09-10-2025
G8981001003,"Changing & maintaining body position functional limitation, current status, at",09-10-2025
G8981002004,Therapy episode outset and at reporting intervals,09-10-2025
G8982001003,"Changing & maintaining body position functional limitation, projected goal",09-10-2025
G8982002004,"Status, at therapy episode outset, at reporting intervals, and at discharge or",09-10-2025
G8982003004,To end reporting,09-10-2025
G8983001003,"Changing & maintaining body position functional limitation, discharge status,",09-10-2025
G8983002004,At discharge from therapy or to end reporting,09-10-2025
G8984001003,"Carrying, moving & handling objects functional limitation, current status, at",09-10-2025
G8984002004,Therapy episode outset and at reporting intervals,09-10-2025
G8985001003,"Carrying, moving and handling objects, projected goal status, at therapy",09-10-2025
G8985002004,"Episode outset, at reporting intervals, and at discharge or to end reporting",09-10-2025
G8986001003,"Carrying, moving & handling objects functional limitation, discharge status, at",09-10-2025
G8986002004,Discharge from therapy or to end reporting,09-10-2025
G8987001003,"Self care functional limitation, current status, at therapy episode outset and",09-10-2025
G8987002004,At reporting intervals,09-10-2025
G8988001003,"Self care functional limitation, projected goal status, at therapy episode",09-10-2025
G8988002004,"Outset, at reporting intervals, and at discharge or to end reporting",09-10-2025
G8989001003,"Self care functional limitation, discharge status, at discharge from therapy or",09-10-2025
G8989002004,To end reporting,09-10-2025
G8990001003,"Other physical or occupational therapy primary functional limitation, current",09-10-2025
G8990002004,"Status, at therapy episode outset and at reporting intervals",09-10-2025
G8991001003,"Other physical or occupational therapy primary functional limitation, projected",09-10-2025
G8991002004,"Goal status, at therapy episode outset, at reporting intervals, and at",09-10-2025
G8991003004,Discharge or to end reporting,09-10-2025
G8992001003,"Other physical or occupational therapy primary functional limitation, discharge",09-10-2025
G8992002004,"Status, at discharge from therapy or to end reporting",09-10-2025
G8993001003,"Other physical or occupational therapy subsequent functional limitation,",09-10-2025
G8993002004,"Current status, at therapy episode outset and at reporting intervals",09-10-2025
G8994001003,"Other physical or occupational therapy subsequent functional limitation,",09-10-2025
G8994002004,"Projected goal status, at therapy episode outset, at reporting intervals, and",09-10-2025
G8994003004,At discharge or to end reporting,09-10-2025
G8995001003,"Other physical or occupational therapy subsequent functional limitation,",09-10-2025
G8995002004,"Discharge status, at discharge from therapy or to end reporting",09-10-2025
G8996001003,"Swallowing functional limitation, current status at therapy episode outset and",09-10-2025
G8996002004,At reporting intervals,09-10-2025
G8997001003,"Swallowing functional limitation, projected goal status, at therapy episode",09-10-2025
G8997002004,"Outset, at reporting intervals, and at discharge or to end reporting",09-10-2025
G8998001003,"Swallowing functional limitation, discharge status, at discharge from therapy",09-10-2025
G8998002004,Or to end reporting,09-10-2025
G8999001003,"Motor speech functional limitation, current status at therapy episode outset",09-10-2025
G8999002004,And at reporting intervals,09-10-2025
G9001001003,"Coordinated care fee, initial rate",09-10-2025
G9002001003,"Coordinated care fee, maintenance rate",09-10-2025
G9003001003,"Coordinated care fee, risk adjusted high, initial",09-10-2025
G9004001003,"Coordinated care fee, risk adjusted low, initial",09-10-2025
G9005001003,"Coordinated care fee, risk adjusted maintenance",09-10-2025
G9006001003,"Coordinated care fee, home monitoring",09-10-2025
G9007001003,"Coordinated care fee, scheduled team conference",09-10-2025
G9008001003,"Coordinated care fee, physician coordinated care oversight services",09-10-2025
G9009001003,"Coordinated care fee, risk adjusted maintenance, level 3",09-10-2025
G9010001003,"Coordinated care fee, risk adjusted maintenance, level 4",09-10-2025
G9011001003,"Coordinated care fee, risk adjusted maintenance, level 5",09-10-2025
G9012001003,Other specified case management service not elsewhere classified,09-10-2025
G9013001003,Esrd demo basic bundle level i,09-10-2025
G9014001003,Esrd demo expanded bundle including venous access and related services,09-10-2025
G9016001003,"Smoking cessation counseling, individual, in the absence of or in addition to",09-10-2025
G9016002004,"Any other evaluation and management service, per session (6-10 minutes) [demo",09-10-2025
G9016003004,Project code only],09-10-2025
G9017001003,"Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved",09-10-2025
G9017002004,Demonstration project),09-10-2025
G9018001003,"Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use",09-10-2025
G9018002004,In a medicare-approved demonstration project),09-10-2025
G9019001003,"Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved",09-10-2025
G9019002004,Demonstration project),09-10-2025
G9020001003,"Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved",09-10-2025
G9020002004,Demonstration project),09-10-2025
G9033001003,"Amantadine hydrochloride, oral brand, per 100 mg (for use in a",09-10-2025
G9033002004,Medicare-approved demonstration project),09-10-2025
G9034001003,"Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg",09-10-2025
G9034002004,(for use in a medicare-approved demonstration project),09-10-2025
G9035001003,"Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved",09-10-2025
G9035002004,Demonstration project),09-10-2025
G9036001003,"Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a",09-10-2025
G9036002004,Medicare-approved demonstration project),09-10-2025
G9037001003,Interprofessional telephone/internet/electronic health record clinical,09-10-2025
G9037002004,Question/request for specialty recommendations by a treating/requesting,09-10-2025
G9037003004,Physician or other qualified health care professional for the care of the,09-10-2025
G9037004004,Patient (i.e. not for professional education or scheduling) and may include,09-10-2025
G9037005004,Subsequent follow up on the specialist's recommendations; 30 minutes,09-10-2025
G9038001003,Co-management services with the following elements: new diagnosis or acute,09-10-2025
G9038002004,Exacerbation and stabilization of existing condition; condition which may,09-10-2025
G9038003004,Benefit from joint care planning; condition for which specialist is taking a,09-10-2025
G9038004004,Co-management role; condition expected to last at least 3 months; comprehensive,09-10-2025
G9038005004,"Care plan established, implemented, revised or monitored in partnership with",09-10-2025
G9038006004,Co-managing clinicians; ongoing communication and care coordination between,09-10-2025
G9038007004,Co-managing clinicians furnishing care,09-10-2025
G9050001003,"Oncology; primary focus of visit; work-up, evaluation, or staging at the time",09-10-2025
G9050002004,Of cancer diagnosis or recurrence (for use in a medicare-approved demonstration,09-10-2025
G9050003004,Project),09-10-2025
G9051001003,Oncology; primary focus of visit; treatment decision-making after disease is,09-10-2025
G9051002004,"Staged or restaged, discussion of treatment options, supervising/coordinating",09-10-2025
G9051003004,Active cancer directed therapy or managing consequences of cancer directed,09-10-2025
G9051004004,Therapy (for use in a medicare-approved demonstration project),09-10-2025
G9052001003,Oncology; primary focus of visit; surveillance for disease recurrence for,09-10-2025
G9052002004,Patient who has completed definitive cancer-directed therapy and currently,09-10-2025
G9052003004,Lacks evidence of recurrent disease; cancer directed therapy might be,09-10-2025
G9052004004,Considered in the future (for use in a medicare-approved demonstration project),09-10-2025
G9053001003,Oncology; primary focus of visit; expectant management of patient with evidence,09-10-2025
G9053002004,Of cancer for whom no cancer directed therapy is being administered or arranged,09-10-2025
G9053003004,At present; cancer directed therapy might be considered in the future (for use,09-10-2025
G9053004004,In a medicare-approved demonstration project),09-10-2025
G9054001003,"Oncology; primary focus of visit; supervising, coordinating or managing care of",09-10-2025
G9054002004,Patient with terminal cancer or for whom other medical illness prevents further,09-10-2025
G9054003004,"Cancer treatment; includes symptom management, end-of-life care planning,",09-10-2025
G9054004004,Management of palliative therapies (for use in a medicare-approved,09-10-2025
G9054005004,Demonstration project),09-10-2025
G9055001003,"Oncology; primary focus of visit; other, unspecified service not otherwise",09-10-2025
G9055002004,Listed (for use in a medicare-approved demonstration project),09-10-2025
G9056001003,Oncology; practice guidelines; management adheres to guidelines (for use in a,09-10-2025
G9056002004,Medicare-approved demonstration project),09-10-2025
G9057001003,Oncology; practice guidelines; management differs from guidelines as a result,09-10-2025
G9057002004,Of patient enrollment in an institutional review board approved clinical trial,09-10-2025
G9057003004,(for use in a medicare-approved demonstration project),09-10-2025
G9058001003,Oncology; practice guidelines; management differs from guidelines because the,09-10-2025
G9058002004,Treating physician disagrees with guideline recommendations (for use in a,09-10-2025
G9058003004,Medicare-approved demonstration project),09-10-2025
G9059001003,Oncology; practice guidelines; management differs from guidelines because the,09-10-2025
G9059002004,"Patient, after being offered treatment consistent with guidelines, has opted",09-10-2025
G9059003004,"For alternative treatment or management, including no treatment (for use in a",09-10-2025
G9059004004,Medicare-approved demonstration project),09-10-2025
G9060001003,Oncology; practice guidelines; management differs from guidelines for reason(s),09-10-2025
G9060002004,Associated with patient comorbid illness or performance status not factored,09-10-2025
G9060003004,Into guidelines (for use in a medicare-approved demonstration project),09-10-2025
G9061001003,Oncology; practice guidelines; patient's condition not addressed by available,09-10-2025
G9061002004,Guidelines (for use in a medicare-approved demonstration project),09-10-2025
G9062001003,Oncology; practice guidelines; management differs from guidelines for other,09-10-2025
G9062002004,Reason(s) not listed (for use in a medicare-approved demonstration project),09-10-2025
G9063001003,Oncology; disease status; limited to non-small cell lung cancer; extent of,09-10-2025
G9063002004,"Disease initially established as stage i (prior to neo-adjuvant therapy, if",09-10-2025
G9063003004,"Any) with no evidence of disease progression, recurrence, or metastases (for",09-10-2025
G9063004004,Use in a medicare-approved demonstration project),09-10-2025
G9064001003,Oncology; disease status; limited to non-small cell lung cancer; extent of,09-10-2025
G9064002004,"Disease initially established as stage ii (prior to neo-adjuvant therapy, if",09-10-2025
G9064003004,"Any) with no evidence of disease progression, recurrence, or metastases (for",09-10-2025
G9064004004,Use in a medicare-approved demonstration project),09-10-2025
G9065001003,Oncology; disease status; limited to non-small cell lung cancer; extent of,09-10-2025
G9065002004,"Disease initially established as stage iii a (prior to neo-adjuvant therapy, if",09-10-2025
G9065003004,"Any) with no evidence of disease progression, recurrence, or metastases (for",09-10-2025
G9065004004,Use in a medicare-approved demonstration project),09-10-2025
G9066001003,Oncology; disease status; limited to non-small cell lung cancer; stage iii b-,09-10-2025
G9066002004,"Iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a",09-10-2025
G9066003004,Medicare-approved demonstration project),09-10-2025
G9067001003,Oncology; disease status; limited to non-small cell lung cancer; extent of,09-10-2025
G9067002004,"Disease unknown, staging in progress, or not listed (for use in a",09-10-2025
G9067003004,Medicare-approved demonstration project),09-10-2025
G9068001003,Oncology; disease status; limited to small cell and combined small,09-10-2025
G9068002004,Cell/non-small cell; extent of disease initially established as limited with no,09-10-2025
G9068003004,"Evidence of disease progression, recurrence, or metastases (for use in a",09-10-2025
G9068004004,Medicare-approved demonstration project),09-10-2025
G9069001003,"Oncology; disease status; small cell lung cancer, limited to small cell and",09-10-2025
G9069002004,"Combined small cell/non-small cell; extensive stage at diagnosis, metastatic,",09-10-2025
G9069003004,"Locally recurrent, or progressive (for use in a medicare-approved demonstration",09-10-2025
G9069004004,Project),09-10-2025
G9070001003,"Oncology; disease status; small cell lung cancer, limited to small cell and",09-10-2025
G9070002004,"Combined small cell/non-small; extent of disease unknown, staging in progress,",09-10-2025
G9070003004,Or not listed (for use in a medicare-approved demonstration project),09-10-2025
G9071001003,Oncology; disease status; invasive female breast cancer (does not include,09-10-2025
G9071002004,Ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or,09-10-2025
G9071003004,"Stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of",09-10-2025
G9071004004,"Disease progression, recurrence, or metastases (for use in a medicare-approved",09-10-2025
G9071005004,Demonstration project),09-10-2025
G9072001003,Oncology; disease status; invasive female breast cancer (does not include,09-10-2025
G9072002004,"Ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or",09-10-2025
G9072003004,"Stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of",09-10-2025
G9072004004,"Disease progression, recurrence, or metastases (for use in a medicare-approved",09-10-2025
G9072005004,Demonstration project),09-10-2025
G9073001003,Oncology; disease status; invasive female breast cancer (does not include,09-10-2025
G9073002004,Ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage,09-10-2025
G9073003004,"Iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of",09-10-2025
G9073004004,"Disease progression, recurrence, or metastases (for use in a medicare-approved",09-10-2025
G9073005004,Demonstration project),09-10-2025
G9074001003,Oncology; disease status; invasive female breast cancer (does not include,09-10-2025
G9074002004,Ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage,09-10-2025
G9074003004,"Iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of",09-10-2025
G9074004004,"Disease progression, recurrence, or metastases (for use in a medicare-approved",09-10-2025
G9074005004,Demonstration project),09-10-2025
G9075001003,Oncology; disease status; invasive female breast cancer (does not include,09-10-2025
G9075002004,Ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at,09-10-2025
G9075003004,"Diagnosis, metastatic, locally recurrent, or progressive (for use in a",09-10-2025
G9075004004,Medicare-approved demonstration project),09-10-2025
G9077001003,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as",09-10-2025
G9077002004,Predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at,09-10-2025
G9077003004,"Diagnosis with no evidence of disease progression, recurrence, or metastases",09-10-2025
G9077004004,(for use in a medicare-approved demonstration project),09-10-2025
G9078001003,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as",09-10-2025
G9078002004,Predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no,09-10-2025
G9078003004,"Evidence of disease progression, recurrence, or metastases (for use in a",09-10-2025
G9078004004,Medicare-approved demonstration project),09-10-2025
G9079001003,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as",09-10-2025
G9079002004,"Predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence",09-10-2025
G9079003004,"Of disease progression, recurrence, or metastases (for use in a",09-10-2025
G9079004004,Medicare-approved demonstration project),09-10-2025
G9080001003,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; after",09-10-2025
G9080002004,Initial treatment with rising psa or failure of psa decline (for use in a,09-10-2025
G9080003004,Medicare-approved demonstration project),09-10-2025
G9083001003,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of",09-10-2025
G9083002004,"Disease unknown, staging in progress, or not listed (for use in a",09-10-2025
G9083003004,Medicare-approved demonstration project),09-10-2025
G9084001003,"Oncology; disease status; colon cancer, limited to invasive cancer,",09-10-2025
G9084002004,Adenocarcinoma as predominant cell type; extent of disease initially,09-10-2025
G9084003004,"Established as t1-3, n0, m0 with no evidence of disease progression,",09-10-2025
G9084004004,"Recurrence, or metastases (for use in a medicare-approved demonstration project",09-10-2025
G9085001003,"Oncology; disease status; colon cancer, limited to invasive cancer,",09-10-2025
G9085002004,Adenocarcinoma as predominant cell type; extent of disease initially,09-10-2025
G9085003004,"Established as t4, n0, m0 with no evidence of disease progression, recurrence,",09-10-2025
G9085004004,Or metastases (for use in a medicare-approved demonstration project),09-10-2025
G9086001003,"Oncology; disease status; colon cancer, limited to invasive cancer,",09-10-2025
G9086002004,Adenocarcinoma as predominant cell type; extent of disease initially,09-10-2025
G9086003004,"Established as t1-4, n1-2, m0 with no evidence of disease progression,",09-10-2025
G9086004004,"Recurrence, or metastases (for use in a medicare-approved demonstration project",09-10-2025
G9087001003,"Oncology; disease status; colon cancer, limited to invasive cancer,",09-10-2025
G9087002004,"Adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally",09-10-2025
G9087003004,"Recurrent, or progressive with current clinical, radiologic, or biochemical",09-10-2025
G9087004004,Evidence of disease (for use in a medicare-approved demonstration project),09-10-2025
G9088001003,"Oncology; disease status; colon cancer, limited to invasive cancer,",09-10-2025
G9088002004,"Adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally",09-10-2025
G9088003004,"Recurrent, or progressive without current clinical, radiologic, or biochemical",09-10-2025
G9088004004,Evidence of disease (for use in a medicare-approved demonstration project),09-10-2025
G9089001003,"Oncology; disease status; colon cancer, limited to invasive cancer,",09-10-2025
G9089002004,"Adenocarcinoma as predominant cell type; extent of disease unknown, staging in",09-10-2025
G9089003004,"Progress, or not listed (for use in a medicare-approved demonstration project)",09-10-2025
G9090001003,"Oncology; disease status; rectal cancer, limited to invasive cancer,",09-10-2025
G9090002004,Adenocarcinoma as predominant cell type; extent of disease initially,09-10-2025
G9090003004,"Established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no",09-10-2025
G9090004004,"Evidence of disease progression, recurrence, or metastases (for use in a",09-10-2025
G9090005004,Medicare-approved demonstration project),09-10-2025
G9091001003,"Oncology; disease status; rectal cancer, limited to invasive cancer,",09-10-2025
G9091002004,Adenocarcinoma as predominant cell type; extent of disease initially,09-10-2025
G9091003004,"Established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no",09-10-2025
G9091004004,"Evidence of disease progression, recurrence, or metastases (for use in a",09-10-2025
G9091005004,Medicare-approved demonstration project),09-10-2025
G9092001003,"Oncology; disease status; rectal cancer, limited to invasive cancer,",09-10-2025
G9092002004,Adenocarcinoma as predominant cell type; extent of disease initially,09-10-2025
G9092003004,"Established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no",09-10-2025
G9092004004,"Evidence of disease progression, recurrence or metastases (for use in a",09-10-2025
G9092005004,Medicare-approved demonstration project),09-10-2025
G9093001003,"Oncology; disease status; rectal cancer, limited to invasive cancer,",09-10-2025
G9093002004,Adenocarcinoma as predominant cell type; extent of disease initially,09-10-2025
G9093003004,"Established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no",09-10-2025
G9093004004,"Evidence of disease progression, recurrence, or metastases (for use in a",09-10-2025
G9093005004,Medicare-approved demonstration project),09-10-2025
G9094001003,"Oncology; disease status; rectal cancer, limited to invasive cancer,",09-10-2025
G9094002004,"Adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally",09-10-2025
G9094003004,"Recurrent, or progressive (for use in a medicare-approved demonstration project",09-10-2025
G9095001003,"Oncology; disease status; rectal cancer, limited to invasive cancer,",09-10-2025
G9095002004,"Adenocarcinoma as predominant cell type; extent of disease unknown, staging in",09-10-2025
G9095003004,"Progress, or not listed (for use in a medicare-approved demonstration project)",09-10-2025
G9096001003,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or",09-10-2025
G9096002004,Squamous cell carcinoma as predominant cell type; extent of disease initially,09-10-2025
G9096003004,"Established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with",09-10-2025
G9096004004,"No evidence of disease progression, recurrence, or metastases (for use in a",09-10-2025
G9096005004,Medicare-approved demonstration project),09-10-2025
G9097001003,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or",09-10-2025
G9097002004,Squamous cell carcinoma as predominant cell type; extent of disease initially,09-10-2025
G9097003004,"Established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no",09-10-2025
G9097004004,"Evidence of disease progression, recurrence, or metastases (for use in a",09-10-2025
G9097005004,Medicare-approved demonstration project),09-10-2025
G9098001003,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or",09-10-2025
G9098002004,"Squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic,",09-10-2025
G9098003004,"Locally recurrent, or progressive (for use in a medicare-approved demonstration",09-10-2025
G9098004004,Project),09-10-2025
G9099001003,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or",09-10-2025
G9099002004,"Squamous cell carcinoma as predominant cell type; extent of disease unknown,",09-10-2025
G9099003004,"Staging in progress, or not listed (for use in a medicare-approved",09-10-2025
G9099004004,Demonstration project),09-10-2025
G9100001003,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as",09-10-2025
G9100002004,Predominant cell type; post r0 resection (with or without neoadjuvant therapy),09-10-2025
G9100003004,"With no evidence of disease recurrence, progression, or metastases (for use in",09-10-2025
G9100004004,A medicare-approved demonstration project),09-10-2025
G9101001003,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as",09-10-2025
G9101002004,Predominant cell type; post r1 or r2 resection (with or without neoadjuvant,09-10-2025
G9101003004,"Therapy) with no evidence of disease progression, or metastases (for use in a",09-10-2025
G9101004004,Medicare-approved demonstration project),09-10-2025
G9102001003,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as",09-10-2025
G9102002004,"Predominant cell type; clinical or pathologic m0, unresectable with no evidence",09-10-2025
G9102003004,"Of disease progression, or metastases (for use in a medicare-approved",09-10-2025
G9102004004,Demonstration project),09-10-2025
G9103001003,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as",09-10-2025
G9103002004,"Predominant cell type; clinical or pathologic m1 at diagnosis, metastatic,",09-10-2025
G9103003004,"Locally recurrent, or progressive (for use in a medicare-approved demonstration",09-10-2025
G9103004004,Project),09-10-2025
G9104001003,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as",09-10-2025
G9104002004,"Predominant cell type; extent of disease unknown, staging in progress, or not",09-10-2025
G9104003004,Listed (for use in a medicare-approved demonstration project),09-10-2025
G9105001003,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as",09-10-2025
G9105002004,Predominant cell type; post r0 resection without evidence of disease,09-10-2025
G9105003004,"Progression, recurrence, or metastases (for use in a medicare-approved",09-10-2025
G9105004004,Demonstration project),09-10-2025
G9106001003,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1",09-10-2025
G9106002004,"Or r2 resection with no evidence of disease progression, or metastases (for use",09-10-2025
G9106003004,In a medicare-approved demonstration project),09-10-2025
G9107001003,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma;",09-10-2025
G9107002004,"Unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or",09-10-2025
G9107003004,Progressive (for use in a medicare-approved demonstration project),09-10-2025
G9108001003,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent",09-10-2025
G9108002004,"Of disease unknown, staging in progress, or not listed (for use in a",09-10-2025
G9108003004,Medicare-approved demonstration project),09-10-2025
G9109001003,"Oncology; disease status; head and neck cancer, limited to cancers of oral",09-10-2025
G9109002004,"Cavity, pharynx and larynx with squamous cell as predominant cell type; extent",09-10-2025
G9109003004,"Of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant",09-10-2025
G9109004004,"Therapy, if any) with no evidence of disease progression, recurrence, or",09-10-2025
G9109005004,Metastases (for use in a medicare-approved demonstration project),09-10-2025
G9110001003,"Oncology; disease status; head and neck cancer, limited to cancers of oral",09-10-2025
G9110002004,"Cavity, pharynx and larynx with squamous cell as predominant cell type; extent",09-10-2025
G9110003004,"Of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant",09-10-2025
G9110004004,"Therapy, if any) with no evidence of disease progression, recurrence, or",09-10-2025
G9110005004,Metastases (for use in a medicare-approved demonstration project),09-10-2025
G9111001003,"Oncology; disease status; head and neck cancer, limited to cancers of oral",09-10-2025
G9111002004,"Cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at",09-10-2025
G9111003004,"Diagnosis, metastatic, locally recurrent, or progressive (for use in a",09-10-2025
G9111004004,Medicare-approved demonstration project),09-10-2025
G9112001003,"Oncology; disease status; head and neck cancer, limited to cancers of oral",09-10-2025
G9112002004,"Cavity, pharynx and larynx with squamous cell as predominant cell type; extent",09-10-2025
G9112003004,"Of disease unknown, staging in progress, or not listed (for use in a",09-10-2025
G9112004004,Medicare-approved demonstration project),09-10-2025
G9113001003,"Oncology; disease status; ovarian cancer, limited to epithelial cancer;",09-10-2025
G9113002004,"Pathologic stage ia-b (grade 1) without evidence of disease progression,",09-10-2025
G9113003004,"Recurrence, or metastases (for use in a medicare-approved demonstration project",09-10-2025
G9114001003,"Oncology; disease status; ovarian cancer, limited to epithelial cancer;",09-10-2025
G9114002004,Pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii;,09-10-2025
G9114003004,"Without evidence of disease progression, recurrence, or metastases (for use in",09-10-2025
G9114004004,A medicare-approved demonstration project),09-10-2025
G9115001003,"Oncology; disease status; ovarian cancer, limited to epithelial cancer;",09-10-2025
G9115002004,"Pathologic stage iii-iv; without evidence of progression, recurrence, or",09-10-2025
G9115003004,Metastases (for use in a medicare-approved demonstration project),09-10-2025
G9116001003,"Oncology; disease status; ovarian cancer, limited to epithelial cancer;",09-10-2025
G9116002004,"Evidence of disease progression, or recurrence, and/or platinum resistance (for",09-10-2025
G9116003004,Use in a medicare-approved demonstration project),09-10-2025
G9117001003,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent",09-10-2025
G9117002004,"Of disease unknown, staging in progress, or not listed (for use in a",09-10-2025
G9117003004,Medicare-approved demonstration project),09-10-2025
G9123001003,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia",09-10-2025
G9123002004,"Chromosome positive and/or bcr-abl positive; chronic phase not in hematologic,",09-10-2025
G9123003004,"Cytogenetic, or molecular remission (for use in a medicare-approved",09-10-2025
G9123004004,Demonstration project),09-10-2025
G9124001003,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia",09-10-2025
G9124002004,Chromosome positive and/or bcr-abl positive; accelerated phase not in,09-10-2025
G9124003004,"Hematologic cytogenetic, or molecular remission (for use in a medicare-approved",09-10-2025
G9124004004,Demonstration project),09-10-2025
G9125001003,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia",09-10-2025
G9125002004,"Chromosome positive and/or bcr-abl positive; blast phase not in hematologic,",09-10-2025
G9125003004,"Cytogenetic, or molecular remission (for use in a medicare-approved",09-10-2025
G9125004004,Demonstration project),09-10-2025
G9126001003,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia",09-10-2025
G9126002004,"Chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or",09-10-2025
G9126003004,Molecular remission (for use in a medicare-approved demonstration project),09-10-2025
G9128001003,"Oncology; disease status; limited to multiple myeloma, systemic disease;",09-10-2025
G9128002004,"Smoldering, stage i (for use in a medicare-approved demonstration project)",09-10-2025
G9129001003,"Oncology; disease status; limited to multiple myeloma, systemic disease; stage",09-10-2025
G9129002004,Ii or higher (for use in a medicare-approved demonstration project),09-10-2025
G9130001003,"Oncology; disease status; limited to multiple myeloma, systemic disease; extent",09-10-2025
G9130002004,"Of disease unknown, staging in progress, or not listed (for use in a",09-10-2025
G9130003004,Medicare-approved demonstration project),09-10-2025
G9131001003,Oncology; disease status; invasive female breast cancer (does not include,09-10-2025
G9131002004,Ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of,09-10-2025
G9131003004,"Disease unknown, staging in progress, or not listed (for use in a",09-10-2025
G9131004004,Medicare-approved demonstration project),09-10-2025
G9132001003,"Oncology; disease status; prostate cancer, limited to adenocarcinoma;",09-10-2025
G9132002004,"Hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen",09-10-2025
G9132003004,Therapy or post-orchiectomy); clinical metastases (for use in a,09-10-2025
G9132004004,Medicare-approved demonstration project),09-10-2025
G9133001003,"Oncology; disease status; prostate cancer, limited to adenocarcinoma;",09-10-2025
G9133002004,Hormone-responsive; clinical metastases or m1 at diagnosis (for use in a,09-10-2025
G9133003004,Medicare-approved demonstration project),09-10-2025
G9134001003,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification;",09-10-2025
G9134002004,"Stage i, ii at diagnosis, not relapsed, not refractory (for use in a",09-10-2025
G9134003004,Medicare-approved demonstration project),09-10-2025
G9135001003,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification;",09-10-2025
G9135002004,"Stage iii, iv, not relapsed, not refractory (for use in a medicare-approved",09-10-2025
G9135003004,Demonstration project),09-10-2025
G9136001003,"Oncology; disease status; non-hodgkin's lymphoma, transformed from original",09-10-2025
G9136002004,Cellular diagnosis to a second cellular classification (for use in a,09-10-2025
G9136003004,Medicare-approved demonstration project),09-10-2025
G9137001003,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification;",09-10-2025
G9137002004,Relapsed/refractory (for use in a medicare-approved demonstration project),09-10-2025
G9138001003,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification;",09-10-2025
G9138002004,"Diagnostic evaluation, stage not determined, evaluation of possible relapse or",09-10-2025
G9138003004,"Non-response to therapy, or not listed (for use in a medicare-approved",09-10-2025
G9138004004,Demonstration project),09-10-2025
G9139001003,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia",09-10-2025
G9139002004,"Chromosome positive and/or bcr-abl positive; extent of disease unknown, staging",09-10-2025
G9139003004,"In progress, not listed (for use in a medicare-approved demonstration project)",09-10-2025
G9140001003,Frontier extended stay clinic demonstration; for a patient stay in a clinic,09-10-2025
G9140002004,Approved for the cms demonstration project; the following measures should be,09-10-2025
G9140003004,Present: the stay must be equal to or greater than 4 hours; weather or other,09-10-2025
G9140004004,Conditions must prevent transfer or the case falls into a category of,09-10-2025
G9140005004,Monitoring and observation cases that are permitted by the rules of the,09-10-2025
G9140006004,Demonstration; there is a maximum frontier extended stay clinic (fesc) visit of,09-10-2025
G9140007004,"48 hours, except in the case when weather or other conditions prevent transfer;",09-10-2025
G9140008004,"Payment is made on each period up to 4 hours, after the first 4 hours",09-10-2025
G9143001003,"Warfarin responsiveness testing by genetic technique using any method, any",09-10-2025
G9143002004,Number of specimen(s),09-10-2025
G9147001003,Outpatient intravenous insulin treatment (oivit) either pulsatile or,09-10-2025
G9147002004,"Continuous, by any means, guided by the results of measurements for:",09-10-2025
G9147003004,"Respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial,",09-10-2025
G9147004004,Venous or capillary glucose; and/or potassium concentration,09-10-2025
G9148001003,National committee for quality assurance - level 1 medical home,09-10-2025
G9149001003,National committee for quality assurance - level 2 medical home,09-10-2025
G9150001003,National committee for quality assurance - level 3 medical home,09-10-2025
G9151001003,Mapcp demonstration - state provided services,09-10-2025
G9152001003,Mapcp demonstration - community health teams,09-10-2025
G9153001003,Mapcp demonstration - physician incentive pool,09-10-2025
G9156001003,Evaluation for wheelchair requiring face to face visit with physician,09-10-2025
G9157001003,Transesophageal doppler measurement of cardiac output (including probe,09-10-2025
G9157002004,"Placement, image acquisition, and interpretation per course of treatment) for",09-10-2025
G9157003004,Monitoring purposes,09-10-2025
G9158001003,"Motor speech functional limitation, discharge status, at discharge from therapy",09-10-2025
G9158002004,Or to end reporting,09-10-2025
G9159001003,"Spoken language comprehension functional limitation, current status at therapy",09-10-2025
G9159002004,Episode outset and at reporting intervals,09-10-2025
G9160001003,"Spoken language comprehension functional limitation, projected goal status at",09-10-2025
G9160002004,"Therapy episode outset, at reporting intervals, and at discharge or to end",09-10-2025
G9160003004,Reporting,09-10-2025
G9161001003,"Spoken language comprehension functional limitation, discharge status, at",09-10-2025
G9161002004,Discharge from therapy or to end reporting,09-10-2025
G9162001003,"Spoken language expression functional limitation, current status at therapy",09-10-2025
G9162002004,Episode outset and at reporting intervals,09-10-2025
G9163001003,"Spoken language expression functional limitation, projected goal status at",09-10-2025
G9163002004,"Therapy episode outset, at reporting intervals, and at discharge or to end",09-10-2025
G9163003004,Reporting,09-10-2025
G9164001003,"Spoken language expression functional limitation, discharge status at discharge",09-10-2025
G9164002004,From therapy or to end reporting,09-10-2025
G9165001003,"Attention functional limitation, current status at therapy episode outset and",09-10-2025
G9165002004,At reporting intervals,09-10-2025
G9166001003,"Attention functional limitation, projected goal status at therapy episode",09-10-2025
G9166002004,"Outset, at reporting intervals, and at discharge or to end reporting",09-10-2025
G9167001003,"Attention functional limitation, discharge status at discharge from therapy or",09-10-2025
G9167002004,To end reporting,09-10-2025
G9168001003,"Memory functional limitation, current status at therapy episode outset and at",09-10-2025
G9168002004,Reporting intervals,09-10-2025
G9169001003,"Memory functional limitation, projected goal status at therapy episode outset,",09-10-2025
G9169002004,"At reporting intervals, and at discharge or to end reporting",09-10-2025
G9170001003,"Memory functional limitation, discharge status at discharge from therapy or to",09-10-2025
G9170002004,End reporting,09-10-2025
G9171001003,"Voice functional limitation, current status at therapy episode outset and at",09-10-2025
G9171002004,Reporting intervals,09-10-2025
G9172001003,"Voice functional limitation, projected goal status at therapy episode outset,",09-10-2025
G9172002004,"At reporting intervals, and at discharge or to end reporting",09-10-2025
G9173001003,"Voice functional limitation, discharge status at discharge from therapy or to",09-10-2025
G9173002004,End reporting,09-10-2025
G9174001003,"Other speech language pathology functional limitation, current status at",09-10-2025
G9174002004,Therapy episode outset and at reporting intervals,09-10-2025
G9175001003,"Other speech language pathology functional limitation, projected goal status at",09-10-2025
G9175002004,"Therapy episode outset, at reporting intervals, and at discharge or to end",09-10-2025
G9175003004,Reporting,09-10-2025
G9176001003,"Other speech language pathology functional limitation, discharge status at",09-10-2025
G9176002004,Discharge from therapy or to end reporting,09-10-2025
G9186001003,"Motor speech functional limitation, projected goal status at therapy episode",09-10-2025
G9186002004,"Outset, at reporting intervals, and at discharge or to end reporting",09-10-2025
G9187001003,Bundled payments for care improvement initiative home visit for patient,09-10-2025
G9187002004,Assessment performed by a qualified health care professional for individuals,09-10-2025
G9187003004,"Not considered homebound including, but not limited to, assessment of safety,",09-10-2025
G9187004004,"Falls, clinical status, fluid status, medication reconciliation/management,",09-10-2025
G9187005004,"Patient compliance with orders/plan of care, performance of activities of daily",09-10-2025
G9187006004,"Living, appropriateness of care setting; (for use only in the meidcare-approved",09-10-2025
G9187007004,Bundled payments for care improvement initiative); may not be billed for a,09-10-2025
G9187008004,30-day period covered by a transitional care management code,09-10-2025
G9188001003,"Beta-blocker therapy not prescribed, reason not given",09-10-2025
G9189001003,Beta-blocker therapy prescribed or currently being taken,09-10-2025
G9190001003,Documentation of medical reason(s) for not prescribing beta-blocker therapy,09-10-2025
G9190002004,"(eg, allergy, intolerance, other medical reasons)",09-10-2025
G9191001003,Documentation of patient reason(s) for not prescribing beta-blocker therapy,09-10-2025
G9191002004,"(eg, patient declined, other patient reasons)",09-10-2025
G9192001003,"Documentation of system reason(s) for not prescribing beta-blocker therapy (eg,",09-10-2025
G9192002004,Other reasons attributable to the health care system),09-10-2025
G9193001003,Clinician documented that patient with a diagnosis of major depression was not,09-10-2025
G9193002004,An eligible candidate for antidepressant medication treatment or patient did,09-10-2025
G9193003004,Not have a diagnosis of major depression,09-10-2025
G9194001003,Patient with a diagnosis of major depression documented as being treated with,09-10-2025
G9194002004,Antidepressant medication during the entire 180 day (6 month) continuation,09-10-2025
G9194003004,Treatment phase,09-10-2025
G9195001003,Patient with a diagnosis of major depression not documented as being treated,09-10-2025
G9195002004,With antidepressant medication during the entire 180 day (6 months),09-10-2025
G9195003004,Continuation treatment phase,09-10-2025
G9196001003,Documentation of medical reason(s) for not ordering a first or second,09-10-2025
G9196002004,"Generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled",09-10-2025
G9196003004,"In clinical trials, patients with documented infection prior to surgical",09-10-2025
G9196004004,"Procedure of interest, patients who were receiving antibiotics more than 24",09-10-2025
G9196005004,Hours prior to surgery [except colon surgery patients taking oral prophylactic,09-10-2025
G9196006004,"Antibiotics], patients who were receiving antibiotics within 24 hours prior to",09-10-2025
G9196007004,"Arrival [except colon surgery patients taking oral prophylactic antibiotics],",09-10-2025
G9196008004,Other medical reason(s)),09-10-2025
G9197001003,Documentation of order for first or second generation cephalosporin for,09-10-2025
G9197002004,Antimicrobial prophylaxis,09-10-2025
G9198001003,Order for first or second generation cephalosporin for antimicrobial,09-10-2025
G9198002004,"Prophylaxis was not documented, reason not given",09-10-2025
G9199001003,Venous thromboembolism (vte) prophylaxis not administered the day of or the day,09-10-2025
G9199002004,"After hospital admission for documented reasons (eg, patient is ambulatory,",09-10-2025
G9199003004,"Patient expired during inpatient stay, patient already on warfarin or another",09-10-2025
G9199004004,"Anticoagulant, other medical reason(s) or eg, patient left against medical",09-10-2025
G9199005004,"Advice, other patient reason(s))",09-10-2025
G9200001003,Venous thromboembolism (vte) prophylaxis was not administered the day of or the,09-10-2025
G9200002004,"Day after hospital admission, reason not given",09-10-2025
G9201001003,Venous thromboembolism (vte) prophylaxis administered the day of or the day,09-10-2025
G9201002004,After hospital admission,09-10-2025
G9202001003,Patients with a positive hepatitis c antibody test,09-10-2025
G9203001003,Rna testing for hepatitis c documented as performed within 12 months prior to,09-10-2025
G9203002004,Initiation of antiviral treatment for hepatitis c,09-10-2025
G9204001003,Rna testing for hepatitis c was not documented as performed within 12 months,09-10-2025
G9204002004,"Prior to initiation of antiviral treatment for hepatitis c, reason not given",09-10-2025
G9205001003,Patient starting antiviral treatmentfor hepatitis c during the measurement,09-10-2025
G9205002004,Period,09-10-2025
G9206001003,Patient starting antiviral treatment for hepatitis c during the measurement,09-10-2025
G9206002004,Period,09-10-2025
G9207001003,Hepatitis c genotype testing documented as performed within 12 months prior to,09-10-2025
G9207002004,Initiation of antiviral treatment for hepatitis c,09-10-2025
G9208001003,Hepatitis c genotype testing was not documented as performed within 12 months,09-10-2025
G9208002004,"Prior to initiation of antiviral treatment for hepatitis c, reason not given",09-10-2025
G9209001003,Hepatitis c quantitative rna testing documented as performed between 4-12 weeks,09-10-2025
G9209002004,After the initiation of antiviral treatment,09-10-2025
G9210001003,Hepatitis c quantitative rna testing not performed between 4-12 weeks after the,09-10-2025
G9210002004,"Initiation of antiviral treatment for documented reason(s) (e.g., patients",09-10-2025
G9210003004,"Whose treatment was discontinued during the testing period prior to testing,",09-10-2025
G9210004004,"Other medical reasons, patient declined, other patient reasons)",09-10-2025
G9211001003,Hepatitis c quantitative rna testing was not documented as performed between,09-10-2025
G9211002004,"4-12 weeks after the initiation of antiviral treatment, reason not given",09-10-2025
G9212001003,Dsm-ivtm criteria for major depressive disorder documented at the initial,09-10-2025
G9212002004,Evaluation,09-10-2025
G9213001003,Dsm-iv-tr criteria for major depressive disorder not documented at the initial,09-10-2025
G9213002004,"Evaluation, reason not otherwise specified",09-10-2025
G9214001003,Cd4+ cell count or cd4+ cell percentage results documented,09-10-2025
G9215001003,"Cd4+ cell count or percentage not documented as performed, reason not given",09-10-2025
G9216001003,"Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not give",09-10-2025
G9217001003,Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below,09-10-2025
G9217002004,"200 cells/mm3, reason not given",09-10-2025
G9218001003,Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below,09-10-2025
G9218002004,"500 cells/mm3 or a cd4 percentage below 15%, reason not given",09-10-2025
G9219001003,Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of,09-10-2025
G9219002004,"Low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient's",09-10-2025
G9219003004,Cd4+ cell count above threshold within 3 months after cd4+ cell count below,09-10-2025
G9219004004,"Threshold, indicating that the patient's cd4+ levels are within an acceptable",09-10-2025
G9219005004,Range and the patient does not require pcp prophylaxis),09-10-2025
G9220001003,Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of,09-10-2025
G9220002004,Low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for,09-10-2025
G9220003004,"Medical reason (i.e., patient's cd4+ cell count above threshold within 3 months",09-10-2025
G9220004004,"After cd4+ cell count below threshold, indicating that the patient's cd4+",09-10-2025
G9220005004,Levels are within an acceptable range and the patient does not require pcp,09-10-2025
G9220006004,Prophylaxis),09-10-2025
G9221001003,Pneumocystis jiroveci pneumonia prophlaxis prescribed,09-10-2025
G9222001003,Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low,09-10-2025
G9222002004,Cd4+ cell count below 200 cells/mm3,09-10-2025
G9223001003,Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low,09-10-2025
G9223002004,Cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%,09-10-2025
G9224001003,"Documentation of medical reason for not performing foot exam (e.g., patient",09-10-2025
G9224002004,With bilateral foot/leg amputation),09-10-2025
G9225001003,"Foot exam was not performed, reason not given",09-10-2025
G9226001003,"Foot examination performed (includes examination through visual inspection,",09-10-2025
G9226002004,Sensory exam with 10-g monofilament plus testing any one of the following:,09-10-2025
G9226003004,"Vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or",09-10-2025
G9226004004,"Vibration perception threshold, and pulse exam; report when all of the 3",09-10-2025
G9226005004,Components are completed),09-10-2025
G9227001003,"Functional outcome assessment documented, care plan not documented,",09-10-2025
G9227002004,Documentation the patient is not eligible for a care plan at the time of the,09-10-2025
G9227003004,Encounter,09-10-2025
G9228001003,"Chlamydia, gonorrhea and syphilis screening results documented (report when",09-10-2025
G9228002004,Results are present for all of the 3 screenings),09-10-2025
G9229001003,"Chlamydia, gonorrhea, and syphilis screening results not documented (patient",09-10-2025
G9229002004,Refusal is the only allowed exception),09-10-2025
G9230001003,"Chlamydia, gonorrhea, and syphilis not screened, reason not given",09-10-2025
G9231001003,"Documentation of end stage renal disease (esrd), dialysis, renal transplant",09-10-2025
G9231002004,Before or during the measurement period or pregnancy during the measurement,09-10-2025
G9231003004,Period,09-10-2025
G9232001003,Clinician treating major depressive disorder did not communicate to clinician,09-10-2025
G9232002004,"Treating comorbid condition for specified patient reason (e.g., patient is",09-10-2025
G9232003004,Unable to communicate the diagnosis of a comorbid condition; the patient is,09-10-2025
G9232004004,Unwilling to communicate the diagnosis of a comorbid condition; or the patient,09-10-2025
G9232005004,"Is unaware of the comorbid condition, or any other specified patient reason)",09-10-2025
G9233001003,All quality actions for the applicable measures in the total knee replacement,09-10-2025
G9233002004,Measures group have been performed for this patient,09-10-2025
G9234001003,I intend to report the total knee replacement measures group,09-10-2025
G9235001003,All quality actions for the applicable measures in the general surgery measures,09-10-2025
G9235002004,Group have been performed for this patient,09-10-2025
G9236001003,All quality actions for the applicable measures in the optimizing patient,09-10-2025
G9236002004,Exposure to ionizing radiation measures group have been performed for this,09-10-2025
G9236003004,Patient,09-10-2025
G9237001003,I intend to report the general surgery measures group,09-10-2025
G9238001003,I intend to report the optimizing patient exposure to ionizing radiation,09-10-2025
G9238002004,Measures group,09-10-2025
G9239001003,Documentation of reasons for patient initiating maintenance hemodialysis with a,09-10-2025
G9239002004,"Catheter as the mode of vascular access (e.g., patient has a maturing",09-10-2025
G9239003004,"Arteriovenous fistula (avf)/arteriovenous graft (avg), time-limited trial of",09-10-2025
G9239004004,"Hemodialysis, other medical reasons, patient declined avf/avg, other patient",09-10-2025
G9239005004,"Reasons, patient followed by reporting nephrologist for fewer than 90 days,",09-10-2025
G9239006004,Other system reasons),09-10-2025
G9240001003,Patient whose mode of vascular access is a catheter at the time maintenance,09-10-2025
G9240002004,Hemodialysis is initiated,09-10-2025
G9241001003,Patient whose mode of vascular access is not a catheter at the time maintenance,09-10-2025
G9241002004,Hemodialysis is initiated,09-10-2025
G9242001003,Documentation of viral load equal to or greater than 200 copies/ml or viral,09-10-2025
G9242002004,Load not performed,09-10-2025
G9243001003,Documentation of viral load less than 200 copies/ml,09-10-2025
G9244001003,Antiretroviral thereapy not prescribed,09-10-2025
G9245001003,Antiretroviral therapy prescribed,09-10-2025
G9246001003,Patient did not have two eligible encounters at least 90 days apart or one,09-10-2025
G9246002004,Eligible encounter and one hiv viral load test at least 90 days apart,09-10-2025
G9247001003,Patient had two eligible encounters at least 90 days apart or one eligible,09-10-2025
G9247002004,Encounter and one hiv viral load test at least 90 days apart,09-10-2025
G9248001003,Patient did not have a medical visit in the last 6 months,09-10-2025
G9249001003,Patient had a medical visit in the last 6 months,09-10-2025
G9250001003,Documentation of patient pain brought to a comfortable level within 48 hours,09-10-2025
G9250002004,From initial assessment,09-10-2025
G9251001003,Documentation of patient with pain not brought to a comfortable level within 48,09-10-2025
G9251002004,Hours from initial assessment,09-10-2025
G9252001003,Adenoma(s) or other neoplasm detected during screening colonoscopy,09-10-2025
G9253001003,Adenoma(s) or other neoplasm not detected during screening colonoscopy,09-10-2025
G9254001003,Documentation of patient discharged to home later than post-operative day 2,09-10-2025
G9254002004,Following cea or cas,09-10-2025
G9255001003,Documentation of patient discharged to home no later than post operative day 2,09-10-2025
G9255002004,Following cea or cas,09-10-2025
G9256001003,Documentation of patient death following cas,09-10-2025
G9257001003,Documentation of patient stroke following cas,09-10-2025
G9258001003,Documentation of patient stroke following cea,09-10-2025
G9259001003,Documentation of patient survival and absence of stroke following cas,09-10-2025
G9260001003,Documentation of patient death following cea,09-10-2025
G9261001003,Documentation of patient survival and absence of stroke following cea,09-10-2025
G9262001003,Documentation of patient death in the hospital following endovascular aaa repai,09-10-2025
G9263001003,Documentation of patient discharged alive following endovascular aaa repair,09-10-2025
G9264001003,Documentation of patient receiving maintenance hemodialysis for greater than or,09-10-2025
G9264002004,"Equal to 90 days with a catheter for documented reasons (e.g., other medical",09-10-2025
G9264003004,"Reasons, patient declined arteriovenous fistula (avf)/arteriovenous graft",09-10-2025
G9264004004,"(avg), other patient reasons)",09-10-2025
G9265001003,Patient receiving maintenance hemodialysis for greater than or equal to 90 days,09-10-2025
G9265002004,With a catheter as the mode of vascular access,09-10-2025
G9266001003,Patient receiving maintenance hemodialysis for greater than or equal to 90 days,09-10-2025
G9266002004,Without a catheter as the mode of vascular access,09-10-2025
G9267001003,Documentation of patient with one or more complications or mortality within 30,09-10-2025
G9267002004,Days,09-10-2025
G9268001003,Documentation of patient with one or more complications within 90 days,09-10-2025
G9269001003,Documentation of patient without one or more complications and without,09-10-2025
G9269002004,Mortality within 30 days,09-10-2025
G9270001003,Documentation of patient without one or more complications within 90 days,09-10-2025
G9271001003,Ldl value < 100,09-10-2025
G9272001003,Ldl value >= 100,09-10-2025
G9273001003,Blood pressure has a systolic value of < 140 and a diastolic value of < 90,09-10-2025
G9274001003,Blood pressure has a systolic value of =140 and a diastolic value of = 90 or,09-10-2025
G9274002004,Systolic value < 140 and diastolic value = 90 or systolic value = 140 and,09-10-2025
G9274003004,Diastolic value < 90,09-10-2025
G9275001003,Documentation that patient is a current non-tobacco user,09-10-2025
G9276001003,Documentation that patient is a current tobacco user,09-10-2025
G9277001003,Documentation that the patient is on daily aspirin or anti-platelet or has,09-10-2025
G9277002004,Documentation of a valid contraindication or exception to,09-10-2025
G9277003004,"Aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use,",09-10-2025
G9277004004,"Allergy to aspirin or anti-platelets, history of gastrointestinal bleed and",09-10-2025
G9277005004,"Bleeding disorder; additionally, the following exceptions documented by the",09-10-2025
G9277006004,Physician as a reason for not taking daily aspirin or anti-platelet are,09-10-2025
G9277007004,"Acceptable (use of non-steroidal anti-inflammatory agents, documented risk for",09-10-2025
G9277008004,"Drug interaction, uncontrolled hypertension defined as >180 systolic or >110",09-10-2025
G9277009004,Diastolic or gastroesophageal reflux),09-10-2025
G9278001003,Documentation that the patient is not on daily aspirin or anti-platelet regimen,09-10-2025
G9279001003,Pneumococcal screening performed and documentation of vaccination received,09-10-2025
G9279002004,Prior to discharge,09-10-2025
G9280001003,"Pneumococcal vaccination not administered prior to discharge, reason not",09-10-2025
G9280002004,Specified,09-10-2025
G9281001003,Screening performed and documentation that vaccination not indicated/patient,09-10-2025
G9281002004,Refusal,09-10-2025
G9282001003,Documentation of medical reason(s) for not reporting the histological type or,09-10-2025
G9282002004,"Nsclc-nos classification with an explanation (e.g., biopsy taken for other",09-10-2025
G9282003004,Purposes in a patient with a history of non-small cell lung cancer or other,09-10-2025
G9282004004,Documented medical reasons),09-10-2025
G9283001003,Non small cell lung cancer biopsy and cytology specimen report documents,09-10-2025
G9283002004,Classification into specific histologic type or classified as nsclc-nos with an,09-10-2025
G9283003004,Explanation,09-10-2025
G9284001003,Non small cell lung cancer biopsy and cytology specimen report does not,09-10-2025
G9284002004,Document classification into specific histologic type or classified as,09-10-2025
G9284003004,Nsclc-nos with an explanation,09-10-2025
G9285001003,Specimen site other than anatomic location of lung or is not classified as non,09-10-2025
G9285002004,Small cell lung cancer,09-10-2025
G9286001003,Antibiotic regimen prescribed within 10 days after onset of symptoms,09-10-2025
G9287001003,Antibiotic regimen not prescribed within 10 days after onset of symptoms,09-10-2025
G9288001003,Documentation of medical reason(s) for not reporting the histological type or,09-10-2025
G9288002004,"Nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in",09-10-2025
G9288003004,A person with a history of non-small cell carcinoma or other documented medical,09-10-2025
G9288004004,Reasons),09-10-2025
G9289001003,Non small cell lung cancer biopsy and cytology specimen report documents,09-10-2025
G9289002004,Classification into specific histologic type or classified as nsclc-nos with an,09-10-2025
G9289003004,Explanation,09-10-2025
G9290001003,Non small cell lung cancer biopsy and cytology specimen report does not,09-10-2025
G9290002004,Document classification into specific histologic type or classified as,09-10-2025
G9290003004,Nsclc-nos with an explanation,09-10-2025
G9291001003,"Specimen site other than anatomic location of lung, is not classified as non",09-10-2025
G9291002004,Small cell lung cancer or classified as nsclc-nos,09-10-2025
G9292001003,Documentation of medical reason(s) for not reporting pt category and a,09-10-2025
G9292002004,"Statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative",09-10-2025
G9292003004,Skin biopsies in a patient with a history of melanoma or other documented,09-10-2025
G9292004004,Medical reasons),09-10-2025
G9293001003,Pathology report does not include the pt category and a statement on thickness,09-10-2025
G9293002004,"And ulceration and for pt1, mitotic rate",09-10-2025
G9294001003,Pathology report includes the pt category and a statement on thickness and,09-10-2025
G9294002004,"Ulceration and for pt1, mitotic rate",09-10-2025
G9295001003,Specimen site other than anatomic cutaneous location,09-10-2025
G9296001003,Patients with documented shared decision-making including discussion of,09-10-2025
G9296002004,"Conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss,",09-10-2025
G9296003004,"Exercise, injections) prior to the procedure",09-10-2025
G9297001003,Shared decision-making including discussion of conservative (non-surgical),09-10-2025
G9297002004,"Therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to",09-10-2025
G9297003004,"The procedure, not documented, reason not given",09-10-2025
G9298001003,Patients who are evaluated for venous thromboembolic and cardiovascular risk,09-10-2025
G9298002004,"Factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi,",09-10-2025
G9298003004,Arrhythmia and stroke),09-10-2025
G9299001003,Patients who are not evaluated for venous thromboembolic and cardiovascular,09-10-2025
G9299002004,"Risk factors within 30 days prior to the procedure (e.g., history of dvt, pe,",09-10-2025
G9299003004,"Mi, arrhythmia and stroke, reason not given)",09-10-2025
G9300001003,Documentation of medical reason(s) for not completely infusing the prophylactic,09-10-2025
G9300002004,"Antibiotic prior to the inflation of the proximal tourniquet (e.g., a",09-10-2025
G9300003004,Tourniquet was not used),09-10-2025
G9301001003,Patients who had the prophylactic antibiotic completely infused prior to the,09-10-2025
G9301002004,Inflation of the proximal tourniquet,09-10-2025
G9302001003,Prophylactic antibiotic not completely infused prior to the inflation of the,09-10-2025
G9302002004,"Proximal tourniquet, reason not given",09-10-2025
G9303001003,Operative report does not identify the prosthetic implant specifications,09-10-2025
G9303002004,"Including the prosthetic implant manufacturer, the brand name of the prosthetic",09-10-2025
G9303003004,"Implant and the size of each prosthetic implant, reason not given",09-10-2025
G9304001003,Operative report identifies the prosthetic implant specifications including the,09-10-2025
G9304002004,"Prosthetic implant manufacturer, the brand name of the prosthetic implant and",09-10-2025
G9304003004,The size of each prosthetic implant,09-10-2025
G9305001003,Intervention for presence of leak of endoluminal contents through an,09-10-2025
G9305002004,Anastomosis not required,09-10-2025
G9306001003,Intervention for presence of leak of endoluminal contents through an,09-10-2025
G9306002004,Anastomosis required,09-10-2025
G9307001003,"No return to the operating room for a surgical procedure, for complications of",09-10-2025
G9307002004,"The principal operative procedure, within 30 days of the principal operative",09-10-2025
G9307003004,Procedure,09-10-2025
G9308001003,"Unplanned return to the operating room for a surgical procedure, for",09-10-2025
G9308002004,"Complications of the principal operative procedure, within 30 days of the",09-10-2025
G9308003004,Principal operative procedure,09-10-2025
G9309001003,No unplanned hospital readmission within 30 days of principal procedure,09-10-2025
G9310001003,Unplanned hospital readmission within 30 days of principal procedure,09-10-2025
G9311001003,No surgical site infection,09-10-2025
G9312001003,Surgical site infection,09-10-2025
G9313001003,"Amoxicillin, with or without clavulanate, not prescribed as first line",09-10-2025
G9313002004,Antibiotic at the time of diagnosis for documented reason,09-10-2025
G9314001003,"Amoxicillin, with or without clavulanate, not prescribed as first line",09-10-2025
G9314002004,"Antibiotic at the time of diagnosis, reason not given",09-10-2025
G9315001003,"Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic",09-10-2025
G9315002004,At the time of diagnosis,09-10-2025
G9316001003,Documentation of patient-specific risk assessment with a risk calculator based,09-10-2025
G9316002004,"On multi-institutional clinical data, the specific risk calculator used, and",09-10-2025
G9316003004,Communication of risk assessment from risk calculator with the patient or famil,09-10-2025
G9317001003,Documentation of patient-specific risk assessment with a risk calculator based,09-10-2025
G9317002004,"On multi-institutional clinical data, the specific risk calculator used, and",09-10-2025
G9317003004,Communication of risk assessment from risk calculator with the patient or,09-10-2025
G9317004004,Family not completed,09-10-2025
G9318001003,Imaging study named according to standardized nomenclature,09-10-2025
G9319001003,"Imaging study not named according to standardized nomenclature, reason not give",09-10-2025
G9320001003,Documentation of medical reason(s) for not naming ct studies according to a,09-10-2025
G9320002004,"Standardized nomenclature provided (eg, ct studies performed for radiation",09-10-2025
G9320003004,Treatment planning or image-guided radiation treatment delivery),09-10-2025
G9321001003,Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial,09-10-2025
G9321002004,Perfusion or infarct avid imaging) studies documented in the 12-month period,09-10-2025
G9321003004,Prior to the current study,09-10-2025
G9322001003,Count of previous ct and cardiac nuclear medicine (myocardial perfusion or,09-10-2025
G9322002004,Infarct avid imaging) studies not documented in the 12-month period prior to,09-10-2025
G9322003004,"The current study, reason not given",09-10-2025
G9323001003,Documentation of medical reason(s) for not counting previous ct and cardiac,09-10-2025
G9323002004,"Nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for",09-10-2025
G9323003004,Radiation treatment planning or image-guided radiation treatment delivery),09-10-2025
G9324001003,"All necessary data elements not included, reason not given",09-10-2025
G9325001003,Ct studies not reported to a radiation dose index registry due to medical,09-10-2025
G9325002004,"Reasons (eg, ct studies performed for radiation treatment planning or",09-10-2025
G9325003004,Image-guided radiation treatment delivery),09-10-2025
G9326001003,Ct studies performed not reported to a radiation dose index registry that is,09-10-2025
G9326002004,"Capable of collecting at a minimum all necessary data elements, reason not give",09-10-2025
G9327001003,Ct studies performed reported to a radiation dose index registry that is,09-10-2025
G9327002004,Capable of collecting at a minimum all necessary data elements,09-10-2025
G9328001003,Dicom format image data availability not documented in final report due to,09-10-2025
G9328002004,"Medical reasons (eg, ct studies performed for radiation treatment planning or",09-10-2025
G9328003004,Image-guided radiation treatment delivery),09-10-2025
G9329001003,Dicom format image data available to non-affiliated external healthcare,09-10-2025
G9329002004,"Facilities or entities on a secure, media free, reciprocally searchable basis",09-10-2025
G9329003004,With patient authorization for at least a 12-month period after the study not,09-10-2025
G9329004004,"Documented in final report, reason not given",09-10-2025
G9340001003,Final report documented that dicom format image data available to,09-10-2025
G9340002004,"Non-affiliated external healthcare facilities or entities on a secure, media",09-10-2025
G9340003004,"Free, reciprocally searchable basis with patient authorization for at least a",09-10-2025
G9340004004,12-month period after the study,09-10-2025
G9341001003,Search conducted for prior patient ct studies completed at non-affiliated,09-10-2025
G9341002004,External healthcare facilities or entities within the past 12-months and are,09-10-2025
G9341003004,"Available through a secure, authorized, media-free, shared archive prior to an",09-10-2025
G9341004004,Imaging study being performed,09-10-2025
G9342001003,Search not conducted prior to an imaging study being performed for prior,09-10-2025
G9342002004,Patient ct studies completed at non-affiliated external healthcare facilities,09-10-2025
G9342003004,"Or entities within the past 12-months and are available through a secure,",09-10-2025
G9342004004,"Authorized, media-free, shared archive, reason not given",09-10-2025
G9343001003,"Due to medical reasons, search not conducted for dicom format images for prior",09-10-2025
G9343002004,Patient ct imaging studies completed at non-affiliated external healthcare,09-10-2025
G9343003004,Facilities or entities within the past 12 months that are available through a,09-10-2025
G9343004004,"Secure, authorized, media-free, shared archive (e.g., ct studies performed for",09-10-2025
G9343005004,Radiation treatment planning or image-guided radiation treatment delivery),09-10-2025
G9344001003,Due to system reasons search not conducted for dicom format images for prior,09-10-2025
G9344002004,Patient ct imaging studies completed at non-affiliated external healthcare,09-10-2025
G9344003004,Facilities or entities within the past 12 months that are available through a,09-10-2025
G9344004004,"Secure, authorized, media-free, shared archive (e.g., non-affiliated external",09-10-2025
G9344005004,Healthcare facilities or entities does not have archival abilities through a,09-10-2025
G9344006004,Shared archival system),09-10-2025
G9345001003,Follow-up recommendations documented according to recommended guidelines for,09-10-2025
G9345002004,"Incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies",09-10-2025
G9345003004,Needed or that no follow-up is needed) based at a minimum on nodule size and,09-10-2025
G9345004004,Patient risk factors,09-10-2025
G9346001003,Follow-up recommendations not documented according to recommended guidelines,09-10-2025
G9346002004,"For incidentally detected pulmonary nodules due to medical reasons (e.g.,",09-10-2025
G9346003004,"Patients with known malignant disease, patients with unexplained fever, ct",09-10-2025
G9346004004,Studies performed for radiation treatment planning or image-guided radiation,09-10-2025
G9346005004,Treatment delivery),09-10-2025
G9347001003,Follow-up recommendations not documented according to recommended guidelines,09-10-2025
G9347002004,"For incidentally detected pulmonary nodules, reason not given",09-10-2025
G9348001003,Ct scan of the paranasal sinuses ordered at the time of diagnosis for,09-10-2025
G9348002004,Documented reasons,09-10-2025
G9349001003,Ct scan of the paranasal sinuses ordered at the time of diagnosis or received,09-10-2025
G9349002004,Within 28 days after date of diagnosis,09-10-2025
G9350001003,Ct scan of the paranasal sinuses not ordered at the time of diagnosis or,09-10-2025
G9350002004,Received within 28 days after date of diagnosis,09-10-2025
G9351001003,More than one ct scan of the paranasal sinuses ordered or received within 90,09-10-2025
G9351002004,Days after diagnosis,09-10-2025
G9352001003,More than one ct scan of the paranasal sinuses ordered or received within 90,09-10-2025
G9352002004,"Days after the date of diagnosis, reason not given",09-10-2025
G9353001003,More than one ct scan of the paranasal sinuses ordered or received within 90,09-10-2025
G9353002004,"Days after the date of diagnosis for documented reasons (eg, patients with",09-10-2025
G9353003004,"Complications, second ct obtained prior to surgery, other medical reasons)",09-10-2025
G9354001003,One ct scan or no ct scan of the paranasal sinuses ordered within 90 days after,09-10-2025
G9354002004,The date of diagnosis,09-10-2025
G9355001003,Elective delivery (without medical indication) by cesarean birth or induction,09-10-2025
G9355002004,Of labor not performed (<39 weeks of gestation),09-10-2025
G9356001003,Elective delivery (without medical indication) by cesarean birth or induction,09-10-2025
G9356002004,Of labor performed (<39 weeks of gestation),09-10-2025
G9357001003,"Post-partum screenings, evaluations and education performed",09-10-2025
G9358001003,"Post-partum screenings, evaluations and education not performed",09-10-2025
G9359001003,Documentation of negative or managed positive tb screen with further evidence,09-10-2025
G9359002004,That tb is not active prior to treatment with a biologic immune response,09-10-2025
G9359003004,Modifier,09-10-2025
G9360001003,No documentation of negative or managed positive tb screen,09-10-2025
G9361001003,Medical indication for delivery by cesarean birth or induction of labor (<39,09-10-2025
G9361002004,"Weeks of gestation) [documentation of reason(s) for elective delivery (e.g.,",09-10-2025
G9361003004,"Hemorrhage and placental complications, hypertension, preeclampsia and",09-10-2025
G9361004004,"Eclampsia, rupture of membranes (premature or prolonged), maternal conditions",09-10-2025
G9361005004,"Complicating pregnancy/delivery, fetal conditions complicating",09-10-2025
G9361006004,"Pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in",09-10-2025
G9361007004,Clinical trial)],09-10-2025
G9362001003,Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb),09-10-2025
G9362002004,Without the use of general anesthesia during an applicable procedure 60 minutes,09-10-2025
G9362003004,"Or longer, as documented in the anesthesia record",09-10-2025
G9363001003,Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb),09-10-2025
G9363002004,Without the use of general anesthesia during an applicable procedure or general,09-10-2025
G9363003004,"Or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia",09-10-2025
G9363004004,Record,09-10-2025
G9364001003,"Sinusitis caused by, or presumed to be caused by, bacterial infection",09-10-2025
G9365001003,One high-risk medication ordered,09-10-2025
G9366001003,One high-risk medication not ordered,09-10-2025
G9367001003,At least two orders for high-risk medications from the same drug class,09-10-2025
G9368001003,At least two orders for high-risk medications from the same drug class not,09-10-2025
G9368002004,Ordered,09-10-2025
G9369001003,Individual filled at least two prescriptions for any antipsychotic medication,09-10-2025
G9369002004,And had a pdc of 0.8 or greater,09-10-2025
G9370001003,Individual who did not fill at least two prescriptions for any antipsychotic,09-10-2025
G9370002004,Medication or did not have a pdc of 0.8 or greater,09-10-2025
G9376001003,Patient continued to have the retina attached at the 6 months follow up visit,09-10-2025
G9376002004,(+/- 1 month) following only one surgery,09-10-2025
G9377001003,Patient did not have the retina attached after 6 months following only one,09-10-2025
G9377002004,Surgery,09-10-2025
G9378001003,Patient continued to have the retina attached at the 6 months follow up visit,09-10-2025
G9378002004,(+/- 1 month),09-10-2025
G9379001003,Patient did not achieve flat retinas six months post surgery,09-10-2025
G9380001003,Patient offered assistance with end of life issues or existing end of life plan,09-10-2025
G9380002004,Was reviewed or updated during the measurement period,09-10-2025
G9381001003,Documentation of medical reason(s) for not offering assistance with end of life,09-10-2025
G9381002004,"Issues (e.g., patient in hospice care, patient in terminal phase) during the",09-10-2025
G9381003004,Measurement period,09-10-2025
G9382001003,Patient not offered assistance with end of life issues or existing end of life,09-10-2025
G9382002004,Plan was not reviewed or updated during the measurement period,09-10-2025
G9383001003,Patient received screening for hcv infection within the 12 month reporting,09-10-2025
G9383002004,Period,09-10-2025
G9384001003,Documentation of medical reason(s) for not receiving annual screening for hcv,09-10-2025
G9384002004,"Infection (e.g., decompensated cirrhosis indicating advanced disease [i.e.,",09-10-2025
G9384003004,"Ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular",09-10-2025
G9384004004,"Carcinoma, waitlist for organ transplant, limited life expectancy, other",09-10-2025
G9384005004,Medical reasons),09-10-2025
G9385001003,Documentation of patient reason(s) for not receiving annual screening for hcv,09-10-2025
G9385002004,"Infection (e.g., patient declined, other patient reasons)",09-10-2025
G9386001003,"Screening for hcv infection not received within the 12 month reporting period,",09-10-2025
G9386002004,Reason not given,09-10-2025
G9389001003,Unplanned rupture of the posterior capsule requiring vitrectomy during cataract,09-10-2025
G9389002004,Surgery,09-10-2025
G9390001003,No unplanned rupture of the posterior capsule requiring vitrectomy during,09-10-2025
G9390002004,Cataract surgery,09-10-2025
G9391001003,"Patient achieves refraction +-1 d for the eye that underwent cataract surgery,",09-10-2025
G9391002004,Measured at the one month follow up visit,09-10-2025
G9392001003,Patient does not achieve refraction +-1 d for the eye that underwent cataract,09-10-2025
G9392002004,"Surgery, measured at the one month follow up visit",09-10-2025
G9393001003,Patient with an initial phq-9 score greater than nine who achieves remission at,09-10-2025
G9393002004,Twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of,09-10-2025
G9393003004,Less than five,09-10-2025
G9394001003,"Patient who had a diagnosis of bipolar disorder or personality disorder, death,",09-10-2025
G9394002004,Permanent nursing home resident or receiving hospice or palliative care any,09-10-2025
G9394003004,Time during the measurement or assessment period,09-10-2025
G9395001003,Patient with an initial phq-9 score greater than nine who did not achieve,09-10-2025
G9395002004,Remission at twelve months as demonstrated by a twelve month (+/- 30 days),09-10-2025
G9395003004,Phq-9 score greater than or equal to five,09-10-2025
G9396001003,Patient with an initial phq-9 score greater than nine who was not assessed for,09-10-2025
G9396002004,Remission at twelve months (+/- 30 days),09-10-2025
G9399001003,Documentation in the patient record of a discussion between the,09-10-2025
G9399002004,Physician/clinician and the patient that includes all of the following:,09-10-2025
G9399003004,"Treatment choices appropriate to genotype, risks and benefits, evidence of",09-10-2025
G9399004004,"Effectiveness, and patient preferences toward the outcome of the treatment",09-10-2025
G9400001003,Documentation of medical or patient reason(s) for not discussing treatment,09-10-2025
G9400002004,Options; medical reasons: patient is not a candidate for treatment due to,09-10-2025
G9400003004,Advanced physical or mental health comorbidity (including active substance,09-10-2025
G9400004004,Use); currently receiving antiviral treatment; successful antiviral treatment,09-10-2025
G9400005004,(with sustained virologic response) prior to reporting period; other documented,09-10-2025
G9400006004,Medical reasons; patient reasons: patient unable or unwilling to participate in,09-10-2025
G9400007004,The discussion or other patient reasons,09-10-2025
G9401001003,No documentation in the patient record of a discussion between the physician or,09-10-2025
G9401002004,Other qualified healthcare professional and the patient that includes all of,09-10-2025
G9401003004,"The following: treatment choices appropriate to genotype, risks and benefits,",09-10-2025
G9401004004,"Evidence of effectiveness, and patient preferences toward treatment",09-10-2025
G9402001003,Patient received follow-up within 30 days after discharge,09-10-2025
G9403001003,Clinician documented reason patient was not able to complete 30 day follow-up,09-10-2025
G9403002004,"From acute inpatient setting discharge (e.g., patient death prior to follow-up",09-10-2025
G9403003004,"Visit, patient non-compliant for visit follow-up)",09-10-2025
G9404001003,Patient did not receive follow-up within 30 days after discharge,09-10-2025
G9405001003,Patient received follow-up within 7 days after discharge,09-10-2025
G9406001003,Clinician documented reason patient was not able to complete 7 day follow-up,09-10-2025
G9406002004,From acute inpatient setting discharge (i.e patient death prior to follow-up,09-10-2025
G9406003004,"Visit, patient non-compliance for visit follow-up)",09-10-2025
G9407001003,Patient did not receive follow-up within 7 days after discharge,09-10-2025
G9408001003,Patients with cardiac tamponade and/or pericardiocentesis occurring within 30,09-10-2025
G9408002004,Days,09-10-2025
G9409001003,Patients without cardiac tamponade and/or pericardiocentesis occurring within,09-10-2025
G9409002004,30 days,09-10-2025
G9410001003,"Patient admitted within 180 days, status post cied implantation, replacement,",09-10-2025
G9410002004,Or revision with an infection requiring device removal or surgical revision,09-10-2025
G9411001003,"Patient not admitted within 180 days, status post cied implantation,",09-10-2025
G9411002004,"Replacement, or revision with an infection requiring device removal or surgical",09-10-2025
G9411003004,Revision,09-10-2025
G9412001003,"Patient admitted within 180 days, status post cied implantation, replacement,",09-10-2025
G9412002004,Or revision with an infection requiring device removal or surgical revision,09-10-2025
G9413001003,"Patient not admitted within 180 days, status post cied implantation,",09-10-2025
G9413002004,"Replacement, or revision with an infection requiring device removal or surgical",09-10-2025
G9413003004,Revision,09-10-2025
G9414001003,"Patient had one dose of meningococcal vaccine (serogroups a, c, w, y) on or",09-10-2025
G9414002004,Between the patient's 11th and 13th birthdays,09-10-2025
G9415001003,"Patient did not have one dose of meningococcal vaccine (serogroups a, c, w, y)",09-10-2025
G9415002004,On or between the patient's 11th and 13th birthdays,09-10-2025
G9416001003,"Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine",09-10-2025
G9416002004,(tdap) on or between the patient's 10th and 13th birthdays,09-10-2025
G9417001003,"Patient did not have one tetanus, diphtheria toxoids and acellular pertussis",09-10-2025
G9417002004,Vaccine (tdap) on or between the patient's 10th and 13th birthdays,09-10-2025
G9418001003,Primary non-small cell lung cancer lung biopsy and cytology specimen report,09-10-2025
G9418002004,Documents classification into specific histologic type following iaslc guidance,09-10-2025
G9418003004,Or classified as nsclc-nos with an explanation,09-10-2025
G9419001003,Documentation of medical reason(s) for not including the histological type or,09-10-2025
G9419002004,Nsclc-nos classification with an explanation (e.g. specimen insufficient or,09-10-2025
G9419003004,"Non-diagnostic, specimen does not contain cancer, or other documented medical",09-10-2025
G9419004004,Reasons),09-10-2025
G9420001003,Specimen site other than anatomic location of lung or is not classified as,09-10-2025
G9420002004,Primary non-small cell lung cancer,09-10-2025
G9421001003,Primary non-small cell lung cancer lung biopsy and cytology specimen report,09-10-2025
G9421002004,Does not document classification into specific histologic type or histologic,09-10-2025
G9421003004,Type does not follow iaslc guidance or is classified as nsclc-nos but without,09-10-2025
G9421004004,An explanation,09-10-2025
G9422001003,"Primary lung carcinoma resection report documents pt category, pn category and",09-10-2025
G9422002004,"For non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma,",09-10-2025
G9422003004,Adenocarcinoma and not nsclc-nos),09-10-2025
G9423001003,"Documentation of medical reason for not including pt category, pn category and",09-10-2025
G9423002004,"Histologic type [for patient with appropriate exclusion criteria (e.g.,",09-10-2025
G9423003004,"Metastatic disease, benign tumors, malignant tumors other than carcinomas,",09-10-2025
G9423004004,Inadequate surgical specimens)],09-10-2025
G9424001003,"Specimen site other than anatomic location of lung, or classified as nsclc-nos",09-10-2025
G9425001003,"Primary lung carcinoma resection report does not document pt category, pn",09-10-2025
G9425002004,"Category and for non-small cell lung cancer, histologic type (e.g., squamous",09-10-2025
G9425003004,"Cell carcinoma, adenocarcinoma)",09-10-2025
G9426001003,Improvement in median time from ed arrival to initial ed oral or parenteral,09-10-2025
G9426002004,Pain medication administration performed for ed admitted patients,09-10-2025
G9427001003,Improvement in median time from ed arrival to initial ed oral or parenteral,09-10-2025
G9427002004,Pain medication administration not performed for ed admitted patients,09-10-2025
G9428001003,"Pathology report includes the pt category, thickness, ulceration and mitotic",09-10-2025
G9428002004,"Rate, peripheral and deep margin status and presence or absence of",09-10-2025
G9428003004,Microsatellitosis for invasive tumors,09-10-2025
G9429001003,"Documentation of medical reason(s) for not including pt category, thickness,",09-10-2025
G9429002004,"Ulceration and mitotic rate, peripheral and deep margin status and presence or",09-10-2025
G9429003004,"Absence of microsatellitosis for invasive tumors (e.g., negative skin biopsies,",09-10-2025
G9429004004,"Insufficient tissue, or other documented medical reasons)",09-10-2025
G9430001003,Specimen site other than anatomic cutaneous location,09-10-2025
G9431001003,"Pathology report does not include the pt category, thickness, ulceration and",09-10-2025
G9431002004,"Mitotic rate, peripheral and deep margin status and presence or absence of",09-10-2025
G9431003004,Microsatellitosis for invasive tumors,09-10-2025
G9432001003,"Asthma well-controlled based on the act, c-act, acq, or ataq score and results",09-10-2025
G9432002004,Documented,09-10-2025
G9433001003,"Death, permanent nursing home resident or receiving hospice or palliative care",09-10-2025
G9433002004,Any time during the measurement period,09-10-2025
G9434001003,"Asthma not well-controlled based on the act, c-act, acq, or ataq score, or",09-10-2025
G9434002004,"Specified asthma control tool not used, reason not given",09-10-2025
G9435001003,Aspirin prescribed at discharge,09-10-2025
G9436001003,"Aspirin not prescribed for documented reasons (e.g., allergy, medical",09-10-2025
G9436002004,"Intolerance, history of bleed)",09-10-2025
G9437001003,Aspirin not prescribed at discharge,09-10-2025
G9438001003,P2y inhibitor prescribed at discharge,09-10-2025
G9439001003,"P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical",09-10-2025
G9439002004,"Intolerance, history of bleed)",09-10-2025
G9440001003,P2y inhibitor not prescribed at discharge,09-10-2025
G9441001003,Statin prescribed at discharge,09-10-2025
G9442001003,"Statin not prescribed for documented reasons (e.g., allergy, medical",09-10-2025
G9442002004,Intolerance),09-10-2025
G9443001003,Statin not prescribed at discharge,09-10-2025
G9448001003,Patients who were born in the years 1945 to 1965,09-10-2025
G9449001003,History of receiving blood transfusions prior to 1992,09-10-2025
G9450001003,History of injection drug use,09-10-2025
G9451001003,Patient received one-time screening for hcv infection,09-10-2025
G9452001003,Documentation of medical reason(s) for not receiving hcv antibody test due to,09-10-2025
G9452002004,Limited life expectancy,09-10-2025
G9453001003,Documentation of patient reason(s) for not receiving one-time screening for hcv,09-10-2025
G9453002004,"Infection (e.g., patient declined, other patient reasons)",09-10-2025
G9454001003,One-time screening for hcv infection not received within 12-month reporting,09-10-2025
G9454002004,"Period and no documentation of prior screening for hcv infection, reason not",09-10-2025
G9454003004,Given,09-10-2025
G9455001003,"Patient underwent abdominal imaging with ultrasound, contrast enhanced ct or",09-10-2025
G9455002004,Contrast mri for hcc,09-10-2025
G9456001003,Documentation of medical or patient reason(s) for not ordering or performing,09-10-2025
G9456002004,Screening for hcc. medical reason: comorbid medical conditions with expected,09-10-2025
G9456003004,"Survival < 5 years, hepatic decompensation and not a candidate for liver",09-10-2025
G9456004004,"Transplantation, or other medical reasons; patient reasons: patient declined or",09-10-2025
G9456005004,"Other patient reasons (e.g., cost of tests, time related to accessing testing",09-10-2025
G9456006004,Equipment),09-10-2025
G9457001003,Patient did not undergo abdominal imaging and did not have a documented reason,09-10-2025
G9457002004,For not undergoing abdominal imaging in the submission period,09-10-2025
G9458001003,Patient documented as tobacco user and received tobacco cessation intervention,09-10-2025
G9458002004,(must include at least one of the following: advice given to quit smoking or,09-10-2025
G9458003004,"Tobacco use, counseling on the benefits of quitting smoking or tobacco use,",09-10-2025
G9458004004,Assistance with or referral to external smoking or tobacco cessation support,09-10-2025
G9458005004,"Programs, or current enrollment in smoking or tobacco use cessation program) if",09-10-2025
G9458006004,Identified as a tobacco user,09-10-2025
G9459001003,Currently a tobacco non-user,09-10-2025
G9460001003,"Tobacco assessment or tobacco cessation intervention not performed, reason not",09-10-2025
G9460002004,Given,09-10-2025
G9463001003,I intend to report the sinusitis measures group,09-10-2025
G9464001003,All quality actions for the applicable measures in the sinusitis measures group,09-10-2025
G9464002004,Have been performed for this patient,09-10-2025
G9465001003,I intend to report the acute otitis externa (aoe) measures group,09-10-2025
G9466001003,All quality actions for the applicable measures in the aoe measures group have,09-10-2025
G9466002004,Been performed for this patient,09-10-2025
G9467001003,Patient who have received or are receiving corticosteroids greater than or,09-10-2025
G9467002004,Equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days,09-10-2025
G9467003004,Or a single prescription equating to 600 mg prednisone or greater for all fills,09-10-2025
G9467004004,Within the last twelve months,09-10-2025
G9468001003,Patient not receiving corticosteroids greater than or equal to 10 mg/day of,09-10-2025
G9468002004,Prednisone equivalents for 60 or greater consecutive days or a single,09-10-2025
G9468003004,Prescription equating to 600 mg prednisone or greater for all fills,09-10-2025
G9469001003,Patients who have received or are receiving corticosteroids greater than or,09-10-2025
G9469002004,Equal to 10 mg/day of prednisone equivalents for 90 or greater consecutive days,09-10-2025
G9469003004,Or a single prescription equating to 900 mg prednisone or greater for all fills,09-10-2025
G9470001003,Patients not receiving corticosteroids greater than or equal to 10 mg/day of,09-10-2025
G9470002004,Prednisone equivalents for 60 or greater consecutive days or a single,09-10-2025
G9470003004,Prescription equating to 600 mg prednisone or greater for all fills,09-10-2025
G9471001003,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not",09-10-2025
G9471002004,Ordered or documented,09-10-2025
G9472001003,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not",09-10-2025
G9472002004,"Ordered and documented, no review of systems and no medication history or",09-10-2025
G9472003004,Pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribe,09-10-2025
G9473001003,"Services performed by chaplain in the hospice setting, each 15 minutes",09-10-2025
G9474001003,"Services performed by dietary counselor in the hospice setting, each 15 minutes",09-10-2025
G9475001003,"Services performed by other counselor in the hospice setting, each 15 minutes",09-10-2025
G9476001003,"Services performed by volunteer in the hospice setting, each 15 minutes",09-10-2025
G9477001003,"Services performed by care coordinator in the hospice setting, each 15 minutes",09-10-2025
G9478001003,"Services performed by other qualified therapist in the hospice setting, each 15",09-10-2025
G9478002004,Minutes,09-10-2025
G9479001003,"Services performed by qualified pharmacist in the hospice setting, each 15",09-10-2025
G9479002004,Minutes,09-10-2025
G9480001003,Admission to medicare care choice model program (mccm),09-10-2025
G9481001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9481002004,"Only in a medicare-approved cms innovation center demonstration project, which",09-10-2025
G9481003004,Requires these 3 key components: a problem focused history; a problem focused,09-10-2025
G9481004004,"Examination; and straightforward medical decision making, furnished in real",09-10-2025
G9481005004,Time using interactive audio and video technology. counseling and coordination,09-10-2025
G9481006004,"Of care with other physicians, other qualified health care professionals or",09-10-2025
G9481007004,Agencies are provided consistent with the nature of the problem(s) and the,09-10-2025
G9481008004,"Needs of the patient or the family or both. usually, the presenting problem(s)",09-10-2025
G9481009004,"Are self limited or minor. typically, 10 minutes are spent with the patient or",09-10-2025
G9481010004,"Family or both via real time, audio and video intercommunications technology",09-10-2025
G9482001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9482002004,"Only in a medicare-approved cms innovation center demonstration project, which",09-10-2025
G9482003004,Requires these 3 key components: an expanded problem focused history; an,09-10-2025
G9482004004,"Expanded problem focused examination; straightforward medical decision making,",09-10-2025
G9482005004,Furnished in real time using interactive audio and video technology.,09-10-2025
G9482006004,"Counseling and coordination of care with other physicians, other qualified",09-10-2025
G9482007004,Health care professionals or agencies are provided consistent with the nature,09-10-2025
G9482008004,"Of the problem(s) and the needs of the patient or the family or both. usually,",09-10-2025
G9482009004,"The presenting problem(s) are of low to moderate severity. typically, 20",09-10-2025
G9482010004,"Minutes are spent with the patient or family or both via real time, audio and",09-10-2025
G9482011004,Video intercommunications technology,09-10-2025
G9483001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9483002004,"Only in a medicare-approved cms innovation center demonstration project, which",09-10-2025
G9483003004,Requires these 3 key components: a detailed history; a detailed examination;,09-10-2025
G9483004004,"Medical decision making of low complexity, furnished in real time using",09-10-2025
G9483005004,Interactive audio and video technology. counseling and coordination of care,09-10-2025
G9483006004,"With other physicians, other qualified health care professionals or agencies",09-10-2025
G9483007004,Are provided consistent with the nature of the problem(s) and the needs of the,09-10-2025
G9483008004,"Patient or the family or both. usually, the presenting problem(s) are of",09-10-2025
G9483009004,"Moderate severity. typically, 30 minutes are spent with the patient or family",09-10-2025
G9483010004,"Or both via real time, audio and video intercommunications technology",09-10-2025
G9484001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9484002004,"Only in a medicare-approved cms innovation center demonstration project, which",09-10-2025
G9484003004,Requires these 3 key components: a comprehensive history; a comprehensive,09-10-2025
G9484004004,"Examination; medical decision making of moderate complexity, furnished in real",09-10-2025
G9484005004,Time using interactive audio and video technology. counseling and coordination,09-10-2025
G9484006004,"Of care with other physicians, other qualified health care professionals or",09-10-2025
G9484007004,Agencies are provided consistent with the nature of the problem(s) and the,09-10-2025
G9484008004,"Needs of the patient or the family or both. usually, the presenting problem(s)",09-10-2025
G9484009004,"Are of moderate to high severity. typically, 45 minutes are spent with the",09-10-2025
G9484010004,"Patient or family or both via real time, audio and video intercommunications",09-10-2025
G9484011004,Technology,09-10-2025
G9485001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9485002004,"Only in a medicare-approved cms innovation center demonstration project, which",09-10-2025
G9485003004,Requires these 3 key components: a comprehensive history; a comprehensive,09-10-2025
G9485004004,"Examination; medical decision making of high complexity, furnished in real time",09-10-2025
G9485005004,Using interactive audio and video technology. counseling and coordination of,09-10-2025
G9485006004,"Care with other physicians, other qualified health care professionals or",09-10-2025
G9485007004,Agencies are provided consistent with the nature of the problem(s) and the,09-10-2025
G9485008004,"Needs of the patient or the family or both. usually, the presenting problem(s)",09-10-2025
G9485009004,"Are of moderate to high severity. typically, 60 minutes are spent with the",09-10-2025
G9485010004,"Patient or family or both via real time, audio and video intercommunications",09-10-2025
G9485011004,Technology,09-10-2025
G9486001003,Remote in-home visit for the evaluation and management of an established,09-10-2025
G9486002004,Patient for use only in a medicare-approved cms innovation center demonstration,09-10-2025
G9486003004,"Project, which requires at least 2 of the following 3 key components: a problem",09-10-2025
G9486004004,Focused history; a problem focused examination; straightforward medical,09-10-2025
G9486005004,"Decision making, furnished in real time using interactive audio and video",09-10-2025
G9486006004,"Technology. counseling and coordination of care with other physicians, other",09-10-2025
G9486007004,Qualified health care professionals or agencies are provided consistent with,09-10-2025
G9486008004,The nature of the problem(s) and the needs of the patient or the family or,09-10-2025
G9486009004,"Both. usually, the presenting problem(s) are self limited or minor.",09-10-2025
G9486010004,"Typically, 10 minutes are spent with the patient or family or both via real",09-10-2025
G9486011004,"Time, audio and video intercommunications technology",09-10-2025
G9487001003,Remote in-home visit for the evaluation and management of an established,09-10-2025
G9487002004,Patient for use only in a medicare-approved cms innovation center demonstration,09-10-2025
G9487003004,"Project, which requires at least 2 of the following 3 key components: an",09-10-2025
G9487004004,Expanded problem focused history; an expanded problem focused examination;,09-10-2025
G9487005004,"Medical decision making of low complexity, furnished in real time using",09-10-2025
G9487006004,Interactive audio and video technology. counseling and coordination of care,09-10-2025
G9487007004,"With other physicians, other qualified health care professionals or agencies",09-10-2025
G9487008004,Are provided consistent with the nature of the problem(s) and the needs of the,09-10-2025
G9487009004,"Patient or the family or both. usually, the presenting problem(s) are of low",09-10-2025
G9487010004,"To moderate severity. typically, 15 minutes are spent with the patient or",09-10-2025
G9487011004,"Family or both via real time, audio and video intercommunications technology",09-10-2025
G9488001003,Remote in-home visit for the evaluation and management of an established,09-10-2025
G9488002004,Patient for use only in a medicare-approved cms innovation center demonstration,09-10-2025
G9488003004,"Project, which requires at least 2 of the following 3 key components: a",09-10-2025
G9488004004,Detailed history; a detailed examination; medical decision making of moderate,09-10-2025
G9488005004,"Complexity, furnished in real time using interactive audio and video",09-10-2025
G9488006004,"Technology. counseling and coordination of care with other physicians, other",09-10-2025
G9488007004,Qualified health care professionals or agencies are provided consistent with,09-10-2025
G9488008004,The nature of the problem(s) and the needs of the patient or the family or,09-10-2025
G9488009004,"Both. usually, the presenting problem(s) are of moderate to high severity.",09-10-2025
G9488010004,"Typically, 25 minutes are spent with the patient or family or both via real",09-10-2025
G9488011004,"Time, audio and video intercommunications technology",09-10-2025
G9489001003,Remote in-home visit for the evaluation and management of an established,09-10-2025
G9489002004,Patient for use only in a medicare-approved coms innovation center,09-10-2025
G9489003004,"Demonstration project, which requires at least 2 of the following 3 key",09-10-2025
G9489004004,Components: a comprehensive history; a comprehensive examination; medical,09-10-2025
G9489005004,"Decision making of high complexity, furnished in real time using interactive",09-10-2025
G9489006004,Audio and video technology. counseling and coordination of care with other,09-10-2025
G9489007004,"Physicians, other qualified health care professionals or agencies are provided",09-10-2025
G9489008004,Consistent with the nature of the problem(s) and the needs of the patient or,09-10-2025
G9489009004,"The family or both. usually, the presenting problem(s) are of moderate to high",09-10-2025
G9489010004,"Severity. typically, 40 minutes are spent with the patient or family or both",09-10-2025
G9489011004,"Via real time, audio and video intercommunications technology",09-10-2025
G9490001003,"Cms innovation center models, home visit for patient assessment performed by",09-10-2025
G9490002004,"Clinical staff for an individual not considered homebound, including, but not",09-10-2025
G9490003004,"Necessarily limited to patient assessment of clinical status, safety/fall",09-10-2025
G9490004004,"Prevention, functional status/ambulation, medication reconciliation/management,",09-10-2025
G9490005004,"Compliance with orders/plan of care, performance of activities of daily living,",09-10-2025
G9490006004,And ensuring beneficiary connections to community and other services. (for use,09-10-2025
G9490007004,Only in medicare-approved cms innovation center models); may not be billed for,09-10-2025
G9490008004,A 30 day period covered by a transitional care management code,09-10-2025
G9496001003,"Documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g.,",09-10-2025
G9496002004,"Neoplasm detected is only diagnosed as traditional serrated adenoma, sessile",09-10-2025
G9496003004,"Serrated polyp, or sessile serrated adenoma",09-10-2025
G9497001003,Received instruction from the anesthesiologist or proxy prior to the day of,09-10-2025
G9497002004,Surgery to abstain from smoking on the day of surgery,09-10-2025
G9498001003,Antibiotic regimen prescribed,09-10-2025
G9499001003,Patient did not start or is not receiving antiviral treatment for hepatitis c,09-10-2025
G9499002004,During the measurement period,09-10-2025
G9500001003,Radiation exposure indices documented in final report for procedure using,09-10-2025
G9500002004,Fluoroscopy,09-10-2025
G9501001003,Radiation exposure indices not documented in final report for procedure using,09-10-2025
G9501002004,"Fluoroscopy, reason not given",09-10-2025
G9502001003,"Documentation of medical reason for not performing foot exam (i.e., patients",09-10-2025
G9502002004,"Who have had either a bilateral amputation above or below the knee, or both a",09-10-2025
G9502003004,Left and right amputation above or below the knee before or during the,09-10-2025
G9502004004,Measurement period),09-10-2025
G9503001003,Patient taking tamsulosin hydrochloride,09-10-2025
G9504001003,"Documented reason for not assessing hepatitis b virus (hbv) status (e.g.,",09-10-2025
G9504002004,"Patient not initiating anti-tnf therapy, patient declined) prior to initiating",09-10-2025
G9504003004,Anti-tnf therapy,09-10-2025
G9505001003,Antibiotic regimen prescribed within 10 days after onset of symptoms for,09-10-2025
G9505002004,Documented medical reason,09-10-2025
G9506001003,Biologic immune response modifier prescribed,09-10-2025
G9507001003,Documentation that the patient is on a statin medication or has documentation,09-10-2025
G9507002004,Of a valid contraindication or exception to statin medications;,09-10-2025
G9507003004,Contraindications/exceptions that can be defined by diagnosis codes include,09-10-2025
G9507004004,"Pregnancy during the measurement period, active liver disease, rhabdomyolysis,",09-10-2025
G9507005004,End stage renal disease on dialysis and heart failure; provider documented,09-10-2025
G9507006004,Contraindications/exceptions include breastfeeding during the measurement,09-10-2025
G9507007004,"Period, woman of child-bearing age not actively taking birth control, allergy",09-10-2025
G9507008004,"To statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine,",09-10-2025
G9507009004,"Gemfibrozil, and danazol) and intolerance (with supporting documentation of",09-10-2025
G9507010004,Trying a statin at least once within the last 5 years or diagnosis codes for,09-10-2025
G9507011004,Myostitis or toxic myopathy related to drugs),09-10-2025
G9508001003,Documentation that the patient is not on a statin medication,09-10-2025
G9509001003,Adult patients 18 years of age or older with major depression or dysthymia who,09-10-2025
G9509002004,Reached remission at twelve months as demonstrated by a twelve month (+/-60,09-10-2025
G9509003004,Days) phq-9 or phq-9m score of less than 5,09-10-2025
G9510001003,Adult patients 18 years of age or older with major depression or dysthymia who,09-10-2025
G9510002004,Did not reach remission at twelve months as demonstrated by a twelve month,09-10-2025
G9510003004,(+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m,09-10-2025
G9510004004,Score was not assessed or is greater than or equal to 5,09-10-2025
G9511001003,Index event date phq-9 or phq-9m score greater than 9 documented during the,09-10-2025
G9511002004,Twelve month denominator identification period,09-10-2025
G9512001003,Individual had a pdc of 0.8 or greater,09-10-2025
G9513001003,Individual did not have a pdc of 0.8 or greater,09-10-2025
G9514001003,Patient required a return to the operating room within 90 days of surgery,09-10-2025
G9515001003,Patient did not require a return to the operating room within 90 days of surger,09-10-2025
G9516001003,"Patient achieved an improvement in visual acuity, from their preoperative",09-10-2025
G9516002004,"Level, within 90 days of surgery",09-10-2025
G9517001003,"Patient did not achieve an improvement in visual acuity, from their",09-10-2025
G9517002004,"Preoperative level, within 90 days of surgery, reason not given",09-10-2025
G9518001003,Documentation of active injection drug use,09-10-2025
G9519001003,Patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of,09-10-2025
G9519002004,Their planned refraction within 90 days of surgery,09-10-2025
G9520001003,Patient does not achieve final refraction (spherical equivalent) +/- 1.0,09-10-2025
G9520002004,Diopters of their planned refraction within 90 days of surgery,09-10-2025
G9521001003,Total number of emergency department visits and inpatient hospitalizations less,09-10-2025
G9521002004,Than two in the past 12 months,09-10-2025
G9522001003,Total number of emergency department visits and inpatient hospitalizations,09-10-2025
G9522002004,"Equal to or greater than two in the past 12 months or patient not screened,",09-10-2025
G9522003004,Reason not given,09-10-2025
G9523001003,Patient discontinued from hemodialysis or peritoneal dialysis,09-10-2025
G9524001003,Patient was referred to hospice care,09-10-2025
G9525001003,"Documentation of patient reason(s) for not referring to hospice care (e.g.,",09-10-2025
G9525002004,"Patient declined, other patient reasons)",09-10-2025
G9526001003,"Patient was not referred to hospice care, reason not given",09-10-2025
G9529001003,Patient with minor blunt head trauma had an appropriate indication(s) for a,09-10-2025
G9529002004,Head ct,09-10-2025
G9530001003,Patient presented with a minor blunt head trauma and had a head ct ordered for,09-10-2025
G9530002004,Trauma by an emergency care provider,09-10-2025
G9531001003,"Patient has documentation of ventricular shunt, brain tumor, multisystem",09-10-2025
G9531002004,"Trauma, or is currently taking an antiplatelet medication including: abciximab,",09-10-2025
G9531003004,"Anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide,",09-10-2025
G9531004004,"Prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar",09-10-2025
G9532001003,Patient had a head ct for trauma ordered by someone other than an emergency,09-10-2025
G9532002004,Care provider or was ordered for a reason other than trauma,09-10-2025
G9533001003,Patient with minor blunt head trauma did not have an appropriate indication(s),09-10-2025
G9533002004,For a head ct,09-10-2025
G9534001003,"Advanced brain imaging (cta, ct, mra or mri) was not ordered",09-10-2025
G9535001003,Patients with a normal neurological examination,09-10-2025
G9536001003,Documentation of medical reason(s) for ordering an advanced brain imaging study,09-10-2025
G9536002004,"(i.e., patient has an abnormal neurological examination; patient has the",09-10-2025
G9536003004,"Coexistence of seizures, or both; recent onset of severe headache; change in",09-10-2025
G9536004004,"The type of headache; signs of increased intracranial pressure (e.g.,",09-10-2025
G9536005004,"Papilledema, absent venous pulsations on funduscopic examination, altered",09-10-2025
G9536006004,"Mental status, focal neurologic deficits, signs of meningeal irritation);",09-10-2025
G9536007004,Hiv-positive patients with a new type of headache; immunocompromised patient,09-10-2025
G9536008004,With unexplained headache symptoms; patient on coagulopathy/anti-coagulation or,09-10-2025
G9536009004,Anti-platelet therapy; very young patients with unexplained headache symptoms),09-10-2025
G9537001003,Imaging needed as part of a clinical trial; or other clinician ordered the stud,09-10-2025
G9538001003,"Advanced brain imaging (cta, ct, mra or mri) was ordered",09-10-2025
G9539001003,Intent for potential removal at time of placement,09-10-2025
G9540001003,Patient alive 3 months post procedure,09-10-2025
G9541001003,Filter removed within 3 months of placement,09-10-2025
G9542001003,Documented re-assessment for the appropriateness of filter removal within 3,09-10-2025
G9542002004,Months of placement,09-10-2025
G9543001003,Documentation of at least two attempts to reach the patient to arrange a,09-10-2025
G9543002004,Clinical re-assessment for the appropriateness of filter removal within 3,09-10-2025
G9543003004,Months of placement,09-10-2025
G9544001003,"Patients that do not have the filter removed, documented re-assessment for the",09-10-2025
G9544002004,"Appropriateness of filter removal, or documentation of at least two attempts to",09-10-2025
G9544003004,Reach the patient to arrange a clinical re-assessment for the appropriateness,09-10-2025
G9544004004,Of filter removal within 3 months of placement,09-10-2025
G9547001003,"Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal",09-10-2025
G9547002004,Lesion less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but,09-10-2025
G9547003004,Less than or equal to 4.0 cm classified as likely benign by unenhanced ct or,09-10-2025
G9547004004,"Washout protocol ct, or mri with in- and opposed-phase sequences or other",09-10-2025
G9547005004,Equivalent institutional imaging protocols,09-10-2025
G9548001003,Final reports for imaging studies stating no follow-up imaging is recommended,09-10-2025
G9549001003,"Documentation of medical reason(s) that follow-up imaging is indicated (e.g.,",09-10-2025
G9549002004,"Patient has lymphadenopathy, signs of metastasis or an active diagnosis or",09-10-2025
G9549003004,"History of cancer, and other medical reason(s))",09-10-2025
G9550001003,"Final reports for imaging studies with follow-up imaging recommended, or final",09-10-2025
G9550002004,Reports that do not include a specific recommendation of no follow-up,09-10-2025
G9551001003,Final reports for imaging studies without an incidentally found lesion noted,09-10-2025
G9552001003,Incidental thyroid nodule < 1.0 cm noted in report,09-10-2025
G9553001003,Prior thyroid disease diagnosis,09-10-2025
G9554001003,"Final reports for ct, cta, mri or mra of the chest or neck with follow-up",09-10-2025
G9554002004,Imaging recommended,09-10-2025
G9555001003,"Documentation of medical reason(s) for recommending follow up imaging (e.g.,",09-10-2025
G9555002004,"Patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy,",09-10-2025
G9555003004,Other medical reason(s)),09-10-2025
G9556001003,"Final reports for ct, cta, mri or mra of the chest or neck with follow-up",09-10-2025
G9556002004,Imaging not recommended,09-10-2025
G9557001003,"Final reports for ct, cta, mri or mra studies of the chest or neck without an",09-10-2025
G9557002004,Incidentally found thyroid nodule < 1.0 cm noted or no nodule found,09-10-2025
G9558001003,Patient treated with a beta-lactam antibiotic as definitive therapy,09-10-2025
G9559001003,Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic,09-10-2025
G9559002004,"(e.g., allergy, intolerance to beta-lactam antibiotics)",09-10-2025
G9560001003,"Patient not treated with a beta-lactam antibiotic as definitive therapy, reason",09-10-2025
G9560002004,Not given,09-10-2025
G9561001003,Patients prescribed opiates for longer than six weeks,09-10-2025
G9562001003,Patients who had a follow-up evaluation conducted at least every three months,09-10-2025
G9562002004,During opioid therapy,09-10-2025
G9563001003,Patients who did not have a follow-up evaluation conducted at least every three,09-10-2025
G9563002004,Months during opioid therapy,09-10-2025
G9572001003,Index date phq-score greater than 9 documented during the twelve month,09-10-2025
G9572002004,Denominator identification period,09-10-2025
G9573001003,Adult patients 18 years of age or older with major depression or dysthymia who,09-10-2025
G9573002004,Did not reach remission at six months as demonstrated by a six month (+/-60,09-10-2025
G9573003004,Days) phq-9 or phq-9m score of less than five,09-10-2025
G9574001003,Adult patients 18 years of age or older with major depression or dysthymia who,09-10-2025
G9574002004,Did not reach remission at six months as demonstrated by a six month (+/-60,09-10-2025
G9574003004,Days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was,09-10-2025
G9574004004,Not assessed or is greater than or equal to five,09-10-2025
G9577001003,Patients prescribed opiates for longer than six weeks,09-10-2025
G9578001003,Documentation of signed opioid treatment agreement at least once during opioid,09-10-2025
G9578002004,Therapy,09-10-2025
G9579001003,No documentation of signed an opioid treatment agreement at least once during,09-10-2025
G9579002004,Opioid therapy,09-10-2025
G9580001003,Door to puncture time of 90 minutes or less,09-10-2025
G9581001003,Door to puncture time of greater than 2 hours for reasons documented by,09-10-2025
G9581002004,"Clinician (e.g., patients who are transferred from one institution to another",09-10-2025
G9581003004,With a known diagnosis of cva for endovascular stroke treatment; hospitalized,09-10-2025
G9581004004,Patients with newly diagnosed cva considered for endovascular stroke treatment),09-10-2025
G9582001003,"Door to puncture time of greater than 90 minutes, no reason given",09-10-2025
G9583001003,Patients prescribed opiates for longer than six weeks,09-10-2025
G9584001003,Patient evaluated for risk of misuse of opiates by using a brief validated,09-10-2025
G9584002004,"Instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least",09-10-2025
G9584003004,Once during opioid therapy,09-10-2025
G9585001003,Patient not evaluated for risk of misuse of opiates by using a brief validated,09-10-2025
G9585002004,"Instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at",09-10-2025
G9585003004,Least once during opioid therapy,09-10-2025
G9593001003,Pediatric patient with minor blunt head trauma classified as low risk according,09-10-2025
G9593002004,To the pecarn prediction rules,09-10-2025
G9594001003,Patient presented with a minor blunt head trauma and had a head ct ordered for,09-10-2025
G9594002004,Trauma by an emergency care provider,09-10-2025
G9595001003,"Patient has documentation of ventricular shunt, brain tumor, or coagulopathy",09-10-2025
G9596001003,Pediatric patient had a head ct for trauma ordered by someone other than an,09-10-2025
G9596002004,Emergency care provider or was ordered for a reason other than trauma,09-10-2025
G9597001003,Pediatric patient with minor blunt head trauma not classified as low risk,09-10-2025
G9597002004,According to the pecarn prediction rules,09-10-2025
G9598001003,Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or,09-10-2025
G9598002004,Minor diameter on axial formatted ct,09-10-2025
G9599001003,Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct,09-10-2025
G9599002004,Or minor diameter on axial formatted ct,09-10-2025
G9600001003,Symptomatic aaas that required urgent/emergent (non-elective) repair,09-10-2025
G9601001003,Patient discharge to home no later than post-operative day #7,09-10-2025
G9602001003,Patient not discharged to home by post-operative day #7,09-10-2025
G9603001003,Patient survey score improved from baseline following treatment,09-10-2025
G9604001003,Patient survey results not available,09-10-2025
G9605001003,Patient survey score did not improve from baseline following treatment,09-10-2025
G9606001003,Intraoperative cystoscopy performed to evaluate for lower tract injury,09-10-2025
G9607001003,"Documented medical reasons for not performing intraoperative cystoscopy (e.g.,",09-10-2025
G9607002004,"Urethral pathology precluding cystoscopy, any patient who has a congenital or",09-10-2025
G9607003004,Acquired absence of the urethra) or in the case of patient death,09-10-2025
G9608001003,Intraoperative cystoscopy not performed to evaluate for lower tract injury,09-10-2025
G9609001003,Documentation of an order for anti-platelet agents,09-10-2025
G9610001003,Documentation of medical reason(s) in the patient's record for not ordering,09-10-2025
G9610002004,Anti-platelet agents,09-10-2025
G9611001003,"Order for anti-platelet agents was not documented in the patient's record,",09-10-2025
G9611002004,Reason not given,09-10-2025
G9612001003,Photodocumentation of two or more cecal landmarks to establish a complete,09-10-2025
G9612002004,Examination,09-10-2025
G9613001003,"Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal",09-10-2025
G9613002004,"Resection, etc.)",09-10-2025
G9614001003,"Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks",09-10-2025
G9614002004,Or only one cecal landmark) to establish a complete examination,09-10-2025
G9615001003,Preoperative assessment documented,09-10-2025
G9616001003,"Documentation of reason(s) for not documenting a preoperative assessment (e.g.,",09-10-2025
G9616002004,Patient with a gynecologic or other pelvic malignancy noted at the time of,09-10-2025
G9616003004,Surgery),09-10-2025
G9617001003,"Preoperative assessment not documented, reason not given",09-10-2025
G9618001003,Documentation of screening for uterine malignancy or those that had an,09-10-2025
G9618002004,Ultrasound and/or endometrial sampling of any kind,09-10-2025
G9619001003,"Documentation of reason(s) for not screening for uterine malignancy (e.g.,",09-10-2025
G9619002004,Prior hysterectomy),09-10-2025
G9620001003,"Patient not screened for uterine malignancy, or those that have not had an",09-10-2025
G9620002004,"Ultrasound and/or endometrial sampling of any kind, reason not given",09-10-2025
G9621001003,Patient identified as an unhealthy alcohol user when screened for unhealthy,09-10-2025
G9621002004,Alcohol use using a systematic screening method and received brief counseling,09-10-2025
G9622001003,Patient not identified as an unhealthy alcohol user when screened for unhealthy,09-10-2025
G9622002004,Alcohol use using a systematic screening method,09-10-2025
G9623001003,Documentation of medical reason(s) for not screening for unhealthy alcohol use,09-10-2025
G9623002004,"(e.g., limited life expectancy, other medical reasons)",09-10-2025
G9624001003,Patient not screened for unhealthy alcohol use using a systematic screening,09-10-2025
G9624002004,Method or patient did not receive brief counseling if identified as an,09-10-2025
G9624003004,Unhealthy alcohol user,09-10-2025
G9625001003,Patient sustained bladder injury at the time of surgery or discovered,09-10-2025
G9625002004,Subsequently up to 30 days post-surgery,09-10-2025
G9626001003,"Documented medical reason for not reporting bladder injury (e.g., gynecologic",09-10-2025
G9626002004,"Or other pelvic malignancy documented, concurrent surgery involving bladder",09-10-2025
G9626003004,"Pathology, injury that occurs during a urinary incontinence procedure, patient",09-10-2025
G9626004004,"Death from non-medical causes not related to surgery, patient died during",09-10-2025
G9626005004,Procedure without evidence of bladder injury),09-10-2025
G9627001003,Patient did not sustain bladder injury at the time of surgery nor discovered,09-10-2025
G9627002004,Subsequently up to 30 days post-surgery,09-10-2025
G9628001003,Patient sustained bowel injury at the time of surgery or discovered,09-10-2025
G9628002004,Subsequently up to 30 days post-surgery,09-10-2025
G9629001003,"Documented medical reasons for not reporting bowel injury (e.g., gynecologic or",09-10-2025
G9629002004,"Other pelvic malignancy documented, planned (e.g., not due to an unexpected",09-10-2025
G9629003004,"Bowel injury) resection and/or re-anastomosis of bowel, or patient death from",09-10-2025
G9629004004,"Non-medical causes not related to surgery, patient died during procedure",09-10-2025
G9629005004,Without evidence of bowel injury),09-10-2025
G9630001003,Patient did not sustain a bowel injury at the time of surgery nor discovered,09-10-2025
G9630002004,Subsequently up to 30 days post-surgery,09-10-2025
G9631001003,Patient sustained ureter injury at the time of surgery or discovered,09-10-2025
G9631002004,Subsequently up to 30 days post-surgery,09-10-2025
G9632001003,"Documented medical reasons for not reporting ureter injury (e.g., gynecologic",09-10-2025
G9632002004,"Or other pelvic malignancy documented, concurrent surgery involving bladder",09-10-2025
G9632003004,"Pathology, injury that occurs during a urinary incontinence procedure, patient",09-10-2025
G9632004004,"Death from non-medical causes not related to surgery, patient died during",09-10-2025
G9632005004,Procedure without evidence of ureter injury),09-10-2025
G9633001003,Patient did not sustain ureter injury at the time of surgery nor discovered,09-10-2025
G9633002004,Subsequently up to 30 days post-surgery,09-10-2025
G9634001003,Health-related quality of life assessed with tool during at least two visits,09-10-2025
G9634002004,And quality of life score remained the same or improved,09-10-2025
G9635001003,Health-related quality of life not assessed with tool for documented reason(s),09-10-2025
G9635002004,"(e.g., patient has a cognitive or neuropsychiatric impairment that impairs",09-10-2025
G9635003004,"His/her ability to complete the hrqol survey, patient has the inability to read",09-10-2025
G9635004004,And/or write in order to complete the hrqol questionnaire),09-10-2025
G9636001003,Health-related quality of life not assessed with tool during at least two,09-10-2025
G9636002004,Visits or quality of life score declined,09-10-2025
G9637001003,Final reports with documentation of one or more dose reduction techniques,09-10-2025
G9637002004,"(e.g., automated exposure control, adjustment of the ma and/or kv according to",09-10-2025
G9637003004,"Patient size, use of iterative reconstruction technique)",09-10-2025
G9638001003,Final reports without documentation of one or more dose reduction techniques,09-10-2025
G9638002004,"(e.g., automated exposure control, adjustment of the ma and/or kv according to",09-10-2025
G9638003004,"Patient size, use of iterative reconstruction technique)",09-10-2025
G9639001003,Major amputation or open surgical bypass not required within 48 hours of the,09-10-2025
G9639002004,Index endovascular lower extremity revascularization procedure,09-10-2025
G9640001003,Documentation of planned hybrid or staged procedure,09-10-2025
G9641001003,Major amputation or open surgical bypass required within 48 hours of the index,09-10-2025
G9641002004,Endovascular lower extremity revascularization procedure,09-10-2025
G9642001003,"Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)",09-10-2025
G9643001003,Elective surgery,09-10-2025
G9644001003,Patients who abstained from smoking prior to anesthesia on the day of surgery,09-10-2025
G9644002004,Or procedure,09-10-2025
G9645001003,Patients who did not abstain from smoking prior to anesthesia on the day of,09-10-2025
G9645002004,Surgery or procedure,09-10-2025
G9646001003,Patients with 90 day mrs score of 0 to 2,09-10-2025
G9647001003,Patients in whom mrs score could not be obtained at 90 day follow-up,09-10-2025
G9648001003,Patients with 90 day mrs score greater than 2,09-10-2025
G9649001003,Psoriasis assessment tool documented meeting any one of the specified,09-10-2025
G9649002004,"Benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa),",09-10-2025
G9649003004,Psoriasis area and severity index (pasi) and/or dermatology life quality index),09-10-2025
G9649004004,(dlqi)),09-10-2025
G9650001003,Documentation that the patient declined therapy change or has documented,09-10-2025
G9650002004,"Contraindications (e.g., experienced adverse effects or lack of efficacy with",09-10-2025
G9650003004,All other therapy options) in order to achieve better disease control as,09-10-2025
G9650004004,"Measured by pga, bsa, pasi, or dlqi",09-10-2025
G9651001003,Psoriasis assessment tool documented not meeting any one of the specified,09-10-2025
G9651002004,"Benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa),",09-10-2025
G9651003004,Psoriasis area and severity index (pasi) and/or dermatology life quality index),09-10-2025
G9651004004,(dlqi)) or psoriasis assessment tool not documented,09-10-2025
G9652001003,Patient has been treated with a systemic or biologic medication for psoriasis,09-10-2025
G9652002004,For at least six months,09-10-2025
G9653001003,Patient has not been treated with a systemic or biologic medication for,09-10-2025
G9653002004,Psoriasis for at least six months,09-10-2025
G9654001003,Monitored anesthesia care (mac),09-10-2025
G9655001003,A transfer of care protocol or handoff tool/checklist that includes the,09-10-2025
G9655002004,Required key handoff elements is used,09-10-2025
G9656001003,Patient transferred directly from anesthetizing location to pacu or other,09-10-2025
G9656002004,Non-icu location,09-10-2025
G9657001003,Transfer of care during an anesthetic or to the intensive care unit,09-10-2025
G9658001003,A transfer of care protocol or handoff tool/checklist that includes the,09-10-2025
G9658002004,Required key handoff elements is not used,09-10-2025
G9659001003,Patients greater than or equal to 86 years of age who underwent a screening,09-10-2025
G9659002004,Colonoscopy and did not have a history of colorectal cancer or other valid,09-10-2025
G9659003004,"Medical reason for the colonoscopy, including: iron deficiency anemia, lower",09-10-2025
G9659004004,"Gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome",09-10-2025
G9659005004,"(i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease",09-10-2025
G9659006004,"(i.e., crohn's disease or ulcerative colitis), abnormal finding of",09-10-2025
G9659007004,"Gastrointestinal tract, weight loss, or changes in bowel habits",09-10-2025
G9660001003,Documentation of medical reason(s) for a colonoscopy performed on a patient,09-10-2025
G9660002004,"Greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower",09-10-2025
G9660003004,"Gastrointestinal bleeding, familial history of adenomatous polyposis, lynch",09-10-2025
G9660004004,"Syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel",09-10-2025
G9660005004,"Disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of",09-10-2025
G9660006004,"Gastrointestinal tract, weight loss, or changes in bowel habits)",09-10-2025
G9661001003,Patients greater than or equal to 86 years of age who received a colonoscopy,09-10-2025
G9661002004,"For an assessment of signs/symptoms of gi tract illness, and/or because the",09-10-2025
G9661003004,"Patient meets high risk criteria, and/or to follow-up on previously diagnosed",09-10-2025
G9661004004,Advanced lesions,09-10-2025
G9662001003,"Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd",09-10-2025
G9662002004,Procedure,09-10-2025
G9663001003,Any ldl-c laboratory result >= 190 mg/dl,09-10-2025
G9664001003,Patients who are currently statin therapy users or received an order,09-10-2025
G9664002004,(prescription) for statin therapy,09-10-2025
G9665001003,Patients who are not currently statin therapy users or did not receive an order,09-10-2025
G9665002004,(prescription) for statin therapy,09-10-2025
G9666001003,Patient's highest fasting or direct ldl-c laboratory test result in the,09-10-2025
G9666002004,Measurement period or two years prior to the beginning of the measurement,09-10-2025
G9666003004,Period is 70-189 mg/dl,09-10-2025
G9667001003,Documentation of medical reason(s) for not currently being a statin therapy,09-10-2025
G9667002004,"User or receive an order (prescription) for statin therapy (e.g., patient with",09-10-2025
G9667003004,"Adverse effect, allergy or intolerance to statin medication therapy, patients",09-10-2025
G9667004004,"Who have an active diagnosis of pregnancy or who are breastfeeding, patients",09-10-2025
G9667005004,"Who are receiving palliative care, patients with active liver disease or",09-10-2025
G9667006004,"Hepatic disease or insufficiency, patients with end stage renal disease (esrd),",09-10-2025
G9667007004,And patients with diabetes who have a fasting or direct ldl-c laboratory test,09-10-2025
G9667008004,Result < 70 mg/dl and are not taking statin therapy),09-10-2025
G9669001003,I intend to report the multiple chronic conditions measures group,09-10-2025
G9670001003,All quality actions for the applicable measures in the multiple chronic,09-10-2025
G9670002004,Conditions measures group have been performed for this patient,09-10-2025
G9671001003,I intend to report the diabetic retinopathy measures group,09-10-2025
G9672001003,All quality actions for the applicable measures in the diabetic retinopathy,09-10-2025
G9672002004,Measures group have been performed for this patient,09-10-2025
G9673001003,I intend to report the cardiovascular prevention measures group,09-10-2025
G9674001003,Patients with clinical ascvd diagnosis,09-10-2025
G9675001003,Patients who have ever had a fasting or direct laboratory result of ldl-c = 190,09-10-2025
G9675002004,Mg/dl,09-10-2025
G9676001003,Patients aged 40 to 75 years at the beginning of the measurement period with,09-10-2025
G9676002004,Type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as,09-10-2025
G9676003004,The highest fasting or direct laboratory test result in the measurement year or,09-10-2025
G9676004004,During the two years prior to the beginning of the measurement period,09-10-2025
G9677001003,All quality actions for the applicable measures in the cardiovascular,09-10-2025
G9677002004,Prevention measures group have been performed for this patient,09-10-2025
G9678001003,Oncology care model (ocm) monthly enhanced oncology services (meos) payment for,09-10-2025
G9678002004,Ocm enhanced services. g9678 payments may only be made to ocm practitioners,09-10-2025
G9678003004,For ocm beneficiaries for the furnishment of enhanced services as defined in,09-10-2025
G9678004004,The ocm participation agreement,09-10-2025
G9679001003,This code is for onsite acute care treatment of a nursing facility resident,09-10-2025
G9679002004,With pneumonia; may only be billed once per day per beneficiary,09-10-2025
G9680001003,This code is for onsite acute care treatment of a nursing facility resident,09-10-2025
G9680002004,With chf; may only be billed once per day per beneficiary,09-10-2025
G9681001003,This code is for onsite acute care treatment of a resident with copd or asthma;,09-10-2025
G9681002004,May only be billed once per day per beneficiary,09-10-2025
G9682001003,This code is for the onsite acute care treatment a nursing facility resident,09-10-2025
G9682002004,With a skin infection; may only be billed once per day per beneficiary,09-10-2025
G9683001003,Facility service(s) for the onsite acute care treatment of a nursing facility,09-10-2025
G9683002004,Resident with fluid or electrolyte disorder. (may only be billed once per day,09-10-2025
G9683003004,Per beneficiary). this service is for a demonstration project,09-10-2025
G9684001003,This code is for the onsite acute care treatment of a nursing facility resident,09-10-2025
G9684002004,For a uti; may only be billed once per day per beneficiary,09-10-2025
G9685001003,Physician service or other qualified health care professional for the,09-10-2025
G9685002004,Evaluation and management of a beneficiary's acute change in condition in a,09-10-2025
G9685003004,Nursing facility. this service is for a demonstration project,09-10-2025
G9686001003,"Onsite nursing facility conference, that is separate and distinct from an",09-10-2025
G9686002004,"Evaluation and management visit, including qualified practitioner and at least",09-10-2025
G9686003004,One member of the nursing facility interdisciplinary care team,09-10-2025
G9687001003,Hospice services provided to patient any time during the measurement period,09-10-2025
G9688001003,Patients using hospice services any time during the measurement period,09-10-2025
G9689001003,Patient admitted for performance of elective carotid intervention,09-10-2025
G9690001003,Patient receiving hospice services any time during the measurement period,09-10-2025
G9691001003,Patient had hospice services any time during the measurement period,09-10-2025
G9692001003,Hospice services received by patient any time during the measurement period,09-10-2025
G9693001003,Patient use of hospice services any time during the measurement period,09-10-2025
G9694001003,Hospice services utilized by patient any time during the measurement period,09-10-2025
G9695001003,Long-acting inhaled bronchodilator prescribed,09-10-2025
G9696001003,Documentation of medical reason(s) for not prescribing a long-acting inhaled,09-10-2025
G9696002004,"Bronchodilator (e.g., patient intolerance or history of side effects)",09-10-2025
G9697001003,Documentation of patient reason(s) for not prescribing a long-acting inhaled,09-10-2025
G9697002004,Bronchodilator,09-10-2025
G9698001003,Documentation of system reason(s) for not prescribing a long-acting inhaled,09-10-2025
G9698002004,"Bronchodilator (e.g., cost of treatment or lack of insurance)",09-10-2025
G9699001003,"Long-acting inhaled bronchodilator not prescribed, reason not otherwise",09-10-2025
G9699002004,Specified,09-10-2025
G9700001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9701001003,Children who are taking antibiotics in the 30 days prior to the date of the,09-10-2025
G9701002004,Encounter during which the diagnosis was established,09-10-2025
G9702001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9703001003,Episodes where the patient is taking antibiotics (table 1) in the 30 days prior,09-10-2025
G9703002004,To the episode date,09-10-2025
G9704001003,Ajcc breast cancer stage i: t1 mic or t1a documented,09-10-2025
G9705001003,Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest,09-10-2025
G9705002004,Dimension) documented,09-10-2025
G9706001003,"Low (or very low) risk of recurrence, prostate cancer",09-10-2025
G9707001003,Patient received hospice services any time during the measurement period,09-10-2025
G9708001003,Women who had a bilateral mastectomy or who have a history of a bilateral,09-10-2025
G9708002004,Mastectomy or for whom there is evidence of a right and a left unilateral,09-10-2025
G9708003004,Mastectomy,09-10-2025
G9709001003,Hospice services used by patient any time during the measurement period,09-10-2025
G9710001003,Patient was provided hospice services any time during the measurement period,09-10-2025
G9711001003,Patients with a diagnosis or past history of total colectomy or colorectal,09-10-2025
G9711002004,Cancer,09-10-2025
G9712001003,Documentation of medical reason(s) for prescribing or dispensing antibiotic,09-10-2025
G9712002004,"(e.g., intestinal infection, pertussis, bacterial infection, lyme disease,",09-10-2025
G9712003004,"Otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic",09-10-2025
G9712004004,"Sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis,",09-10-2025
G9712005004,"Cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin",09-10-2025
G9712006004,"Staph infections, pneumonia, gonococcal infections/venereal disease (syphilis,",09-10-2025
G9712007004,"Chlamydia, inflammatory diseases [female reproductive organs]), infections of",09-10-2025
G9712008004,"The kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis,",09-10-2025
G9712009004,"Disorders of the immune system, malignancy neoplasms, chronic bronchitis,",09-10-2025
G9712010004,"Emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway",09-10-2025
G9712011004,"Obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease",09-10-2025
G9712012004,"Due to external agents, other diseases of the respiratory system, and",09-10-2025
G9712013004,Tuberculosis,09-10-2025
G9713001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9714001003,Patient is using hospice services any time during the measurement period,09-10-2025
G9715001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9716001003,"Bmi is documented as being outside of normal parameters, follow-up plan is not",09-10-2025
G9716002004,Completed for documented medical reason,09-10-2025
G9717001003,Documentation stating the patient has had a diagnosis of bipolar disorder,09-10-2025
G9718001003,Hospice services for patient provided any time during the measurement period,09-10-2025
G9719001003,"Patient is not ambulatory, bed ridden, immobile, confined to chair, wheelchair",09-10-2025
G9719002004,"Bound, dependent on helper pushing wheelchair, independent in wheelchair or",09-10-2025
G9719003004,Minimal help in wheelchair,09-10-2025
G9720001003,Hospice services for patient occurred any time during the measurement period,09-10-2025
G9721001003,"Patient not ambulatory, bed ridden, immobile, confined to chair, wheelchair",09-10-2025
G9721002004,"Bound, dependent on helper pushing wheelchair, independent in wheelchair or",09-10-2025
G9721003004,Minimal help in wheelchair,09-10-2025
G9722001003,Documented history of renal failure or baseline serum creatinine >= 4.0 mg/dl;,09-10-2025
G9722002004,Renal transplant recipients are not considered to have preoperative renal,09-10-2025
G9722003004,"Failure, unless, since transplantation the cr has been or is 4.0 or higher",09-10-2025
G9723001003,Hospice services for patient received any time during the measurement period,09-10-2025
G9724001003,Patients who had documentation of use of anticoagulant medications overlapping,09-10-2025
G9724002004,The measurement year,09-10-2025
G9725001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9726001003,Patient refused to participate,09-10-2025
G9727001003,Patient unable to complete the lepf prom at initial evaluation and/or discharge,09-10-2025
G9727002004,"Due to blindness, illiteracy, severe mental incapacity or language",09-10-2025
G9727003004,Incompatibility and an adequate proxy is not available,09-10-2025
G9728001003,Patient refused to participate,09-10-2025
G9729001003,Patient unable to complete the lepf prom at initial evaluation and/or discharge,09-10-2025
G9729002004,"Due to blindness, illiteracy, severe mental incapacity or language",09-10-2025
G9729003004,Incompatibility and an adequate proxy is not available,09-10-2025
G9730001003,Patient refused to participate,09-10-2025
G9731001003,Patient unable to complete the lepf prom at initial evaluation and/or discharge,09-10-2025
G9731002004,"Due to blindness, illiteracy, severe mental incapacity or language",09-10-2025
G9731003004,Incompatibility and an adequate proxy is not available,09-10-2025
G9732001003,Patient refused to participate,09-10-2025
G9733001003,Patient unable to complete the low back fs prom at initial evaluation and/or,09-10-2025
G9733002004,"Discharge due to blindness, illiteracy, severe mental incapacity or language",09-10-2025
G9733003004,Incompatibility and an adequate proxy is not available,09-10-2025
G9734001003,Patient refused to participate,09-10-2025
G9735001003,Patient unable to complete the shoulder fs prom at initial evaluation and/or,09-10-2025
G9735002004,"Discharge due to blindness, illiteracy, severe mental incapacity or language",09-10-2025
G9735003004,Incompatibility and an adequate proxy is not available,09-10-2025
G9736001003,Patient refused to participate,09-10-2025
G9737001003,Patient unable to complete the elbow/wrist/hand fs prom at initial evaluation,09-10-2025
G9737002004,"And/or discharge due to blindness, illiteracy, severe mental incapacity or",09-10-2025
G9737003004,Language incompatibility and an adequate proxy is not available,09-10-2025
G9738001003,Patient refused to participate,09-10-2025
G9739001003,Patient unable to complete the general orthopedic fs prom at initial evaluation,09-10-2025
G9739002004,"And/or discharge due to blindness, illiteracy, severe mental incapacity or",09-10-2025
G9739003004,Language incompatibility and an adequate proxy is not available,09-10-2025
G9740001003,Hospice services given to patient any time during the measurement period,09-10-2025
G9741001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9742001003,Psychiatric symptoms assessed,09-10-2025
G9743001003,"Psychiatric symptoms not assessed, reason not otherwise specified",09-10-2025
G9744001003,Patient not eligible due to active diagnosis of hypertension,09-10-2025
G9745001003,Documented reason for not screening or recommending a follow-up for high blood,09-10-2025
G9745002004,Pressure,09-10-2025
G9746001003,Patient has mitral stenosis or prosthetic heart valves or patient has transient,09-10-2025
G9746002004,"Or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac",09-10-2025
G9746003004,Surgery),09-10-2025
G9747001003,Patient is undergoing palliative dialysis with a catheter,09-10-2025
G9748001003,Patient approved by a qualified transplant program and scheduled to receive a,09-10-2025
G9748002004,Living donor kidney transplant,09-10-2025
G9749001003,Patient is undergoing palliative dialysis with a catheter,09-10-2025
G9750001003,Patient approved by a qualified transplant program and scheduled to receive a,09-10-2025
G9750002004,Living donor kidney transplant,09-10-2025
G9751001003,Patient died at any time during the 24-month measurement period,09-10-2025
G9752001003,Emergency surgery,09-10-2025
G9753001003,Documentation of medical reason for not conducting a search for dicom format,09-10-2025
G9753002004,Images for prior patient ct imaging studies completed at non-affiliated,09-10-2025
G9753003004,External healthcare facilities or entities within the past 12 months that are,09-10-2025
G9753004004,"Available through a secure, authorized, media-free, shared archive (e.g.,",09-10-2025
G9753005004,"Trauma, acute myocardial infarction, stroke, aortic aneurysm where time is of",09-10-2025
G9753006004,The essence),09-10-2025
G9754001003,A finding of an incidental pulmonary nodule,09-10-2025
G9755001003,Documentation of medical reason(s) for not including a recommended interval and,09-10-2025
G9755002004,"Modality for follow-up or for no follow-up, and source of recommendations",09-10-2025
G9755003004,"(e.g., patients with unexplained fever, immunocompromised patients who are at",09-10-2025
G9755004004,Risk for infection),09-10-2025
G9756001003,Surgical procedures that included the use of silicone oil,09-10-2025
G9757001003,Surgical procedures that included the use of silicone oil,09-10-2025
G9758001003,Patient in hospice at any time during the measurement period,09-10-2025
G9759001003,History of preoperative posterior capsule rupture,09-10-2025
G9760001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9761001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9762001003,Patient had at least two hpv vaccines (with at least 146 days between the two),09-10-2025
G9762002004,Or three hpv vaccines on or between the patient's 9th and 13th birthdays,09-10-2025
G9763001003,Patient did not have at least two hpv vaccines (with at least 146 days between,09-10-2025
G9763002004,The two) or three hpv vaccines on or between the patient's 9th and 13th,09-10-2025
G9763003004,Birthdays,09-10-2025
G9764001003,Patient has been treated with a systemic medication for psoriasis vulgaris,09-10-2025
G9765001003,Documentation that the patient declined change in medication or alternative,09-10-2025
G9765002004,"Therapies were unavailable, has documented contraindications, or has not been",09-10-2025
G9765003004,"Treated with a systemic medication for at least six consecutive months (e.g.,",09-10-2025
G9765004004,Experienced adverse effects or lack of efficacy with all other therapy options),09-10-2025
G9765005004,"In order to achieve better disease control as measured by pga, bsa, pasi, or",09-10-2025
G9765006004,Dlqi,09-10-2025
G9766001003,Patients who are transferred from one institution to another with a known,09-10-2025
G9766002004,Diagnosis of cva for endovascular stroke treatment,09-10-2025
G9767001003,Hospitalized patients with newly diagnosed cva considered for endovascular,09-10-2025
G9767002004,Stroke treatment,09-10-2025
G9768001003,Patients who utilize hospice services any time during the measurement period,09-10-2025
G9769001003,Patient had a bone mineral density test in the past two years or received,09-10-2025
G9769002004,Osteoporosis medication or therapy in the past 12 months,09-10-2025
G9770001003,Peripheral nerve block (pnb),09-10-2025
G9771001003,At least 1 body temperature measurement equal to or greater than 35.5 degrees,09-10-2025
G9771002004,Celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately,09-10-2025
G9771003004,Before or 15 minutes immediately after anesthesia end time,09-10-2025
G9772001003,Documentation of medical reason(s) for not achieving at least 1 body,09-10-2025
G9772002004,Temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9,09-10-2025
G9772003004,Degrees fahrenheit) within the 30 minutes immediately before or 15 minutes,09-10-2025
G9772004004,"Immediately after anesthesia end time (e.g., emergency cases, intentional",09-10-2025
G9772005004,"Hypothermia, etc.)",09-10-2025
G9773001003,At least 1 body temperature measurement equal to or greater than 35.5 degrees,09-10-2025
G9773002004,Celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes,09-10-2025
G9773003004,"Immediately before or 15 minutes immediately after anesthesia end time, reason",09-10-2025
G9773004004,Not given,09-10-2025
G9774001003,Patients who have had a hysterectomy,09-10-2025
G9775001003,Patient received at least 2 prophylactic pharmacologic anti-emetic agents of,09-10-2025
G9775002004,Different classes preoperatively and/or intraoperatively,09-10-2025
G9776001003,Documentation of medical reason for not receiving at least 2 prophylactic,09-10-2025
G9776002004,Pharmacologic anti-emetic agents of different classes preoperatively and/or,09-10-2025
G9776003004,"Intraoperatively (e.g., intolerance or other medical reason)",09-10-2025
G9777001003,Patient did not receive at least 2 prophylactic pharmacologic anti-emetic,09-10-2025
G9777002004,Agents of different classes preoperatively and/or intraoperatively,09-10-2025
G9778001003,Patients who have a diagnosis of pregnancy at any time during the measurement,09-10-2025
G9778002004,Period,09-10-2025
G9779001003,Patients who are breastfeeding at any time during the performance period,09-10-2025
G9780001003,Patients who have a diagnosis of rhabdomyolysis at any time during the,09-10-2025
G9780002004,Performance period,09-10-2025
G9781001003,Documentation of medical reason(s) for not currently being a statin therapy,09-10-2025
G9781002004,"User or receiving an order (prescription) for statin therapy (e.g., patients",09-10-2025
G9781003004,With statin-associated muscle symptoms or an allergy to statin medication,09-10-2025
G9781004004,"Therapy, patients who are receiving palliative or hospice care, patients with",09-10-2025
G9781005004,"Active liver disease or hepatic disease or insufficiency, patients with end",09-10-2025
G9781006004,"Stage renal disease [esrd], or other medical reasons)",09-10-2025
G9782001003,History of or active diagnosis of familial hypercholesterolemia,09-10-2025
G9783001003,Documentation of patients with diabetes who have a most recent fasting or,09-10-2025
G9783002004,Direct ldl- c laboratory test result < 70 mg/dl and are not taking statin,09-10-2025
G9783003004,Therapy,09-10-2025
G9784001003,Pathologists/dermatopathologists providing a second opinion on a biopsy,09-10-2025
G9785001003,"Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell",09-10-2025
G9785002004,"Carcinoma, or melanoma (to include in situ disease) sent from the pathologist/",09-10-2025
G9785003004,Dermatopathologist to the biopsying clinician for review within 7 days from the,09-10-2025
G9785004004,Time when the tissue specimen was received by the pathologist,09-10-2025
G9786001003,"Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell",09-10-2025
G9786002004,"Carcinoma, or melanoma (to include in situ disease) was not sent from the",09-10-2025
G9786003004,Pathologist/ dermatopathologist to the biopsying clinician for review within 7,09-10-2025
G9786004004,Days from the time when the tissue specimen was received by the pathologist,09-10-2025
G9787001003,Patient alive as of the last day of the measurement year,09-10-2025
G9788001003,Most recent bp is less than or equal to 140/90 mm hg,09-10-2025
G9789001003,"Blood pressure recorded during inpatient stays, emergency room visits, or",09-10-2025
G9789002004,Urgent care visits,09-10-2025
G9790001003,"Most recent bp is greater than 140/90 mm hg, or blood pressure not documented",09-10-2025
G9791001003,Most recent tobacco status is tobacco free,09-10-2025
G9792001003,Most recent tobacco status is not tobacco free,09-10-2025
G9793001003,Patient is currently on a daily aspirin or other antiplatelet,09-10-2025
G9794001003,Documentation of medical reason(s) for not on a daily aspirin or other,09-10-2025
G9794002004,"Antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed,",09-10-2025
G9794003004,"Idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of",09-10-2025
G9794004004,Active anticoagulant use during the measurement period),09-10-2025
G9795001003,Patient is not currently on a daily aspirin or other antiplatelet,09-10-2025
G9796001003,Patient is currently on a statin therapy,09-10-2025
G9797001003,Patient is not on a statin therapy,09-10-2025
G9798001003,Discharge(s) for ami between july 1 of the year prior measurement period to,09-10-2025
G9798002004,June 30 of the measurement period,09-10-2025
G9799001003,Patients with a medication dispensing event indicator of a history of asthma,09-10-2025
G9799002004,Any time during the patient's history through the end of the measure period,09-10-2025
G9800001003,Patients who are identified as having an intolerance or allergy to beta-blocker,09-10-2025
G9800002004,Therapy,09-10-2025
G9801001003,Hospitalizations in which the patient was transferred directly to a non-acute,09-10-2025
G9801002004,Care facility for any diagnosis,09-10-2025
G9802001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9803001003,Patient prescribed at least a 135 day treatment within the 180-day measurement,09-10-2025
G9803002004,Interval with beta-blockers post-discharge for ami,09-10-2025
G9804001003,Patient was not prescribed at least a 135 day treatment within the 180-day,09-10-2025
G9804002004,Measurement interval with beta-blockers post-discharge for ami,09-10-2025
G9805001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9806001003,Patients who received cervical cytology or an hpv test,09-10-2025
G9807001003,Patients who did not receive cervical cytology or an hpv test,09-10-2025
G9808001003,Any patients who had no asthma controller medications dispensed during the,09-10-2025
G9808002004,Measurement year,09-10-2025
G9809001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9810001003,Patient achieved a pdc of at least 75% for their asthma controller medication,09-10-2025
G9811001003,Patient did not achieve a pdc of at least 75% for their asthma controller,09-10-2025
G9811002004,Medication,09-10-2025
G9812001003,Patient died including all deaths occurring during the hospitalization in which,09-10-2025
G9812002004,"The operation was performed, even if after 30 days, and those deaths occurring",09-10-2025
G9812003004,"After discharge from the hospital, but within 30 days of the procedure",09-10-2025
G9813001003,Patient did not die within 30 days of the procedure or during the index,09-10-2025
G9813002004,Hospitalization,09-10-2025
G9814001003,Death occurring during the index acute care hospitalization,09-10-2025
G9815001003,Death did not occur during the index acute care hospitalization,09-10-2025
G9816001003,Death occurring after discharge from the hospital but within 30 days post,09-10-2025
G9816002004,Procedure,09-10-2025
G9817001003,Death did not occur after discharge from the hospital within 30 days post,09-10-2025
G9817002004,Procedure,09-10-2025
G9818001003,Documentation of sexual activity,09-10-2025
G9819001003,Patients who use hospice services any time during the measurement period,09-10-2025
G9820001003,Documentation of a chlamydia screening test with proper follow-up,09-10-2025
G9821001003,No documentation of a chlamydia screening test with proper follow-up,09-10-2025
G9822001003,Patients who had an endometrial ablation procedure during the 12 months prior,09-10-2025
G9822002004,To the index date (exclusive of the index date),09-10-2025
G9823001003,Endometrial sampling or hysteroscopy with biopsy and results documented during,09-10-2025
G9823002004,The 12 months prior to the index date (exclusive of the index date) of the,09-10-2025
G9823003004,Endometrial ablation,09-10-2025
G9824001003,Endometrial sampling or hysteroscopy with biopsy and results not documented,09-10-2025
G9824002004,During the 12 months prior to the index date (exclusive of the index date) of,09-10-2025
G9824003004,The endometrial ablation,09-10-2025
G9825001003,Her-2/neu negative or undocumented/unknown,09-10-2025
G9826001003,Patient transferred to practice after initiation of chemotherapy,09-10-2025
G9827001003,Her2-targeted therapies not administered during the initial course of treatment,09-10-2025
G9828001003,Her2-targeted therapies administered during the initial course of treatment,09-10-2025
G9829001003,Breast adjuvant chemotherapy administered,09-10-2025
G9830001003,Her-2/neu positive,09-10-2025
G9831001003,Ajcc stage at breast cancer diagnosis = ii or iii,09-10-2025
G9832001003,Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast,09-10-2025
G9832002004,"Cancer diagnosis does not equal = t1, t1a, t1b",09-10-2025
G9833001003,Patient transfer to practice after initiation of chemotherapy,09-10-2025
G9834001003,Patient has metastatic disease at diagnosis,09-10-2025
G9835001003,Trastuzumab administered within 12 months of diagnosis,09-10-2025
G9836001003,"Reason for not administering trastuzumab documented (e.g. patient declined,",09-10-2025
G9836002004,"Patient died, patient transferred, contraindication or other clinical",09-10-2025
G9836003004,"Exclusion, neoadjuvant chemotherapy or radiation not complete)",09-10-2025
G9837001003,Trastuzumab not administered within 12 months of diagnosis,09-10-2025
G9838001003,Patient has metastatic disease at diagnosis,09-10-2025
G9839001003,Anti-egfr monoclonal antibody therapy,09-10-2025
G9840001003,Ras (kras and nras) gene mutation testing performed before initiation of,09-10-2025
G9840002004,Anti-egfr moab,09-10-2025
G9841001003,Ras (kras and nras) gene mutation testing not performed before initiation of,09-10-2025
G9841002004,Anti-egfr moab,09-10-2025
G9842001003,Patient has metastatic disease at diagnosis,09-10-2025
G9843001003,Ras (kras or nras) gene mutation,09-10-2025
G9844001003,Patient did not receive anti-egfr monoclonal antibody therapy,09-10-2025
G9845001003,Patient received anti-egfr monoclonal antibody therapy,09-10-2025
G9846001003,Patients who died from cancer,09-10-2025
G9847001003,Patient received systemic cancer-directed therapy in the last 14 days of life,09-10-2025
G9848001003,Patient did not receive systemic cancer-directed therapy in the last 14 days of,09-10-2025
G9848002004,Life,09-10-2025
G9849001003,Patients who died from cancer,09-10-2025
G9850001003,Patient had more than one emergency department visit in the last 30 days of lif,09-10-2025
G9851001003,Patient had one or less emergency department visits in the last 30 days of life,09-10-2025
G9852001003,Patients who died from cancer,09-10-2025
G9853001003,Patient admitted to the icu in the last 30 days of life,09-10-2025
G9854001003,Patient was not admitted to the icu in the last 30 days of life,09-10-2025
G9855001003,Patients who died from cancer,09-10-2025
G9856001003,Patient was not admitted to hospice,09-10-2025
G9857001003,Patient admitted to hospice,09-10-2025
G9858001003,Patient enrolled in hospice,09-10-2025
G9859001003,Patients who died from cancer,09-10-2025
G9860001003,Patient spent less than three days in hospice care,09-10-2025
G9861001003,Patient spent greater than or equal to three days in hospice care,09-10-2025
G9862001003,Documentation of medical reason(s) for not recommending at least a 10 year,09-10-2025
G9862002004,"Follow-up interval (e.g., inadequate prep, familial or personal history of",09-10-2025
G9862003004,"Colonic polyps, patient had no adenoma and age is = 66 years old, or life",09-10-2025
G9862004004,"Expectancy < 10 years old, other medical reasons)",09-10-2025
G9868001003,"Receipt and analysis of remote, asynchronous images for dermatologic and/or",09-10-2025
G9868002004,"Ophthalmologic evaluation, for use only in a medicare-approved cmmi model, less",09-10-2025
G9868003004,Than 10 minutes,09-10-2025
G9869001003,"Receipt and analysis of remote, asynchronous images for dermatologic and/or",09-10-2025
G9869002004,"Ophthalmologic evaluation, for use only in a medicare-approved cmmi model,",09-10-2025
G9869003004,10-20 minutes,09-10-2025
G9870001003,"Receipt and analysis of remote, asynchronous images for dermatologic and/or",09-10-2025
G9870002004,"Ophthalmologic evaluation, for use only in a medicare-approved cmmi model, more",09-10-2025
G9870003004,Than 20 minutes,09-10-2025
G9873001003,First medicare diabetes prevention program (mdpp) core session was attended by,09-10-2025
G9873002004,An mdpp beneficiary under the mdpp expanded model (em). a core session is an,09-10-2025
G9873003004,Mdpp service that: (1) is furnished by an mdpp supplier during months 1,09-10-2025
G9873004004,Through 6 of the mdpp services period; (2) is approximately 1 hour in length;,09-10-2025
G9873005004,And (3) adheres to a cdc-approved dpp curriculum for core sessions,09-10-2025
G9874001003,Four total medicare diabetes prevention program (mdpp) core sessions were,09-10-2025
G9874002004,Attended by an mdpp beneficiary under the mdpp expanded model (em). a core,09-10-2025
G9874003004,Session is an mdpp service that: (1) is furnished by an mdpp supplier during,09-10-2025
G9874004004,Months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in,09-10-2025
G9874005004,Length; and (3) adheres to a cdc-approved dpp curriculum for core sessions,09-10-2025
G9875001003,Nine total medicare diabetes prevention program (mdpp) core sessions were,09-10-2025
G9875002004,Attended by an mdpp beneficiary under the mdpp expanded model (em). a core,09-10-2025
G9875003004,Session is an mdpp service that: (1) is furnished by an mdpp supplier during,09-10-2025
G9875004004,Months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in,09-10-2025
G9875005004,Length; and (3) adheres to a cdc-approved dpp curriculum for core sessions,09-10-2025
G9876001003,Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms),09-10-2025
G9876002004,Were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded,09-10-2025
G9876003004,Model (em). a core maintenance session is an mdpp service that: (1) is,09-10-2025
G9876004004,Furnished by an mdpp supplier during months 7 through 12 of the mdpp services,09-10-2025
G9876005004,Period; (2) is approximately 1 hour in length; and (3) adheres to a,09-10-2025
G9876006004,Cdc-approved dpp curriculum for maintenance sessions. the beneficiary did not,09-10-2025
G9876007004,"Achieve at least 5% weight loss (wl) from his/her baseline weight, as measured",09-10-2025
G9876008004,By at least one in-person weight measurement at a core maintenance session in,09-10-2025
G9876009004,Months 7-9,09-10-2025
G9877001003,Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms),09-10-2025
G9877002004,Were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp,09-10-2025
G9877003004,Expanded model (em). a core maintenance session is an mdpp service that: (1),09-10-2025
G9877004004,Is furnished by an mdpp supplier during months 7 through 12 of the mdpp,09-10-2025
G9877005004,Services period; (2) is approximately 1 hour in length; and (3) adheres to a,09-10-2025
G9877006004,Cdc-approved dpp curriculum for maintenance sessions. the beneficiary did not,09-10-2025
G9877007004,"Achieve at least 5% weight loss (wl) from his/her baseline weight, as measured",09-10-2025
G9877008004,By at least one in-person weight measurement at a core maintenance session in,09-10-2025
G9877009004,Months 10-12,09-10-2025
G9878001003,Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms),09-10-2025
G9878002004,Were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded,09-10-2025
G9878003004,Model (em). a core maintenance session is an mdpp service that: (1) is,09-10-2025
G9878004004,Furnished by an mdpp supplier during months 7 through 12 of the mdpp services,09-10-2025
G9878005004,Period; (2) is approximately 1 hour in length; and (3) adheres to a,09-10-2025
G9878006004,Cdc-approved dpp curriculum for maintenance sessions.the beneficiary achieved,09-10-2025
G9878007004,"At least 5% weight loss (wl) from his/her baseline weight, as measured by at",09-10-2025
G9878008004,Least one in-person weight measurement at a core maintenance session in months,09-10-2025
G9878009004,7-9,09-10-2025
G9879001003,Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms),09-10-2025
G9879002004,Were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp,09-10-2025
G9879003004,Expanded model (em). a core maintenance session is an mdpp service that: (1),09-10-2025
G9879004004,Is furnished by an mdpp supplier during months 7 through 12 of the mdpp,09-10-2025
G9879005004,Services period; (2) is approximately 1 hour in length; and (3) adheres to a,09-10-2025
G9879006004,Cdc-approved dpp curriculum for maintenance sessions. the beneficiary achieved,09-10-2025
G9879007004,"At least 5% weight loss (wl) from his/her baseline weight, as measured by at",09-10-2025
G9879008004,Least one in-person weight measurement at a core maintenance session in months,09-10-2025
G9879009004,10-12,09-10-2025
G9880001003,The mdpp beneficiary achieved at least 5% weight loss (wl) from his/her,09-10-2025
G9880002004,Baseline weight in months 1-12 of the mdpp services period under the mdpp,09-10-2025
G9880003004,Expanded model (em). this is a one-time payment available when a beneficiary,09-10-2025
G9880004004,First achieves at least 5% weight loss from baseline as measured by an,09-10-2025
G9880005004,In-person weight measurement at a core session or core maintenance session,09-10-2025
G9881001003,The mdpp beneficiary achieved at least 9% weight loss (wl) from his/her,09-10-2025
G9881002004,Baseline weight in months 1-24 under the mdpp expanded model (em). this is a,09-10-2025
G9881003004,One-time payment available when a beneficiary first achieves at least 9% weight,09-10-2025
G9881004004,Loss from baseline as measured by an in-person weight measurement at a core,09-10-2025
G9881005004,"Session, core maintenance session, or ongoing maintenance session",09-10-2025
G9882001003,Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions,09-10-2025
G9882002004,(ms) were attended by an mdpp beneficiary in months (mo) 13-15 under the mdpp,09-10-2025
G9882003004,Expanded model (em). an ongoing maintenance session is an mdpp service that:,09-10-2025
G9882004004,(1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp,09-10-2025
G9882005004,Services period; (2) is approximately 1 hour in length; and (3) adheres to a,09-10-2025
G9882006004,Cdc-approved dpp curriculum for maintenance sessions. the beneficiary,09-10-2025
G9882007004,"Maintained at least 5% weight loss (wl) from his/her baseline weight, as",09-10-2025
G9882008004,Measured by at least one in-person weight measurement at an ongoing maintenance,09-10-2025
G9882009004,Session in months 13-15,09-10-2025
G9883001003,Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions,09-10-2025
G9883002004,(ms) were attended by an mdpp beneficiary in months (mo) 16-18 under the mdpp,09-10-2025
G9883003004,Expanded model (em). an ongoing maintenance session is an mdpp service that:,09-10-2025
G9883004004,(1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp,09-10-2025
G9883005004,Services period; (2) is approximately 1 hour in length; and (3) adheres to a,09-10-2025
G9883006004,Cdc-approved dpp curriculum for maintenance sessions. the beneficiary,09-10-2025
G9883007004,"Maintained at least 5% weight loss (wl) from his/her baseline weight, as",09-10-2025
G9883008004,Measured by at least one in-person weight measurement at an ongoing maintenance,09-10-2025
G9883009004,Session in months 16-18,09-10-2025
G9884001003,Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions,09-10-2025
G9884002004,(ms) were attended by an mdpp beneficiary in months (mo) 19-21 under the mdpp,09-10-2025
G9884003004,Expanded model (em). an ongoing maintenance session is an mdpp service that:,09-10-2025
G9884004004,(1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp,09-10-2025
G9884005004,Services period; (2) is approximately 1 hour in length; and (3) adheres to a,09-10-2025
G9884006004,Cdc-approved dpp curriculum for maintenance sessions. the beneficiary,09-10-2025
G9884007004,"Maintained at least 5% weight loss (wl) from his/her baseline weight, as",09-10-2025
G9884008004,Measured by at least one in-person weight measurement at an ongoing maintenance,09-10-2025
G9884009004,Session in months 19-21,09-10-2025
G9885001003,Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions,09-10-2025
G9885002004,(ms) were attended by an mdpp beneficiary in months (mo) 22-24 under the mdpp,09-10-2025
G9885003004,Expanded model (em). an ongoing maintenance session is an mdpp service that:,09-10-2025
G9885004004,(1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp,09-10-2025
G9885005004,Services period; (2) is approximately 1 hour in length; and (3) adheres to a,09-10-2025
G9885006004,Cdc-approved dpp curriculum for maintenance sessions. the beneficiary,09-10-2025
G9885007004,"Maintained at least 5% weight loss (wl) from his/her baseline weight, as",09-10-2025
G9885008004,Measured by at least one in-person weight measurement at an ongoing maintenance,09-10-2025
G9885009004,Session in months 22-24,09-10-2025
G9886001003,"Behavioral counseling for diabetes prevention, in-person, group, 60 minutes",09-10-2025
G9887001003,"Behavioral counseling for diabetes prevention, distance learning, 60 minutes",09-10-2025
G9888001003,Maintenance 5% wl from baseline weight in months 7-12,09-10-2025
G9890001003,Bridge payment: a one-time payment for the first medicare diabetes prevention,09-10-2025
G9890002004,"Program (mdpp) core session, core maintenance session, or ongoing maintenance",09-10-2025
G9890003004,Session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24,09-10-2025
G9890004004,Of the mdpp expanded model (em) who has previously received mdpp services from,09-10-2025
G9890005004,A different mdpp supplier under the mdpp expanded model. a supplier may only,09-10-2025
G9890006004,Receive one bridge payment per mdpp beneficiary,09-10-2025
G9891001003,Mdpp session reported as a line-item on a claim for a payable mdpp expanded,09-10-2025
G9891002004,Model (em) hcpcs code for a session furnished by the billing supplier under,09-10-2025
G9891003004,The mdpp expanded model and counting toward achievement of the attendance,09-10-2025
G9891004004,Performance goal for the payable mdpp expanded model hcpcs code (this code is,09-10-2025
G9891005004,For reporting purposes only),09-10-2025
G9892001003,Documentation of patient reason(s) for not performing a dilated macular,09-10-2025
G9892002004,Examination,09-10-2025
G9893001003,"Dilated macular exam was not performed, reason not otherwise specified",09-10-2025
G9894001003,Androgen deprivation therapy prescribed/administered in combination with,09-10-2025
G9894002004,External beam radiotherapy to the prostate,09-10-2025
G9895001003,Documentation of medical reason(s) for not prescribing/administering androgen,09-10-2025
G9895002004,Deprivation therapy in combination with external beam radiotherapy to the,09-10-2025
G9895003004,"Prostate (e.g., salvage therapy)",09-10-2025
G9896001003,Documentation of patient reason(s) for not prescribing/administering androgen,09-10-2025
G9896002004,Deprivation therapy in combination with external beam radiotherapy to the,09-10-2025
G9896003004,Prostate,09-10-2025
G9897001003,Patients who were not prescribed/administered androgen deprivation therapy in,09-10-2025
G9897002004,"Combination with external beam radiotherapy to the prostate, reason not given",09-10-2025
G9898001003,Patients age 66 or older in institutional special needs plans (snp) or residing,09-10-2025
G9898002004,"In long-term care with pos code 32, 33, 34, 54, or 56 for more than 90",09-10-2025
G9898003004,Consecutive days during the measurement period,09-10-2025
G9899001003,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d)",09-10-2025
G9899002004,Mammography results documented and reviewed,09-10-2025
G9900001003,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d)",09-10-2025
G9900002004,"Mammography results were not documented and reviewed, reason not otherwise",09-10-2025
G9900003004,Specified,09-10-2025
G9901001003,Patient age 66 or older in institutional special needs plans (snp) or residing,09-10-2025
G9901002004,"In long-term care with pos code 32, 33, 34, 54, or 56 for more than 90",09-10-2025
G9901003004,Consecutive days during the measurement period,09-10-2025
G9902001003,Patient screened for tobacco use and identified as a tobacco user,09-10-2025
G9903001003,Patient screened for tobacco use and identified as a tobacco non-user,09-10-2025
G9904001003,"Documentation of medical reason(s) for not screening for tobacco use (e.g.,",09-10-2025
G9904002004,"Limited life expectancy, other medical reason)",09-10-2025
G9905001003,Patient not screened for tobacco use,09-10-2025
G9906001003,Patient identified as a tobacco user received tobacco cessation intervention,09-10-2025
G9906002004,During the measurement period or in the six months prior to the measurement,09-10-2025
G9906003004,Period (counseling and/or pharmacotherapy),09-10-2025
G9907001003,Documentation of medical reason(s) for not providing tobacco cessation,09-10-2025
G9907002004,Intervention on the date of the encounter or within the previous 12 months,09-10-2025
G9907003004,"(e.g., limited life expectancy, other medical reason)",09-10-2025
G9908001003,Patient identified as tobacco user did not receive tobacco cessation,09-10-2025
G9908002004,Intervention during the measurement period or in the six months prior to the,09-10-2025
G9908003004,Measurement period (counseling and/or pharmacotherapy),09-10-2025
G9909001003,Documentation of medical reason(s) for not providing tobacco cessation,09-10-2025
G9909002004,Intervention on the date of the encounter or within the previous 12 months if,09-10-2025
G9909003004,"Identified as a tobacco user (e.g., limited life expectancy, other medical",09-10-2025
G9909004004,Reason),09-10-2025
G9910001003,Patients age 66 or older in institutional special needs plans (snp) or residing,09-10-2025
G9910002004,"In long-term care with pos code 32, 33, 34, 54 or 56 for more than 90",09-10-2025
G9910003004,Consecutive days during the measurement period,09-10-2025
G9911001003,Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or,09-10-2025
G9911002004,After neoadjuvant systemic therapy,09-10-2025
G9912001003,Hepatitis b virus (hbv) status assessed and results interpreted prior to,09-10-2025
G9912002004,Initiating anti-tnf (tumor necrosis factor) therapy,09-10-2025
G9913001003,Hepatitis b virus (hbv) status not assessed and results interpreted prior to,09-10-2025
G9913002004,"Initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise",09-10-2025
G9913003004,Specified,09-10-2025
G9914001003,Patient initiated an anti-tnf agent,09-10-2025
G9915001003,No record of hbv results documented,09-10-2025
G9916001003,Functional status performed once in the last 12 months,09-10-2025
G9917001003,Documentation of advanced stage dementia and caregiver knowledge is limited,09-10-2025
G9918001003,"Functional status not performed, reason not otherwise specified",09-10-2025
G9919001003,Screening performed and positive and provision of recommendations,09-10-2025
G9920001003,Screening performed and negative,09-10-2025
G9921001003,"No screening performed, partial screening performed or positive screen without",09-10-2025
G9921002004,Recommendations and reason is not given or otherwise specified,09-10-2025
G9922001003,Safety concerns screen provided and if positive then documented mitigation,09-10-2025
G9922002004,Recommendations,09-10-2025
G9923001003,Safety concerns screen provided and negative,09-10-2025
G9924001003,Documentation of medical reason(s) for not providing safety concerns screen or,09-10-2025
G9924002004,"For not providing recommendations, orders or referrals for positive screen",09-10-2025
G9924003004,"(e.g., patient in palliative care, other medical reason)",09-10-2025
G9925001003,"Safety concerns screening not provided, reason not otherwise specified",09-10-2025
G9926001003,Safety concerns screening positive screen is without provision of mitigation,09-10-2025
G9926002004,"Recommendations, including but not limited to referral to other resources",09-10-2025
G9927001003,Documentation of system reason(s) for not prescribing an fda-approved,09-10-2025
G9927002004,Anticoagulation due to patient being currently enrolled in a clinical trial,09-10-2025
G9927003004,Related to af/atrial flutter treatment,09-10-2025
G9928001003,"Fda-approved anticoagulant not prescribed, reason not given",09-10-2025
G9929001003,"Patient with transient or reversible cause of af (e.g., pneumonia,",09-10-2025
G9929002004,"Hyperthyroidism, pregnancy, cardiac surgery)",09-10-2025
G9930001003,Patients who are receiving comfort care only,09-10-2025
G9931001003,"Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for",09-10-2025
G9931002004,Women,09-10-2025
G9932001003,Documentation of patient reason(s) for not having records of negative or,09-10-2025
G9932002004,"Managed positive tb screen (e.g., patient does not return for mantoux (ppd)",09-10-2025
G9932003004,Skin test evaluation),09-10-2025
G9933001003,Adenoma(s) or colorectal cancer detected during screening colonoscopy,09-10-2025
G9934001003,Documentation that neoplasm detected is only diagnosed as traditional serrated,09-10-2025
G9934002004,"Adenoma, sessile serrated polyp, or sessile serrated adenoma",09-10-2025
G9935001003,Adenoma(s) or colorectal cancer not detected during screening colonoscopy,09-10-2025
G9936001003,"Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or",09-10-2025
G9936002004,"Other malignant neoplasm of rectum, rectosigmoid junction, and anus",09-10-2025
G9937001003,Diagnostic colonoscopy,09-10-2025
G9938001003,Patients aged 66 or older in institutional special needs plans (snp) or,09-10-2025
G9938002004,"Residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90",09-10-2025
G9938003004,Consecutive days during the six months prior to the measurement period through,09-10-2025
G9938004004,December 31 of the measurement period,09-10-2025
G9939001003,Pathologists/dermatopathologists is the same clinician who performed the biopsy,09-10-2025
G9940001003,"Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in",09-10-2025
G9940002004,"Vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease",09-10-2025
G9940003004,During the measurement period or prior year),09-10-2025
G9941001003,Back pain was measured by the visual analog scale (vas) within three months,09-10-2025
G9941002004,Preoperatively and at three months (6 - 20 weeks) postoperatively,09-10-2025
G9942001003,Patient had any additional spine procedures performed on the same date as the,09-10-2025
G9942002004,Lumbar discectomy/laminectomy,09-10-2025
G9943001003,Back pain was not measured by the visual analog scale (vas) or numeric pain,09-10-2025
G9943002004,Scale at three months (6 - 20 weeks) postoperatively,09-10-2025
G9944001003,Back pain was measured by the visual analog scale (vas) within three months,09-10-2025
G9944002004,Preoperatively and at one year (9 to 15 months) postoperatively,09-10-2025
G9945001003,"Patient had cancer, acute fracture or infection related to the lumbar spine or",09-10-2025
G9945002004,"Patient had neuromuscular, idiopathic or congenital lumbar scoliosis",09-10-2025
G9946001003,Back pain was not measured by the visual analog scale (vas) or numeric pain,09-10-2025
G9946002004,Scale at one year (9 to 15 months) postoperatively,09-10-2025
G9947001003,Leg pain was measured by the visual analog scale (vas) within three months,09-10-2025
G9947002004,Preoperatively and at three months (6 to 20 weeks) postoperatively,09-10-2025
G9948001003,Patient had any additional spine procedures performed on the same date as the,09-10-2025
G9948002004,Lumbar discectomy/laminectomy,09-10-2025
G9949001003,Leg pain was not measured by the visual analog scale (vas) or numeric pain,09-10-2025
G9949002004,Scale at three months (6 - 20 weeks) postoperatively,09-10-2025
G9954001003,Patient exhibits 2 or more risk factors for post-operative vomiting,09-10-2025
G9955001003,Cases in which an inhalational anesthetic is used only for induction,09-10-2025
G9956001003,Patient received combination therapy consisting of at least two prophylactic,09-10-2025
G9956002004,Pharmacologic anti-emetic agents of different classes preoperatively and/or,09-10-2025
G9956003004,Intraoperatively,09-10-2025
G9957001003,Documentation of medical reason for not receiving combination therapy,09-10-2025
G9957002004,Consisting of at least two prophylactic pharmacologic anti-emetic agents of,09-10-2025
G9957003004,"Different classes preoperatively and/or intraoperatively (e.g., intolerance or",09-10-2025
G9957004004,Other medical reason),09-10-2025
G9958001003,Patient did not receive combination therapy consisting of at least two,09-10-2025
G9958002004,Prophylactic pharmacologic anti-emetic agents of different classes,09-10-2025
G9958003004,Preoperatively and/or intraoperatively,09-10-2025
G9959001003,Systemic antimicrobials not prescribed,09-10-2025
G9960001003,Documentation of medical reason(s) for prescribing systemic antimicrobials,09-10-2025
G9961001003,Systemic antimicrobials prescribed,09-10-2025
G9962001003,Embolization endpoints are documented separately for each embolized vessel and,09-10-2025
G9962002004,Ovarian artery angiography or embolization performed in the presence of variant,09-10-2025
G9962003004,Uterine artery anatomy,09-10-2025
G9963001003,Embolization endpoints are not documented separately for each embolized vessel,09-10-2025
G9963002004,Or ovarian artery angiography or embolization not performed in the presence of,09-10-2025
G9963003004,Variant uterine artery anatomy,09-10-2025
G9964001003,Patient received at least one well-child visit with a pcp during the,09-10-2025
G9964002004,Performance period,09-10-2025
G9965001003,Patient did not receive at least one well-child visit with a pcp during the,09-10-2025
G9965002004,Performance period,09-10-2025
G9966001003,"Children who were screened for risk of developmental, behavioral and social",09-10-2025
G9966002004,Delays using a standardized tool with interpretation and report,09-10-2025
G9967001003,"Children who were not screened for risk of developmental, behavioral and social",09-10-2025
G9967002004,Delays using a standardized tool with interpretation and report,09-10-2025
G9968001003,Patient was referred to another clinician or specialist during the measurement,09-10-2025
G9968002004,Period,09-10-2025
G9969001003,Clinician who referred the patient to another clinician received a report from,09-10-2025
G9969002004,The clinician to whom the patient was referred,09-10-2025
G9970001003,Clinician who referred the patient to another clinician did not receive a,09-10-2025
G9970002004,Report from the clinician to whom the patient was referred,09-10-2025
G9974001003,"Dilated macular exam performed, including documentation of the presence or",09-10-2025
G9974002004,Absence of macular thickening or geographic atrophy or hemorrhage and the level,09-10-2025
G9974003004,Of macular degeneration severity,09-10-2025
G9975001003,Documentation of medical reason(s) for not performing a dilated macular,09-10-2025
G9975002004,Examination,09-10-2025
G9978001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9978002004,Only in a medicare-approved bundled payments for care improvement advanced,09-10-2025
G9978003004,"(bpci advanced) model episode of care, which requires these 3 key components: a",09-10-2025
G9978004004,Problem focused history; a problem focused examination; and straightforward,09-10-2025
G9978005004,"Medical decision making, furnished in real time using interactive audio and",09-10-2025
G9978006004,"Video technology. counseling and coordination of care with other physicians,",09-10-2025
G9978007004,Other qualified health care professionals or agencies are provided consistent,09-10-2025
G9978008004,With the nature of the problem(s) and the needs of the patient or the family or,09-10-2025
G9978009004,"Both. usually, the presenting problem(s) are self limited or minor. typically,",09-10-2025
G9978010004,"10 minutes are spent with the patient or family or both via real time, audio",09-10-2025
G9978011004,And video intercommunications technology,09-10-2025
G9979001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9979002004,Only in a medicare-approved bundled payments for care improvement advanced,09-10-2025
G9979003004,"(bpci advanced) model episode of care, which requires these 3 key components:",09-10-2025
G9979004004,An expanded problem focused history; an expanded problem focused examination;,09-10-2025
G9979005004,"Straightforward medical decision making, furnished in real time using",09-10-2025
G9979006004,Interactive audio and video technology. counseling and coordination of care,09-10-2025
G9979007004,"With other physicians, other qualified health care professionals or agencies",09-10-2025
G9979008004,Are provided consistent with the nature of the problem(s) and the needs of the,09-10-2025
G9979009004,"Patient or the family or both. usually, the presenting problem(s) are of low to",09-10-2025
G9979010004,"Moderate severity. typically, 20 minutes are spent with the patient or family",09-10-2025
G9979011004,"Or both via real time, audio and video intercommunications technology",09-10-2025
G9980001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9980002004,Only in a medicare-approved bundled payments for care improvement advanced,09-10-2025
G9980003004,"(bpci advanced) model episode of care, which requires these 3 key components: a",09-10-2025
G9980004004,Detailed history; a detailed examination; medical decision making of low,09-10-2025
G9980005004,"Complexity, furnished in real time using interactive audio and video",09-10-2025
G9980006004,"Technology. counseling and coordination of care with other physicians, other",09-10-2025
G9980007004,Qualified health care professionals or agencies are provided consistent with,09-10-2025
G9980008004,The nature of the problem(s) and the needs of the patient or the family or,09-10-2025
G9980009004,"Both. usually, the presenting problem(s) are of moderate severity. typically,",09-10-2025
G9980010004,"30 minutes are spent with the patient or family or both via real time, audio",09-10-2025
G9980011004,And video intercommunications technology,09-10-2025
G9981001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9981002004,Only in a medicare-approved bundled payments for care improvement advanced,09-10-2025
G9981003004,"(bpci advanced) model episode of care, which requires these 3 key components: a",09-10-2025
G9981004004,Comprehensive history; a comprehensive examination; medical decision making of,09-10-2025
G9981005004,"Moderate complexity, furnished in real time using interactive audio and video",09-10-2025
G9981006004,"Technology. counseling and coordination of care with other physicians, other",09-10-2025
G9981007004,Qualified health care professionals or agencies are provided consistent with,09-10-2025
G9981008004,The nature of the problem(s) and the needs of the patient or the family or,09-10-2025
G9981009004,"Both. usually, the presenting problem(s) are of moderate to high severity.",09-10-2025
G9981010004,"Typically, 45 minutes are spent with the patient or family or both via real",09-10-2025
G9981011004,"Time, audio and video intercommunications technology",09-10-2025
G9982001003,Remote in-home visit for the evaluation and management of a new patient for use,09-10-2025
G9982002004,Only in a medicare-approved bundled payments for care improvement advanced,09-10-2025
G9982003004,"(bpci advanced) model episode of care, which requires these 3 key components: a",09-10-2025
G9982004004,Comprehensive history; a comprehensive examination; medical decision making of,09-10-2025
G9982005004,"High complexity, furnished in real time using interactive audio and video",09-10-2025
G9982006004,"Technology. counseling and coordination of care with other physicians, other",09-10-2025
G9982007004,Qualified health care professionals or agencies are provided consistent with,09-10-2025
G9982008004,The nature of the problem(s) and the needs of the patient or the family or,09-10-2025
G9982009004,"Both. usually, the presenting problem(s) are of moderate to high severity.",09-10-2025
G9982010004,"Typically, 60 minutes are spent with the patient or family or both via real",09-10-2025
G9982011004,"Time, audio and video intercommunications technology",09-10-2025
G9983001003,Remote in-home visit for the evaluation and management of an established,09-10-2025
G9983002004,Patient for use only in a medicare-approved bundled payments for care,09-10-2025
G9983003004,"Improvement advanced (bpci advanced) model episode of care, which requires at",09-10-2025
G9983004004,Least 2 of the following 3 key components: a problem focused history; a problem,09-10-2025
G9983005004,"Focused examination; straightforward medical decision making, furnished in real",09-10-2025
G9983006004,Time using interactive audio and video technology. counseling and coordination,09-10-2025
G9983007004,"Of care with other physicians, other qualified health care professionals or",09-10-2025
G9983008004,Agencies are provided consistent with the nature of the problem(s) and the,09-10-2025
G9983009004,"Needs of the patient or the family or both. usually, the presenting problem(s)",09-10-2025
G9983010004,"Are self limited or minor. typically, 10 minutes are spent with the patient or",09-10-2025
G9983011004,"Family or both via real time, audio and video intercommunications technology",09-10-2025
G9984001003,Remote in-home visit for the evaluation and management of an established,09-10-2025
G9984002004,Patient for use only in a medicare-approved bundled payments for care,09-10-2025
G9984003004,"Improvement advanced (bpci advanced) model episode of care, which requires at",09-10-2025
G9984004004,Least 2 of the following 3 key components: an expanded problem focused history;,09-10-2025
G9984005004,An expanded problem focused examination; medical decision making of low,09-10-2025
G9984006004,"Complexity, furnished in real time using interactive audio and video",09-10-2025
G9984007004,"Technology. counseling and coordination of care with other physicians, other",09-10-2025
G9984008004,Qualified health care professionals or agencies are provided consistent with,09-10-2025
G9984009004,The nature of the problem(s) and the needs of the patient or the family or,09-10-2025
G9984010004,"Both. usually, the presenting problem(s) are of low to moderate severity.",09-10-2025
G9984011004,"Typically, 15 minutes are spent with the patient or family or both via real",09-10-2025
G9984012004,"Time, audio and video intercommunications technology",09-10-2025
G9985001003,Remote in-home visit for the evaluation and management of an established,09-10-2025
G9985002004,Patient for use only in a medicare-approved bundled payments for care,09-10-2025
G9985003004,"Improvement advanced (bpci advanced) model episode of care, which requires at",09-10-2025
G9985004004,Least 2 of the following 3 key components: a detailed history; a detailed,09-10-2025
G9985005004,"Examination; medical decision making of moderate complexity, furnished in real",09-10-2025
G9985006004,Time using interactive audio and video technology. counseling and coordination,09-10-2025
G9985007004,"Of care with other physicians, other qualified health care professionals or",09-10-2025
G9985008004,Agencies are provided consistent with the nature of the problem(s) and the,09-10-2025
G9985009004,"Needs of the patient or the family or both. usually, the presenting problem(s)",09-10-2025
G9985010004,"Are of moderate to high severity. typically, 25 minutes are spent with the",09-10-2025
G9985011004,"Patient or family or both via real time, audio and video intercommunications",09-10-2025
G9985012004,Technology,09-10-2025
G9986001003,Remote in-home visit for the evaluation and management of an established,09-10-2025
G9986002004,Patient for use only in a medicare-approved bundled payments for care,09-10-2025
G9986003004,"Improvement advanced (bpci advanced) model episode of care, which requires at",09-10-2025
G9986004004,Least 2 of the following 3 key components: a comprehensive history; a,09-10-2025
G9986005004,"Comprehensive examination; medical decision making of high complexity,",09-10-2025
G9986006004,Furnished in real time using interactive audio and video technology.,09-10-2025
G9986007004,"Counseling and coordination of care with other physicians, other qualified",09-10-2025
G9986008004,Health care professionals or agencies are provided consistent with the nature,09-10-2025
G9986009004,"Of the problem(s) and the needs of the patient or the family or both. usually,",09-10-2025
G9986010004,"The presenting problem(s) are of moderate to high severity. typically, 40",09-10-2025
G9986011004,"Minutes are spent with the patient or family or both via real time, audio and",09-10-2025
G9986012004,Video intercommunications technology,09-10-2025
G9987001003,Bundled payments for care improvement advanced (bpci advanced) model home visit,09-10-2025
G9987002004,For patient assessment performed by clinical staff for an individual not,09-10-2025
G9987003004,"Considered homebound, including, but not necessarily limited to patient",09-10-2025
G9987004004,"Assessment of clinical status, safety/fall prevention, functional",09-10-2025
G9987005004,"Status/ambulation, medication reconciliation/management, compliance with",09-10-2025
G9987006004,"Orders/plan of care, performance of activities of daily living, and ensuring",09-10-2025
G9987007004,Beneficiary connections to community and other services; for use only for a,09-10-2025
G9987008004,Bpci advanced model episode of care; may not be billed for a 30-day period,09-10-2025
G9987009004,Covered by a transitional care management code,09-10-2025
G9988001003,Palliative care services provided to patient any time during the measurement,09-10-2025
G9988002004,Period,09-10-2025
G9989001003,Documentation of medical reason(s) for not administering pneumococcal vaccine,09-10-2025
G9989002004,"(e.g., adverse reaction to vaccine)",09-10-2025
G9990001003,Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on,09-10-2025
G9990002004,Or after their 19th birthday and before the end of the measurement period,09-10-2025
G9991001003,Patient received any pneumococcal conjugate or polysaccharide vaccine on or,09-10-2025
G9991002004,After their 19th birthday and before the end of the measurement period,09-10-2025
G9992001003,Palliative care services used by patient any time during the measurement period,09-10-2025
G9993001003,Patient was provided palliative care services any time during the measurement,09-10-2025
G9993002004,Period,09-10-2025
G9994001003,Patient is using palliative care services any time during the measurement perio,09-10-2025
G9995001003,Patients who use palliative care services any time during the measurement perio,09-10-2025
G9996001003,Documentation stating the patient has received or is currently receiving,09-10-2025
G9996002004,Palliative or hospice care,09-10-2025
G9997001003,Documentation of patient pregnancy anytime during the measurement period prior,09-10-2025
G9997002004,To and including the current encounter,09-10-2025
G9998001003,Documentation of medical reason(s) for an interval of less than 3 years since,09-10-2025
G9998002004,"The last colonoscopy (e.g., last colonoscopy incomplete, last colonoscopy had",09-10-2025
G9998003004,"Inadequate prep, piecemeal removal of adenomas, or sessile serrated polyps >=",09-10-2025
G9998004004,"20 mm in size, last colonoscopy found greater than 10 adenomas, lower",09-10-2025
G9998005004,"Gastrointestinal bleeding, or patient at high risk for colon cancer due to",09-10-2025
G9998006004,"Underlying medical history ([i.e. crohn's disease, ulcerative colitis, personal",09-10-2025
G9998007004,"Or family history of colon cancer, hereditary colorectal cancer syndromes])",09-10-2025
G9999001003,Documentation of system reason(s) for an interval of less than 3 years since,09-10-2025
G9999002004,"The last colonoscopy (e.g., unable to locate previous colonoscopy report,",09-10-2025
G9999003004,"Patient cannot provide precise date or details from previous colonoscopy,",09-10-2025
G9999004004,Previous colonoscopy report was incomplete),09-10-2025
H0001001003,Alcohol and/or drug assessment,09-10-2025
H0002001003,Behavioral health screening to determine eligibility for admission to treatment,09-10-2025
H0002002004,Program,09-10-2025
H0003001003,Alcohol and/or drug screening; laboratory analysis of specimens for presence of,09-10-2025
H0003002004,Alcohol and/or drugs,09-10-2025
H0004001003,"Behavioral health counseling and therapy, per 15 minutes",09-10-2025
H0005001003,Alcohol and/or drug services; group counseling by a clinician,09-10-2025
H0006001003,Alcohol and/or drug services; case management,09-10-2025
H0007001003,Alcohol and/or drug services; crisis intervention (outpatient),09-10-2025
H0008001003,Alcohol and/or drug services; sub-acute detoxification (hospital inpatient),09-10-2025
H0009001003,Alcohol and/or drug services; acute detoxification (hospital inpatient),09-10-2025
H0010001003,Alcohol and/or drug services; sub-acute detoxification (residential addiction,09-10-2025
H0010002004,Program inpatient),09-10-2025
H0011001003,Alcohol and/or drug services; acute detoxification (residential addiction,09-10-2025
H0011002004,Program inpatient),09-10-2025
H0012001003,Alcohol and/or drug services; sub-acute detoxification (residential addiction,09-10-2025
H0012002004,Program outpatient),09-10-2025
H0013001003,Alcohol and/or drug services; acute detoxification (residential addiction,09-10-2025
H0013002004,Program outpatient),09-10-2025
H0014001003,Alcohol and/or drug services; ambulatory detoxification,09-10-2025
H0015001003,Alcohol and/or drug services; intensive outpatient (treatment program that,09-10-2025
H0015002004,Operates at least 3 hours/day and at least 3 days/week and is based on an,09-10-2025
H0015003004,"Individualized treatment plan), including assessment, counseling; crisis",09-10-2025
H0015004004,"Intervention, and activity therapies or education",09-10-2025
H0016001003,Alcohol and/or drug services; medical/somatic (medical intervention in,09-10-2025
H0016002004,Ambulatory setting),09-10-2025
H0017001003,"Behavioral health; residential (hospital residential treatment program),",09-10-2025
H0017002004,"Without room and board, per diem",09-10-2025
H0018001003,Behavioral health; short-term residential (non-hospital residential treatment,09-10-2025
H0018002004,"Program), without room and board, per diem",09-10-2025
H0019001003,"Behavioral health; long-term residential (non-medical, non-acute care in a",09-10-2025
H0019002004,"Residential treatment program where stay is typically longer than 30 days),",09-10-2025
H0019003004,"Without room and board, per diem",09-10-2025
H0020001003,Alcohol and/or drug services; methadone administration and/or service,09-10-2025
H0020002004,(provision of the drug by a licensed program),09-10-2025
H0021001003,Alcohol and/or drug training service (for staff and personnel not employed by,09-10-2025
H0021002004,Providers),09-10-2025
H0022001003,Alcohol and/or drug intervention service (planned facilitation),09-10-2025
H0023001003,Behavioral health outreach service (planned approach to reach a targeted,09-10-2025
H0023002004,Population),09-10-2025
H0024001003,Behavioral health prevention information dissemination service (one-way direct,09-10-2025
H0024002004,Or non-direct contact with service audiences to affect knowledge and attitude),09-10-2025
H0025001003,Behavioral health prevention education service (delivery of services with,09-10-2025
H0025002004,"Target population to affect knowledge, attitude and/or behavior)",09-10-2025
H0026001003,"Alcohol and/or drug prevention process service, community-based (delivery of",09-10-2025
H0026002004,Services to develop skills of impactors),09-10-2025
H0027001003,Alcohol and/or drug prevention environmental service (broad range of external,09-10-2025
H0027002004,Activities geared toward modifying systems in order to mainstream prevention,09-10-2025
H0027003004,Through policy and law),09-10-2025
H0028001003,Alcohol and/or drug prevention problem identification and referral service,09-10-2025
H0028002004,"(e.g., student assistance and employee assistance programs), does not include",09-10-2025
H0028003004,Assessment,09-10-2025
H0029001003,Alcohol and/or drug prevention alternatives service (services for populations,09-10-2025
H0029002004,"That exclude alcohol and other drug use e.g., alcohol free social events)",09-10-2025
H0030001003,Behavioral health hotline service,09-10-2025
H0031001003,"Mental health assessment, by non-physician",09-10-2025
H0032001003,Mental health service plan development by non-physician,09-10-2025
H0033001003,"Oral medication administration, direct observation",09-10-2025
H0034001003,"Medication training and support, per 15 minutes",09-10-2025
H0035001003,"Mental health partial hospitalization, treatment, less than 24 hours",09-10-2025
H0036001003,"Community psychiatric supportive treatment, face-to-face, per 15 minutes",09-10-2025
H0037001003,"Community psychiatric supportive treatment program, per diem",09-10-2025
H0038001003,"Self-help/peer services, per 15 minutes",09-10-2025
H0039001003,"Assertive community treatment, face-to-face, per 15 minutes",09-10-2025
H0040001003,"Assertive community treatment program, per diem",09-10-2025
H0041001003,"Foster care, child, non-therapeutic, per diem",09-10-2025
H0042001003,"Foster care, child, non-therapeutic, per month",09-10-2025
H0043001003,"Supported housing, per diem",09-10-2025
H0044001003,"Supported housing, per month",09-10-2025
H0045001003,"Respite care services, not in the home, per diem",09-10-2025
H0046001003,"Mental health services, not otherwise specified",09-10-2025
H0047001003,"Alcohol and/or other drug abuse services, not otherwise specified",09-10-2025
H0048001003,"Alcohol and/or other drug testing: collection and handling only, specimens",09-10-2025
H0048002004,Other than blood,09-10-2025
H0049001003,Alcohol and/or drug screening,09-10-2025
H0050001003,"Alcohol and/or drug services, brief intervention, per 15 minutes",09-10-2025
H0051001003,Traditional healing service,09-10-2025
H0052001003,Missing and murdered indigenous persons (mmip) mental health and clinical care,09-10-2025
H0053001003,Historical trauma (ht) mental health and clinical care for indigenous persons,09-10-2025
H1000001003,"Prenatal care, at-risk assessment",09-10-2025
H1001001003,"Prenatal care, at-risk enhanced service; antepartum management",09-10-2025
H1002001003,"Prenatal care, at risk enhanced service; care coordination",09-10-2025
H1003001003,"Prenatal care, at-risk enhanced service; education",09-10-2025
H1004001003,"Prenatal care, at-risk enhanced service; follow-up home visit",09-10-2025
H1005001003,"Prenatal care, at-risk enhanced service package (includes h1001-h1004)",09-10-2025
H1010001003,"Non-medical family planning education, per session",09-10-2025
H1011001003,Family assessment by licensed behavioral health professional for state defined,09-10-2025
H1011002004,Purposes,09-10-2025
H2000001003,Comprehensive multidisciplinary evaluation,09-10-2025
H2001001003,"Rehabilitation program, per 1/2 day",09-10-2025
H2010001003,"Comprehensive medication services, per 15 minutes",09-10-2025
H2011001003,"Crisis intervention service, per 15 minutes",09-10-2025
H2012001003,"Behavioral health day treatment, per hour",09-10-2025
H2013001003,"Psychiatric health facility service, per diem",09-10-2025
H2014001003,"Skills training and development, per 15 minutes",09-10-2025
H2015001003,"Comprehensive community support services, per 15 minutes",09-10-2025
H2016001003,"Comprehensive community support services, per diem",09-10-2025
H2017001003,"Psychosocial rehabilitation services, per 15 minutes",09-10-2025
H2018001003,"Psychosocial rehabilitation services, per diem",09-10-2025
H2019001003,"Therapeutic behavioral services, per 15 minutes",09-10-2025
H2020001003,"Therapeutic behavioral services, per diem",09-10-2025
H2021001003,"Community-based wrap-around services, per 15 minutes",09-10-2025
H2022001003,"Community-based wrap-around services, per diem",09-10-2025
H2023001003,"Supported employment, per 15 minutes",09-10-2025
H2024001003,"Supported employment, per diem",09-10-2025
H2025001003,"Ongoing support to maintain employment, per 15 minutes",09-10-2025
H2026001003,"Ongoing support to maintain employment, per diem",09-10-2025
H2027001003,"Psychoeducational service, per 15 minutes",09-10-2025
H2028001003,"Sexual offender treatment service, per 15 minutes",09-10-2025
H2029001003,"Sexual offender treatment service, per diem",09-10-2025
H2030001003,"Mental health clubhouse services, per 15 minutes",09-10-2025
H2031001003,"Mental health clubhouse services, per diem",09-10-2025
H2032001003,"Activity therapy, per 15 minutes",09-10-2025
H2033001003,"Multisystemic therapy for juveniles, per 15 minutes",09-10-2025
H2034001003,"Alcohol and/or drug abuse halfway house services, per diem",09-10-2025
H2035001003,"Alcohol and/or other drug treatment program, per hour",09-10-2025
H2036001003,"Alcohol and/or other drug treatment program, per diem",09-10-2025
H2037001003,"Developmental delay prevention activities, dependent child of client, per 15",09-10-2025
H2037002004,Minutes,09-10-2025
H2038001003,"Skills training and development, per diem",09-10-2025
H2040001003,"Coordinated specialty care, team-based, for first episode psychosis, per month",09-10-2025
H2041001003,"Coordinated specialty care, team-based, for first episode psychosis, per",09-10-2025
H2041002004,Encounter,09-10-2025
J0120001003,"Injection, tetracycline, up to 250 mg",09-10-2025
J0121001003,"Injection, omadacycline, 1 mg",09-10-2025
J0122001003,"Injection, eravacycline, 1 mg",09-10-2025
J0129001003,"Injection, abatacept, 10 mg (code may be used for medicare when drug",09-10-2025
J0129002004,"Administered under the direct supervision of a physician, not for use when drug",09-10-2025
J0129003004,Is self administered),09-10-2025
J0130001003,"Injection abciximab, 10 mg",09-10-2025
J0131001003,"Injection, acetaminophen, not otherwise specified,10 mg",09-10-2025
J0132001003,"Injection, acetylcysteine, 100 mg",09-10-2025
J0133001003,"Injection, acyclovir, 5 mg",09-10-2025
J0134001003,"Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to",09-10-2025
J0134002004,"J0131, 10 mg",09-10-2025
J0135001003,"Injection, adalimumab, 20 mg",09-10-2025
J0136001003,"Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10",09-10-2025
J0136002004,Mg,09-10-2025
J0137001003,"Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 m",09-10-2025
J0138001003,"Injection, acetaminophen 10 mg and ibuprofen 3 mg",09-10-2025
J0139001003,"Injection, adalimumab, 1 mg",09-10-2025
J0150001003,"Injection, adenosine for therapeutic use, 6 mg (not to be used to report any",09-10-2025
J0150002004,"Adenosine phosphate compounds, instead use a9270)",09-10-2025
J0151001003,"Injection, adenosine for diagnostic use, 1 mg (not to be used to report any",09-10-2025
J0151002004,"Adenosine phosphate compounds, instead use a9270)",09-10-2025
J0153001003,"Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate",09-10-2025
J0153002004,Compounds),09-10-2025
J0163001003,"Injection, epinephrine in sodium chloride (endo), 0.1 mg",09-10-2025
J0164001003,"Injection, epinephrine in sodium chloride (baxter), 0.1 mg",09-10-2025
J0165001003,"Injection, epinephrine, not otherwise specified, 0.1 mg",09-10-2025
J0166001003,"Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg",09-10-2025
J0167001003,"Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1",09-10-2025
J0167002004,Mg,09-10-2025
J0168001003,"Injection, epinephrine (international medication systems), not therapeutically",09-10-2025
J0168002004,"Equivalent to j0165, 0.1 mg",09-10-2025
J0169001003,"Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165,",09-10-2025
J0169002004,0.1 mg,09-10-2025
J0171001003,"Injection, adrenalin, epinephrine, 0.1 mg",09-10-2025
J0172001003,"Injection, aducanumab-avwa, 2 mg",09-10-2025
J0173001003,"Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1",09-10-2025
J0173002004,Mg,09-10-2025
J0174001003,"Injection, lecanemab-irmb, 1 mg",09-10-2025
J0175001003,"Injection, donanemab-azbt, 2 mg",09-10-2025
J0177001003,"Injection, aflibercept hd, 1 mg",09-10-2025
J0178001003,"Injection, aflibercept, 1 mg",09-10-2025
J0179001003,"Injection, brolucizumab-dbll, 1 mg",09-10-2025
J0180001003,"Injection, agalsidase beta, 1 mg",09-10-2025
J0184001003,"Injection, amisulpride, 1 mg",09-10-2025
J0185001003,"Injection, aprepitant, 1 mg",09-10-2025
J0190001003,"Injection, biperiden lactate, per 5 mg",09-10-2025
J0200001003,"Injection, alatrofloxacin mesylate, 100 mg",09-10-2025
J0202001003,"Injection, alemtuzumab, 1 mg",09-10-2025
J0205001003,"Injection, alglucerase, per 10 units",09-10-2025
J0206001003,"Injection, allopurinol sodium, 1 mg",09-10-2025
J0207001003,"Injection, amifostine, 500 mg",09-10-2025
J0208001003,"Injection, sodium thiosulfate (pedmark), 100 mg",09-10-2025
J0209001003,"Injection, sodium thiosulfate (hope), 100 mg",09-10-2025
J0210001003,"Injection, methyldopate hcl, up to 250 mg",09-10-2025
J0211001003,"Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)",09-10-2025
J0215001003,"Injection, alefacept, 0.5 mg",09-10-2025
J0216001003,"Injection, alfentanil hydrochloride, 500 micrograms",09-10-2025
J0217001003,"Injection, velmanase alfa-tycv, 1 mg",09-10-2025
J0218001003,"Injection, olipudase alfa-rpcp, 1 mg",09-10-2025
J0219001003,"Injection, avalglucosidase alfa-ngpt, 4 mg",09-10-2025
J0220001003,"Injection, alglucosidase alfa, 10 mg, not otherwise specified",09-10-2025
J0221001003,"Injection, alglucosidase alfa, (lumizyme), 10 mg",09-10-2025
J0222001003,"Injection, patisiran, 0.1 mg",09-10-2025
J0223001003,"Injection, givosiran, 0.5 mg",09-10-2025
J0224001003,"Injection, lumasiran, 0.5 mg",09-10-2025
J0225001003,"Injection, vutrisiran, 1 mg",09-10-2025
J0248001003,"Injection, remdesivir, 1 mg",09-10-2025
J0256001003,"Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg",09-10-2025
J0257001003,"Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg",09-10-2025
J0270001003,"Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug",09-10-2025
J0270002004,"Administered under the direct supervision of a physician, not for use when drug",09-10-2025
J0270003004,Is self administered),09-10-2025
J0275001003,Alprostadil urethral suppository (code may be used for medicare when drug,09-10-2025
J0275002004,"Administered under the direct supervision of a physician, not for use when drug",09-10-2025
J0275003004,Is self administered),09-10-2025
J0278001003,"Injection, amikacin sulfate, 100 mg",09-10-2025
J0280001003,"Injection, aminophyllin, up to 250 mg",09-10-2025
J0281001003,"Injection, aminocaproic acid, 1 gram",09-10-2025
J0282001003,"Injection, amiodarone hydrochloride, 30 mg",09-10-2025
J0283001003,"Injection, amiodarone hydrochloride (nexterone), 30 mg",09-10-2025
J0285001003,"Injection, amphotericin b, 50 mg",09-10-2025
J0287001003,"Injection, amphotericin b lipid complex, 10 mg",09-10-2025
J0288001003,"Injection, amphotericin b cholesteryl sulfate complex, 10 mg",09-10-2025
J0289001003,"Injection, amphotericin b liposome, 10 mg",09-10-2025
J0290001003,"Injection, ampicillin sodium, 500 mg",09-10-2025
J0291001003,"Injection, plazomicin, 5 mg",09-10-2025
J0295001003,"Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm",09-10-2025
J0300001003,"Injection, amobarbital, up to 125 mg",09-10-2025
J0330001003,"Injection, succinylcholine chloride, up to 20 mg",09-10-2025
J0348001003,"Injection, anidulafungin, 1 mg",09-10-2025
J0349001003,"Injection, rezafungin, 1 mg",09-10-2025
J0350001003,"Injection, anistreplase, per 30 units",09-10-2025
J0360001003,"Injection, hydralazine hcl, up to 20 mg",09-10-2025
J0364001003,"Injection, apomorphine hydrochloride, 1 mg",09-10-2025
J0365001003,"Injection, aprotonin, 10,000 kiu",09-10-2025
J0380001003,"Injection, metaraminol bitartrate, per 10 mg",09-10-2025
J0390001003,"Injection, chloroquine hydrochloride, up to 250 mg",09-10-2025
J0391001003,"Injection, artesunate, 1 mg",09-10-2025
J0395001003,"Injection, arbutamine hcl, 1 mg",09-10-2025
J0400001003,"Injection, aripiprazole, intramuscular, 0.25 mg",09-10-2025
J0401001003,"Injection, aripiprazole (abilify maintena), 1 mg",09-10-2025
J0402001003,"Injection, aripiprazole (abilify asimtufii), 1 mg",09-10-2025
J0456001003,"Injection, azithromycin, 500 mg",09-10-2025
J0457001003,"Injection, aztreonam, 100 mg",09-10-2025
J0458001003,"Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)",09-10-2025
J0461001003,"Injection, atropine sulfate, 0.01 mg",09-10-2025
J0462001003,"Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg",09-10-2025
J0470001003,"Injection, dimercaprol, per 100 mg",09-10-2025
J0475001003,"Injection, baclofen, 10 mg",09-10-2025
J0476001003,"Injection, baclofen, 50 mcg for intrathecal trial",09-10-2025
J0480001003,"Injection, basiliximab, 20 mg",09-10-2025
J0485001003,"Injection, belatacept, 1 mg",09-10-2025
J0490001003,"Injection, belimumab, 10 mg",09-10-2025
J0491001003,"Injection, anifrolumab-fnia, 1 mg",09-10-2025
J0500001003,"Injection, dicyclomine hcl, up to 20 mg",09-10-2025
J0515001003,"Injection, benztropine mesylate, per 1 mg",09-10-2025
J0517001003,"Injection, benralizumab, 1 mg",09-10-2025
J0520001003,"Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg",09-10-2025
J0525001003,"Injection, cefotetan disodium, 10 mg",09-10-2025
J0558001003,"Injection, penicillin g benzathine and penicillin g procaine, 100,000 units",09-10-2025
J0561001003,"Injection, penicillin g benzathine, 100,000 units",09-10-2025
J0565001003,"Injection, bezlotoxumab, 10 mg",09-10-2025
J0567001003,"Injection, cerliponase alfa, 1 mg",09-10-2025
J0570001003,"Buprenorphine implant, 74.2 mg",09-10-2025
J0571001003,"Buprenorphine, oral, 1 mg",09-10-2025
J0572001003,"Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine",09-10-2025
J0573001003,"Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg",09-10-2025
J0573002004,Buprenorphine,09-10-2025
J0574001003,"Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10",09-10-2025
J0574002004,Mg buprenorphine,09-10-2025
J0575001003,"Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine",09-10-2025
J0576001003,"Injection, buprenorphine extended-release (brixadi), 1 mg",09-10-2025
J0577001003,"Injection, buprenorphine extended-release (brixadi), less than or equal to 7",09-10-2025
J0577002004,Days of therapy,09-10-2025
J0578001003,"Injection, buprenorphine extended release (brixadi), greater than 7 days and up",09-10-2025
J0578002004,To 28 days of therapy,09-10-2025
J0582001003,"Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg",09-10-2025
J0583001003,"Injection, bivalirudin, 1 mg",09-10-2025
J0584001003,"Injection, burosumab-twza 1 mg",09-10-2025
J0585001003,"Injection, onabotulinumtoxina, 1 unit",09-10-2025
J0586001003,"Injection, abobotulinumtoxina, 5 units",09-10-2025
J0587001003,"Injection, rimabotulinumtoxinb, 100 units",09-10-2025
J0588001003,"Injection, incobotulinumtoxin a, 1 unit",09-10-2025
J0589001003,"Injection, daxibotulinumtoxina-lanm, 1 unit",09-10-2025
J0591001003,"Injection, deoxycholic acid, 1 mg",09-10-2025
J0592001003,"Injection, buprenorphine hydrochloride, 0.1 mg",09-10-2025
J0593001003,"Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug",09-10-2025
J0593002004,"Administered under direct supervision of a physician, not for use when drug is",09-10-2025
J0593003004,Self-administered),09-10-2025
J0594001003,"Injection, busulfan, 1 mg",09-10-2025
J0595001003,"Injection, butorphanol tartrate, 1 mg",09-10-2025
J0596001003,"Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units",09-10-2025
J0597001003,"Injection, c-1 esterase inhibitor (human), berinert, 10 units",09-10-2025
J0598001003,"Injection, c-1 esterase inhibitor (human), cinryze, 10 units",09-10-2025
J0599001003,"Injection, c-1 esterase inhibitor (human), (haegarda), 10 units",09-10-2025
J0600001003,"Injection, edetate calcium disodium, up to 1000 mg",09-10-2025
J0601001003,"Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for",09-10-2025
J0601002004,Esrd on dialysis),09-10-2025
J0602001003,"Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20",09-10-2025
J0602002004,Mg (for esrd on dialysis),09-10-2025
J0603001003,"Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg",09-10-2025
J0603002004,(for esrd on dialysis),09-10-2025
J0604001003,"Cinacalcet, oral, 1 mg, (for esrd on dialysis)",09-10-2025
J0605001003,"Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)",09-10-2025
J0606001003,"Injection, etelcalcetide, 0.1 mg",09-10-2025
J0607001003,"Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)",09-10-2025
J0608001003,"Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to",09-10-2025
J0608002004,J0607 (for esrd on dialysis),09-10-2025
J0609001003,"Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)",09-10-2025
J0610001003,"Injection, calcium gluconate (fresenius kabi), per 10 ml",09-10-2025
J0611001003,"Injection, calcium gluconate (wg critical care), per 10 ml",09-10-2025
J0612001003,"Injection, calcium gluconate, not otherwise specified, 10 mg",09-10-2025
J0613001003,"Injection, calcium gluconate (wg critical care), not therapeutically equivalent",09-10-2025
J0613002004,"To j0612, 10 mg",09-10-2025
J0614001003,"Injection, treosulfan, 50 mg",09-10-2025
J0615001003,"Calcium acetate, oral, 23 mg (for esrd on dialysis)",09-10-2025
J0616001003,"Injection, metoprolol tartrate, 1 mg",09-10-2025
J0618001003,"Injection, calcium chloride, 2 mg",09-10-2025
J0620001003,"Injection, calcium glycerophosphate and calcium lactate, per 10 ml",09-10-2025
J0630001003,"Injection, calcitonin salmon, up to 400 units",09-10-2025
J0636001003,"Injection, calcitriol, 0.1 mcg",09-10-2025
J0637001003,"Injection, caspofungin acetate, 5 mg",09-10-2025
J0638001003,"Injection, canakinumab, 1 mg",09-10-2025
J0640001003,"Injection, leucovorin calcium, per 50 mg",09-10-2025
J0641001003,"Injection, levoleucovorin, not otherwise specified, 0.5 mg",09-10-2025
J0642001003,"Injection, levoleucovorin (khapzory), 0.5 mg",09-10-2025
J0650001003,"Injection, levothyroxine sodium, not otherwise specified, 10 mcg",09-10-2025
J0651001003,"Injection, levothyroxine sodium (fresenius kabi), not therapeutically",09-10-2025
J0651002004,"Equivalent to j0650, 10 mcg",09-10-2025
J0652001003,"Injection, levothyroxine sodium (hikma), not therapeutically equivalent to",09-10-2025
J0652002004,"J0650, 10 mcg",09-10-2025
J0665001003,"Injection, bupivicaine, not otherwise specified, 0.5 mg",09-10-2025
J0666001003,"Injection, bupivacaine liposome, 1 mg",09-10-2025
J0668001003,"Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg",09-10-2025
J0670001003,"Injection, mepivacaine hydrochloride, per 10 ml",09-10-2025
J0675001003,"Injection, carboprost tromethamine, 0.1 mg",09-10-2025
J0681001003,"Injection, ceftobiprole medocaril sodium, 3 mg",09-10-2025
J0687001003,"Injection, cefazolin sodium (wg critical care), not therapeutically equivalent",09-10-2025
J0687002004,"To j0690, 500 mg",09-10-2025
J0688001003,"Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690,",09-10-2025
J0688002004,500 mg,09-10-2025
J0689001003,"Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690,",09-10-2025
J0689002004,500 mg,09-10-2025
J0690001003,"Injection, cefazolin sodium, 500 mg",09-10-2025
J0691001003,"Injection, lefamulin, 1 mg",09-10-2025
J0692001003,"Injection, cefepime hydrochloride, 500 mg",09-10-2025
J0693001003,"Injection, cefiderocol, 5 mg",09-10-2025
J0694001003,"Injection, cefoxitin sodium, 1 gm",09-10-2025
J0695001003,"Injection, ceftolozane 50 mg and tazobactam 25 mg",09-10-2025
J0696001003,"Injection, ceftriaxone sodium, per 250 mg",09-10-2025
J0697001003,"Injection, sterile cefuroxime sodium, per 750 mg",09-10-2025
J0698001003,"Injection, cefotaxime sodium, per gm",09-10-2025
J0699001003,"Injection, cefiderocol, 10 mg",09-10-2025
J0701001003,"Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to",09-10-2025
J0701002004,"Maxipime, 500 mg",09-10-2025
J0702001003,"Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg",09-10-2025
J0703001003,"Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to",09-10-2025
J0703002004,"Maxipime, 500 mg",09-10-2025
J0706001003,"Injection, caffeine citrate, 5 mg",09-10-2025
J0710001003,"Injection, cephapirin sodium, up to 1 gm",09-10-2025
J0712001003,"Injection, ceftaroline fosamil, 10 mg",09-10-2025
J0713001003,"Injection, ceftazidime, per 500 mg",09-10-2025
J0714001003,"Injection, ceftazidime and avibactam, 0.5 g/0.125 g",09-10-2025
J0715001003,"Injection, ceftizoxime sodium, per 500 mg",09-10-2025
J0716001003,"Injection, centruroides immune f(ab)2, up to 120 milligrams",09-10-2025
J0717001003,"Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug",09-10-2025
J0717002004,"Administered under the direct supervision of a physician, not for use when drug",09-10-2025
J0717003004,Is self administered),09-10-2025
J0720001003,"Injection, chloramphenicol sodium succinate, up to 1 gm",09-10-2025
J0725001003,"Injection, chorionic gonadotropin, per 1,000 usp units",09-10-2025
J0735001003,"Injection, clonidine hydrochloride, 1 mg",09-10-2025
J0736001003,"Injection, clindamycin phosphate, 300 mg",09-10-2025
J0737001003,"Injection, clindamycin phosphate (baxter), not therapeutically equivalent to",09-10-2025
J0737002004,"J0736, 300 mg",09-10-2025
J0738001003,"Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv",09-10-2025
J0738002004,Pre-exposure prophylaxis (not for use as treatment for hiv),09-10-2025
J0739001003,"Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv",09-10-2025
J0739002004,Pre-exposure prophylaxis (not for use as treatment for hiv),09-10-2025
J0740001003,"Injection, cidofovir, 375 mg",09-10-2025
J0741001003,"Injection, cabotegravir and rilpivirine, 2mg/3mg",09-10-2025
J0742001003,"Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg",09-10-2025
J0743001003,"Injection, cilastatin sodium; imipenem, per 250 mg",09-10-2025
J0744001003,"Injection, ciprofloxacin for intravenous infusion, 200 mg",09-10-2025
J0745001003,"Injection, codeine phosphate, per 30 mg",09-10-2025
J0750001003,"Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved",09-10-2025
J0750002004,"Prescription, only for use as hiv pre-exposure prophylaxis (not for use as",09-10-2025
J0750003004,Treatment of hiv),09-10-2025
J0751001003,"Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved",09-10-2025
J0751002004,"Prescription, only for use as hiv pre-exposure prophylaxis (not for use as",09-10-2025
J0751003004,Treatment of hiv),09-10-2025
J0752001003,"Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv",09-10-2025
J0752002004,Pre-exposure prophylaxis (not for use as treatment for hiv),09-10-2025
J0759001003,"Injection, clevidipine butyrate, 1 mg",09-10-2025
J0760001003,"Injection, colchicine, per 1 mg",09-10-2025
J0770001003,"Injection, colistimethate sodium, up to 150 mg",09-10-2025
J0775001003,"Injection, collagenase, clostridium histolyticum, 0.01 mg",09-10-2025
J0780001003,"Injection, prochlorperazine, up to 10 mg",09-10-2025
J0791001003,"Injection, crizanlizumab-tmca, 5 mg",09-10-2025
J0795001003,"Injection, corticorelin ovine triflutate, 1 microgram",09-10-2025
J0799001003,"Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis",09-10-2025
J0799002004,"(not for use as treatment of hiv), not otherwise classified",09-10-2025
J0800001003,"Injection, corticotropin, up to 40 units",09-10-2025
J0801001003,"Injection, corticotropin (acthar gel), up to 40 units",09-10-2025
J0802001003,"Injection, corticotropin (ani), up to 40 units",09-10-2025
J0833001003,"Injection, cosyntropin, not otherwise specified, 0.25 mg",09-10-2025
J0834001003,"Injection, cosyntropin, 0.25 mg",09-10-2025
J0840001003,"Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram",09-10-2025
J0841001003,"Injection, crotalidae immune f(ab')2 (equine), 120 mg",09-10-2025
J0850001003,"Injection, cytomegalovirus immune globulin intravenous (human), per vial",09-10-2025
J0870001003,"Injection, imetelstat, 1 mg",09-10-2025
J0872001003,"Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent",09-10-2025
J0872002004,"To j0878 or j0873, 1 mg",09-10-2025
J0873001003,"Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or",09-10-2025
J0873002004,"J0872, 1 mg",09-10-2025
J0874001003,"Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg",09-10-2025
J0875001003,"Injection, dalbavancin, 5 mg",09-10-2025
J0877001003,"Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg",09-10-2025
J0878001003,"Injection, daptomycin, 1 mg",09-10-2025
J0879001003,"Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)",09-10-2025
J0881001003,"Injection, darbepoetin alfa, 1 microgram (non-esrd use)",09-10-2025
J0882001003,"Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)",09-10-2025
J0883001003,"Injection, argatroban, 1 mg (for non-esrd use)",09-10-2025
J0884001003,"Injection, argatroban, 1 mg (for esrd on dialysis)",09-10-2025
J0885001003,"Injection, epoetin alfa, (for non-esrd use), 1000 units",09-10-2025
J0886001003,"Injection, epoetin alfa, 1000 units (for esrd on dialysis)",09-10-2025
J0887001003,"Injection, epoetin beta, 1 microgram, (for esrd on dialysis)",09-10-2025
J0888001003,"Injection, epoetin beta, 1 microgram, (for non esrd use)",09-10-2025
J0889001003,"Daprodustat, oral, 1 mg, (for esrd on dialysis)",09-10-2025
J0890001003,"Injection, peginesatide, 0.1 mg (for esrd on dialysis)",09-10-2025
J0891001003,"Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg",09-10-2025
J0891002004,(for non-esrd use),09-10-2025
J0892001003,"Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg",09-10-2025
J0892002004,(for esrd on dialysis),09-10-2025
J0893001003,"Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1",09-10-2025
J0893002004,Mg,09-10-2025
J0894001003,"Injection, decitabine, 1 mg",09-10-2025
J0895001003,"Injection, deferoxamine mesylate, 500 mg",09-10-2025
J0896001003,"Injection, luspatercept-aamt, 0.25 mg",09-10-2025
J0897001003,"Injection, denosumab, 1 mg",09-10-2025
J0898001003,"Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1",09-10-2025
J0898002004,Mg (for non-esrd use),09-10-2025
J0899001003,"Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1",09-10-2025
J0899002004,Mg (for esrd on dialysis),09-10-2025
J0900001003,"Injection, testosterone enanthate and estradiol valerate, up to 1 cc",09-10-2025
J0901001003,"Vadadustat, oral, 1 mg (for esrd on dialysis)",09-10-2025
J0911001003,"Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous",09-10-2025
J0911002004,Catheter lock for adult patients receiving chronic hemodialysis),09-10-2025
J0945001003,"Injection, brompheniramine maleate, per 10 mg",09-10-2025
J1000001003,"Injection, depo-estradiol cypionate, up to 5 mg",09-10-2025
J1010001003,"Injection, methylprednisolone acetate, 1 mg",09-10-2025
J1020001003,"Injection, methylprednisolone acetate, 20 mg",09-10-2025
J1030001003,"Injection, methylprednisolone acetate, 40 mg",09-10-2025
J1040001003,"Injection, methylprednisolone acetate, 80 mg",09-10-2025
J1050001003,"Injection, medroxyprogesterone acetate, 1 mg",09-10-2025
J1060001003,"Injection, testosterone cypionate and estradiol cypionate, up to 1 ml",09-10-2025
J1070001003,"Injection, testosterone cypionate, up to 100 mg",09-10-2025
J1071001003,"Injection, testosterone cypionate, 1 mg",09-10-2025
J1072001003,"Injection, testosterone cypionate (azmiro), 1 mg",09-10-2025
J1080001003,"Injection, testosterone cypionate, 1 cc, 200 mg",09-10-2025
J1094001003,"Injection, dexamethasone acetate, 1 mg",09-10-2025
J1095001003,"Injection, dexamethasone 9 percent, intraocular, 1 microgram",09-10-2025
J1096001003,"Dexamethasone, lacrimal ophthalmic insert, 0.1 mg",09-10-2025
J1097001003,Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation,09-10-2025
J1097002004,"Solution, 1 ml",09-10-2025
J1100001003,"Injection, dexamethasone sodium phosphate, 1 mg",09-10-2025
J1105001003,"Dexmedetomidine, oral, 1 mcg",09-10-2025
J1110001003,"Injection, dihydroergotamine mesylate, per 1 mg",09-10-2025
J1120001003,"Injection, acetazolamide sodium, up to 500 mg",09-10-2025
J1130001003,"Injection, diclofenac sodium, 0.5 mg",09-10-2025
J1160001003,"Injection, digoxin, up to 0.5 mg",09-10-2025
J1162001003,"Injection, digoxin immune fab (ovine), per vial",09-10-2025
J1163001003,"Injection, diltiazem hydrochloride, 0.5 mg",09-10-2025
J1165001003,"Injection, phenytoin sodium, per 50 mg",09-10-2025
J1170001003,"Injection, hydromorphone, up to 4 mg",09-10-2025
J1171001003,"Injection, hydromorphone, 0.1 mg",09-10-2025
J1180001003,"Injection, dyphylline, up to 500 mg",09-10-2025
J1190001003,"Injection, dexrazoxane hydrochloride, per 250 mg",09-10-2025
J1200001003,"Injection, diphenhydramine hcl, up to 50 mg",09-10-2025
J1201001003,"Injection, cetirizine hydrochloride, 0.5 mg",09-10-2025
J1202001003,"Miglustat, oral, 65 mg",09-10-2025
J1203001003,"Injection, cipaglucosidase alfa-atga, 5 mg",09-10-2025
J1205001003,"Injection, chlorothiazide sodium, per 500 mg",09-10-2025
J1212001003,"Injection, dmso, dimethyl sulfoxide, 50%, 50 ml",09-10-2025
J1230001003,"Injection, methadone hcl, up to 10 mg",09-10-2025
J1240001003,"Injection, dimenhydrinate, up to 50 mg",09-10-2025
J1245001003,"Injection, dipyridamole, per 10 mg",09-10-2025
J1250001003,"Injection, dobutamine hydrochloride, per 250 mg",09-10-2025
J1260001003,"Injection, dolasetron mesylate, 10 mg",09-10-2025
J1265001003,"Injection, dopamine hcl, 40 mg",09-10-2025
J1267001003,"Injection, doripenem, 10 mg",09-10-2025
J1270001003,"Injection, doxercalciferol, 1 mcg",09-10-2025
J1271001003,"Injection, doxycycline hyclate, 1 mg",09-10-2025
J1290001003,"Injection, ecallantide, 1 mg",09-10-2025
J1299001003,"Injection, eculizumab, 2 mg",09-10-2025
J1300001003,"Injection, eculizumab, 10 mg",09-10-2025
J1301001003,"Injection, edaravone, 1 mg",09-10-2025
J1302001003,"Injection, sutimlimab-jome, 10 mg",09-10-2025
J1303001003,"Injection, ravulizumab-cwvz, 10 mg",09-10-2025
J1304001003,"Injection, tofersen, 1 mg",09-10-2025
J1305001003,"Injection, evinacumab-dgnb, 5mg",09-10-2025
J1306001003,"Injection, inclisiran, 1 mg",09-10-2025
J1307001003,"Injection, crovalimab-akkz, 10 mg",09-10-2025
J1308001003,"Injection, famotidine, 0.25 mg",09-10-2025
J1320001003,"Injection, amitriptyline hcl, up to 20 mg",09-10-2025
J1322001003,"Injection, elosulfase alfa, 1 mg",09-10-2025
J1323001003,"Injection, elranatamab-bcmm, 1 mg",09-10-2025
J1324001003,"Injection, enfuvirtide, 1 mg",09-10-2025
J1325001003,"Injection, epoprostenol, 0.5 mg",09-10-2025
J1326001003,"Injection, zolbetuximab-clzb, 2 mg",09-10-2025
J1327001003,"Injection, eptifibatide, 5 mg",09-10-2025
J1330001003,"Injection, ergonovine maleate, up to 0.2 mg",09-10-2025
J1335001003,"Injection, ertapenem sodium, 500 mg",09-10-2025
J1364001003,"Injection, erythromycin lactobionate, per 500 mg",09-10-2025
J1370001003,"Injection, esomeprazole sodium, 1 mg",09-10-2025
J1380001003,"Injection, estradiol valerate, up to 10 mg",09-10-2025
J1410001003,"Injection, estrogen conjugated, per 25 mg",09-10-2025
J1411001003,"Injection, etranacogene dezaparvovec-drlb, per therapeutic dose",09-10-2025
J1412001003,"Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x",09-10-2025
J1412002004,10^13 vector genomes,09-10-2025
J1413001003,"Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose",09-10-2025
J1414001003,"Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose",09-10-2025
J1426001003,"Injection, casimersen, 10 mg",09-10-2025
J1427001003,"Injection, viltolarsen, 10 mg",09-10-2025
J1428001003,"Injection, eteplirsen, 10 mg",09-10-2025
J1429001003,"Injection, golodirsen, 10 mg",09-10-2025
J1430001003,"Injection, ethanolamine oleate, 100 mg",09-10-2025
J1434001003,"Injection, fosaprepitant (focinvez), 1 mg",09-10-2025
J1435001003,"Injection, estrone, per 1 mg",09-10-2025
J1436001003,"Injection, etidronate disodium, per 300 mg",09-10-2025
J1437001003,"Injection, ferric derisomaltose, 10 mg",09-10-2025
J1438001003,"Injection, etanercept, 25 mg (code may be used for medicare when drug",09-10-2025
J1438002004,"Administered under the direct supervision of a physician, not for use when drug",09-10-2025
J1438003004,Is self administered),09-10-2025
J1439001003,"Injection, ferric carboxymaltose, 1 mg",09-10-2025
J1440001003,"Fecal microbiota, live - jslm, 1 ml",09-10-2025
J1442001003,"Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram",09-10-2025
J1443001003,"Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron",09-10-2025
J1444001003,"Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron",09-10-2025
J1445001003,"Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iro",09-10-2025
J1446001003,"Injection, tbo-filgrastim, 5 micrograms",09-10-2025
J1447001003,"Injection, tbo-filgrastim, 1 microgram",09-10-2025
J1448001003,"Injection, trilaciclib, 1mg",09-10-2025
J1449001003,"Injection, eflapegrastim-xnst, 0.1 mg",09-10-2025
J1450001003,"Injection fluconazole, 200 mg",09-10-2025
J1451001003,"Injection, fomepizole, 15 mg",09-10-2025
J1452001003,"Injection, fomivirsen sodium, intraocular, 1.65 mg",09-10-2025
J1453001003,"Injection, fosaprepitant, 1 mg",09-10-2025
J1454001003,"Injection, fosnetupitant 235 mg and palonosetron 0.25 mg",09-10-2025
J1455001003,"Injection, foscarnet sodium, per 1000 mg",09-10-2025
J1456001003,"Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg",09-10-2025
J1457001003,"Injection, gallium nitrate, 1 mg",09-10-2025
J1458001003,"Injection, galsulfase, 1 mg",09-10-2025
J1459001003,"Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g.,",09-10-2025
J1459002004,"Liquid), 500 mg",09-10-2025
J1460001003,"Injection, gamma globulin, intramuscular, 1 cc",09-10-2025
J1551001003,"Injection, immune globulin (cutaquig), 100 mg",09-10-2025
J1552001003,"Injection, immune globulin (alyglo), 500 mg",09-10-2025
J1554001003,"Injection, immune globulin (asceniv), 500 mg",09-10-2025
J1555001003,"Injection, immune globulin (cuvitru), 100 mg",09-10-2025
J1556001003,"Injection, immune globulin (bivigam), 500 mg",09-10-2025
J1557001003,"Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g.,",09-10-2025
J1557002004,"Liquid), 500 mg",09-10-2025
J1558001003,"Injection, immune globulin (xembify), 100 mg",09-10-2025
J1559001003,"Injection, immune globulin (hizentra), 100 mg",09-10-2025
J1560001003,"Injection, gamma globulin, intramuscular, over 10 cc",09-10-2025
J1561001003,"Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g.,",09-10-2025
J1561002004,"Liquid), 500 mg",09-10-2025
J1562001003,"Injection, immune globulin (vivaglobin), 100 mg",09-10-2025
J1566001003,"Injection, immune globulin, intravenous, lyophilized (e.g., powder), not",09-10-2025
J1566002004,"Otherwise specified, 500 mg",09-10-2025
J1568001003,"Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g.,",09-10-2025
J1568002004,"Liquid), 500 mg",09-10-2025
J1569001003,"Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g.,",09-10-2025
J1569002004,"Liquid), 500 mg",09-10-2025
J1570001003,"Injection, ganciclovir sodium, 500 mg",09-10-2025
J1571001003,"Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml",09-10-2025
J1572001003,"Injection, immune globulin, (flebogamma/flebogamma dif), intravenous,",09-10-2025
J1572002004,"Non-lyophilized (e.g., liquid), 500 mg",09-10-2025
J1573001003,"Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml",09-10-2025
J1574001003,"Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570,",09-10-2025
J1574002004,500 mg,09-10-2025
J1575001003,"Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin",09-10-2025
J1576001003,"Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g.,",09-10-2025
J1576002004,"Liquid), 500 mg",09-10-2025
J1580001003,"Injection, garamycin, gentamicin, up to 80 mg",09-10-2025
J1590001003,"Injection, gatifloxacin, 10 mg",09-10-2025
J1595001003,"Injection, glatiramer acetate, 20 mg",09-10-2025
J1596001003,"Injection, glycopyrrolate, 0.1 mg",09-10-2025
J1597001003,"Injection, glycopyrrolate (glyrx-pf), 0.1 mg",09-10-2025
J1598001003,"Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to",09-10-2025
J1598002004,"J1596, 0.1 mg",09-10-2025
J1599001003,"Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not",09-10-2025
J1599002004,"Otherwise specified, 500 mg",09-10-2025
J1600001003,"Injection, gold sodium thiomalate, up to 50 mg",09-10-2025
J1602001003,"Injection, golimumab, 1 mg, for intravenous use",09-10-2025
J1610001003,"Injection, glucagon hydrochloride, per 1 mg",09-10-2025
J1611001003,"Injection, glucagon hydrochloride (fresenius kabi), not therapeutically",09-10-2025
J1611002004,"Equivalent to j1610, per 1 mg",09-10-2025
J1612001003,"Injection, glucagon (gvoke), 0.01 mg",09-10-2025
J1620001003,"Injection, gonadorelin hydrochloride, per 100 mcg",09-10-2025
J1626001003,"Injection, granisetron hydrochloride, 100 mcg",09-10-2025
J1627001003,"Injection, granisetron, extended-release, 0.1 mg",09-10-2025
J1628001003,"Injection, guselkumab, 1 mg",09-10-2025
J1630001003,"Injection, haloperidol, up to 5 mg",09-10-2025
J1631001003,"Injection, haloperidol decanoate, per 50 mg",09-10-2025
J1632001003,"Injection, brexanolone, 1 mg",09-10-2025
J1640001003,"Injection, hemin, 1 mg",09-10-2025
J1642001003,"Injection, heparin sodium, (heparin lock flush), per 10 units",09-10-2025
J1643001003,"Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644,",09-10-2025
J1643002004,Per 1000 units,09-10-2025
J1644001003,"Injection, heparin sodium, per 1000 units",09-10-2025
J1645001003,"Injection, dalteparin sodium, per 2500 iu",09-10-2025
J1650001003,"Injection, enoxaparin sodium, 10 mg",09-10-2025
J1652001003,"Injection, fondaparinux sodium, 0.5 mg",09-10-2025
J1655001003,"Injection, tinzaparin sodium, 1000 iu",09-10-2025
J1670001003,"Injection, tetanus immune globulin, human, up to 250 units",09-10-2025
J1675001003,"Injection, histrelin acetate, 10 micrograms",09-10-2025
J1700001003,"Injection, hydrocortisone acetate, up to 25 mg",09-10-2025
J1710001003,"Injection, hydrocortisone sodium phosphate, up to 50 mg",09-10-2025
J1720001003,"Injection, hydrocortisone sodium succinate, up to 100 mg",09-10-2025
J1725001003,"Injection, hydroxyprogesterone caproate, 1 mg",09-10-2025
J1726001003,"Injection, hydroxyprogesterone caproate, (makena), 10 mg",09-10-2025
J1729001003,"Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg",09-10-2025
J1730001003,"Injection, diazoxide, up to 300 mg",09-10-2025
J1738001003,"Injection, meloxicam, 1 mg",09-10-2025
J1740001003,"Injection, ibandronate sodium, 1 mg",09-10-2025
J1741001003,"Injection, ibuprofen, 100 mg",09-10-2025
J1742001003,"Injection, ibutilide fumarate, 1 mg",09-10-2025
J1743001003,"Injection, idursulfase, 1 mg",09-10-2025
J1744001003,"Injection, icatibant, 1 mg",09-10-2025
J1745001003,"Injection, infliximab, excludes biosimilar, 10 mg",09-10-2025
J1746001003,"Injection, ibalizumab-uiyk, 10 mg",09-10-2025
J1747001003,"Injection, spesolimab-sbzo, 1 mg",09-10-2025
J1748001003,"Injection, infliximab-dyyb (zymfentra), 10 mg",09-10-2025
J1749001003,"Injection, iloprost, 0.1 mcg",09-10-2025
J1750001003,"Injection, iron dextran, 50 mg",09-10-2025
J1756001003,"Injection, iron sucrose, 1 mg",09-10-2025
J1786001003,"Injection, imiglucerase, 10 units",09-10-2025
J1790001003,"Injection, droperidol, up to 5 mg",09-10-2025
J1800001003,"Injection, propranolol hcl, up to 1 mg",09-10-2025
J1805001003,"Injection, esmolol hydrochloride, 10 mg",09-10-2025
J1806001003,"Injection, esmolol hydrochloride (wg critical care), not therapeutically",09-10-2025
J1806002004,"Equivalent to j1805, 10 mg",09-10-2025
J1807001003,"Injection, ethacrynate sodium, 1 mg",09-10-2025
J1808001003,"Injection, folic acid, 0.1 mg",09-10-2025
J1809001003,"Injection, fosdenopterin, 0.1 mg",09-10-2025
J1810001003,"Injection, droperidol and fentanyl citrate, up to 2 ml ampule",09-10-2025
J1811001003,"Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 unit",09-10-2025
J1812001003,"Insulin (fiasp), per 5 units",09-10-2025
J1813001003,"Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50",09-10-2025
J1813002004,Units,09-10-2025
J1814001003,"Insulin (lyumjev), per 5 units",09-10-2025
J1815001003,"Injection, insulin, per 5 units",09-10-2025
J1817001003,"Insulin for administration through dme (i.e., insulin pump) per 50 units",09-10-2025
J1823001003,"Injection, inebilizumab-cdon, 1 mg",09-10-2025
J1826001003,"Injection, interferon beta-1a, 30 mcg",09-10-2025
J1830001003,"Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug",09-10-2025
J1830002004,"Administered under the direct supervision of a physician, not for use when drug",09-10-2025
J1830003004,Is self administered),09-10-2025
J1833001003,"Injection, isavuconazonium, 1 mg",09-10-2025
J1834001003,"Injection, isoniazid, 1 mg",09-10-2025
J1835001003,"Injection, itraconazole, 50 mg",09-10-2025
J1836001003,"Injection, metronidazole, 10 mg",09-10-2025
J1840001003,"Injection, kanamycin sulfate, up to 500 mg",09-10-2025
J1850001003,"Injection, kanamycin sulfate, up to 75 mg",09-10-2025
J1885001003,"Injection, ketorolac tromethamine, per 15 mg",09-10-2025
J1890001003,"Injection, cephalothin sodium, up to 1 gram",09-10-2025
J1920001003,"Injection, labetalol hydrochloride, 5 mg",09-10-2025
J1921001003,"Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to",09-10-2025
J1921002004,"J1920, 5 mg",09-10-2025
J1930001003,"Injection, lanreotide, 1 mg",09-10-2025
J1931001003,"Injection, laronidase, 0.1 mg",09-10-2025
J1932001003,"Injection, lanreotide, (cipla), 1 mg",09-10-2025
J1938001003,"Injection, furosemide, 1 mg",09-10-2025
J1939001003,"Injection, bumetanide, 0.5 mg",09-10-2025
J1940001003,"Injection, furosemide, up to 20 mg",09-10-2025
J1941001003,"Injection, furosemide (furoscix), 20 mg",09-10-2025
J1942001003,"Injection, aripiprazole lauroxil, 1 mg",09-10-2025
J1943001003,"Injection, aripiprazole lauroxil, (aristada initio), 1 mg",09-10-2025
J1944001003,"Injection, aripiprazole lauroxil, (aristada), 1 mg",09-10-2025
J1945001003,"Injection, lepirudin, 50 mg",09-10-2025
J1950001003,"Injection, leuprolide acetate (for depot suspension), per 3.75 mg",09-10-2025
J1951001003,"Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg",09-10-2025
J1952001003,"Leuprolide injectable, camcevi, 1 mg",09-10-2025
J1953001003,"Injection, levetiracetam, 10 mg",09-10-2025
J1954001003,"Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg",09-10-2025
J1955001003,"Injection, levocarnitine, per 1 gm",09-10-2025
J1956001003,"Injection, levofloxacin, 250 mg",09-10-2025
J1960001003,"Injection, levorphanol tartrate, up to 2 mg",09-10-2025
J1961001003,"Injection, lenacapavir (only for use as hiv treatment), 1 mg",09-10-2025
J1980001003,"Injection, hyoscyamine sulfate, up to 0.25 mg",09-10-2025
J1990001003,"Injection, chlordiazepoxide hcl, up to 100 mg",09-10-2025
J2001001003,"Injection, lidocaine hcl for intravenous infusion, 10 mg",09-10-2025
J2002001003,"Injection, lidocaine hcl in 5% dextrose, 1 mg",09-10-2025
J2003001003,"Injection, lidocaine hydrochloride, 1 mg",09-10-2025
J2004001003,"Injection, lidocaine hcl with epinephrine, 1 mg",09-10-2025
J2010001003,"Injection, lincomycin hcl, up to 300 mg",09-10-2025
J2020001003,"Injection, linezolid, 200 mg",09-10-2025
J2021001003,"Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg",09-10-2025
J2060001003,"Injection, lorazepam, 2 mg",09-10-2025
J2062001003,"Loxapine for inhalation, 1 mg",09-10-2025
J2150001003,"Injection, mannitol, 25% in 50 ml",09-10-2025
J2151001003,"Injection, mannitol, 250 mg",09-10-2025
J2170001003,"Injection, mecasermin, 1 mg",09-10-2025
J2175001003,"Injection, meperidine hydrochloride, per 100 mg",09-10-2025
J2180001003,"Injection, meperidine and promethazine hcl, up to 50 mg",09-10-2025
J2182001003,"Injection, mepolizumab, 1 mg",09-10-2025
J2183001003,"Injection, meropenem (wg critical care), not therapeutically equivalent to",09-10-2025
J2183002004,"J2185, 100 mg",09-10-2025
J2184001003,"Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 m",09-10-2025
J2185001003,"Injection, meropenem, 100 mg",09-10-2025
J2186001003,"Injection, meropenem and vaborbactam, 10mg/10mg (20mg)",09-10-2025
J2210001003,"Injection, methylergonovine maleate, up to 0.2 mg",09-10-2025
J2212001003,"Injection, methylnaltrexone, 0.1 mg",09-10-2025
J2246001003,"Injection, micafungin in sodium (baxter), not therapeutically equivalent to",09-10-2025
J2246002004,"J2248, 1 mg",09-10-2025
J2247001003,"Injection, micafungin sodium (par pharm) not thereapeutically equivalent to",09-10-2025
J2247002004,"J2248, 1 mg",09-10-2025
J2248001003,"Injection, micafungin sodium, 1 mg",09-10-2025
J2249001003,"Injection, remimazolam, 1 mg",09-10-2025
J2250001003,"Injection, midazolam hydrochloride, per 1 mg",09-10-2025
J2251001003,"Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically",09-10-2025
J2251002004,"Equivalent to j2250, 1 mg",09-10-2025
J2252001003,"Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically",09-10-2025
J2252002004,"Equivalent to j2250, 1 mg",09-10-2025
J2253001003,"Injection, midazolam (seizalam), 1 mg",09-10-2025
J2260001003,"Injection, milrinone lactate, 5 mg",09-10-2025
J2265001003,"Injection, minocycline hydrochloride, 1 mg",09-10-2025
J2267001003,"Injection, mirikizumab-mrkz, 1 mg",09-10-2025
J2270001003,"Injection, morphine sulfate, up to 10 mg",09-10-2025
J2271001003,"Injection, morphine sulfate, 100mg",09-10-2025
J2272001003,"Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to",09-10-2025
J2272002004,"J2270, up to 10 mg",09-10-2025
J2274001003,"Injection, morphine sulfate, preservative-free for epidural or intrathecal use,",09-10-2025
J2274002004,10 mg,09-10-2025
J2275001003,"Injection, morphine sulfate (preservative-free sterile solution), per 10 mg",09-10-2025
J2277001003,"Injection, motixafortide, 0.25 mg",09-10-2025
J2278001003,"Injection, ziconotide, 1 microgram",09-10-2025
J2280001003,"Injection, moxifloxacin, 100 mg",09-10-2025
J2281001003,"Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to",09-10-2025
J2281002004,"J2280, 100 mg",09-10-2025
J2290001003,"Injection, nafcillin sodium, 20 mg",09-10-2025
J2291001003,"Injection, nafcillin sodium (baxter), 20 mg",09-10-2025
J2300001003,"Injection, nalbuphine hydrochloride, per 10 mg",09-10-2025
J2305001003,"Injection, nitroglycerin, 5 mg",09-10-2025
J2310001003,"Injection, naloxone hydrochloride, per 1 mg",09-10-2025
J2311001003,"Injection, naloxone hydrochloride (zimhi), 1 mg",09-10-2025
J2312001003,"Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg",09-10-2025
J2313001003,"Injection, naloxone hydrochloride (zimhi), 0.01 mg",09-10-2025
J2315001003,"Injection, naltrexone, depot form, 1 mg",09-10-2025
J2320001003,"Injection, nandrolone decanoate, up to 50 mg",09-10-2025
J2323001003,"Injection, natalizumab, 1 mg",09-10-2025
J2325001003,"Injection, nesiritide, 0.1 mg",09-10-2025
J2326001003,"Injection, nusinersen, 0.1 mg",09-10-2025
J2327001003,"Injection, risankizumab-rzaa, intravenous, 1 mg",09-10-2025
J2329001003,"Injection, ublituximab-xiiy, 1mg",09-10-2025
J2350001003,"Injection, ocrelizumab, 1 mg",09-10-2025
J2351001003,"Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq",09-10-2025
J2353001003,"Injection, octreotide, depot form for intramuscular injection, 1 mg",09-10-2025
J2354001003,"Injection, octreotide, non-depot form for subcutaneous or intravenous",09-10-2025
J2354002004,"Injection, 25 mcg",09-10-2025
J2355001003,"Injection, oprelvekin, 5 mg",09-10-2025
J2356001003,"Injection, tezepelumab-ekko, 1 mg",09-10-2025
J2357001003,"Injection, omalizumab, 5 mg",09-10-2025
J2358001003,"Injection, olanzapine, long-acting, 1 mg",09-10-2025
J2359001003,"Injection, olanzapine, 0.5 mg",09-10-2025
J2360001003,"Injection, orphenadrine citrate, up to 60 mg",09-10-2025
J2370001003,"Injection, phenylephrine hcl, up to 1 ml",09-10-2025
J2371001003,"Injection, phenylephrine hydrochloride, 20 micrograms",09-10-2025
J2372001003,"Injection, phenylephrine hydrochloride (biorphen), 20 micrograms",09-10-2025
J2373001003,"Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms",09-10-2025
J2400001003,"Injection, chloroprocaine hydrochloride, per 30 ml",09-10-2025
J2401001003,"Injection, chloroprocaine hydrochloride, per 1 mg",09-10-2025
J2402001003,"Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg",09-10-2025
J2403001003,"Chloroprocaine hcl ophthalmic, 3% gel, 1 mg",09-10-2025
J2404001003,"Injection, nicardipine, 0.1 mg",09-10-2025
J2405001003,"Injection, ondansetron hydrochloride, per 1 mg",09-10-2025
J2406001003,"Injection, oritavancin (kimyrsa), 10 mg",09-10-2025
J2407001003,"Injection, oritavancin (orbactiv), 10 mg",09-10-2025
J2410001003,"Injection, oxymorphone hcl, up to 1 mg",09-10-2025
J2425001003,"Injection, palifermin, 50 micrograms",09-10-2025
J2426001003,"Injection, paliperidone palmitate extended release (invega sustenna), 1 mg",09-10-2025
J2427001003,"Injection, paliperidone palmitate extended release (invega hafyera, or invega",09-10-2025
J2427002004,"Trinza), 1 mg",09-10-2025
J2428001003,"Injection, paliperidone palmitate extended release (erzofri), 1 mg",09-10-2025
J2430001003,"Injection, pamidronate disodium, per 30 mg",09-10-2025
J2440001003,"Injection, papaverine hcl, up to 60 mg",09-10-2025
J2460001003,"Injection, oxytetracycline hcl, up to 50 mg",09-10-2025
J2468001003,"Injection, palonosetron hydrochloride (posfrea), 25 micrograms",09-10-2025
J2469001003,"Injection, palonosetron hcl, 25 mcg",09-10-2025
J2470001003,"Injection, pantoprazole sodium, 40 mg",09-10-2025
J2471001003,"Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg",09-10-2025
J2472001003,"Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg",09-10-2025
J2501001003,"Injection, paricalcitol, 1 mcg",09-10-2025
J2502001003,"Injection, pasireotide long acting, 1 mg",09-10-2025
J2503001003,"Injection, pegaptanib sodium, 0.3 mg",09-10-2025
J2504001003,"Injection, pegademase bovine, 25 iu",09-10-2025
J2505001003,"Injection, pegfilgrastim, 6 mg",09-10-2025
J2506001003,"Injection, pegfilgrastim, excludes biosimilar, 0.5 mg",09-10-2025
J2507001003,"Injection, pegloticase, 1 mg",09-10-2025
J2508001003,"Injection, pegunigalsidase alfa-iwxj, 1 mg",09-10-2025
J2510001003,"Injection, penicillin g procaine, aqueous, up to 600,000 units",09-10-2025
J2513001003,"Injection, pentastarch, 10% solution, 100 ml",09-10-2025
J2515001003,"Injection, pentobarbital sodium, per 50 mg",09-10-2025
J2540001003,"Injection, penicillin g potassium, up to 600,000 units",09-10-2025
J2543001003,"Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125",09-10-2025
J2543002004,Grams),09-10-2025
J2545001003,"Pentamidine isethionate, inhalation solution, fda-approved final product,",09-10-2025
J2545002004,"Non-compounded, administered through dme, unit dose form, per 300 mg",09-10-2025
J2547001003,"Injection, peramivir, 1 mg",09-10-2025
J2550001003,"Injection, promethazine hcl, up to 50 mg",09-10-2025
J2560001003,"Injection, phenobarbital sodium, up to 120 mg",09-10-2025
J2561001003,"Injection, phenobarbital sodium (sezaby), 1 mg",09-10-2025
J2562001003,"Injection, plerixafor, 1 mg",09-10-2025
J2590001003,"Injection, oxytocin, up to 10 units",09-10-2025
J2597001003,"Injection, desmopressin acetate, per 1 mcg",09-10-2025
J2598001003,"Injection, vasopressin, 1 unit",09-10-2025
J2599001003,"Injection, vasopressin (american regent), not therapeutically equivalent to",09-10-2025
J2599002004,"J2598, 1 unit",09-10-2025
J2601001003,"Injection, vasopressin (baxter), 1 unit",09-10-2025
J2650001003,"Injection, prednisolone acetate, up to 1 ml",09-10-2025
J2670001003,"Injection, tolazoline hcl, up to 25 mg",09-10-2025
J2675001003,"Injection, progesterone, per 50 mg",09-10-2025
J2679001003,"Injection, fluphenazine hcl, 1.25 mg",09-10-2025
J2680001003,"Injection, fluphenazine decanoate, up to 25 mg",09-10-2025
J2690001003,"Injection, procainamide hcl, up to 1 gm",09-10-2025
J2700001003,"Injection, oxacillin sodium, up to 250 mg",09-10-2025
J2704001003,"Injection, propofol, 10 mg",09-10-2025
J2710001003,"Injection, neostigmine methylsulfate, up to 0.5 mg",09-10-2025
J2720001003,"Injection, protamine sulfate, per 10 mg",09-10-2025
J2724001003,"Injection, protein c concentrate, intravenous, human, 10 iu",09-10-2025
J2725001003,"Injection, protirelin, per 250 mcg",09-10-2025
J2730001003,"Injection, pralidoxime chloride, up to 1 gm",09-10-2025
J2760001003,"Injection, phentolamine mesylate, up to 5 mg",09-10-2025
J2765001003,"Injection, metoclopramide hcl, up to 10 mg",09-10-2025
J2770001003,"Injection, quinupristin/dalfopristin, 500 mg (150/350)",09-10-2025
J2777001003,"Injection, faricimab-svoa, 0.1 mg",09-10-2025
J2778001003,"Injection, ranibizumab, 0.1 mg",09-10-2025
J2779001003,"Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg",09-10-2025
J2780001003,"Injection, ranitidine hydrochloride, 25 mg",09-10-2025
J2781001003,"Injection, pegcetacoplan, intravitreal, 1 mg",09-10-2025
J2782001003,"Injection, avacincaptad pegol, 0.1 mg",09-10-2025
J2783001003,"Injection, rasburicase, 0.5 mg",09-10-2025
J2785001003,"Injection, regadenoson, 0.1 mg",09-10-2025
J2786001003,"Injection, reslizumab, 1 mg",09-10-2025
J2787001003,"Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml",09-10-2025
J2788001003,"Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)",09-10-2025
J2790001003,"Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)",09-10-2025
J2791001003,"Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or",09-10-2025
J2791002004,"Intravenous, 100 iu",09-10-2025
J2792001003,"Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu",09-10-2025
J2793001003,"Injection, rilonacept, 1 mg",09-10-2025
J2794001003,"Injection, risperidone (risperdal consta), 0.5 mg",09-10-2025
J2795001003,"Injection, ropivacaine hydrochloride, 1 mg",09-10-2025
J2796001003,"Injection, romiplostim, 10 micrograms",09-10-2025
J2797001003,"Injection, rolapitant, 0.5 mg",09-10-2025
J2798001003,"Injection, risperidone, (perseris), 0.5 mg",09-10-2025
J2799001003,"Injection, risperidone (uzedy), 1 mg",09-10-2025
J2800001003,"Injection, methocarbamol, up to 10 ml",09-10-2025
J2801001003,"Injection, risperidone (rykindo), 0.5 mg",09-10-2025
J2802001003,"Injection, romiplostim, 1 microgram",09-10-2025
J2804001003,"Injection, rifampin, 1 mg",09-10-2025
J2805001003,"Injection, sincalide, 5 micrograms",09-10-2025
J2806001003,"Injection, sincalide (maia), not therapeutically equivalent to j2805, 5",09-10-2025
J2806002004,Micrograms,09-10-2025
J2810001003,"Injection, theophylline, per 40 mg",09-10-2025
J2820001003,"Injection, sargramostim (gm-csf), 50 mcg",09-10-2025
J2840001003,"Injection, sebelipase alfa, 1 mg",09-10-2025
J2850001003,"Injection, secretin, synthetic, human, 1 microgram",09-10-2025
J2860001003,"Injection, siltuximab, 10 mg",09-10-2025
J2865001003,"Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg",09-10-2025
J2910001003,"Injection, aurothioglucose, up to 50 mg",09-10-2025
J2916001003,"Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg",09-10-2025
J2919001003,"Injection, methylprednisolone sodium succinate, 5 mg",09-10-2025
J2920001003,"Injection, methylprednisolone sodium succinate, up to 40 mg",09-10-2025
J2930001003,"Injection, methylprednisolone sodium succinate, up to 125 mg",09-10-2025
J2940001003,"Injection, somatrem, 1 mg",09-10-2025
J2941001003,"Injection, somatropin, 1 mg",09-10-2025
J2950001003,"Injection, promazine hcl, up to 25 mg",09-10-2025
J2993001003,"Injection, reteplase, 18.1 mg",09-10-2025
J2995001003,"Injection, streptokinase, per 250,000 iu",09-10-2025
J2997001003,"Injection, alteplase recombinant, 1 mg",09-10-2025
J2998001003,"Injection, plasminogen, human-tvmh, 1 mg",09-10-2025
J3000001003,"Injection, streptomycin, up to 1 gm",09-10-2025
J3010001003,"Injection, fentanyl citrate, 0.1 mg",09-10-2025
J3030001003,"Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug",09-10-2025
J3030002004,"Administered under the direct supervision of a physician, not for use when drug",09-10-2025
J3030003004,Is self administered),09-10-2025
J3031001003,"Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug",09-10-2025
J3031002004,"Administered under the direct supervision of a physician, not for use when drug",09-10-2025
J3031003004,Is self-administered),09-10-2025
J3032001003,"Injection, eptinezumab-jjmr, 1 mg",09-10-2025
J3055001003,"Injection, talquetamab-tgvs, 0.25 mg",09-10-2025
J3060001003,"Injection, taliglucerase alfa, 10 units",09-10-2025
J3070001003,"Injection, pentazocine, 30 mg",09-10-2025
J3090001003,"Injection, tedizolid phosphate, 1 mg",09-10-2025
J3095001003,"Injection, telavancin, 10 mg",09-10-2025
J3101001003,"Injection, tenecteplase, 1 mg",09-10-2025
J3105001003,"Injection, terbutaline sulfate, up to 1 mg",09-10-2025
J3110001003,"Injection, teriparatide, 10 mcg",09-10-2025
J3111001003,"Injection, romosozumab-aqqg, 1 mg",09-10-2025
J3120001003,"Injection, testosterone enanthate, up to 100 mg",09-10-2025
J3121001003,"Injection, testosterone enanthate, 1 mg",09-10-2025
J3130001003,"Injection, testosterone enanthate, up to 200 mg",09-10-2025
J3140001003,"Injection, testosterone suspension, up to 50 mg",09-10-2025
J3145001003,"Injection, testosterone undecanoate, 1 mg",09-10-2025
J3150001003,"Injection, testosterone propionate, up to 100 mg",09-10-2025
J3230001003,"Injection, chlorpromazine hcl, up to 50 mg",09-10-2025
J3240001003,"Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial",09-10-2025
J3241001003,"Injection, teprotumumab-trbw, 10 mg",09-10-2025
J3243001003,"Injection, tigecycline, 1 mg",09-10-2025
J3244001003,"Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg",09-10-2025
J3245001003,"Injection, tildrakizumab, 1 mg",09-10-2025
J3246001003,"Injection, tirofiban hcl, 0.25 mg",09-10-2025
J3247001003,"Injection, secukinumab, intravenous, 1 mg",09-10-2025
J3250001003,"Injection, trimethobenzamide hcl, up to 200 mg",09-10-2025
J3260001003,"Injection, tobramycin sulfate, up to 80 mg",09-10-2025
J3262001003,"Injection, tocilizumab, 1 mg",09-10-2025
J3263001003,"Injection, toripalimab-tpzi, 1 mg",09-10-2025
J3265001003,"Injection, torsemide, 10 mg/ml",09-10-2025
J3280001003,"Injection, thiethylperazine maleate, up to 10 mg",09-10-2025
J3285001003,"Injection, treprostinil, 1 mg",09-10-2025
J3290001003,"Injection, tranexamic acid, 5 mg",09-10-2025
J3299001003,"Injection, triamcinolone acetonide (xipere), 1 mg",09-10-2025
J3300001003,"Injection, triamcinolone acetonide, preservative free, 1 mg",09-10-2025
J3301001003,"Injection, triamcinolone acetonide, not otherwise specified, 10 mg",09-10-2025
J3302001003,"Injection, triamcinolone diacetate, per 5 mg",09-10-2025
J3303001003,"Injection, triamcinolone hexacetonide, per 5 mg",09-10-2025
J3304001003,"Injection, triamcinolone acetonide, preservative-free, extended-release,",09-10-2025
J3304002004,"Microsphere formulation, 1 mg",09-10-2025
J3305001003,"Injection, trimetrexate glucuronate, per 25 mg",09-10-2025
J3310001003,"Injection, perphenazine, up to 5 mg",09-10-2025
J3315001003,"Injection, triptorelin pamoate, 3.75 mg",09-10-2025
J3316001003,"Injection, triptorelin, extended-release, 3.75 mg",09-10-2025
J3320001003,"Injection, spectinomycin dihydrochloride, up to 2 gm",09-10-2025
J3350001003,"Injection, urea, up to 40 gm",09-10-2025
J3355001003,"Injection, urofollitropin, 75 iu",09-10-2025
J3357001003,"Ustekinumab, for subcutaneous injection, 1 mg",09-10-2025
J3358001003,"Ustekinumab, for intravenous injection, 1 mg",09-10-2025
J3360001003,"Injection, diazepam, up to 5 mg",09-10-2025
J3364001003,"Injection, urokinase, 5000 iu vial",09-10-2025
J3365001003,"Injection, iv, urokinase, 250,000 i.u. vial",09-10-2025
J3370001003,"Injection, vancomycin hcl, 500 mg",09-10-2025
J3371001003,"Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500",09-10-2025
J3371002004,Mg,09-10-2025
J3372001003,"Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370,",09-10-2025
J3372002004,500 mg,09-10-2025
J3373001003,"Injection, vancomycin hydrochloride, 10 mg",09-10-2025
J3374001003,"Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to",09-10-2025
J3374002004,"J3373, 10 mg",09-10-2025
J3375001003,"Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to",09-10-2025
J3375002004,"J3373, 10 mg",09-10-2025
J3380001003,"Injection, vedolizumab, intravenous, 1 mg",09-10-2025
J3385001003,"Injection, velaglucerase alfa, 100 units",09-10-2025
J3391001003,"Injection, atidarsagene autotemcel, per treatment",09-10-2025
J3392001003,"Injection, exagamglogene autotemcel, per treatment",09-10-2025
J3393001003,"Injection, betibeglogene autotemcel, per treatment",09-10-2025
J3394001003,"Injection, lovotibeglogene autotemcel, per treatment",09-10-2025
J3396001003,"Injection, verteporfin, 0.1 mg",09-10-2025
J3397001003,"Injection, vestronidase alfa-vjbk, 1 mg",09-10-2025
J3398001003,"Injection, voretigene neparvovec-rzyl, 1 billion vector genomes",09-10-2025
J3399001003,"Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector",09-10-2025
J3399002004,Genomes,09-10-2025
J3400001003,"Injection, triflupromazine hcl, up to 20 mg",09-10-2025
J3401001003,"Beremagene geperpavec-svdt for topical administration, containing nominal 5 x",09-10-2025
J3401002004,"10^9 pfu/ml vector genomes, per 0.1 ml",09-10-2025
J3402001003,"Injection, remestemcel-l-rknd, per therapeutic dose",09-10-2025
J3403001003,"Revakinagene taroretcel-lwey, per implant",09-10-2025
J3410001003,"Injection, hydroxyzine hcl, up to 25 mg",09-10-2025
J3411001003,"Injection, thiamine hcl, 100 mg",09-10-2025
J3415001003,"Injection, pyridoxine hcl, 100 mg",09-10-2025
J3420001003,"Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg",09-10-2025
J3424001003,"Injection, hydroxocobalamin, intravenous, 25 mg",09-10-2025
J3425001003,"Injection, hydroxocobalamin, intramuscular, 10 mcg",09-10-2025
J3430001003,"Injection, phytonadione (vitamin k), per 1 mg",09-10-2025
J3465001003,"Injection, voriconazole, 10 mg",09-10-2025
J3470001003,"Injection, hyaluronidase, up to 150 units",09-10-2025
J3471001003,"Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999",09-10-2025
J3471002004,Usp units),09-10-2025
J3472001003,"Injection, hyaluronidase, ovine, preservative free, per 1000 usp units",09-10-2025
J3473001003,"Injection, hyaluronidase, recombinant, 1 usp unit",09-10-2025
J3475001003,"Injection, magnesium sulfate, per 500 mg",09-10-2025
J3480001003,"Injection, potassium chloride, per 2 meq",09-10-2025
J3485001003,"Injection, zidovudine, 10 mg",09-10-2025
J3486001003,"Injection, ziprasidone mesylate, 10 mg",09-10-2025
J3489001003,"Injection, zoledronic acid, 1 mg",09-10-2025
J3490001003,Unclassified drugs,09-10-2025
J3520001003,"Edetate disodium, per 150 mg",09-10-2025
J3530001003,Nasal vaccine inhalation,09-10-2025
J3535001003,Drug administered through a metered dose inhaler,09-10-2025
J3570001003,"Laetrile, amygdalin, vitamin b17",09-10-2025
J3590001003,Unclassified biologics,09-10-2025
J3591001003,Unclassified drug or biological used for esrd on dialysis,09-10-2025
J7030001003,"Infusion, normal saline solution , 1000 cc",09-10-2025
J7040001003,"Infusion, normal saline solution, sterile (500 ml = 1 unit)",09-10-2025
J7042001003,5% dextrose/normal saline (500 ml = 1 unit),09-10-2025
J7050001003,"Infusion, normal saline solution, 250 cc",09-10-2025
J7060001003,5% dextrose/water (500 ml = 1 unit),09-10-2025
J7070001003,"Infusion, d5w, 1000 cc",09-10-2025
J7100001003,"Infusion, dextran 40, 500 ml",09-10-2025
J7110001003,"Infusion, dextran 75, 500 ml",09-10-2025
J7120001003,"Ringers lactate infusion, up to 1000 cc",09-10-2025
J7121001003,"5% dextrose in lactated ringers infusion, up to 1000 cc",09-10-2025
J7131001003,"Hypertonic saline solution, 1 ml",09-10-2025
J7165001003,"Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix",09-10-2025
J7165002004,Activity,09-10-2025
J7168001003,"Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activit",09-10-2025
J7169001003,"Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10",09-10-2025
J7169002004,Mg,09-10-2025
J7170001003,"Injection, emicizumab-kxwh, 0.5 mg",09-10-2025
J7171001003,"Injection, adamts13, recombinant-krhn, 10 iu",09-10-2025
J7172001003,"Injection, marstacimab-hncq, 0.5 mg",09-10-2025
J7173001003,"Injection, concizumab-mtci, 0.5 mg",09-10-2025
J7174001003,"Injection, fitusiran, 0.04 mg",09-10-2025
J7175001003,"Injection, factor x, (human), 1 i.u.",09-10-2025
J7177001003,"Injection, human fibrinogen concentrate (fibryga), 1 mg",09-10-2025
J7178001003,"Injection, human fibrinogen concentrate, not otherwise specified, 1 mg",09-10-2025
J7179001003,"Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco",09-10-2025
J7180001003,"Injection, factor xiii (antihemophilic factor, human), 1 i.u.",09-10-2025
J7181001003,"Injection, factor xiii a-subunit, (recombinant), per iu",09-10-2025
J7182001003,"Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per",09-10-2025
J7182002004,Iu,09-10-2025
J7183001003,"Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco",09-10-2025
J7185001003,"Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.",09-10-2025
J7186001003,"Injection, antihemophilic factor viii/von willebrand factor complex (human),",09-10-2025
J7186002004,Per factor viii i.u.,09-10-2025
J7187001003,"Injection, von willebrand factor complex (humate-p), per iu vwf:rco",09-10-2025
J7188001003,"Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.",09-10-2025
J7189001003,"Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram",09-10-2025
J7190001003,"Factor viii (antihemophilic factor, human) per i.u.",09-10-2025
J7191001003,"Factor viii (antihemophilic factor (porcine)), per i.u.",09-10-2025
J7192001003,"Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise",09-10-2025
J7192002004,Specified,09-10-2025
J7193001003,"Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.",09-10-2025
J7194001003,"Factor ix, complex, per i.u.",09-10-2025
J7195001003,"Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise",09-10-2025
J7195002004,Specified,09-10-2025
J7196001003,"Injection, antithrombin recombinant, 50 i.u.",09-10-2025
J7197001003,"Antithrombin iii (human), per i.u.",09-10-2025
J7198001003,"Anti-inhibitor, per i.u.",09-10-2025
J7199001003,"Hemophilia clotting factor, not otherwise classified",09-10-2025
J7200001003,"Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu",09-10-2025
J7201001003,"Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.",09-10-2025
J7202001003,"Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.",09-10-2025
J7203001003,"Injection factor ix, (antihemophilic factor, recombinant), glycopegylated,",09-10-2025
J7203002004,"(rebinyn), 1 iu",09-10-2025
J7204001003,"Injection, factor viii, antihemophilic factor (recombinant), (esperoct),",09-10-2025
J7204002004,"Glycopegylated-exei, per iu",09-10-2025
J7205001003,"Injection, factor viii fc fusion protein (recombinant), per iu",09-10-2025
J7207001003,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.",09-10-2025
J7208001003,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl,",09-10-2025
J7208002004,"(jivi), 1 i.u.",09-10-2025
J7209001003,"Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.",09-10-2025
J7210001003,"Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.",09-10-2025
J7211001003,"Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u",09-10-2025
J7212001003,"Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram",09-10-2025
J7213001003,"Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.",09-10-2025
J7214001003,"Injection, factor viii/von willebrand factor complex, recombinant (altuviiio),",09-10-2025
J7214002004,Per factor viii i.u.,09-10-2025
J7294001003,"Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly",09-10-2025
J7294002004,"Vaginal system, each",09-10-2025
J7295001003,"Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly",09-10-2025
J7295002004,"Vaginal ring, each",09-10-2025
J7296001003,"Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg",09-10-2025
J7297001003,"Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg",09-10-2025
J7298001003,"Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg",09-10-2025
J7300001003,Intrauterine copper contraceptive (paragard),09-10-2025
J7301001003,"Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg",09-10-2025
J7302001003,"Levonorgestrel-releasing intrauterine contraceptive system, 52 mg",09-10-2025
J7303001003,"Contraceptive supply, hormone containing vaginal ring, each",09-10-2025
J7304001003,"Contraceptive supply, hormone containing patch, each",09-10-2025
J7306001003,"Levonorgestrel (contraceptive) implant system, including implants and supplies",09-10-2025
J7307001003,"Etonogestrel (contraceptive) implant system, including implant and supplies",09-10-2025
J7308001003,"Aminolevulinic acid hcl for topical administration, 20%, single unit dosage",09-10-2025
J7308002004,Form (354 mg),09-10-2025
J7309001003,"Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram",09-10-2025
J7310001003,"Ganciclovir, 4.5 mg, long-acting implant",09-10-2025
J7311001003,"Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg",09-10-2025
J7312001003,"Injection, dexamethasone, intravitreal implant, 0.1 mg",09-10-2025
J7313001003,"Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg",09-10-2025
J7314001003,"Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg",09-10-2025
J7315001003,"Mitomycin, ophthalmic, 0.2 mg",09-10-2025
J7316001003,"Injection, ocriplasmin, 0.125 mg",09-10-2025
J7318001003,"Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg",09-10-2025
J7320001003,"Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg",09-10-2025
J7321001003,"Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular",09-10-2025
J7321002004,"Injection, per dose",09-10-2025
J7322001003,"Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg",09-10-2025
J7323001003,"Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose",09-10-2025
J7324001003,"Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose",09-10-2025
J7325001003,"Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular",09-10-2025
J7325002004,"Injection, 1 mg",09-10-2025
J7326001003,"Hyaluronan or derivative, gel-one, for intra-articular injection, per dose",09-10-2025
J7327001003,"Hyaluronan or derivative, monovisc, for intra-articular injection, per dose",09-10-2025
J7328001003,"Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg",09-10-2025
J7329001003,"Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg",09-10-2025
J7330001003,"Autologous cultured chondrocytes, implant",09-10-2025
J7331001003,"Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg",09-10-2025
J7332001003,"Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg",09-10-2025
J7333001003,"Hyaluronan or derivative, visco-3, for intra-articular injection, per dose",09-10-2025
J7335001003,"Capsaicin 8% patch, per 10 square centimeters",09-10-2025
J7336001003,"Capsaicin 8% patch, per square centimeter",09-10-2025
J7340001003,"Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml",09-10-2025
J7342001003,"Instillation, ciprofloxacin otic suspension, 6 mg",09-10-2025
J7345001003,"Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg",09-10-2025
J7351001003,"Injection, bimatoprost, intracameral implant, 1 microgram",09-10-2025
J7352001003,"Afamelanotide implant, 1 mg",09-10-2025
J7353001003,"Anacaulase-bcdb, 8.8% gel, 1 gram",09-10-2025
J7354001003,"Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2",09-10-2025
J7354002004,Mg),09-10-2025
J7355001003,"Injection, travoprost, intracameral implant, 1 microgram",09-10-2025
J7356001003,"Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg",09-10-2025
J7401001003,"Mometasone furoate sinus implant, 10 micrograms",09-10-2025
J7402001003,"Mometasone furoate sinus implant, (sinuva), 10 micrograms",09-10-2025
J7500001003,"Azathioprine, oral, 50 mg",09-10-2025
J7501001003,"Azathioprine, parenteral, 100 mg",09-10-2025
J7502001003,"Cyclosporine, oral, 100 mg",09-10-2025
J7503001003,"Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg",09-10-2025
J7504001003,"Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg",09-10-2025
J7505001003,"Muromonab-cd3, parenteral, 5 mg",09-10-2025
J7506001003,"Prednisone, oral, per 5 mg",09-10-2025
J7507001003,"Tacrolimus, immediate release, oral, 1 mg",09-10-2025
J7508001003,"Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg",09-10-2025
J7509001003,"Methylprednisolone oral, per 4 mg",09-10-2025
J7510001003,"Prednisolone oral, per 5 mg",09-10-2025
J7511001003,"Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg",09-10-2025
J7512001003,"Prednisone, immediate release or delayed release, oral, 1 mg",09-10-2025
J7513001003,"Daclizumab, parenteral, 25 mg",09-10-2025
J7514001003,"Mycophenolate mofetil (myhibbin), oral suspension, 100 mg",09-10-2025
J7515001003,"Cyclosporine, oral, 25 mg",09-10-2025
J7516001003,"Injection, cyclosporine, 250 mg",09-10-2025
J7517001003,"Mycophenolate mofetil, oral, 250 mg",09-10-2025
J7518001003,"Mycophenolic acid, oral, 180 mg",09-10-2025
J7519001003,"Injection, mycophenolate mofetil, 10 mg",09-10-2025
J7520001003,"Sirolimus, oral, 1 mg",09-10-2025
J7521001003,"Tacrolimus, granules, oral suspension, 0.1 mg",09-10-2025
J7525001003,"Tacrolimus, parenteral, 5 mg",09-10-2025
J7527001003,"Everolimus, oral, 0.25 mg",09-10-2025
J7599001003,"Immunosuppressive drug, not otherwise classified",09-10-2025
J7601001003,"Ensifentrine, inhalation suspension, fda approved final product,",09-10-2025
J7601002004,"Non-compounded, administered through dme, unit dose form, 3 mg",09-10-2025
J7604001003,"Acetylcysteine, inhalation solution, compounded product, administered through",09-10-2025
J7604002004,"Dme, unit dose form, per gram",09-10-2025
J7605001003,"Arformoterol, inhalation solution, fda approved final product, non-compounded,",09-10-2025
J7605002004,"Administered through dme, unit dose form, 15 micrograms",09-10-2025
J7606001003,"Formoterol fumarate, inhalation solution, fda approved final product,",09-10-2025
J7606002004,"Non-compounded, administered through dme, unit dose form, 20 micrograms",09-10-2025
J7607001003,"Levalbuterol, inhalation solution, compounded product, administered through",09-10-2025
J7607002004,"Dme, concentrated form, 0.5 mg",09-10-2025
J7608001003,"Acetylcysteine, inhalation solution, fda-approved final product,",09-10-2025
J7608002004,"Non-compounded, administered through dme, unit dose form, per gram",09-10-2025
J7609001003,"Albuterol, inhalation solution, compounded product, administered through dme,",09-10-2025
J7609002004,"Unit dose, 1 mg",09-10-2025
J7610001003,"Albuterol, inhalation solution, compounded product, administered through dme,",09-10-2025
J7610002004,"Concentrated form, 1 mg",09-10-2025
J7611001003,"Albuterol, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7611002004,"Administered through dme, concentrated form, 1 mg",09-10-2025
J7612001003,"Levalbuterol, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7612002004,"Administered through dme, concentrated form, 0.5 mg",09-10-2025
J7613001003,"Albuterol, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7613002004,"Administered through dme, unit dose, 1 mg",09-10-2025
J7614001003,"Levalbuterol, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7614002004,"Administered through dme, unit dose, 0.5 mg",09-10-2025
J7615001003,"Levalbuterol, inhalation solution, compounded product, administered through",09-10-2025
J7615002004,"Dme, unit dose, 0.5 mg",09-10-2025
J7620001003,"Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved",09-10-2025
J7620002004,"Final product, non-compounded, administered through dme",09-10-2025
J7622001003,"Beclomethasone, inhalation solution, compounded product, administered through",09-10-2025
J7622002004,"Dme, unit dose form, per milligram",09-10-2025
J7624001003,"Betamethasone, inhalation solution, compounded product, administered through",09-10-2025
J7624002004,"Dme, unit dose form, per milligram",09-10-2025
J7626001003,"Budesonide, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7626002004,"Administered through dme, unit dose form, up to 0.5 mg",09-10-2025
J7627001003,"Budesonide, inhalation solution, compounded product, administered through dme,",09-10-2025
J7627002004,"Unit dose form, up to 0.5 mg",09-10-2025
J7628001003,"Bitolterol mesylate, inhalation solution, compounded product, administered",09-10-2025
J7628002004,"Through dme, concentrated form, per milligram",09-10-2025
J7629001003,"Bitolterol mesylate, inhalation solution, compounded product, administered",09-10-2025
J7629002004,"Through dme, unit dose form, per milligram",09-10-2025
J7631001003,"Cromolyn sodium, inhalation solution, fda-approved final product,",09-10-2025
J7631002004,"Non-compounded, administered through dme, unit dose form, per 10 milligrams",09-10-2025
J7632001003,"Cromolyn sodium, inhalation solution, compounded product, administered through",09-10-2025
J7632002004,"Dme, unit dose form, per 10 milligrams",09-10-2025
J7633001003,"Budesonide, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7633002004,"Administered through dme, concentrated form, per 0.25 milligram",09-10-2025
J7634001003,"Budesonide, inhalation solution, compounded product, administered through dme,",09-10-2025
J7634002004,"Concentrated form, per 0.25 milligram",09-10-2025
J7635001003,"Atropine, inhalation solution, compounded product, administered through dme,",09-10-2025
J7635002004,"Concentrated form, per milligram",09-10-2025
J7636001003,"Atropine, inhalation solution, compounded product, administered through dme,",09-10-2025
J7636002004,"Unit dose form, per milligram",09-10-2025
J7637001003,"Dexamethasone, inhalation solution, compounded product, administered through",09-10-2025
J7637002004,"Dme, concentrated form, per milligram",09-10-2025
J7638001003,"Dexamethasone, inhalation solution, compounded product, administered through",09-10-2025
J7638002004,"Dme, unit dose form, per milligram",09-10-2025
J7639001003,"Dornase alfa, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7639002004,"Administered through dme, unit dose form, per milligram",09-10-2025
J7640001003,"Formoterol, inhalation solution, compounded product, administered through dme,",09-10-2025
J7640002004,"Unit dose form, 12 micrograms",09-10-2025
J7641001003,"Flunisolide, inhalation solution, compounded product, administered through dme,",09-10-2025
J7641002004,"Unit dose, per milligram",09-10-2025
J7642001003,"Glycopyrrolate, inhalation solution, compounded product, administered through",09-10-2025
J7642002004,"Dme, concentrated form, per milligram",09-10-2025
J7643001003,"Glycopyrrolate, inhalation solution, compounded product, administered through",09-10-2025
J7643002004,"Dme, unit dose form, per milligram",09-10-2025
J7644001003,"Ipratropium bromide, inhalation solution, fda-approved final product,",09-10-2025
J7644002004,"Non-compounded, administered through dme, unit dose form, per milligram",09-10-2025
J7645001003,"Ipratropium bromide, inhalation solution, compounded product, administered",09-10-2025
J7645002004,"Through dme, unit dose form, per milligram",09-10-2025
J7647001003,"Isoetharine hcl, inhalation solution, compounded product, administered through",09-10-2025
J7647002004,"Dme, concentrated form, per milligram",09-10-2025
J7648001003,"Isoetharine hcl, inhalation solution, fda-approved final product,",09-10-2025
J7648002004,"Non-compounded, administered through dme, concentrated form, per milligram",09-10-2025
J7649001003,"Isoetharine hcl, inhalation solution, fda-approved final product,",09-10-2025
J7649002004,"Non-compounded, administered through dme, unit dose form, per milligram",09-10-2025
J7650001003,"Isoetharine hcl, inhalation solution, compounded product, administered through",09-10-2025
J7650002004,"Dme, unit dose form, per milligram",09-10-2025
J7657001003,"Isoproterenol hcl, inhalation solution, compounded product, administered",09-10-2025
J7657002004,"Through dme, concentrated form, per milligram",09-10-2025
J7658001003,"Isoproterenol hcl, inhalation solution, fda-approved final product,",09-10-2025
J7658002004,"Non-compounded, administered through dme, concentrated form, per milligram",09-10-2025
J7659001003,"Isoproterenol hcl, inhalation solution, fda-approved final product,",09-10-2025
J7659002004,"Non-compounded, administered through dme, unit dose form, per milligram",09-10-2025
J7660001003,"Isoproterenol hcl, inhalation solution, compounded product, administered",09-10-2025
J7660002004,"Through dme, unit dose form, per milligram",09-10-2025
J7665001003,"Mannitol, administered through an inhaler, 5 mg",09-10-2025
J7667001003,"Metaproterenol sulfate, inhalation solution, compounded product, concentrated",09-10-2025
J7667002004,"Form, per 10 milligrams",09-10-2025
J7668001003,"Metaproterenol sulfate, inhalation solution, fda-approved final product,",09-10-2025
J7668002004,"Non-compounded, administered through dme, concentrated form, per 10 milligrams",09-10-2025
J7669001003,"Metaproterenol sulfate, inhalation solution, fda-approved final product,",09-10-2025
J7669002004,"Non-compounded, administered through dme, unit dose form, per 10 milligrams",09-10-2025
J7670001003,"Metaproterenol sulfate, inhalation solution, compounded product, administered",09-10-2025
J7670002004,"Through dme, unit dose form, per 10 milligrams",09-10-2025
J7674001003,"Methacholine chloride administered as inhalation solution through a nebulizer,",09-10-2025
J7674002004,Per 1 mg,09-10-2025
J7676001003,"Pentamidine isethionate, inhalation solution, compounded product, administered",09-10-2025
J7676002004,"Through dme, unit dose form, per 300 mg",09-10-2025
J7677001003,"Revefenacin inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7677002004,"Administered through dme, 1 microgram",09-10-2025
J7680001003,"Terbutaline sulfate, inhalation solution, compounded product, administered",09-10-2025
J7680002004,"Through dme, concentrated form, per milligram",09-10-2025
J7681001003,"Terbutaline sulfate, inhalation solution, compounded product, administered",09-10-2025
J7681002004,"Through dme, unit dose form, per milligram",09-10-2025
J7682001003,"Tobramycin, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7682002004,"Unit dose form, administered through dme, per 300 milligrams",09-10-2025
J7683001003,"Triamcinolone, inhalation solution, compounded product, administered through",09-10-2025
J7683002004,"Dme, concentrated form, per milligram",09-10-2025
J7684001003,"Triamcinolone, inhalation solution, compounded product, administered through",09-10-2025
J7684002004,"Dme, unit dose form, per milligram",09-10-2025
J7685001003,"Tobramycin, inhalation solution, compounded product, administered through dme,",09-10-2025
J7685002004,"Unit dose form, per 300 milligrams",09-10-2025
J7686001003,"Treprostinil, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
J7686002004,"Administered through dme, unit dose form, 1.74 mg",09-10-2025
J7699001003,"Noc drugs, inhalation solution administered through dme",09-10-2025
J7799001003,"Noc drugs, other than inhalation drugs, administered through dme",09-10-2025
J7999001003,"Compounded drug, not otherwise classified",09-10-2025
J8498001003,"Antiemetic drug, rectal/suppository, not otherwise specified",09-10-2025
J8499001003,"Prescription drug, oral, non chemotherapeutic, nos",09-10-2025
J8501001003,"Aprepitant, oral, 5 mg",09-10-2025
J8510001003,"Busulfan; oral, 2 mg",09-10-2025
J8515001003,"Cabergoline, oral, 0.25 mg",09-10-2025
J8520001003,"Capecitabine, oral, 150 mg",09-10-2025
J8521001003,"Capecitabine, oral, 500 mg",09-10-2025
J8522001003,"Capecitabine, oral, 50 mg",09-10-2025
J8530001003,"Cyclophosphamide; oral, 25 mg",09-10-2025
J8540001003,"Dexamethasone, oral, 0.25 mg",09-10-2025
J8541001003,"Dexamethasone (hemady), oral, 0.25 mg",09-10-2025
J8560001003,"Etoposide; oral, 50 mg",09-10-2025
J8562001003,"Fludarabine phosphate, oral, 10 mg",09-10-2025
J8565001003,"Gefitinib, oral, 250 mg",09-10-2025
J8597001003,"Antiemetic drug, oral, not otherwise specified",09-10-2025
J8600001003,"Melphalan; oral, 2 mg",09-10-2025
J8610001003,"Methotrexate; oral, 2.5 mg",09-10-2025
J8611001003,"Methotrexate (jylamvo), oral, 2.5 mg",09-10-2025
J8612001003,"Methotrexate (xatmep), oral, 2.5 mg",09-10-2025
J8650001003,"Nabilone, oral, 1 mg",09-10-2025
J8655001003,"Netupitant 300 mg and palonosetron 0.5 mg, oral",09-10-2025
J8670001003,"Rolapitant, oral, 1 mg",09-10-2025
J8700001003,"Temozolomide, oral, 5 mg",09-10-2025
J8705001003,"Topotecan, oral, 0.25 mg",09-10-2025
J8999001003,"Prescription drug, oral, chemotherapeutic, nos",09-10-2025
J9000001003,"Injection, doxorubicin hydrochloride, 10 mg",09-10-2025
J9010001003,"Injection, alemtuzumab, 10 mg",09-10-2025
J9011001003,"Injection, datopotamab deruxtecan-dlnk, 1 mg",09-10-2025
J9015001003,"Injection, aldesleukin, per single use vial",09-10-2025
J9017001003,"Injection, arsenic trioxide, 1 mg",09-10-2025
J9019001003,"Injection, asparaginase (erwinaze), 1,000 iu",09-10-2025
J9020001003,"Injection, asparaginase, not otherwise specified, 10,000 units",09-10-2025
J9021001003,"Injection, asparaginase, recombinant, (rylaze), 0.1 mg",09-10-2025
J9022001003,"Injection, atezolizumab, 10 mg",09-10-2025
J9023001003,"Injection, avelumab, 10 mg",09-10-2025
J9024001003,"Injection, atezolizumab, 5 mg and hyaluronidase-tqjs",09-10-2025
J9025001003,"Injection, azacitidine, 1 mg",09-10-2025
J9026001003,"Injection, tarlatamab-dlle, 1 mg",09-10-2025
J9027001003,"Injection, clofarabine, 1 mg",09-10-2025
J9028001003,"Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram",09-10-2025
J9029001003,"Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose",09-10-2025
J9030001003,"Bcg live intravesical instillation, 1 mg",09-10-2025
J9031001003,Bcg (intravesical) per instillation,09-10-2025
J9032001003,"Injection, belinostat, 10 mg",09-10-2025
J9033001003,"Injection, bendamustine hydrochloride, 1 mg",09-10-2025
J9034001003,"Injection, bendamustine hcl (bendeka), 1 mg",09-10-2025
J9035001003,"Injection, bevacizumab, 10 mg",09-10-2025
J9036001003,"Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg",09-10-2025
J9037001003,"Injection, belantamab mafodotin-blmf, 0.5 mg",09-10-2025
J9038001003,"Injection, axatilimab-csfr, 0.1 mg",09-10-2025
J9039001003,"Injection, blinatumomab, 1 microgram",09-10-2025
J9040001003,"Injection, bleomycin sulfate, 15 units",09-10-2025
J9041001003,"Injection, bortezomib, 0.1 mg",09-10-2025
J9042001003,"Injection, brentuximab vedotin, 1 mg",09-10-2025
J9043001003,"Injection, cabazitaxel, 1 mg",09-10-2025
J9044001003,"Injection, bortezomib, not otherwise specified, 0.1 mg",09-10-2025
J9045001003,"Injection, carboplatin, 50 mg",09-10-2025
J9046001003,"Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041,",09-10-2025
J9046002004,0.1 mg,09-10-2025
J9047001003,"Injection, carfilzomib, 1 mg",09-10-2025
J9048001003,"Injection, bortezomib (fresenius kabi), not therapeutically equivalent to",09-10-2025
J9048002004,"J9041, 0.1 mg",09-10-2025
J9049001003,"Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 m",09-10-2025
J9050001003,"Injection, carmustine, 100 mg",09-10-2025
J9051001003,"Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg",09-10-2025
J9052001003,"Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg",09-10-2025
J9054001003,"Injection, bortezomib (boruzu), 0.1 mg",09-10-2025
J9055001003,"Injection, cetuximab, 10 mg",09-10-2025
J9056001003,"Injection, bendamustine hydrochloride (vivimusta), 1 mg",09-10-2025
J9057001003,"Injection, copanlisib, 1 mg",09-10-2025
J9058001003,"Injection, bendamustine hydrochloride (apotex), 1 mg",09-10-2025
J9059001003,"Injection, bendamustine hydrochloride (baxter), 1 mg",09-10-2025
J9060001003,"Injection, cisplatin, powder or solution, 10 mg",09-10-2025
J9061001003,"Injection, amivantamab-vmjw, 2 mg",09-10-2025
J9063001003,"Injection, mirvetuximab soravtansine-gynx, 1 mg",09-10-2025
J9064001003,"Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg",09-10-2025
J9065001003,"Injection, cladribine, per 1 mg",09-10-2025
J9070001003,"Cyclophosphamide, 100 mg",09-10-2025
J9071001003,"Injection, cyclophosphamide (auromedics), 5 mg",09-10-2025
J9072001003,"Injection, cyclophosphamide (frindovyx), 5 mg",09-10-2025
J9073001003,"Injection, cyclophosphamide (dr. reddy's), 5 mg",09-10-2025
J9074001003,"Injection, cyclophosphamide (sandoz), 5 mg",09-10-2025
J9075001003,"Injection, cyclophosphamide, not otherwise specified, 5 mg",09-10-2025
J9076001003,"Injection, cyclophosphamide (baxter), 5 mg",09-10-2025
J9098001003,"Injection, cytarabine liposome, 10 mg",09-10-2025
J9100001003,"Injection, cytarabine, 100 mg",09-10-2025
J9118001003,"Injection, calaspargase pegol-mknl, 10 units",09-10-2025
J9119001003,"Injection, cemiplimab-rwlc, 1 mg",09-10-2025
J9120001003,"Injection, dactinomycin, 0.5 mg",09-10-2025
J9130001003,"Dacarbazine, 100 mg",09-10-2025
J9144001003,"Injection, daratumumab, 10 mg and hyaluronidase-fihj",09-10-2025
J9145001003,"Injection, daratumumab, 10 mg",09-10-2025
J9150001003,"Injection, daunorubicin, 10 mg",09-10-2025
J9151001003,"Injection, daunorubicin citrate, liposomal formulation, 10 mg",09-10-2025
J9153001003,"Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine",09-10-2025
J9155001003,"Injection, degarelix, 1 mg",09-10-2025
J9160001003,"Injection, denileukin diftitox, 300 micrograms",09-10-2025
J9161001003,"Injection, denileukin diftitox-cxdl, 1 mcg",09-10-2025
J9165001003,"Injection, diethylstilbestrol diphosphate, 250 mg",09-10-2025
J9171001003,"Injection, docetaxel, 1 mg",09-10-2025
J9172001003,"Injection, docetaxel (docivyx), 1 mg",09-10-2025
J9173001003,"Injection, durvalumab, 10 mg",09-10-2025
J9174001003,"Injection, docetaxel (beizray), 1 mg",09-10-2025
J9175001003,"Injection, elliotts' b solution, 1 ml",09-10-2025
J9176001003,"Injection, elotuzumab, 1 mg",09-10-2025
J9177001003,"Injection, enfortumab vedotin-ejfv, 0.25 mg",09-10-2025
J9178001003,"Injection, epirubicin hcl, 2 mg",09-10-2025
J9179001003,"Injection, eribulin mesylate, 0.1 mg",09-10-2025
J9181001003,"Injection, etoposide, 10 mg",09-10-2025
J9185001003,"Injection, fludarabine phosphate, 50 mg",09-10-2025
J9190001003,"Injection, fluorouracil, 500 mg",09-10-2025
J9196001003,"Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent",09-10-2025
J9196002004,"To j9201, 200 mg",09-10-2025
J9198001003,"Injection, gemcitabine hydrochloride, (infugem), 100 mg",09-10-2025
J9199001003,"Injection, gemcitabine hydrochloride (infugem), 200 mg",09-10-2025
J9200001003,"Injection, floxuridine, 500 mg",09-10-2025
J9201001003,"Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg",09-10-2025
J9202001003,"Goserelin acetate implant, per 3.6 mg",09-10-2025
J9203001003,"Injection, gemtuzumab ozogamicin, 0.1 mg",09-10-2025
J9204001003,"Injection, mogamulizumab-kpkc, 1 mg",09-10-2025
J9205001003,"Injection, irinotecan liposome, 1 mg",09-10-2025
J9206001003,"Injection, irinotecan, 20 mg",09-10-2025
J9207001003,"Injection, ixabepilone, 1 mg",09-10-2025
J9208001003,"Injection, ifosfamide, 1 gram",09-10-2025
J9209001003,"Injection, mesna, 200 mg",09-10-2025
J9210001003,"Injection, emapalumab-lzsg, 1 mg",09-10-2025
J9211001003,"Injection, idarubicin hydrochloride, 5 mg",09-10-2025
J9212001003,"Injection, interferon alfacon-1, recombinant, 1 microgram",09-10-2025
J9213001003,"Injection, interferon, alfa-2a, recombinant, 3 million units",09-10-2025
J9214001003,"Injection, interferon, alfa-2b, recombinant, 1 million units",09-10-2025
J9215001003,"Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu",09-10-2025
J9216001003,"Injection, interferon, gamma 1-b, 3 million units",09-10-2025
J9217001003,"Leuprolide acetate (for depot suspension), 7.5 mg",09-10-2025
J9218001003,"Leuprolide acetate, per 1 mg",09-10-2025
J9219001003,"Leuprolide acetate implant, 65 mg",09-10-2025
J9220001003,"Injection, indigotindisulfonate sodium, 1 mg",09-10-2025
J9223001003,"Injection, lurbinectedin, 0.1 mg",09-10-2025
J9225001003,"Histrelin implant (vantas), 50 mg",09-10-2025
J9226001003,"Histrelin implant (supprelin la), 50 mg",09-10-2025
J9227001003,"Injection, isatuximab-irfc, 10 mg",09-10-2025
J9228001003,"Injection, ipilimumab, 1 mg",09-10-2025
J9229001003,"Injection, inotuzumab ozogamicin, 0.1 mg",09-10-2025
J9230001003,"Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg",09-10-2025
J9245001003,"Injection, melphalan hydrochloride, not otherwise specified, 50 mg",09-10-2025
J9246001003,"Injection, melphalan (evomela), 1 mg",09-10-2025
J9247001003,"Injection, melphalan flufenamide, 1mg",09-10-2025
J9248001003,"Injection, melphalan (hepzato), 1 mg",09-10-2025
J9249001003,"Injection, melphalan (apotex), 1 mg",09-10-2025
J9250001003,"Methotrexate sodium, 5 mg",09-10-2025
J9255001003,"Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 m",09-10-2025
J9258001003,"Injection, paclitaxel protein-bound particles (teva), not therapeutically",09-10-2025
J9258002004,"Equivalent to j9264, 1 mg",09-10-2025
J9259001003,"Injection, paclitaxel protein-bound particles (american regent), not",09-10-2025
J9259002004,"Therapeutically equivalent to j9264, 1 mg",09-10-2025
J9260001003,"Injection, methotrexate sodium, 50 mg",09-10-2025
J9261001003,"Injection, nelarabine, 50 mg",09-10-2025
J9262001003,"Injection, omacetaxine mepesuccinate, 0.01 mg",09-10-2025
J9263001003,"Injection, oxaliplatin, 0.5 mg",09-10-2025
J9264001003,"Injection, paclitaxel protein-bound particles, 1 mg",09-10-2025
J9265001003,"Injection, paclitaxel, 30 mg",09-10-2025
J9266001003,"Injection, pegaspargase, per single dose vial",09-10-2025
J9267001003,"Injection, paclitaxel, 1 mg",09-10-2025
J9268001003,"Injection, pentostatin, 10 mg",09-10-2025
J9269001003,"Injection, tagraxofusp-erzs, 10 micrograms",09-10-2025
J9270001003,"Injection, plicamycin, 2.5 mg",09-10-2025
J9271001003,"Injection, pembrolizumab, 1 mg",09-10-2025
J9272001003,"Injection, dostarlimab-gxly, 10 mg",09-10-2025
J9273001003,"Injection, tisotumab vedotin-tftv, 1 mg",09-10-2025
J9274001003,"Injection, tebentafusp-tebn, 1 microgram",09-10-2025
J9275001003,"Injection, cosibelimab-ipdl, 2 mg",09-10-2025
J9276001003,"Injection, zanidatamab-hrii, 2 mg",09-10-2025
J9280001003,"Injection, mitomycin, 5 mg",09-10-2025
J9281001003,"Mitomycin pyelocalyceal instillation, 1 mg",09-10-2025
J9285001003,"Injection, olaratumab, 10 mg",09-10-2025
J9286001003,"Injection, glofitamab-gxbm, 2.5 mg",09-10-2025
J9289001003,"Injection, nivolumab, 2 mg and hyaluronidase-nvhy",09-10-2025
J9292001003,"Injection, pemetrexed dipotassium, 10 mg",09-10-2025
J9293001003,"Injection, mitoxantrone hydrochloride, per 5 mg",09-10-2025
J9294001003,"Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg",09-10-2025
J9295001003,"Injection, necitumumab, 1 mg",09-10-2025
J9296001003,"Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg",09-10-2025
J9297001003,"Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg",09-10-2025
J9298001003,"Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg",09-10-2025
J9299001003,"Injection, nivolumab, 1 mg",09-10-2025
J9300001003,"Injection, gemtuzumab ozogamicin, 5 mg",09-10-2025
J9301001003,"Injection, obinutuzumab, 10 mg",09-10-2025
J9302001003,"Injection, ofatumumab, 10 mg",09-10-2025
J9303001003,"Injection, panitumumab, 10 mg",09-10-2025
J9304001003,"Injection, pemetrexed (pemfexy), 10 mg",09-10-2025
J9305001003,"Injection, pemetrexed, not otherwise specified, 10 mg",09-10-2025
J9306001003,"Injection, pertuzumab, 1 mg",09-10-2025
J9307001003,"Injection, pralatrexate, 1 mg",09-10-2025
J9308001003,"Injection, ramucirumab, 5 mg",09-10-2025
J9309001003,"Injection, polatuzumab vedotin-piiq, 1 mg",09-10-2025
J9310001003,"Injection, rituximab, 100 mg",09-10-2025
J9311001003,"Injection, rituximab 10 mg and hyaluronidase",09-10-2025
J9312001003,"Injection, rituximab, 10 mg",09-10-2025
J9313001003,"Injection, moxetumomab pasudotox-tdfk, 0.01 mg",09-10-2025
J9314001003,"Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg",09-10-2025
J9315001003,"Injection, romidepsin, 1 mg",09-10-2025
J9316001003,"Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg",09-10-2025
J9317001003,"Injection, sacituzumab govitecan-hziy, 2.5 mg",09-10-2025
J9318001003,"Injection, romidepsin, non-lyophilized, 0.1 mg",09-10-2025
J9319001003,"Injection, romidepsin, lyophilized, 0.1 mg",09-10-2025
J9320001003,"Injection, streptozocin, 1 gram",09-10-2025
J9321001003,"Injection, epcoritamab-bysp, 0.16 mg",09-10-2025
J9322001003,"Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10",09-10-2025
J9322002004,Mg,09-10-2025
J9323001003,"Injection, pemetrexed ditromethamine, 10 mg",09-10-2025
J9324001003,"Injection, pemetrexed (pemrydi rtu), 10 mg",09-10-2025
J9325001003,"Injection, talimogene laherparepvec, per 1 million plaque forming units",09-10-2025
J9328001003,"Injection, temozolomide, 1 mg",09-10-2025
J9329001003,"Injection, tislelizumab-jsgr, 1mg",09-10-2025
J9330001003,"Injection, temsirolimus, 1 mg",09-10-2025
J9331001003,"Injection, sirolimus protein-bound particles, 1 mg",09-10-2025
J9332001003,"Injection, efgartigimod alfa-fcab, 2mg",09-10-2025
J9333001003,"Injection, rozanolixizumab-noli, 1 mg",09-10-2025
J9334001003,"Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc",09-10-2025
J9340001003,"Injection, thiotepa, 15 mg",09-10-2025
J9341001003,"Injection, thiotepa (tepylute), 1 mg",09-10-2025
J9342001003,"Injection, thiotepa, not otherwise specified, 1 mg",09-10-2025
J9345001003,"Injection, retifanlimab-dlwr, 1 mg",09-10-2025
J9347001003,"Injection, tremelimumab-actl, 1 mg",09-10-2025
J9348001003,"Injection, naxitamab-gqgk, 1 mg",09-10-2025
J9349001003,"Injection, tafasitamab-cxix, 2 mg",09-10-2025
J9350001003,"Injection, mosunetuzumab-axgb, 1 mg",09-10-2025
J9351001003,"Injection, topotecan, 0.1 mg",09-10-2025
J9352001003,"Injection, trabectedin, 0.1 mg",09-10-2025
J9353001003,"Injection, margetuximab-cmkb, 5 mg",09-10-2025
J9354001003,"Injection, ado-trastuzumab emtansine, 1 mg",09-10-2025
J9355001003,"Injection, trastuzumab, excludes biosimilar, 10 mg",09-10-2025
J9356001003,"Injection, trastuzumab, 10 mg and hyaluronidase-oysk",09-10-2025
J9357001003,"Injection, valrubicin, intravesical, 200 mg",09-10-2025
J9358001003,"Injection, fam-trastuzumab deruxtecan-nxki, 1 mg",09-10-2025
J9359001003,"Injection, loncastuximab tesirine-lpyl, 0.075 mg",09-10-2025
J9360001003,"Injection, vinblastine sulfate, 1 mg",09-10-2025
J9361001003,"Injection, efbemalenograstim alfa-vuxw, 0.5 mg",09-10-2025
J9370001003,"Vincristine sulfate, 1 mg",09-10-2025
J9371001003,"Injection, vincristine sulfate liposome, 1 mg",09-10-2025
J9376001003,"Injection, pozelimab-bbfg, 1 mg",09-10-2025
J9380001003,"Injection, teclistamab-cqyv, 0.5 mg",09-10-2025
J9381001003,"Injection, teplizumab-mzwv, 5 mcg",09-10-2025
J9382001003,"Injection, zenocutuzumab-zbco, 1 mg",09-10-2025
J9390001003,"Injection, vinorelbine tartrate, 10 mg",09-10-2025
J9393001003,"Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg",09-10-2025
J9394001003,"Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to",09-10-2025
J9394002004,"J9395, 25 mg",09-10-2025
J9395001003,"Injection, fulvestrant, 25 mg",09-10-2025
J9400001003,"Injection, ziv-aflibercept, 1 mg",09-10-2025
J9600001003,"Injection, porfimer sodium, 75 mg",09-10-2025
J9999001003,"Not otherwise classified, antineoplastic drugs",09-10-2025
K0001001003,Standard wheelchair,09-10-2025
K0002001003,Standard hemi (low seat) wheelchair,09-10-2025
K0003001003,Lightweight wheelchair,09-10-2025
K0004001003,"High strength, lightweight wheelchair",09-10-2025
K0005001003,Ultralightweight wheelchair,09-10-2025
K0006001003,Heavy duty wheelchair,09-10-2025
K0007001003,Extra heavy duty wheelchair,09-10-2025
K0008001003,Custom manual wheelchair/base,09-10-2025
K0009001003,Other manual wheelchair/base,09-10-2025
K0010001003,Standard - weight frame motorized/power wheelchair,09-10-2025
K0011001003,Standard - weight frame motorized/power wheelchair with programmable control,09-10-2025
K0011002004,"Parameters for speed adjustment, tremor dampening, acceleration control and",09-10-2025
K0011003004,Braking,09-10-2025
K0012001003,Lightweight portable motorized/power wheelchair,09-10-2025
K0013001003,Custom motorized/power wheelchair base,09-10-2025
K0014001003,Other motorized/power wheelchair base,09-10-2025
K0015001003,"Detachable, non-adjustable height armrest, replacement only, each",09-10-2025
K0017001003,"Detachable, adjustable height armrest, base, replacement only, each",09-10-2025
K0018001003,"Detachable, adjustable height armrest, upper portion, replacement only, each",09-10-2025
K0019001003,"Arm pad, replacement only, each",09-10-2025
K0020001003,"Fixed, adjustable height armrest, pair",09-10-2025
K0037001003,"High mount flip-up footrest, each",09-10-2025
K0038001003,"Leg strap, each",09-10-2025
K0039001003,"Leg strap, h style, each",09-10-2025
K0040001003,"Adjustable angle footplate, each",09-10-2025
K0041001003,"Large size footplate, each",09-10-2025
K0042001003,"Standard size footplate, replacement only, each",09-10-2025
K0043001003,"Footrest, lower extension tube, replacement only, each",09-10-2025
K0044001003,"Footrest, upper hanger bracket, replacement only, each",09-10-2025
K0045001003,"Footrest, complete assembly, replacement only, each",09-10-2025
K0046001003,"Elevating legrest, lower extension tube, replacement only, each",09-10-2025
K0047001003,"Elevating legrest, upper hanger bracket, replacement only, each",09-10-2025
K0050001003,"Ratchet assembly, replacement only",09-10-2025
K0051001003,"Cam release assembly, footrest or legrest, replacement only, each",09-10-2025
K0052001003,"Swingaway, detachable footrests, replacement only, each",09-10-2025
K0053001003,"Elevating footrests, articulating (telescoping), each",09-10-2025
K0056001003,"Seat height less than 17"" or equal to or greater than 21"" for a high strength,",09-10-2025
K0056002004,"Lightweight, or ultralightweight wheelchair",09-10-2025
K0065001003,"Spoke protectors, each",09-10-2025
K0069001003,"Rear wheel assembly, complete, with solid tire, spokes or molded, replacement",09-10-2025
K0069002004,"Only, each",09-10-2025
K0070001003,"Rear wheel assembly, complete, with pneumatic tire, spokes or molded,",09-10-2025
K0070002004,"Replacement only, each",09-10-2025
K0071001003,"Front caster assembly, complete, with pneumatic tire, replacement only, each",09-10-2025
K0072001003,"Front caster assembly, complete, with semi-pneumatic tire, replacement only,",09-10-2025
K0072002004,Each,09-10-2025
K0073001003,"Caster pin lock, each",09-10-2025
K0077001003,"Front caster assembly, complete, with solid tire, replacement only, each",09-10-2025
K0098001003,"Drive belt for power wheelchair, replacement only",09-10-2025
K0105001003,"Iv hanger, each",09-10-2025
K0108001003,"Wheelchair component or accessory, not otherwise specified",09-10-2025
K0195001003,"Elevating leg rests, pair (for use with capped rental wheelchair base)",09-10-2025
K0455001003,"Infusion pump used for uninterrupted parenteral administration of medication,",09-10-2025
K0455002004,"(e.g., epoprostenol or treprostinol)",09-10-2025
K0462001003,"Temporary replacement for patient owned equipment being repaired, any type",09-10-2025
K0552001003,"Supplies for external non-insulin drug infusion pump, syringe type cartridge,",09-10-2025
K0552002004,"Sterile, each",09-10-2025
K0553001003,"Supply allowance for therapeutic continuous glucose monitor (cgm), includes all",09-10-2025
K0553002004,"Supplies and accessories, 1 month supply = 1 unit of service",09-10-2025
K0554001003,"Receiver (monitor), dedicated, for use with therapeutic glucose continuous",09-10-2025
K0554002004,Monitor system,09-10-2025
K0601001003,"Replacement battery for external infusion pump owned by patient, silver oxide,",09-10-2025
K0601002004,"1.5 volt, each",09-10-2025
K0602001003,"Replacement battery for external infusion pump owned by patient, silver oxide,",09-10-2025
K0602002004,"3 volt, each",09-10-2025
K0603001003,"Replacement battery for external infusion pump owned by patient, alkaline, 1.5",09-10-2025
K0603002004,"Volt, each",09-10-2025
K0604001003,"Replacement battery for external infusion pump owned by patient, lithium, 3.6",09-10-2025
K0604002004,"Volt, each",09-10-2025
K0605001003,"Replacement battery for external infusion pump owned by patient, lithium, 4.5",09-10-2025
K0605002004,"Volt, each",09-10-2025
K0606001003,"Automatic external defibrillator, with integrated electrocardiogram analysis,",09-10-2025
K0606002004,Garment type,09-10-2025
K0607001003,"Replacement battery for automated external defibrillator, garment type only,",09-10-2025
K0607002004,Each,09-10-2025
K0608001003,"Replacement garment for use with automated external defibrillator, each",09-10-2025
K0609001003,"Replacement electrodes for use with automated external defibrillator, garment",09-10-2025
K0609002004,"Type only, each",09-10-2025
K0669001003,"Wheelchair accessory, wheelchair seat or back cushion, does not meet specific",09-10-2025
K0669002004,Code criteria or no written coding verification from dme pdac,09-10-2025
K0672001003,"Addition to lower extremity orthosis, removable soft interface, all components,",09-10-2025
K0672002004,"Replacement only, each",09-10-2025
K0730001003,Controlled dose inhalation drug delivery system,09-10-2025
K0733001003,"Power wheelchair accessory, 12 to 24 amp hour sealed lead acid battery, each",09-10-2025
K0733002004,"(e.g., gel cell, absorbed glassmat)",09-10-2025
K0738001003,"Portable gaseous oxygen system, rental; home compressor used to fill portable",09-10-2025
K0738002004,"Oxygen cylinders; includes portable containers, regulator, flowmeter,",09-10-2025
K0738003004,"Humidifier, cannula or mask, and tubing",09-10-2025
K0739001003,Repair or nonroutine service for durable medical equipment other than oxygen,09-10-2025
K0739002004,"Equipment requiring the skill of a technician, labor component, per 15 minutes",09-10-2025
K0740001003,Repair or nonroutine service for oxygen equipment requiring the skill of a,09-10-2025
K0740002004,"Technician, labor component, per 15 minutes",09-10-2025
K0743001003,"Suction pump, home model, portable, for use on wounds",09-10-2025
K0744001003,"Absorptive wound dressing for use with suction pump, home model, portable, pad",09-10-2025
K0744002004,Size 16 square inches or less,09-10-2025
K0745001003,"Absorptive wound dressing for use with suction pump, home model, portable, pad",09-10-2025
K0745002004,Size more than 16 square inches but less than or equal to 48 square inches,09-10-2025
K0746001003,"Absorptive wound dressing for use with suction pump, home model, portable, pad",09-10-2025
K0746002004,Size greater than 48 square inches,09-10-2025
K0800001003,"Power operated vehicle, group 1 standard, patient weight capacity up to and",09-10-2025
K0800002004,Including 300 pounds,09-10-2025
K0801001003,"Power operated vehicle, group 1 heavy duty, patient weight capacity 301 to 450",09-10-2025
K0801002004,Pounds,09-10-2025
K0802001003,"Power operated vehicle, group 1 very heavy duty, patient weight capacity 451 to",09-10-2025
K0802002004,600 pounds,09-10-2025
K0806001003,"Power operated vehicle, group 2 standard, patient weight capacity up to and",09-10-2025
K0806002004,Including 300 pounds,09-10-2025
K0807001003,"Power operated vehicle, group 2 heavy duty, patient weight capacity 301 to 450",09-10-2025
K0807002004,Pounds,09-10-2025
K0808001003,"Power operated vehicle, group 2 very heavy duty, patient weight capacity 451 to",09-10-2025
K0808002004,600 pounds,09-10-2025
K0812001003,"Power operated vehicle, not otherwise classified",09-10-2025
K0813001003,"Power wheelchair, group 1 standard, portable, sling/solid seat and back,",09-10-2025
K0813002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0814001003,"Power wheelchair, group 1 standard, portable, captains chair, patient weight",09-10-2025
K0814002004,Capacity up to and including 300 pounds,09-10-2025
K0815001003,"Power wheelchair, group 1 standard, sling/solid seat and back, patient weight",09-10-2025
K0815002004,Capacity up to and including 300 pounds,09-10-2025
K0816001003,"Power wheelchair, group 1 standard, captains chair, patient weight capacity up",09-10-2025
K0816002004,To and including 300 pounds,09-10-2025
K0820001003,"Power wheelchair, group 2 standard, portable, sling/solid seat/back, patient",09-10-2025
K0820002004,Weight capacity up to and including 300 pounds,09-10-2025
K0821001003,"Power wheelchair, group 2 standard, portable, captains chair, patient weight",09-10-2025
K0821002004,Capacity up to and including 300 pounds,09-10-2025
K0822001003,"Power wheelchair, group 2 standard, sling/solid seat/back, patient weight",09-10-2025
K0822002004,Capacity up to and including 300 pounds,09-10-2025
K0823001003,"Power wheelchair, group 2 standard, captains chair, patient weight capacity up",09-10-2025
K0823002004,To and including 300 pounds,09-10-2025
K0824001003,"Power wheelchair, group 2 heavy duty, sling/solid seat/back, patient weight",09-10-2025
K0824002004,Capacity 301 to 450 pounds,09-10-2025
K0825001003,"Power wheelchair, group 2 heavy duty, captains chair, patient weight capacity",09-10-2025
K0825002004,301 to 450 pounds,09-10-2025
K0826001003,"Power wheelchair, group 2 very heavy duty, sling/solid seat/back, patient",09-10-2025
K0826002004,Weight capacity 451 to 600 pounds,09-10-2025
K0827001003,"Power wheelchair, group 2 very heavy duty, captains chair, patient weight",09-10-2025
K0827002004,Capacity 451 to 600 pounds,09-10-2025
K0828001003,"Power wheelchair, group 2 extra heavy duty, sling/solid seat/back, patient",09-10-2025
K0828002004,Weight capacity 601 pounds or more,09-10-2025
K0829001003,"Power wheelchair, group 2 extra heavy duty, captains chair, patient weight 601",09-10-2025
K0829002004,Pounds or more,09-10-2025
K0830001003,"Power wheelchair, group 2 standard, seat elevator, sling/solid seat/back,",09-10-2025
K0830002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0831001003,"Power wheelchair, group 2 standard, seat elevator, captains chair, patient",09-10-2025
K0831002004,Weight capacity up to and including 300 pounds,09-10-2025
K0835001003,"Power wheelchair, group 2 standard, single power option, sling/solid seat/back,",09-10-2025
K0835002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0836001003,"Power wheelchair, group 2 standard, single power option, captains chair,",09-10-2025
K0836002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0837001003,"Power wheelchair, group 2 heavy duty, single power option, sling/solid",09-10-2025
K0837002004,"Seat/back, patient weight capacity 301 to 450 pounds",09-10-2025
K0838001003,"Power wheelchair, group 2 heavy duty, single power option, captains chair,",09-10-2025
K0838002004,Patient weight capacity 301 to 450 pounds,09-10-2025
K0839001003,"Power wheelchair, group 2 very heavy duty, single power option, sling/solid",09-10-2025
K0839002004,"Seat/back, patient weight capacity 451 to 600 pounds",09-10-2025
K0840001003,"Power wheelchair, group 2 extra heavy duty, single power option, sling/solid",09-10-2025
K0840002004,"Seat/back, patient weight capacity 601 pounds or more",09-10-2025
K0841001003,"Power wheelchair, group 2 standard, multiple power option, sling/solid",09-10-2025
K0841002004,"Seat/back, patient weight capacity up to and including 300 pounds",09-10-2025
K0842001003,"Power wheelchair, group 2 standard, multiple power option, captains chair,",09-10-2025
K0842002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0843001003,"Power wheelchair, group 2 heavy duty, multiple power option, sling/solid",09-10-2025
K0843002004,"Seat/back, patient weight capacity 301 to 450 pounds",09-10-2025
K0848001003,"Power wheelchair, group 3 standard, sling/solid seat/back, patient weight",09-10-2025
K0848002004,Capacity up to and including 300 pounds,09-10-2025
K0849001003,"Power wheelchair, group 3 standard, captains chair, patient weight capacity up",09-10-2025
K0849002004,To and including 300 pounds,09-10-2025
K0850001003,"Power wheelchair, group 3 heavy duty, sling/solid seat/back, patient weight",09-10-2025
K0850002004,Capacity 301 to 450 pounds,09-10-2025
K0851001003,"Power wheelchair, group 3 heavy duty, captains chair, patient weight capacity",09-10-2025
K0851002004,301 to 450 pounds,09-10-2025
K0852001003,"Power wheelchair, group 3 very heavy duty, sling/solid seat/back, patient",09-10-2025
K0852002004,Weight capacity 451 to 600 pounds,09-10-2025
K0853001003,"Power wheelchair, group 3 very heavy duty, captains chair, patient weight",09-10-2025
K0853002004,Capacity 451 to 600 pounds,09-10-2025
K0854001003,"Power wheelchair, group 3 extra heavy duty, sling/solid seat/back, patient",09-10-2025
K0854002004,Weight capacity 601 pounds or more,09-10-2025
K0855001003,"Power wheelchair, group 3 extra heavy duty, captains chair, patient weight",09-10-2025
K0855002004,Capacity 601 pounds or more,09-10-2025
K0856001003,"Power wheelchair, group 3 standard, single power option, sling/solid seat/back,",09-10-2025
K0856002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0857001003,"Power wheelchair, group 3 standard, single power option, captains chair,",09-10-2025
K0857002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0858001003,"Power wheelchair, group 3 heavy duty, single power option, sling/solid",09-10-2025
K0858002004,"Seat/back, patient weight 301 to 450 pounds",09-10-2025
K0859001003,"Power wheelchair, group 3 heavy duty, single power option, captains chair,",09-10-2025
K0859002004,Patient weight capacity 301 to 450 pounds,09-10-2025
K0860001003,"Power wheelchair, group 3 very heavy duty, single power option, sling/solid",09-10-2025
K0860002004,"Seat/back, patient weight capacity 451 to 600 pounds",09-10-2025
K0861001003,"Power wheelchair, group 3 standard, multiple power option, sling/solid",09-10-2025
K0861002004,"Seat/back, patient weight capacity up to and including 300 pounds",09-10-2025
K0862001003,"Power wheelchair, group 3 heavy duty, multiple power option, sling/solid",09-10-2025
K0862002004,"Seat/back, patient weight capacity 301 to 450 pounds",09-10-2025
K0863001003,"Power wheelchair, group 3 very heavy duty, multiple power option, sling/solid",09-10-2025
K0863002004,"Seat/back, patient weight capacity 451 to 600 pounds",09-10-2025
K0864001003,"Power wheelchair, group 3 extra heavy duty, multiple power option, sling/solid",09-10-2025
K0864002004,"Seat/back, patient weight capacity 601 pounds or more",09-10-2025
K0868001003,"Power wheelchair, group 4 standard, sling/solid seat/back, patient weight",09-10-2025
K0868002004,Capacity up to and including 300 pounds,09-10-2025
K0869001003,"Power wheelchair, group 4 standard, captains chair, patient weight capacity up",09-10-2025
K0869002004,To and including 300 pounds,09-10-2025
K0870001003,"Power wheelchair, group 4 heavy duty, sling/solid seat/back, patient weight",09-10-2025
K0870002004,Capacity 301 to 450 pounds,09-10-2025
K0871001003,"Power wheelchair, group 4 very heavy duty, sling/solid seat/back, patient",09-10-2025
K0871002004,Weight capacity 451 to 600 pounds,09-10-2025
K0877001003,"Power wheelchair, group 4 standard, single power option, sling/solid seat/back,",09-10-2025
K0877002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0878001003,"Power wheelchair, group 4 standard, single power option, captains chair,",09-10-2025
K0878002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0879001003,"Power wheelchair, group 4 heavy duty, single power option, sling/solid",09-10-2025
K0879002004,"Seat/back, patient weight capacity 301 to 450 pounds",09-10-2025
K0880001003,"Power wheelchair, group 4 very heavy duty, single power option, sling/solid",09-10-2025
K0880002004,"Seat/back, patient weight 451 to 600 pounds",09-10-2025
K0884001003,"Power wheelchair, group 4 standard, multiple power option, sling/solid",09-10-2025
K0884002004,"Seat/back, patient weight capacity up to and including 300 pounds",09-10-2025
K0885001003,"Power wheelchair, group 4 standard, multiple power option, captains chair,",09-10-2025
K0885002004,Patient weight capacity up to and including 300 pounds,09-10-2025
K0886001003,"Power wheelchair, group 4 heavy duty, multiple power option, sling/solid",09-10-2025
K0886002004,"Seat/back, patient weight capacity 301 to 450 pounds",09-10-2025
K0890001003,"Power wheelchair, group 5 pediatric, single power option, sling/solid",09-10-2025
K0890002004,"Seat/back, patient weight capacity up to and including 125 pounds",09-10-2025
K0891001003,"Power wheelchair, group 5 pediatric, multiple power option, sling/solid",09-10-2025
K0891002004,"Seat/back, patient weight capacity up to and including 125 pounds",09-10-2025
K0898001003,"Power wheelchair, not otherwise classified",09-10-2025
K0899001003,"Power mobility device, not coded by dme pdac or does not meet criteria",09-10-2025
K0900001003,"Customized durable medical equipment, other than wheelchair",09-10-2025
K0901001003,"Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and",09-10-2025
K0901002004,"Extension joint (unicentric or polycentric), medial-lateral and rotation",09-10-2025
K0901003004,"Control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",09-10-2025
K0902001003,"Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and",09-10-2025
K0902002004,"Extension joint (unicentric or polycentric), medial-lateral and rotation",09-10-2025
K0902003004,"Control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",09-10-2025
K0903001003,"For diabetics only, multiple density insert, made by direct carving with cam",09-10-2025
K0903002004,Technology from a rectified cad model created from a digitized scan of the,09-10-2025
K0903003004,"Patient, total contact with patient's foot, including arch, base layer minimum",09-10-2025
K0903004004,"Of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler",09-10-2025
K0903005004,"And other shaping material, custom fabricated, each",09-10-2025
K1001001003,"Electronic positional obstructive sleep apnea treatment, with sensor, includes",09-10-2025
K1001002004,"All components and accessories, any type",09-10-2025
K1002001003,"Cranial electrotherapy stimulation (ces) system, any type",09-10-2025
K1003001003,"Whirlpool tub, walk-in, portable",09-10-2025
K1004001003,Low frequency ultrasonic diathermy treatment device for home use,09-10-2025
K1005001003,"Disposable collection and storage bag for breast milk, any size, any type, each",09-10-2025
K1006001003,"Suction pump, home model, portable or stationary, electric, any type, for use",09-10-2025
K1006002004,With external urine management system,09-10-2025
K1007001003,"Bilateral hip, knee, ankle, foot device, powered, includes pelvic component,",09-10-2025
K1007002004,"Single or double upright(s), knee joints any type, with or without ankle joints",09-10-2025
K1007003004,"Any type, includes all components and accessories, motors, microprocessors,",09-10-2025
K1007004004,Sensors,09-10-2025
K1009001003,"Speech volume modulation system, any type, including all components and",09-10-2025
K1009002004,Accessories,09-10-2025
K1010001003,"Indwelling intraurethral drainage device with valve, patient inserted,",09-10-2025
K1010002004,"Replacement only, each",09-10-2025
K1011001003,"Activation device for intraurethral drainage device with valve, replacement",09-10-2025
K1011002004,"Only, each",09-10-2025
K1012001003,"Charger and base station for intraurethral activation device, replacement only",09-10-2025
K1013001003,"Enema tube, with or without adapter, any type, replacement only, each",09-10-2025
K1014001003,"Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid",09-10-2025
K1014002004,Swing and stance phase control,09-10-2025
K1015001003,"Foot, adductus positioning device, adjustable",09-10-2025
K1016001003,Transcutaneous electrical nerve stimulator for electrical stimulation of the,09-10-2025
K1016002004,Trigeminal nerve,09-10-2025
K1017001003,Monthly supplies for use of device coded at k1016,09-10-2025
K1018001003,External upper limb tremor stimulator of the peripheral nerves of the wrist,09-10-2025
K1019001003,Supplies and accessories for external upper limb tremor stimulator of the,09-10-2025
K1019002004,Peripheral nerves of the wrist,09-10-2025
K1020001003,Non-invasive vagus nerve stimulator,09-10-2025
K1021001003,"Exsufflation belt, includes all supplies and accessories",09-10-2025
K1022001003,"Addition to lower extremity prosthesis, endoskeletal, knee disarticulation,",09-10-2025
K1022002004,"Above knee, hip disarticulation, positional rotation unit, any type",09-10-2025
K1023001003,"Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves",09-10-2025
K1023002004,Of the upper arm,09-10-2025
K1024001003,Non-pneumatic compression controller with sequential calibrated gradient,09-10-2025
K1024002004,Pressure,09-10-2025
K1025001003,"Non-pneumatic sequential compression garment, full arm",09-10-2025
K1026001003,"Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical",09-10-2025
K1027001003,"Oral device/appliance used to reduce upper airway collapsibility, without fixed",09-10-2025
K1027002004,"Mechanical hinge, custom fabricated, includes fitting and adjustment",09-10-2025
K1028001003,Power source and control electronics unit for oral device/appliance for,09-10-2025
K1028002004,"Neuromuscular electrical stimulation of the tongue muscle, controlled by phone",09-10-2025
K1028003004,Application,09-10-2025
K1029001003,Oral device/appliance for neuromuscular electrical stimulation of the tongue,09-10-2025
K1029002004,"Muscle, used in conjunction with the power source and control electronics unit,",09-10-2025
K1029003004,"Controlled by phone application, 90-day supply",09-10-2025
K1030001003,External recharging system for battery (internal) for use with implanted,09-10-2025
K1030002004,"Cardiac contractility modulation generator, replacement only",09-10-2025
K1031001003,Non-pneumatic compression controller without calibrated gradient pressure,09-10-2025
K1032001003,"Non-pneumatic sequential compression garment, full leg",09-10-2025
K1033001003,"Non-pneumatic sequential compression garment, half leg",09-10-2025
K1034001003,"Provision of covid-19 test, nonprescription self-administered and",09-10-2025
K1034002004,"Self-collected use, fda approved, authorized or cleared, one test count",09-10-2025
K1035001003,"Molecular diagnostic test reader, nonprescription self-administered and",09-10-2025
K1035002004,"Self-collected use, fda approved, authorized or cleared",09-10-2025
K1036001003,"Supplies and accessories (e.g., transducer) for low frequency ultrasonic",09-10-2025
K1036002004,"Diathermy treatment device, per month",09-10-2025
K1037001003,Docking station for use with oral device/appliance used to reduce upper airway,09-10-2025
K1037002004,Collapsibility,09-10-2025
L0112001003,"Cranial cervical orthosis, congenital torticollis type, with or without soft",09-10-2025
L0112002004,"Interface material, adjustable range of motion joint, custom fabricated",09-10-2025
L0113001003,"Cranial cervical orthosis, torticollis type, with or without joint, with or",09-10-2025
L0113002004,"Without soft interface material, prefabricated, includes fitting and adjustment",09-10-2025
L0120001003,"Cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar)",09-10-2025
L0130001003,"Cervical, flexible, thermoplastic collar, molded to patient",09-10-2025
L0140001003,"Cervical, semi-rigid, adjustable (plastic collar)",09-10-2025
L0150001003,"Cervical, semi-rigid, adjustable molded chin cup (plastic collar with",09-10-2025
L0150002004,Mandibular/occipital piece),09-10-2025
L0160001003,"Cervical, semi-rigid, wire frame occipital/mandibular support, prefabricated,",09-10-2025
L0160002004,Off-the-shelf,09-10-2025
L0170001003,"Cervical, collar, molded to patient model",09-10-2025
L0172001003,"Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated,",09-10-2025
L0172002004,Off-the-shelf,09-10-2025
L0174001003,"Cervical, collar, semi-rigid, thermoplastic foam, two piece with thoracic",09-10-2025
L0174002004,"Extension, prefabricated, off-the-shelf",09-10-2025
L0180001003,"Cervical, multiple post collar, occipital/mandibular supports, adjustable",09-10-2025
L0190001003,"Cervical, multiple post collar, occipital/mandibular supports, adjustable",09-10-2025
L0190002004,"Cervical bars (somi, guilford, taylor types)",09-10-2025
L0200001003,"Cervical, multiple post collar, occipital/mandibular supports, adjustable",09-10-2025
L0200002004,"Cervical bars, and thoracic extension",09-10-2025
L0220001003,"Thoracic, rib belt, custom fabricated",09-10-2025
L0450001003,"Tlso, flexible, provides trunk support, upper thoracic region, produces",09-10-2025
L0450002004,Intracavitary pressure to reduce load on the intervertebral disks with rigid,09-10-2025
L0450003004,"Stays or panel(s), includes shoulder straps and closures, prefabricated,",09-10-2025
L0450004004,Off-the-shelf,09-10-2025
L0452001003,"Tlso, flexible, provides trunk support, upper thoracic region, produces",09-10-2025
L0452002004,Intracavitary pressure to reduce load on the intervertebral disks with rigid,09-10-2025
L0452003004,"Stays or panel(s), includes shoulder straps and closures, custom fabricated",09-10-2025
L0454001003,"Tlso flexible, provides trunk support, extends from sacrococcygeal junction to",09-10-2025
L0454002004,"Above t-9 vertebra, restricts gross trunk motion in the sagittal plane,",09-10-2025
L0454003004,Produces intracavitary pressure to reduce load on the intervertebral disks with,09-10-2025
L0454004004,"Rigid stays or panel(s), includes shoulder straps and closures, prefabricated",09-10-2025
L0454005004,"Item that has been trimmed, bent, molded, assembled, or otherwise customized to",09-10-2025
L0454006004,Fit a specific patient by an individual with expertise,09-10-2025
L0455001003,"Tlso, flexible, provides trunk support, extends from sacrococcygeal junction to",09-10-2025
L0455002004,"Above t-9 vertebra, restricts gross trunk motion in the sagittal plane,",09-10-2025
L0455003004,Produces intracavitary pressure to reduce load on the intervertebral disks with,09-10-2025
L0455004004,"Rigid stays or panel(s), includes shoulder straps and closures, prefabricated,",09-10-2025
L0455005004,Off-the-shelf,09-10-2025
L0456001003,"Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel",09-10-2025
L0456002004,"And soft anterior apron, extends from the sacrococcygeal junction and",09-10-2025
L0456003004,"Terminates just inferior to the scapular spine, restricts gross trunk motion in",09-10-2025
L0456004004,"The sagittal plane, produces intracavitary pressure to reduce load on the",09-10-2025
L0456005004,"Intervertebral disks, includes straps and closures, prefabricated item that has",09-10-2025
L0456006004,"Been trimmed, bent, molded, assembled, or otherwise customized to fit a",09-10-2025
L0456007004,Specific patient by an individual with expertise,09-10-2025
L0457001003,"Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel",09-10-2025
L0457002004,"And soft anterior apron, extends from the sacrococcygeal junction and",09-10-2025
L0457003004,"Terminates just inferior to the scapular spine, restricts gross trunk motion in",09-10-2025
L0457004004,"The sagittal plane, produces intracavitary pressure to reduce load on the",09-10-2025
L0457005004,"Intervertebral disks, includes straps and closures, prefabricated, off-the-shel",09-10-2025
L0458001003,"Tlso, triplanar control, modular segmented spinal system, two rigid plastic",09-10-2025
L0458002004,"Shells, posterior extends from the sacrococcygeal junction and terminates just",09-10-2025
L0458003004,"Inferior to the scapular spine, anterior extends from the symphysis pubis to",09-10-2025
L0458004004,"The xiphoid, soft liner, restricts gross trunk motion in the sagittal, coronal,",09-10-2025
L0458005004,"And transverse planes, lateral strength is provided by overlapping plastic and",09-10-2025
L0458006004,"Stabilizing closures, includes straps and closures, prefabricated, includes",09-10-2025
L0458007004,Fitting and adjustment,09-10-2025
L0460001003,"Tlso, triplanar control, modular segmented spinal system, two rigid plastic",09-10-2025
L0460002004,"Shells, posterior extends from the sacrococcygeal junction and terminates just",09-10-2025
L0460003004,"Inferior to the scapular spine, anterior extends from the symphysis pubis to",09-10-2025
L0460004004,"The sternal notch, soft liner, restricts gross trunk motion in the sagittal,",09-10-2025
L0460005004,"Coronal, and transverse planes, lateral strength is provided by overlapping",09-10-2025
L0460006004,"Plastic and stabilizing closures, includes straps and closures, prefabricated",09-10-2025
L0460007004,"Item that has been trimmed, bent, molded, assembled, or otherwise customized to",09-10-2025
L0460008004,Fit a specific patient by an individual with expertise,09-10-2025
L0462001003,"Tlso, triplanar control, modular segmented spinal system, three rigid plastic",09-10-2025
L0462002004,"Shells, posterior extends from the sacrococcygeal junction and terminates just",09-10-2025
L0462003004,"Inferior to the scapular spine, anterior extends from the symphysis pubis to",09-10-2025
L0462004004,"The sternal notch, soft liner, restricts gross trunk motion in the sagittal,",09-10-2025
L0462005004,"Coronal, and transverse planes, lateral strength is provided by overlapping",09-10-2025
L0462006004,"Plastic and stabilizing closures, includes straps and closures, prefabricated,",09-10-2025
L0462007004,Includes fitting and adjustment,09-10-2025
L0464001003,"Tlso, triplanar control, modular segmented spinal system, four rigid plastic",09-10-2025
L0464002004,"Shells, posterior extends from sacrococcygeal junction and terminates just",09-10-2025
L0464003004,"Inferior to scapular spine, anterior extends from symphysis pubis to the",09-10-2025
L0464004004,"Sternal notch, soft liner, restricts gross trunk motion in sagittal, coronal,",09-10-2025
L0464005004,"And transverse planes, lateral strength is provided by overlapping plastic and",09-10-2025
L0464006004,"Stabilizing closures, includes straps and closures, prefabricated, includes",09-10-2025
L0464007004,Fitting and adjustment,09-10-2025
L0466001003,"Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron",09-10-2025
L0466002004,"With straps, closures and padding, restricts gross trunk motion in sagittal",09-10-2025
L0466003004,"Plane, produces intracavitary pressure to reduce load on intervertebral disks,",09-10-2025
L0466004004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L0466005004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L0467001003,"Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron",09-10-2025
L0467002004,"With straps, closures and padding, restricts gross trunk motion in sagittal",09-10-2025
L0467003004,"Plane, produces intracavitary pressure to reduce load on intervertebral disks,",09-10-2025
L0467004004,"Prefabricated, off-the-shelf",09-10-2025
L0468001003,"Tlso, sagittal-coronal control, rigid posterior frame and flexible soft",09-10-2025
L0468002004,"Anterior apron with straps, closures and padding, extends from sacrococcygeal",09-10-2025
L0468003004,"Junction over scapulae, lateral strength provided by pelvic, thoracic, and",09-10-2025
L0468004004,"Lateral frame pieces, restricts gross trunk motion in sagittal, and coronal",09-10-2025
L0468005004,"Planes, produces intracavitary pressure to reduce load on intervertebral disks,",09-10-2025
L0468006004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L0468007004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L0469001003,"Tlso, sagittal-coronal control, rigid posterior frame and flexible soft",09-10-2025
L0469002004,"Anterior apron with straps, closures and padding, extends from sacrococcygeal",09-10-2025
L0469003004,"Junction over scapulae, lateral strength provided by pelvic, thoracic, and",09-10-2025
L0469004004,"Lateral frame pieces, restricts gross trunk motion in sagittal and coronal",09-10-2025
L0469005004,"Planes, produces intracavitary pressure to reduce load on intervertebral disks,",09-10-2025
L0469006004,"Prefabricated, off-the-shelf",09-10-2025
L0470001003,"Tlso, triplanar control, rigid posterior frame and flexible soft anterior apron",09-10-2025
L0470002004,"With straps, closures and padding, extends from sacrococcygeal junction to",09-10-2025
L0470003004,"Scapula, lateral strength provided by pelvic, thoracic, and lateral frame",09-10-2025
L0470004004,"Pieces, rotational strength provided by subclavicular extensions, restricts",09-10-2025
L0470005004,"Gross trunk motion in sagittal, coronal, and transverse planes, provides",09-10-2025
L0470006004,"Intracavitary pressure to reduce load on the intervertebral disks, includes",09-10-2025
L0470007004,"Fitting and shaping the frame, prefabricated, includes fitting and adjustment",09-10-2025
L0472001003,"Tlso, triplanar control, hyperextension, rigid anterior and lateral frame",09-10-2025
L0472002004,Extends from symphysis pubis to sternal notch with two anterior components (one,09-10-2025
L0472003004,"Pubic and one sternal), posterior and lateral pads with straps and closures,",09-10-2025
L0472004004,"Limits spinal flexion, restricts gross trunk motion in sagittal, coronal, and",09-10-2025
L0472005004,"Transverse planes, includes fitting and shaping the frame, prefabricated,",09-10-2025
L0472006004,Includes fitting and adjustment,09-10-2025
L0480001003,"Tlso, triplanar control, one piece rigid plastic shell without interface liner,",09-10-2025
L0480002004,"With multiple straps and closures, posterior extends from sacrococcygeal",09-10-2025
L0480003004,"Junction and terminates just inferior to scapular spine, anterior extends from",09-10-2025
L0480004004,"Symphysis pubis to sternal notch, anterior or posterior opening, restricts",09-10-2025
L0480005004,"Gross trunk motion in sagittal, coronal, and transverse planes, includes a",09-10-2025
L0480006004,"Carved plaster or cad-cam model, custom fabricated",09-10-2025
L0482001003,"Tlso, triplanar control, one piece rigid plastic shell with interface liner,",09-10-2025
L0482002004,"Multiple straps and closures, posterior extends from sacrococcygeal junction",09-10-2025
L0482003004,"And terminates just inferior to scapular spine, anterior extends from symphysis",09-10-2025
L0482004004,"Pubis to sternal notch, anterior or posterior opening, restricts gross trunk",09-10-2025
L0482005004,"Motion in sagittal, coronal, and transverse planes, includes a carved plaster",09-10-2025
L0482006004,"Or cad-cam model, custom fabricated",09-10-2025
L0484001003,"Tlso, triplanar control, two piece rigid plastic shell without interface liner,",09-10-2025
L0484002004,"With multiple straps and closures, posterior extends from sacrococcygeal",09-10-2025
L0484003004,"Junction and terminates just inferior to scapular spine, anterior extends from",09-10-2025
L0484004004,"Symphysis pubis to sternal notch, lateral strength is enhanced by overlapping",09-10-2025
L0484005004,"Plastic, restricts gross trunk motion in the sagittal, coronal, and transverse",09-10-2025
L0484006004,"Planes, includes a carved plaster or cad-cam model, custom fabricated",09-10-2025
L0486001003,"Tlso, triplanar control, two piece rigid plastic shell with interface liner,",09-10-2025
L0486002004,"Multiple straps and closures, posterior extends from sacrococcygeal junction",09-10-2025
L0486003004,"And terminates just inferior to scapular spine, anterior extends from symphysis",09-10-2025
L0486004004,"Pubis to sternal notch, lateral strength is enhanced by overlapping plastic,",09-10-2025
L0486005004,"Restricts gross trunk motion in the sagittal, coronal, and transverse planes,",09-10-2025
L0486006004,"Includes a carved plaster or cad-cam model, custom fabricated",09-10-2025
L0488001003,"Tlso, triplanar control, one piece rigid plastic shell with interface liner,",09-10-2025
L0488002004,"Multiple straps and closures, posterior extends from sacrococcygeal junction",09-10-2025
L0488003004,"And terminates just inferior to scapular spine, anterior extends from symphysis",09-10-2025
L0488004004,"Pubis to sternal notch, anterior or posterior opening, restricts gross trunk",09-10-2025
L0488005004,"Motion in sagittal, coronal, and transverse planes, prefabricated, includes",09-10-2025
L0488006004,Fitting and adjustment,09-10-2025
L0490001003,"Tlso, sagittal-coronal control, one piece rigid plastic shell, with overlapping",09-10-2025
L0490002004,"Reinforced anterior, with multiple straps and closures, posterior extends from",09-10-2025
L0490003004,"Sacrococcygeal junction and terminates at or before the t-9 vertebra, anterior",09-10-2025
L0490004004,"Extends from symphysis pubis to xiphoid, anterior opening, restricts gross",09-10-2025
L0490005004,"Trunk motion in sagittal and coronal planes, prefabricated, includes fitting",09-10-2025
L0490006004,And adjustment,09-10-2025
L0491001003,"Tlso, sagittal-coronal control, modular segmented spinal system, two rigid",09-10-2025
L0491002004,"Plastic shells, posterior extends from the sacrococcygeal junction and",09-10-2025
L0491003004,"Terminates just inferior to the scapular spine, anterior extends from the",09-10-2025
L0491004004,"Symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the",09-10-2025
L0491005004,"Sagittal and coronal planes, lateral strength is provided by overlapping",09-10-2025
L0491006004,"Plastic and stabilizing closures, includes straps and closures, prefabricated,",09-10-2025
L0491007004,Includes fitting and adjustment,09-10-2025
L0492001003,"Tlso, sagittal-coronal control, modular segmented spinal system, three rigid",09-10-2025
L0492002004,"Plastic shells, posterior extends from the sacrococcygeal junction and",09-10-2025
L0492003004,"Terminates just inferior to the scapular spine, anterior extends from the",09-10-2025
L0492004004,"Symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the",09-10-2025
L0492005004,"Sagittal and coronal planes, lateral strength is provided by overlapping",09-10-2025
L0492006004,"Plastic and stabilizing closures, includes straps and closures, prefabricated,",09-10-2025
L0492007004,Includes fitting and adjustment,09-10-2025
L0621001003,"Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion",09-10-2025
L0621002004,"About the sacroiliac joint, includes straps, closures, may include pendulous",09-10-2025
L0621003004,"Abdomen design, prefabricated, off-the-shelf",09-10-2025
L0622001003,"Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion",09-10-2025
L0622002004,"About the sacroiliac joint, includes straps, closures, may include pendulous",09-10-2025
L0622003004,"Abdomen design, custom fabricated",09-10-2025
L0623001003,"Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid",09-10-2025
L0623002004,"Panels over the sacrum and abdomen, reduces motion about the sacroiliac joint,",09-10-2025
L0623003004,"Includes straps, closures, may include pendulous abdomen design, prefabricated,",09-10-2025
L0623004004,Off-the-shelf,09-10-2025
L0624001003,"Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid",09-10-2025
L0624002004,"Panels placed over the sacrum and abdomen, reduces motion about the sacroiliac",09-10-2025
L0624003004,"Joint, includes straps, closures, may include pendulous abdomen design, custom",09-10-2025
L0624004004,Fabricated,09-10-2025
L0625001003,"Lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1",09-10-2025
L0625002004,"To below l-5 vertebra, produces intracavitary pressure to reduce load on the",09-10-2025
L0625003004,"Intervertebral discs, includes straps, closures, may include pendulous abdomen",09-10-2025
L0625004004,"Design, shoulder straps, stays, prefabricated, off-the-shelf",09-10-2025
L0626001003,"Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior",09-10-2025
L0626002004,"Extends from l-1 to below l-5 vertebra, produces intracavitary pressure to",09-10-2025
L0626003004,"Reduce load on the intervertebral discs, includes straps, closures, may include",09-10-2025
L0626004004,"Padding, stays, shoulder straps, pendulous abdomen design, prefabricated item",09-10-2025
L0626005004,"That has been trimmed, bent, molded, assembled, or otherwise customized to fit",09-10-2025
L0626006004,A specific patient by an individual with expertise,09-10-2025
L0627001003,"Lumbar orthosis, sagittal control, with rigid anterior and posterior panels,",09-10-2025
L0627002004,"Posterior extends from l-1 to below l-5 vertebra, produces intracavitary",09-10-2025
L0627003004,"Pressure to reduce load on the intervertebral discs, includes straps, closures,",09-10-2025
L0627004004,"May include padding, shoulder straps, pendulous abdomen design, prefabricated",09-10-2025
L0627005004,"Item that has been trimmed, bent, molded, assembled, or otherwise customized to",09-10-2025
L0627006004,Fit a specific patient by an individual with expertise,09-10-2025
L0628001003,"Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior",09-10-2025
L0628002004,"Extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary",09-10-2025
L0628003004,"Pressure to reduce load on the intervertebral discs, includes straps, closures,",09-10-2025
L0628004004,"May include stays, shoulder straps, pendulous abdomen design, prefabricated,",09-10-2025
L0628005004,Off-the-shelf,09-10-2025
L0629001003,"Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior",09-10-2025
L0629002004,"Extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary",09-10-2025
L0629003004,"Pressure to reduce load on the intervertebral discs, includes straps, closures,",09-10-2025
L0629004004,"May include stays, shoulder straps, pendulous abdomen design, custom fabricated",09-10-2025
L0630001003,"Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s),",09-10-2025
L0630002004,"Posterior extends from sacrococcygeal junction to t-9 vertebra, produces",09-10-2025
L0630003004,"Intracavitary pressure to reduce load on the intervertebral discs, includes",09-10-2025
L0630004004,"Straps, closures, may include padding, stays, shoulder straps, pendulous",09-10-2025
L0630005004,"Abdomen design, prefabricated item that has been trimmed, bent, molded,",09-10-2025
L0630006004,"Assembled, or otherwise customized to fit a specific patient by an individual",09-10-2025
L0630007004,With expertise,09-10-2025
L0631001003,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior",09-10-2025
L0631002004,"Panels, posterior extends from sacrococcygeal junction to t-9 vertebra,",09-10-2025
L0631003004,"Produces intracavitary pressure to reduce load on the intervertebral discs,",09-10-2025
L0631004004,"Includes straps, closures, may include padding, shoulder straps, pendulous",09-10-2025
L0631005004,"Abdomen design, prefabricated item that has been trimmed, bent, molded,",09-10-2025
L0631006004,"Assembled, or otherwise customized to fit a specific patient by an individual",09-10-2025
L0631007004,With expertise,09-10-2025
L0632001003,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior",09-10-2025
L0632002004,"Panels, posterior extends from sacrococcygeal junction to t-9 vertebra,",09-10-2025
L0632003004,"Produces intracavitary pressure to reduce load on the intervertebral discs,",09-10-2025
L0632004004,"Includes straps, closures, may include padding, shoulder straps, pendulous",09-10-2025
L0632005004,"Abdomen design, custom fabricated",09-10-2025
L0633001003,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior",09-10-2025
L0633002004,"Frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra,",09-10-2025
L0633003004,"Lateral strength provided by rigid lateral frame/panels, produces intracavitary",09-10-2025
L0633004004,"Pressure to reduce load on intervertebral discs, includes straps, closures, may",09-10-2025
L0633005004,"Include padding, stays, shoulder straps, pendulous abdomen design,",09-10-2025
L0633006004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L0633007004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L0634001003,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior",09-10-2025
L0634002004,"Frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra,",09-10-2025
L0634003004,"Lateral strength provided by rigid lateral frame/panel(s), produces",09-10-2025
L0634004004,"Intracavitary pressure to reduce load on intervertebral discs, includes straps,",09-10-2025
L0634005004,"Closures, may include padding, stays, shoulder straps, pendulous abdomen",09-10-2025
L0634006004,"Design, custom fabricated",09-10-2025
L0635001003,"Lumbar-sacral orthosis, sagittal-coronal control, lumbar flexion, rigid",09-10-2025
L0635002004,"Posterior frame/panel(s), lateral articulating design to flex the lumbar spine,",09-10-2025
L0635003004,"Posterior extends from sacrococcygeal junction to t-9 vertebra, lateral",09-10-2025
L0635004004,"Strength provided by rigid lateral frame/panel(s), produces intracavitary",09-10-2025
L0635005004,"Pressure to reduce load on intervertebral discs, includes straps, closures, may",09-10-2025
L0635006004,"Include padding, anterior panel, pendulous abdomen design, prefabricated,",09-10-2025
L0635007004,Includes fitting and adjustment,09-10-2025
L0636001003,"Lumbar sacral orthosis, sagittal-coronal control, lumbar flexion, rigid",09-10-2025
L0636002004,"Posterior frame/panels, lateral articulating design to flex the lumbar spine,",09-10-2025
L0636003004,"Posterior extends from sacrococcygeal junction to t-9 vertebra, lateral",09-10-2025
L0636004004,"Strength provided by rigid lateral frame/panels, produces intracavitary",09-10-2025
L0636005004,"Pressure to reduce load on intervertebral discs, includes straps, closures, may",09-10-2025
L0636006004,"Include padding, anterior panel, pendulous abdomen design, custom fabricated",09-10-2025
L0637001003,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and",09-10-2025
L0637002004,"Posterior frame/panels, posterior extends from sacrococcygeal junction to t-9",09-10-2025
L0637003004,"Vertebra, lateral strength provided by rigid lateral frame/panels, produces",09-10-2025
L0637004004,"Intracavitary pressure to reduce load on intervertebral discs, includes straps,",09-10-2025
L0637005004,"Closures, may include padding, shoulder straps, pendulous abdomen design,",09-10-2025
L0637006004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L0637007004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L0638001003,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and",09-10-2025
L0638002004,"Posterior frame/panels, posterior extends from sacrococcygeal junction to t-9",09-10-2025
L0638003004,"Vertebra, lateral strength provided by rigid lateral frame/panels, produces",09-10-2025
L0638004004,"Intracavitary pressure to reduce load on intervertebral discs, includes straps,",09-10-2025
L0638005004,"Closures, may include padding, shoulder straps, pendulous abdomen design,",09-10-2025
L0638006004,Custom fabricated,09-10-2025
L0639001003,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s),",09-10-2025
L0639002004,"Posterior extends from sacrococcygeal junction to t-9 vertebra, anterior",09-10-2025
L0639003004,"Extends from symphysis pubis to xyphoid, produces intracavitary pressure to",09-10-2025
L0639004004,"Reduce load on the intervertebral discs, overall strength is provided by",09-10-2025
L0639005004,"Overlapping rigid material and stabilizing closures, includes straps, closures,",09-10-2025
L0639006004,"May include soft interface, pendulous abdomen design, prefabricated item that",09-10-2025
L0639007004,"Has been trimmed, bent, molded, assembled, or otherwise customized to fit a",09-10-2025
L0639008004,Specific patient by an individual with expertise,09-10-2025
L0640001003,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s),",09-10-2025
L0640002004,"Posterior extends from sacrococcygeal junction to t-9 vertebra, anterior",09-10-2025
L0640003004,"Extends from symphysis pubis to xyphoid, produces intracavitary pressure to",09-10-2025
L0640004004,"Reduce load on the intervertebral discs, overall strength is provided by",09-10-2025
L0640005004,"Overlapping rigid material and stabilizing closures, includes straps, closures,",09-10-2025
L0640006004,"May include soft interface, pendulous abdomen design, custom fabricated",09-10-2025
L0641001003,"Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior",09-10-2025
L0641002004,"Extends from l-1 to below l-5 vertebra, produces intracavitary pressure to",09-10-2025
L0641003004,"Reduce load on the intervertebral discs, includes straps, closures, may include",09-10-2025
L0641004004,"Padding, stays, shoulder straps, pendulous abdomen design, prefabricated,",09-10-2025
L0641005004,Off-the-shelf,09-10-2025
L0642001003,"Lumbar orthosis, sagittal control, with rigid anterior and posterior panels,",09-10-2025
L0642002004,"Posterior extends from l-1 to below l-5 vertebra, produces intracavitary",09-10-2025
L0642003004,"Pressure to reduce load on the intervertebral discs, includes straps, closures,",09-10-2025
L0642004004,"May include padding, shoulder straps, pendulous abdomen design, prefabricated,",09-10-2025
L0642005004,Off-the-shelf,09-10-2025
L0643001003,"Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s),",09-10-2025
L0643002004,"Posterior extends from sacrococcygeal junction to t-9 vertebra, produces",09-10-2025
L0643003004,"Intracavitary pressure to reduce load on the intervertebral discs, includes",09-10-2025
L0643004004,"Straps, closures, may include padding, stays, shoulder straps, pendulous",09-10-2025
L0643005004,"Abdomen design, prefabricated, off-the-shelf",09-10-2025
L0648001003,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior",09-10-2025
L0648002004,"Panels, posterior extends from sacrococcygeal junction to t-9 vertebra,",09-10-2025
L0648003004,"Produces intracavitary pressure to reduce load on the intervertebral discs,",09-10-2025
L0648004004,"Includes straps, closures, may include padding, shoulder straps, pendulous",09-10-2025
L0648005004,"Abdomen design, prefabricated, off-the-shelf",09-10-2025
L0649001003,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior",09-10-2025
L0649002004,"Frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra,",09-10-2025
L0649003004,"Lateral strength provided by rigid lateral frame/panels, produces intracavitary",09-10-2025
L0649004004,"Pressure to reduce load on intervertebral discs, includes straps, closures, may",09-10-2025
L0649005004,"Include padding, stays, shoulder straps, pendulous abdomen design,",09-10-2025
L0649006004,"Prefabricated, off-the-shelf",09-10-2025
L0650001003,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and",09-10-2025
L0650002004,"Posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9",09-10-2025
L0650003004,"Vertebra, lateral strength provided by rigid lateral frame/panel(s), produces",09-10-2025
L0650004004,"Intracavitary pressure to reduce load on intervertebral discs, includes straps,",09-10-2025
L0650005004,"Closures, may include padding, shoulder straps, pendulous abdomen design,",09-10-2025
L0650006004,"Prefabricated, off-the-shelf",09-10-2025
L0651001003,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s),",09-10-2025
L0651002004,"Posterior extends from sacrococcygeal junction to t-9 vertebra, anterior",09-10-2025
L0651003004,"Extends from symphysis pubis to xyphoid, produces intracavitary pressure to",09-10-2025
L0651004004,"Reduce load on the intervertebral discs, overall strength is provided by",09-10-2025
L0651005004,"Overlapping rigid material and stabilizing closures, includes straps, closures,",09-10-2025
L0651006004,"May include soft interface, pendulous abdomen design, prefabricated,",09-10-2025
L0651007004,Off-the-shelf,09-10-2025
L0700001003,"Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral",09-10-2025
L0700002004,"Control, molded to patient model, (minerva type)",09-10-2025
L0710001003,"Ctlso, anterior-posterior-lateral-control, molded to patient model, with",09-10-2025
L0710002004,"Interface material, (minerva type)",09-10-2025
L0720001003,"Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral",09-10-2025
L0720002004,"Control, prefabricated item that has been trimmed, bent, molded, assembled, or",09-10-2025
L0720003004,Otherwise customized to fit a specific patient by an individual with expertise,09-10-2025
L0810001003,"Halo procedure, cervical halo incorporated into jacket vest",09-10-2025
L0820001003,"Halo procedure, cervical halo incorporated into plaster body jacket",09-10-2025
L0830001003,"Halo procedure, cervical halo incorporated into milwaukee type orthosis",09-10-2025
L0859001003,"Addition to halo procedure, magnetic resonance image compatible systems, rings",09-10-2025
L0859002004,"And pins, any material",09-10-2025
L0861001003,"Addition to halo procedure, replacement liner/interface material",09-10-2025
L0970001003,"Tlso, corset front",09-10-2025
L0972001003,"Lso, corset front",09-10-2025
L0974001003,"Tlso, full corset",09-10-2025
L0976001003,"Lso, full corset",09-10-2025
L0978001003,Axillary crutch extension,09-10-2025
L0980001003,"Peroneal straps, prefabricated, off-the-shelf, pair",09-10-2025
L0982001003,"Stocking supporter grips, prefabricated, off-the-shelf, set of four (4)",09-10-2025
L0984001003,"Protective body sock, prefabricated, off-the-shelf, each",09-10-2025
L0999001003,"Addition to spinal orthosis, not otherwise specified",09-10-2025
L1000001003,"Cervical-thoracic-lumbar-sacral orthosis (ctlso) (milwaukee), inclusive of",09-10-2025
L1000002004,"Furnishing initial orthosis, including model",09-10-2025
L1001001003,"Cervical thoracic lumbar sacral orthosis, immobilizer, infant size,",09-10-2025
L1001002004,"Prefabricated, includes fitting and adjustment",09-10-2025
L1005001003,"Tension based scoliosis orthosis and accessory pads, includes fitting and",09-10-2025
L1005002004,Adjustment,09-10-2025
L1006001003,"Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame,",09-10-2025
L1006002004,"Extends from axilla to trochanter, includes all accessory pads, straps and",09-10-2025
L1006003004,"Interface, prefabricated item that has been trimmed, bent, molded, assembled,",09-10-2025
L1006004004,Or otherwise customized to fit a specific patient by an individual with,09-10-2025
L1006005004,Expertise,09-10-2025
L1007001003,"Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame,",09-10-2025
L1007002004,"Extends from axilla, to trochanter, includes all accessory pads, straps, and",09-10-2025
L1007003004,"Interface, custom fabricated",09-10-2025
L1010001003,Addition to cervical-thoracic-lumbar-sacral orthosis (ctlso) or scoliosis,09-10-2025
L1010002004,"Orthosis, axilla sling",09-10-2025
L1020001003,"Addition to ctlso or scoliosis orthosis, kyphosis pad",09-10-2025
L1025001003,"Addition to ctlso or scoliosis orthosis, kyphosis pad, floating",09-10-2025
L1030001003,"Addition to ctlso or scoliosis orthosis, lumbar bolster pad",09-10-2025
L1040001003,"Addition to ctlso or scoliosis orthosis, lumbar or lumbar rib pad",09-10-2025
L1050001003,"Addition to ctlso or scoliosis orthosis, sternal pad",09-10-2025
L1060001003,"Addition to ctlso or scoliosis orthosis, thoracic pad",09-10-2025
L1070001003,"Addition to ctlso or scoliosis orthosis, trapezius sling",09-10-2025
L1080001003,"Addition to ctlso or scoliosis orthosis, outrigger",09-10-2025
L1085001003,"Addition to ctlso or scoliosis orthosis, outrigger, bilateral with vertical",09-10-2025
L1085002004,Extensions,09-10-2025
L1090001003,"Addition to ctlso or scoliosis orthosis, lumbar sling",09-10-2025
L1100001003,"Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather",09-10-2025
L1110001003,"Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather,",09-10-2025
L1110002004,Molded to patient model,09-10-2025
L1120001003,"Addition to ctlso, scoliosis orthosis, cover for upright, each",09-10-2025
L1200001003,"Thoracic-lumbar-sacral-orthosis (tlso), inclusive of furnishing initial",09-10-2025
L1200002004,Orthosis only,09-10-2025
L1210001003,"Addition to tlso, (low profile), lateral thoracic extension",09-10-2025
L1220001003,"Addition to tlso, (low profile), anterior thoracic extension",09-10-2025
L1230001003,"Addition to tlso, (low profile), milwaukee type superstructure",09-10-2025
L1240001003,"Addition to tlso, (low profile), lumbar derotation pad",09-10-2025
L1250001003,"Addition to tlso, (low profile), anterior asis pad",09-10-2025
L1260001003,"Addition to tlso, (low profile), anterior thoracic derotation pad",09-10-2025
L1270001003,"Addition to tlso, (low profile), abdominal pad",09-10-2025
L1280001003,"Addition to tlso, (low profile), rib gusset (elastic), each",09-10-2025
L1290001003,"Addition to tlso, (low profile), lateral trochanteric pad",09-10-2025
L1300001003,"Other scoliosis procedure, body jacket molded to patient model",09-10-2025
L1310001003,"Other scoliosis procedure, post-operative body jacket",09-10-2025
L1320001003,"Thoracic, pectus carinatum orthosis, sternal compression, rigid circumferential",09-10-2025
L1320002004,"Frame with anterior and posterior rigid pads, custom fabricated",09-10-2025
L1499001003,"Spinal orthosis, not otherwise specified",09-10-2025
L1600001003,"Hip orthosis, abduction control of hip joints, flexible, frejka type with",09-10-2025
L1600002004,"Cover, prefabricated item that has been trimmed, bent, molded, assembled, or",09-10-2025
L1600003004,Otherwise customized to fit a specific patient by an inidividual with expertise,09-10-2025
L1610001003,"Hip orthosis, abduction control of hip joints, flexible, (frejka cover only),",09-10-2025
L1610002004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L1610003004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L1620001003,"Hip orthosis, abduction control of hip joints, flexible, (pavlik harness),",09-10-2025
L1620002004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L1620003004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L1630001003,"Hip orthosis, abduction control of hip joints, semi-flexible (von rosen type),",09-10-2025
L1630002004,Custom fabricated,09-10-2025
L1640001003,"Hip orthosis, abduction control of hip joints, static, pelvic band or spreader",09-10-2025
L1640002004,"Bar, thigh cuffs, custom fabricated",09-10-2025
L1650001003,"Hip orthosis, abduction control of hip joints, static, adjustable, (ilfled",09-10-2025
L1650002004,"Type), prefabricated, includes fitting and adjustment",09-10-2025
L1652001003,"Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar,",09-10-2025
L1652002004,"Adult size, prefabricated, includes fitting and adjustment, prefabricated item",09-10-2025
L1652003004,"That has been trimmed, bent, molded, assembled, or otherwise customized to fit",09-10-2025
L1652004004,A specific patient by an individual with expertise,09-10-2025
L1653001003,"Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar,",09-10-2025
L1653002004,"Adult size, prefabricated, off the shelf",09-10-2025
L1660001003,"Hip orthosis, abduction control of hip joints, static, plastic, prefabricated,",09-10-2025
L1660002004,Includes fitting and adjustment,09-10-2025
L1680001003,"Hip orthosis, abduction control of hip joints, dynamic, pelvic control,",09-10-2025
L1680002004,"Adjustable hip motion control, thigh cuffs (rancho hip action type), custom",09-10-2025
L1680003004,Fabricated,09-10-2025
L1681001003,"Hip orthosis, bilateral hip joints and thigh cuffs, adjustable flexion,",09-10-2025
L1681002004,"Extension, abduction control of hip joint, postoperative hip abduction type,",09-10-2025
L1681003004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L1681004004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L1685001003,"Hip orthosis, abduction control of hip joint, postoperative hip abduction type,",09-10-2025
L1685002004,Custom fabricated,09-10-2025
L1686001003,"Hip orthosis, abduction control of hip joint, postoperative hip abduction type,",09-10-2025
L1686002004,"Prefabricated, includes fitting and adjustment",09-10-2025
L1690001003,"Combination, bilateral, lumbo-sacral, hip, femur orthosis providing adduction",09-10-2025
L1690002004,"And internal rotation control, prefabricated, includes fitting and adjustment",09-10-2025
L1700001003,"Legg perthes orthosis, (toronto type), custom fabricated",09-10-2025
L1710001003,"Legg perthes orthosis, (newington type), custom fabricated",09-10-2025
L1720001003,"Legg perthes orthosis, trilateral, (tachdijan type), custom fabricated",09-10-2025
L1730001003,"Legg perthes orthosis, (scottish rite type), custom fabricated",09-10-2025
L1755001003,"Legg perthes orthosis, (patten bottom type), custom fabricated",09-10-2025
L1810001003,"Knee orthosis, elastic with joints, prefabricated item that has been trimmed,",09-10-2025
L1810002004,"Bent, molded, assembled, or otherwise customized to fit a specific patient by",09-10-2025
L1810003004,An individual with expertise,09-10-2025
L1812001003,"Knee orthosis, elastic with joints, prefabricated, off-the-shelf",09-10-2025
L1820001003,"Knee orthosis, elastic with condylar pads and joints, with or without patellar",09-10-2025
L1820002004,"Control, prefabricated item that has been trimmed, bent, molded, assembled, or",09-10-2025
L1820003004,Otherwise customized to fit a specific patient by an individual with expertise,09-10-2025
L1821001003,"Knee orthosis, elastic with condylar pads and joints, with or without patellar",09-10-2025
L1821002004,"Control, prefabricated, off the shelf",09-10-2025
L1830001003,"Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf",09-10-2025
L1831001003,"Knee orthosis, locking knee joint(s), positional orthosis, prefabricated,",09-10-2025
L1831002004,Includes fitting and adjustment,09-10-2025
L1832001003,"Knee orthosis, adjustable knee joints (unicentric or polycentric), positional",09-10-2025
L1832002004,"Orthosis, rigid support, prefabricated item that has been trimmed, bent,",09-10-2025
L1832003004,"Molded, assembled, or otherwise customized to fit a specific patient by an",09-10-2025
L1832004004,Individual with expertise,09-10-2025
L1833001003,"Knee orthosis, adjustable knee joints (unicentric or polycentric), positional",09-10-2025
L1833002004,"Orthosis, rigid support, prefabricated, off-the shelf",09-10-2025
L1834001003,"Knee orthosis, without knee joint, rigid, custom fabricated",09-10-2025
L1836001003,"Knee orthosis, rigid, without joint(s), includes soft interface material,",09-10-2025
L1836002004,"Prefabricated, off-the-shelf",09-10-2025
L1840001003,"Knee orthosis, derotation, medial-lateral, anterior cruciate ligament, custom",09-10-2025
L1840002004,Fabricated,09-10-2025
L1843001003,"Knee orthosis, single upright, thigh and calf, with adjustable flexion and",09-10-2025
L1843002004,"Extension joint (unicentric or polycentric), medial-lateral and rotation",09-10-2025
L1843003004,"Control, with or without varus/valgus adjustment, prefabricated item that has",09-10-2025
L1843004004,"Been trimmed, bent, molded, assembled, or otherwise customized to fit a",09-10-2025
L1843005004,Specific patient by an individual with expertise,09-10-2025
L1844001003,"Knee orthosis, single upright, thigh and calf, with adjustable flexion and",09-10-2025
L1844002004,"Extension joint (unicentric or polycentric), medial-lateral and rotation",09-10-2025
L1844003004,"Control, with or without varus/valgus adjustment, custom fabricated",09-10-2025
L1845001003,"Knee orthosis, double upright, thigh and calf, with adjustable flexion and",09-10-2025
L1845002004,"Extension joint (unicentric or polycentric), medial-lateral and rotation",09-10-2025
L1845003004,"Control, with or without varus/valgus adjustment, prefabricated item that has",09-10-2025
L1845004004,"Been trimmed, bent, molded, assembled, or otherwise customized to fit a",09-10-2025
L1845005004,Specific patient by an individual with expertise,09-10-2025
L1846001003,"Knee orthosis, double upright, thigh and calf, with adjustable flexion and",09-10-2025
L1846002004,"Extension joint (unicentric or polycentric), medial-lateral and rotation",09-10-2025
L1846003004,"Control, with or without varus/valgus adjustment, custom fabricated",09-10-2025
L1847001003,"Knee orthosis, double upright with adjustable joint, with inflatable air",09-10-2025
L1847002004,"Support chamber(s), prefabricated item that has been trimmed, bent, molded,",09-10-2025
L1847003004,"Assembled, or otherwise customized to fit a specific patient by an individual",09-10-2025
L1847004004,With expertise,09-10-2025
L1848001003,"Knee orthosis, double upright with adjustable joint, with inflatable air",09-10-2025
L1848002004,"Support chamber(s), prefabricated, off-the-shelf",09-10-2025
L1850001003,"Knee orthosis, swedish type, prefabricated, off-the-shelf",09-10-2025
L1851001003,"Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and",09-10-2025
L1851002004,"Extension joint (unicentric or polycentric), medial-lateral and rotation",09-10-2025
L1851003004,"Control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",09-10-2025
L1852001003,"Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and",09-10-2025
L1852002004,"Extension joint (unicentric or polycentric), medial-lateral and rotation",09-10-2025
L1852003004,"Control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",09-10-2025
L1860001003,"Knee orthosis, modification of supracondylar prosthetic socket, custom",09-10-2025
L1860002004,Fabricated (sk),09-10-2025
L1900001003,"Ankle foot orthosis, spring wire, dorsiflexion assist calf band, custom",09-10-2025
L1900002004,Fabricated,09-10-2025
L1902001003,"Ankle orthosis, ankle gauntlet or similar, with or without joints,",09-10-2025
L1902002004,"Prefabricated, off-the-shelf",09-10-2025
L1904001003,"Ankle orthosis, ankle gauntlet or similar, with or without joints, custom",09-10-2025
L1904002004,Fabricated,09-10-2025
L1906001003,"Ankle foot orthosis, multiligamentous ankle support, prefabricated,",09-10-2025
L1906002004,Off-the-shelf,09-10-2025
L1907001003,"Ankle orthosis, supramalleolar with straps, with or without interface/pads,",09-10-2025
L1907002004,Custom fabricated,09-10-2025
L1910001003,"Ankle foot orthosis, posterior, single bar, clasp attachment to shoe counter,",09-10-2025
L1910002004,"Prefabricated, includes fitting and adjustment",09-10-2025
L1920001003,"Ankle foot orthosis, single upright with static or adjustable stop (phelps or",09-10-2025
L1920002004,"Perlstein type), custom fabricated",09-10-2025
L1930001003,"Ankle foot orthosis, plastic or other material, prefabricated, includes fitting",09-10-2025
L1930002004,And adjustment,09-10-2025
L1932001003,"Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal",09-10-2025
L1932002004,"Material, prefabricated item that has been trimmed, bent, molded, assembled, or",09-10-2025
L1932003004,Otherwise customized to fit a specific patient by an individual with expertise,09-10-2025
L1933001003,"Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal",09-10-2025
L1933002004,"Material, prefabricated, off-the-shelf",09-10-2025
L1940001003,"Ankle foot orthosis, plastic or other material, custom fabricated",09-10-2025
L1945001003,"Ankle foot orthosis, plastic, rigid anterior tibial section (floor reaction),",09-10-2025
L1945002004,Custom fabricated,09-10-2025
L1950001003,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type),",09-10-2025
L1950002004,"Plastic, custom fabricated",09-10-2025
L1951001003,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type),",09-10-2025
L1951002004,"Plastic or other material, prefabricated item that has been trimmed, bent,",09-10-2025
L1951003004,"Molded, assembled, or otherwise customized to fit a specific patient by an",09-10-2025
L1951004004,Individual with expertise,09-10-2025
L1952001003,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type),",09-10-2025
L1952002004,"Plastic or other material, prefabricated, off-the-shelf",09-10-2025
L1960001003,"Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated",09-10-2025
L1970001003,"Ankle foot orthosis, plastic with ankle joint, custom fabricated",09-10-2025
L1971001003,"Ankle foot orthosis, plastic or other material with ankle joint, with or",09-10-2025
L1971002004,"Without dorsiflexion assist, prefabricated, includes fitting and adjustment",09-10-2025
L1980001003,"Ankle foot orthosis, single upright free plantar dorsiflexion, solid stirrup,",09-10-2025
L1980002004,"Calf band/cuff (single bar 'bk' orthosis), custom fabricated",09-10-2025
L1990001003,"Ankle foot orthosis, double upright free plantar dorsiflexion, solid stirrup,",09-10-2025
L1990002004,"Calf band/cuff (double bar 'bk' orthosis), custom fabricated",09-10-2025
L2000001003,"Knee ankle foot orthosis, single upright, free knee, free ankle, solid stirrup,",09-10-2025
L2000002004,"Thigh and calf bands/cuffs (single bar 'ak' orthosis), custom fabricated",09-10-2025
L2005001003,"Knee ankle foot orthosis, any material, single or double upright, stance",09-10-2025
L2005002004,"Control, automatic lock and swing phase release, any type activation, includes",09-10-2025
L2005003004,"Ankle joint, any type, custom fabricated",09-10-2025
L2006001003,"Knee ankle foot device, any material, single or double upright, swing and",09-10-2025
L2006002004,"Stance phase microprocessor control with adjustability, includes all components",09-10-2025
L2006003004,"(e.g., sensors, batteries, charger), any type activation, with or without ankle",09-10-2025
L2006004004,"Joint(s), custom fabricated",09-10-2025
L2010001003,"Knee ankle foot orthosis, single upright, free ankle, solid stirrup, thigh and",09-10-2025
L2010002004,"Calf bands/cuffs (single bar 'ak' orthosis), without knee joint, custom",09-10-2025
L2010003004,Fabricated,09-10-2025
L2020001003,"Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and",09-10-2025
L2020002004,"Calf bands/cuffs (double bar 'ak' orthosis), custom fabricated",09-10-2025
L2030001003,"Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and",09-10-2025
L2030002004,"Calf bands/cuffs, (double bar 'ak' orthosis), without knee joint, custom",09-10-2025
L2030003004,Fabricated,09-10-2025
L2034001003,"Knee ankle foot orthosis, full plastic, single upright, with or without free",09-10-2025
L2034002004,"Motion knee, medial lateral rotation control, with or without free motion",09-10-2025
L2034003004,"Ankle, custom fabricated",09-10-2025
L2035001003,"Knee ankle foot orthosis, full plastic, static (pediatric size), without free",09-10-2025
L2035002004,"Motion ankle, prefabricated, includes fitting and adjustment",09-10-2025
L2036001003,"Knee ankle foot orthosis, full plastic, double upright, with or without free",09-10-2025
L2036002004,"Motion knee, with or without free motion ankle, custom fabricated",09-10-2025
L2037001003,"Knee ankle foot orthosis, full plastic, single upright, with or without free",09-10-2025
L2037002004,"Motion knee, with or without free motion ankle, custom fabricated",09-10-2025
L2038001003,"Knee ankle foot orthosis, full plastic, with or without free motion knee,",09-10-2025
L2038002004,"Multi-axis ankle, custom fabricated",09-10-2025
L2040001003,"Hip knee ankle foot orthosis, torsion control, bilateral rotation straps,",09-10-2025
L2040002004,"Pelvic band/belt, custom fabricated",09-10-2025
L2050001003,"Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, hip",09-10-2025
L2050002004,"Joint, pelvic band/belt, custom fabricated",09-10-2025
L2060001003,"Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, ball",09-10-2025
L2060002004,"Bearing hip joint, pelvic band/ belt, custom fabricated",09-10-2025
L2070001003,"Hip knee ankle foot orthosis, torsion control, unilateral rotation straps,",09-10-2025
L2070002004,"Pelvic band/belt, custom fabricated",09-10-2025
L2080001003,"Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, hip",09-10-2025
L2080002004,"Joint, pelvic band/belt, custom fabricated",09-10-2025
L2090001003,"Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, ball",09-10-2025
L2090002004,"Bearing hip joint, pelvic band/ belt, custom fabricated",09-10-2025
L2106001003,"Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis,",09-10-2025
L2106002004,"Thermoplastic type casting material, custom fabricated",09-10-2025
L2108001003,"Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, custom",09-10-2025
L2108002004,Fabricated,09-10-2025
L2112001003,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, soft,",09-10-2025
L2112002004,"Prefabricated, includes fitting and adjustment",09-10-2025
L2114001003,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, semi-rigid,",09-10-2025
L2114002004,"Prefabricated, includes fitting and adjustment",09-10-2025
L2116001003,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, rigid,",09-10-2025
L2116002004,"Prefabricated, includes fitting and adjustment",09-10-2025
L2126001003,"Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis,",09-10-2025
L2126002004,"Thermoplastic type casting material, custom fabricated",09-10-2025
L2128001003,"Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis,",09-10-2025
L2128002004,Custom fabricated,09-10-2025
L2132001003,"Kafo, fracture orthosis, femoral fracture cast orthosis, soft, prefabricated,",09-10-2025
L2132002004,Includes fitting and adjustment,09-10-2025
L2134001003,"Kafo, fracture orthosis, femoral fracture cast orthosis, semi-rigid,",09-10-2025
L2134002004,"Prefabricated, includes fitting and adjustment",09-10-2025
L2136001003,"Kafo, fracture orthosis, femoral fracture cast orthosis, rigid, prefabricated,",09-10-2025
L2136002004,Includes fitting and adjustment,09-10-2025
L2180001003,"Addition to lower extremity fracture orthosis, plastic shoe insert with ankle",09-10-2025
L2180002004,Joints,09-10-2025
L2182001003,"Addition to lower extremity fracture orthosis, drop lock knee joint",09-10-2025
L2184001003,"Addition to lower extremity fracture orthosis, limited motion knee joint",09-10-2025
L2186001003,"Addition to lower extremity fracture orthosis, adjustable motion knee joint,",09-10-2025
L2186002004,Lerman type,09-10-2025
L2188001003,"Addition to lower extremity fracture orthosis, quadrilateral brim",09-10-2025
L2190001003,"Addition to lower extremity fracture orthosis, waist belt",09-10-2025
L2192001003,"Addition to lower extremity fracture orthosis, hip joint, pelvic band, thigh",09-10-2025
L2192002004,"Flange, and pelvic belt",09-10-2025
L2200001003,"Addition to lower extremity, limited ankle motion, each joint",09-10-2025
L2210001003,"Addition to lower extremity, dorsiflexion assist (plantar flexion resist), each",09-10-2025
L2210002004,Joint,09-10-2025
L2220001003,"Addition to lower extremity, dorsiflexion and plantar flexion assist/resist,",09-10-2025
L2220002004,Each joint,09-10-2025
L2230001003,"Addition to lower extremity, split flat caliper stirrups and plate attachment",09-10-2025
L2232001003,"Addition to lower extremity orthosis, rocker bottom for total contact ankle",09-10-2025
L2232002004,"Foot orthosis, for custom fabricated orthosis only",09-10-2025
L2240001003,"Addition to lower extremity, round caliper and plate attachment",09-10-2025
L2250001003,"Addition to lower extremity, foot plate, molded to patient model, stirrup",09-10-2025
L2250002004,Attachment,09-10-2025
L2260001003,"Addition to lower extremity, reinforced solid stirrup (scott-craig type)",09-10-2025
L2265001003,"Addition to lower extremity, long tongue stirrup",09-10-2025
L2270001003,"Addition to lower extremity, varus/valgus correction ('t') strap, padded/lined",09-10-2025
L2270002004,Or malleolus pad,09-10-2025
L2275001003,"Addition to lower extremity, varus/valgus correction, plastic modification,",09-10-2025
L2275002004,Padded/lined,09-10-2025
L2280001003,"Addition to lower extremity, molded inner boot",09-10-2025
L2300001003,"Addition to lower extremity, abduction bar (bilateral hip involvement),",09-10-2025
L2300002004,"Jointed, adjustable",09-10-2025
L2310001003,"Addition to lower extremity, abduction bar-straight",09-10-2025
L2320001003,"Addition to lower extremity, non-molded lacer, for custom fabricated orthosis",09-10-2025
L2320002004,Only,09-10-2025
L2330001003,"Addition to lower extremity, lacer molded to patient model, for custom",09-10-2025
L2330002004,Fabricated orthosis only,09-10-2025
L2335001003,"Addition to lower extremity, anterior swing band",09-10-2025
L2340001003,"Addition to lower extremity, pre-tibial shell, molded to patient model",09-10-2025
L2350001003,"Addition to lower extremity, prosthetic type, (bk) socket, molded to patient",09-10-2025
L2350002004,"Model, (used for 'ptb' 'afo' orthoses)",09-10-2025
L2360001003,"Addition to lower extremity, extended steel shank",09-10-2025
L2370001003,"Addition to lower extremity, patten bottom",09-10-2025
L2375001003,"Addition to lower extremity, torsion control, ankle joint and half solid stirru",09-10-2025
L2380001003,"Addition to lower extremity, torsion control, straight knee joint, each joint",09-10-2025
L2385001003,"Addition to lower extremity, straight knee joint, heavy duty, each joint",09-10-2025
L2387001003,"Addition to lower extremity, polycentric knee joint, for custom fabricated knee",09-10-2025
L2387002004,"Ankle foot orthosis, each joint",09-10-2025
L2390001003,"Addition to lower extremity, offset knee joint, each joint",09-10-2025
L2395001003,"Addition to lower extremity, offset knee joint, heavy duty, each joint",09-10-2025
L2397001003,"Addition to lower extremity orthosis, suspension sleeve",09-10-2025
L2405001003,"Addition to knee joint, drop lock, each",09-10-2025
L2415001003,"Addition to knee lock with integrated release mechanism (bail, cable, or",09-10-2025
L2415002004,"Equal), any material, each joint",09-10-2025
L2425001003,"Addition to knee joint, disc or dial lock for adjustable knee flexion, each",09-10-2025
L2425002004,Joint,09-10-2025
L2430001003,"Addition to knee joint, ratchet lock for active and progressive knee extension,",09-10-2025
L2430002004,Each joint,09-10-2025
L2492001003,"Addition to knee joint, lift loop for drop lock ring",09-10-2025
L2500001003,"Addition to lower extremity, thigh/weight bearing, gluteal/ ischial weight",09-10-2025
L2500002004,"Bearing, ring",09-10-2025
L2510001003,"Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, molded",09-10-2025
L2510002004,To patient model,09-10-2025
L2520001003,"Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, custom",09-10-2025
L2520002004,Fitted,09-10-2025
L2525001003,"Addition to lower extremity, thigh/weight bearing, ischial containment/narrow",09-10-2025
L2525002004,M-l brim molded to patient model,09-10-2025
L2526001003,"Addition to lower extremity, thigh/weight bearing, ischial containment/narrow",09-10-2025
L2526002004,"M-l brim, custom fitted",09-10-2025
L2530001003,"Addition to lower extremity, thigh-weight bearing, lacer, non-molded",09-10-2025
L2540001003,"Addition to lower extremity, thigh/weight bearing, lacer, molded to patient",09-10-2025
L2540002004,Model,09-10-2025
L2550001003,"Addition to lower extremity, thigh/weight bearing, high roll cuff",09-10-2025
L2570001003,"Addition to lower extremity, pelvic control, hip joint, clevis type two",09-10-2025
L2570002004,"Position joint, each",09-10-2025
L2580001003,"Addition to lower extremity, pelvic control, pelvic sling",09-10-2025
L2600001003,"Addition to lower extremity, pelvic control, hip joint, clevis type, or thrust",09-10-2025
L2600002004,"Bearing, free, each",09-10-2025
L2610001003,"Addition to lower extremity, pelvic control, hip joint, clevis or thrust",09-10-2025
L2610002004,"Bearing, lock, each",09-10-2025
L2620001003,"Addition to lower extremity, pelvic control, hip joint, heavy duty, each",09-10-2025
L2622001003,"Addition to lower extremity, pelvic control, hip joint, adjustable flexion, eac",09-10-2025
L2624001003,"Addition to lower extremity, pelvic control, hip joint, adjustable flexion,",09-10-2025
L2624002004,"Extension, abduction control, each",09-10-2025
L2627001003,"Addition to lower extremity, pelvic control, plastic, molded to patient model,",09-10-2025
L2627002004,Reciprocating hip joint and cables,09-10-2025
L2628001003,"Addition to lower extremity, pelvic control, metal frame, reciprocating hip",09-10-2025
L2628002004,Joint and cables,09-10-2025
L2630001003,"Addition to lower extremity, pelvic control, band and belt, unilateral",09-10-2025
L2640001003,"Addition to lower extremity, pelvic control, band and belt, bilateral",09-10-2025
L2650001003,"Addition to lower extremity, pelvic and thoracic control, gluteal pad, each",09-10-2025
L2660001003,"Addition to lower extremity, thoracic control, thoracic band",09-10-2025
L2670001003,"Addition to lower extremity, thoracic control, paraspinal uprights",09-10-2025
L2680001003,"Addition to lower extremity, thoracic control, lateral support uprights",09-10-2025
L2750001003,"Addition to lower extremity orthosis, plating chrome or nickel, per bar",09-10-2025
L2755001003,"Addition to lower extremity orthosis, high strength, lightweight material, all",09-10-2025
L2755002004,"Hybrid lamination/prepreg composite, per segment, for custom fabricated",09-10-2025
L2755003004,Orthosis only,09-10-2025
L2760001003,"Addition to lower extremity orthosis, extension, per extension, per bar (for",09-10-2025
L2760002004,Lineal adjustment for growth),09-10-2025
L2768001003,"Orthotic side bar disconnect device, per bar",09-10-2025
L2780001003,"Addition to lower extremity orthosis, non-corrosive finish, per bar",09-10-2025
L2785001003,"Addition to lower extremity orthosis, drop lock retainer, each",09-10-2025
L2795001003,"Addition to lower extremity orthosis, knee control, full kneecap",09-10-2025
L2800001003,"Addition to lower extremity orthosis, knee control, knee cap, medial or lateral",09-10-2025
L2800002004,"Pull, for use with custom fabricated orthosis only",09-10-2025
L2810001003,"Addition to lower extremity orthosis, knee control, condylar pad",09-10-2025
L2820001003,"Addition to lower extremity orthosis, soft interface for molded plastic, below",09-10-2025
L2820002004,Knee section,09-10-2025
L2830001003,"Addition to lower extremity orthosis, soft interface for molded plastic, above",09-10-2025
L2830002004,Knee section,09-10-2025
L2840001003,"Addition to lower extremity orthosis, tibial length sock, fracture or equal,",09-10-2025
L2840002004,Each,09-10-2025
L2850001003,"Addition to lower extremity orthosis, femoral length sock, fracture or equal,",09-10-2025
L2850002004,Each,09-10-2025
L2861001003,"Addition to lower extremity joint, knee or ankle, concentric adjustable torsion",09-10-2025
L2861002004,"Style mechanism for custom fabricated orthotics only, each",09-10-2025
L2999001003,"Lower extremity orthoses, not otherwise specified",09-10-2025
L3000001003,"Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell,",09-10-2025
L3000002004,Each,09-10-2025
L3001001003,"Foot, insert, removable, molded to patient model, spenco, each",09-10-2025
L3002001003,"Foot, insert, removable, molded to patient model, plastazote or equal, each",09-10-2025
L3003001003,"Foot, insert, removable, molded to patient model, silicone gel, each",09-10-2025
L3010001003,"Foot, insert, removable, molded to patient model, longitudinal arch support,",09-10-2025
L3010002004,Each,09-10-2025
L3020001003,"Foot, insert, removable, molded to patient model, longitudinal/ metatarsal",09-10-2025
L3020002004,"Support, each",09-10-2025
L3030001003,"Foot, insert, removable, formed to patient foot, each",09-10-2025
L3031001003,"Foot, insert/plate, removable, addition to lower extremity orthosis, high",09-10-2025
L3031002004,"Strength, lightweight material, all hybrid lamination/prepreg composite, each",09-10-2025
L3040001003,"Foot, arch support, removable, premolded, longitudinal, each",09-10-2025
L3050001003,"Foot, arch support, removable, premolded, metatarsal, each",09-10-2025
L3060001003,"Foot, arch support, removable, premolded, longitudinal/ metatarsal, each",09-10-2025
L3070001003,"Foot, arch support, non-removable attached to shoe, longitudinal, each",09-10-2025
L3080001003,"Foot, arch support, non-removable attached to shoe, metatarsal, each",09-10-2025
L3090001003,"Foot, arch support, non-removable attached to shoe, longitudinal/metatarsal,",09-10-2025
L3090002004,Each,09-10-2025
L3100001003,"Hallus-valgus night dynamic splint, prefabricated, off-the-shelf",09-10-2025
L3140001003,"Foot, abduction rotation bar, including shoes",09-10-2025
L3150001003,"Foot, abduction rotation bar, without shoes",09-10-2025
L3160001003,"Foot, adjustable shoe-styled positioning device",09-10-2025
L3161001003,"Foot, adductus positioning device, adjustable",09-10-2025
L3170001003,"Foot, plastic, silicone or equal, heel stabilizer, prefabricated,",09-10-2025
L3170002004,"Off-the-shelf, each",09-10-2025
L3201001003,"Orthopedic shoe, oxford with supinator or pronator, infant",09-10-2025
L3202001003,"Orthopedic shoe, oxford with supinator or pronator, child",09-10-2025
L3203001003,"Orthopedic shoe, oxford with supinator or pronator, junior",09-10-2025
L3204001003,"Orthopedic shoe, hightop with supinator or pronator, infant",09-10-2025
L3206001003,"Orthopedic shoe, hightop with supinator or pronator, child",09-10-2025
L3207001003,"Orthopedic shoe, hightop with supinator or pronator, junior",09-10-2025
L3208001003,"Surgical boot, each, infant",09-10-2025
L3209001003,"Surgical boot, each, child",09-10-2025
L3211001003,"Surgical boot, each, junior",09-10-2025
L3212001003,"Benesch boot, pair, infant",09-10-2025
L3213001003,"Benesch boot, pair, child",09-10-2025
L3214001003,"Benesch boot, pair, junior",09-10-2025
L3215001003,"Orthopedic footwear, ladies shoe, oxford, each",09-10-2025
L3216001003,"Orthopedic footwear, ladies shoe, depth inlay, each",09-10-2025
L3217001003,"Orthopedic footwear, ladies shoe, hightop, depth inlay, each",09-10-2025
L3219001003,"Orthopedic footwear, mens shoe, oxford, each",09-10-2025
L3221001003,"Orthopedic footwear, mens shoe, depth inlay, each",09-10-2025
L3222001003,"Orthopedic footwear, mens shoe, hightop, depth inlay, each",09-10-2025
L3224001003,"Orthopedic footwear, woman's shoe, oxford, used as an integral part of a brace",09-10-2025
L3224002004,(orthosis),09-10-2025
L3225001003,"Orthopedic footwear, man's shoe, oxford, used as an integral part of a brace",09-10-2025
L3225002004,(orthosis),09-10-2025
L3230001003,"Orthopedic footwear, custom shoe, depth inlay, each",09-10-2025
L3250001003,"Orthopedic footwear, custom molded shoe, removable inner mold, prosthetic shoe,",09-10-2025
L3250002004,Each,09-10-2025
L3251001003,"Foot, shoe molded to patient model, silicone shoe, each",09-10-2025
L3252001003,"Foot, shoe molded to patient model, plastazote (or similar), custom fabricated,",09-10-2025
L3252002004,Each,09-10-2025
L3253001003,"Foot, molded shoe plastazote (or similar) custom fitted, each",09-10-2025
L3254001003,Non-standard size or width,09-10-2025
L3255001003,Non-standard size or length,09-10-2025
L3257001003,"Orthopedic footwear, additional charge for split size",09-10-2025
L3260001003,"Surgical boot/shoe, each",09-10-2025
L3265001003,"Plastazote sandal, each",09-10-2025
L3300001003,"Lift, elevation, heel, tapered to metatarsals, per inch",09-10-2025
L3310001003,"Lift, elevation, heel and sole, neoprene, per inch",09-10-2025
L3320001003,"Lift, elevation, heel and sole, cork, per inch",09-10-2025
L3330001003,"Lift, elevation, metal extension (skate)",09-10-2025
L3332001003,"Lift, elevation, inside shoe, tapered, up to one-half inch",09-10-2025
L3334001003,"Lift, elevation, heel, per inch",09-10-2025
L3340001003,"Heel wedge, sach",09-10-2025
L3350001003,Heel wedge,09-10-2025
L3360001003,"Sole wedge, outside sole",09-10-2025
L3370001003,"Sole wedge, between sole",09-10-2025
L3380001003,Clubfoot wedge,09-10-2025
L3390001003,Outflare wedge,09-10-2025
L3400001003,"Metatarsal bar wedge, rocker",09-10-2025
L3410001003,"Metatarsal bar wedge, between sole",09-10-2025
L3420001003,"Full sole and heel wedge, between sole",09-10-2025
L3430001003,"Heel, counter, plastic reinforced",09-10-2025
L3440001003,"Heel, counter, leather reinforced",09-10-2025
L3450001003,"Heel, sach cushion type",09-10-2025
L3455001003,"Heel, new leather, standard",09-10-2025
L3460001003,"Heel, new rubber, standard",09-10-2025
L3465001003,"Heel, thomas with wedge",09-10-2025
L3470001003,"Heel, thomas extended to ball",09-10-2025
L3480001003,"Heel, pad and depression for spur",09-10-2025
L3485001003,"Heel, pad, removable for spur",09-10-2025
L3500001003,"Orthopedic shoe addition, insole, leather",09-10-2025
L3510001003,"Orthopedic shoe addition, insole, rubber",09-10-2025
L3520001003,"Orthopedic shoe addition, insole, felt covered with leather",09-10-2025
L3530001003,"Orthopedic shoe addition, sole, half",09-10-2025
L3540001003,"Orthopedic shoe addition, sole, full",09-10-2025
L3550001003,"Orthopedic shoe addition, toe tap standard",09-10-2025
L3560001003,"Orthopedic shoe addition, toe tap, horseshoe",09-10-2025
L3570001003,"Orthopedic shoe addition, special extension to instep (leather with eyelets)",09-10-2025
L3580001003,"Orthopedic shoe addition, convert instep to velcro closure",09-10-2025
L3590001003,"Orthopedic shoe addition, convert firm shoe counter to soft counter",09-10-2025
L3595001003,"Orthopedic shoe addition, march bar",09-10-2025
L3600001003,"Transfer of an orthosis from one shoe to another, caliper plate, existing",09-10-2025
L3610001003,"Transfer of an orthosis from one shoe to another, caliper plate, new",09-10-2025
L3620001003,"Transfer of an orthosis from one shoe to another, solid stirrup, existing",09-10-2025
L3630001003,"Transfer of an orthosis from one shoe to another, solid stirrup, new",09-10-2025
L3640001003,"Transfer of an orthosis from one shoe to another, dennis browne splint",09-10-2025
L3640002004,"(riveton), both shoes",09-10-2025
L3649001003,"Orthopedic shoe, modification, addition or transfer, not otherwise specified",09-10-2025
L3650001003,"Shoulder orthosis, figure of eight design abduction restrainer, prefabricated,",09-10-2025
L3650002004,Off-the-shelf,09-10-2025
L3660001003,"Shoulder orthosis, figure of eight design abduction restrainer, canvas and",09-10-2025
L3660002004,"Webbing, prefabricated, off-the-shelf",09-10-2025
L3670001003,"Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated,",09-10-2025
L3670002004,Off-the-shelf,09-10-2025
L3671001003,"Shoulder orthosis, shoulder joint design, without joints, may include soft",09-10-2025
L3671002004,"Interface, straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3674001003,"Shoulder orthosis, abduction positioning (airplane design), thoracic component",09-10-2025
L3674002004,"And support bar, with or without nontorsion joint/turnbuckle, may include soft",09-10-2025
L3674003004,"Interface, straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3675001003,"Shoulder orthosis, vest type abduction restrainer, canvas webbing type or",09-10-2025
L3675002004,"Equal, prefabricated, off-the-shelf",09-10-2025
L3677001003,"Shoulder orthosis, shoulder joint design, without joints, may include soft",09-10-2025
L3677002004,"Interface, straps, prefabricated item that has been trimmed, bent, molded,",09-10-2025
L3677003004,"Assembled, or otherwise customized to fit a specific patient by an individual",09-10-2025
L3677004004,With expertise,09-10-2025
L3678001003,"Shoulder orthosis, shoulder joint design, without joints, may include soft",09-10-2025
L3678002004,"Interface, straps, prefabricated, off-the-shelf",09-10-2025
L3702001003,"Elbow orthosis, without joints, may include soft interface, straps, custom",09-10-2025
L3702002004,"Fabricated, includes fitting and adjustment",09-10-2025
L3710001003,"Elbow orthosis, elastic with metal joints, prefabricated, off-the-shelf",09-10-2025
L3720001003,"Elbow orthosis, double upright with forearm/arm cuffs, free motion, custom",09-10-2025
L3720002004,Fabricated,09-10-2025
L3730001003,"Elbow orthosis, double upright with forearm/arm cuffs, extension/ flexion",09-10-2025
L3730002004,"Assist, custom fabricated",09-10-2025
L3740001003,"Elbow orthosis, double upright with forearm/arm cuffs, adjustable position lock",09-10-2025
L3740002004,"With active control, custom fabricated",09-10-2025
L3760001003,"Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated,",09-10-2025
L3760002004,"Item that has been trimmed, bent, molded, assembled, or otherwise customized to",09-10-2025
L3760003004,Fit a specific patient by an individual with expertise,09-10-2025
L3761001003,"Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated,",09-10-2025
L3761002004,Off-the-shelf,09-10-2025
L3762001003,"Elbow orthosis, rigid, without joints, includes soft interface material,",09-10-2025
L3762002004,"Prefabricated, off-the-shelf",09-10-2025
L3763001003,"Elbow wrist hand orthosis, rigid, without joints, may include soft interface,",09-10-2025
L3763002004,"Straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3764001003,"Elbow wrist hand orthosis, includes one or more nontorsion joints, elastic",09-10-2025
L3764002004,"Bands, turnbuckles, may include soft interface, straps, custom fabricated,",09-10-2025
L3764003004,Includes fitting and adjustment,09-10-2025
L3765001003,"Elbow wrist hand finger orthosis, rigid, without joints, may include soft",09-10-2025
L3765002004,"Interface, straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3766001003,"Elbow wrist hand finger orthosis, includes one or more nontorsion joints,",09-10-2025
L3766002004,"Elastic bands, turnbuckles, may include soft interface, straps, custom",09-10-2025
L3766003004,"Fabricated, includes fitting and adjustment",09-10-2025
L3806001003,"Wrist hand finger orthosis, includes one or more nontorsion joint(s),",09-10-2025
L3806002004,"Turnbuckles, elastic bands/springs, may include soft interface material,",09-10-2025
L3806003004,"Straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3807001003,"Wrist hand finger orthosis, without joint(s), prefabricated item that has been",09-10-2025
L3807002004,"Trimmed, bent, molded, assembled, or otherwise customized to fit a specific",09-10-2025
L3807003004,Patient by an individual with expertise,09-10-2025
L3808001003,"Wrist hand finger orthosis, rigid without joints, may include soft interface",09-10-2025
L3808002004,"Material; straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3809001003,"Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any",09-10-2025
L3809002004,Type,09-10-2025
L3891001003,"Addition to upper extremity joint, wrist or elbow, concentric adjustable",09-10-2025
L3891002004,"Torsion style mechanism for custom fabricated orthotics only, each",09-10-2025
L3900001003,"Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/",09-10-2025
L3900002004,"Flexion, finger flexion/extension, wrist or finger driven, custom fabricated",09-10-2025
L3901001003,"Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/",09-10-2025
L3901002004,"Flexion, finger flexion/extension, cable driven, custom fabricated",09-10-2025
L3904001003,"Wrist hand finger orthosis, external powered, electric, custom fabricated",09-10-2025
L3905001003,"Wrist hand orthosis, includes one or more nontorsion joints, elastic bands,",09-10-2025
L3905002004,"Turnbuckles, may include soft interface, straps, custom fabricated, includes",09-10-2025
L3905003004,Fitting and adjustment,09-10-2025
L3906001003,"Wrist hand orthosis, without joints, may include soft interface, straps, custom",09-10-2025
L3906002004,"Fabricated, includes fitting and adjustment",09-10-2025
L3908001003,"Wrist hand orthosis, wrist extension control cock-up, non molded,",09-10-2025
L3908002004,"Prefabricated, off-the-shelf",09-10-2025
L3912001003,"Hand finger orthosis (hfo), flexion glove with elastic finger control,",09-10-2025
L3912002004,"Prefabricated, off-the-shelf",09-10-2025
L3913001003,"Hand finger orthosis, without joints, may include soft interface, straps,",09-10-2025
L3913002004,"Custom fabricated, includes fitting and adjustment",09-10-2025
L3915001003,"Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands,",09-10-2025
L3915002004,"Turnbuckles, may include soft interface, straps, prefabricated item that has",09-10-2025
L3915003004,"Been trimmed, bent, molded, assembled, or otherwise customized to fit a",09-10-2025
L3915004004,Specific patient by an individual with expertise,09-10-2025
L3916001003,"Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands,",09-10-2025
L3916002004,"Turnbuckles, may include soft interface, straps, prefabricated, off-the-shelf",09-10-2025
L3917001003,"Hand orthosis, metacarpal fracture orthosis, prefabricated item that has been",09-10-2025
L3917002004,"Trimmed, bent, molded, assembled, or otherwise customized to fit a specific",09-10-2025
L3917003004,Patient by an individual with expertise,09-10-2025
L3918001003,"Hand orthosis, metacarpal fracture orthosis, prefabricated, off-the-shelf",09-10-2025
L3919001003,"Hand orthosis, without joints, may include soft interface, straps, custom",09-10-2025
L3919002004,"Fabricated, includes fitting and adjustment",09-10-2025
L3921001003,"Hand finger orthosis, includes one or more nontorsion joints, elastic bands,",09-10-2025
L3921002004,"Turnbuckles, may include soft interface, straps, custom fabricated, includes",09-10-2025
L3921003004,Fitting and adjustment,09-10-2025
L3923001003,"Hand finger orthosis, without joints, may include soft interface, straps,",09-10-2025
L3923002004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L3923003004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L3924001003,"Hand finger orthosis, without joints, may include soft interface, straps,",09-10-2025
L3924002004,"Prefabricated, off-the-shelf",09-10-2025
L3925001003,"Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip),",09-10-2025
L3925002004,"Non torsion joint/spring, extension/flexion, may include soft interface",09-10-2025
L3925003004,"Material, prefabricated, off-the-shelf",09-10-2025
L3927001003,"Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip),",09-10-2025
L3927002004,"Without joint/spring, extension/flexion (e.g., static or ring type), may",09-10-2025
L3927003004,"Include soft interface material, prefabricated, off-the-shelf",09-10-2025
L3929001003,"Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles,",09-10-2025
L3929002004,"Elastic bands/springs, may include soft interface material, straps,",09-10-2025
L3929003004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L3929004004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L3930001003,"Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles,",09-10-2025
L3930002004,"Elastic bands/springs, may include soft interface material, straps,",09-10-2025
L3930003004,"Prefabricated, off-the-shelf",09-10-2025
L3931001003,"Wrist hand finger orthosis, includes one or more nontorsion joint(s),",09-10-2025
L3931002004,"Turnbuckles, elastic bands/springs, may include soft interface material,",09-10-2025
L3931003004,"Straps, prefabricated, includes fitting and adjustment",09-10-2025
L3933001003,"Finger orthosis, without joints, may include soft interface, custom fabricated,",09-10-2025
L3933002004,Includes fitting and adjustment,09-10-2025
L3935001003,"Finger orthosis, nontorsion joint, may include soft interface, custom",09-10-2025
L3935002004,"Fabricated, includes fitting and adjustment",09-10-2025
L3956001003,"Addition of joint to upper extremity orthosis, any material; per joint",09-10-2025
L3960001003,"Shoulder elbow wrist hand orthosis, abduction positioning, airplane design,",09-10-2025
L3960002004,"Prefabricated, includes fitting and adjustment",09-10-2025
L3961001003,"Shoulder elbow wrist hand orthosis, shoulder cap design, without joints, may",09-10-2025
L3961002004,"Include soft interface, straps, custom fabricated, includes fitting and",09-10-2025
L3961003004,Adjustment,09-10-2025
L3962001003,"Shoulder elbow wrist hand orthosis, abduction positioning, erb's palsey design,",09-10-2025
L3962002004,"Prefabricated, includes fitting and adjustment",09-10-2025
L3967001003,"Shoulder elbow wrist hand orthosis, abduction positioning (airplane design),",09-10-2025
L3967002004,"Thoracic component and support bar, without joints, may include soft interface,",09-10-2025
L3967003004,"Straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3971001003,"Shoulder elbow wrist hand orthosis, shoulder cap design, includes one or more",09-10-2025
L3971002004,"Nontorsion joints, elastic bands, turnbuckles, may include soft interface,",09-10-2025
L3971003004,"Straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3973001003,"Shoulder elbow wrist hand orthosis, abduction positioning (airplane design),",09-10-2025
L3973002004,"Thoracic component and support bar, includes one or more nontorsion joints,",09-10-2025
L3973003004,"Elastic bands, turnbuckles, may include soft interface, straps, custom",09-10-2025
L3973004004,"Fabricated, includes fitting and adjustment",09-10-2025
L3975001003,"Shoulder elbow wrist hand finger orthosis, shoulder cap design, without joints,",09-10-2025
L3975002004,"May include soft interface, straps, custom fabricated, includes fitting and",09-10-2025
L3975003004,Adjustment,09-10-2025
L3976001003,"Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane",09-10-2025
L3976002004,"Design), thoracic component and support bar, without joints, may include soft",09-10-2025
L3976003004,"Interface, straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3977001003,"Shoulder elbow wrist hand finger orthosis, shoulder cap design, includes one or",09-10-2025
L3977002004,"More nontorsion joints, elastic bands, turnbuckles, may include soft interface,",09-10-2025
L3977003004,"Straps, custom fabricated, includes fitting and adjustment",09-10-2025
L3978001003,"Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane",09-10-2025
L3978002004,"Design), thoracic component and support bar, includes one or more nontorsion",09-10-2025
L3978003004,"Joints, elastic bands, turnbuckles, may include soft interface, straps, custom",09-10-2025
L3978004004,"Fabricated, includes fitting and adjustment",09-10-2025
L3980001003,"Upper extremity fracture orthosis, humeral, prefabricated, includes fitting and",09-10-2025
L3980002004,Adjustment,09-10-2025
L3981001003,"Upper extremity fracture orthosis, humeral, prefabricated, includes shoulder",09-10-2025
L3981002004,"Cap design, with or without joints, forearm section, may include soft",09-10-2025
L3981003004,"Interface, straps, includes fitting and adjustments",09-10-2025
L3982001003,"Upper extremity fracture orthosis, radius/ulnar, prefabricated, includes",09-10-2025
L3982002004,Fitting and adjustment,09-10-2025
L3984001003,"Upper extremity fracture orthosis, wrist, prefabricated, includes fitting and",09-10-2025
L3984002004,Adjustment,09-10-2025
L3995001003,"Addition to upper extremity orthosis, sock, fracture or equal, each",09-10-2025
L3999001003,"Upper limb orthosis, not otherwise specified",09-10-2025
L4000001003,Replace girdle for spinal orthosis (ctlso or so),09-10-2025
L4002001003,"Replacement strap, any orthosis, includes all components, any length, any type",09-10-2025
L4010001003,Replace trilateral socket brim,09-10-2025
L4020001003,"Replace quadrilateral socket brim, molded to patient model",09-10-2025
L4030001003,"Replace quadrilateral socket brim, custom fitted",09-10-2025
L4040001003,"Replace molded thigh lacer, for custom fabricated orthosis only",09-10-2025
L4045001003,"Replace non-molded thigh lacer, for custom fabricated orthosis only",09-10-2025
L4050001003,"Replace molded calf lacer, for custom fabricated orthosis only",09-10-2025
L4055001003,"Replace non-molded calf lacer, for custom fabricated orthosis only",09-10-2025
L4060001003,Replace high roll cuff,09-10-2025
L4070001003,Replace proximal and distal upright for kafo,09-10-2025
L4080001003,"Replace metal bands kafo, proximal thigh",09-10-2025
L4090001003,"Replace metal bands kafo-afo, calf or distal thigh",09-10-2025
L4100001003,"Replace leather cuff kafo, proximal thigh",09-10-2025
L4110001003,"Replace leather cuff kafo-afo, calf or distal thigh",09-10-2025
L4130001003,Replace pretibial shell,09-10-2025
L4205001003,"Repair of orthotic device, labor component, per 15 minutes",09-10-2025
L4210001003,"Repair of orthotic device, repair or replace minor parts",09-10-2025
L4350001003,"Ankle control orthosis, stirrup style, rigid, includes any type interface",09-10-2025
L4350002004,"(e.g., pneumatic, gel), prefabricated, off-the-shelf",09-10-2025
L4360001003,"Walking boot, pneumatic and/or vacuum, with or without joints, with or without",09-10-2025
L4360002004,"Interface material, prefabricated item that has been trimmed, bent, molded,",09-10-2025
L4360003004,"Assembled, or otherwise customized to fit a specific patient by an individual",09-10-2025
L4360004004,With expertise,09-10-2025
L4361001003,"Walking boot, pneumatic and/or vacuum, with or without joints, with or without",09-10-2025
L4361002004,"Interface material, prefabricated, off-the-shelf",09-10-2025
L4370001003,"Pneumatic full leg splint, prefabricated, off-the-shelf",09-10-2025
L4386001003,"Walking boot, non-pneumatic, with or without joints, with or without interface",09-10-2025
L4386002004,"Material, prefabricated item that has been trimmed, bent, molded, assembled, or",09-10-2025
L4386003004,Otherwise customized to fit a specific patient by an individual with expertise,09-10-2025
L4387001003,"Walking boot, non-pneumatic, with or without joints, with or without interface",09-10-2025
L4387002004,"Material, prefabricated, off-the-shelf",09-10-2025
L4392001003,"Replacement, soft interface material, static afo",09-10-2025
L4394001003,"Replace soft interface material, foot drop splint",09-10-2025
L4396001003,"Static or dynamic ankle foot orthosis, including soft interface material,",09-10-2025
L4396002004,"Adjustable for fit, for positioning, may be used for minimal ambulation,",09-10-2025
L4396003004,"Prefabricated item that has been trimmed, bent, molded, assembled, or otherwise",09-10-2025
L4396004004,Customized to fit a specific patient by an individual with expertise,09-10-2025
L4397001003,"Static or dynamic ankle foot orthosis, including soft interface material,",09-10-2025
L4397002004,"Adjustable for fit, for positioning, may be used for minimal ambulation,",09-10-2025
L4397003004,"Prefabricated, off-the-shelf",09-10-2025
L4398001003,"Foot drop splint, recumbent positioning device, prefabricated, off-the-shelf",09-10-2025
L4631001003,"Ankle foot orthosis, walking boot type, varus/valgus correction, rocker bottom,",09-10-2025
L4631002004,"Anterior tibial shell, soft interface, custom arch support, plastic or other",09-10-2025
L4631003004,"Material, includes straps and closures, custom fabricated",09-10-2025
L5000001003,"Partial foot, shoe insert with longitudinal arch, toe filler",09-10-2025
L5010001003,"Partial foot, molded socket, ankle height, with toe filler",09-10-2025
L5020001003,"Partial foot, molded socket, tibial tubercle height, with toe filler",09-10-2025
L5050001003,"Ankle, symes, molded socket, sach foot",09-10-2025
L5060001003,"Ankle, symes, metal frame, molded leather socket, articulated ankle/foot",09-10-2025
L5100001003,"Below knee, molded socket, shin, sach foot",09-10-2025
L5105001003,"Below knee, plastic socket, joints and thigh lacer, sach foot",09-10-2025
L5150001003,"Knee disarticulation (or through knee), molded socket, external knee joints,",09-10-2025
L5150002004,"Shin, sach foot",09-10-2025
L5160001003,"Knee disarticulation (or through knee), molded socket, bent knee configuration,",09-10-2025
L5160002004,"External knee joints, shin, sach foot",09-10-2025
L5200001003,"Above knee, molded socket, single axis constant friction knee, shin, sach foot",09-10-2025
L5210001003,"Above knee, short prosthesis, no knee joint ('stubbies'), with foot blocks, no",09-10-2025
L5210002004,"Ankle joints, each",09-10-2025
L5220001003,"Above knee, short prosthesis, no knee joint ('stubbies'), with articulated",09-10-2025
L5220002004,"Ankle/foot, dynamically aligned, each",09-10-2025
L5230001003,"Above knee, for proximal femoral focal deficiency, constant friction knee,",09-10-2025
L5230002004,"Shin, sach foot",09-10-2025
L5250001003,"Hip disarticulation, canadian type; molded socket, hip joint, single axis",09-10-2025
L5250002004,"Constant friction knee, shin, sach foot",09-10-2025
L5270001003,"Hip disarticulation, tilt table type; molded socket, locking hip joint, single",09-10-2025
L5270002004,"Axis constant friction knee, shin, sach foot",09-10-2025
L5280001003,"Hemipelvectomy, canadian type; molded socket, hip joint, single axis constant",09-10-2025
L5280002004,"Friction knee, shin, sach foot",09-10-2025
L5301001003,"Below knee, molded socket, shin, sach foot, endoskeletal system",09-10-2025
L5312001003,"Knee disarticulation (or through knee), molded socket, single axis knee, pylon,",09-10-2025
L5312002004,"Sach foot, endoskeletal system",09-10-2025
L5321001003,"Above knee, molded socket, open end, sach foot, endoskeletal system, single",09-10-2025
L5321002004,Axis knee,09-10-2025
L5331001003,"Hip disarticulation, canadian type, molded socket, endoskeletal system, hip",09-10-2025
L5331002004,"Joint, single axis knee, sach foot",09-10-2025
L5341001003,"Hemipelvectomy, canadian type, molded socket, endoskeletal system, hip joint,",09-10-2025
L5341002004,"Single axis knee, sach foot",09-10-2025
L5400001003,"Immediate post surgical or early fitting, application of initial rigid",09-10-2025
L5400002004,"Dressing, including fitting, alignment, suspension, and one cast change, below",09-10-2025
L5400003004,Knee,09-10-2025
L5410001003,"Immediate post surgical or early fitting, application of initial rigid",09-10-2025
L5410002004,"Dressing, including fitting, alignment and suspension, below knee, each",09-10-2025
L5410003004,Additional cast change and realignment,09-10-2025
L5420001003,"Immediate post surgical or early fitting, application of initial rigid",09-10-2025
L5420002004,"Dressing, including fitting, alignment and suspension and one cast change 'ak'",09-10-2025
L5420003004,Or knee disarticulation,09-10-2025
L5430001003,"Immediate post surgical or early fitting, application of initial rigid",09-10-2025
L5430002004,"Dressing, incl. fitting, alignment and supension, 'ak' or knee disarticulation,",09-10-2025
L5430003004,Each additional cast change and realignment,09-10-2025
L5450001003,"Immediate post surgical or early fitting, application of non-weight bearing",09-10-2025
L5450002004,"Rigid dressing, below knee",09-10-2025
L5460001003,"Immediate post surgical or early fitting, application of non-weight bearing",09-10-2025
L5460002004,"Rigid dressing, above knee",09-10-2025
L5500001003,"Initial, below knee 'ptb' type socket, non-alignable system, pylon, no cover,",09-10-2025
L5500002004,"Sach foot, plaster socket, direct formed",09-10-2025
L5505001003,"Initial, above knee - knee disarticulation, ischial level socket, non-alignable",09-10-2025
L5505002004,"System, pylon, no cover, sach foot, plaster socket, direct formed",09-10-2025
L5510001003,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no",09-10-2025
L5510002004,"Cover, sach foot, plaster socket, molded to model",09-10-2025
L5520001003,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no",09-10-2025
L5520002004,"Cover, sach foot, thermoplastic or equal, direct formed",09-10-2025
L5530001003,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no",09-10-2025
L5530002004,"Cover, sach foot, thermoplastic or equal, molded to model",09-10-2025
L5535001003,"Preparatory, below knee 'ptb' type socket, non-alignable system, no cover, sach",09-10-2025
L5535002004,"Foot, prefabricated, adjustable open end socket",09-10-2025
L5540001003,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no",09-10-2025
L5540002004,"Cover, sach foot, laminated socket, molded to model",09-10-2025
L5560001003,"Preparatory, above knee- knee disarticulation, ischial level socket,",09-10-2025
L5560002004,"Non-alignable system, pylon, no cover, sach foot, plaster socket, molded to",09-10-2025
L5560003004,Model,09-10-2025
L5570001003,"Preparatory, above knee - knee disarticulation, ischial level socket,",09-10-2025
L5570002004,"Non-alignable system, pylon, no cover, sach foot, thermoplastic or equal,",09-10-2025
L5570003004,Direct formed,09-10-2025
L5580001003,"Preparatory, above knee - knee disarticulation ischial level socket,",09-10-2025
L5580002004,"Non-alignable system, pylon, no cover, sach foot, thermoplastic or equal,",09-10-2025
L5580003004,Molded to model,09-10-2025
L5585001003,"Preparatory, above knee - knee disarticulation, ischial level socket,",09-10-2025
L5585002004,"Non-alignable system, pylon, no cover, sach foot, prefabricated adjustable open",09-10-2025
L5585003004,End socket,09-10-2025
L5590001003,"Preparatory, above knee - knee disarticulation ischial level socket,",09-10-2025
L5590002004,"Non-alignable system, pylon no cover, sach foot, laminated socket, molded to",09-10-2025
L5590003004,Model,09-10-2025
L5595001003,"Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot,",09-10-2025
L5595002004,"Thermoplastic or equal, molded to patient model",09-10-2025
L5600001003,"Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot,",09-10-2025
L5600002004,"Laminated socket, molded to patient model",09-10-2025
L5610001003,"Addition to lower extremity, endoskeletal system, above knee, hydracadence",09-10-2025
L5610002004,System,09-10-2025
L5611001003,"Addition to lower extremity, endoskeletal system, above knee - knee",09-10-2025
L5611002004,"Disarticulation, 4 bar linkage, with friction swing phase control",09-10-2025
L5613001003,"Addition to lower extremity, endoskeletal system, above knee-knee",09-10-2025
L5613002004,"Disarticulation, 4 bar linkage, with hydraulic swing phase control",09-10-2025
L5614001003,"Addition to lower extremity, exoskeletal system, above knee-knee",09-10-2025
L5614002004,"Disarticulation, 4 bar linkage, with pneumatic swing phase control",09-10-2025
L5615001003,"Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid",09-10-2025
L5615002004,Swing and stance phase control,09-10-2025
L5616001003,"Addition to lower extremity, endoskeletal system, above knee, universal",09-10-2025
L5616002004,"Multiplex system, friction swing phase control",09-10-2025
L5617001003,"Addition to lower extremity, quick change self-aligning unit, above knee or",09-10-2025
L5617002004,"Below knee, each",09-10-2025
L5618001003,"Addition to lower extremity, test socket, symes",09-10-2025
L5620001003,"Addition to lower extremity, test socket, below knee",09-10-2025
L5622001003,"Addition to lower extremity, test socket, knee disarticulation",09-10-2025
L5624001003,"Addition to lower extremity, test socket, above knee",09-10-2025
L5626001003,"Addition to lower extremity, test socket, hip disarticulation",09-10-2025
L5628001003,"Addition to lower extremity, test socket, hemipelvectomy",09-10-2025
L5629001003,"Addition to lower extremity, below knee, acrylic socket",09-10-2025
L5630001003,"Addition to lower extremity, symes type, expandable wall socket",09-10-2025
L5631001003,"Addition to lower extremity, above knee or knee disarticulation, acrylic socket",09-10-2025
L5632001003,"Addition to lower extremity, symes type, 'ptb' brim design socket",09-10-2025
L5634001003,"Addition to lower extremity, symes type, posterior opening (canadian) socket",09-10-2025
L5636001003,"Addition to lower extremity, symes type, medial opening socket",09-10-2025
L5637001003,"Addition to lower extremity, below knee, total contact",09-10-2025
L5638001003,"Addition to lower extremity, below knee, leather socket",09-10-2025
L5639001003,"Addition to lower extremity, below knee, wood socket",09-10-2025
L5640001003,"Addition to lower extremity, knee disarticulation, leather socket",09-10-2025
L5642001003,"Addition to lower extremity, above knee, leather socket",09-10-2025
L5643001003,"Addition to lower extremity, hip disarticulation, flexible inner socket,",09-10-2025
L5643002004,External frame,09-10-2025
L5644001003,"Addition to lower extremity, above knee, wood socket",09-10-2025
L5645001003,"Addition to lower extremity, below knee, flexible inner socket, external frame",09-10-2025
L5646001003,"Addition to lower extremity, below knee, air, fluid, gel or equal, cushion",09-10-2025
L5646002004,Socket,09-10-2025
L5647001003,"Addition to lower extremity, below knee suction socket",09-10-2025
L5648001003,"Addition to lower extremity, above knee, air, fluid, gel or equal, cushion",09-10-2025
L5648002004,Socket,09-10-2025
L5649001003,"Addition to lower extremity, ischial containment/narrow m-l socket",09-10-2025
L5650001003,"Additions to lower extremity, total contact, above knee or knee disarticulation",09-10-2025
L5650002004,Socket,09-10-2025
L5651001003,"Addition to lower extremity, above knee, flexible inner socket, external frame",09-10-2025
L5652001003,"Addition to lower extremity, suction suspension, above knee or knee",09-10-2025
L5652002004,Disarticulation socket,09-10-2025
L5653001003,"Addition to lower extremity, knee disarticulation, expandable wall socket",09-10-2025
L5654001003,"Addition to lower extremity, socket insert, symes, (kemblo, pelite, aliplast,",09-10-2025
L5654002004,Plastazote or equal),09-10-2025
L5655001003,"Addition to lower extremity, socket insert, below knee (kemblo, pelite,",09-10-2025
L5655002004,"Aliplast, plastazote or equal)",09-10-2025
L5656001003,"Addition to lower extremity, socket insert, knee disarticulation (kemblo,",09-10-2025
L5656002004,"Pelite, aliplast, plastazote or equal)",09-10-2025
L5657001003,"Addition to lower extremity prosthesis, manual/automated adjustable air, fluid,",09-10-2025
L5657002004,"Gel or equal socket insert for limb volume management, any materials",09-10-2025
L5658001003,"Addition to lower extremity, socket insert, above knee (kemblo, pelite,",09-10-2025
L5658002004,"Aliplast, plastazote or equal)",09-10-2025
L5661001003,"Addition to lower extremity, socket insert, multi-durometer symes",09-10-2025
L5665001003,"Addition to lower extremity, socket insert, multi-durometer, below knee",09-10-2025
L5666001003,"Addition to lower extremity, below knee, cuff suspension",09-10-2025
L5668001003,"Addition to lower extremity, below knee, molded distal cushion",09-10-2025
L5670001003,"Addition to lower extremity, below knee, molded supracondylar suspension ('pts'",09-10-2025
L5670002004,Or similar),09-10-2025
L5671001003,"Addition to lower extremity, below knee / above knee suspension locking",09-10-2025
L5671002004,"Mechanism (shuttle, lanyard or equal), excludes socket insert",09-10-2025
L5672001003,"Addition to lower extremity, below knee, removable medial brim suspension",09-10-2025
L5673001003,"Addition to lower extremity, below knee/above knee, custom fabricated from",09-10-2025
L5673002004,"Existing mold or prefabricated, socket insert, silicone gel, elastomeric, or",09-10-2025
L5673003004,"Equal, with or without perforations, with or without breathable material, for",09-10-2025
L5673004004,Use with locking mechanism,09-10-2025
L5676001003,"Additions to lower extremity, below knee, knee joints, single axis, pair",09-10-2025
L5677001003,"Additions to lower extremity, below knee, knee joints, polycentric, pair",09-10-2025
L5678001003,"Additions to lower extremity, below knee, joint covers, pair",09-10-2025
L5679001003,"Addition to lower extremity, below knee/above knee, custom fabricated from",09-10-2025
L5679002004,"Existing mold or prefabricated, socket insert, silicone gel, elastomeric, or",09-10-2025
L5679003004,"Equal, with or without perforations, with or without breathable material, not",09-10-2025
L5679004004,For use with locking mechanism,09-10-2025
L5680001003,"Addition to lower extremity, below knee, thigh lacer, nonmolded",09-10-2025
L5681001003,"Addition to lower extremity, below knee/above knee, custom fabricated socket",09-10-2025
L5681002004,"Insert for congenital or atypical traumatic amputee, silicone gel, elastomeric",09-10-2025
L5681003004,"Or equal, for use with or without locking mechanism, initial only (for other",09-10-2025
L5681004004,"Than initial, use code l5673 or l5679)",09-10-2025
L5682001003,"Addition to lower extremity, below knee, thigh lacer, gluteal/ischial, molded",09-10-2025
L5683001003,"Addition to lower extremity, below knee/above knee, custom fabricated socket",09-10-2025
L5683002004,"Insert for other than congenital or atypical traumatic amputee, silicone gel,",09-10-2025
L5683003004,"Elastomeric or equal, for use with or without locking mechanism, initial only",09-10-2025
L5683004004,"(for other than initial, use code l5673 or l5679)",09-10-2025
L5684001003,"Addition to lower extremity, below knee, fork strap",09-10-2025
L5685001003,"Addition to lower extremity prosthesis, below knee, suspension/sealing sleeve,",09-10-2025
L5685002004,"With or without valve, any material, each",09-10-2025
L5686001003,"Addition to lower extremity, below knee, back check (extension control)",09-10-2025
L5688001003,"Addition to lower extremity, below knee, waist belt, webbing",09-10-2025
L5690001003,"Addition to lower extremity, below knee, waist belt, padded and lined",09-10-2025
L5692001003,"Addition to lower extremity, above knee, pelvic control belt, light",09-10-2025
L5694001003,"Addition to lower extremity, above knee, pelvic control belt, padded and lined",09-10-2025
L5695001003,"Addition to lower extremity, above knee, pelvic control, sleeve suspension,",09-10-2025
L5695002004,"Neoprene or equal, each",09-10-2025
L5696001003,"Addition to lower extremity, above knee or knee disarticulation, pelvic joint",09-10-2025
L5697001003,"Addition to lower extremity, above knee or knee disarticulation, pelvic band",09-10-2025
L5698001003,"Addition to lower extremity, above knee or knee disarticulation, silesian",09-10-2025
L5698002004,Bandage,09-10-2025
L5699001003,"All lower extremity prostheses, shoulder harness",09-10-2025
L5700001003,"Replacement, socket, below knee, molded to patient model",09-10-2025
L5701001003,"Replacement, socket, above knee/knee disarticulation, including attachment",09-10-2025
L5701002004,"Plate, molded to patient model",09-10-2025
L5702001003,"Replacement, socket, hip disarticulation, including hip joint, molded to",09-10-2025
L5702002004,Patient model,09-10-2025
L5703001003,"Ankle, symes, molded to patient model, socket without solid ankle cushion heel",09-10-2025
L5703002004,"(sach) foot, replacement only",09-10-2025
L5704001003,"Custom shaped protective cover, below knee",09-10-2025
L5705001003,"Custom shaped protective cover, above knee",09-10-2025
L5706001003,"Custom shaped protective cover, knee disarticulation",09-10-2025
L5707001003,"Custom shaped protective cover, hip disarticulation",09-10-2025
L5710001003,"Addition, exoskeletal knee-shin system, single axis, manual lock",09-10-2025
L5711001003,"Additions exoskeletal knee-shin system, single axis, manual lock, ultra-light",09-10-2025
L5711002004,Material,09-10-2025
L5712001003,"Addition, exoskeletal knee-shin system, single axis, friction swing and stance",09-10-2025
L5712002004,Phase control (safety knee),09-10-2025
L5714001003,"Addition, exoskeletal knee-shin system, single axis, variable friction swing",09-10-2025
L5714002004,Phase control,09-10-2025
L5716001003,"Addition, exoskeletal knee-shin system, polycentric, mechanical stance phase",09-10-2025
L5716002004,Lock,09-10-2025
L5718001003,"Addition, exoskeletal knee-shin system, polycentric, friction swing and stance",09-10-2025
L5718002004,Phase control,09-10-2025
L5722001003,"Addition, exoskeletal knee-shin system, single axis, pneumatic swing, friction",09-10-2025
L5722002004,Stance phase control,09-10-2025
L5724001003,"Addition, exoskeletal knee-shin system, single axis, fluid swing phase control",09-10-2025
L5726001003,"Addition, exoskeletal knee-shin system, single axis, external joints fluid",09-10-2025
L5726002004,Swing phase control,09-10-2025
L5728001003,"Addition, exoskeletal knee-shin system, single axis, fluid swing and stance",09-10-2025
L5728002004,Phase control,09-10-2025
L5780001003,"Addition, exoskeletal knee-shin system, single axis, pneumatic/hydra pneumatic",09-10-2025
L5780002004,Swing phase control,09-10-2025
L5781001003,"Addition to lower limb prosthesis, vacuum pump, residual limb volume management",09-10-2025
L5781002004,And moisture evacuation system,09-10-2025
L5782001003,"Addition to lower limb prosthesis, vacuum pump, residual limb volume management",09-10-2025
L5782002004,"And moisture evacuation system, heavy duty",09-10-2025
L5783001003,"Addition to lower extremity, user adjustable, mechanical, residual limb volume",09-10-2025
L5783002004,Management system (with or without lamination kit),09-10-2025
L5785001003,"Addition, exoskeletal system, below knee, ultra-light material (titanium,",09-10-2025
L5785002004,Carbon fiber or equal),09-10-2025
L5790001003,"Addition, exoskeletal system, above knee, ultra-light material (titanium,",09-10-2025
L5790002004,Carbon fiber or equal),09-10-2025
L5795001003,"Addition, exoskeletal system, hip disarticulation, ultra-light material",09-10-2025
L5795002004,"(titanium, carbon fiber or equal)",09-10-2025
L5810001003,"Addition, endoskeletal knee-shin system, single axis, manual lock",09-10-2025
L5811001003,"Addition, endoskeletal knee-shin system, single axis, manual lock, ultra-light",09-10-2025
L5811002004,Material,09-10-2025
L5812001003,"Addition, endoskeletal knee-shin system, single axis, friction swing and stance",09-10-2025
L5812002004,Phase control (safety knee),09-10-2025
L5814001003,"Addition, endoskeletal knee-shin system, polycentric, hydraulic swing phase",09-10-2025
L5814002004,"Control, mechanical stance phase lock",09-10-2025
L5816001003,"Addition, endoskeletal knee-shin system, polycentric, mechanical stance phase",09-10-2025
L5816002004,Lock,09-10-2025
L5818001003,"Addition, endoskeletal knee-shin system, polycentric, friction swing, and",09-10-2025
L5818002004,Stance phase control,09-10-2025
L5822001003,"Addition, endoskeletal knee-shin system, single axis, pneumatic swing, friction",09-10-2025
L5822002004,Stance phase control,09-10-2025
L5824001003,"Addition, endoskeletal knee-shin system, single axis, fluid swing phase control",09-10-2025
L5826001003,"Addition, endoskeletal knee-shin system, single axis, hydraulic swing phase",09-10-2025
L5826002004,"Control, with miniature high activity frame",09-10-2025
L5827001003,"Endoskeletal knee-shin system, single axis, electromechanical swing and stance",09-10-2025
L5827002004,"Phase control, with or without shock absorption and stance extension damping",09-10-2025
L5828001003,"Addition, endoskeletal knee-shin system, single axis, fluid swing and stance",09-10-2025
L5828002004,Phase control,09-10-2025
L5830001003,"Addition, endoskeletal knee-shin system, single axis, pneumatic/ swing phase",09-10-2025
L5830002004,Control,09-10-2025
L5840001003,"Addition, endoskeletal knee/shin system, 4-bar linkage or multiaxial, pneumatic",09-10-2025
L5840002004,Swing phase control,09-10-2025
L5841001003,"Addition, endoskeletal knee-shin system, polycentric, pneumatic swing, and",09-10-2025
L5841002004,Stance phase control,09-10-2025
L5845001003,"Addition, endoskeletal, knee-shin system, stance flexion feature, adjustable",09-10-2025
L5848001003,"Addition to endoskeletal knee-shin system, fluid stance extension, dampening",09-10-2025
L5848002004,"Feature, with or without adjustability",09-10-2025
L5850001003,"Addition, endoskeletal system, above knee or hip disarticulation, knee",09-10-2025
L5850002004,Extension assist,09-10-2025
L5855001003,"Addition, endoskeletal system, hip disarticulation, mechanical hip extension",09-10-2025
L5855002004,Assist,09-10-2025
L5856001003,"Addition to lower extremity prosthesis, endoskeletal knee-shin system,",09-10-2025
L5856002004,"Microprocessor control feature, swing and stance phase, includes electronic",09-10-2025
L5856003004,"Sensor(s), any type",09-10-2025
L5857001003,"Addition to lower extremity prosthesis, endoskeletal knee-shin system,",09-10-2025
L5857002004,"Microprocessor control feature, swing phase only, includes electronic",09-10-2025
L5857003004,"Sensor(s), any type",09-10-2025
L5858001003,"Addition to lower extremity prosthesis, endoskeletal knee shin system,",09-10-2025
L5858002004,"Microprocessor control feature, stance phase only, includes electronic",09-10-2025
L5858003004,"Sensor(s), any type",09-10-2025
L5859001003,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, powered",09-10-2025
L5859002004,"And programmable flexion/extension assist control, includes any type motor(s)",09-10-2025
L5910001003,"Addition, endoskeletal system, below knee, alignable system",09-10-2025
L5920001003,"Addition, endoskeletal system, above knee or hip disarticulation, alignable",09-10-2025
L5920002004,System,09-10-2025
L5925001003,"Addition, endoskeletal system, above knee, knee disarticulation or hip",09-10-2025
L5925002004,"Disarticulation, manual lock",09-10-2025
L5926001003,"Addition to lower extremity prosthesis, endoskeletal, knee disarticulation,",09-10-2025
L5926002004,"Above knee, hip disarticulation, positional rotation unit, any type",09-10-2025
L5930001003,"Addition, endoskeletal system, high activity knee control frame",09-10-2025
L5940001003,"Addition, endoskeletal system, below knee, ultra-light material (titanium,",09-10-2025
L5940002004,Carbon fiber or equal),09-10-2025
L5950001003,"Addition, endoskeletal system, above knee, ultra-light material (titanium,",09-10-2025
L5950002004,Carbon fiber or equal),09-10-2025
L5960001003,"Addition, endoskeletal system, hip disarticulation, ultra-light material",09-10-2025
L5960002004,"(titanium, carbon fiber or equal)",09-10-2025
L5961001003,"Addition, endoskeletal system, polycentric hip joint, pneumatic or hydraulic",09-10-2025
L5961002004,"Control, rotation control, with or without flexion and/or extension control",09-10-2025
L5962001003,"Addition, endoskeletal system, below knee, flexible protective outer surface",09-10-2025
L5962002004,Covering system,09-10-2025
L5964001003,"Addition, endoskeletal system, above knee, flexible protective outer surface",09-10-2025
L5964002004,Covering system,09-10-2025
L5966001003,"Addition, endoskeletal system, hip disarticulation, flexible protective outer",09-10-2025
L5966002004,Surface covering system,09-10-2025
L5968001003,"Addition to lower limb prosthesis, multiaxial ankle with swing phase active",09-10-2025
L5968002004,Dorsiflexion feature,09-10-2025
L5969001003,"Addition, endoskeletal ankle-foot or ankle system, power assist, includes any",09-10-2025
L5969002004,Type motor(s),09-10-2025
L5970001003,"All lower extremity prostheses, foot, external keel, sach foot",09-10-2025
L5971001003,"All lower extremity prosthesis, solid ankle cushion heel (sach) foot,",09-10-2025
L5971002004,Replacement only,09-10-2025
L5972001003,"All lower extremity prostheses, foot, flexible keel",09-10-2025
L5973001003,"Endoskeletal ankle foot system, microprocessor controlled feature, dorsiflexion",09-10-2025
L5973002004,"And/or plantar flexion control, includes power source",09-10-2025
L5974001003,"All lower extremity prostheses, foot, single axis ankle/foot",09-10-2025
L5975001003,"All lower extremity prosthesis, combination single axis ankle and flexible keel",09-10-2025
L5975002004,Foot,09-10-2025
L5976001003,"All lower extremity prostheses, energy storing foot (seattle carbon copy ii or",09-10-2025
L5976002004,Equal),09-10-2025
L5978001003,"All lower extremity prostheses, foot, multiaxial ankle/foot",09-10-2025
L5979001003,"All lower extremity prosthesis, multi-axial ankle, dynamic response foot, one",09-10-2025
L5979002004,Piece system,09-10-2025
L5980001003,"All lower extremity prostheses, flex foot system",09-10-2025
L5981001003,"All lower extremity prostheses, flex-walk system or equal",09-10-2025
L5982001003,"All exoskeletal lower extremity prostheses, axial rotation unit",09-10-2025
L5984001003,"All endoskeletal lower extremity prosthesis, axial rotation unit, with or",09-10-2025
L5984002004,Without adjustability,09-10-2025
L5985001003,"All endoskeletal lower extremity prostheses, dynamic prosthetic pylon",09-10-2025
L5986001003,"All lower extremity prostheses, multi-axial rotation unit ('mcp' or equal)",09-10-2025
L5987001003,"All lower extremity prosthesis, shank foot system with vertical loading pylon",09-10-2025
L5988001003,"Addition to lower limb prosthesis, vertical shock reducing pylon feature",09-10-2025
L5990001003,"Addition to lower extremity prosthesis, user adjustable heel height",09-10-2025
L5991001003,"Addition to lower extremity prostheses, osseointegrated external prosthetic",09-10-2025
L5991002004,Connector,09-10-2025
L5999001003,"Lower extremity prosthesis, not otherwise specified",09-10-2025
L6000001003,"Partial hand, thumb remaining",09-10-2025
L6010001003,"Partial hand, little and/or ring finger remaining",09-10-2025
L6020001003,"Partial hand, no finger remaining",09-10-2025
L6025001003,"Transcarpal/metacarpal or partial hand disarticulation prosthesis, external",09-10-2025
L6025002004,"Power, self-suspended, inner socket with removable forearm section, electrodes",09-10-2025
L6025003004,"And cables, two batteries, charger, myoelectric control of terminal device",09-10-2025
L6026001003,"Transcarpal/metacarpal or partial hand disarticulation prosthesis, external",09-10-2025
L6026002004,"Power, self-suspended, inner socket with removable forearm section, electrodes",09-10-2025
L6026003004,"And cables, two batteries, charger, myoelectric control of terminal device,",09-10-2025
L6026004004,Excludes terminal device(s),09-10-2025
L6028001003,"Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb,",09-10-2025
L6028002004,"Amputation at metacarpal level, including flexible or non-flexible interface,",09-10-2025
L6028003004,"Molded to patient model, including palm, for use without external power and/or",09-10-2025
L6028004004,"Passive prosthetic digit/thumb, not including inserts described by l6692",09-10-2025
L6029001003,"Upper extremity addition, test socket/interface, partial hand including fingers",09-10-2025
L6030001003,"Upper extremity addition, external frame, partial hand including fingers",09-10-2025
L6031001003,"Replacement socket/interface, partial hand including fingers, molded to patient",09-10-2025
L6031002004,"Model, for use with or without external power",09-10-2025
L6032001003,"Addition to upper extremity prosthesis, partial hand including fingers,",09-10-2025
L6032002004,"Ultralight material (titanium, carbon fiber or equal)",09-10-2025
L6033001003,"Addition to upper extremity prosthesis, partial hand including fingers, acrylic",09-10-2025
L6033002004,Material,09-10-2025
L6034001003,"Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb,",09-10-2025
L6034002004,"Amputation at transmetacarpal level, including flexible or non-flexible",09-10-2025
L6034003004,"Interface, molded to patient model, for use without external power and/or",09-10-2025
L6034004004,"Passive prosthetic digit/thumb, not including inserts described by l6692",09-10-2025
L6035001003,"Single prosthetic digit, mechanical, can include metacarpophalangeal (mcp),",09-10-2025
L6035002004,"Proximal interphalangeal (pip), and/or distal interphalangeal (dip) joint(s),",09-10-2025
L6035003004,"With or without locking mechanism, can include flexion or extension assist, any",09-10-2025
L6035004004,"Material, attachment, initial issue or replacement",09-10-2025
L6036001003,"Prosthetic thumb, mechanical, can include metacarpophalangeal (mcp),",09-10-2025
L6036002004,"Interphalangeal (ip) joint(s), with or without locking mechanism, can include",09-10-2025
L6036003004,"Flexion or extension assist, any material, attachment, initial issue or",09-10-2025
L6036004004,Replacement,09-10-2025
L6037001003,"Immediate post-surgical or early fitting, application of initial rigid",09-10-2025
L6037002004,"Dressing, including fitting alignment and suspension of components, and one",09-10-2025
L6037003004,"Cast change, partial hand including fingers",09-10-2025
L6038001003,"Addition to single prosthetic digit or thumb, mechanical, attachment,",09-10-2025
L6038002004,"Multiaxial and/or internal/external rotation/abduction/adduction mechanism,",09-10-2025
L6038003004,"With or without locking feature, any material",09-10-2025
L6039001003,Passive prosthetic digit or thumb prosthesis not including hand restoration,09-10-2025
L6039002004,"Partial hand, full or partial, custom made, any material, initial or",09-10-2025
L6039003004,"Replacement, per single passive prosthetic digit or thumb",09-10-2025
L6050001003,"Wrist disarticulation, molded socket, flexible elbow hinges, triceps pad",09-10-2025
L6055001003,"Wrist disarticulation, molded socket with expandable interface, flexible elbow",09-10-2025
L6055002004,"Hinges, triceps pad",09-10-2025
L6100001003,"Below elbow, molded socket, flexible elbow hinge, triceps pad",09-10-2025
L6110001003,"Below elbow, molded socket, (muenster or northwestern suspension types)",09-10-2025
L6120001003,"Below elbow, molded double wall split socket, step-up hinges, half cuff",09-10-2025
L6130001003,"Below elbow, molded double wall split socket, stump activated locking hinge,",09-10-2025
L6130002004,Half cuff,09-10-2025
L6200001003,"Elbow disarticulation, molded socket, outside locking hinge, forearm",09-10-2025
L6205001003,"Elbow disarticulation, molded socket with expandable interface, outside locking",09-10-2025
L6205002004,"Hinges, forearm",09-10-2025
L6250001003,"Above elbow, molded double wall socket, internal locking elbow, forearm",09-10-2025
L6300001003,"Shoulder disarticulation, molded socket, shoulder bulkhead, humeral section,",09-10-2025
L6300002004,"Internal locking elbow, forearm",09-10-2025
L6310001003,"Shoulder disarticulation, passive restoration (complete prosthesis)",09-10-2025
L6320001003,"Shoulder disarticulation, passive restoration (shoulder cap only)",09-10-2025
L6350001003,"Interscapular thoracic, molded socket, shoulder bulkhead, humeral section,",09-10-2025
L6350002004,"Internal locking elbow, forearm",09-10-2025
L6360001003,"Interscapular thoracic, passive restoration (complete prosthesis)",09-10-2025
L6370001003,"Interscapular thoracic, passive restoration (shoulder cap only)",09-10-2025
L6380001003,"Immediate post surgical or early fitting, application of initial rigid",09-10-2025
L6380002004,"Dressing, including fitting alignment and suspension of components, and one",09-10-2025
L6380003004,"Cast change, wrist disarticulation or below elbow",09-10-2025
L6382001003,"Immediate post surgical or early fitting, application of initial rigid dressing",09-10-2025
L6382002004,"Including fitting alignment and suspension of components, and one cast change,",09-10-2025
L6382003004,Elbow disarticulation or above elbow,09-10-2025
L6384001003,"Immediate post surgical or early fitting, application of initial rigid dressing",09-10-2025
L6384002004,"Including fitting alignment and suspension of components, and one cast change,",09-10-2025
L6384003004,Shoulder disarticulation or interscapular thoracic,09-10-2025
L6386001003,"Immediate post surgical or early fitting, each additional cast change and",09-10-2025
L6386002004,Realignment,09-10-2025
L6388001003,"Immediate post surgical or early fitting, application of rigid dressing only",09-10-2025
L6400001003,"Below elbow, molded socket, endoskeletal system, including soft prosthetic",09-10-2025
L6400002004,Tissue shaping,09-10-2025
L6450001003,"Elbow disarticulation, molded socket, endoskeletal system, including soft",09-10-2025
L6450002004,Prosthetic tissue shaping,09-10-2025
L6500001003,"Above elbow, molded socket, endoskeletal system, including soft prosthetic",09-10-2025
L6500002004,Tissue shaping,09-10-2025
L6550001003,"Shoulder disarticulation, molded socket, endoskeletal system, including soft",09-10-2025
L6550002004,Prosthetic tissue shaping,09-10-2025
L6570001003,"Interscapular thoracic, molded socket, endoskeletal system, including soft",09-10-2025
L6570002004,Prosthetic tissue shaping,09-10-2025
L6580001003,"Preparatory, wrist disarticulation or below elbow, single wall plastic socket,",09-10-2025
L6580002004,"Friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff,",09-10-2025
L6580003004,"Bowden cable control, usmc or equal pylon, no cover, molded to patient model",09-10-2025
L6582001003,"Preparatory, wrist disarticulation or below elbow, single wall socket, friction",09-10-2025
L6582002004,"Wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden",09-10-2025
L6582003004,"Cable control, usmc or equal pylon, no cover, direct formed",09-10-2025
L6584001003,"Preparatory, elbow disarticulation or above elbow, single wall plastic socket,",09-10-2025
L6584002004,"Friction wrist, locking elbow, figure of eight harness, fair lead cable",09-10-2025
L6584003004,"Control, usmc or equal pylon, no cover, molded to patient model",09-10-2025
L6586001003,"Preparatory, elbow disarticulation or above elbow, single wall socket, friction",09-10-2025
L6586002004,"Wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or",09-10-2025
L6586003004,"Equal pylon, no cover, direct formed",09-10-2025
L6588001003,"Preparatory, shoulder disarticulation or interscapular thoracic, single wall",09-10-2025
L6588002004,"Plastic socket, shoulder joint, locking elbow, friction wrist, chest strap,",09-10-2025
L6588003004,"Fair lead cable control, usmc or equal pylon, no cover, molded to patient model",09-10-2025
L6590001003,"Preparatory, shoulder disarticulation or interscapular thoracic, single wall",09-10-2025
L6590002004,"Socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead",09-10-2025
L6590003004,"Cable control, usmc or equal pylon, no cover, direct formed",09-10-2025
L6600001003,"Upper extremity additions, polycentric hinge, pair",09-10-2025
L6605001003,"Upper extremity additions, single pivot hinge, pair",09-10-2025
L6610001003,"Upper extremity additions, flexible metal hinge, pair",09-10-2025
L6611001003,"Addition to upper extremity prosthesis, external powered, additional switch,",09-10-2025
L6611002004,Any type,09-10-2025
L6615001003,"Upper extremity addition, disconnect locking wrist unit",09-10-2025
L6616001003,"Upper extremity addition, additional disconnect insert for locking wrist unit,",09-10-2025
L6616002004,Each,09-10-2025
L6620001003,"Upper extremity addition, flexion/extension wrist unit, with or without frictio",09-10-2025
L6621001003,"Upper extremity prosthesis addition, flexion/extension wrist with or without",09-10-2025
L6621002004,"Friction, for use with external powered terminal device",09-10-2025
L6623001003,"Upper extremity addition, spring assisted rotational wrist unit with latch",09-10-2025
L6623002004,Release,09-10-2025
L6624001003,"Upper extremity addition, flexion/extension and rotation wrist unit",09-10-2025
L6625001003,"Upper extremity addition, rotation wrist unit with cable lock",09-10-2025
L6628001003,"Upper extremity addition, quick disconnect hook adapter, otto bock or equal",09-10-2025
L6629001003,"Upper extremity addition, quick disconnect lamination collar with coupling",09-10-2025
L6629002004,"Piece, otto bock or equal",09-10-2025
L6630001003,"Upper extremity addition, stainless steel, any wrist",09-10-2025
L6632001003,"Upper extremity addition, latex suspension sleeve, each",09-10-2025
L6635001003,"Upper extremity addition, lift assist for elbow",09-10-2025
L6637001003,"Upper extremity addition, nudge control elbow lock",09-10-2025
L6638001003,"Upper extremity addition to prosthesis, electric locking feature, only for use",09-10-2025
L6638002004,With manually powered elbow,09-10-2025
L6640001003,"Upper extremity additions, shoulder abduction joint, pair",09-10-2025
L6641001003,"Upper extremity addition, excursion amplifier, pulley type",09-10-2025
L6642001003,"Upper extremity addition, excursion amplifier, lever type",09-10-2025
L6645001003,"Upper extremity addition, shoulder flexion-abduction joint, each",09-10-2025
L6646001003,"Upper extremity addition, shoulder joint, multipositional locking, flexion,",09-10-2025
L6646002004,"Adjustable abduction friction control, for use with body powered or external",09-10-2025
L6646003004,Powered system,09-10-2025
L6647001003,"Upper extremity addition, shoulder lock mechanism, body powered actuator",09-10-2025
L6648001003,"Upper extremity addition, shoulder lock mechanism, external powered actuator",09-10-2025
L6650001003,"Upper extremity addition, shoulder universal joint, each",09-10-2025
L6655001003,"Upper extremity addition, standard control cable, extra",09-10-2025
L6660001003,"Upper extremity addition, heavy duty control cable",09-10-2025
L6665001003,"Upper extremity addition, teflon, or equal, cable lining",09-10-2025
L6670001003,"Upper extremity addition, hook to hand, cable adapter",09-10-2025
L6672001003,"Upper extremity addition, harness, chest or shoulder, saddle type",09-10-2025
L6675001003,"Upper extremity addition, harness, (e.g., figure of eight type), single cable",09-10-2025
L6675002004,Design,09-10-2025
L6676001003,"Upper extremity addition, harness, (e.g., figure of eight type), dual cable",09-10-2025
L6676002004,Design,09-10-2025
L6677001003,"Upper extremity addition, harness, triple control, simultaneous operation of",09-10-2025
L6677002004,Terminal device and elbow,09-10-2025
L6680001003,"Upper extremity addition, test socket, wrist disarticulation or below elbow",09-10-2025
L6682001003,"Upper extremity addition, test socket, elbow disarticulation or above elbow",09-10-2025
L6684001003,"Upper extremity addition, test socket, shoulder disarticulation or",09-10-2025
L6684002004,Interscapular thoracic,09-10-2025
L6686001003,"Upper extremity addition, suction socket",09-10-2025
L6687001003,"Upper extremity addition, frame type socket, below elbow or wrist",09-10-2025
L6687002004,Disarticulation,09-10-2025
L6688001003,"Upper extremity addition, frame type socket, above elbow or elbow",09-10-2025
L6688002004,Disarticulation,09-10-2025
L6689001003,"Upper extremity addition, frame type socket, shoulder disarticulation",09-10-2025
L6690001003,"Upper extremity addition, frame type socket, interscapular-thoracic",09-10-2025
L6691001003,"Upper extremity addition, removable insert, each",09-10-2025
L6692001003,"Upper extremity addition, silicone gel insert or equal, with or without locking",09-10-2025
L6692002004,"Mechanism, each",09-10-2025
L6693001003,"Upper extremity addition, locking elbow, forearm counterbalance",09-10-2025
L6694001003,"Addition to upper extremity prosthesis, below elbow/above elbow, custom",09-10-2025
L6694002004,"Fabricated from existing mold or prefabricated, socket insert, silicone gel,",09-10-2025
L6694003004,"Elastomeric or equal, for use with locking mechanism",09-10-2025
L6695001003,"Addition to upper extremity prosthesis, below elbow/above elbow, custom",09-10-2025
L6695002004,"Fabricated from existing mold or prefabricated, socket insert, silicone gel,",09-10-2025
L6695003004,"Elastomeric or equal, not for use with locking mechanism",09-10-2025
L6696001003,"Addition to upper extremity prosthesis, below elbow/above elbow, custom",09-10-2025
L6696002004,"Fabricated socket insert for congenital or atypical traumatic amputee, silicone",09-10-2025
L6696003004,"Gel, elastomeric or equal, for use with or without locking mechanism, initial",09-10-2025
L6696004004,"Only (for other than initial, use code l6694 or l6695)",09-10-2025
L6697001003,"Addition to upper extremity prosthesis, below elbow/above elbow, custom",09-10-2025
L6697002004,Fabricated socket insert for other than congenital or atypical traumatic,09-10-2025
L6697003004,"Amputee, silicone gel, elastomeric or equal, for use with or without locking",09-10-2025
L6697004004,"Mechanism, initial only (for other than initial, use code l6694 or l6695)",09-10-2025
L6698001003,"Addition to upper extremity prosthesis, lock mechanism, excludes socket insert",09-10-2025
L6700001003,"Upper extremity addition, external powered feature, myoelectronic control",09-10-2025
L6700002004,"Module, additional emg inputs, pattern-recognition decoding intent movement",09-10-2025
L6703001003,"Terminal device, passive hand/mitt, any material, any size",09-10-2025
L6704001003,"Terminal device, sport/recreational/work attachment, any material, any size",09-10-2025
L6706001003,"Terminal device, hook, mechanical, voluntary opening, any material, any size,",09-10-2025
L6706002004,Lined or unlined,09-10-2025
L6707001003,"Terminal device, hook, mechanical, voluntary closing, any material, any size,",09-10-2025
L6707002004,Lined or unlined,09-10-2025
L6708001003,"Terminal device, hand, mechanical, voluntary opening, any material, any size",09-10-2025
L6709001003,"Terminal device, hand, mechanical, voluntary closing, any material, any size",09-10-2025
L6711001003,"Terminal device, hook, mechanical, voluntary opening, any material, any size,",09-10-2025
L6711002004,"Lined or unlined, pediatric",09-10-2025
L6712001003,"Terminal device, hook, mechanical, voluntary closing, any material, any size,",09-10-2025
L6712002004,"Lined or unlined, pediatric",09-10-2025
L6713001003,"Terminal device, hand, mechanical, voluntary opening, any material, any size,",09-10-2025
L6713002004,Pediatric,09-10-2025
L6714001003,"Terminal device, hand, mechanical, voluntary closing, any material, any size,",09-10-2025
L6714002004,Pediatric,09-10-2025
L6715001003,"Terminal device, multiple articulating digit, includes motor(s), initial issue",09-10-2025
L6715002004,Or replacement,09-10-2025
L6721001003,"Terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any",09-10-2025
L6721002004,"Material, any size, lined or unlined",09-10-2025
L6722001003,"Terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any",09-10-2025
L6722002004,"Material, any size, lined or unlined",09-10-2025
L6805001003,"Addition to terminal device, modifier wrist unit",09-10-2025
L6810001003,"Addition to terminal device, precision pinch device",09-10-2025
L6880001003,"Electric hand, switch or myoelectric controlled, independently articulating",09-10-2025
L6880002004,"Digits, any grasp pattern or combination of grasp patterns, includes motor(s)",09-10-2025
L6881001003,"Automatic grasp feature, addition to upper limb electric prosthetic terminal",09-10-2025
L6881002004,Device,09-10-2025
L6882001003,"Microprocessor control feature, addition to upper limb prosthetic terminal",09-10-2025
L6882002004,Device,09-10-2025
L6883001003,"Replacement socket, below elbow/wrist disarticulation, molded to patient model,",09-10-2025
L6883002004,For use with or without external power,09-10-2025
L6884001003,"Replacement socket, above elbow/elbow disarticulation, molded to patient model,",09-10-2025
L6884002004,For use with or without external power,09-10-2025
L6885001003,"Replacement socket, shoulder disarticulation/interscapular thoracic, molded to",09-10-2025
L6885002004,"Patient model, for use with or without external power",09-10-2025
L6890001003,"Addition to upper extremity prosthesis, glove for terminal device, any",09-10-2025
L6890002004,"Material, prefabricated, includes fitting and adjustment",09-10-2025
L6895001003,"Addition to upper extremity prosthesis, glove for terminal device, any",09-10-2025
L6895002004,"Material, custom fabricated",09-10-2025
L6900001003,"Hand restoration (casts, shading and measurements included), partial hand, with",09-10-2025
L6900002004,"Glove, thumb or one finger remaining",09-10-2025
L6905001003,"Hand restoration (casts, shading and measurements included), partial hand, with",09-10-2025
L6905002004,"Glove, multiple fingers remaining",09-10-2025
L6910001003,"Hand restoration (casts, shading and measurements included), partial hand, with",09-10-2025
L6910002004,"Glove, no fingers remaining",09-10-2025
L6915001003,"Hand restoration (shading, and measurements included), replacement glove for",09-10-2025
L6915002004,Above,09-10-2025
L6920001003,"Wrist disarticulation, external power, self-suspended inner socket, removable",09-10-2025
L6920002004,"Forearm shell, otto bock or equal, switch, cables, two batteries and one",09-10-2025
L6920003004,"Charger, switch control of terminal device",09-10-2025
L6925001003,"Wrist disarticulation, external power, self-suspended inner socket, removable",09-10-2025
L6925002004,"Forearm shell, otto bock or equal electrodes, cables, two batteries and one",09-10-2025
L6925003004,"Charger, myoelectronic control of terminal device",09-10-2025
L6930001003,"Below elbow, external power, self-suspended inner socket, removable forearm",09-10-2025
L6930002004,"Shell, otto bock or equal switch, cables, two batteries and one charger, switch",09-10-2025
L6930003004,Control of terminal device,09-10-2025
L6935001003,"Below elbow, external power, self-suspended inner socket, removable forearm",09-10-2025
L6935002004,"Shell, otto bock or equal electrodes, cables, two batteries and one charger,",09-10-2025
L6935003004,Myoelectronic control of terminal device,09-10-2025
L6940001003,"Elbow disarticulation, external power, molded inner socket, removable humeral",09-10-2025
L6940002004,"Shell, outside locking hinges, forearm, otto bock or equal switch, cables, two",09-10-2025
L6940003004,"Batteries and one charger, switch control of terminal device",09-10-2025
L6945001003,"Elbow disarticulation, external power, molded inner socket, removable humeral",09-10-2025
L6945002004,"Shell, outside locking hinges, forearm, otto bock or equal electrodes, cables,",09-10-2025
L6945003004,"Two batteries and one charger, myoelectronic control of terminal device",09-10-2025
L6950001003,"Above elbow, external power, molded inner socket, removable humeral shell,",09-10-2025
L6950002004,"Internal locking elbow, forearm, otto bock or equal switch, cables, two",09-10-2025
L6950003004,"Batteries and one charger, switch control of terminal device",09-10-2025
L6955001003,"Above elbow, external power, molded inner socket, removable humeral shell,",09-10-2025
L6955002004,"Internal locking elbow, forearm, otto bock or equal electrodes, cables, two",09-10-2025
L6955003004,"Batteries and one charger, myoelectronic control of terminal device",09-10-2025
L6960001003,"Shoulder disarticulation, external power, molded inner socket, removable",09-10-2025
L6960002004,"Shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm,",09-10-2025
L6960003004,"Otto bock or equal switch, cables, two batteries and one charger, switch",09-10-2025
L6960004004,Control of terminal device,09-10-2025
L6965001003,"Shoulder disarticulation, external power, molded inner socket, removable",09-10-2025
L6965002004,"Shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm,",09-10-2025
L6965003004,"Otto bock or equal electrodes, cables, two batteries and one charger,",09-10-2025
L6965004004,Myoelectronic control of terminal device,09-10-2025
L6970001003,"Interscapular-thoracic, external power, molded inner socket, removable shoulder",09-10-2025
L6970002004,"Shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock",09-10-2025
L6970003004,"Or equal switch, cables, two batteries and one charger, switch control of",09-10-2025
L6970004004,Terminal device,09-10-2025
L6975001003,"Interscapular-thoracic, external power, molded inner socket, removable shoulder",09-10-2025
L6975002004,"Shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock",09-10-2025
L6975003004,"Or equal electrodes, cables, two batteries and one charger, myoelectronic",09-10-2025
L6975004004,Control of terminal device,09-10-2025
L7007001003,"Electric hand, switch or myoelectric controlled, adult",09-10-2025
L7008001003,"Electric hand, switch or myoelectric, controlled, pediatric",09-10-2025
L7009001003,"Electric hook, switch or myoelectric controlled, adult",09-10-2025
L7040001003,"Prehensile actuator, switch controlled",09-10-2025
L7045001003,"Electric hook, switch or myoelectric controlled, pediatric",09-10-2025
L7170001003,"Electronic elbow, hosmer or equal, switch controlled",09-10-2025
L7180001003,"Electronic elbow, microprocessor sequential control of elbow and terminal devic",09-10-2025
L7181001003,"Electronic elbow, microprocessor simultaneous control of elbow and terminal",09-10-2025
L7181002004,Device,09-10-2025
L7185001003,"Electronic elbow, adolescent, variety village or equal, switch controlled",09-10-2025
L7186001003,"Electronic elbow, child, variety village or equal, switch controlled",09-10-2025
L7190001003,"Electronic elbow, adolescent, variety village or equal, myoelectronically",09-10-2025
L7190002004,Controlled,09-10-2025
L7191001003,"Electronic elbow, child, variety village or equal, myoelectronically controlled",09-10-2025
L7259001003,"Electronic wrist rotator, any type",09-10-2025
L7260001003,"Electronic wrist rotator, otto bock or equal",09-10-2025
L7261001003,"Electronic wrist rotator, for utah arm",09-10-2025
L7360001003,"Six volt battery, each",09-10-2025
L7362001003,"Battery charger, six volt, each",09-10-2025
L7364001003,"Twelve volt battery, each",09-10-2025
L7366001003,"Battery charger, twelve volt, each",09-10-2025
L7367001003,"Lithium ion battery, rechargeable, replacement",09-10-2025
L7368001003,"Lithium ion battery charger, replacement only",09-10-2025
L7400001003,"Addition to upper extremity prosthesis, below elbow/wrist disarticulation,",09-10-2025
L7400002004,"Ultralight material (titanium, carbon fiber or equal)",09-10-2025
L7401001003,"Addition to upper extremity prosthesis, above elbow disarticulation, ultralight",09-10-2025
L7401002004,"Material (titanium, carbon fiber or equal)",09-10-2025
L7402001003,"Addition to upper extremity prosthesis, shoulder disarticulation/interscapular",09-10-2025
L7402002004,"Thoracic, ultralight material (titanium, carbon fiber or equal)",09-10-2025
L7403001003,"Addition to upper extremity prosthesis, below elbow/wrist disarticulation,",09-10-2025
L7403002004,Acrylic material,09-10-2025
L7404001003,"Addition to upper extremity prosthesis, above elbow disarticulation, acrylic",09-10-2025
L7404002004,Material,09-10-2025
L7405001003,"Addition to upper extremity prosthesis, shoulder disarticulation/interscapular",09-10-2025
L7405002004,"Thoracic, acrylic material",09-10-2025
L7406001003,"Addition to upper extremity prosthesis, user adjustable, mechanical, residual",09-10-2025
L7406002004,Limb volume management system (with or without lamination kit),09-10-2025
L7499001003,"Upper extremity prosthesis, not otherwise specified",09-10-2025
L7510001003,"Repair of prosthetic device, repair or replace minor parts",09-10-2025
L7520001003,"Repair prosthetic device, labor component, per 15 minutes",09-10-2025
L7600001003,"Prosthetic donning sleeve, any material, each",09-10-2025
L7700001003,"Gasket or seal, for use with prosthetic socket insert, any type, each",09-10-2025
L7900001003,Male vacuum erection system,09-10-2025
L7902001003,"Tension ring, for vacuum erection device, any type, replacement only, each",09-10-2025
L8000001003,"Breast prosthesis, mastectomy bra, without integrated breast prosthesis form,",09-10-2025
L8000002004,"Any size, any type",09-10-2025
L8001001003,"Breast prosthesis, mastectomy bra, with integrated breast prosthesis form,",09-10-2025
L8001002004,"Unilateral, any size, any type",09-10-2025
L8002001003,"Breast prosthesis, mastectomy bra, with integrated breast prosthesis form,",09-10-2025
L8002002004,"Bilateral, any size, any type",09-10-2025
L8010001003,"Breast prosthesis, mastectomy sleeve",09-10-2025
L8015001003,"External breast prosthesis garment, with mastectomy form, post mastectomy",09-10-2025
L8020001003,"Breast prosthesis, mastectomy form",09-10-2025
L8030001003,"Breast prosthesis, silicone or equal, without integral adhesive",09-10-2025
L8031001003,"Breast prosthesis, silicone or equal, with integral adhesive",09-10-2025
L8032001003,"Nipple prosthesis, prefabricated, reusable, any type, each",09-10-2025
L8033001003,"Nipple prosthesis, custom fabricated, reusable, any material, any type, each",09-10-2025
L8035001003,"Custom breast prosthesis, post mastectomy, molded to patient model",09-10-2025
L8039001003,"Breast prosthesis, not otherwise specified",09-10-2025
L8040001003,"Nasal prosthesis, provided by a non-physician",09-10-2025
L8041001003,"Midfacial prosthesis, provided by a non-physician",09-10-2025
L8042001003,"Orbital prosthesis, provided by a non-physician",09-10-2025
L8043001003,"Upper facial prosthesis, provided by a non-physician",09-10-2025
L8044001003,"Hemi-facial prosthesis, provided by a non-physician",09-10-2025
L8045001003,"Auricular prosthesis, provided by a non-physician",09-10-2025
L8046001003,"Partial facial prosthesis, provided by a non-physician",09-10-2025
L8047001003,"Nasal septal prosthesis, provided by a non-physician",09-10-2025
L8048001003,"Unspecified maxillofacial prosthesis, by report, provided by a non-physician",09-10-2025
L8049001003,"Repair or modification of maxillofacial prosthesis, labor component, 15 minute",09-10-2025
L8049002004,"Increments, provided by a non-physician",09-10-2025
L8300001003,"Truss, single with standard pad",09-10-2025
L8310001003,"Truss, double with standard pads",09-10-2025
L8320001003,"Truss, addition to standard pad, water pad",09-10-2025
L8330001003,"Truss, addition to standard pad, scrotal pad",09-10-2025
L8400001003,"Prosthetic sheath, below knee, each",09-10-2025
L8410001003,"Prosthetic sheath, above knee, each",09-10-2025
L8415001003,"Prosthetic sheath, upper limb, each",09-10-2025
L8417001003,"Prosthetic sheath/sock, including a gel cushion layer, below knee or above",09-10-2025
L8417002004,"Knee, each",09-10-2025
L8420001003,"Prosthetic sock, multiple ply, below knee, each",09-10-2025
L8430001003,"Prosthetic sock, multiple ply, above knee, each",09-10-2025
L8435001003,"Prosthetic sock, multiple ply, upper limb, each",09-10-2025
L8440001003,"Prosthetic shrinker, below knee, each",09-10-2025
L8460001003,"Prosthetic shrinker, above knee, each",09-10-2025
L8465001003,"Prosthetic shrinker, upper limb, each",09-10-2025
L8470001003,"Prosthetic sock, single ply, fitting, below knee, each",09-10-2025
L8480001003,"Prosthetic sock, single ply, fitting, above knee, each",09-10-2025
L8485001003,"Prosthetic sock, single ply, fitting, upper limb, each",09-10-2025
L8499001003,Unlisted procedure for miscellaneous prosthetic services,09-10-2025
L8500001003,"Artificial larynx, any type",09-10-2025
L8501001003,Tracheostomy speaking valve,09-10-2025
L8505001003,"Artificial larynx replacement battery / accessory, any type",09-10-2025
L8507001003,"Tracheo-esophageal voice prosthesis, patient inserted, any type, each",09-10-2025
L8509001003,"Tracheo-esophageal voice prosthesis, inserted by a licensed health care",09-10-2025
L8509002004,"Provider, any type",09-10-2025
L8510001003,Voice amplifier,09-10-2025
L8511001003,"Insert for indwelling tracheoesophageal prosthesis, with or without valve,",09-10-2025
L8511002004,"Replacement only, each",09-10-2025
L8512001003,"Gelatin capsules or equivalent, for use with tracheoesophageal voice",09-10-2025
L8512002004,"Prosthesis, replacement only, per 10",09-10-2025
L8513001003,"Cleaning device used with tracheoesophageal voice prosthesis, pipet, brush, or",09-10-2025
L8513002004,"Equal, replacement only, each",09-10-2025
L8514001003,"Tracheoesophageal puncture dilator, replacement only, each",09-10-2025
L8515001003,"Gelatin capsule, application device for use with tracheoesophageal voice",09-10-2025
L8515002004,"Prosthesis, each",09-10-2025
L8600001003,"Implantable breast prosthesis, silicone or equal",09-10-2025
L8603001003,"Injectable bulking agent, collagen implant, urinary tract, 2.5 ml syringe,",09-10-2025
L8603002004,Includes shipping and necessary supplies,09-10-2025
L8604001003,"Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant,",09-10-2025
L8604002004,"Urinary tract, 1 ml, includes shipping and necessary supplies",09-10-2025
L8605001003,"Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal",09-10-2025
L8605002004,"Canal, 1 ml, includes shipping and necessary supplies",09-10-2025
L8606001003,"Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe,",09-10-2025
L8606002004,Includes shipping and necessary supplies,09-10-2025
L8607001003,"Injectable bulking agent for vocal cord medialization, 0.1 ml, includes",09-10-2025
L8607002004,Shipping and necessary supplies,09-10-2025
L8608001003,"Miscellaneous external component, supply or accessory for use with the argus ii",09-10-2025
L8608002004,Retinal prosthesis system,09-10-2025
L8609001003,Artificial cornea,09-10-2025
L8610001003,Ocular implant,09-10-2025
L8612001003,Aqueous shunt,09-10-2025
L8613001003,Ossicula implant,09-10-2025
L8614001003,"Cochlear device, includes all internal and external components",09-10-2025
L8615001003,"Headset/headpiece for use with cochlear implant device, replacement",09-10-2025
L8616001003,"Microphone for use with cochlear implant device, replacement",09-10-2025
L8617001003,"Transmitting coil for use with cochlear implant device, replacement",09-10-2025
L8618001003,Transmitter cable for use with cochlear implant device or auditory,09-10-2025
L8618002004,"Osseointegrated device, replacement",09-10-2025
L8619001003,"Cochlear implant, external speech processor and controller, integrated system,",09-10-2025
L8619002004,Replacement,09-10-2025
L8621001003,Zinc air battery for use with cochlear implant device and auditory,09-10-2025
L8621002004,"Osseointegrated sound processors, replacement, each",09-10-2025
L8622001003,"Alkaline battery for use with cochlear implant device, any size, replacement,",09-10-2025
L8622002004,Each,09-10-2025
L8623001003,"Lithium ion battery for use with cochlear implant device speech processor,",09-10-2025
L8623002004,"Other than ear level, replacement, each",09-10-2025
L8624001003,Lithium ion battery for use with cochlear implant or auditory osseointegrated,09-10-2025
L8624002004,"Device speech processor, ear level, replacement, each",09-10-2025
L8625001003,External recharging system for battery for use with cochlear implant or,09-10-2025
L8625002004,"Auditory osseointegrated device, replacement only, each",09-10-2025
L8627001003,"Cochlear implant, external speech processor, component, replacement",09-10-2025
L8628001003,"Cochlear implant, external controller component, replacement",09-10-2025
L8629001003,"Transmitting coil and cable, integrated, for use with cochlear implant device,",09-10-2025
L8629002004,Replacement,09-10-2025
L8630001003,Metacarpophalangeal joint implant,09-10-2025
L8631001003,"Metacarpal phalangeal joint replacement, two or more pieces, metal (e.g.,",09-10-2025
L8631002004,"Stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon),",09-10-2025
L8631003004,"For surgical implantation (all sizes, includes entire system)",09-10-2025
L8641001003,Metatarsal joint implant,09-10-2025
L8642001003,Hallux implant,09-10-2025
L8658001003,"Interphalangeal joint spacer, silicone or equal, each",09-10-2025
L8659001003,"Interphalangeal finger joint replacement, 2 or more pieces, metal (e.g.,",09-10-2025
L8659002004,"Stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon) for",09-10-2025
L8659003004,"Surgical implantation, any size",09-10-2025
L8670001003,"Vascular graft material, synthetic, implant",09-10-2025
L8678001003,Electrical stimulator supplies (external) for use with implantable,09-10-2025
L8678002004,"Neurostimulator, per month",09-10-2025
L8679001003,"Implantable neurostimulator, pulse generator, any type",09-10-2025
L8680001003,"Implantable neurostimulator electrode, each",09-10-2025
L8681001003,Patient programmer (external) for use with implantable programmable,09-10-2025
L8681002004,"Neurostimulator pulse generator, replacement only",09-10-2025
L8682001003,Implantable neurostimulator radiofrequency receiver,09-10-2025
L8683001003,Radiofrequency transmitter (external) for use with implantable neurostimulator,09-10-2025
L8683002004,Radiofrequency receiver,09-10-2025
L8684001003,Radiofrequency transmitter (external) for use with implantable sacral root,09-10-2025
L8684002004,"Neurostimulator receiver for bowel and bladder management, replacement",09-10-2025
L8685001003,"Implantable neurostimulator pulse generator, single array, rechargeable,",09-10-2025
L8685002004,Includes extension,09-10-2025
L8686001003,"Implantable neurostimulator pulse generator, single array, non-rechargeable,",09-10-2025
L8686002004,Includes extension,09-10-2025
L8687001003,"Implantable neurostimulator pulse generator, dual array, rechargeable, includes",09-10-2025
L8687002004,Extension,09-10-2025
L8688001003,"Implantable neurostimulator pulse generator, dual array, non-rechargeable,",09-10-2025
L8688002004,Includes extension,09-10-2025
L8689001003,External recharging system for battery (internal) for use with implantable,09-10-2025
L8689002004,"Neurostimulator, replacement only",09-10-2025
L8690001003,"Auditory osseointegrated device, includes all internal and external components",09-10-2025
L8691001003,"Auditory osseointegrated device, external sound processor, excludes",09-10-2025
L8691002004,"Transducer/actuator, replacement only, each",09-10-2025
L8692001003,"Auditory osseointegrated device, external sound processor, used without",09-10-2025
L8692002004,"Osseointegration, body worn, includes headband or other means of external",09-10-2025
L8692003004,Attachment,09-10-2025
L8693001003,"Auditory osseointegrated device abutment, any length, replacement only",09-10-2025
L8694001003,"Auditory osseointegrated device, transducer/actuator, replacement only, each",09-10-2025
L8695001003,External recharging system for battery (external) for use with implantable,09-10-2025
L8695002004,"Neurostimulator, replacement only",09-10-2025
L8696001003,Antenna (external) for use with implantable diaphragmatic/phrenic nerve,09-10-2025
L8696002004,"Stimulation device, replacement, each",09-10-2025
L8698001003,"Miscellaneous component, supply or accessory for use with total artificial",09-10-2025
L8698002004,Heart system,09-10-2025
L8699001003,"Prosthetic implant, not otherwise specified",09-10-2025
L8701001003,"Powered upper extremity range of motion assist device, elbow, wrist, hand with",09-10-2025
L8701002004,"Single or double upright(s), includes microprocessor, sensors, all components",09-10-2025
L8701003004,"And accessories, custom fabricated",09-10-2025
L8702001003,"Powered upper extremity range of motion assist device, elbow, wrist, hand,",09-10-2025
L8702002004,"Finger, single or double upright(s), includes microprocessor, sensors, all",09-10-2025
L8702003004,"Components and accessories, custom fabricated",09-10-2025
L8720001003,"External lower extremity sensory prosthetic device, cutaneous stimulation of",09-10-2025
L8720002004,"Mechanoreceptors proximal to the ankle, per leg",09-10-2025
L8721001003,"Receptor sole for use with l8720, replacement, each",09-10-2025
L9900001003,"Orthotic and prosthetic supply, accessory, and/or service component of another",09-10-2025
L9900002004,"Hcpcs ""l"" code",09-10-2025
M0001001003,Advancing cancer care mips value pathways,09-10-2025
M0002001003,Optimal care for kidney health mips value pathways,09-10-2025
M0003001003,Optimal care for patients with episodic neurological conditions mips value,09-10-2025
M0003002004,Pathways,09-10-2025
M0004001003,Quality care for patients with neurological conditions mips value pathway,09-10-2025
M0005001003,Value in primary care mips value pathway,09-10-2025
M0010001003,Enhancing oncology model (eom) monthly enhanced oncology services (meos),09-10-2025
M0010002004,Payment for eom enhanced services,09-10-2025
M0064001003,Brief office visit for the sole purpose of monitoring or changing drug,09-10-2025
M0064002004,Prescriptions used in the treatment of mental psychoneurotic and personality,09-10-2025
M0064003004,Disorders,09-10-2025
M0075001003,Cellular therapy,09-10-2025
M0076001003,Prolotherapy,09-10-2025
M0100001003,Intragastric hypothermia using gastric freezing,09-10-2025
M0201001003,"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine",09-10-2025
M0201002004,Inside a patient's home; reported only once per individual home per date of,09-10-2025
M0201003004,Service when such vaccine administration(s) are performed at the patient's home,09-10-2025
M0220001003,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only,",09-10-2025
M0220002004,For certain adults and pediatric individuals (12 years of age and older,09-10-2025
M0220003004,"Weighing at least 40kg) with no known sars-cov-2 exposure, who either have",09-10-2025
M0220004004,Moderate to severely compromised immune systems or for whom vaccination with,09-10-2025
M0220005004,Any available covid-19 vaccine is not recommended due to a history of severe,09-10-2025
M0220006004,"Adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s),",09-10-2025
M0220007004,Includes injection and post administration monitoring,09-10-2025
M0221001003,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only,",09-10-2025
M0221002004,For certain adults and pediatric individuals (12 years of age and older,09-10-2025
M0221003004,"Weighing at least 40kg) with no known sars-cov-2 exposure, who either have",09-10-2025
M0221004004,Moderate to severely compromised immune systems or for whom vaccination with,09-10-2025
M0221005004,Any available covid-19 vaccine is not recommended due to a history of severe,09-10-2025
M0221006004,"Adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s),",09-10-2025
M0221007004,Includes injection and post administration monitoring in the home or residence;,09-10-2025
M0221008004,This includes a beneficiary's home that has been made provider-based to the,09-10-2025
M0221009004,Hospital during the covid-19 public health emergency,09-10-2025
M0222001003,"Intravenous injection, bebtelovimab, includes injection and post administration",09-10-2025
M0222002004,Monitoring,09-10-2025
M0223001003,"Intravenous injection, bebtelovimab, includes injection and post administration",09-10-2025
M0223002004,Monitoring in the home or residence; this includes a beneficiary's home that,09-10-2025
M0223003004,Has been made provider-based to the hospital during the covid-19 public health,09-10-2025
M0223004004,Emergency,09-10-2025
M0224001003,"Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for",09-10-2025
M0224002004,Certain adults and adolescents (12 years of age and older weighing at least 40,09-10-2025
M0224003004,"Kg) with no known sars-cov-2 exposure, who either have moderate-to-severe",09-10-2025
M0224004004,Immune compromise due to a medical condition or receipt of immunosuppressive,09-10-2025
M0224005004,"Medications or treatments, includes infusion and post administration monitoring",09-10-2025
M0235001003,"Intravenous infusion, monoclonal antibody products with an indication for",09-10-2025
M0235002004,"Post-exposure prophylaxis or treatment of covid-19, for hospitalized adults",09-10-2025
M0235003004,And/or pediatric patients who are receiving systemic corticosteroids and,09-10-2025
M0235004004,"Require supplemental oxygen, non-invasive or invasive mechanical ventilation,",09-10-2025
M0235005004,"Or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post",09-10-2025
M0235006004,"Administration monitoring, not otherwise classified, first dose",09-10-2025
M0236001003,"Intravenous infusion, monoclonal antibody products with an indication for",09-10-2025
M0236002004,"Post-exposure prophylaxis or treatment of covid-19, for hospitalized adults",09-10-2025
M0236003004,And/or pediatric patients who are receiving systemic corticosteroids and,09-10-2025
M0236004004,"Require supplemental oxygen, non-invasive or invasive mechanical ventilation,",09-10-2025
M0236005004,"Or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post",09-10-2025
M0236006004,"Administration monitoring, not otherwise classified, second dose",09-10-2025
M0237001003,"Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with",09-10-2025
M0237002004,Covid-19 who are receiving systemic corticosteroids and require supplemental,09-10-2025
M0237003004,"Oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal",09-10-2025
M0237004004,"Membrane oxygenation (ecmo) only, includes infusion and post administration",09-10-2025
M0237005004,"Monitoring, first dose",09-10-2025
M0238001003,"Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with",09-10-2025
M0238002004,Covid-19 who are receiving systemic corticosteroids and require supplemental,09-10-2025
M0238003004,"Oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal",09-10-2025
M0238004004,"Membrane oxygenation (ecmo) only, includes infusion and post administration",09-10-2025
M0238005004,"Monitoring, second dose",09-10-2025
M0239001003,"Intravenous infusion, bamlanivimab-xxxx, includes infusion and post",09-10-2025
M0239002004,Administration monitoring,09-10-2025
M0240001003,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab",09-10-2025
M0240002004,"Includes infusion or injection, and post administration monitoring, subsequent",09-10-2025
M0240003004,Repeat doses,09-10-2025
M0241001003,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab",09-10-2025
M0241002004,"Includes infusion or injection, and post administration monitoring in the home",09-10-2025
M0241003004,Or residence; this includes a beneficiary's home that has been made,09-10-2025
M0241004004,"Provider-based to the hospital during the covid-19 public health emergency,",09-10-2025
M0241005004,Subsequent repeat doses,09-10-2025
M0243001003,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab",09-10-2025
M0243002004,"Includes infusion or injection, and post administration monitoring",09-10-2025
M0244001003,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab",09-10-2025
M0244002004,"Includes infusion or injection, and post administration monitoring in the home",09-10-2025
M0244003004,Or residence; this includes a beneficiary's home that has been made,09-10-2025
M0244004004,Provider-based to the hospital during the covid-19 public health emergency,09-10-2025
M0245001003,"Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post",09-10-2025
M0245002004,Administration monitoring,09-10-2025
M0246001003,"Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post",09-10-2025
M0246002004,Administration monitoring in the home or residence; this includes a,09-10-2025
M0246003004,Beneficiary's home that has been made provider based to the hospital during the,09-10-2025
M0246004004,Covid 19 public health emergency,09-10-2025
M0247001003,"Intravenous infusion, sotrovimab, includes infusion and post administration",09-10-2025
M0247002004,Monitoring,09-10-2025
M0248001003,"Intravenous infusion, sotrovimab, includes infusion and post administration",09-10-2025
M0248002004,Monitoring in the home or residence; this includes a beneficiary's home that,09-10-2025
M0248003004,Has been made provider-based to the hospital during the covid-19 public health,09-10-2025
M0248004004,Emergency,09-10-2025
M0249001003,"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric",09-10-2025
M0249002004,Patients (2 years of age and older) with covid-19 who are receiving systemic,09-10-2025
M0249003004,"Corticosteroids and require supplemental oxygen, non-invasive or invasive",09-10-2025
M0249004004,"Mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only,",09-10-2025
M0249005004,"Includes infusion and post administration monitoring, first dose",09-10-2025
M0250001003,"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric",09-10-2025
M0250002004,Patients (2 years of age and older) with covid-19 who are receiving systemic,09-10-2025
M0250003004,"Corticosteroids and require supplemental oxygen, non-invasive or invasive",09-10-2025
M0250004004,"Mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only,",09-10-2025
M0250005004,"Includes infusion and post administration monitoring, second dose",09-10-2025
M0300001003,Iv chelation therapy (chemical endarterectomy),09-10-2025
M0301001003,Fabric wrapping of abdominal aneurysm,09-10-2025
M1000001003,Pain screened as moderate to severe,09-10-2025
M1001001003,Plan of care to address moderate to severe pain documented on or before the,09-10-2025
M1001002004,Date of the second visit with a clinician,09-10-2025
M1002001003,Plan of care for moderate to severe pain not documented on or before the date,09-10-2025
M1002002004,"Of the second visit with a clinician, reason not given",09-10-2025
M1003001003,Tb screening performed and results interpreted within twelve months prior to,09-10-2025
M1003002004,Initiation of first-time biologic and/or immune response modifier therapy,09-10-2025
M1004001003,Documentation of medical reason for not screening for tb or interpreting,09-10-2025
M1004002004,"Results (i.e., patient positive for tb and documentation of past treatment;",09-10-2025
M1004003004,Patient who has recently completed a course of anti-tb therapy),09-10-2025
M1005001003,"Tb screening not performed or results not interpreted, reason not given",09-10-2025
M1006001003,"Disease activity not assessed, reason not given",09-10-2025
M1007001003,>=50% of total number of a patient's outpatient ra encounters assessed,09-10-2025
M1008001003,<50% of total number of a patient's outpatient ra encounters assessed,09-10-2025
M1009001003,Discharge/discontinuation of the episode of care documented in the medical,09-10-2025
M1009002004,Record,09-10-2025
M1010001003,Discharge/discontinuation of the episode of care documented in the medical,09-10-2025
M1010002004,Record,09-10-2025
M1011001003,Discharge/discontinuation of the episode of care documented in the medical,09-10-2025
M1011002004,Record,09-10-2025
M1012001003,Discharge/discontinuation of the episode of care documented in the medical,09-10-2025
M1012002004,Record,09-10-2025
M1013001003,Discharge/discontinuation of the episode of care documented in the medical,09-10-2025
M1013002004,Record,09-10-2025
M1014001003,Discharge/discontinuation of the episode of care documented in the medical,09-10-2025
M1014002004,Record,09-10-2025
M1015001003,Discharge/discontinuation of the episode of care documented in the medical,09-10-2025
M1015002004,Record,09-10-2025
M1016001003,Female patients unable to bear children,09-10-2025
M1017001003,Patient admitted to palliative care services,09-10-2025
M1018001003,Patients with an active diagnosis or history of cancer (except basal cell and,09-10-2025
M1018002004,"Squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung",09-10-2025
M1018003004,Cancer screening patients,09-10-2025
M1019001003,Adolescent patients 12 to 17 years of age with major depression or dysthymia,09-10-2025
M1019002004,Who reached remission at twelve months as demonstrated by a twelve month (+/-60,09-10-2025
M1019003004,Days) phq-9 or phq-9m score of less than 5,09-10-2025
M1020001003,Adolescent patients 12 to 17 years of age with major depression or dysthymia,09-10-2025
M1020002004,Who did not reach remission at twelve months as demonstrated by a twelve month,09-10-2025
M1020003004,(+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score,09-10-2025
M1020004004,Was not assessed or is greater than or equal to 5,09-10-2025
M1021001003,Patient had only urgent care visits during the performance period,09-10-2025
M1022001003,Patients who were in hospice at any time during the performance period,09-10-2025
M1023001003,Adolescent patients 12 to 17 years of age with major depression or dysthymia,09-10-2025
M1023002004,Who reached remission at six months as demonstrated by a six month (+/-60 days),09-10-2025
M1023003004,Phq-9 or phq-9m score of less than five,09-10-2025
M1024001003,Adolescent patients 12 to 17 years of age with major depression or dysthymia,09-10-2025
M1024002004,Who did not reach remission at six months as demonstrated by a six month (+/-60,09-10-2025
M1024003004,Days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was,09-10-2025
M1024004004,Not assessed or is greater than or equal to five,09-10-2025
M1025001003,Patients who were in hospice at any time during the performance period,09-10-2025
M1026001003,Patients who were in hospice at any time during the performance period,09-10-2025
M1027001003,Imaging of the head (ct or mri) was obtained,09-10-2025
M1028001003,Documentation of patients with primary headache diagnosis and imaging other,09-10-2025
M1028002004,Than ct or mri obtained,09-10-2025
M1029001003,"Imaging of the head (ct or mri) was not obtained, reason not given",09-10-2025
M1030001003,Patients with clinical indications for imaging of the head,09-10-2025
M1031001003,Patients with no clinical indications for imaging of the head,09-10-2025
M1032001003,Adults currently taking pharmacotherapy for oud,09-10-2025
M1033001003,Pharmacotherapy for oud initiated after june 30th of performance period,09-10-2025
M1034001003,Adults who have at least 180 days of continuous pharmacotherapy with a,09-10-2025
M1034002004,Medication prescribed for oud without a gap of more than seven days,09-10-2025
M1035001003,Adults who are deliberately phased out of medication assisted treatment (mat),09-10-2025
M1035002004,Prior to 180 days of continuous treatment,09-10-2025
M1036001003,Adults who have not had at least 180 days of continuous pharmacotherapy with a,09-10-2025
M1036002004,Medication prescribed for oud without a gap of more than seven days,09-10-2025
M1037001003,Patients with a diagnosis of lumbar spine region cancer at the time of the,09-10-2025
M1037002004,Procedure,09-10-2025
M1038001003,Patients with a diagnosis of lumbar spine region fracture at the time of the,09-10-2025
M1038002004,Procedure,09-10-2025
M1039001003,Patients with a diagnosis of lumbar spine region infection at the time of the,09-10-2025
M1039002004,Procedure,09-10-2025
M1040001003,Patients with a diagnosis of lumbar idiopathic or congenital scoliosis,09-10-2025
M1041001003,"Patient had cancer, acute fracture or infection related to the lumbar spine or",09-10-2025
M1041002004,"Patient had neuromuscular, idiopathic or congenital lumbar scoliosis",09-10-2025
M1042001003,Functional status measurement with score was obtained utilizing the oswestry,09-10-2025
M1042002004,Disability index (odi version 2.1a) patient reported outcome tool within three,09-10-2025
M1042003004,Months preoperatively and at one year (9 to 15 months) postoperatively,09-10-2025
M1043001003,Functional status was not measured by the oswestry disability index (odi,09-10-2025
M1043002004,Version 2.1a) at one year (9 to 15 months) postoperatively,09-10-2025
M1044001003,Functional status was measured by the oswestry disability index (odi version,09-10-2025
M1044002004,2.1a) patient reported outcome tool within three months preoperatively and at,09-10-2025
M1044003004,One year (9 to 15 months) postoperatively,09-10-2025
M1045001003,Functional status measured by the oxford knee score (oks) at one year (9 to 15,09-10-2025
M1045002004,Months) postoperatively was greater than or equal to 37 or knee injury and,09-10-2025
M1045003004,"Osteoarthritis outcome score joint replacement (koos, jr.) was greater than or",09-10-2025
M1045004004,Equal to 71,09-10-2025
M1046001003,Functional status measured by the oxford knee score (oks) at one year (9 to 15,09-10-2025
M1046002004,Months) postoperatively was less than 37 or the knee injury and osteoarthritis,09-10-2025
M1046003004,"Outcome score joint replacement (koos, jr.) was less than 71 postoperatively",09-10-2025
M1047001003,Functional status was measured by the oxford knee score (oks) patient reported,09-10-2025
M1047002004,Outcome tool within three months preoperatively and at one year (9 to 15,09-10-2025
M1047003004,Months) postoperatively,09-10-2025
M1048001003,Functional status measurement with score was obtained utilizing the oswestry,09-10-2025
M1048002004,Disability index (odi version 2.1a) patient reported outcome tool within three,09-10-2025
M1048003004,Months preoperatively and at three months (6 to 20 weeks) postoperatively,09-10-2025
M1049001003,Functional status was not measured by the oswestry disability index (odi,09-10-2025
M1049002004,Version 2.1a) at three months (6 - 20 weeks) postoperatively,09-10-2025
M1050001003,Functional status was measured by the oswestry disability index (odi version,09-10-2025
M1050002004,2.1a) patient reported outcome tool within three months preoperatively and at,09-10-2025
M1050003004,Three months (6 to 20 weeks) postoperatively,09-10-2025
M1051001003,"Patient had cancer, acute fracture or infection related to the lumbar spine or",09-10-2025
M1051002004,"Patient had neuromuscular, idiopathic or congenital lumbar scoliosis",09-10-2025
M1052001003,Leg pain was not measured by the visual analog scale (vas) or numeric pain,09-10-2025
M1052002004,Scale at one year (9 to 15 months) postoperatively,09-10-2025
M1053001003,Leg pain was measured by the visual analog scale (vas) within three months,09-10-2025
M1053002004,Preoperatively and at one year (9 to 15 months) postoperatively,09-10-2025
M1054001003,Patient had only urgent care visits during the performance period,09-10-2025
M1055001003,Aspirin or another antiplatelet therapy used,09-10-2025
M1056001003,"Prescribed anticoagulant medication during the performance period, history of",09-10-2025
M1056002004,"Gi bleeding, history of intracranial bleeding, bleeding disorder and specific",09-10-2025
M1056003004,"Provider documented reasons: allergy to aspirin or anti-platelets, use of",09-10-2025
M1056004004,"Non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled",09-10-2025
M1056005004,Hypertension > 180/110 mmhg or gastroesophageal reflux disease,09-10-2025
M1057001003,"Aspirin or another antiplatelet therapy not used, reason not given",09-10-2025
M1058001003,Patient was a permanent nursing home resident at any time during the,09-10-2025
M1058002004,Performance period,09-10-2025
M1059001003,Patient was in hospice or receiving palliative care at any time during the,09-10-2025
M1059002004,Performance period,09-10-2025
M1060001003,Patient died prior to the end of the performance period,09-10-2025
M1061001003,Patient pregnancy,09-10-2025
M1062001003,Patient immunocompromised,09-10-2025
M1063001003,Patients receiving high doses of immunosuppressive therapy,09-10-2025
M1064001003,Shingrix vaccine documented as administered or previously received,09-10-2025
M1065001003,Shingrix vaccine was not administered for reasons documented by clinician (e.g.,09-10-2025
M1065002004,"Patient administered vaccine other than shingrix, patient allergy or other",09-10-2025
M1065003004,"Medical reasons, patient declined or other patient reasons, vaccine not",09-10-2025
M1065004004,Available or other system reasons),09-10-2025
M1066001003,"Shingrix vaccine not documented as administered, reason not given",09-10-2025
M1067001003,Hospice services for patient provided any time during the measurement period,09-10-2025
M1068001003,Adults who are not ambulatory,09-10-2025
M1069001003,Patient screened for future fall risk,09-10-2025
M1070001003,"Patient not screened for future fall risk, reason not given",09-10-2025
M1071001003,Patient had any additional spine procedures performed on the same date as the,09-10-2025
M1071002004,Lumbar discectomy/laminotomy,09-10-2025
M1106001003,The start of an episode of care documented in the medical record,09-10-2025
M1107001003,Documentation stating patient has a diagnosis of a degenerative neurological,09-10-2025
M1107002004,"Condition such as als, ms, or parkinson's diagnosed at any time before or",09-10-2025
M1107003004,During the episode of care,09-10-2025
M1108001003,Ongoing care not clinically indicated because the patient needed a home program,09-10-2025
M1108002004,"Only, referral to another provider or facility, or consultation only, as",09-10-2025
M1108003004,Documented in the medical record,09-10-2025
M1109001003,Ongoing care not medically possible because the patient was discharged early,09-10-2025
M1109002004,"Due to specific medical events, documented in the medical record, such as the",09-10-2025
M1109003004,Patient became hospitalized or scheduled for surgery,09-10-2025
M1110001003,"Ongoing care not possible because the patient self-discharged early (e.g.,",09-10-2025
M1110002004,"Financial or insurance reasons, transportation problems, or reason unknown)",09-10-2025
M1111001003,The start of an episode of care documented in the medical record,09-10-2025
M1112001003,Documentation stating patient has a diagnosis of a degenerative neurological,09-10-2025
M1112002004,"Condition such as als, ms, or parkinson's diagnosed at any time before or",09-10-2025
M1112003004,During the episode of care,09-10-2025
M1113001003,Ongoing care not clinically indicated because the patient needed a home program,09-10-2025
M1113002004,"Only, referral to another provider or facility, or consultation only, as",09-10-2025
M1113003004,Documented in the medical record,09-10-2025
M1114001003,Ongoing care not medically possible because the patient was discharged early,09-10-2025
M1114002004,"Due to specific medical events, documented in the medical record, such as the",09-10-2025
M1114003004,Patient became hospitalized or scheduled for surgery,09-10-2025
M1115001003,"Ongoing care not possible because the patient self-discharged early (e.g.,",09-10-2025
M1115002004,"Financial or insurance reasons, transportation problems, or reason unknown)",09-10-2025
M1116001003,The start of an episode of care documented in the medical record,09-10-2025
M1117001003,Documentation stating patient has a diagnosis of a degenerative neurological,09-10-2025
M1117002004,"Condition such as als, ms, or parkinson's diagnosed at any time before or",09-10-2025
M1117003004,During the episode of care,09-10-2025
M1118001003,Ongoing care not clinically indicated because the patient needed a home program,09-10-2025
M1118002004,"Only, referral to another provider or facility, or consultation only, as",09-10-2025
M1118003004,Documented in the medical record,09-10-2025
M1119001003,Ongoing care not medically possible because the patient was discharged early,09-10-2025
M1119002004,"Due to specific medical events, documented in the medical record, such as the",09-10-2025
M1119003004,Patient became hospitalized or scheduled for surgery,09-10-2025
M1120001003,"Ongoing care not possible because the patient self-discharged early (e.g.,",09-10-2025
M1120002004,"Financial or insurance reasons, transportation problems, or reason unknown)",09-10-2025
M1121001003,The start of an episode of care documented in the medical record,09-10-2025
M1122001003,Documentation stating patient has a diagnosis of a degenerative neurological,09-10-2025
M1122002004,"Condition such as als, ms, or parkinson's diagnosed at any time before or",09-10-2025
M1122003004,During the episode of care,09-10-2025
M1123001003,Ongoing care not clinically indicated because the patient needed a home program,09-10-2025
M1123002004,"Only, referral to another provider or facility, or consultation only, as",09-10-2025
M1123003004,Documented in the medical record,09-10-2025
M1124001003,Ongoing care not medically possible because the patient was discharged early,09-10-2025
M1124002004,"Due to specific medical events, documented in the medical record, such as the",09-10-2025
M1124003004,Patient became hospitalized or scheduled for surgery,09-10-2025
M1125001003,"Ongoing care not possible because the patient self-discharged early (e.g.,",09-10-2025
M1125002004,"Financial or insurance reasons, transportation problems, or reason unknown)",09-10-2025
M1126001003,The start of an episode of care documented in the medical record,09-10-2025
M1127001003,Documentation stating patient has a diagnosis of a degenerative neurological,09-10-2025
M1127002004,"Condition such as als, ms, or parkinson's diagnosed at any time before or",09-10-2025
M1127003004,During the episode of care,09-10-2025
M1128001003,Ongoing care not clinically indicated because the patient needed a home program,09-10-2025
M1128002004,"Only, referral to another provider or facility, or consultation only, as",09-10-2025
M1128003004,Documented in the medical record,09-10-2025
M1129001003,Ongoing care not medically possible because the patient was discharged early,09-10-2025
M1129002004,"Due to specific medical events, documented in the medical record, such as the",09-10-2025
M1129003004,Patient became hospitalized or scheduled for surgery,09-10-2025
M1130001003,"Ongoing care not possible because the patient self-discharged early (e.g.,",09-10-2025
M1130002004,"Financial or insurance reasons, transportation problems, or reason unknown)",09-10-2025
M1131001003,Documentation stating patient has a diagnosis of a degenerative neurological,09-10-2025
M1131002004,"Condition such as als, ms, or parkinson's diagnosed at any time before or",09-10-2025
M1131003004,During the episode of care,09-10-2025
M1132001003,Ongoing care not clinically indicated because the patient needed a home program,09-10-2025
M1132002004,"Only, referral to another provider or facility, or consultation only, as",09-10-2025
M1132003004,Documented in the medical record,09-10-2025
M1133001003,Ongoing care not medically possible because the patient was discharged early,09-10-2025
M1133002004,"Due to specific medical events, documented in the medical record, such as the",09-10-2025
M1133003004,Patient became hospitalized or scheduled for surgery,09-10-2025
M1134001003,"Ongoing care not possible because the patient self-discharged early (e.g.,",09-10-2025
M1134002004,"Financial or insurance reasons, transportation problems, or reason unknown)",09-10-2025
M1135001003,The start of an episode of care documented in the medical record,09-10-2025
M1136001003,The start of an episode of care documented in the medical record,09-10-2025
M1137001003,Documentation stating patient has a diagnosis of a degenerative neurological,09-10-2025
M1137002004,"Condition such as als, ms, or parkinson's diagnosed at any time before or",09-10-2025
M1137003004,During the episode of care,09-10-2025
M1138001003,"Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program",09-10-2025
M1138002004,"Only, referred to another provider or facility, consultation only)",09-10-2025
M1139001003,"Ongoing care not indicated, patient self-discharged early and seen only 1-2",09-10-2025
M1139002004,"Visits (e.g., financial or insurance reasons, transportation problems, or",09-10-2025
M1139003004,Reason unknown),09-10-2025
M1140001003,"Ongoing care not indicated, patient discharged after only 1-2 visits due to",09-10-2025
M1140002004,"Specific medical events, documented in the medical record that make the",09-10-2025
M1140003004,Treatment episode impossible such as the patient becomes hospitalized or,09-10-2025
M1140004004,Scheduled for surgery for surgery or hospitalized,09-10-2025
M1141001003,Functional status was not measured by the oxford knee score (oks) or the knee,09-10-2025
M1141002004,"Injury and osteoarthritis outcome score joint replacement (koos, jr.) at one",09-10-2025
M1141003004,Year (9 to 15 months) postoperatively,09-10-2025
M1142001003,Emergent cases,09-10-2025
M1143001003,"Initiated episode of rehabilitation therapy, medical, or chiropractic care for",09-10-2025
M1143002004,Neck impairment,09-10-2025
M1144001003,"Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program",09-10-2025
M1144002004,"Only, referred to another provider or facility, consultation only",09-10-2025
M1145001003,"Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with",09-10-2025
M1145002004,Line items that have the jw modifier),09-10-2025
M1146001003,Ongoing care not clinically indicated because the patient needed a home program,09-10-2025
M1146002004,"Only, referral to another provider or facility, or consultation only, as",09-10-2025
M1146003004,Documented in the medical record,09-10-2025
M1147001003,Ongoing care not medically possible because the patient was discharged early,09-10-2025
M1147002004,"Due to specific medical events, documented in the medical record, such as the",09-10-2025
M1147003004,Patient became hospitalized or scheduled for surgery,09-10-2025
M1148001003,"Ongoing care not possible because the patient self-discharged early (e.g.,",09-10-2025
M1148002004,"Financial or insurance reasons, transportation problems, or reason unknown)",09-10-2025
M1149001003,Patient unable to complete the neck fs prom at initial evaluation and/or,09-10-2025
M1149002004,"Discharge due to blindness, illiteracy, severe mental incapacity or language",09-10-2025
M1149003004,"Incompatibility, and an adequate proxy is not available",09-10-2025
M1150001003,Current or prior left ventricular ejection fraction (lvef) less than or equal,09-10-2025
M1150002004,To 40% or documentation of moderately or severely depressed left ventricular,09-10-2025
M1150003004,Systolic function,09-10-2025
M1151001003,Patients with a history of heart transplant or with a left ventricular assist,09-10-2025
M1151002004,Device (lvad),09-10-2025
M1152001003,Patients with a history of heart transplant or with a left ventricular assist,09-10-2025
M1152002004,Device (lvad),09-10-2025
M1153001003,Patient with diagnosis of osteoporosis on date of encounter,09-10-2025
M1154001003,Hospice services provided to patient any time during the measurement period,09-10-2025
M1155001003,Patient had anaphylaxis due to the pneumococcal vaccine any time during or,09-10-2025
M1155002004,Before the measurement period,09-10-2025
M1156001003,Patient received active chemotherapy any time during the measurement period,09-10-2025
M1157001003,Patient received bone marrow transplant any time during the measurement period,09-10-2025
M1158001003,Patient had history of immunocompromising conditions prior to or during the,09-10-2025
M1158002004,Measurement period,09-10-2025
M1159001003,Hospice services provided to patient any time during the measurement period,09-10-2025
M1160001003,Patient had anaphylaxis due to the meningococcal vaccine any time on or before,09-10-2025
M1160002004,The patient's 13th birthday,09-10-2025
M1161001003,"Patient had anaphylaxis due to the tetanus, diphtheria or pertussis vaccine any",09-10-2025
M1161002004,Time on or before the patient's 13th birthday,09-10-2025
M1162001003,"Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine",09-10-2025
M1162002004,Any time on or before the patient's 13th birthday,09-10-2025
M1163001003,Patient had anaphylaxis due to the hpv vaccine any time on or before the,09-10-2025
M1163002004,Patient's 13th birthday,09-10-2025
M1164001003,Patients with dementia any time during the patient's history through the end of,09-10-2025
M1164002004,The measurement period,09-10-2025
M1165001003,Patients who use hospice services any time during the measurement period,09-10-2025
M1166001003,Pathology report for tissue specimens produced from wide local excisions or,09-10-2025
M1166002004,Re-excisions,09-10-2025
M1167001003,In hospice or using hospice services during the measurement period,09-10-2025
M1168001003,Patient received an influenza vaccine on or between july 1 of the year prior to,09-10-2025
M1168002004,The measurement period and june 30 of the measurement period,09-10-2025
M1169001003,Documentation of medical reason(s) for not administering influenza vaccine,09-10-2025
M1169002004,"(e.g., prior anaphylaxis due to the influenza vaccine)",09-10-2025
M1170001003,Patient did not receive an influenza vaccine on or between july 1 of the year,09-10-2025
M1170002004,Prior to the measurement period and june 30 of the measurement period,09-10-2025
M1171001003,Patient received at least one td vaccine or one tdap vaccine between nine years,09-10-2025
M1171002004,Prior to the encounter and the end of the measurement period,09-10-2025
M1172001003,Documentation of medical reason(s) for not administering td or tdap vaccine,09-10-2025
M1172002004,"(e.g., prior anaphylaxis due to the td or tdap vaccine or history of",09-10-2025
M1172003004,Encephalopathy within seven days after a previous dose of a td-containing,09-10-2025
M1172004004,Vaccine),09-10-2025
M1173001003,Patient did not receive at least one td vaccine or one tdap vaccine between,09-10-2025
M1173002004,Nine years prior to the encounter and the end of the measurement period,09-10-2025
M1174001003,Patient received at least two doses of the herpes zoster recombinant vaccine,09-10-2025
M1174002004,(at least 28 days apart) anytime on or after the patient's 50th birthday before,09-10-2025
M1174003004,Or during the measurement period,09-10-2025
M1175001003,"Documentation of medical reason(s) for not administering zoster vaccine (e.g.,",09-10-2025
M1175002004,Prior anaphylaxis due to the zoster vaccine),09-10-2025
M1176001003,Patient did not receive two doses of the herpes zoster recombinant vaccine (at,09-10-2025
M1176002004,Least 28 days apart) anytime on or after the patient's 50th birthday before or,09-10-2025
M1176003004,During the measurement period,09-10-2025
M1177001003,Patient received any pneumococcal conjugate or polysaccharide vaccine on or,09-10-2025
M1177002004,After their 19th birthday and before the end of the measurement period,09-10-2025
M1178001003,Documentation of medical reason(s) for not administering pneumococcal vaccine,09-10-2025
M1178002004,"(e.g., prior anaphylaxis due to the pneumococcal vaccine)",09-10-2025
M1179001003,"Patient did not receive any pneumococcal conjugate or polysaccharide vaccine,",09-10-2025
M1179002004,On or after their 19th birthday and before or during measurement period,09-10-2025
M1180001003,Patients on immune checkpoint inhibitor therapy,09-10-2025
M1181001003,Grade 2 or above diarrhea and/or grade 2 or above colitis,09-10-2025
M1182001003,Patients not eligible due to pre-existing inflammatory bowel disease (ibd),09-10-2025
M1182002004,"(e.g., ulcerative colitis, crohn's disease)",09-10-2025
M1183001003,Documentation of immune checkpoint inhibitor therapy held and corticosteroids,09-10-2025
M1183002004,Or immunosuppressants prescribed or administered,09-10-2025
M1184001003,Documentation of medical reason(s) for not prescribing or administering,09-10-2025
M1184002004,"Corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance,",09-10-2025
M1184003004,"Infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel",09-10-2025
M1184004004,"Surgical interventions, celiac disease, receiving other medication, awaiting",09-10-2025
M1184005004,"Diagnostic workup results for alternative etiologies, other medical",09-10-2025
M1184006004,Reasons/contraindication),09-10-2025
M1185001003,Documentation of immune checkpoint inhibitor therapy not held and/or,09-10-2025
M1185002004,Corticosteroids or immunosuppressants prescribed or administered was not,09-10-2025
M1185003004,"Performed, reason not given",09-10-2025
M1186001003,Patients who have an order for or are receiving hospice or palliative care,09-10-2025
M1187001003,Patients with a diagnosis of end stage renal disease (esrd),09-10-2025
M1188001003,Patients with a diagnosis of chronic kidney disease (ckd) stage 5,09-10-2025
M1189001003,Documentation of a kidney health evaluation defined by an estimated glomerular,09-10-2025
M1189002004,Filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed,09-10-2025
M1190001003,Documentation of a kidney health evaluation was not performed or defined by an,09-10-2025
M1190002004,Estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio,09-10-2025
M1190003004,(uacr),09-10-2025
M1191001003,Hospice services provided to patient any time during the measurement period,09-10-2025
M1192001003,Patients with an existing diagnosis of squamous cell carcinoma of the esophagus,09-10-2025
M1193001003,Surgical pathology reports that contain impression or conclusion of or,09-10-2025
M1193002004,"Recommendation for testing of mmr by immunohistochemistry, msi by dna-based",09-10-2025
M1193003004,"Testing status, or both",09-10-2025
M1194001003,Documentation of medical reason(s) surgical pathology reports did not contain,09-10-2025
M1194002004,Impression or conclusion of or recommendation for testing of mmr by,09-10-2025
M1194003004,"Immunohistochemistry, msi by dna-based testing status, or both tests were not",09-10-2025
M1194004004,"Included (e.g., patient will not be treated with checkpoint inhibitor therapy,",09-10-2025
M1194005004,No residual carcinoma is present in the sample [tissue exhausted or status post,09-10-2025
M1194006004,"Neoadjuvant treatment], insufficient tumor for testing)",09-10-2025
M1195001003,Surgical pathology reports that do not contain impression or conclusion of or,09-10-2025
M1195002004,"Recommendation for testing of mmr by immunohistochemistry, msi by dna-based",09-10-2025
M1195003004,"Testing status, or both, reason not given",09-10-2025
M1196001003,"Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or",09-10-2025
M1196002004,Itchyquant assessment score of greater than or equal to 4,09-10-2025
M1197001003,Itch severity assessment score is reduced by 3 or more points from the initial,09-10-2025
M1197002004,(index) assessment score to the follow-up visit score,09-10-2025
M1198001003,Itch severity assessment score was not reduced by at least 3 points from,09-10-2025
M1198002004,Initial (index) score to the follow-up visit score or assessment was not,09-10-2025
M1198003004,Completed during the follow-up encounter,09-10-2025
M1199001003,Patients receiving rrt,09-10-2025
M1200001003,Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period,09-10-2025
M1201001003,Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or,09-10-2025
M1201002004,"Arb therapy during the measurement period (e.g., pregnancy, history of",09-10-2025
M1201003004,"Angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of",09-10-2025
M1201004004,"Hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or",09-10-2025
M1201005004,"Arb therapy), other medical reasons)",09-10-2025
M1202001003,Documentation of patient reason(s) for not prescribing ace inhibitor or arb,09-10-2025
M1202002004,"Therapy during the measurement period, (e.g., patient declined, other patient",09-10-2025
M1202003004,Reasons),09-10-2025
M1203001003,"Ace inhibitor or arb therapy not prescribed during the measurement period,",09-10-2025
M1203002004,Reason not given,09-10-2025
M1204001003,"Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or",09-10-2025
M1204002004,Itchyquant assessment score of greater than or equal to 4,09-10-2025
M1205001003,Itch severity assessment score is reduced by 3 or more points from the initial,09-10-2025
M1205002004,(index) assessment score to the follow-up visit score,09-10-2025
M1206001003,Itch severity assessment score was not reduced by at least 3 points from,09-10-2025
M1206002004,Initial (index) score to the follow-up visit score or assessment was not,09-10-2025
M1206003004,Completed during the follow-up encounter,09-10-2025
M1207001003,"Patient is screened for food insecurity, housing instability, transportation",09-10-2025
M1207002004,"Needs, utility difficulties, and interpersonal safety",09-10-2025
M1208001003,"Patient is not screened for food insecurity, housing instability,",09-10-2025
M1208002004,"Transportation needs, utility difficulties, and interpersonal safety",09-10-2025
M1209001003,"At least two orders for high-risk medications from the same drug class, (table",09-10-2025
M1209002004,"4), without appropriate diagnoses",09-10-2025
M1210001003,"At least two orders for high-risk medications from the same drug class, (table",09-10-2025
M1210002004,"4), not ordered",09-10-2025
M1211001003,Most recent glycemic status assessment (hba1c or gmi) level > 9.0%,09-10-2025
M1212001003,"Glycemic status assessment (hba1c or gmi) level is missing, or was not",09-10-2025
M1212002004,Performed during the measurement period,09-10-2025
M1213001003,No history of spirometry results with confirmed airflow obstruction (fev1/fvc <,09-10-2025
M1213002004,70%) and present spirometry is >= 70%,09-10-2025
M1214001003,Spirometry results with confirmed airflow obstruction (fev1/fvc < 70%),09-10-2025
M1214002004,Documented and reviewed,09-10-2025
M1215001003,Documentation of medical reason(s) for not documenting and reviewing spirometry,09-10-2025
M1215002004,"Results (e.g., patients with dementia or tracheostomy)",09-10-2025
M1216001003,No spirometry results with confirmed airflow obstruction (fev1/fvc < 70%),09-10-2025
M1216002004,Documented and/or no spirometry performed with results documented during the,09-10-2025
M1216003004,Encounter,09-10-2025
M1217001003,Documentation of system reason(s) for not documenting and reviewing spirometry,09-10-2025
M1217002004,"Results (e.g., spirometry equipment not available at the time of the encounter)",09-10-2025
M1218001003,"Patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)",09-10-2025
M1219001003,Anaphylaxis due to the vaccine on or before the date of the encounter,09-10-2025
M1220001003,Dilated retinal eye exam with interpretation by an ophthalmologist or,09-10-2025
M1220002004,Optometrist or artificial intelligence (ai) interpretation documented and,09-10-2025
M1220003004,Reviewed; with evidence of retinopathy,09-10-2025
M1221001003,Dilated retinal eye exam with interpretation by an ophthalmologist or,09-10-2025
M1221002004,Optometrist or artificial intelligence (ai) interpretation documented and,09-10-2025
M1221003004,Reviewed; without evidence of retinopathy,09-10-2025
M1222001003,"Glaucoma plan of care not documented, reason not otherwise specified",09-10-2025
M1223001003,Glaucoma plan of care documented,09-10-2025
M1224001003,Intraocular pressure (iop) reduced by a value less than 20% from the,09-10-2025
M1224002004,Pre-intervention level,09-10-2025
M1225001003,Intraocular pressure (iop) reduced by a value of greater than or equal to 20%,09-10-2025
M1225002004,From the pre-intervention level,09-10-2025
M1226001003,"Iop measurement not documented, reason not otherwise specified",09-10-2025
M1227001003,Evidence-based therapy was prescribed,09-10-2025
M1228001003,"Patient, who has a reactive hcv antibody test, and has a follow up hcv viral",09-10-2025
M1228002004,"Test that detected hcv viremia, has hcv treatment initiated within 3 months of",09-10-2025
M1228003004,The reactive hcv antibody test,09-10-2025
M1229001003,"Patient, who has a reactive hcv antibody test, and has a follow up hcv viral",09-10-2025
M1229002004,"Test that detected hcv viremia, is referred within 1 month of the reactive hcv",09-10-2025
M1229003004,Antibody test to a clinician who treats hcv infection,09-10-2025
M1230001003,Patient has a reactive hcv antibody test and does not have a follow up hcv,09-10-2025
M1230002004,"Viral test, or patient has a reactive hcv antibody test and has a follow up hcv",09-10-2025
M1230003004,Viral test that detects hcv viremia and is not referred to a clinician who,09-10-2025
M1230004004,Treats hcv infection within 1 month and does not have hcv treatment initiated,09-10-2025
M1230005004,"Within 3 months of the reactive hcv antibody test, reason not given",09-10-2025
M1231001003,Patient receives hcv antibody test with nonreactive result,09-10-2025
M1232001003,Patient receives hcv antibody test with reactive result,09-10-2025
M1233001003,Patient does not receive hcv antibody test or patient does receive hcv antibody,09-10-2025
M1233002004,"Test but results not documented, reason not given",09-10-2025
M1234001003,"Patient has a reactive hcv antibody test, and has a follow up hcv viral test",09-10-2025
M1234002004,That does not detect hcv viremia,09-10-2025
M1235001003,Documentation or patient report of hcv antibody test or hcv rna test which,09-10-2025
M1235002004,Occurred prior to the performance period,09-10-2025
M1236001003,Baseline mrs > 2,09-10-2025
M1237001003,"Patient reason for not screening for food insecurity, housing instability,",09-10-2025
M1237002004,"Transportation needs, utility difficulties, and interpersonal safety (e.g.,",09-10-2025
M1237003004,Patient declined or other patient reasons),09-10-2025
M1238001003,Documentation that administration of second recombinant zoster vaccine could,09-10-2025
M1238002004,Not occur during the performance period due to the recommended 2-6 month,09-10-2025
M1238003004,"Interval between doses (i.e, first dose received after october 31)",09-10-2025
M1239001003,Patient did not respond to the question of patient felt heard and understood by,09-10-2025
M1239002004,This provider and team,09-10-2025
M1240001003,Patient did not respond to the question of patient felt this provider and team,09-10-2025
M1240002004,Put my best interests first when making recommendations about my care,09-10-2025
M1241001003,Patient did not respond to the question of patient felt this provider and team,09-10-2025
M1241002004,"Saw me as a person, not just someone with a medical problem",09-10-2025
M1242001003,Patient did not respond to the question of patient felt this provider and team,09-10-2025
M1242002004,Understood what is important to me in my life,09-10-2025
M1243001003,"Patient provided a response other than ""completely true"" for the question of",09-10-2025
M1243002004,Patient felt heard and understood by this provider and team,09-10-2025
M1244001003,"Patient provided a response other than ""completely true"" for the question of",09-10-2025
M1244002004,Patient felt this provider and team put my best interests first when making,09-10-2025
M1244003004,Recommendations about my care,09-10-2025
M1245001003,"Patient provided a response other than ""completely true"" for the question of",09-10-2025
M1245002004,"Patient felt this provider and team saw me as a person, not just someone with a",09-10-2025
M1245003004,Medical problem,09-10-2025
M1246001003,"Patient provided a response other than ""completely true"" for the question of",09-10-2025
M1246002004,Patient felt this provider and team understood what is important to me in my,09-10-2025
M1246003004,Life,09-10-2025
M1247001003,"Patient responded ""completely true"" for the question of patient felt this",09-10-2025
M1247002004,Provider and team put my best interests first when making recommendations about,09-10-2025
M1247003004,My care,09-10-2025
M1248001003,"Patient responded ""completely true"" for the question of patient felt this",09-10-2025
M1248002004,"Provider and team saw me as a person, not just someone with a medical problem",09-10-2025
M1249001003,"Patient responded ""completely true"" for the question of patient felt this",09-10-2025
M1249002004,Provider and team understood what is important to me in my life,09-10-2025
M1250001003,"Patient responded as ""completely true"" for the question of patient felt heard",09-10-2025
M1250002004,And understood by this provider and team,09-10-2025
M1251001003,Patients for whom a proxy completed the entire hu survey on their behalf for,09-10-2025
M1251002004,Any reason (no patient involvement),09-10-2025
M1252001003,Patients who did not complete at least one of the four patient experience hu,09-10-2025
M1252002004,Survey items and return the hu survey within 60 days of the ambulatory,09-10-2025
M1252003004,Palliative care visit,09-10-2025
M1253001003,Patients who respond on the patient experience hu survey that they did not,09-10-2025
M1253002004,Receive care by the listed ambulatory palliative care provider in the last 60,09-10-2025
M1253003004,Days (disavowal),09-10-2025
M1254001003,Patients who were deceased when the hu survey reached them,09-10-2025
M1255001003,Patients who have another reason for visiting the clinic [not prenatal or,09-10-2025
M1255002004,Postpartum care] and have a positive pregnancy test but have not established,09-10-2025
M1255003004,"The clinic as an ob provider (e.g., plan to terminate the pregnancy or seek",09-10-2025
M1255004004,Prenatal services elsewhere),09-10-2025
M1256001003,Prior history of known cvd,09-10-2025
M1257001003,"Cvd risk assessment not performed or incomplete (e.g., cvd risk assessment was",09-10-2025
M1257002004,"Not documented), reason not otherwise specified",09-10-2025
M1258001003,"Cvd risk assessment performed, have a documented calculated risk score",09-10-2025
M1259001003,Patient status documented within the first year of initiating dialysis,09-10-2025
M1260001003,Patient status not documented within the first year of initiating dialysis,09-10-2025
M1261001003,Patients that were on the kidney or kidney-pancreas waitlist prior to,09-10-2025
M1261002004,Initiation of dialysis,09-10-2025
M1262001003,Patients who had a transplant prior to initiation of dialysis,09-10-2025
M1263001003,Patients in hospice on their initiation of dialysis date or during the month of,09-10-2025
M1263002004,Evaluation,09-10-2025
M1264001003,Patients age 75 or older on their initiation of dialysis date,09-10-2025
M1265001003,Cms medical evidence form 2728 for dialysis patients: initial form completed,09-10-2025
M1266001003,Patients admitted to a skilled nursing facility (snf),09-10-2025
M1267001003,Patients not observed in active status on any kidney or kidney-pancreas,09-10-2025
M1267002004,Transplant waitlist as of the last day of each month during the measurement,09-10-2025
M1267003004,Period,09-10-2025
M1268001003,Patients observed in active status on any kidney or kidney-pancreas transplant,09-10-2025
M1268002004,Waitlist as of the last day of each month during the measurement period,09-10-2025
M1269001003,Receiving esrd mcp dialysis services by the provider on the last day of the,09-10-2025
M1269002004,Reporting month,09-10-2025
M1270001003,Patients not on any kidney or kidney-pancreas transplant waitlist as of the,09-10-2025
M1270002004,Last day of each month during the measurement period,09-10-2025
M1271001003,Patients with dementia at any time prior to or during the month,09-10-2025
M1272001003,Patients observed on any kidney or kidney-pancreas transplant waitlist as of,09-10-2025
M1272002004,The last day of each month during the measurement period,09-10-2025
M1273001003,Patients who were admitted to a skilled nursing facility (snf) within one year,09-10-2025
M1273002004,Of dialysis initiation according to the cms-2728 form,09-10-2025
M1274001003,Patients who were admitted to a skilled nursing facility (snf) during the month,09-10-2025
M1274002004,Of evaluation were excluded from that month,09-10-2025
M1275001003,Patients determined to be in hospice were excluded from month of evaluation and,09-10-2025
M1275002004,The remainder of reporting period,09-10-2025
M1276001003,"Bmi documented outside normal parameters, no follow-up plan documented, no",09-10-2025
M1276002004,Reason given,09-10-2025
M1277001003,Colorectal cancer screening results documented and reviewed,09-10-2025
M1278001003,"Elevated or hypertensive blood pressure reading documented, and the indicated",09-10-2025
M1278002004,Follow-up is documented,09-10-2025
M1279001003,"Elevated or hypertensive blood pressure reading documented, indicated follow-up",09-10-2025
M1279002004,"Not documented, reason not given",09-10-2025
M1280001003,Women who had a bilateral mastectomy or who have a history of a bilateral,09-10-2025
M1280002004,Mastectomy or for whom there is evidence of a right and a left unilateral,09-10-2025
M1280003004,Mastectomy,09-10-2025
M1281001003,"Blood pressure reading not documented, reason not given",09-10-2025
M1282001003,Patient screened for tobacco use and identified as a tobacco non-user,09-10-2025
M1283001003,Patient screened for tobacco use and identified as a tobacco user,09-10-2025
M1284001003,Patients age 66 or older in institutional special needs plans (snp) or residing,09-10-2025
M1284002004,"In long term care with pos code 32, 33, 34, 54, or 56 for more than 90",09-10-2025
M1284003004,Consecutive days during the measurement period,09-10-2025
M1285001003,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d)",09-10-2025
M1285002004,"Mammography results were not documented and reviewed, reason not otherwise",09-10-2025
M1285003004,Specified,09-10-2025
M1286001003,"Bmi is documented as being outside of normal parameters, follow-up plan is not",09-10-2025
M1286002004,Completed for documented medical reason,09-10-2025
M1287001003,Bmi is documented below normal parameters and a follow-up plan is documented,09-10-2025
M1288001003,Documented reason for not screening or recommending a follow-up for high blood,09-10-2025
M1288002004,Pressure,09-10-2025
M1289001003,Patient identified as tobacco user did not receive tobacco cessation,09-10-2025
M1289002004,Intervention during the measurement period or in the six months prior to the,09-10-2025
M1289003004,Measurement period (counseling and/or pharmacotherapy),09-10-2025
M1290001003,Patient not eligible due to active diagnosis of hypertension,09-10-2025
M1291001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
M1291002004,Frailty during the measurement period and a dispensed medication for dementia,09-10-2025
M1291003004,During the measurement period or the year prior to the measurement period,09-10-2025
M1292001003,Patients 66 years of age and older with at least one claim/encounter for,09-10-2025
M1292002004,Frailty during the measurement period and an advanced illness diagnosis during,09-10-2025
M1292003004,The measurement period or the year prior to the measurement period,09-10-2025
M1293001003,Bmi is documented above normal parameters and a follow-up plan is documented,09-10-2025
M1294001003,"Normal blood pressure reading documented, follow-up not required",09-10-2025
M1295001003,Patients with a diagnosis or past history of total colectomy or colorectal,09-10-2025
M1295002004,Cancer,09-10-2025
M1296001003,Bmi is documented within normal parameters and no follow-up plan is required,09-10-2025
M1297001003,Bmi not documented due to medical reason or patient refusal of height or weight,09-10-2025
M1297002004,Measurement,09-10-2025
M1298001003,Documentation of patient pregnancy anytime during the measurement period prior,09-10-2025
M1298002004,To and including the current encounter,09-10-2025
M1299001003,Influenza immunization administered or previously received,09-10-2025
M1300001003,Influenza immunization was not administered for reasons documented by clinician,09-10-2025
M1300002004,"(e.g., patient allergy or other medical reasons, patient declined or other",09-10-2025
M1300003004,"Patient reasons, vaccine not available or other system reasons)",09-10-2025
M1301001003,Patient identified as a tobacco user received tobacco cessation intervention,09-10-2025
M1301002004,During the measurement period or in the six months prior to the measurement,09-10-2025
M1301003004,Period (counseling and/or pharmacotherapy),09-10-2025
M1302001003,"Screening, diagnostic, film digital or digital breast tomosynthesis (3d)",09-10-2025
M1302002004,Mammography results documented and reviewed,09-10-2025
M1303001003,Hospice services provided to patient any time during the measurement period,09-10-2025
M1304001003,Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on,09-10-2025
M1304002004,Or after their 19th birthday and before the end of the measurement period,09-10-2025
M1305001003,Patient received any pneumococcal conjugate or polysaccharide vaccine on or,09-10-2025
M1305002004,After their 19th birthday and before the end of the measurement period,09-10-2025
M1306001003,Patient had anaphylaxis due to the pneumococcal vaccine any time during or,09-10-2025
M1306002004,Before the measurement period,09-10-2025
M1307001003,Documentation stating the patient has received or is currently receiving,09-10-2025
M1307002004,Palliative or hospice care,09-10-2025
M1308001003,"Influenza immunization was not administered, reason not given",09-10-2025
M1309001003,Palliative care services provided to patient any time during the measurement,09-10-2025
M1309002004,Period,09-10-2025
M1310001003,Patient screened for tobacco use and received tobacco cessation intervention,09-10-2025
M1310002004,During the measurement period or in the six months prior to the measurement,09-10-2025
M1310003004,"Period (counseling, pharmacotherapy, or both), if identified as a tobacco user",09-10-2025
M1311001003,Anaphylaxis due to the vaccine on or before the date of the encounter,09-10-2025
M1312001003,Patient not screened for tobacco use,09-10-2025
M1313001003,Tobacco screening not performed or tobacco cessation intervention not provided,09-10-2025
M1313002004,During the measurement period or in the six months prior to the measurement,09-10-2025
M1313003004,Period,09-10-2025
M1314001003,Bmi not documented and no reason is given,09-10-2025
M1315001003,Colorectal cancer screening results were not documented and reviewed; reason,09-10-2025
M1315002004,Not otherwise specified,09-10-2025
M1316001003,Current tobacco non-user,09-10-2025
M1317001003,Patients who are counseled on connection with a csp and explicitly opt out,09-10-2025
M1318001003,Patients who did not have documented contact with a csp for at least one of,09-10-2025
M1318002004,Their screened positive hrsns within 60 days after screening or documentation,09-10-2025
M1318003004,That there was no contact with a csp,09-10-2025
M1319001003,Patients who had documented contact with a csp for at least one of their,09-10-2025
M1319002004,Screened positive hrsns within 60 days after screening,09-10-2025
M1320001003,Patients who screened positive for at least 1 of the 5 hrsns,09-10-2025
M1321001003,Patients who were not seen within 7 weeks following the date of injection for,09-10-2025
M1321002004,Follow up or who did not have a documented iop or no plan of care documented if,09-10-2025
M1321003004,The iop was >25 mm hg,09-10-2025
M1322001003,Patients seen within 7 weeks following the date of injection and are screened,09-10-2025
M1322002004,For elevated intraocular pressure (iop) with tonometry with documented iop =<25,09-10-2025
M1322003004,Mm hg for injected eye,09-10-2025
M1323001003,Patients seen within 7 weeks following the date of injection and are screened,09-10-2025
M1323002004,For elevated intraocular pressure (iop) with tonometry with documented iop >25,09-10-2025
M1323003004,Mm hg and a plan of care was documented,09-10-2025
M1324001003,"Patients who had an intravitreal or periocular corticosteroid injection (e.g.,",09-10-2025
M1324002004,"Triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone",09-10-2025
M1324003004,"Intravitreal implant, or fluocinolone intravitreal implant)",09-10-2025
M1325001003,Patients who were not seen for reasons documented by clinician for patient or,09-10-2025
M1325002004,"Medical reasons (e.g., inadequate time for follow-up, patients who received a",09-10-2025
M1325003004,Prior intravitreal or periocular steroid injection within the last six (6),09-10-2025
M1325004004,Months and had a subsequent iop evaluation with iop <25mm hg within seven (7),09-10-2025
M1325005004,Weeks of treatment),09-10-2025
M1326001003,Patients with a diagnosis of hypotony,09-10-2025
M1327001003,Patients who were not appropriately evaluated during the initial exam and/or,09-10-2025
M1327002004,Who were not re-evaluated within 8 weeks,09-10-2025
M1328001003,Patients with a diagnosis of acute vitreous hemorrhage,09-10-2025
M1329001003,Patients with a post-operative encounter of the eye with the acute pvd within 2,09-10-2025
M1329002004,Weeks before the initial encounter or 8 weeks after initial acute pvd encounter,09-10-2025
M1330001003,"Documentation of patient reason(s) for not having a follow up exam (e.g.,",09-10-2025
M1330002004,Inadequate time for follow up),09-10-2025
M1331001003,Patients who were appropriately evaluated during the initial exam and were,09-10-2025
M1331002004,Re-evaluated no later than 8 weeks from initial exam,09-10-2025
M1332001003,Patients who were not appropriately evaluated during the initial exam and/or,09-10-2025
M1332002004,Who were not re-evaluated within 2 weeks,09-10-2025
M1333001003,Acute vitreous hemorrhage,09-10-2025
M1334001003,Patients with a post-operative encounter of the eye with the acute pvd within 2,09-10-2025
M1334002004,Weeks before the initial encounter or 2 weeks after initial acute pvd encounter,09-10-2025
M1335001003,"Documentation of patient reason(s) for not having a follow up exam (e.g.,",09-10-2025
M1335002004,Inadequate time for follow up),09-10-2025
M1336001003,Patients who were appropriately evaluated during the initial exam and were,09-10-2025
M1336002004,Re-evaluated no later than 2 weeks,09-10-2025
M1337001003,Acute pvd,09-10-2025
M1338001003,Patients who had follow-up assessment 30 to 180 days after the index assessment,09-10-2025
M1338002004,Who did not demonstrate positive improvement or maintenance of functioning,09-10-2025
M1338003004,Scores during the performance period,09-10-2025
M1339001003,Patients who had follow-up assessment 30 to 180 days after the index assessment,09-10-2025
M1339002004,Who demonstrated positive improvement or maintenance of functioning scores,09-10-2025
M1339003004,During the performance period,09-10-2025
M1340001003,Index assessment completed using the 12-item whodas 2.0 or sds during the,09-10-2025
M1340002004,Denominator identification period,09-10-2025
M1341001003,Patients who did not have a follow-up assessment or did not have an assessment,09-10-2025
M1341002004,Within 30 to 180 days after the index assessment during the performance period,09-10-2025
M1342001003,Patients who died during the performance period,09-10-2025
M1343001003,Patients who are at pam level 4 at baseline or patients who are flagged with,09-10-2025
M1343002004,Extreme straight line response sets on the pam or with excessive missing,09-10-2025
M1343003004,Responses,09-10-2025
M1344001003,Patients who did not have a baseline pam score and/or a second score within 4,09-10-2025
M1344002004,To 12 months of baseline pam score,09-10-2025
M1345001003,Patients who had a baseline pam score and a second score within 4 to 12 month,09-10-2025
M1345002004,Of baseline pam score,09-10-2025
M1346001003,Patients who did not have a net increase in pam score of at least 6 points,09-10-2025
M1346002004,Within a 4 to 12 month period,09-10-2025
M1347001003,Patients who achieved a net increase in pam score of at least 3 points in a 4,09-10-2025
M1347002004,To 12 month period (passing),09-10-2025
M1348001003,Patients who achieved a net increase in pam score of at least 6-points in a 4,09-10-2025
M1348002004,To 12 month period (excellent),09-10-2025
M1349001003,Patients who did not have a net increase in pam score of at least 3 points,09-10-2025
M1349002004,Within a 4 to 12 month period,09-10-2025
M1350001003,"Patients who had a completed suicide safety plan initiated, reviewed or updated",09-10-2025
M1350002004,In collaboration with their clinician (concurrent or within 24 hours) of the,09-10-2025
M1350003004,Index clinical encounter,09-10-2025
M1351001003,"Patients who had a suicide safety plan initiated, reviewed, or updated and",09-10-2025
M1351002004,Reviewed and updated in collaboration with the patient and their clinician,09-10-2025
M1351003004,Concurrent or within 24 hours of clinical encounter and within 120 days after,09-10-2025
M1351004004,Initiation,09-10-2025
M1352001003,Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent,09-10-2025
M1352002004,Assessment,09-10-2025
M1353001003,"Patients who did not have a completed suicide safety plan initiated, reviewed",09-10-2025
M1353002004,Or updated in collaboration with their clinician (concurrent or within 24,09-10-2025
M1353003004,Hours) of the index clinical encounter,09-10-2025
M1354001003,"Patients who did not have a suicide safety plan initiated, reviewed, or updated",09-10-2025
M1354002004,Or reviewed and updated in collaboration with the patient and their clinician,09-10-2025
M1354003004,Concurrent or within 24 hours of clinical encounter and within 120 days after,09-10-2025
M1354004004,Initiation,09-10-2025
M1355001003,Suicide risk based on their clinician's evaluation or a clinician-rated tool,09-10-2025
M1356001003,Patients who died during the measurement period,09-10-2025
M1357001003,Patients who had a reduction in suicidal ideation and/or behavior upon,09-10-2025
M1357002004,Follow-up assessment within 120 days of index assessment,09-10-2025
M1358001003,Patients who did not have a reduction in suicidal ideation and/or behavior upon,09-10-2025
M1358002004,Follow-up assessment within 120 days of index assessment,09-10-2025
M1359001003,Index assessment during the denominator period when the suicidal ideation,09-10-2025
M1359002004,And/or behavior symptoms or increased suicide risk by clinician determination,09-10-2025
M1359003004,Occurs and a non-zero c-ssrs score is obtained,09-10-2025
M1360001003,Suicidal ideation and/or behavior symptoms based on the c-ssrs,09-10-2025
M1361001003,Suicide risk based on their clinician's evaluation or a clinician-rated tool,09-10-2025
M1362001003,Patients who died during the measurement period,09-10-2025
M1363001003,Patients who did not have a follow-up assessment within 120 days of the index,09-10-2025
M1363002004,Assessment,09-10-2025
M1364001003,Calculated 10-year ascvd risk score of >= 20 percent during the performance,09-10-2025
M1364002004,Period,09-10-2025
M1365001003,Patient encounter during the performance period with hospice and palliative,09-10-2025
M1365002004,Care specialty code 17,09-10-2025
M1366001003,Focusing on women's health mips value pathway,09-10-2025
M1367001003,"Quality care for the treatment of ear, nose, and throat disorders mips value",09-10-2025
M1367002004,Pathway,09-10-2025
M1368001003,Prevention and treatment of infectious disorders including hepatitis c and hiv,09-10-2025
M1368002004,Mips value pathway,09-10-2025
M1369001003,Quality care in mental health and substance use disorders mips value pathway,09-10-2025
M1370001003,Rehabilitative support for musculoskeletal care mips value pathway,09-10-2025
M1371001003,Most recent glycemic status assessment (hba1c or gmi) level < 7.0%,09-10-2025
M1372001003,Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%,09-10-2025
M1373001003,Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%,09-10-2025
M1374001003,An additional encounter with an ra diagnosis during the performance period or,09-10-2025
M1374002004,Prior performance period that is at least 90 days before or after an encounter,09-10-2025
M1374003004,With an ra diagnosis during the performance period,09-10-2025
M1375001003,An additional encounter with an ra diagnosis during the performance period or,09-10-2025
M1375002004,Prior performance period that is at least 90 days before or after an encounter,09-10-2025
M1375003004,With an ra diagnosis during the performance period,09-10-2025
M1376001003,An additional encounter with an ra diagnosis during the performance period or,09-10-2025
M1376002004,Prior performance period that is at least 90 days before or after an encounter,09-10-2025
M1376003004,With an ra diagnosis during the performance period,09-10-2025
M1377001003,Recommended follow-up interval for repeat colonoscopy of 10 years documented,09-10-2025
M1377002004,In colonoscopy report and communicated with patient,09-10-2025
M1378001003,Documentation of medical reason(s) for not recommending a 10 year follow-up,09-10-2025
M1378002004,"Interval (e.g., inadequate prep, familial or personal history of colonic",09-10-2025
M1378003004,"Polyps, patient had no adenoma and age is >= 66 years old, or life expectancy <",09-10-2025
M1378004004,"10 years, other medical reasons)",09-10-2025
M1379001003,"A 10 year follow-up interval for colonoscopy not recommended, reason not",09-10-2025
M1379002004,Otherwise specified,09-10-2025
M1380001003,Filled at least two prescriptions during the performance period for any,09-10-2025
M1380002004,Combination of the qualifying oral antipsychotic medications listed under,09-10-2025
M1380003004,"""denominator note"" or the long-acting injectable antipsychotic medications",09-10-2025
M1380004004,"Listed under ""denominator note""",09-10-2025
M1381001003,"Patients with secondary stroke (e.g., a subsequent stroke that may occur with",09-10-2025
M1381002004,Vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the,09-10-2025
M1381003004,Initial procedure,09-10-2025
M1382001003,Patient encounter during the performance period with place of service code 11,09-10-2025
M1383001003,Acute pvd,09-10-2025
M1384001003,Patients who died during the performance period,09-10-2025
M1385001003,Documentation of patient reasons for patients who were not seen for the second,09-10-2025
M1385002004,"Pam survey (e.g., less than four months between baseline pam assessment and",09-10-2025
M1385003004,Follow-up,09-10-2025
M1386001003,Patients with an excisional surgery for melanoma or melanoma in situ in the,09-10-2025
M1386002004,"Past 5 years with an initial ajcc staging of 0, i, or ii at the start of the",09-10-2025
M1386003004,Performance period,09-10-2025
M1387001003,Patients who died during the performance period,09-10-2025
M1388001003,Patients with documentation of an exam performed for recurrence of melanoma,09-10-2025
M1390001003,Patients who do not have a documented exam performed for recurrence of melanoma,09-10-2025
M1390002004,Or no documentation within the performance period,09-10-2025
M1391001003,All patients who were diagnosed with recurrent melanoma during the current,09-10-2025
M1391002004,Performance period,09-10-2025
M1392001003,"Documentation of patient reasons for no examination, i.e., refusal of",09-10-2025
M1392002004,Examination or lost to follow-up (documentation must include information that,09-10-2025
M1392003004,"The clinician was unable to reach the patient by phone, mail or secure",09-10-2025
M1392004004,Electronic mail - at least one method must be documented),09-10-2025
M1393001003,Patients who were not diagnosed with recurrent melanoma during the current,09-10-2025
M1393002004,Performance period,09-10-2025
M1394001003,Stages i-iii breast cancer,09-10-2025
M1395001003,Patients receiving an initial chemotherapy regimen with a defined duration with,09-10-2025
M1395002004,The eligible clinician or group,09-10-2025
M1396001003,Patients on a therapeutic clinical trial,09-10-2025
M1397001003,Patients with recurrence/disease progression,09-10-2025
M1398001003,Patients with baseline and follow-up promis surveys documented in the medical,09-10-2025
M1398002004,Record,09-10-2025
M1399001003,Patients who leave the practice during the follow-up period,09-10-2025
M1400001003,Patients who died during the follow-up period,09-10-2025
M1401001003,Stages i-iii breast cancer,09-10-2025
M1402001003,Patients receiving an initial chemotherapy regimen with a defined duration with,09-10-2025
M1402002004,The eligible clinician or group,09-10-2025
M1403001003,Patients with baseline and follow-up promis surveys documented in the medical,09-10-2025
M1403002004,Record,09-10-2025
M1404001003,Patients on a therapeutic clinical trial,09-10-2025
M1405001003,Patients with recurrence/disease progression,09-10-2025
M1406001003,Patients who leave the practice during the follow-up period,09-10-2025
M1407001003,Patients who died during the follow-up period,09-10-2025
M1408001003,Patients who have germline brca testing completed before diagnosis of,09-10-2025
M1408002004,"Epithelial ovarian, fallopian tube, or primary peritoneal cancer",09-10-2025
M1409001003,Patients who received germline testing for brca1 and brca2 or genetic,09-10-2025
M1409002004,Counseling completed within 6 months of diagnosis,09-10-2025
M1410001003,Patients who did not have germline testing for brca1 and brca2 or genetic,09-10-2025
M1410002004,Counseling completed within 6 months of diagnosis,09-10-2025
M1411001003,Currently on first-line immune checkpoint inhibitors without chemotherapy,09-10-2025
M1412001003,Patients with metastatic nsclc with epidermal growth factor receptor (egfr),09-10-2025
M1412002004,"Mutations, alk genomic tumor aberrations, or other targetable genomic",09-10-2025
M1412003004,"Abnormalities with approved first-line targeted therapy, such as nsclc with",09-10-2025
M1412004004,"Ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14",09-10-2025
M1412005004,"Skipping mutation, and ret rearrangement",09-10-2025
M1413001003,Patients who had a positive pd-l1 biomarker expression test result prior to the,09-10-2025
M1413002004,Initiation of first-line immune checkpoint inhibitor therapy,09-10-2025
M1414001003,Documentation of medical reason(s) for not performing the pd-l1 biomarker,09-10-2025
M1414002004,Expression test prior to initiation of first-line immune checkpoint inhibitor,09-10-2025
M1414003004,"Therapy (e.g., patient is in an urgent or emergent situation where delay of",09-10-2025
M1414004004,Treatment would jeopardize the patient's health status; other medical,09-10-2025
M1414005004,Reasons/contraindication),09-10-2025
M1415001003,Patients who did not have a positive pd-l1 biomarker expression test result,09-10-2025
M1415002004,Prior to the initiation of first-line immune checkpoint inhibitor therapy,09-10-2025
M1416001003,Patient received hospice services any time during the performance period,09-10-2025
M1417001003,Patients who are up to date on their covid-19 vaccinations as defined by cdc,09-10-2025
M1417002004,Recommendations on current vaccination,09-10-2025
M1418001003,Patients who are not up to date on their covid-19 vaccinations as defined by,09-10-2025
M1418002004,Cdc recommendations on current vaccination because of a medical,09-10-2025
M1418003004,Contraindication documented by clinician,09-10-2025
M1419001003,Patients who are not up to date on their covid-19 vaccinations as defined by,09-10-2025
M1419002004,Cdc recommendations on current vaccination,09-10-2025
M1420001003,Complete ophthalmologic care mips value pathway,09-10-2025
M1421001003,Dermatological care mips value pathway,09-10-2025
M1422001003,Gastroenterology care mips value pathway,09-10-2025
M1423001003,Optimal care for patients with urologic conditions mips value pathway,09-10-2025
M1424001003,Pulmonology care mips value pathway,09-10-2025
M1425001003,Surgical care mips value pathway,09-10-2025
P2028001003,"Cephalin floculation, blood",09-10-2025
P2029001003,"Congo red, blood",09-10-2025
P2031001003,Hair analysis (excluding arsenic),09-10-2025
P2033001003,"Thymol turbidity, blood",09-10-2025
P2038001003,"Mucoprotein, blood (seromucoid) (medical necessity procedure)",09-10-2025
P3000001003,"Screening papanicolaou smear, cervical or vaginal, up to three smears, by",09-10-2025
P3000002004,Technician under physician supervision,09-10-2025
P3001001003,"Screening papanicolaou smear, cervical or vaginal, up to three smears,",09-10-2025
P3001002004,Requiring interpretation by physician,09-10-2025
P7001001003,"Culture, bacterial, urine; quantitative, sensitivity study",09-10-2025
P9010001003,"Blood (whole), for transfusion, per unit",09-10-2025
P9011001003,"Blood, split unit",09-10-2025
P9012001003,"Cryoprecipitate, each unit",09-10-2025
P9016001003,"Red blood cells, leukocytes reduced, each unit",09-10-2025
P9017001003,"Fresh frozen plasma (single donor), frozen within 8 hours of collection, each",09-10-2025
P9017002004,Unit,09-10-2025
P9019001003,"Platelets, each unit",09-10-2025
P9020001003,"Platelet rich plasma, each unit",09-10-2025
P9021001003,"Red blood cells, each unit",09-10-2025
P9022001003,"Red blood cells, washed, each unit",09-10-2025
P9023001003,"Plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit",09-10-2025
P9025001003,"Plasma, cryoprecipitate reduced, pathogen reduced, each unit",09-10-2025
P9026001003,"Cryoprecipitated fibrinogen complex, pathogen reduced, each unit",09-10-2025
P9027001003,"Red blood cells, leukocytes reduced, oxygen/ carbon dioxide reduced, each unit",09-10-2025
P9031001003,"Platelets, leukocytes reduced, each unit",09-10-2025
P9032001003,"Platelets, irradiated, each unit",09-10-2025
P9033001003,"Platelets, leukocytes reduced, irradiated, each unit",09-10-2025
P9034001003,"Platelets, pheresis, each unit",09-10-2025
P9035001003,"Platelets, pheresis, leukocytes reduced, each unit",09-10-2025
P9036001003,"Platelets, pheresis, irradiated, each unit",09-10-2025
P9037001003,"Platelets, pheresis, leukocytes reduced, irradiated, each unit",09-10-2025
P9038001003,"Red blood cells, irradiated, each unit",09-10-2025
P9039001003,"Red blood cells, deglycerolized, each unit",09-10-2025
P9040001003,"Red blood cells, leukocytes reduced, irradiated, each unit",09-10-2025
P9041001003,"Infusion, albumin (human), 5%, 50 ml",09-10-2025
P9043001003,"Infusion, plasma protein fraction (human), 5%, 50 ml",09-10-2025
P9044001003,"Plasma, cryoprecipitate reduced, each unit",09-10-2025
P9045001003,"Infusion, albumin (human), 5%, 250 ml",09-10-2025
P9046001003,"Infusion, albumin (human), 25%, 20 ml",09-10-2025
P9047001003,"Infusion, albumin (human), 25%, 50 ml",09-10-2025
P9048001003,"Infusion, plasma protein fraction (human), 5%, 250 ml",09-10-2025
P9050001003,"Granulocytes, pheresis, each unit",09-10-2025
P9051001003,"Whole blood or red blood cells, leukocytes reduced, cmv-negative, each unit",09-10-2025
P9052001003,"Platelets, hla-matched leukocytes reduced, apheresis/pheresis, each unit",09-10-2025
P9053001003,"Platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit",09-10-2025
P9054001003,"Whole blood or red blood cells, leukocytes reduced, frozen, deglycerol, washed,",09-10-2025
P9054002004,Each unit,09-10-2025
P9055001003,"Platelets, leukocytes reduced, cmv-negative, apheresis/pheresis, each unit",09-10-2025
P9056001003,"Whole blood, leukocytes reduced, irradiated, each unit",09-10-2025
P9057001003,"Red blood cells, frozen/deglycerolized/washed, leukocytes reduced, irradiated,",09-10-2025
P9057002004,Each unit,09-10-2025
P9058001003,"Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit",09-10-2025
P9059001003,"Fresh frozen plasma between 8-24 hours of collection, each unit",09-10-2025
P9060001003,"Fresh frozen plasma, donor retested, each unit",09-10-2025
P9070001003,"Plasma, pooled multiple donor, pathogen reduced, frozen, each unit",09-10-2025
P9071001003,"Plasma (single donor), pathogen reduced, frozen, each unit",09-10-2025
P9072001003,"Platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit",09-10-2025
P9073001003,"Platelets, pheresis, pathogen-reduced, each unit",09-10-2025
P9099001003,Blood component or product not otherwise classified,09-10-2025
P9100001003,Pathogen(s) test for platelets,09-10-2025
P9603001003,Travel allowance one way in connection with medically necessary laboratory,09-10-2025
P9603002004,Specimen collection drawn from home bound or nursing home bound patient;,09-10-2025
P9603003004,Prorated miles actually travelled,09-10-2025
P9604001003,Travel allowance one way in connection with medically necessary laboratory,09-10-2025
P9604002004,Specimen collection drawn from home bound or nursing home bound patient;,09-10-2025
P9604003004,Prorated trip charge,09-10-2025
P9612001003,"Catheterization for collection of specimen, single patient, all places of",09-10-2025
P9612002004,Service,09-10-2025
P9615001003,Catheterization for collection of specimen(s) (multiple patients),09-10-2025
Q0035001003,Cardiokymography,09-10-2025
Q0081001003,"Infusion therapy, using other than chemotherapeutic drugs, per visit",09-10-2025
Q0083001003,"Chemotherapy administration by other than infusion technique only (e.g.,",09-10-2025
Q0083002004,"Subcutaneous, intramuscular, push), per visit",09-10-2025
Q0084001003,"Chemotherapy administration by infusion technique only, per visit",09-10-2025
Q0085001003,Chemotherapy administration by both infusion technique and other technique(s),09-10-2025
Q0085002004,"(e.g., subcutaneous, intramuscular, push), per visit",09-10-2025
Q0091001003,"Screening papanicolaou smear; obtaining, preparing and conveyance of cervical",09-10-2025
Q0091002004,Or vaginal smear to laboratory,09-10-2025
Q0092001003,Set-up portable x-ray equipment,09-10-2025
Q0111001003,"Wet mounts, including preparations of vaginal, cervical or skin specimens",09-10-2025
Q0112001003,All potassium hydroxide (koh) preparations,09-10-2025
Q0113001003,Pinworm examinations,09-10-2025
Q0114001003,Fern test,09-10-2025
Q0115001003,"Post-coital direct, qualitative examinations of vaginal or cervical mucous",09-10-2025
Q0138001003,"Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd",09-10-2025
Q0138002004,Use),09-10-2025
Q0139001003,"Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd",09-10-2025
Q0139002004,On dialysis),09-10-2025
Q0144001003,"Azithromycin dihydrate, oral, capsules/powder, 1 gram",09-10-2025
Q0155001003,"Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for",09-10-2025
Q0155002004,Use as a complete therapeutic substitute for an iv anti-emetic at the time of,09-10-2025
Q0155003004,"Chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0161001003,"Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription",09-10-2025
Q0161002004,"Anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic",09-10-2025
Q0161003004,"At the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0162001003,"Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a",09-10-2025
Q0162002004,Complete therapeutic substitute for an iv anti-emetic at the time of,09-10-2025
Q0162003004,"Chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0163001003,"Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription",09-10-2025
Q0163002004,"Anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic",09-10-2025
Q0163003004,At time of chemotherapy treatment not to exceed a 48 hour dosage regimen,09-10-2025
Q0164001003,"Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic,",09-10-2025
Q0164002004,For use as a complete therapeutic substitute for an iv anti-emetic at the time,09-10-2025
Q0164003004,"Of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0166001003,"Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic,",09-10-2025
Q0166002004,For use as a complete therapeutic substitute for an iv anti-emetic at the time,09-10-2025
Q0166003004,"Of chemotherapy treatment, not to exceed a 24 hour dosage regimen",09-10-2025
Q0167001003,"Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a",09-10-2025
Q0167002004,Complete therapeutic substitute for an iv anti-emetic at the time of,09-10-2025
Q0167003004,"Chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0169001003,"Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription",09-10-2025
Q0169002004,"Anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic",09-10-2025
Q0169003004,"At the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0173001003,"Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription",09-10-2025
Q0173002004,"Anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic",09-10-2025
Q0173003004,"At the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0174001003,"Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic,",09-10-2025
Q0174002004,For use as a complete therapeutic substitute for an iv anti-emetic at the time,09-10-2025
Q0174003004,"Of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0175001003,"Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a",09-10-2025
Q0175002004,Complete therapeutic substitute for an iv anti-emetic at the time of,09-10-2025
Q0175003004,"Chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0177001003,"Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for",09-10-2025
Q0177002004,Use as a complete therapeutic substitute for an iv anti-emetic at the time of,09-10-2025
Q0177003004,"Chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0180001003,"Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for",09-10-2025
Q0180002004,Use as a complete therapeutic substitute for an iv anti-emetic at the time of,09-10-2025
Q0180003004,"Chemotherapy treatment, not to exceed a 24 hour dosage regimen",09-10-2025
Q0181001003,"Unspecified oral dosage form, fda approved prescription anti-emetic, for use as",09-10-2025
Q0181002004,A complete therapeutic substitute for a iv anti-emetic at the time of,09-10-2025
Q0181003004,"Chemotherapy treatment, not to exceed a 48 hour dosage regimen",09-10-2025
Q0220001003,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only,",09-10-2025
Q0220002004,For certain adults and pediatric individuals (12 years of age and older,09-10-2025
Q0220003004,"Weighing at least 40kg) with no known sars-cov-2 exposure, who either have",09-10-2025
Q0220004004,Moderate to severely compromised immune systems or for whom vaccination with,09-10-2025
Q0220005004,Any available covid-19 vaccine is not recommended due to a history of severe,09-10-2025
Q0220006004,"Adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s),",09-10-2025
Q0220007004,300 mg,09-10-2025
Q0221001003,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only,",09-10-2025
Q0221002004,For certain adults and pediatric individuals (12 years of age and older,09-10-2025
Q0221003004,"Weighing at least 40kg) with no known sars-cov-2 exposure, who either have",09-10-2025
Q0221004004,Moderate to severely compromised immune systems or for whom vaccination with,09-10-2025
Q0221005004,Any available covid-19 vaccine is not recommended due to a history of severe,09-10-2025
Q0221006004,"Adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s),",09-10-2025
Q0221007004,600 mg,09-10-2025
Q0222001003,"Injection, bebtelovimab, 175 mg",09-10-2025
Q0224001003,"Injection, pemivibart, for the pre-exposure prophylaxis only, for certain",09-10-2025
Q0224002004,Adults and adolescents (12 years of age and older weighing at least 40 kg) with,09-10-2025
Q0224003004,"No known sars-cov-2 exposure, and who either have moderate-to-severe immune",09-10-2025
Q0224004004,Compromise due to a medical condition or receipt of immunosuppressive,09-10-2025
Q0224005004,"Medications or treatments, and are unlikely to mount an adequate immune",09-10-2025
Q0224006004,"Response to covid-19 vaccination, 4500 mg",09-10-2025
Q0235001003,"Injection, monoclonal antibody products with an indication for post-exposure",09-10-2025
Q0235002004,"Prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric",09-10-2025
Q0235003004,Patients who are receiving systemic corticosteroids and require supplemental,09-10-2025
Q0235004004,"Oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal",09-10-2025
Q0235005004,"Membrane oxygenation (ecmo) only, not otherwise classified, 1 mg",09-10-2025
Q0237001003,"Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who",09-10-2025
Q0237002004,"Are receiving systemic corticosteroids and require supplemental oxygen,",09-10-2025
Q0237003004,"Non-invasive or invasive mechanical ventilation, or extracorporeal membrane",09-10-2025
Q0237004004,"Oxygenation (ecmo) only, 1 mg",09-10-2025
Q0239001003,"Injection, bamlanivimab-xxxx, 700 mg",09-10-2025
Q0240001003,"Injection, casirivimab and imdevimab, 600 mg",09-10-2025
Q0243001003,"Injection, casirivimab and imdevimab, 2400 mg",09-10-2025
Q0244001003,"Injection, casirivimab and imdevimab, 1200 mg",09-10-2025
Q0245001003,"Injection, bamlanivimab and etesevimab, 2100 mg",09-10-2025
Q0247001003,"Injection, sotrovimab, 500 mg",09-10-2025
Q0249001003,"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years",09-10-2025
Q0249002004,Of age and older) with covid-19 who are receiving systemic corticosteroids and,09-10-2025
Q0249003004,"Require supplemental oxygen, non-invasive or invasive mechanical ventilation,",09-10-2025
Q0249004004,"Or extracorporeal membrane oxygenation (ecmo) only, 1 mg",09-10-2025
Q0477001003,Power module patient cable for use with electric or electric/pneumatic,09-10-2025
Q0477002004,"Ventricular assist device, replacement only",09-10-2025
Q0478001003,Power adapter for use with electric or electric/pneumatic ventricular assist,09-10-2025
Q0478002004,"Device, vehicle type",09-10-2025
Q0479001003,Power module for use with electric or electric/pneumatic ventricular assist,09-10-2025
Q0479002004,"Device, replacement only",09-10-2025
Q0480001003,"Driver for use with pneumatic ventricular assist device, replacement only",09-10-2025
Q0481001003,"Microprocessor control unit for use with electric ventricular assist device,",09-10-2025
Q0481002004,Replacement only,09-10-2025
Q0482001003,Microprocessor control unit for use with electric/pneumatic combination,09-10-2025
Q0482002004,"Ventricular assist device, replacement only",09-10-2025
Q0483001003,"Monitor/display module for use with electric ventricular assist device,",09-10-2025
Q0483002004,Replacement only,09-10-2025
Q0484001003,Monitor/display module for use with electric or electric/pneumatic ventricular,09-10-2025
Q0484002004,"Assist device, replacement only",09-10-2025
Q0485001003,"Monitor control cable for use with electric ventricular assist device,",09-10-2025
Q0485002004,Replacement only,09-10-2025
Q0486001003,Monitor control cable for use with electric/pneumatic ventricular assist,09-10-2025
Q0486002004,"Device, replacement only",09-10-2025
Q0487001003,Leads (pneumatic/electrical) for use with any type electric/pneumatic,09-10-2025
Q0487002004,"Ventricular assist device, replacement only",09-10-2025
Q0488001003,"Power pack base for use with electric ventricular assist device, replacement",09-10-2025
Q0488002004,Only,09-10-2025
Q0489001003,"Power pack base for use with electric/pneumatic ventricular assist device,",09-10-2025
Q0489002004,Replacement only,09-10-2025
Q0490001003,"Emergency power source for use with electric ventricular assist device,",09-10-2025
Q0490002004,Replacement only,09-10-2025
Q0491001003,Emergency power source for use with electric/pneumatic ventricular assist,09-10-2025
Q0491002004,"Device, replacement only",09-10-2025
Q0492001003,"Emergency power supply cable for use with electric ventricular assist device,",09-10-2025
Q0492002004,Replacement only,09-10-2025
Q0493001003,Emergency power supply cable for use with electric/pneumatic ventricular assist,09-10-2025
Q0493002004,"Device, replacement only",09-10-2025
Q0494001003,Emergency hand pump for use with electric or electric/pneumatic ventricular,09-10-2025
Q0494002004,"Assist device, replacement only",09-10-2025
Q0495001003,Battery/power pack charger for use with electric or electric/pneumatic,09-10-2025
Q0495002004,"Ventricular assist device, replacement only",09-10-2025
Q0496001003,"Battery, other than lithium-ion, for use with electric or electric/pneumatic",09-10-2025
Q0496002004,"Ventricular assist device, replacement only",09-10-2025
Q0497001003,Battery clips for use with electric or electric/pneumatic ventricular assist,09-10-2025
Q0497002004,"Device, replacement only",09-10-2025
Q0498001003,"Holster for use with electric or electric/pneumatic ventricular assist device,",09-10-2025
Q0498002004,Replacement only,09-10-2025
Q0499001003,Belt/vest/bag for use to carry external peripheral components of any type,09-10-2025
Q0499002004,"Ventricular assist device, replacement only",09-10-2025
Q0500001003,"Filters for use with electric or electric/pneumatic ventricular assist device,",09-10-2025
Q0500002004,Replacement only,09-10-2025
Q0501001003,Shower cover for use with electric or electric/pneumatic ventricular assist,09-10-2025
Q0501002004,"Device, replacement only",09-10-2025
Q0502001003,"Mobility cart for pneumatic ventricular assist device, replacement only",09-10-2025
Q0503001003,"Battery for pneumatic ventricular assist device, replacement only, each",09-10-2025
Q0504001003,"Power adapter for pneumatic ventricular assist device, replacement only,",09-10-2025
Q0504002004,Vehicle type,09-10-2025
Q0506001003,"Battery, lithium-ion, for use with electric or electric/pneumatic ventricular",09-10-2025
Q0506002004,"Assist device, replacement only",09-10-2025
Q0507001003,Miscellaneous supply or accessory for use with an external ventricular assist,09-10-2025
Q0507002004,Device,09-10-2025
Q0508001003,Miscellaneous supply or accessory for use with an implanted ventricular assist,09-10-2025
Q0508002004,Device,09-10-2025
Q0509001003,Miscellaneous supply or accessory for use with any implanted ventricular assist,09-10-2025
Q0509002004,Device for which payment was not made under medicare part a,09-10-2025
Q0510001003,"Pharmacy supply fee for initial immunosuppressive drug(s), first month",09-10-2025
Q0510002004,Following transplant,09-10-2025
Q0511001003,"Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive",09-10-2025
Q0511002004,Drug(s); for the first prescription in a 30-day period,09-10-2025
Q0512001003,"Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive",09-10-2025
Q0512002004,Drug(s); for a subsequent prescription in a 30-day period,09-10-2025
Q0513001003,Pharmacy dispensing fee for inhalation drug(s); per 30 days,09-10-2025
Q0514001003,Pharmacy dispensing fee for inhalation drug(s); per 90 days,09-10-2025
Q0515001003,"Injection, sermorelin acetate, 1 microgram",09-10-2025
Q0516001003,Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved,09-10-2025
Q0516002004,"Prescription oral drug, per 30-days",09-10-2025
Q0517001003,Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved,09-10-2025
Q0517002004,"Prescription oral drug, per 60-days",09-10-2025
Q0518001003,Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved,09-10-2025
Q0518002004,"Prescription oral drug, per 90-days",09-10-2025
Q0519001003,Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved,09-10-2025
Q0519002004,"Prescription injectable drug, per 30-days",09-10-2025
Q0520001003,Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved,09-10-2025
Q0520002004,"Prescription injectable drug, per 60-days",09-10-2025
Q0521001003,Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved,09-10-2025
Q0521002004,Prescription,09-10-2025
Q1004001003,New technology intraocular lens category 4 as defined in federal register notic,09-10-2025
Q1005001003,New technology intraocular lens category 5 as defined in federal register notic,09-10-2025
Q2004001003,"Irrigation solution for treatment of bladder calculi, for example renacidin,",09-10-2025
Q2004002004,Per 500 ml,09-10-2025
Q2009001003,"Injection, fosphenytoin, 50 mg phenytoin equivalent",09-10-2025
Q2017001003,"Injection, teniposide, 50 mg",09-10-2025
Q2026001003,"Injection, radiesse, 0.1 ml",09-10-2025
Q2028001003,"Injection, sculptra, 0.5 mg",09-10-2025
Q2034001003,"Influenza virus vaccine, split virus, for intramuscular use (agriflu)",09-10-2025
Q2035001003,"Influenza virus vaccine, split virus, when administered to individuals 3 years",09-10-2025
Q2035002004,"Of age and older, for intramuscular use (afluria)",09-10-2025
Q2036001003,"Influenza virus vaccine, split virus, when administered to individuals 3 years",09-10-2025
Q2036002004,"Of age and older, for intramuscular use (flulaval)",09-10-2025
Q2037001003,"Influenza virus vaccine, split virus, when administered to individuals 3 years",09-10-2025
Q2037002004,"Of age and older, for intramuscular use (fluvirin)",09-10-2025
Q2038001003,"Influenza virus vaccine, split virus, when administered to individuals 3 years",09-10-2025
Q2038002004,"Of age and older, for intramuscular use (fluzone)",09-10-2025
Q2039001003,"Influenza virus vaccine, not otherwise specified",09-10-2025
Q2040001003,"Tisagenlecleucel, up to 250 million car-positive viable t cells, including",09-10-2025
Q2040002004,"Leukapheresis and dose preparation procedures, per infusion",09-10-2025
Q2041001003,"Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive",09-10-2025
Q2041002004,"Viable t cells, including leukapheresis and dose preparation procedures, per",09-10-2025
Q2041003004,Therapeutic dose,09-10-2025
Q2042001003,"Tisagenlecleucel, up to 600 million car-positive viable t cells, including",09-10-2025
Q2042002004,"Leukapheresis and dose preparation procedures, per therapeutic dose",09-10-2025
Q2043001003,"Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with",09-10-2025
Q2043002004,"Pap-gm-csf, including leukapheresis and all other preparatory procedures, per",09-10-2025
Q2043003004,Infusion,09-10-2025
Q2049001003,"Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg",09-10-2025
Q2050001003,"Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg",09-10-2025
Q2052001003,"Services, supplies and accessories used in the home for the administration of",09-10-2025
Q2052002004,Intravenous immune globulin (ivig),09-10-2025
Q2053001003,"Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive",09-10-2025
Q2053002004,"Viable t cells, including leukapheresis and dose preparation procedures, per",09-10-2025
Q2053003004,Therapeutic dose,09-10-2025
Q2054001003,"Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive",09-10-2025
Q2054002004,"Viable t cells, including leukapheresis and dose preparation procedures, per",09-10-2025
Q2054003004,Therapeutic dose,09-10-2025
Q2055001003,"Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen",09-10-2025
Q2055002004,"(bcma) directed car-positive t cells, including leukapheresis and dose",09-10-2025
Q2055003004,"Preparation procedures, per therapeutic dose",09-10-2025
Q2056001003,"Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation",09-10-2025
Q2056002004,"Antigen (bcma) directed car-positive t cells, including leukapheresis and dose",09-10-2025
Q2056003004,"Preparation procedures, per therapeutic dose",09-10-2025
Q2057001003,"Afamitresgene autoleucel, including leukapheresis and dose preparation",09-10-2025
Q2057002004,"Procedures, per therapeutic dose",09-10-2025
Q2058001003,"Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells,",09-10-2025
Q2058002004,"Including leukapheresis and dose preparation procedures, per infusion",09-10-2025
Q3001001003,"Radioelements for brachytherapy, any type, each",09-10-2025
Q3014001003,Telehealth originating site facility fee,09-10-2025
Q3027001003,"Injection, interferon beta-1a, 1 mcg for intramuscular use",09-10-2025
Q3028001003,"Injection, interferon beta-1a, 1 mcg for subcutaneous use",09-10-2025
Q3031001003,Collagen skin test,09-10-2025
Q4001001003,"Casting supplies, body cast adult, with or without head, plaster",09-10-2025
Q4002001003,"Cast supplies, body cast adult, with or without head, fiberglass",09-10-2025
Q4003001003,"Cast supplies, shoulder cast, adult (11 years +), plaster",09-10-2025
Q4004001003,"Cast supplies, shoulder cast, adult (11 years +), fiberglass",09-10-2025
Q4005001003,"Cast supplies, long arm cast, adult (11 years +), plaster",09-10-2025
Q4006001003,"Cast supplies, long arm cast, adult (11 years +), fiberglass",09-10-2025
Q4007001003,"Cast supplies, long arm cast, pediatric (0-10 years), plaster",09-10-2025
Q4008001003,"Cast supplies, long arm cast, pediatric (0-10 years), fiberglass",09-10-2025
Q4009001003,"Cast supplies, short arm cast, adult (11 years +), plaster",09-10-2025
Q4010001003,"Cast supplies, short arm cast, adult (11 years +), fiberglass",09-10-2025
Q4011001003,"Cast supplies, short arm cast, pediatric (0-10 years), plaster",09-10-2025
Q4012001003,"Cast supplies, short arm cast, pediatric (0-10 years), fiberglass",09-10-2025
Q4013001003,"Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years",09-10-2025
Q4013002004,"+), plaster",09-10-2025
Q4014001003,"Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years",09-10-2025
Q4014002004,"+), fiberglass",09-10-2025
Q4015001003,"Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10",09-10-2025
Q4015002004,"Years), plaster",09-10-2025
Q4016001003,"Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10",09-10-2025
Q4016002004,"Years), fiberglass",09-10-2025
Q4017001003,"Cast supplies, long arm splint, adult (11 years +), plaster",09-10-2025
Q4018001003,"Cast supplies, long arm splint, adult (11 years +), fiberglass",09-10-2025
Q4019001003,"Cast supplies, long arm splint, pediatric (0-10 years), plaster",09-10-2025
Q4020001003,"Cast supplies, long arm splint, pediatric (0-10 years), fiberglass",09-10-2025
Q4021001003,"Cast supplies, short arm splint, adult (11 years +), plaster",09-10-2025
Q4022001003,"Cast supplies, short arm splint, adult (11 years +), fiberglass",09-10-2025
Q4023001003,"Cast supplies, short arm splint, pediatric (0-10 years), plaster",09-10-2025
Q4024001003,"Cast supplies, short arm splint, pediatric (0-10 years), fiberglass",09-10-2025
Q4025001003,"Cast supplies, hip spica (one or both legs), adult (11 years +), plaster",09-10-2025
Q4026001003,"Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass",09-10-2025
Q4027001003,"Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster",09-10-2025
Q4028001003,"Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass",09-10-2025
Q4029001003,"Cast supplies, long leg cast, adult (11 years +), plaster",09-10-2025
Q4030001003,"Cast supplies, long leg cast, adult (11 years +), fiberglass",09-10-2025
Q4031001003,"Cast supplies, long leg cast, pediatric (0-10 years), plaster",09-10-2025
Q4032001003,"Cast supplies, long leg cast, pediatric (0-10 years), fiberglass",09-10-2025
Q4033001003,"Cast supplies, long leg cylinder cast, adult (11 years +), plaster",09-10-2025
Q4034001003,"Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass",09-10-2025
Q4035001003,"Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster",09-10-2025
Q4036001003,"Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass",09-10-2025
Q4037001003,"Cast supplies, short leg cast, adult (11 years +), plaster",09-10-2025
Q4038001003,"Cast supplies, short leg cast, adult (11 years +), fiberglass",09-10-2025
Q4039001003,"Cast supplies, short leg cast, pediatric (0-10 years), plaster",09-10-2025
Q4040001003,"Cast supplies, short leg cast, pediatric (0-10 years), fiberglass",09-10-2025
Q4041001003,"Cast supplies, long leg splint, adult (11 years +), plaster",09-10-2025
Q4042001003,"Cast supplies, long leg splint, adult (11 years +), fiberglass",09-10-2025
Q4043001003,"Cast supplies, long leg splint, pediatric (0-10 years), plaster",09-10-2025
Q4044001003,"Cast supplies, long leg splint, pediatric (0-10 years), fiberglass",09-10-2025
Q4045001003,"Cast supplies, short leg splint, adult (11 years +), plaster",09-10-2025
Q4046001003,"Cast supplies, short leg splint, adult (11 years +), fiberglass",09-10-2025
Q4047001003,"Cast supplies, short leg splint, pediatric (0-10 years), plaster",09-10-2025
Q4048001003,"Cast supplies, short leg splint, pediatric (0-10 years), fiberglass",09-10-2025
Q4049001003,"Finger splint, static",09-10-2025
Q4050001003,"Cast supplies, for unlisted types and materials of casts",09-10-2025
Q4051001003,"Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners,",09-10-2025
Q4051002004,Padding and other supplies),09-10-2025
Q4074001003,"Iloprost, inhalation solution, fda-approved final product, non-compounded,",09-10-2025
Q4074002004,"Administered through dme, unit dose form, up to 20 micrograms",09-10-2025
Q4081001003,"Injection, epoetin alfa, 100 units (for esrd on dialysis)",09-10-2025
Q4082001003,"Drug or biological, not otherwise classified, part b drug competitive",09-10-2025
Q4082002004,Acquisition program (cap),09-10-2025
Q4100001003,"Skin substitute, not otherwise specified",09-10-2025
Q4101001003,"Apligraf, per square centimeter",09-10-2025
Q4102001003,"Oasis wound matrix, per square centimeter",09-10-2025
Q4103001003,"Oasis burn matrix, per square centimeter",09-10-2025
Q4104001003,"Integra bilayer matrix wound dressing (bmwd), per square centimeter",09-10-2025
Q4105001003,Integra dermal regeneration template (drt) or integra omnigraft dermal,09-10-2025
Q4105002004,"Regeneration matrix, per square centimeter",09-10-2025
Q4106001003,"Dermagraft, per square centimeter",09-10-2025
Q4107001003,"Graftjacket, per square centimeter",09-10-2025
Q4108001003,"Integra matrix, per square centimeter",09-10-2025
Q4110001003,"Primatrix, per square centimeter",09-10-2025
Q4111001003,"Gammagraft, per square centimeter",09-10-2025
Q4112001003,"Cymetra, injectable, 1 cc",09-10-2025
Q4113001003,"Graftjacket xpress, injectable, 1 cc",09-10-2025
Q4114001003,"Integra flowable wound matrix, injectable, 1 cc",09-10-2025
Q4115001003,"Alloskin, per square centimeter",09-10-2025
Q4116001003,"Alloderm, per square centimeter",09-10-2025
Q4117001003,"Hyalomatrix, per square centimeter",09-10-2025
Q4118001003,"Matristem micromatrix, 1 mg",09-10-2025
Q4119001003,"Matristem wound matrix, per square centimeter",09-10-2025
Q4120001003,"Matristem burn matrix, per square centimeter",09-10-2025
Q4121001003,"Theraskin, per square centimeter",09-10-2025
Q4122001003,"Dermacell, dermacell awm or dermacell awm porous, per square centimeter",09-10-2025
Q4123001003,"Alloskin rt, per square centimeter",09-10-2025
Q4124001003,"Oasis ultra tri-layer wound matrix, per square centimeter",09-10-2025
Q4125001003,"Arthroflex, per square centimeter",09-10-2025
Q4126001003,"Memoderm, dermaspan, tranzgraft or integuply, per square centimeter",09-10-2025
Q4127001003,"Talymed, per square centimeter",09-10-2025
Q4128001003,"Flex hd, or allopatch hd, per square centimeter",09-10-2025
Q4129001003,"Unite biomatrix, per square centimeter",09-10-2025
Q4130001003,"Strattice tm, per square centimeter",09-10-2025
Q4131001003,"Epifix or epicord, per square centimeter",09-10-2025
Q4132001003,"Grafix core and grafixpl core, per square centimeter",09-10-2025
Q4133001003,"Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter",09-10-2025
Q4134001003,"Hmatrix, per square centimeter",09-10-2025
Q4135001003,"Mediskin, per square centimeter",09-10-2025
Q4136001003,"Ez-derm, per square centimeter",09-10-2025
Q4137001003,"Amnioexcel, amnioexcel plus or biodexcel, per square centimeter",09-10-2025
Q4138001003,"Biodfence dryflex, per square centimeter",09-10-2025
Q4139001003,"Amniomatrix or biodmatrix, injectable, 1 cc",09-10-2025
Q4140001003,"Biodfence, per square centimeter",09-10-2025
Q4141001003,"Alloskin ac, per square centimeter",09-10-2025
Q4142001003,"Xcm biologic tissue matrix, per square centimeter",09-10-2025
Q4143001003,"Repriza, per square centimeter",09-10-2025
Q4145001003,"Epifix, injectable, 1 mg",09-10-2025
Q4146001003,"Tensix, per square centimeter",09-10-2025
Q4147001003,"Architect, architect px, or architect fx, extracellular matrix, per square",09-10-2025
Q4147002004,Centimeter,09-10-2025
Q4148001003,"Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter",09-10-2025
Q4149001003,"Excellagen, 0.1 cc",09-10-2025
Q4150001003,"Allowrap ds or dry, per square centimeter",09-10-2025
Q4151001003,"Amnioband or guardian, per square centimeter",09-10-2025
Q4152001003,"Dermapure, per square centimeter",09-10-2025
Q4153001003,"Dermavest and plurivest, per square centimeter",09-10-2025
Q4154001003,"Biovance, per square centimeter",09-10-2025
Q4155001003,"Neoxflo or clarixflo, 1 mg",09-10-2025
Q4156001003,"Neox 100 or clarix 100, per square centimeter",09-10-2025
Q4157001003,"Revitalon, per square centimeter",09-10-2025
Q4158001003,"Kerecis omega3, per square centimeter",09-10-2025
Q4159001003,"Affinity, per square centimeter",09-10-2025
Q4160001003,"Nushield, per square centimeter",09-10-2025
Q4161001003,"Bio-connekt wound matrix, per square centimeter",09-10-2025
Q4162001003,"Woundex flow, bioskin flow, 0.5 cc",09-10-2025
Q4163001003,"Woundex, bioskin, per square centimeter",09-10-2025
Q4164001003,"Helicoll, per square centimeter",09-10-2025
Q4165001003,"Keramatrix or kerasorb, per square centimeter",09-10-2025
Q4166001003,"Cytal, per square centimeter",09-10-2025
Q4167001003,"Truskin, per square centimeter",09-10-2025
Q4168001003,"Amnioband, 1 mg",09-10-2025
Q4169001003,"Artacent wound, per square centimeter",09-10-2025
Q4170001003,"Cygnus, per square centimeter",09-10-2025
Q4171001003,"Interfyl, 1 mg",09-10-2025
Q4172001003,"Puraply or puraply am, per square centimeter",09-10-2025
Q4173001003,"Palingen or palingen xplus, per square centimeter",09-10-2025
Q4174001003,"Palingen or promatrx, 0.36 mg per 0.25 cc",09-10-2025
Q4175001003,"Miroderm, per square centimeter",09-10-2025
Q4176001003,"Neopatch or therion, per square centimeter",09-10-2025
Q4177001003,"Floweramnioflo, 0.1 cc",09-10-2025
Q4178001003,"Floweramniopatch, per square centimeter",09-10-2025
Q4179001003,"Flowerderm, per square centimeter",09-10-2025
Q4180001003,"Revita, per square centimeter",09-10-2025
Q4181001003,"Amnio wound, per square centimeter",09-10-2025
Q4182001003,"Transcyte, per square centimeter",09-10-2025
Q4183001003,"Surgigraft, per square centimeter",09-10-2025
Q4184001003,"Cellesta or cellesta duo, per square centimeter",09-10-2025
Q4185001003,Cellesta flowable amnion (25 mg per cc); per 0.5 cc,09-10-2025
Q4186001003,"Epifix, per square centimeter",09-10-2025
Q4187001003,"Epicord, per square centimeter",09-10-2025
Q4188001003,"Amnioarmor, per square centimeter",09-10-2025
Q4189001003,"Artacent ac, 1 mg",09-10-2025
Q4190001003,"Artacent ac, per square centimeter",09-10-2025
Q4191001003,"Restorigin, per square centimeter",09-10-2025
Q4192001003,"Restorigin, 1 cc",09-10-2025
Q4193001003,"Coll-e-derm, per square centimeter",09-10-2025
Q4194001003,"Novachor, per square centimeter",09-10-2025
Q4195001003,"Puraply, per square centimeter",09-10-2025
Q4196001003,"Puraply am, per square centimeter",09-10-2025
Q4197001003,"Puraply xt, per square centimeter",09-10-2025
Q4198001003,"Genesis amniotic membrane, per square centimeter",09-10-2025
Q4199001003,"Cygnus matrix, per square centimeter",09-10-2025
Q4200001003,"Skin te, per square centimeter",09-10-2025
Q4201001003,"Matrion, per square centimeter",09-10-2025
Q4202001003,"Keroxx (2.5g/cc), 1cc",09-10-2025
Q4203001003,"Derma-gide, per square centimeter",09-10-2025
Q4204001003,"Xwrap, per square centimeter",09-10-2025
Q4205001003,"Membrane graft or membrane wrap, per square centimeter",09-10-2025
Q4206001003,"Fluid flow or fluid gf, 1 cc",09-10-2025
Q4208001003,"Novafix, per square cenitmeter",09-10-2025
Q4209001003,"Surgraft, per square centimeter",09-10-2025
Q4210001003,"Axolotl graft or axolotl dualgraft, per square centimeter",09-10-2025
Q4211001003,"Amnion bio or axobiomembrane, per square centimeter",09-10-2025
Q4212001003,"Allogen, per cc",09-10-2025
Q4213001003,"Ascent, 0.5 mg",09-10-2025
Q4214001003,"Cellesta cord, per square centimeter",09-10-2025
Q4215001003,"Axolotl ambient or axolotl cryo, 0.1 mg",09-10-2025
Q4216001003,"Artacent cord, per square centimeter",09-10-2025
Q4217001003,"Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound",09-10-2025
Q4217002004,"Xplus, per square centimeter",09-10-2025
Q4218001003,"Surgicord, per square centimeter",09-10-2025
Q4219001003,"Surgigraft-dual, per square centimeter",09-10-2025
Q4220001003,"Bellacell hd or surederm, per square centimeter",09-10-2025
Q4221001003,"Amniowrap2, per square centimeter",09-10-2025
Q4222001003,"Progenamatrix, per square centimeter",09-10-2025
Q4224001003,"Human health factor 10 amniotic patch (hhf10-p), per square centimeter",09-10-2025
Q4225001003,"Amniobind or dermabind tl, per square centimeter",09-10-2025
Q4226001003,"Myown skin, includes harvesting and preparation procedures, per square",09-10-2025
Q4226002004,Centimeter,09-10-2025
Q4227001003,"Amniocore, per square centimeter",09-10-2025
Q4228001003,"Bionextpatch, per square centimeter",09-10-2025
Q4229001003,"Cogenex amniotic membrane, per square centimeter",09-10-2025
Q4230001003,"Cogenex flowable amnion, per 0.5 cc",09-10-2025
Q4231001003,"Corplex p, per cc",09-10-2025
Q4232001003,"Corplex, per square centimeter",09-10-2025
Q4233001003,"Surfactor or nudyn, per 0.5 cc",09-10-2025
Q4234001003,"Xcellerate, per square centimeter",09-10-2025
Q4235001003,"Amniorepair or altiply, per square centimeter",09-10-2025
Q4236001003,"Carepatch, per square centimeter",09-10-2025
Q4237001003,"Cryo-cord, per square centimeter",09-10-2025
Q4238001003,"Derm-maxx, per square centimeter",09-10-2025
Q4239001003,"Amnio-maxx or amnio-maxx lite, per square centimeter",09-10-2025
Q4240001003,"Corecyte, for topical use only, per 0.5 cc",09-10-2025
Q4241001003,"Polycyte, for topical use only, per 0.5 cc",09-10-2025
Q4242001003,"Amniocyte plus, per 0.5 cc",09-10-2025
Q4244001003,"Procenta, per 200 mg",09-10-2025
Q4245001003,"Amniotext, per cc",09-10-2025
Q4246001003,"Coretext or protext, per cc",09-10-2025
Q4247001003,"Amniotext patch, per square centimeter",09-10-2025
Q4248001003,"Dermacyte amniotic membrane allograft, per square centimeter",09-10-2025
Q4249001003,"Amniply, for topical use only, per square centimeter",09-10-2025
Q4250001003,"Amnioamp-mp, per square centimeter",09-10-2025
Q4251001003,"Vim, per square centimeter",09-10-2025
Q4252001003,"Vendaje, per square centimeter",09-10-2025
Q4253001003,"Zenith amniotic membrane, per square centimeter",09-10-2025
Q4254001003,"Novafix dl, per square centimeter",09-10-2025
Q4255001003,"Reguard, for topical use only, per square centimeter",09-10-2025
Q4256001003,"Mlg-complete, per square centimeter",09-10-2025
Q4257001003,"Relese, per square centimeter",09-10-2025
Q4258001003,"Enverse, per square centimeter",09-10-2025
Q4259001003,"Celera dual layer or celera dual membrane, per square centimeter",09-10-2025
Q4260001003,"Signature apatch, per square centimeter",09-10-2025
Q4261001003,"Tag, per square centimeter",09-10-2025
Q4262001003,"Dual layer impax membrane, per square centimeter",09-10-2025
Q4263001003,"Surgraft tl, per square centimeter",09-10-2025
Q4264001003,"Cocoon membrane, per square centimeter",09-10-2025
Q4265001003,"Neostim tl, per square centimeter",09-10-2025
Q4266001003,"Neostim membrane, per square centimeter",09-10-2025
Q4267001003,"Neostim dl, per square centimeter",09-10-2025
Q4268001003,"Surgraft ft, per square centimeter",09-10-2025
Q4269001003,"Surgraft xt, per square centimeter",09-10-2025
Q4270001003,"Complete sl, per square centimeter",09-10-2025
Q4271001003,"Complete ft, per square centimeter",09-10-2025
Q4272001003,"Esano a, per square centimeter",09-10-2025
Q4273001003,"Esano aaa, per square centimeter",09-10-2025
Q4274001003,"Esano ac, per square centimeter",09-10-2025
Q4275001003,"Esano aca, per square centimeter",09-10-2025
Q4276001003,"Orion, per square centimeter",09-10-2025
Q4277001003,"Woundplus membrane or e-graft, per square centimeter",09-10-2025
Q4278001003,"Epieffect, per square centimeter",09-10-2025
Q4279001003,"Vendaje ac, per square centimeter",09-10-2025
Q4280001003,"Xcell amnio matrix, per square centimeter",09-10-2025
Q4281001003,"Barrera sl or barrera dl, per square centimeter",09-10-2025
Q4282001003,"Cygnus dual, per square centimeter",09-10-2025
Q4283001003,"Biovance tri-layer or biovance 3l, per square centimeter",09-10-2025
Q4284001003,"Dermabind sl, per square centimeter",09-10-2025
Q4285001003,"Nudyn dl or nudyn dl mesh, per square centimeter",09-10-2025
Q4286001003,"Nudyn sl or nudyn slw, per square centimeter",09-10-2025
Q4287001003,"Dermabind dl, per square centimeter",09-10-2025
Q4288001003,"Dermabind ch, per square centimeter",09-10-2025
Q4289001003,"Revoshield + amniotic barrier, per square centimeter",09-10-2025
Q4290001003,"Membrane wrap-hydro, per square centimeter",09-10-2025
Q4291001003,"Lamellas xt, per square centimeter",09-10-2025
Q4292001003,"Lamellas, per square centimeter",09-10-2025
Q4293001003,"Acesso dl, per square centimeter",09-10-2025
Q4294001003,"Amnio quad-core, per square centimeter",09-10-2025
Q4295001003,"Amnio tri-core amniotic, per square centimeter",09-10-2025
Q4296001003,"Rebound matrix, per square centimeter",09-10-2025
Q4297001003,"Emerge matrix, per square centimeter",09-10-2025
Q4298001003,"Amnicore pro, per square centimeter",09-10-2025
Q4299001003,"Amnicore pro+, per square centimeter",09-10-2025
Q4300001003,"Acesso tl, per square centimeter",09-10-2025
Q4301001003,"Activate matrix, per square centimeter",09-10-2025
Q4302001003,"Complete aca, per square centimeter",09-10-2025
Q4303001003,"Complete aa, per square centimeter",09-10-2025
Q4304001003,"Grafix plus, per square centimeter",09-10-2025
Q4305001003,"American amnion ac tri-layer, per square centimeter",09-10-2025
Q4306001003,"American amnion ac, per square centimeter",09-10-2025
Q4307001003,"American amnion, per square centimeter",09-10-2025
Q4308001003,"Sanopellis, per square centimeter",09-10-2025
Q4309001003,"Via matrix, per square centimeter",09-10-2025
Q4310001003,"Procenta, per 100 mg",09-10-2025
Q4311001003,"Acesso, per square centimeter",09-10-2025
Q4312001003,"Acesso ac, per square centimeter",09-10-2025
Q4313001003,"Dermabind fm, per square centimeter",09-10-2025
Q4314001003,"Reeva ft, per square cenitmeter",09-10-2025
Q4315001003,"Regenelink amniotic membrane allograft, per square centimeter",09-10-2025
Q4316001003,"Amchoplast, per square centimeter",09-10-2025
Q4317001003,"Vitograft, per square centimeter",09-10-2025
Q4318001003,"E-graft, per square centimeter",09-10-2025
Q4319001003,"Sanograft, per square centimeter",09-10-2025
Q4320001003,"Pellograft, per square centimeter",09-10-2025
Q4321001003,"Renograft, per square centimeter",09-10-2025
Q4322001003,"Caregraft, per square centimeter",09-10-2025
Q4323001003,"Alloply, per square centimeter",09-10-2025
Q4324001003,"Amniotx, per square centimeter",09-10-2025
Q4325001003,"Acapatch, per square centimeter",09-10-2025
Q4326001003,"Woundplus, per square centimeter",09-10-2025
Q4327001003,"Duoamnion, per square centimeter",09-10-2025
Q4328001003,"Most, per square centimeter",09-10-2025
Q4329001003,"Singlay, per square centimeter",09-10-2025
Q4330001003,"Total, per square centimeter",09-10-2025
Q4331001003,"Axolotl graft, per square centimeter",09-10-2025
Q4332001003,"Axolotl dualgraft, per square centimeter",09-10-2025
Q4333001003,"Ardeograft, per square centimeter",09-10-2025
Q4334001003,"Amnioplast 1, per square centimeter",09-10-2025
Q4335001003,"Amnioplast 2, per square centimeter",09-10-2025
Q4336001003,"Artacent c, per square centimeter",09-10-2025
Q4337001003,"Artacent trident, per square centimeter",09-10-2025
Q4338001003,"Artacent velos, per square centimeter",09-10-2025
Q4339001003,"Artacent vericlen, per square centimeter",09-10-2025
Q4340001003,"Simpligraft, per square centimeter",09-10-2025
Q4341001003,"Simplimax, per square centimeter",09-10-2025
Q4342001003,"Theramend, per square centimeter",09-10-2025
Q4343001003,"Dermacyte ac matrix amniotic membrane allograft, per square centimeter",09-10-2025
Q4344001003,"Tri-membrane wrap, per square centimeter",09-10-2025
Q4345001003,"Matrix hd allograft dermis, per square centimeter",09-10-2025
Q4346001003,"Shelter dm matrix, per square centimeter",09-10-2025
Q4347001003,"Rampart dl matrix, per square centimeter",09-10-2025
Q4348001003,"Sentry sl matrix, per square centimeter",09-10-2025
Q4349001003,"Mantle dl matrix, per square centimeter",09-10-2025
Q4350001003,"Palisade dm matrix, per square centimeter",09-10-2025
Q4351001003,"Enclose tl matrix, per square centimeter",09-10-2025
Q4352001003,"Overlay sl matrix, per square centimeter",09-10-2025
Q4353001003,"Xceed tl matrix, per square centimeter",09-10-2025
Q4354001003,"Palingen dual-layer membrane, per square centimeter",09-10-2025
Q4355001003,"Abiomend xplus membrane and abiomend xplus hydromembrane, per square centimeter",09-10-2025
Q4356001003,"Abiomend membrane and abiomend hydromembrane, per square centimeter",09-10-2025
Q4357001003,"Xwrap plus, per square centimeter",09-10-2025
Q4358001003,"Xwrap dual, per square centimeter",09-10-2025
Q4359001003,"Choriply, per square centimeter",09-10-2025
Q4360001003,"Amchoplast fd, per square centimeter",09-10-2025
Q4361001003,"Epixpress, per square centimeter",09-10-2025
Q4362001003,"Cygnus disk, per square centimeter",09-10-2025
Q4363001003,"Amnio burgeon membrane and hydromembrane, per square centimeter",09-10-2025
Q4364001003,"Amnio burgeon xplus membrane and xplus hydromembrane, per square centimeter",09-10-2025
Q4365001003,"Amnio burgeon dual-layer membrane, per square centimeter",09-10-2025
Q4366001003,"Dual layer amnio burgeon x-membrane, per square centimeter",09-10-2025
Q4367001003,"Amniocore sl, per square centimeter",09-10-2025
Q4368001003,"Amchothick, per square centimeter",09-10-2025
Q4369001003,"Amnioplast 3, per square centimeter",09-10-2025
Q4370001003,"Aeroguard, per square centimeter",09-10-2025
Q4371001003,"Neoguard, per square centimeter",09-10-2025
Q4372001003,"Amchoplast excel, per square centimeter",09-10-2025
Q4373001003,"Membrane wrap lite, per square centimeter",09-10-2025
Q4375001003,"Duograft ac, per square centimeter",09-10-2025
Q4376001003,"Duograft aa, per square centimeter",09-10-2025
Q4377001003,"Trigraft ft, per square centimeter",09-10-2025
Q4378001003,"Renew ft matrix, per square centimeter",09-10-2025
Q4379001003,"Amniodefend ft matrix, per square centimeter",09-10-2025
Q4380001003,"Advograft one, per square centimeter",09-10-2025
Q4382001003,"Advograft dual, per square centimeter",09-10-2025
Q4383001003,"Axolotl graft ultra, per square centimeter",09-10-2025
Q4384001003,"Axolotl dualgraft ultra, per square centimeter",09-10-2025
Q4385001003,"Apollo ft, per square centimeter",09-10-2025
Q4386001003,"Acesso trifaca, per square centimeter",09-10-2025
Q4387001003,"Neothelium ft, per square centimeter",09-10-2025
Q4388001003,"Neothelium 4l, per square centimeter",09-10-2025
Q4389001003,"Neothelium 4l+, per square centimeter",09-10-2025
Q4390001003,"Ascendion, per square centimeter",09-10-2025
Q4391001003,"Amnioplast double, per square centimeter",09-10-2025
Q4392001003,"Grafix duo, per square centimeter",09-10-2025
Q4393001003,"Surgraft ac, per square centimeter",09-10-2025
Q4394001003,"Surgraft aca, per square centimeter",09-10-2025
Q4395001003,"Acelagraft, per square centimeter",09-10-2025
Q4396001003,"Natalin, per square centimeter",09-10-2025
Q4397001003,"Summit aaa, per square centimeter",09-10-2025
Q5001001003,Hospice or home health care provided in patient's home/residence,09-10-2025
Q5002001003,Hospice or home health care provided in assisted living facility,09-10-2025
Q5003001003,Hospice care provided in nursing long term care facility (ltc) or non-skilled,09-10-2025
Q5003002004,Nursing facility (nf),09-10-2025
Q5004001003,Hospice care provided in skilled nursing facility (snf),09-10-2025
Q5005001003,Hospice care provided in inpatient hospital,09-10-2025
Q5006001003,Hospice care provided in inpatient hospice facility,09-10-2025
Q5007001003,Hospice care provided in long term care facility,09-10-2025
Q5008001003,Hospice care provided in inpatient psychiatric facility,09-10-2025
Q5009001003,Hospice or home health care provided in place not otherwise specified (nos),09-10-2025
Q5010001003,Hospice home care provided in a hospice facility,09-10-2025
Q5098001003,"Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg",09-10-2025
Q5099001003,"Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg",09-10-2025
Q5100001003,"Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg",09-10-2025
Q5101001003,"Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram",09-10-2025
Q5102001003,"Injection, infliximab, biosimilar, 10 mg",09-10-2025
Q5103001003,"Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg",09-10-2025
Q5104001003,"Injection, infliximab-abda, biosimilar, (renflexis), 10 mg",09-10-2025
Q5105001003,"Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis),",09-10-2025
Q5105002004,100 units,09-10-2025
Q5106001003,"Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000",09-10-2025
Q5106002004,Units,09-10-2025
Q5107001003,"Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg",09-10-2025
Q5108001003,"Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg",09-10-2025
Q5109001003,"Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg",09-10-2025
Q5110001003,"Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram",09-10-2025
Q5111001003,"Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg",09-10-2025
Q5112001003,"Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg",09-10-2025
Q5113001003,"Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg",09-10-2025
Q5114001003,"Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg",09-10-2025
Q5115001003,"Injection, rituximab-abbs, biosimilar, (truxima), 10 mg",09-10-2025
Q5116001003,"Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg",09-10-2025
Q5117001003,"Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg",09-10-2025
Q5118001003,"Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg",09-10-2025
Q5119001003,"Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg",09-10-2025
Q5120001003,"Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg",09-10-2025
Q5121001003,"Injection, infliximab-axxq, biosimilar, (avsola), 10 mg",09-10-2025
Q5122001003,"Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg",09-10-2025
Q5123001003,"Injection, rituximab-arrx, biosimilar, (riabni), 10 mg",09-10-2025
Q5124001003,"Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg",09-10-2025
Q5125001003,"Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram",09-10-2025
Q5126001003,"Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg",09-10-2025
Q5127001003,"Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg",09-10-2025
Q5128001003,"Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg",09-10-2025
Q5129001003,"Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg",09-10-2025
Q5130001003,"Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg",09-10-2025
Q5131001003,"Injection, adalimumab-aacf (idacio), biosimilar, 20 mg",09-10-2025
Q5132001003,"Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg",09-10-2025
Q5133001003,"Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg",09-10-2025
Q5134001003,"Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg",09-10-2025
Q5135001003,"Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg",09-10-2025
Q5136001003,"Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg",09-10-2025
Q5137001003,"Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg",09-10-2025
Q5138001003,"Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg",09-10-2025
Q5139001003,"Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg",09-10-2025
Q5140001003,"Injection, adalimumab-fkjp, biosimilar, 1 mg",09-10-2025
Q5141001003,"Injection, adalimumab-aaty, biosimilar, 1 mg",09-10-2025
Q5142001003,"Injection, adalimumab-ryvk biosimilar, 1 mg",09-10-2025
Q5143001003,"Injection, adalimumab-adbm, biosimilar, 1 mg",09-10-2025
Q5144001003,"Injection, adalimumab-aacf (idacio), biosimilar, 1 mg",09-10-2025
Q5145001003,"Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg",09-10-2025
Q5146001003,"Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg",09-10-2025
Q5147001003,"Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg",09-10-2025
Q5148001003,"Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram",09-10-2025
Q5149001003,"Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg",09-10-2025
Q5150001003,"Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg",09-10-2025
Q5151001003,"Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg",09-10-2025
Q5152001003,"Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg",09-10-2025
Q5153001003,"Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg",09-10-2025
Q5154001003,"Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg",09-10-2025
Q5155001003,"Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg",09-10-2025
Q5156001003,"Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg",09-10-2025
Q5157001003,"Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg",09-10-2025
Q5158001003,"Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg",09-10-2025
Q5159001003,"Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg",09-10-2025
Q9001001003,Assessment by chaplain services,09-10-2025
Q9002001003,"Counseling, individual, by chaplain services",09-10-2025
Q9003001003,"Counseling, group, by chaplain services",09-10-2025
Q9004001003,Department of veterans affairs whole health partner services,09-10-2025
Q9950001003,"Injection, sulfur hexafluoride lipid microspheres, per ml",09-10-2025
Q9951001003,"Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per m",09-10-2025
Q9953001003,"Injection, iron-based magnetic resonance contrast agent, per ml",09-10-2025
Q9954001003,"Oral magnetic resonance contrast agent, per 100 ml",09-10-2025
Q9955001003,"Injection, perflexane lipid microspheres, per ml",09-10-2025
Q9956001003,"Injection, octafluoropropane microspheres, per ml",09-10-2025
Q9957001003,"Injection, perflutren lipid microspheres, per ml",09-10-2025
Q9958001003,"High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml",09-10-2025
Q9959001003,"High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml",09-10-2025
Q9960001003,"High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml",09-10-2025
Q9961001003,"High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml",09-10-2025
Q9962001003,"High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml",09-10-2025
Q9963001003,"High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml",09-10-2025
Q9964001003,"High osmolar contrast material, 400 or greater mg/ml iodine concentration, per",09-10-2025
Q9964002004,Ml,09-10-2025
Q9965001003,"Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml",09-10-2025
Q9966001003,"Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml",09-10-2025
Q9967001003,"Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml",09-10-2025
Q9968001003,"Injection, non-radioactive, non-contrast, visualization adjunct (e.g.,",09-10-2025
Q9968002004,"Methylene blue, isosulfan blue), 1 mg",09-10-2025
Q9969001003,"Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per",09-10-2025
Q9969002004,Study dose,09-10-2025
Q9970001003,"Injection, ferric carboxymaltose, 1mg",09-10-2025
Q9972001003,"Injection, epoetin beta, 1 microgram, (for esrd on dialysis)",09-10-2025
Q9973001003,"Injection, epoetin beta, 1 microgram, (non-esrd use)",09-10-2025
Q9974001003,"Injection, morphine sulfate, preservative-free for epidural or intrathecal use,",09-10-2025
Q9974002004,10 mg,09-10-2025
Q9975001003,"Injection, factor viii fc fusion protein (recombinant), per iu",09-10-2025
Q9976001003,"Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron",09-10-2025
Q9977001003,"Compounded drug, not otherwise classified",09-10-2025
Q9978001003,Netupitant 300 mg and palonosetron 0.5 mg,09-10-2025
Q9979001003,"Injection, alemtuzumab, 1 mg",09-10-2025
Q9980001003,"Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg",09-10-2025
Q9981001003,"Rolapitant, oral, 1 mg",09-10-2025
Q9982001003,"Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries",09-10-2025
Q9983001003,"Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries",09-10-2025
Q9984001003,"Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg",09-10-2025
Q9985001003,"Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg",09-10-2025
Q9986001003,"Injection, hydroxyprogesterone caproate, (makena), 10 mg",09-10-2025
Q9987001003,Pathogen(s) test for platelets,09-10-2025
Q9988001003,"Platelets, pheresis, pathogen-reduced, each unit",09-10-2025
Q9989001003,"Ustekinumab, for intravenous injection, 1 mg",09-10-2025
Q9991001003,"Injection, buprenorphine extended-release (sublocade), less than or equal to",09-10-2025
Q9991002004,100 mg,09-10-2025
Q9992001003,"Injection, buprenorphine extended-release (sublocade), greater than 100 mg",09-10-2025
Q9993001003,"Injection, triamcinolone acetonide, preservative-free, extended-release,",09-10-2025
Q9993002004,"Microsphere formulation, 1 mg",09-10-2025
Q9994001003,"In-line cartridge containing digestive enzyme(s) for enteral feeding, each",09-10-2025
Q9995001003,"Injection, emicizumab-kxwh, 0.5 mg",09-10-2025
Q9996001003,"Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg",09-10-2025
Q9997001003,"Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg",09-10-2025
Q9998001003,"Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg",09-10-2025
Q9999001003,"Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg",09-10-2025
R0070001003,Transportation of portable x-ray equipment and personnel to home or nursing,09-10-2025
R0070002004,"Home, per trip to facility or location, one patient seen",09-10-2025
R0075001003,Transportation of portable x-ray equipment and personnel to home or nursing,09-10-2025
R0075002004,"Home, per trip to facility or location, more than one patient seen",09-10-2025
R0076001003,"Transportation of portable ekg to facility or location, per patient",09-10-2025
S0012001003,"Butorphanol tartrate, nasal spray, 25 mg",09-10-2025
S0013001003,"Esketamine, nasal spray, 1 mg",09-10-2025
S0014001003,"Tacrine hydrochloride, 10 mg",09-10-2025
S0017001003,"Injection, aminocaproic acid, 5 grams",09-10-2025
S0020001003,"Injection, bupivicaine hydrochloride, 30 ml",09-10-2025
S0021001003,"Injection, cefoperazone sodium, 1 gram",09-10-2025
S0023001003,"Injection, cimetidine hydrochloride, 300 mg",09-10-2025
S0028001003,"Injection, famotidine, 20 mg",09-10-2025
S0030001003,"Injection, metronidazole, 500 mg",09-10-2025
S0032001003,"Injection, nafcillin sodium, 2 grams",09-10-2025
S0034001003,"Injection, ofloxacin, 400 mg",09-10-2025
S0039001003,"Injection, sulfamethoxazole and trimethoprim, 10 ml",09-10-2025
S0040001003,"Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams",09-10-2025
S0073001003,"Injection, aztreonam, 500 mg",09-10-2025
S0074001003,"Injection, cefotetan disodium, 500 mg",09-10-2025
S0077001003,"Injection, clindamycin phosphate, 300 mg",09-10-2025
S0078001003,"Injection, fosphenytoin sodium, 750 mg",09-10-2025
S0080001003,"Injection, pentamidine isethionate, 300 mg",09-10-2025
S0081001003,"Injection, piperacillin sodium, 500 mg",09-10-2025
S0088001003,"Imatinib, 100 mg",09-10-2025
S0090001003,"Sildenafil citrate, 25 mg",09-10-2025
S0091001003,"Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare",09-10-2025
S0091002004,"Statute, use q0166)",09-10-2025
S0092001003,"Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)",09-10-2025
S0093001003,"Injection, morphine sulfate, 500 mg (loading dose for infusion pump)",09-10-2025
S0104001003,"Zidovudine, oral, 100 mg",09-10-2025
S0106001003,"Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets",09-10-2025
S0108001003,"Mercaptopurine, oral, 50 mg",09-10-2025
S0109001003,"Methadone, oral, 5 mg",09-10-2025
S0117001003,"Tretinoin, topical, 5 grams",09-10-2025
S0119001003,"Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute,",09-10-2025
S0119002004,Use hcpcs q code),09-10-2025
S0122001003,"Injection, menotropins, 75 iu",09-10-2025
S0126001003,"Injection, follitropin alfa, 75 iu",09-10-2025
S0128001003,"Injection, follitropin beta, 75 iu",09-10-2025
S0132001003,"Injection, ganirelix acetate, 250 mcg",09-10-2025
S0136001003,"Clozapine, 25 mg",09-10-2025
S0137001003,"Didanosine (ddi), 25 mg",09-10-2025
S0138001003,"Finasteride, 5 mg",09-10-2025
S0139001003,"Minoxidil, 10 mg",09-10-2025
S0140001003,"Saquinavir, 200 mg",09-10-2025
S0142001003,"Colistimethate sodium, inhalation solution administered through dme,",09-10-2025
S0142002004,"Concentrated form, per mg",09-10-2025
S0144001003,"Injection, propofol, 10 mg",09-10-2025
S0145001003,"Injection, pegylated interferon alfa-2a, 180 mcg per ml",09-10-2025
S0148001003,"Injection, pegylated interferon alfa-2b, 10 mcg",09-10-2025
S0155001003,"Sterile dilutant for epoprostenol, 50 ml",09-10-2025
S0156001003,"Exemestane, 25 mg",09-10-2025
S0157001003,"Becaplermin gel 0.01%, 0.5 gm",09-10-2025
S0160001003,"Dextroamphetamine sulfate, 5 mg",09-10-2025
S0164001003,"Injection, pantoprazole sodium, 40 mg",09-10-2025
S0166001003,"Injection, olanzapine, 2.5 mg",09-10-2025
S0169001003,"Calcitrol, 0.25 microgram",09-10-2025
S0170001003,"Anastrozole, oral, 1 mg",09-10-2025
S0171001003,"Injection, bumetanide, 0.5 mg",09-10-2025
S0172001003,"Chlorambucil, oral, 2 mg",09-10-2025
S0174001003,"Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare",09-10-2025
S0174002004,"Statute, use q0180)",09-10-2025
S0175001003,"Flutamide, oral, 125 mg",09-10-2025
S0176001003,"Hydroxyurea, oral, 500 mg",09-10-2025
S0177001003,"Levamisole hydrochloride, oral, 50 mg",09-10-2025
S0178001003,"Lomustine, oral, 10 mg",09-10-2025
S0179001003,"Megestrol acetate, oral, 20 mg",09-10-2025
S0182001003,"Procarbazine hydrochloride, oral, 50 mg",09-10-2025
S0183001003,"Prochlorperazine maleate, oral, 5 mg (for circumstances falling under the",09-10-2025
S0183002004,"Medicare statute, use q0164)",09-10-2025
S0187001003,"Tamoxifen citrate, oral, 10 mg",09-10-2025
S0189001003,"Testosterone pellet, 75 mg",09-10-2025
S0190001003,"Mifepristone, oral, 200 mg",09-10-2025
S0191001003,"Misoprostol, oral, 200 mcg",09-10-2025
S0194001003,"Dialysis/stress vitamin supplement, oral, 100 capsules",09-10-2025
S0195001003,"Pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from",09-10-2025
S0195002004,Five years to nine years of age who have not previously received the vaccine,09-10-2025
S0197001003,"Prenatal vitamins, 30-day supply",09-10-2025
S0199001003,Medically induced abortion by oral ingestion of medication including all,09-10-2025
S0199002004,"Associated services and supplies (e.g., patient counseling, office visits,",09-10-2025
S0199003004,"Confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy,",09-10-2025
S0199004004,Ultrasound to confirm completion of abortion) except drugs,09-10-2025
S0201001003,"Partial hospitalization services, less than 24 hours, per diem",09-10-2025
S0207001003,"Paramedic intercept, non-hospital-based als service (non-voluntary),",09-10-2025
S0207002004,Non-transport,09-10-2025
S0208001003,"Paramedic intercept, hospital-based als service (non-voluntary), non-transport",09-10-2025
S0209001003,"Wheelchair van, mileage, per mile",09-10-2025
S0215001003,"Non-emergency transportation; mileage, per mile",09-10-2025
S0220001003,Medical conference by a physician with interdisciplinary team of health,09-10-2025
S0220002004,Professionals or representatives of community agencies to coordinate activities,09-10-2025
S0220003004,Of patient care (patient is present); approximately 30 minutes,09-10-2025
S0221001003,Medical conference by a physician with interdisciplinary team of health,09-10-2025
S0221002004,Professionals or representatives of community agencies to coordinate activities,09-10-2025
S0221003004,Of patient care (patient is present); approximately 60 minutes,09-10-2025
S0250001003,Comprehensive geriatric assessment and treatment planning performed by,09-10-2025
S0250002004,Assessment team,09-10-2025
S0255001003,Hospice referral visit (advising patient and family of care options) performed,09-10-2025
S0255002004,"By nurse, social worker, or other designated staff",09-10-2025
S0257001003,Counseling and discussion regarding advance directives or end of life care,09-10-2025
S0257002004,"Planning and decisions, with patient and/or surrogate (list separately in",09-10-2025
S0257003004,Addition to code for appropriate evaluation and management service),09-10-2025
S0260001003,History and physical (outpatient or office) related to surgical procedure (list,09-10-2025
S0260002004,Separately in addition to code for appropriate evaluation and management,09-10-2025
S0260003004,Service),09-10-2025
S0265001003,"Genetic counseling, under physician supervision, each 15 minutes",09-10-2025
S0270001003,"Physician management of patient home care, standard monthly case rate (per 30",09-10-2025
S0270002004,Days),09-10-2025
S0271001003,"Physician management of patient home care, hospice monthly case rate (per 30",09-10-2025
S0271002004,Days),09-10-2025
S0272001003,"Physician management of patient home care, episodic care monthly case rate (per",09-10-2025
S0272002004,30 days),09-10-2025
S0273001003,"Physician visit at member's home, outside of a capitation arrangement",09-10-2025
S0274001003,"Nurse practitioner visit at member's home, outside of a capitation arrangement",09-10-2025
S0280001003,"Medical home program, comprehensive care coordination and planning, initial pla",09-10-2025
S0281001003,"Medical home program, comprehensive care coordination and planning, maintenance",09-10-2025
S0281002004,Of plan,09-10-2025
S0285001003,Colonoscopy consultation performed prior to a screening colonoscopy procedure,09-10-2025
S0302001003,Completed early periodic screening diagnosis and treatment (epsdt) service,09-10-2025
S0302002004,(list in addition to code for appropriate evaluation and management service),09-10-2025
S0310001003,Hospitalist services (list separately in addition to code for appropriate,09-10-2025
S0310002004,Evaluation and management service),09-10-2025
S0311001003,"Comprehensive management and care coordination for advanced illness, per",09-10-2025
S0311002004,Calendar month,09-10-2025
S0315001003,Disease management program; initial assessment and initiation of the program,09-10-2025
S0316001003,"Disease management program, follow-up/reassessment",09-10-2025
S0317001003,Disease management program; per diem,09-10-2025
S0320001003,Telephone calls by a registered nurse to a disease management program member,09-10-2025
S0320002004,For monitoring purposes; per month,09-10-2025
S0340001003,"Lifestyle modification program for management of coronary artery disease,",09-10-2025
S0340002004,Including all supportive services; first quarter / stage,09-10-2025
S0341001003,"Lifestyle modification program for management of coronary artery disease,",09-10-2025
S0341002004,Including all supportive services; second or third quarter / stage,09-10-2025
S0342001003,"Lifestyle modification program for management of coronary artery disease,",09-10-2025
S0342002004,Including all supportive services; fourth quarter / stage,09-10-2025
S0353001003,"Treatment planning and care coordination management for cancer, initial",09-10-2025
S0353002004,Treatment,09-10-2025
S0354001003,"Treatment planning and care coordination management for cancer, established",09-10-2025
S0354002004,Patient with a change of regimen,09-10-2025
S0390001003,"Routine foot care; removal and/or trimming of corns, calluses and/or nails and",09-10-2025
S0390002004,"Preventive maintenance in specific medical conditions (e.g., diabetes), per",09-10-2025
S0390003004,Visit,09-10-2025
S0395001003,Impression casting of a foot performed by a practitioner other than the,09-10-2025
S0395002004,Manufacturer of the orthotic,09-10-2025
S0400001003,Global fee for extracorporeal shock wave lithotripsy treatment of kidney,09-10-2025
S0400002004,Stone(s),09-10-2025
S0500001003,"Disposable contact lens, per lens",09-10-2025
S0504001003,"Single vision prescription lens (safety, athletic, or sunglass), per lens",09-10-2025
S0506001003,"Bifocal vision prescription lens (safety, athletic, or sunglass), per lens",09-10-2025
S0508001003,"Trifocal vision prescription lens (safety, athletic, or sunglass), per lens",09-10-2025
S0510001003,"Non-prescription lens (safety, athletic, or sunglass), per lens",09-10-2025
S0512001003,"Daily wear specialty contact lens, per lens",09-10-2025
S0514001003,"Color contact lens, per lens",09-10-2025
S0515001003,"Scleral lens, liquid bandage device, per lens",09-10-2025
S0516001003,Safety eyeglass frames,09-10-2025
S0518001003,Sunglasses frames,09-10-2025
S0580001003,Polycarbonate lens (list this code in addition to the basic code for the lens),09-10-2025
S0581001003,Nonstandard lens (list this code in addition to the basic code for the lens),09-10-2025
S0590001003,"Integral lens service, miscellaneous services reported separately",09-10-2025
S0592001003,Comprehensive contact lens evaluation,09-10-2025
S0595001003,Dispensing new spectacle lenses for patient supplied frame,09-10-2025
S0596001003,Phakic intraocular lens for correction of refractive error,09-10-2025
S0601001003,Screening proctoscopy,09-10-2025
S0610001003,"Annual gynecological examination, new patient",09-10-2025
S0612001003,"Annual gynecological examination, established patient",09-10-2025
S0613001003,Annual gynecological examination; clinical breast examination without pelvic,09-10-2025
S0613002004,Evaluation,09-10-2025
S0618001003,Audiometry for hearing aid evaluation to determine the level and degree of,09-10-2025
S0618002004,Hearing loss,09-10-2025
S0620001003,Routine ophthalmological examination including refraction; new patient,09-10-2025
S0621001003,Routine ophthalmological examination including refraction; established patient,09-10-2025
S0622001003,"Physical exam for college, new or established patient (list separately in",09-10-2025
S0622002004,Addition to appropriate evaluation and management code),09-10-2025
S0630001003,Removal of sutures; by a physician other than the physician who originally,09-10-2025
S0630002004,Closed the wound,09-10-2025
S0800001003,Laser in situ keratomileusis (lasik),09-10-2025
S0810001003,Photorefractive keratectomy (prk),09-10-2025
S0812001003,Phototherapeutic keratectomy (ptk),09-10-2025
S1001001003,"Deluxe item, patient aware (list in addition to code for basic item)",09-10-2025
S1002001003,Customized item (list in addition to code for basic item),09-10-2025
S1015001003,Iv tubing extension set,09-10-2025
S1016001003,"Non-pvc (polyvinyl chloride) intravenous administration set, for use with drugs",09-10-2025
S1016002004,"That are not stable in pvc e.g., paclitaxel",09-10-2025
S1030001003,"Continuous noninvasive glucose monitoring device, purchase (for physician",09-10-2025
S1030002004,"Interpretation of data, use cpt code)",09-10-2025
S1031001003,"Continuous noninvasive glucose monitoring device, rental, including sensor,",09-10-2025
S1031002004,"Sensor replacement, and download to monitor (for physician interpretation of",09-10-2025
S1031003004,"Data, use cpt code)",09-10-2025
S1034001003,"Artificial pancreas device system (e.g., low glucose suspend (lgs) feature)",09-10-2025
S1034002004,"Including continuous glucose monitor, blood glucose device, insulin pump and",09-10-2025
S1034003004,Computer algorithm that communicates with all of the devices,09-10-2025
S1035001003,"Sensor; invasive (e.g., subcutaneous), disposable, for use with artificial",09-10-2025
S1035002004,Pancreas device system,09-10-2025
S1036001003,"Transmitter; external, for use with artificial pancreas device system",09-10-2025
S1037001003,"Receiver (monitor); external, for use with artificial pancreas device system",09-10-2025
S1040001003,"Cranial remolding orthosis, pediatric, rigid, with soft interface material,",09-10-2025
S1040002004,"Custom fabricated, includes fitting and adjustment(s)",09-10-2025
S1090001003,"Mometasone furoate sinus implant, 370 micrograms",09-10-2025
S1091001003,"Stent, non-coronary, temporary, with delivery system (propel)",09-10-2025
S2053001003,Transplantation of small intestine and liver allografts,09-10-2025
S2054001003,Transplantation of multivisceral organs,09-10-2025
S2055001003,"Harvesting of donor multivisceral organs, with preparation and maintenance of",09-10-2025
S2055002004,Allografts; from cadaver donor,09-10-2025
S2060001003,Lobar lung transplantation,09-10-2025
S2061001003,"Donor lobectomy (lung) for transplantation, living donor",09-10-2025
S2065001003,Simultaneous pancreas kidney transplantation,09-10-2025
S2066001003,"Breast reconstruction with gluteal artery perforator (gap) flap, including",09-10-2025
S2066002004,"Harvesting of the flap, microvascular transfer, closure of donor site and",09-10-2025
S2066003004,"Shaping the flap into a breast, unilateral",09-10-2025
S2067001003,"Breast reconstruction of a single breast with ""stacked"" deep inferior",09-10-2025
S2067002004,Epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap),09-10-2025
S2067003004,"Flap(s), including harvesting of the flap(s), microvascular transfer, closure",09-10-2025
S2067004004,"Of donor site(s) and shaping the flap into a breast, unilateral",09-10-2025
S2068001003,Breast reconstruction with deep inferior epigastric perforator (diep) flap or,09-10-2025
S2068002004,"Superficial inferior epigastric artery (siea) flap, including harvesting of the",09-10-2025
S2068003004,"Flap, microvascular transfer, closure of donor site and shaping the flap into a",09-10-2025
S2068004004,"Breast, unilateral",09-10-2025
S2070001003,"Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with endoscopic laser",09-10-2025
S2070002004,Treatment of ureteral calculi (includes ureteral catheterization),09-10-2025
S2079001003,Laparoscopic esophagomyotomy (heller type),09-10-2025
S2080001003,Laser-assisted uvulopalatoplasty (laup),09-10-2025
S2083001003,Adjustment of gastric band diameter via subcutaneous port by injection or,09-10-2025
S2083002004,Aspiration of saline,09-10-2025
S2095001003,"Transcatheter occlusion or embolization for tumor destruction, percutaneous,",09-10-2025
S2095002004,"Any method, using yttrium-90 microspheres",09-10-2025
S2102001003,Islet cell tissue transplant from pancreas; allogeneic,09-10-2025
S2103001003,Adrenal tissue transplant to brain,09-10-2025
S2107001003,Adoptive immunotherapy i.e. development of specific anti-tumor reactivity,09-10-2025
S2107002004,"(e.g., tumor-infiltrating lymphocyte therapy) per course of treatment",09-10-2025
S2112001003,"Arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)",09-10-2025
S2115001003,"Osteotomy, periacetabular, with internal fixation",09-10-2025
S2117001003,"Arthroereisis, subtalar",09-10-2025
S2118001003,"Metal-on-metal total hip resurfacing, including acetabular and femoral",09-10-2025
S2118002004,Components,09-10-2025
S2120001003,Low density lipoprotein (ldl) apheresis using heparin-induced extracorporeal,09-10-2025
S2120002004,Ldl precipitation,09-10-2025
S2140001003,"Cord blood harvesting for transplantation, allogeneic",09-10-2025
S2142001003,"Cord blood-derived stem-cell transplantation, allogeneic",09-10-2025
S2150001003,"Bone marrow or blood-derived stem cells (peripheral or umbilical), allogeneic",09-10-2025
S2150002004,"Or autologous, harvesting, transplantation, and related complications;",09-10-2025
S2150003004,Including: pheresis and cell preparation/storage; marrow ablative therapy;,09-10-2025
S2150004004,"Drugs, supplies, hospitalization with outpatient follow-up; medical/surgical,",09-10-2025
S2150005004,"Diagnostic, emergency, and rehabilitative services; and the number of days of",09-10-2025
S2150006004,Pre-and post-transplant care in the global definition,09-10-2025
S2152001003,"Solid organ(s), complete or segmental, single organ or combination of organs;",09-10-2025
S2152002004,"Deceased or living donor(s), procurement, transplantation, and related",09-10-2025
S2152003004,Complications; including: drugs; supplies; hospitalization with outpatient,09-10-2025
S2152004004,"Follow-up; medical/surgical, diagnostic, emergency, and rehabilitative",09-10-2025
S2152005004,"Services, and the number of days of pre- and post-transplant care in the global",09-10-2025
S2152006004,Definition,09-10-2025
S2202001003,Echosclerotherapy,09-10-2025
S2205001003,Minimally invasive direct coronary artery bypass surgery involving,09-10-2025
S2205002004,"Mini-thoracotomy or mini-sternotomy surgery, performed under direct vision;",09-10-2025
S2205003004,"Using arterial graft(s), single coronary arterial graft",09-10-2025
S2206001003,Minimally invasive direct coronary artery bypass surgery involving,09-10-2025
S2206002004,"Mini-thoracotomy or mini-sternotomy surgery, performed under direct vision;",09-10-2025
S2206003004,"Using arterial graft(s), two coronary arterial grafts",09-10-2025
S2207001003,Minimally invasive direct coronary artery bypass surgery involving,09-10-2025
S2207002004,"Mini-thoracotomy or mini-sternotomy surgery, performed under direct vision;",09-10-2025
S2207003004,"Using venous graft only, single coronary venous graft",09-10-2025
S2208001003,Minimally invasive direct coronary artery bypass surgery involving,09-10-2025
S2208002004,"Mini-thoracotomy or mini-sternotomy surgery, performed under direct vision;",09-10-2025
S2208003004,"Using single arterial and venous graft(s), single venous graft",09-10-2025
S2209001003,Minimally invasive direct coronary artery bypass surgery involving,09-10-2025
S2209002004,"Mini-thoracotomy or mini-sternotomy surgery, performed under direct vision;",09-10-2025
S2209003004,Using two arterial grafts and single venous graft,09-10-2025
S2225001003,"Myringotomy, laser-assisted",09-10-2025
S2230001003,Implantation of magnetic component of semi-implantable hearing device on,09-10-2025
S2230002004,Ossicles in middle ear,09-10-2025
S2235001003,Implantation of auditory brain stem implant,09-10-2025
S2260001003,"Induced abortion, 17 to 24 weeks",09-10-2025
S2265001003,"Induced abortion, 25 to 28 weeks",09-10-2025
S2266001003,"Induced abortion, 29 to 31 weeks",09-10-2025
S2267001003,"Induced abortion, 32 weeks or greater",09-10-2025
S2300001003,"Arthroscopy, shoulder, surgical; with thermally-induced capsulorrhaphy",09-10-2025
S2325001003,Hip core decompression,09-10-2025
S2340001003,Chemodenervation of abductor muscle(s) of vocal cord,09-10-2025
S2341001003,Chemodenervation of adductor muscle(s) of vocal cord,09-10-2025
S2342001003,Nasal endoscopy for post-operative debridement following functional endoscopic,09-10-2025
S2342002004,"Sinus surgery, nasal and/or sinus cavity(s), unilateral or bilateral",09-10-2025
S2348001003,"Decompression procedure, percutaneous, of nucleus pulposus of intervertebral",09-10-2025
S2348002004,"Disc, using radiofrequency energy, single or multiple levels, lumbar",09-10-2025
S2350001003,"Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s),",09-10-2025
S2350002004,"Including osteophytectomy; lumbar, single interspace",09-10-2025
S2351001003,"Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s),",09-10-2025
S2351002004,"Including osteophytectomy; lumbar, each additional interspace (list separately",09-10-2025
S2351003004,In addition to code for primary procedure),09-10-2025
S2360001003,"Percutaneous vertebroplasty, one vertebral body, unilateral or bilateral",09-10-2025
S2360002004,Injection; cervical,09-10-2025
S2361001003,Each additional cervical vertebral body (list separately in addition to code,09-10-2025
S2361002004,For primary procedure),09-10-2025
S2400001003,"Repair, congenital diaphragmatic hernia in the fetus using temporary tracheal",09-10-2025
S2400002004,"Occlusion, procedure performed in utero",09-10-2025
S2401001003,"Repair, urinary tract obstruction in the fetus, procedure performed in utero",09-10-2025
S2402001003,"Repair, congenital cystic adenomatoid malformation in the fetus, procedure",09-10-2025
S2402002004,Performed in utero,09-10-2025
S2403001003,"Repair, extralobar pulmonary sequestration in the fetus, procedure performed in",09-10-2025
S2403002004,Utero,09-10-2025
S2404001003,"Repair, myelomeningocele in the fetus, procedure performed in utero",09-10-2025
S2405001003,"Repair of sacrococcygeal teratoma in the fetus, procedure performed in utero",09-10-2025
S2409001003,"Repair, congenital malformation of fetus, procedure performed in utero, not",09-10-2025
S2409002004,Otherwise classified,09-10-2025
S2411001003,Fetoscopic laser therapy for treatment of twin-to-twin transfusion syndrome,09-10-2025
S2900001003,Surgical techniques requiring use of robotic surgical system (list separately,09-10-2025
S2900002004,In addition to code for primary procedure),09-10-2025
S3000001003,"Diabetic indicator; retinal eye exam, dilated, bilateral",09-10-2025
S3005001003,"Performance measurement, evaluation of patient self assessment, depression",09-10-2025
S3600001003,Stat laboratory request (situations other than s3601),09-10-2025
S3601001003,Emergency stat laboratory charge for patient who is homebound or residing in a,09-10-2025
S3601002004,Nursing facility,09-10-2025
S3620001003,"Newborn metabolic screening panel, includes test kit, postage and the",09-10-2025
S3620002004,"Laboratory tests specified by the state for inclusion in this panel (e.g.,",09-10-2025
S3620003004,"Galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d;",09-10-2025
S3620004004,"Phenylalanine (pku); and thyroxine, total)",09-10-2025
S3630001003,"Eosinophil count, blood, direct",09-10-2025
S3645001003,Hiv-1 antibody testing of oral mucosal transudate,09-10-2025
S3650001003,"Saliva test, hormone level; during menopause",09-10-2025
S3652001003,"Saliva test, hormone level; to assess preterm labor risk",09-10-2025
S3655001003,Antisperm antibodies test (immunobead),09-10-2025
S3708001003,Gastrointestinal fat absorption study,09-10-2025
S3721001003,Prostate cancer antigen 3 (pca3) testing,09-10-2025
S3722001003,"Dose optimization by area under the curve (auc) analysis, for infusional",09-10-2025
S3722002004,5-fluorouracil,09-10-2025
S3800001003,Genetic testing for amyotrophic lateral sclerosis (als),09-10-2025
S3840001003,Dna analysis for germline mutations of the ret proto-oncogene for,09-10-2025
S3840002004,Susceptibility to multiple endocrine neoplasia type 2,09-10-2025
S3841001003,Genetic testing for retinoblastoma,09-10-2025
S3842001003,Genetic testing for von hippel-lindau disease,09-10-2025
S3844001003,"Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital,",09-10-2025
S3844002004,Profound deafness,09-10-2025
S3845001003,Genetic testing for alpha-thalassemia,09-10-2025
S3846001003,Genetic testing for hemoglobin e beta-thalassemia,09-10-2025
S3849001003,Genetic testing for niemann-pick disease,09-10-2025
S3850001003,Genetic testing for sickle cell anemia,09-10-2025
S3852001003,Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's diseas,09-10-2025
S3853001003,Genetic testing for myotonic muscular dystrophy,09-10-2025
S3854001003,Gene expression profiling panel for use in the management of breast cancer,09-10-2025
S3854002004,Treatment,09-10-2025
S3855001003,Genetic testing for detection of mutations in the presenilin - 1 gene,09-10-2025
S3861001003,"Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a)",09-10-2025
S3861002004,And variants for suspected brugada syndrome,09-10-2025
S3865001003,Comprehensive gene sequence analysis for hypertrophic cardiomyopathy,09-10-2025
S3866001003,Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy,09-10-2025
S3866002004,(hcm) in an individual with a known hcm mutation in the family,09-10-2025
S3870001003,Comparative genomic hybridization (cgh) microarray testing for developmental,09-10-2025
S3870002004,"Delay, autism spectrum disorder and/or intellectual disability",09-10-2025
S3890001003,"Dna analysis, fecal, for colorectal cancer screening",09-10-2025
S3900001003,Surface electromyography (emg),09-10-2025
S3902001003,Ballistocardiogram,09-10-2025
S3904001003,Masters two step,09-10-2025
S4005001003,Interim labor facility global (labor occurring but not resulting in delivery),09-10-2025
S4011001003,In vitro fertilization; including but not limited to identification and,09-10-2025
S4011002004,"Incubation of mature oocytes, fertilization with sperm, incubation of",09-10-2025
S4011003004,"Embryo(s), and subsequent visualization for determination of development",09-10-2025
S4013001003,"Complete cycle, gamete intrafallopian transfer (gift), case rate",09-10-2025
S4014001003,"Complete cycle, zygote intrafallopian transfer (zift), case rate",09-10-2025
S4015001003,"Complete in vitro fertilization cycle, not otherwise specified, case rate",09-10-2025
S4016001003,"Frozen in vitro fertilization cycle, case rate",09-10-2025
S4017001003,"Incomplete cycle, treatment cancelled prior to stimulation, case rate",09-10-2025
S4018001003,"Frozen embryo transfer procedure cancelled before transfer, case rate",09-10-2025
S4020001003,"In vitro fertilization procedure cancelled before aspiration, case rate",09-10-2025
S4021001003,"In vitro fertilization procedure cancelled after aspiration, case rate",09-10-2025
S4022001003,"Assisted oocyte fertilization, case rate",09-10-2025
S4023001003,"Donor egg cycle, incomplete, case rate",09-10-2025
S4024001003,"Air polymer-type a intrauterine foam, per study dose",09-10-2025
S4025001003,"Donor services for in vitro fertilization (sperm or embryo), case rate",09-10-2025
S4026001003,Procurement of donor sperm from sperm bank,09-10-2025
S4027001003,Storage of previously frozen embryos,09-10-2025
S4028001003,Microsurgical epididymal sperm aspiration (mesa),09-10-2025
S4030001003,Sperm procurement and cryopreservation services; initial visit,09-10-2025
S4031001003,Sperm procurement and cryopreservation services; subsequent visit,09-10-2025
S4035001003,"Stimulated intrauterine insemination (iui), case rate",09-10-2025
S4037001003,"Cryopreserved embryo transfer, case rate",09-10-2025
S4040001003,"Monitoring and storage of cryopreserved embryos, per 30 days",09-10-2025
S4042001003,Management of ovulation induction (interpretation of diagnostic tests and,09-10-2025
S4042002004,"Studies, non-face-to-face medical management of the patient), per cycle",09-10-2025
S4981001003,Insertion of levonorgestrel-releasing intrauterine system,09-10-2025
S4988001003,"Penile contracture device, manual, greater than 3 lbs traction force",09-10-2025
S4989001003,"Contraceptive intrauterine device (e.g., progestacert iud), including implants",09-10-2025
S4989002004,And supplies,09-10-2025
S4990001003,"Nicotine patches, legend",09-10-2025
S4991001003,"Nicotine patches, non-legend",09-10-2025
S4993001003,Contraceptive pills for birth control,09-10-2025
S4995001003,Smoking cessation gum,09-10-2025
S5000001003,"Prescription drug, generic",09-10-2025
S5001001003,"Prescription drug, brand name",09-10-2025
S5010001003,"5% dextrose and 0.45% normal saline, 1000 ml",09-10-2025
S5011001003,"5% dextrose in lactated ringer's, 1000 ml",09-10-2025
S5012001003,"5% dextrose with potassium chloride, 1000 ml",09-10-2025
S5013001003,"5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate,",09-10-2025
S5013002004,1000 ml,09-10-2025
S5014001003,"5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate,",09-10-2025
S5014002004,1500 ml,09-10-2025
S5035001003,"Home infusion therapy, routine service of infusion device (e.g., pump",09-10-2025
S5035002004,Maintenance),09-10-2025
S5036001003,"Home infusion therapy, repair of infusion device (e.g., pump repair)",09-10-2025
S5100001003,"Day care services, adult; per 15 minutes",09-10-2025
S5101001003,"Day care services, adult; per half day",09-10-2025
S5102001003,"Day care services, adult; per diem",09-10-2025
S5105001003,"Day care services, center-based; services not included in program fee, per diem",09-10-2025
S5108001003,"Home care training to home care client, per 15 minutes",09-10-2025
S5109001003,"Home care training to home care client, per session",09-10-2025
S5110001003,"Home care training, family; per 15 minutes",09-10-2025
S5111001003,"Home care training, family; per session",09-10-2025
S5115001003,"Home care training, non-family; per 15 minutes",09-10-2025
S5116001003,"Home care training, non-family; per session",09-10-2025
S5120001003,Chore services; per 15 minutes,09-10-2025
S5121001003,Chore services; per diem,09-10-2025
S5125001003,Attendant care services; per 15 minutes,09-10-2025
S5126001003,Attendant care services; per diem,09-10-2025
S5130001003,"Homemaker service, nos; per 15 minutes",09-10-2025
S5131001003,"Homemaker service, nos; per diem",09-10-2025
S5135001003,"Companion care, adult (e.g., iadl/adl); per 15 minutes",09-10-2025
S5136001003,"Companion care, adult (e.g., iadl/adl); per diem",09-10-2025
S5140001003,"Foster care, adult; per diem",09-10-2025
S5141001003,"Foster care, adult; per month",09-10-2025
S5145001003,"Foster care, therapeutic, child; per diem",09-10-2025
S5146001003,"Foster care, therapeutic, child; per month",09-10-2025
S5150001003,"Unskilled respite care, not hospice; per 15 minutes",09-10-2025
S5151001003,"Unskilled respite care, not hospice; per diem",09-10-2025
S5160001003,Emergency response system; installation and testing,09-10-2025
S5161001003,"Emergency response system; service fee, per month (excludes installation and",09-10-2025
S5161002004,Testing),09-10-2025
S5162001003,Emergency response system; purchase only,09-10-2025
S5165001003,Home modifications; per service,09-10-2025
S5170001003,"Home delivered meals, including preparation; per meal",09-10-2025
S5175001003,"Laundry service, external, professional; per order",09-10-2025
S5180001003,"Home health respiratory therapy, initial evaluation",09-10-2025
S5181001003,"Home health respiratory therapy, nos, per diem",09-10-2025
S5185001003,"Medication reminder service, non-face-to-face; per month",09-10-2025
S5190001003,"Wellness assessment, performed by non-physician",09-10-2025
S5199001003,"Personal care item, nos, each",09-10-2025
S5497001003,"Home infusion therapy, catheter care / maintenance, not otherwise classified;",09-10-2025
S5497002004,"Includes administrative services, professional pharmacy services, care",09-10-2025
S5497003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S5497004004,"Visits coded separately), per diem",09-10-2025
S5498001003,"Home infusion therapy, catheter care / maintenance, simple (single lumen),",09-10-2025
S5498002004,"Includes administrative services, professional pharmacy services, care",09-10-2025
S5498003004,"Coordination and all necessary supplies and equipment, (drugs and nursing",09-10-2025
S5498004004,"Visits coded separately), per diem",09-10-2025
S5501001003,"Home infusion therapy, catheter care / maintenance, complex (more than one",09-10-2025
S5501002004,"Lumen), includes administrative services, professional pharmacy services, care",09-10-2025
S5501003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S5501004004,"Visits coded separately), per diem",09-10-2025
S5502001003,"Home infusion therapy, catheter care / maintenance, implanted access device,",09-10-2025
S5502002004,"Includes administrative services, professional pharmacy services, care",09-10-2025
S5502003004,"Coordination and all necessary supplies and equipment, (drugs and nursing",09-10-2025
S5502004004,"Visits coded separately), per diem (use this code for interim maintenance of",09-10-2025
S5502005004,Vascular access not currently in use),09-10-2025
S5517001003,"Home infusion therapy, all supplies necessary for restoration of catheter",09-10-2025
S5517002004,Patency or declotting,09-10-2025
S5518001003,"Home infusion therapy, all supplies necessary for catheter repair",09-10-2025
S5520001003,"Home infusion therapy, all supplies (including catheter) necessary for a",09-10-2025
S5520002004,Peripherally inserted central venous catheter (picc) line insertion,09-10-2025
S5521001003,"Home infusion therapy, all supplies (including catheter) necessary for a",09-10-2025
S5521002004,Midline catheter insertion,09-10-2025
S5522001003,"Home infusion therapy, insertion of peripherally inserted central venous",09-10-2025
S5522002004,"Catheter (picc), nursing services only (no supplies or catheter included)",09-10-2025
S5523001003,"Home infusion therapy, insertion of midline venous catheter, nursing services",09-10-2025
S5523002004,Only (no supplies or catheter included),09-10-2025
S5550001003,"Insulin, rapid onset, 5 units",09-10-2025
S5551001003,"Insulin, most rapid onset (lispro or aspart); 5 units",09-10-2025
S5552001003,"Insulin, intermediate acting (nph or lente); 5 units",09-10-2025
S5553001003,"Insulin, long acting; 5 units",09-10-2025
S5560001003,"Insulin delivery device, reusable pen; 1.5 ml size",09-10-2025
S5561001003,"Insulin delivery device, reusable pen; 3 ml size",09-10-2025
S5565001003,Insulin cartridge for use in insulin delivery device other than pump; 150 units,09-10-2025
S5566001003,Insulin cartridge for use in insulin delivery device other than pump; 300 units,09-10-2025
S5570001003,"Insulin delivery device, disposable pen (including insulin); 1.5 ml size",09-10-2025
S5571001003,"Insulin delivery device, disposable pen (including insulin); 3 ml size",09-10-2025
S8030001003,Scleral application of tantalum ring(s) for localization of lesions for proton,09-10-2025
S8030002004,Beam therapy,09-10-2025
S8032001003,Low-dose computed tomography for lung cancer screening,09-10-2025
S8035001003,Magnetic source imaging,09-10-2025
S8037001003,Magnetic resonance cholangiopancreatography (mrcp),09-10-2025
S8040001003,Topographic brain mapping,09-10-2025
S8042001003,"Magnetic resonance imaging (mri), low-field",09-10-2025
S8055001003,"Ultrasound guidance for multifetal pregnancy reduction(s), technical component",09-10-2025
S8055002004,(only to be used when the physician doing the reduction procedure does not,09-10-2025
S8055003004,"Perform the ultrasound, guidance is included in the cpt code for multifetal",09-10-2025
S8055004004,Pregnancy reduction - 59866),09-10-2025
S8080001003,"Scintimammography (radioimmunoscintigraphy of the breast), unilateral,",09-10-2025
S8080002004,Including supply of radiopharmaceutical,09-10-2025
S8085001003,Fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence,09-10-2025
S8085002004,Detection system (non-dedicated pet scan),09-10-2025
S8092001003,"Electron beam computed tomography (also known as ultrafast ct, cine ct)",09-10-2025
S8096001003,Portable peak flow meter,09-10-2025
S8097001003,"Asthma kit (including but not limited to portable peak expiratory flow meter,",09-10-2025
S8097002004,"Instructional video, brochure, and/or spacer)",09-10-2025
S8100001003,Holding chamber or spacer for use with an inhaler or nebulizer; without mask,09-10-2025
S8101001003,Holding chamber or spacer for use with an inhaler or nebulizer; with mask,09-10-2025
S8110001003,Peak expiratory flow rate (physician services),09-10-2025
S8120001003,"Oxygen contents, gaseous, 1 unit equals 1 cubic foot",09-10-2025
S8121001003,"Oxygen contents, liquid, 1 unit equals 1 pound",09-10-2025
S8130001003,"Interferential current stimulator, 2 channel",09-10-2025
S8131001003,"Interferential current stimulator, 4 channel",09-10-2025
S8185001003,Flutter device,09-10-2025
S8186001003,Swivel adapter,09-10-2025
S8189001003,"Tracheostomy supply, not otherwise classified",09-10-2025
S8210001003,Mucus trap,09-10-2025
S8262001003,"Mandibular orthopedic repositioning device, each",09-10-2025
S8265001003,Haberman feeder for cleft lip/palate,09-10-2025
S8270001003,"Enuresis alarm, using auditory buzzer and/or vibration device",09-10-2025
S8301001003,"Infection control supplies, not otherwise specified",09-10-2025
S8415001003,Supplies for home delivery of infant,09-10-2025
S8420001003,"Gradient pressure aid (sleeve and glove combination), custom made",09-10-2025
S8421001003,"Gradient pressure aid (sleeve and glove combination), ready made",09-10-2025
S8422001003,"Gradient pressure aid (sleeve), custom made, medium weight",09-10-2025
S8423001003,"Gradient pressure aid (sleeve), custom made, heavy weight",09-10-2025
S8424001003,"Gradient pressure aid (sleeve), ready made",09-10-2025
S8425001003,"Gradient pressure aid (glove), custom made, medium weight",09-10-2025
S8426001003,"Gradient pressure aid (glove), custom made, heavy weight",09-10-2025
S8427001003,"Gradient pressure aid (glove), ready made",09-10-2025
S8428001003,"Gradient pressure aid (gauntlet), ready made",09-10-2025
S8429001003,Gradient pressure exterior wrap,09-10-2025
S8430001003,"Padding for compression bandage, roll",09-10-2025
S8431001003,"Compression bandage, roll",09-10-2025
S8450001003,"Splint, prefabricated, digit (specify digit by use of modifier)",09-10-2025
S8451001003,"Splint, prefabricated, wrist or ankle",09-10-2025
S8452001003,"Splint, prefabricated, elbow",09-10-2025
S8460001003,"Camisole, post-mastectomy",09-10-2025
S8490001003,"Insulin syringes (100 syringes, any size)",09-10-2025
S8930001003,Electrical stimulation of auricular acupuncture points; each 15 minutes of,09-10-2025
S8930002004,Personal one-on-one contact with the patient,09-10-2025
S8940001003,"Equestrian/hippotherapy, per session",09-10-2025
S8948001003,Application of a modality (requiring constant provider attendance) to one or,09-10-2025
S8948002004,More areas; low-level laser; each 15 minutes,09-10-2025
S8950001003,"Complex lymphedema therapy, each 15 minutes",09-10-2025
S8990001003,Physical or manipulative therapy performed for maintenance rather than,09-10-2025
S8990002004,Restoration,09-10-2025
S8999001003,Resuscitation bag (for use by patient on artificial respiration during power,09-10-2025
S8999002004,Failure or other catastrophic event),09-10-2025
S9001001003,Home uterine monitor with or without associated nursing services,09-10-2025
S9002001003,"Intra-vaginal motion sensor system, provides biofeedback for pelvic floor",09-10-2025
S9002002004,Muscle rehabilitation device,09-10-2025
S9007001003,Ultrafiltration monitor,09-10-2025
S9015001003,Automated eeg monitoring,09-10-2025
S9024001003,Paranasal sinus ultrasound,09-10-2025
S9025001003,Omnicardiogram/cardiointegram,09-10-2025
S9034001003,"Extracorporeal shockwave lithotripsy for gall stones (if performed with ercp,",09-10-2025
S9034002004,Use 43265),09-10-2025
S9055001003,Procuren or other growth factor preparation to promote wound healing,09-10-2025
S9056001003,Coma stimulation per diem,09-10-2025
S9061001003,"Home administration of aerosolized drug therapy (e.g., pentamidine);",09-10-2025
S9061002004,"Administrative services, professional pharmacy services, care coordination, all",09-10-2025
S9061003004,"Necessary supplies and equipment (drugs and nursing visits coded separately),",09-10-2025
S9061004004,Per diem,09-10-2025
S9083001003,Global fee urgent care centers,09-10-2025
S9088001003,Services provided in an urgent care center (list in addition to code for,09-10-2025
S9088002004,Service),09-10-2025
S9090001003,"Vertebral axial decompression, per session",09-10-2025
S9097001003,Home visit for wound care,09-10-2025
S9098001003,"Home visit, phototherapy services (e.g., bili-lite), including equipment",09-10-2025
S9098002004,"Rental, nursing services, blood draw, supplies, and other services, per diem",09-10-2025
S9110001003,"Telemonitoring of patient in their home, including all necessary equipment;",09-10-2025
S9110002004,"Computer system, connections, and software; maintenance; patient education and",09-10-2025
S9110003004,Support; per month,09-10-2025
S9117001003,"Back school, per visit",09-10-2025
S9122001003,"Home health aide or certified nurse assistant, providing care in the home; per",09-10-2025
S9122002004,Hour,09-10-2025
S9123001003,"Nursing care, in the home; by registered nurse, per hour (use for general",09-10-2025
S9123002004,"Nursing care only, not to be used when cpt codes 99500-99602 can be used)",09-10-2025
S9124001003,"Nursing care, in the home; by licensed practical nurse, per hour",09-10-2025
S9125001003,"Respite care, in the home, per diem",09-10-2025
S9126001003,"Hospice care, in the home, per diem",09-10-2025
S9127001003,"Social work visit, in the home, per diem",09-10-2025
S9128001003,"Speech therapy, in the home, per diem",09-10-2025
S9129001003,"Occupational therapy, in the home, per diem",09-10-2025
S9131001003,"Physical therapy; in the home, per diem",09-10-2025
S9140001003,"Diabetic management program, follow-up visit to non-md provider",09-10-2025
S9141001003,"Diabetic management program, follow-up visit to md provider",09-10-2025
S9145001003,"Insulin pump initiation, instruction in initial use of pump (pump not included)",09-10-2025
S9150001003,Evaluation by ocularist,09-10-2025
S9152001003,"Speech therapy, re-evaluation",09-10-2025
S9208001003,"Home management of preterm labor, including administrative services,",09-10-2025
S9208002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9208003004,"Or equipment (drugs and nursing visits coded separately), per diem (do not use",09-10-2025
S9208004004,This code with any home infusion per diem code),09-10-2025
S9209001003,"Home management of preterm premature rupture of membranes (pprom), including",09-10-2025
S9209002004,"Administrative services, professional pharmacy services, care coordination, and",09-10-2025
S9209003004,All necessary supplies or equipment (drugs and nursing visits coded,09-10-2025
S9209004004,"Separately), per diem (do not use this code with any home infusion per diem",09-10-2025
S9209005004,Code),09-10-2025
S9211001003,"Home management of gestational hypertension, includes administrative services,",09-10-2025
S9211002004,"Professional pharmacy services, care coordination and all necessary supplies",09-10-2025
S9211003004,And equipment (drugs and nursing visits coded separately); per diem (do not use,09-10-2025
S9211004004,This code with any home infusion per diem code),09-10-2025
S9212001003,"Home management of postpartum hypertension, includes administrative services,",09-10-2025
S9212002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9212003004,"And equipment (drugs and nursing visits coded separately), per diem (do not use",09-10-2025
S9212004004,This code with any home infusion per diem code),09-10-2025
S9213001003,"Home management of preeclampsia, includes administrative services, professional",09-10-2025
S9213002004,"Pharmacy services, care coordination, and all necessary supplies and equipment",09-10-2025
S9213003004,(drugs and nursing services coded separately); per diem (do not use this code,09-10-2025
S9213004004,With any home infusion per diem code),09-10-2025
S9214001003,"Home management of gestational diabetes, includes administrative services,",09-10-2025
S9214002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9214003004,And equipment (drugs and nursing visits coded separately); per diem (do not use,09-10-2025
S9214004004,This code with any home infusion per diem code),09-10-2025
S9325001003,"Home infusion therapy, pain management infusion; administrative services,",09-10-2025
S9325002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9325003004,"And equipment, (drugs and nursing visits coded separately), per diem (do not",09-10-2025
S9325004004,"Use this code with s9326, s9327 or s9328)",09-10-2025
S9326001003,"Home infusion therapy, continuous (twenty-four hours or more) pain management",09-10-2025
S9326002004,"Infusion; administrative services, professional pharmacy services, care",09-10-2025
S9326003004,Coordination and all necessary supplies and equipment (drugs and nursing visits,09-10-2025
S9326004004,"Coded separately), per diem",09-10-2025
S9327001003,"Home infusion therapy, intermittent (less than twenty-four hours) pain",09-10-2025
S9327002004,"Management infusion; administrative services, professional pharmacy services,",09-10-2025
S9327003004,"Care coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9327004004,"Visits coded separately), per diem",09-10-2025
S9328001003,"Home infusion therapy, implanted pump pain management infusion; administrative",09-10-2025
S9328002004,"Services, professional pharmacy services, care coordination, and all necessary",09-10-2025
S9328003004,"Supplies and equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9329001003,"Home infusion therapy, chemotherapy infusion; administrative services,",09-10-2025
S9329002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9329003004,"And equipment (drugs and nursing visits coded separately), per diem (do not use",09-10-2025
S9329004004,This code with s9330 or s9331),09-10-2025
S9330001003,"Home infusion therapy, continuous (twenty-four hours or more) chemotherapy",09-10-2025
S9330002004,"Infusion; administrative services, professional pharmacy services, care",09-10-2025
S9330003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9330004004,"Visits coded separately), per diem",09-10-2025
S9331001003,"Home infusion therapy, intermittent (less than twenty-four hours) chemotherapy",09-10-2025
S9331002004,"Infusion; administrative services, professional pharmacy services, care",09-10-2025
S9331003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9331004004,"Visits coded separately), per diem",09-10-2025
S9335001003,"Home therapy, hemodialysis; administrative services, professional pharmacy",09-10-2025
S9335002004,"Services, care coordination, and all necessary supplies and equipment (drugs",09-10-2025
S9335003004,"And nursing services coded separately), per diem",09-10-2025
S9336001003,"Home infusion therapy, continuous anticoagulant infusion therapy (e.g.,",09-10-2025
S9336002004,"Heparin), administrative services, professional pharmacy services, care",09-10-2025
S9336003004,Coordination and all necessary supplies and equipment (drugs and nursing visits,09-10-2025
S9336004004,"Coded separately), per diem",09-10-2025
S9338001003,"Home infusion therapy, immunotherapy, administrative services, professional",09-10-2025
S9338002004,"Pharmacy services, care coordination, and all necessary supplies and equipment",09-10-2025
S9338003004,"(drugs and nursing visits coded separately), per diem",09-10-2025
S9339001003,"Home therapy; peritoneal dialysis, administrative services, professional",09-10-2025
S9339002004,"Pharmacy services, care coordination and all necessary supplies and equipment",09-10-2025
S9339003004,"(drugs and nursing visits coded separately), per diem",09-10-2025
S9340001003,"Home therapy; enteral nutrition; administrative services, professional pharmacy",09-10-2025
S9340002004,"Services, care coordination, and all necessary supplies and equipment (enteral",09-10-2025
S9340003004,"Formula and nursing visits coded separately), per diem",09-10-2025
S9341001003,"Home therapy; enteral nutrition via gravity; administrative services,",09-10-2025
S9341002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9341003004,"And equipment (enteral formula and nursing visits coded separately), per diem",09-10-2025
S9342001003,"Home therapy; enteral nutrition via pump; administrative services, professional",09-10-2025
S9342002004,"Pharmacy services, care coordination, and all necessary supplies and equipment",09-10-2025
S9342003004,"(enteral formula and nursing visits coded separately), per diem",09-10-2025
S9343001003,"Home therapy; enteral nutrition via bolus; administrative services,",09-10-2025
S9343002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9343003004,"And equipment (enteral formula and nursing visits coded separately), per diem",09-10-2025
S9345001003,"Home infusion therapy, anti-hemophilic agent infusion therapy (e.g., factor",09-10-2025
S9345002004,"Viii); administrative services, professional pharmacy services, care",09-10-2025
S9345003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9345004004,"Visits coded separately), per diem",09-10-2025
S9346001003,"Home infusion therapy, alpha-1-proteinase inhibitor (e.g., prolastin);",09-10-2025
S9346002004,"Administrative services, professional pharmacy services, care coordination, and",09-10-2025
S9346003004,All necessary supplies and equipment (drugs and nursing visits coded,09-10-2025
S9346004004,"Separately), per diem",09-10-2025
S9347001003,"Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or",09-10-2025
S9347002004,"Subcutaneous infusion therapy (e.g., epoprostenol); administrative services,",09-10-2025
S9347003004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9347004004,"And equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9348001003,"Home infusion therapy, sympathomimetic/inotropic agent infusion therapy (e.g.,",09-10-2025
S9348002004,"Dobutamine); administrative services, professional pharmacy services, care",09-10-2025
S9348003004,"Coordination, all necessary supplies and equipment (drugs and nursing visits",09-10-2025
S9348004004,"Coded separately), per diem",09-10-2025
S9349001003,"Home infusion therapy, tocolytic infusion therapy; administrative services,",09-10-2025
S9349002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9349003004,"And equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9351001003,"Home infusion therapy, continuous or intermittent anti-emetic infusion therapy;",09-10-2025
S9351002004,"Administrative services, professional pharmacy services, care coordination, and",09-10-2025
S9351003004,"All necessary supplies and equipment (drugs and visits coded separately), per",09-10-2025
S9351004004,Diem,09-10-2025
S9353001003,"Home infusion therapy, continuous insulin infusion therapy; administrative",09-10-2025
S9353002004,"Services, professional pharmacy services, care coordination, and all necessary",09-10-2025
S9353003004,"Supplies and equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9355001003,"Home infusion therapy, chelation therapy; administrative services, professional",09-10-2025
S9355002004,"Pharmacy services, care coordination, and all necessary supplies and equipment",09-10-2025
S9355003004,"(drugs and nursing visits coded separately), per diem",09-10-2025
S9357001003,"Home infusion therapy, enzyme replacement intravenous therapy; (e.g.,",09-10-2025
S9357002004,"Imiglucerase); administrative services, professional pharmacy services, care",09-10-2025
S9357003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9357004004,"Visits coded separately), per diem",09-10-2025
S9359001003,"Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g.,",09-10-2025
S9359002004,"Infliximab); administrative services, professional pharmacy services, care",09-10-2025
S9359003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9359004004,"Visits coded separately), per diem",09-10-2025
S9361001003,"Home infusion therapy, diuretic intravenous therapy; administrative services,",09-10-2025
S9361002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9361003004,"And equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9363001003,"Home infusion therapy, anti-spasmotic therapy; administrative services,",09-10-2025
S9363002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9363003004,"And equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9364001003,"Home infusion therapy, total parenteral nutrition (tpn); administrative",09-10-2025
S9364002004,"Services, professional pharmacy services, care coordination, and all necessary",09-10-2025
S9364003004,"Supplies and equipment including standard tpn formula (lipids, specialty amino",09-10-2025
S9364004004,"Acid formulas, drugs other than in standard formula and nursing visits coded",09-10-2025
S9364005004,"Separately), per diem (do not use with home infusion codes s9365-s9368 using",09-10-2025
S9364006004,Daily volume scales),09-10-2025
S9365001003,"Home infusion therapy, total parenteral nutrition (tpn); one liter per day,",09-10-2025
S9365002004,"Administrative services, professional pharmacy services, care coordination, and",09-10-2025
S9365003004,"All necessary supplies and equipment including standard tpn formula (lipids,",09-10-2025
S9365004004,"Specialty amino acid formulas, drugs other than in standard formula and nursing",09-10-2025
S9365005004,"Visits coded separately), per diem",09-10-2025
S9366001003,"Home infusion therapy, total parenteral nutrition (tpn); more than one liter",09-10-2025
S9366002004,"But no more than two liters per day, administrative services, professional",09-10-2025
S9366003004,"Pharmacy services, care coordination, and all necessary supplies and equipment",09-10-2025
S9366004004,"Including standard tpn formula (lipids, specialty amino acid formulas, drugs",09-10-2025
S9366005004,"Other than in standard formula and nursing visits coded separately), per diem",09-10-2025
S9367001003,"Home infusion therapy, total parenteral nutrition (tpn); more than two liters",09-10-2025
S9367002004,"But no more than three liters per day, administrative services, professional",09-10-2025
S9367003004,"Pharmacy services, care coordination, and all necessary supplies and equipment",09-10-2025
S9367004004,"Including standard tpn formula (lipids, specialty amino acid formulas, drugs",09-10-2025
S9367005004,"Other than in standard formula and nursing visits coded separately), per diem",09-10-2025
S9368001003,"Home infusion therapy, total parenteral nutrition (tpn); more than three liters",09-10-2025
S9368002004,"Per day, administrative services, professional pharmacy services, care",09-10-2025
S9368003004,"Coordination, and all necessary supplies and equipment including standard tpn",09-10-2025
S9368004004,"Formula (lipids, specialty amino acid formulas, drugs other than in standard",09-10-2025
S9368005004,"Formula and nursing visits coded separately), per diem",09-10-2025
S9370001003,"Home therapy, intermittent anti-emetic injection therapy; administrative",09-10-2025
S9370002004,"Services, professional pharmacy services, care coordination, and all necessary",09-10-2025
S9370003004,"Supplies and equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9372001003,"Home therapy; intermittent anticoagulant injection therapy (e.g., heparin);",09-10-2025
S9372002004,"Administrative services, professional pharmacy services, care coordination, and",09-10-2025
S9372003004,All necessary supplies and equipment (drugs and nursing visits coded,09-10-2025
S9372004004,"Separately), per diem (do not use this code for flushing of infusion devices",09-10-2025
S9372005004,With heparin to maintain patency),09-10-2025
S9373001003,"Home infusion therapy, hydration therapy; administrative services, professional",09-10-2025
S9373002004,"Pharmacy services, care coordination, and all necessary supplies and equipment",09-10-2025
S9373003004,"(drugs and nursing visits coded separately), per diem (do not use with",09-10-2025
S9373004004,Hydration therapy codes s9374-s9377 using daily volume scales),09-10-2025
S9374001003,"Home infusion therapy, hydration therapy; one liter per day, administrative",09-10-2025
S9374002004,"Services, professional pharmacy services, care coordination, and all necessary",09-10-2025
S9374003004,"Supplies and equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9375001003,"Home infusion therapy, hydration therapy; more than one liter but no more than",09-10-2025
S9375002004,"Two liters per day, administrative services, professional pharmacy services,",09-10-2025
S9375003004,"Care coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9375004004,"Visits coded separately), per diem",09-10-2025
S9376001003,"Home infusion therapy, hydration therapy; more than two liters but no more than",09-10-2025
S9376002004,"Three liters per day, administrative services, professional pharmacy services,",09-10-2025
S9376003004,"Care coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9376004004,"Visits coded separately), per diem",09-10-2025
S9377001003,"Home infusion therapy, hydration therapy; more than three liters per day,",09-10-2025
S9377002004,"Administrative services, professional pharmacy services, care coordination, and",09-10-2025
S9377003004,"All necessary supplies (drugs and nursing visits coded separately), per diem",09-10-2025
S9379001003,"Home infusion therapy, infusion therapy, not otherwise classified;",09-10-2025
S9379002004,"Administrative services, professional pharmacy services, care coordination, and",09-10-2025
S9379003004,All necessary supplies and equipment (drugs and nursing visits coded,09-10-2025
S9379004004,"Separately), per diem",09-10-2025
S9381001003,"Delivery or service to high risk areas requiring escort or extra protection,",09-10-2025
S9381002004,Per visit,09-10-2025
S9401001003,"Anticoagulation clinic, inclusive of all services except laboratory tests, per",09-10-2025
S9401002004,Session,09-10-2025
S9430001003,Pharmacy compounding and dispensing services,09-10-2025
S9432001003,Medical foods for non-inborn errors of metabolism,09-10-2025
S9433001003,"Medical food nutritionally complete, administered orally, providing 100% of",09-10-2025
S9433002004,Nutritional intake,09-10-2025
S9434001003,Modified solid food supplements for inborn errors of metabolism,09-10-2025
S9435001003,Medical foods for inborn errors of metabolism,09-10-2025
S9436001003,"Childbirth preparation/lamaze classes, non-physician provider, per session",09-10-2025
S9437001003,"Childbirth refresher classes, non-physician provider, per session",09-10-2025
S9438001003,"Cesarean birth classes, non-physician provider, per session",09-10-2025
S9439001003,"Vbac (vaginal birth after cesarean) classes, non-physician provider, per sessio",09-10-2025
S9441001003,"Asthma education, non-physician provider, per session",09-10-2025
S9442001003,"Birthing classes, non-physician provider, per session",09-10-2025
S9443001003,"Lactation classes, non-physician provider, per session",09-10-2025
S9444001003,"Parenting classes, non-physician provider, per session",09-10-2025
S9445001003,"Patient education, not otherwise classified, non-physician provider,",09-10-2025
S9445002004,"Individual, per session",09-10-2025
S9446001003,"Patient education, not otherwise classified, non-physician provider, group, per",09-10-2025
S9446002004,Session,09-10-2025
S9447001003,"Infant safety (including cpr) classes, non-physician provider, per session",09-10-2025
S9449001003,"Weight management classes, non-physician provider, per session",09-10-2025
S9451001003,"Exercise classes, non-physician provider, per session",09-10-2025
S9452001003,"Nutrition classes, non-physician provider, per session",09-10-2025
S9453001003,"Smoking cessation classes, non-physician provider, per session",09-10-2025
S9454001003,"Stress management classes, non-physician provider, per session",09-10-2025
S9455001003,"Diabetic management program, group session",09-10-2025
S9460001003,"Diabetic management program, nurse visit",09-10-2025
S9465001003,"Diabetic management program, dietitian visit",09-10-2025
S9470001003,"Nutritional counseling, dietitian visit",09-10-2025
S9472001003,"Cardiac rehabilitation program, non-physician provider, per diem",09-10-2025
S9473001003,"Pulmonary rehabilitation program, non-physician provider, per diem",09-10-2025
S9474001003,"Enterostomal therapy by a registered nurse certified in enterostomal therapy,",09-10-2025
S9474002004,Per diem,09-10-2025
S9475001003,"Ambulatory setting substance abuse treatment or detoxification services, per",09-10-2025
S9475002004,Diem,09-10-2025
S9476001003,"Vestibular rehabilitation program, non-physician provider, per diem",09-10-2025
S9480001003,"Intensive outpatient psychiatric services, per diem",09-10-2025
S9482001003,"Family stabilization services, per 15 minutes",09-10-2025
S9484001003,"Crisis intervention mental health services, per hour",09-10-2025
S9485001003,"Crisis intervention mental health services, per diem",09-10-2025
S9490001003,"Home infusion therapy, corticosteroid infusion; administrative services,",09-10-2025
S9490002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9490003004,"And equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9494001003,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy;",09-10-2025
S9494002004,"Administrative services, professional pharmacy services, care coordination, and",09-10-2025
S9494003004,All necessary supplies and equipment (drugs and nursing visits coded,09-10-2025
S9494004004,"Separately), per diem (do not use this code with home infusion codes for hourly",09-10-2025
S9494005004,Dosing schedules s9497-s9504),09-10-2025
S9497001003,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every",09-10-2025
S9497002004,"3 hours; administrative services, professional pharmacy services, care",09-10-2025
S9497003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9497004004,"Visits coded separately), per diem",09-10-2025
S9500001003,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every",09-10-2025
S9500002004,"24 hours; administrative services, professional pharmacy services, care",09-10-2025
S9500003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9500004004,"Visits coded separately), per diem",09-10-2025
S9501001003,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every",09-10-2025
S9501002004,"12 hours; administrative services, professional pharmacy services, care",09-10-2025
S9501003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9501004004,"Visits coded separately), per diem",09-10-2025
S9502001003,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every",09-10-2025
S9502002004,"8 hours, administrative services, professional pharmacy services, care",09-10-2025
S9502003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9502004004,"Visits coded separately), per diem",09-10-2025
S9503001003,"Home infusion therapy, antibiotic, antiviral, or antifungal; once every 6",09-10-2025
S9503002004,"Hours; administrative services, professional pharmacy services, care",09-10-2025
S9503003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9503004004,"Visits coded separately), per diem",09-10-2025
S9504001003,"Home infusion therapy, antibiotic, antiviral, or antifungal; once every 4",09-10-2025
S9504002004,"Hours; administrative services, professional pharmacy services, care",09-10-2025
S9504003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9504004004,"Visits coded separately), per diem",09-10-2025
S9529001003,"Routine venipuncture for collection of specimen(s), single home bound, nursing",09-10-2025
S9529002004,"Home, or skilled nursing facility patient",09-10-2025
S9537001003,"Home therapy; hematopoietic hormone injection therapy (e.g., erythropoietin,",09-10-2025
S9537002004,"G-csf, gm-csf); administrative services, professional pharmacy services, care",09-10-2025
S9537003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9537004004,"Visits coded separately), per diem",09-10-2025
S9538001003,"Home transfusion of blood product(s); administrative services, professional",09-10-2025
S9538002004,"Pharmacy services, care coordination and all necessary supplies and equipment",09-10-2025
S9538003004,"(blood products, drugs, and nursing visits coded separately), per diem",09-10-2025
S9542001003,"Home injectable therapy, not otherwise classified, including administrative",09-10-2025
S9542002004,"Services, professional pharmacy services, care coordination, and all necessary",09-10-2025
S9542003004,"Supplies and equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9558001003,"Home injectable therapy; growth hormone, including administrative services,",09-10-2025
S9558002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9558003004,"And equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9559001003,"Home injectable therapy, interferon, including administrative services,",09-10-2025
S9559002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9559003004,"And equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9560001003,"Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin),",09-10-2025
S9560002004,"Including administrative services, professional pharmacy services, care",09-10-2025
S9560003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9560004004,"Visits coded separately), per diem",09-10-2025
S9562001003,"Home injectable therapy, palivizumab or other monoclonal antibody for rsv,",09-10-2025
S9562002004,"Including administrative services, professional pharmacy services, care",09-10-2025
S9562003004,"Coordination, and all necessary supplies and equipment (drugs and nursing",09-10-2025
S9562004004,"Visits coded separately), per diem",09-10-2025
S9563001003,"Home injectable therapy, immunotherapy, including administrative services,",09-10-2025
S9563002004,"Professional pharmacy services, care coordination, and all necessary supplies",09-10-2025
S9563003004,"And equipment (drugs and nursing visits coded separately), per diem",09-10-2025
S9590001003,"Home therapy, irrigation therapy (e.g., sterile irrigation of an organ or",09-10-2025
S9590002004,"Anatomical cavity); including administrative services, professional pharmacy",09-10-2025
S9590003004,"Services, care coordination, and all necessary supplies and equipment (drugs",09-10-2025
S9590004004,"And nursing visits coded separately), per diem",09-10-2025
S9810001003,"Home therapy; professional pharmacy services for provision of infusion,",09-10-2025
S9810002004,"Specialty drug administration, and/or disease state management, not otherwise",09-10-2025
S9810003004,"Classified, per hour (do not use this code with any per diem code)",09-10-2025
S9900001003,Services by a journal-listed christian science practitioner for the purpose of,09-10-2025
S9900002004,"Healing, per diem",09-10-2025
S9901001003,"Services by a journal-listed christian science nurse, per hour",09-10-2025
S9960001003,"Ambulance service, conventional air service, nonemergency transport, one way",09-10-2025
S9960002004,(fixed wing),09-10-2025
S9961001003,"Ambulance service, conventional air service, nonemergency transport, one way",09-10-2025
S9961002004,(rotary wing),09-10-2025
S9970001003,"Health club membership, annual",09-10-2025
S9975001003,"Transplant related lodging, meals and transportation, per diem",09-10-2025
S9976001003,"Lodging, per diem, not otherwise classified",09-10-2025
S9977001003,"Meals, per diem, not otherwise specified",09-10-2025
S9981001003,"Medical records copying fee, administrative",09-10-2025
S9982001003,"Medical records copying fee, per page",09-10-2025
S9986001003,Not medically necessary service (patient is aware that service not medically,09-10-2025
S9986002004,Necessary),09-10-2025
S9988001003,Services provided as part of a phase i clinical trial,09-10-2025
S9989001003,Services provided outside of the united states of america (list in addition to,09-10-2025
S9989002004,Code(s) for service(s)),09-10-2025
S9990001003,Services provided as part of a phase ii clinical trial,09-10-2025
S9991001003,Services provided as part of a phase iii clinical trial,09-10-2025
S9992001003,Transportation costs to and from trial location and local transportation costs,09-10-2025
S9992002004,"(e.g., fares for taxicab or bus) for clinical trial participant and one",09-10-2025
S9992003004,Caregiver/companion,09-10-2025
S9994001003,"Lodging costs (e.g., hotel charges) for clinical trial participant and one",09-10-2025
S9994002004,Caregiver/companion,09-10-2025
S9996001003,Meals for clinical trial participant and one caregiver/companion,09-10-2025
S9999001003,Sales tax,09-10-2025
T1000001003,"Private duty / independent nursing service(s) - licensed, up to 15 minutes",09-10-2025
T1001001003,Nursing assessment / evaluation,09-10-2025
T1002001003,"Rn services, up to 15 minutes",09-10-2025
T1003001003,"Lpn/lvn services, up to 15 minutes",09-10-2025
T1004001003,"Services of a qualified nursing aide, up to 15 minutes",09-10-2025
T1005001003,"Respite care services, up to 15 minutes",09-10-2025
T1006001003,"Alcohol and/or substance abuse services, family/couple counseling",09-10-2025
T1007001003,"Alcohol and/or substance abuse services, treatment plan development and/or",09-10-2025
T1007002004,Modification,09-10-2025
T1009001003,Child sitting services for children of the individual receiving alcohol and/or,09-10-2025
T1009002004,Substance abuse services,09-10-2025
T1010001003,Meals for individuals receiving alcohol and/or substance abuse services (when,09-10-2025
T1010002004,Meals not included in the program),09-10-2025
T1012001003,"Alcohol and/or substance abuse services, skills development",09-10-2025
T1013001003,"Sign language or oral interpretive services, per 15 minutes",09-10-2025
T1014001003,"Telehealth transmission, per minute, professional services bill separately",09-10-2025
T1015001003,"Clinic visit/encounter, all-inclusive",09-10-2025
T1016001003,"Case management, each 15 minutes",09-10-2025
T1017001003,"Targeted case management, each 15 minutes",09-10-2025
T1018001003,"School-based individualized education program (iep) services, bundled",09-10-2025
T1019001003,"Personal care services, per 15 minutes, not for an inpatient or resident of a",09-10-2025
T1019002004,"Hospital, nursing facility, icf/mr or imd, part of the individualized plan of",09-10-2025
T1019003004,Treatment (code may not be used to identify services provided by home health,09-10-2025
T1019004004,Aide or certified nurse assistant),09-10-2025
T1020001003,"Personal care services, per diem, not for an inpatient or resident of a",09-10-2025
T1020002004,"Hospital, nursing facility, icf/mr or imd, part of the individualized plan of",09-10-2025
T1020003004,Treatment (code may not be used to identify services provided by home health,09-10-2025
T1020004004,Aide or certified nurse assistant),09-10-2025
T1021001003,"Home health aide or certified nurse assistant, per visit",09-10-2025
T1022001003,"Contracted home health agency services, all services provided under contract,",09-10-2025
T1022002004,Per day,09-10-2025
T1023001003,Screening to determine the appropriateness of consideration of an individual,09-10-2025
T1023002004,"For participation in a specified program, project or treatment protocol, per",09-10-2025
T1023003004,Encounter,09-10-2025
T1024001003,"Evaluation and treatment by an integrated, specialty team contracted to provide",09-10-2025
T1024002004,"Coordinated care to multiple or severely handicapped children, per encounter",09-10-2025
T1025001003,"Intensive, extended multidisciplinary services provided in a clinic setting to",09-10-2025
T1025002004,"Children with complex medical, physical, mental and psychosocial impairments,",09-10-2025
T1025003004,Per diem,09-10-2025
T1026001003,"Intensive, extended multidisciplinary services provided in a clinic setting to",09-10-2025
T1026002004,"Children with complex medical, physical, mental and psychosocial impairments,",09-10-2025
T1026003004,Per hour,09-10-2025
T1027001003,"Family training and counseling for child development, per 15 minutes",09-10-2025
T1028001003,"Assessment of home, physical and family environment, to determine suitability",09-10-2025
T1028002004,To meet patient's medical needs,09-10-2025
T1029001003,"Comprehensive environmental lead investigation, not including laboratory",09-10-2025
T1029002004,"Analysis, per dwelling",09-10-2025
T1030001003,"Nursing care, in the home, by registered nurse, per diem",09-10-2025
T1031001003,"Nursing care, in the home, by licensed practical nurse, per diem",09-10-2025
T1032001003,"Services performed by a doula birth worker, per 15 minutes",09-10-2025
T1033001003,"Services performed by a doula birth worker, per diem",09-10-2025
T1040001003,"Medicaid certified community behavioral health clinic services, per diem",09-10-2025
T1041001003,"Medicaid certified community behavioral health clinic services, per month",09-10-2025
T1502001003,"Administration of oral, intramuscular and/or subcutaneous medication by health",09-10-2025
T1502002004,"Care agency/professional, per visit",09-10-2025
T1503001003,"Administration of medication, other than oral and/or injectable, by a health",09-10-2025
T1503002004,"Care agency/professional, per visit",09-10-2025
T1505001003,"Electronic medication compliance management device, includes all components and",09-10-2025
T1505002004,"Accessories, not otherwise classified",09-10-2025
T1999001003,"Miscellaneous therapeutic items and supplies, retail purchases, not otherwise",09-10-2025
T1999002004,"Classified; identify product in ""remarks""",09-10-2025
T2001001003,Non-emergency transportation; patient attendant/escort,09-10-2025
T2002001003,Non-emergency transportation; per diem,09-10-2025
T2003001003,Non-emergency transportation; encounter/trip,09-10-2025
T2004001003,"Non-emergency transport; commercial carrier, multi-pass",09-10-2025
T2005001003,Non-emergency transportation; stretcher van,09-10-2025
T2007001003,"Transportation waiting time, air ambulance and non-emergency vehicle, one-half",09-10-2025
T2007002004,(1/2) hour increments,09-10-2025
T2010001003,Preadmission screening and resident review (pasrr) level i identification,09-10-2025
T2010002004,"Screening, per screen",09-10-2025
T2011001003,"Preadmission screening and resident review (pasrr) level ii evaluation, per",09-10-2025
T2011002004,Evaluation,09-10-2025
T2012001003,"Habilitation, educational; waiver, per diem",09-10-2025
T2013001003,"Habilitation, educational, waiver; per hour",09-10-2025
T2014001003,"Habilitation, prevocational, waiver; per diem",09-10-2025
T2015001003,"Habilitation, prevocational, waiver; per hour",09-10-2025
T2016001003,"Habilitation, residential, waiver; per diem",09-10-2025
T2017001003,"Habilitation, residential, waiver; 15 minutes",09-10-2025
T2018001003,"Habilitation, supported employment, waiver; per diem",09-10-2025
T2019001003,"Habilitation, supported employment, waiver; per 15 minutes",09-10-2025
T2020001003,"Day habilitation, waiver; per diem",09-10-2025
T2021001003,"Day habilitation, waiver; per 15 minutes",09-10-2025
T2022001003,"Case management, per month",09-10-2025
T2023001003,Targeted case management; per month,09-10-2025
T2024001003,"Service assessment/plan of care development, waiver",09-10-2025
T2025001003,Waiver services; not otherwise specified (nos),09-10-2025
T2026001003,"Specialized childcare, waiver; per diem",09-10-2025
T2027001003,"Specialized childcare, waiver; per 15 minutes",09-10-2025
T2028001003,"Specialized supply, not otherwise specified, waiver",09-10-2025
T2029001003,"Specialized medical equipment, not otherwise specified, waiver",09-10-2025
T2030001003,"Assisted living, waiver; per month",09-10-2025
T2031001003,"Assisted living; waiver, per diem",09-10-2025
T2032001003,"Residential care, not otherwise specified (nos), waiver; per month",09-10-2025
T2033001003,"Residential care, not otherwise specified (nos), waiver; per diem",09-10-2025
T2034001003,"Crisis intervention, waiver; per diem",09-10-2025
T2035001003,"Utility services to support medical equipment and assistive technology/devices,",09-10-2025
T2035002004,Waiver,09-10-2025
T2036001003,"Therapeutic camping, overnight, waiver; each session",09-10-2025
T2037001003,"Therapeutic camping, day, waiver; each session",09-10-2025
T2038001003,"Community transition, waiver; per service",09-10-2025
T2039001003,"Vehicle modifications, waiver; per service",09-10-2025
T2040001003,"Financial management, self-directed, waiver; per 15 minutes",09-10-2025
T2041001003,"Supports brokerage, self-directed, waiver; per 15 minutes",09-10-2025
T2042001003,Hospice routine home care; per diem,09-10-2025
T2043001003,Hospice continuous home care; per hour,09-10-2025
T2044001003,Hospice inpatient respite care; per diem,09-10-2025
T2045001003,Hospice general inpatient care; per diem,09-10-2025
T2046001003,"Hospice long term care, room and board only; per diem",09-10-2025
T2047001003,"Habilitation, prevocational, waiver; per 15 minutes",09-10-2025
T2048001003,Behavioral health; long-term care residential (non-acute care in a residential,09-10-2025
T2048002004,"Treatment program where stay is typically longer than 30 days), with room and",09-10-2025
T2048003004,"Board, per diem",09-10-2025
T2049001003,"Non-emergency transportation; stretcher van, mileage; per mile",09-10-2025
T2050001003,"Financial management, self-directed, waiver; per diem",09-10-2025
T2051001003,"Supports brokerage, self-directed, waiver; per diem",09-10-2025
T2101001003,"Human breast milk processing, storage and distribution only",09-10-2025
T4521001003,"Adult sized disposable incontinence product, brief/diaper, small, each",09-10-2025
T4522001003,"Adult sized disposable incontinence product, brief/diaper, medium, each",09-10-2025
T4523001003,"Adult sized disposable incontinence product, brief/diaper, large, each",09-10-2025
T4524001003,"Adult sized disposable incontinence product, brief/diaper, extra large, each",09-10-2025
T4525001003,"Adult sized disposable incontinence product, protective underwear/pull-on,",09-10-2025
T4525002004,"Small size, each",09-10-2025
T4526001003,"Adult sized disposable incontinence product, protective underwear/pull-on,",09-10-2025
T4526002004,"Medium size, each",09-10-2025
T4527001003,"Adult sized disposable incontinence product, protective underwear/pull-on,",09-10-2025
T4527002004,"Large size, each",09-10-2025
T4528001003,"Adult sized disposable incontinence product, protective underwear/pull-on,",09-10-2025
T4528002004,"Extra large size, each",09-10-2025
T4529001003,"Pediatric sized disposable incontinence product, brief/diaper, small/medium",09-10-2025
T4529002004,"Size, each",09-10-2025
T4530001003,"Pediatric sized disposable incontinence product, brief/diaper, large size, each",09-10-2025
T4531001003,"Pediatric sized disposable incontinence product, protective underwear/pull-on,",09-10-2025
T4531002004,"Small/medium size, each",09-10-2025
T4532001003,"Pediatric sized disposable incontinence product, protective underwear/pull-on,",09-10-2025
T4532002004,"Large size, each",09-10-2025
T4533001003,"Youth sized disposable incontinence product, brief/diaper, each",09-10-2025
T4534001003,"Youth sized disposable incontinence product, protective underwear/pull-on, each",09-10-2025
T4535001003,"Disposable liner/shield/guard/pad/undergarment, for incontinence, each",09-10-2025
T4536001003,"Incontinence product, protective underwear/pull-on, reusable, any size, each",09-10-2025
T4537001003,"Incontinence product, protective underpad, reusable, bed size, each",09-10-2025
T4538001003,"Diaper service, reusable diaper, each diaper",09-10-2025
T4539001003,"Incontinence product, diaper/brief, reusable, any size, each",09-10-2025
T4540001003,"Incontinence product, protective underpad, reusable, chair size, each",09-10-2025
T4541001003,"Incontinence product, disposable underpad, large, each",09-10-2025
T4542001003,"Incontinence product, disposable underpad, small size, each",09-10-2025
T4543001003,"Adult sized disposable incontinence product, protective brief/diaper, above",09-10-2025
T4543002004,"Extra large, each",09-10-2025
T4544001003,"Adult sized disposable incontinence product, protective underwear/pull-on,",09-10-2025
T4544002004,"Above extra large, each",09-10-2025
T4545001003,"Incontinence product, disposable, penile wrap, each",09-10-2025
T5001001003,Positioning seat for persons with special orthopedic needs,09-10-2025
T5999001003,"Supply, not otherwise specified",09-10-2025
U0001001003,Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel,09-10-2025
U0002001003,"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple",09-10-2025
U0002002004,"Types or subtypes (includes all targets), non-cdc",09-10-2025
U0003001003,Infectious agent detection by nucleic acid (dna or rna); severe acute,09-10-2025
U0003002004,Respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease,09-10-2025
U0003003004,"[covid-19]), amplified probe technique, making use of high throughput",09-10-2025
U0003004004,Technologies as described by cms-2020-01-r,09-10-2025
U0004001003,"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple",09-10-2025
U0004002004,"Types or subtypes (includes all targets), non-cdc, making use of high",09-10-2025
U0004003004,Throughput technologies as described by cms-2020-01-r,09-10-2025
U0005001003,Infectious agent detection by nucleic acid (dna or rna); severe acute,09-10-2025
U0005002004,Respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease,09-10-2025
U0005003004,"[covid-19]), amplified probe technique, cdc or non-cdc, making use of high",09-10-2025
U0005004004,"Throughput technologies, completed within 2 calendar days from date of specimen",09-10-2025
U0005005004,Collection (list separately in addition to either hcpcs code u0003 or u0004) as,09-10-2025
U0005006004,Described by cms-2020-01-r2,09-10-2025
V2020001003,"Frames, purchases",09-10-2025
V2025001003,Deluxe frame,09-10-2025
V2100001003,"Sphere, single vision, plano to plus or minus 4.00, per lens",09-10-2025
V2101001003,"Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens",09-10-2025
V2102001003,"Sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens",09-10-2025
V2103001003,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to",09-10-2025
V2103002004,"2.00d cylinder, per lens",09-10-2025
V2104001003,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to",09-10-2025
V2104002004,"4.00d cylinder, per lens",09-10-2025
V2105001003,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to",09-10-2025
V2105002004,"6.00d cylinder, per lens",09-10-2025
V2106001003,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, over 6.00d",09-10-2025
V2106002004,"Cylinder, per lens",09-10-2025
V2107001003,"Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere,",09-10-2025
V2107002004,".12 to 2.00d cylinder, per lens",09-10-2025
V2108001003,"Spherocylinder, single vision, plus or minus 4.25d to plus or minus 7.00d",09-10-2025
V2108002004,"Sphere, 2.12 to 4.00d cylinder, per lens",09-10-2025
V2109001003,"Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00d",09-10-2025
V2109002004,"Sphere, 4.25 to 6.00d cylinder, per lens",09-10-2025
V2110001003,"Spherocylinder, single vision, plus or minus 4.25 to 7.00d sphere, over 6.00d",09-10-2025
V2110002004,"Cylinder, per lens",09-10-2025
V2111001003,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d",09-10-2025
V2111002004,"Sphere, .25 to 2.25d cylinder, per lens",09-10-2025
V2112001003,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d",09-10-2025
V2112002004,"Sphere, 2.25d to 4.00d cylinder, per lens",09-10-2025
V2113001003,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d",09-10-2025
V2113002004,"Sphere, 4.25 to 6.00d cylinder, per lens",09-10-2025
V2114001003,"Spherocylinder, single vision, sphere over plus or minus 12.00d, per lens",09-10-2025
V2115001003,"Lenticular, (myodisc), per lens, single vision",09-10-2025
V2118001003,"Aniseikonic lens, single vision",09-10-2025
V2121001003,"Lenticular lens, per lens, single",09-10-2025
V2199001003,"Not otherwise classified, single vision lens",09-10-2025
V2200001003,"Sphere, bifocal, plano to plus or minus 4.00d, per lens",09-10-2025
V2201001003,"Sphere, bifocal, plus or minus 4.12 to plus or minus 7.00d, per lens",09-10-2025
V2202001003,"Sphere, bifocal, plus or minus 7.12 to plus or minus 20.00d, per lens",09-10-2025
V2203001003,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d",09-10-2025
V2203002004,"Cylinder, per lens",09-10-2025
V2204001003,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 2.12 to 4.00d",09-10-2025
V2204002004,"Cylinder, per lens",09-10-2025
V2205001003,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00d",09-10-2025
V2205002004,"Cylinder, per lens",09-10-2025
V2206001003,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, over 6.00d",09-10-2025
V2206002004,"Cylinder, per lens",09-10-2025
V2207001003,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere,.12",09-10-2025
V2207002004,"To 2.00d cylinder, per lens",09-10-2025
V2208001003,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12",09-10-2025
V2208002004,"To 4.00d cylinder, per lens",09-10-2025
V2209001003,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25",09-10-2025
V2209002004,"To 6.00d cylinder, per lens",09-10-2025
V2210001003,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over",09-10-2025
V2210002004,"6.00d cylinder, per lens",09-10-2025
V2211001003,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25",09-10-2025
V2211002004,"To 2.25d cylinder, per lens",09-10-2025
V2212001003,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere,",09-10-2025
V2212002004,"2.25 to 4.00d cylinder, per lens",09-10-2025
V2213001003,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere,",09-10-2025
V2213002004,"4.25 to 6.00d cylinder, per lens",09-10-2025
V2214001003,"Spherocylinder, bifocal, sphere over plus or minus 12.00d, per lens",09-10-2025
V2215001003,"Lenticular (myodisc), per lens, bifocal",09-10-2025
V2218001003,"Aniseikonic, per lens, bifocal",09-10-2025
V2219001003,Bifocal seg width over 28 mm,09-10-2025
V2220001003,Bifocal add over 3.25d,09-10-2025
V2221001003,"Lenticular lens, per lens, bifocal",09-10-2025
V2299001003,Specialty bifocal (by report),09-10-2025
V2300001003,"Sphere, trifocal, plano to plus or minus 4.00d, per lens",09-10-2025
V2301001003,"Sphere, trifocal, plus or minus 4.12 to plus or minus 7.00d, per lens",09-10-2025
V2302001003,"Sphere, trifocal, plus or minus 7.12 to plus or minus 20.00, per lens",09-10-2025
V2303001003,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d",09-10-2025
V2303002004,"Cylinder, per lens",09-10-2025
V2304001003,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 2.25-4.00d",09-10-2025
V2304002004,"Cylinder, per lens",09-10-2025
V2305001003,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00",09-10-2025
V2305002004,"Cylinder, per lens",09-10-2025
V2306001003,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, over 6.00d",09-10-2025
V2306002004,"Cylinder, per lens",09-10-2025
V2307001003,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, .12",09-10-2025
V2307002004,"To 2.00d cylinder, per lens",09-10-2025
V2308001003,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere,",09-10-2025
V2308002004,"2.12 to 4.00d cylinder, per lens",09-10-2025
V2309001003,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere,",09-10-2025
V2309002004,"4.25 to 6.00d cylinder, per lens",09-10-2025
V2310001003,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere,",09-10-2025
V2310002004,"Over 6.00d cylinder, per lens",09-10-2025
V2311001003,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere,",09-10-2025
V2311002004,".25 to 2.25d cylinder, per lens",09-10-2025
V2312001003,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere,",09-10-2025
V2312002004,"2.25 to 4.00d cylinder, per lens",09-10-2025
V2313001003,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere,",09-10-2025
V2313002004,"4.25 to 6.00d cylinder, per lens",09-10-2025
V2314001003,"Spherocylinder, trifocal, sphere over plus or minus 12.00d, per lens",09-10-2025
V2315001003,"Lenticular, (myodisc), per lens, trifocal",09-10-2025
V2318001003,"Aniseikonic lens, trifocal",09-10-2025
V2319001003,Trifocal seg width over 28 mm,09-10-2025
V2320001003,Trifocal add over 3.25d,09-10-2025
V2321001003,"Lenticular lens, per lens, trifocal",09-10-2025
V2399001003,Specialty trifocal (by report),09-10-2025
V2410001003,"Variable asphericity lens, single vision, full field, glass or plastic, per len",09-10-2025
V2430001003,"Variable asphericity lens, bifocal, full field, glass or plastic, per lens",09-10-2025
V2499001003,"Variable sphericity lens, other type",09-10-2025
V2500001003,"Contact lens, pmma, spherical, per lens",09-10-2025
V2501001003,"Contact lens, pmma, toric or prism ballast, per lens",09-10-2025
V2502001003,"Contact lens, pmma, bifocal, per lens",09-10-2025
V2503001003,"Contact lens, pmma, color vision deficiency, per lens",09-10-2025
V2510001003,"Contact lens, gas permeable, spherical, per lens",09-10-2025
V2511001003,"Contact lens, gas permeable, toric, prism ballast, per lens",09-10-2025
V2512001003,"Contact lens, gas permeable, bifocal, per lens",09-10-2025
V2513001003,"Contact lens, gas permeable, extended wear, per lens",09-10-2025
V2520001003,"Contact lens, hydrophilic, spherical, per lens",09-10-2025
V2521001003,"Contact lens, hydrophilic, toric, or prism ballast, per lens",09-10-2025
V2522001003,"Contact lens, hydrophilic, bifocal, per lens",09-10-2025
V2523001003,"Contact lens, hydrophilic, extended wear, per lens",09-10-2025
V2524001003,"Contact lens, hydrophilic, spherical, photochromic additive, per lens",09-10-2025
V2525001003,"Contact lens, hydrophilic, dual focus, per lens",09-10-2025
V2526001003,"Contact lens, hydrophilic, with blue-violet filter, per lens",09-10-2025
V2530001003,"Contact lens, scleral, gas impermeable, per lens (for contact lens",09-10-2025
V2530002004,"Modification, see 92325)",09-10-2025
V2531001003,"Contact lens, scleral, gas permeable, per lens (for contact lens modification,",09-10-2025
V2531002004,See 92325),09-10-2025
V2599001003,"Contact lens, other type",09-10-2025
V2600001003,Hand held low vision aids and other nonspectacle mounted aids,09-10-2025
V2610001003,Single lens spectacle mounted low vision aids,09-10-2025
V2615001003,"Telescopic and other compound lens system, including distance vision",09-10-2025
V2615002004,"Telescopic, near vision telescopes and compound microscopic lens system",09-10-2025
V2623001003,"Prosthetic eye, plastic, custom",09-10-2025
V2624001003,Polishing/resurfacing of ocular prosthesis,09-10-2025
V2625001003,Enlargement of ocular prosthesis,09-10-2025
V2626001003,Reduction of ocular prosthesis,09-10-2025
V2627001003,Scleral cover shell,09-10-2025
V2628001003,Fabrication and fitting of ocular conformer,09-10-2025
V2629001003,"Prosthetic eye, other type",09-10-2025
V2630001003,Anterior chamber intraocular lens,09-10-2025
V2631001003,Iris supported intraocular lens,09-10-2025
V2632001003,Posterior chamber intraocular lens,09-10-2025
V2700001003,"Balance lens, per lens",09-10-2025
V2702001003,Deluxe lens feature,09-10-2025
V2710001003,"Slab off prism, glass or plastic, per lens",09-10-2025
V2715001003,"Prism, per lens",09-10-2025
V2718001003,"Press-on lens, fresnell prism, per lens",09-10-2025
V2730001003,"Special base curve, glass or plastic, per lens",09-10-2025
V2744001003,"Tint, photochromatic, per lens",09-10-2025
V2745001003,"Addition to lens; tint, any color, solid, gradient or equal, excludes",09-10-2025
V2745002004,"Photochromatic, any lens material, per lens",09-10-2025
V2750001003,"Anti-reflective coating, per lens",09-10-2025
V2755001003,"U-v lens, per lens",09-10-2025
V2756001003,Eye glass case,09-10-2025
V2760001003,"Scratch resistant coating, per lens",09-10-2025
V2761001003,"Mirror coating, any type, solid, gradient or equal, any lens material, per lens",09-10-2025
V2762001003,"Polarization, any lens material, per lens",09-10-2025
V2770001003,"Occluder lens, per lens",09-10-2025
V2780001003,"Oversize lens, per lens",09-10-2025
V2781001003,"Progressive lens, per lens",09-10-2025
V2782001003,"Lens, index 1.54 to 1.65 plastic or 1.60 to 1.79 glass, excludes polycarbonate,",09-10-2025
V2782002004,Per lens,09-10-2025
V2783001003,"Lens, index greater than or equal to 1.66 plastic or greater than or equal to",09-10-2025
V2783002004,"1.80 glass, excludes polycarbonate, per lens",09-10-2025
V2784001003,"Lens, polycarbonate or equal, any index, per lens",09-10-2025
V2785001003,"Processing, preserving and transporting corneal tissue",09-10-2025
V2786001003,"Specialty occupational multifocal lens, per lens",09-10-2025
V2787001003,Astigmatism correcting function of intraocular lens,09-10-2025
V2788001003,Presbyopia correcting function of intraocular lens,09-10-2025
V2790001003,"Amniotic membrane for surgical reconstruction, per procedure",09-10-2025
V2797001003,"Vision supply, accessory and/or service component of another hcpcs vision code",09-10-2025
V2799001003,"Vision item or service, miscellaneous",09-10-2025
V5008001003,Hearing screening,09-10-2025
V5010001003,Assessment for hearing aid,09-10-2025
V5011001003,Fitting/orientation/checking of hearing aid,09-10-2025
V5014001003,Repair/modification of a hearing aid,09-10-2025
V5020001003,Conformity evaluation,09-10-2025
V5030001003,"Hearing aid, monaural, body worn, air conduction",09-10-2025
V5040001003,"Hearing aid, monaural, body worn, bone conduction",09-10-2025
V5050001003,"Hearing aid, monaural, in the ear",09-10-2025
V5060001003,"Hearing aid, monaural, behind the ear",09-10-2025
V5070001003,"Glasses, air conduction",09-10-2025
V5080001003,"Glasses, bone conduction",09-10-2025
V5090001003,"Dispensing fee, unspecified hearing aid",09-10-2025
V5095001003,Semi-implantable middle ear hearing prosthesis,09-10-2025
V5100001003,"Hearing aid, bilateral, body worn",09-10-2025
V5110001003,"Dispensing fee, bilateral",09-10-2025
V5120001003,"Binaural, body",09-10-2025
V5130001003,"Binaural, in the ear",09-10-2025
V5140001003,"Binaural, behind the ear",09-10-2025
V5150001003,"Binaural, glasses",09-10-2025
V5160001003,"Dispensing fee, binaural",09-10-2025
V5170001003,"Hearing aid, cros, in the ear",09-10-2025
V5171001003,"Hearing aid, contralateral routing device, monaural, in the ear (ite)",09-10-2025
V5172001003,"Hearing aid, contralateral routing device, monaural, in the canal (itc)",09-10-2025
V5180001003,"Hearing aid, cros, behind the ear",09-10-2025
V5181001003,"Hearing aid, contralateral routing device, monaural, behind the ear (bte)",09-10-2025
V5190001003,"Hearing aid, contralateral routing, monaural, glasses",09-10-2025
V5200001003,"Dispensing fee, contralateral, monaural",09-10-2025
V5210001003,"Hearing aid, bicros, in the ear",09-10-2025
V5211001003,"Hearing aid, contralateral routing system, binaural, ite/ite",09-10-2025
V5212001003,"Hearing aid, contralateral routing system, binaural, ite/itc",09-10-2025
V5213001003,"Hearing aid, contralateral routing system, binaural, ite/bte",09-10-2025
V5214001003,"Hearing aid, contralateral routing system, binaural, itc/itc",09-10-2025
V5215001003,"Hearing aid, contralateral routing system, binaural, itc/bte",09-10-2025
V5220001003,"Hearing aid, bicros, behind the ear",09-10-2025
V5221001003,"Hearing aid, contralateral routing system, binaural, bte/bte",09-10-2025
V5230001003,"Hearing aid, contralateral routing system, binaural, glasses",09-10-2025
V5240001003,"Dispensing fee, contralateral routing system, binaural",09-10-2025
V5241001003,"Dispensing fee, monaural hearing aid, any type",09-10-2025
V5242001003,"Hearing aid, analog, monaural, cic (completely in the ear canal)",09-10-2025
V5243001003,"Hearing aid, analog, monaural, itc (in the canal)",09-10-2025
V5244001003,"Hearing aid, digitally programmable analog, monaural, cic",09-10-2025
V5245001003,"Hearing aid, digitally programmable, analog, monaural, itc",09-10-2025
V5246001003,"Hearing aid, digitally programmable analog, monaural, ite (in the ear)",09-10-2025
V5247001003,"Hearing aid, digitally programmable analog, monaural, bte (behind the ear)",09-10-2025
V5248001003,"Hearing aid, analog, binaural, cic",09-10-2025
V5249001003,"Hearing aid, analog, binaural, itc",09-10-2025
V5250001003,"Hearing aid, digitally programmable analog, binaural, cic",09-10-2025
V5251001003,"Hearing aid, digitally programmable analog, binaural, itc",09-10-2025
V5252001003,"Hearing aid, digitally programmable, binaural, ite",09-10-2025
V5253001003,"Hearing aid, digitally programmable, binaural, bte",09-10-2025
V5254001003,"Hearing aid, digital, monaural, cic",09-10-2025
V5255001003,"Hearing aid, digital, monaural, itc",09-10-2025
V5256001003,"Hearing aid, digital, monaural, ite",09-10-2025
V5257001003,"Hearing aid, digital, monaural, bte",09-10-2025
V5258001003,"Hearing aid, digital, binaural, cic",09-10-2025
V5259001003,"Hearing aid, digital, binaural, itc",09-10-2025
V5260001003,"Hearing aid, digital, binaural, ite",09-10-2025
V5261001003,"Hearing aid, digital, binaural, bte",09-10-2025
V5262001003,"Hearing aid, disposable, any type, monaural",09-10-2025
V5263001003,"Hearing aid, disposable, any type, binaural",09-10-2025
V5264001003,"Ear mold/insert, not disposable, any type",09-10-2025
V5265001003,"Ear mold/insert, disposable, any type",09-10-2025
V5266001003,Battery for use in hearing device,09-10-2025
V5267001003,"Hearing aid or assistive listening device/supplies/accessories, not otherwise",09-10-2025
V5267002004,Specified,09-10-2025
V5268001003,"Assistive listening device, telephone amplifier, any type",09-10-2025
V5269001003,"Assistive listening device, alerting, any type",09-10-2025
V5270001003,"Assistive listening device, television amplifier, any type",09-10-2025
V5271001003,"Assistive listening device, television caption decoder",09-10-2025
V5272001003,"Assistive listening device, tdd",09-10-2025
V5273001003,"Assistive listening device, for use with cochlear implant",09-10-2025
V5274001003,"Assistive listening device, not otherwise specified",09-10-2025
V5275001003,"Ear impression, each",09-10-2025
V5281001003,"Assistive listening device, personal fm/dm system, monaural, (1 receiver,",09-10-2025
V5281002004,"Transmitter, microphone), any type",09-10-2025
V5282001003,"Assistive listening device, personal fm/dm system, binaural, (2 receivers,",09-10-2025
V5282002004,"Transmitter, microphone), any type",09-10-2025
V5283001003,"Assistive listening device, personal fm/dm neck, loop induction receiver",09-10-2025
V5284001003,"Assistive listening device, personal fm/dm, ear level receiver",09-10-2025
V5285001003,"Assistive listening device, personal fm/dm, direct audio input receiver",09-10-2025
V5286001003,"Assistive listening device, personal blue tooth fm/dm receiver",09-10-2025
V5287001003,"Assistive listening device, personal fm/dm receiver, not otherwise specified",09-10-2025
V5288001003,"Assistive listening device, personal fm/dm transmitter assistive listening",09-10-2025
V5288002004,Device,09-10-2025
V5289001003,"Assistive listening device, personal fm/dm adapter/boot coupling device for",09-10-2025
V5289002004,"Receiver, any type",09-10-2025
V5290001003,"Assistive listening device, transmitter microphone, any type",09-10-2025
V5298001003,"Hearing aid, not otherwise classified",09-10-2025
V5299001003,"Hearing service, miscellaneous",09-10-2025
V5336001003,Repair/modification of augmentative communicative system or device (excludes,09-10-2025
V5336002004,Adaptive hearing aid),09-10-2025
V5362001003,Speech screening,09-10-2025
V5363001003,Language screening,09-10-2025
V5364001003,Dysphagia screening,09-10-2025
